Citrus Sinensis ID: 018744
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.874 | 0.741 | 0.503 | 5e-82 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.817 | 0.629 | 0.523 | 5e-82 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.803 | 0.379 | 0.510 | 7e-81 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.840 | 0.598 | 0.474 | 2e-78 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.883 | 0.732 | 0.482 | 4e-78 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.846 | 0.763 | 0.471 | 7e-78 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.811 | 0.695 | 0.488 | 6e-77 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.803 | 0.392 | 0.5 | 6e-77 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.820 | 0.422 | 0.496 | 9e-77 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.823 | 0.408 | 0.483 | 4e-76 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 304 bits (779), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 157/312 (50%), Positives = 210/312 (67%), Gaps = 5/312 (1%)
Query: 9 VDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRK 67
V+ + K EVT + Q F+F++L +AT F + ++G GGFG VY+G L G
Sbjct: 45 VNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMI 104
Query: 68 VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEH 126
VA+K +D+ G QG EF +EV +L L +L+ L+GYC+D ++LLVY+YM+ G L++H
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 127 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186
L LDW+TR+RIAL AA GLE+LH+ +PPVI+RD K++NILLD F+AK
Sbjct: 165 LLDLTPDQI---PLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAK 221
Query: 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
+SDFGLAK+G HVS+RV+GT GY APEY TG LTTKSDVYS+GVVLLEL+TGR
Sbjct: 222 LSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRR 281
Query: 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEAD 306
ID +P E LV+WA P + + E+ DP+LEG + K + Q A+AAMC+Q EA
Sbjct: 282 VIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEAT 341
Query: 307 YRPLMADVVQSL 318
RPLM+DVV +L
Sbjct: 342 VRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 153/292 (52%), Positives = 201/292 (68%), Gaps = 5/292 (1%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKME 87
F F++L +AT F +G GGFG VY+G L S G+ VA+K +D+ G QG EF +E
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 88 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
V +L L P L+ L+GYC+D ++LLVY++M G L++HL+ LDW R+
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNMRM 188
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IA AAKGLEFLH+ +PPVI+RDFKSSNILLD+ FH K+SDFGLAK+G HVST
Sbjct: 189 KIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVST 248
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GY APEYA+TG LT KSDVYS+GVV LEL+TGR ID P GE LV+WA P
Sbjct: 249 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
DR K +++ DP L+G++ + + Q A+A+MC+Q +A RPL+ADVV +L
Sbjct: 309 FNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (770), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 149/292 (51%), Positives = 206/292 (70%), Gaps = 10/292 (3%)
Query: 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME 87
++ FT +L AT FS V+G GGFG VY+G + +G +VA+KL+ + + + EF E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393
Query: 88 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
VE+L RL L+ L+G C + R + L+Y+ + NG ++ HL+ LDW+ RL
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--------EGTLDWDARL 445
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IAL AA+GL +LHE +P VIHRDFK+SN+LL+ +F KVSDFGLA+ ++ H+ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE-GSQHIST 504
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSGE LV+WA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
L +RE + +++DPAL G Y+ ++ +VAAIA+MCV E +RP M +VVQ+L
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 148/312 (47%), Positives = 202/312 (64%), Gaps = 17/312 (5%)
Query: 21 EVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS----------NGRKVAI 70
E+ + L+ FTF L +T F +++G GGFG V++G + G VA+
Sbjct: 120 ELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 179
Query: 71 KLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYP 129
K ++ G QG E+ E+ LG L P L+ L+GYC D ++LLVY++M G L+ HL+
Sbjct: 180 KTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF- 238
Query: 130 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189
+ L W R++IAL AAKGL FLHE PVI+RDFK+SNILLD +++AK+SD
Sbjct: 239 -----RRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293
Query: 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
FGLAK D+ HVSTRV+GT GY APEY +TGHLT+KSDVYS+GVVLLE+LTGR +D
Sbjct: 294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353
Query: 250 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
N+P+GE LV WA P L D+ + ++DP LEG +S+K +V +AA C+ + RP
Sbjct: 354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413
Query: 310 LMADVVQSLVPL 321
M+DVV++L PL
Sbjct: 414 KMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 154/319 (48%), Positives = 211/319 (66%), Gaps = 9/319 (2%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKME 87
Q FTF++L ATG F +G GGFG V++G + + VAIK +D+ G QG EF +E
Sbjct: 89 QTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVE 148
Query: 88 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
V L P L+ L+G+C++ ++LLVY+YM G L++HL+ S LDW TR+
Sbjct: 149 VLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLP---SGKKPLDWNTRM 205
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IA AA+GLE+LH+ +PPVI+RD K SNILL +++ K+SDFGLAK+G HVST
Sbjct: 206 KIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVST 265
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GY AP+YA+TG LT KSD+YS+GVVLLEL+TGR ID K + LV WA P
Sbjct: 266 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPL 325
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV--KY 324
DR +++DP L+GQY ++ + Q AI+AMCVQ + RP+++DVV +L L KY
Sbjct: 326 FKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKY 385
Query: 325 NRSTPKISS--SPSFHASR 341
+ ++P SS +PSFH R
Sbjct: 386 DPNSPSSSSGKNPSFHRDR 404
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 147/312 (47%), Positives = 205/312 (65%), Gaps = 15/312 (4%)
Query: 21 EVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS----------NGRKVAI 70
E+ + L+ F+ +L SAT F +VVG GGFG V++G + G +A+
Sbjct: 46 EILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAV 105
Query: 71 KLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYP 129
K ++Q G QG E+ E+ LG+L P L+ L+GYC + +LLVY++M G L+ HL+
Sbjct: 106 KRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFR 165
Query: 130 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189
+ L W TR+R+AL AA+GL FLH + P VI+RDFK+SNILLD N++AK+SD
Sbjct: 166 ---RGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSD 221
Query: 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
FGLA+ G HVSTRV+GTQGY APEY TGHL+ KSDVYS+GVVLLELL+GR ID
Sbjct: 222 FGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAID 281
Query: 250 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
N+P GE LV WA P LT++ ++L +MDP L+GQYS+ +++A +A C+ +A RP
Sbjct: 282 KNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRP 341
Query: 310 LMADVVQSLVPL 321
M ++V+++ L
Sbjct: 342 TMNEIVKTMEEL 353
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 146/299 (48%), Positives = 197/299 (65%), Gaps = 14/299 (4%)
Query: 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKV-------AIKLMDQAGKQGEDE 83
FT +L + T F ++G GGFG VY+G + + +V A+K++++ G QG E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 84 FKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW 142
+ EV LG+LR P L+ L+GYC D +LLVY++M G L+ HL+ + L W
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF-----RKTTAPLSW 171
Query: 143 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202
R+ IAL AAKGL FLH + PVI+RDFK+SNILLD ++ AK+SDFGLAK G
Sbjct: 172 SRRMMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 230
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262
HVSTRV+GT GY APEY +TGHLT +SDVYS+GVVLLE+LTGR +D +PS E LV W
Sbjct: 231 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDW 290
Query: 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321
A P+L D+ K+L+I+DP LE QYS++ + ++A C+ RPLM+DVV++L PL
Sbjct: 291 ARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 287 bits (735), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 146/292 (50%), Positives = 199/292 (68%), Gaps = 10/292 (3%)
Query: 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL 90
FT+++L T GF KS VVG GGFG VY+G+L G+ VAIK + +G EFK EVE+
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 91 LGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 149
+ R+ +L++L+GYC S++ + L+Y+++ N L HL+ N L+W R+RIA
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKN-----LPVLEWSRRVRIA 472
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209
+ AAKGL +LHE C P +IHRD KSSNILLD F A+V+DFGLA++ +D A H+STRV+
Sbjct: 473 IGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARL-NDTAQSHISTRVM 531
Query: 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-- 267
GT GY+APEYA +G LT +SDV+S+GVVLLEL+TGR P+D ++P GE LV WA PRL
Sbjct: 532 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIE 591
Query: 268 -TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
++ I E++DP LE Y EV ++ AA CV+ A RP M VV++L
Sbjct: 592 AIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 9e-77, Method: Compositional matrix adjust.
Identities = 148/298 (49%), Positives = 203/298 (68%), Gaps = 10/298 (3%)
Query: 26 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK 85
N F++ +L T GFS+ N++G GGFG VY+GVLS+GR+VA+K + G QGE EFK
Sbjct: 322 NQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381
Query: 86 MEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET 144
EVE++ R+ +L+ L+GYC S++ +LLVYDY+ N L HL+ A G + WET
Sbjct: 382 AEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH-APGR----PVMTWET 436
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-KAGGH 203
R+R+A AA+G+ +LHE C P +IHRD KSSNILLD +F A V+DFGLAKI + H
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263
VSTRV+GT GY+APEYA +G L+ K+DVYSYGV+LLEL+TGR P+D ++P G+ LV WA
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWA 556
Query: 264 LPRL---TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
P L + E+ E++DP L + E+ ++ AA CV+ A RP M+ VV++L
Sbjct: 557 RPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 145/300 (48%), Positives = 204/300 (68%), Gaps = 11/300 (3%)
Query: 26 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK 85
N +F++++L AT GFS+ N++G GGFG VY+G+L +GR VA+K + G QG+ EFK
Sbjct: 360 NSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFK 419
Query: 86 MEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET 144
EVE L R+ +L++++G+C S R+LL+YDY++N L HL+ G SV LDW T
Sbjct: 420 AEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLH---GEKSV---LDWAT 473
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 204
R++IA AA+GL +LHE C P +IHRD KSSNILL+ NF A+VSDFGLA++ D H+
Sbjct: 474 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALD-CNTHI 532
Query: 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264
+TRV+GT GY+APEYA +G LT KSDV+S+GVVLLEL+TGR P+D ++P G+ LV WA
Sbjct: 533 TTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWAR 592
Query: 265 PRLT---DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321
P ++ + E+ + DP L G Y E+ ++ A CV+ A RP M +V++ L
Sbjct: 593 PLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| 225446643 | 398 | PREDICTED: serine/threonine-protein kina | 0.954 | 0.841 | 0.845 | 1e-166 | |
| 297817182 | 400 | kinase family protein [Arabidopsis lyrat | 0.965 | 0.847 | 0.809 | 1e-159 | |
| 255558744 | 397 | Serine/threonine-protein kinase PBS1, pu | 0.948 | 0.838 | 0.821 | 1e-159 | |
| 42566031 | 400 | protein kinase family protein [Arabidops | 0.965 | 0.847 | 0.803 | 1e-158 | |
| 224128764 | 382 | predicted protein [Populus trichocarpa] | 0.925 | 0.850 | 0.834 | 1e-157 | |
| 312283495 | 400 | unnamed protein product [Thellungiella h | 0.960 | 0.842 | 0.799 | 1e-157 | |
| 7630064 | 386 | serine/threonine-specific protein kinase | 0.968 | 0.880 | 0.795 | 1e-157 | |
| 255636997 | 396 | unknown [Glycine max] | 0.965 | 0.856 | 0.793 | 1e-156 | |
| 363808298 | 396 | uncharacterized protein LOC100804893 [Gl | 0.925 | 0.820 | 0.801 | 1e-155 | |
| 358248154 | 382 | serine/threonine-protein kinase PBS1-lik | 0.923 | 0.848 | 0.821 | 1e-154 |
| >gi|225446643|ref|XP_002281166.1| PREDICTED: serine/threonine-protein kinase PBS1 isoform 1 [Vitis vinifera] gi|302143438|emb|CBI21999.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-166, Method: Compositional matrix adjust.
Identities = 284/336 (84%), Positives = 311/336 (92%), Gaps = 1/336 (0%)
Query: 9 VDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKV 68
+D E+KG L+V T+ GLQVFTFKQLHSATGGF KSNVVGHGGFGLVYRGVL +GRKV
Sbjct: 53 IDYEDKGGFANLQVATEKGLQVFTFKQLHSATGGFGKSNVVGHGGFGLVYRGVLHDGRKV 112
Query: 69 AIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHL 127
A+KLMD+AGKQGE+EFK+EVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHL
Sbjct: 113 AVKLMDRAGKQGEEEFKVEVELLSRLRSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHL 172
Query: 128 YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187
YP +GSNSV+S+LDWETRLRIAL+AAKGLE+LHEH SPPVIHRDFKSSNILLDKNFHAKV
Sbjct: 173 YPISGSNSVSSRLDWETRLRIALDAAKGLEYLHEHVSPPVIHRDFKSSNILLDKNFHAKV 232
Query: 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
SDFGLAK+GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP
Sbjct: 233 SDFGLAKLGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 292
Query: 248 IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADY 307
+D+ + SGEGVLVSWALP LTDREK+++IMDPALEGQYSMKEVIQVAAIA MCVQPEADY
Sbjct: 293 VDMKRASGEGVLVSWALPHLTDREKVVQIMDPALEGQYSMKEVIQVAAIATMCVQPEADY 352
Query: 308 RPLMADVVQSLVPLVKYNRSTPKISSSPSFHASRSP 343
RPLMADVVQSLVPLVK +R T K+ S SFHA++SP
Sbjct: 353 RPLMADVVQSLVPLVKNHRPTSKVGSCSSFHATKSP 388
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817182|ref|XP_002876474.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297322312|gb|EFH52733.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1462), Expect = e-159, Method: Compositional matrix adjust.
Identities = 276/341 (80%), Positives = 303/341 (88%), Gaps = 2/341 (0%)
Query: 10 DREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVA 69
D EEKG+ K++ TDNGLQ+FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL++GRKVA
Sbjct: 54 DCEEKGDCQKVQDVTDNGLQIFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLNDGRKVA 113
Query: 70 IKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLY 128
IK MD AGKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY
Sbjct: 114 IKFMDHAGKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLY 173
Query: 129 PANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188
N S SV +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVS
Sbjct: 174 RTNRSGSVPVRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVS 233
Query: 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
DFGLAK+GSDKAGGHVSTRVL TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+
Sbjct: 234 DFGLAKVGSDKAGGHVSTRVLSTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPV 293
Query: 249 DVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 308
D+ + SGEGVLVSWALP+L DREK+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYR
Sbjct: 294 DMKRASGEGVLVSWALPQLADREKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYR 353
Query: 309 PLMADVVQSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 348
PLMADVVQSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 354 PLMADVVQSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558744|ref|XP_002520396.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223540443|gb|EEF42012.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1460), Expect = e-159, Method: Compositional matrix adjust.
Identities = 277/337 (82%), Positives = 303/337 (89%), Gaps = 4/337 (1%)
Query: 12 EEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIK 71
EEKG L+V T+ GLQVFTFKQL+SATGGFSKSNVVGHGGFG VYRGVL++GRKVA+K
Sbjct: 58 EEKGNFENLQVATEKGLQVFTFKQLYSATGGFSKSNVVGHGGFGSVYRGVLNDGRKVAVK 117
Query: 72 LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPA 130
LMDQ GKQGE+EFK+EVELL LRSPYLLAL+G+CSD KLLVYD+M NGGLQEHLYP
Sbjct: 118 LMDQGGKQGEEEFKVEVELLSHLRSPYLLALIGFCSDSNHKLLVYDFMENGGLQEHLYP- 176
Query: 131 NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190
++++ +LDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILLDK FHAKVSDF
Sbjct: 177 --TSAMHLRLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLDKYFHAKVSDF 234
Query: 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
GLAK+G DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+
Sbjct: 235 GLAKLGPDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDM 294
Query: 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 310
+P GEGVLVSW LPRLTDREK+++IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL
Sbjct: 295 KRPPGEGVLVSWVLPRLTDREKVVQIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 354
Query: 311 MADVVQSLVPLVKYNRSTPKISSSPSFHASRSPAFPD 347
MADVVQSLVPLVK RST K+ S SF+A RSPA D
Sbjct: 355 MADVVQSLVPLVKTQRSTSKLGSYSSFNALRSPASQD 391
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566031|ref|NP_191428.3| protein kinase family protein [Arabidopsis thaliana] gi|332646297|gb|AEE79818.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-158, Method: Compositional matrix adjust.
Identities = 274/341 (80%), Positives = 305/341 (89%), Gaps = 2/341 (0%)
Query: 10 DREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVA 69
D EEKG+ K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKVA
Sbjct: 54 DCEEKGDCQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVA 113
Query: 70 IKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLY 128
IKLMD AGKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY
Sbjct: 114 IKLMDHAGKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLY 173
Query: 129 PANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188
N S SV +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVS
Sbjct: 174 LPNRSGSVPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVS 233
Query: 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
DFGLAK+GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+
Sbjct: 234 DFGLAKVGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPV 293
Query: 249 DVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 308
D+ + +GEGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYR
Sbjct: 294 DMKRATGEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYR 353
Query: 309 PLMADVVQSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 348
PLMADVVQSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 354 PLMADVVQSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128764|ref|XP_002320416.1| predicted protein [Populus trichocarpa] gi|222861189|gb|EEE98731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1443), Expect = e-157, Method: Compositional matrix adjust.
Identities = 272/326 (83%), Positives = 294/326 (90%), Gaps = 1/326 (0%)
Query: 12 EEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIK 71
E+KG LEV GL VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS+GRKVAIK
Sbjct: 57 EDKGCFTDLEVVAGKGLNVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSDGRKVAIK 116
Query: 72 LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDYMANGGLQEHLYPA 130
LMDQAGKQGEDEFK+EVELL L SPYLLALLGYCS D K+LVY++M NGGLQEHL+
Sbjct: 117 LMDQAGKQGEDEFKVEVELLSHLHSPYLLALLGYCSGDNHKVLVYEFMPNGGLQEHLHRI 176
Query: 131 NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190
SN+V+ LDWETRLRIALEAAKGLE+LHEH +PPVIHRDFKSSNILLD+N HAKVSDF
Sbjct: 177 TSSNTVSISLDWETRLRIALEAAKGLEYLHEHVNPPVIHRDFKSSNILLDRNLHAKVSDF 236
Query: 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
GLAK+G DKAGGHVSTRVLGTQGY+APEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+
Sbjct: 237 GLAKLGPDKAGGHVSTRVLGTQGYIAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDI 296
Query: 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 310
+P+GEGVLVSWALPRLTDREK++EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL
Sbjct: 297 KRPAGEGVLVSWALPRLTDREKVVEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 356
Query: 311 MADVVQSLVPLVKYNRSTPKISSSPS 336
MADVVQSLVPLVK RST K+ S +
Sbjct: 357 MADVVQSLVPLVKTQRSTSKVGSCSN 382
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312283495|dbj|BAJ34613.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-157, Method: Compositional matrix adjust.
Identities = 271/339 (79%), Positives = 301/339 (88%), Gaps = 2/339 (0%)
Query: 12 EEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIK 71
EEKG+ +E T+NGLQ+F FKQLHSATGGFSKSNVVGHGGFGLVYRGVL++GRKVAIK
Sbjct: 56 EEKGDCQIVEDVTENGLQIFNFKQLHSATGGFSKSNVVGHGGFGLVYRGVLNDGRKVAIK 115
Query: 72 LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPA 130
MD GKQGEDEFK+EVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLYP
Sbjct: 116 FMDNTGKQGEDEFKIEVELLSRLRSPYLLALLGYCSDNNHKLLVYEFMANGGLQEHLYPN 175
Query: 131 NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190
+ S SV +LDWE R+RIALEAAKGLE+LHE+ SPPVIHRDFKSSNILLD+NFHAKVSDF
Sbjct: 176 SRSGSVPPRLDWEIRMRIALEAAKGLEYLHENVSPPVIHRDFKSSNILLDRNFHAKVSDF 235
Query: 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
GLAK+GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG+VLLELLTGRVP+D+
Sbjct: 236 GLAKVGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGIVLLELLTGRVPVDM 295
Query: 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 310
+ +GEGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPL
Sbjct: 296 KRANGEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPL 355
Query: 311 MADVVQSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 348
MADVVQSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 356 MADVVQSLVPLVRSRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7630064|emb|CAB88286.1| serine/threonine-specific protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-157, Method: Compositional matrix adjust.
Identities = 272/342 (79%), Positives = 305/342 (89%), Gaps = 2/342 (0%)
Query: 9 VDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKV 68
+ +EKG+ K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKV
Sbjct: 39 IRNKEKGDCQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKV 98
Query: 69 AIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHL 127
AIKLMD AGKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHL
Sbjct: 99 AIKLMDHAGKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHL 158
Query: 128 YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187
Y N S SV +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKV
Sbjct: 159 YLPNRSGSVPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKV 218
Query: 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
SDFGLAK+GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP
Sbjct: 219 SDFGLAKVGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 278
Query: 248 IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADY 307
+D+ + +GEGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADY
Sbjct: 279 VDMKRATGEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADY 338
Query: 308 RPLMADVVQSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 348
RPLMADVVQSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 339 RPLMADVVQSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255636997|gb|ACU18831.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-156, Method: Compositional matrix adjust.
Identities = 272/343 (79%), Positives = 299/343 (87%), Gaps = 4/343 (1%)
Query: 7 EGVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGR 66
E + EK + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GR
Sbjct: 54 EDANLNEKSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGR 113
Query: 67 KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQE 125
KVAIK MDQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQE
Sbjct: 114 KVAIKFMDQAGKQGEEEFKVEVELLTRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQE 173
Query: 126 HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185
HLYP + S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILL K FHA
Sbjct: 174 HLYPVSNSIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLGKKFHA 233
Query: 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
KVSDFGLAK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR
Sbjct: 234 KVSDFGLAKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 293
Query: 246 VPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEA 305
VP+D+ +P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAA+CVQPEA
Sbjct: 294 VPVDMKRPPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAICVQPEA 353
Query: 306 DYRPLMADVVQSLVPLVKYNRSTPKISSSPSFHA---SRSPAF 345
DYRPLMADVVQSLVPLVK RS K+ S SF++ S P F
Sbjct: 354 DYRPLMADVVQSLVPLVKTQRSPSKVGSCSSFNSPKLSPGPTF 396
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808298|ref|NP_001241988.1| uncharacterized protein LOC100804893 [Glycine max] gi|255639199|gb|ACU19898.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1429), Expect = e-155, Method: Compositional matrix adjust.
Identities = 270/337 (80%), Positives = 296/337 (87%), Gaps = 12/337 (3%)
Query: 13 EKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKL 72
EK + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GRKVAIK
Sbjct: 60 EKSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGRKVAIKF 119
Query: 73 MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPAN 131
MDQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQEHLYP +
Sbjct: 120 MDQAGKQGEEEFKVEVELLSRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHLYPVS 179
Query: 132 GSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191
S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILLDK FHAKVSDFG
Sbjct: 180 NSIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLDKKFHAKVSDFG 239
Query: 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251
LAK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+
Sbjct: 240 LAKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMK 299
Query: 252 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 311
+P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAAMCVQPEADYRPLM
Sbjct: 300 RPPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAMCVQPEADYRPLM 359
Query: 312 ADVVQSLVPLVKYNR-----------STPKISSSPSF 337
ADVVQSLVPLVK R ++PK+S P+F
Sbjct: 360 ADVVQSLVPLVKTQRSPSKVGSSSSFNSPKLSPGPTF 396
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248154|ref|NP_001240082.1| serine/threonine-protein kinase PBS1-like [Glycine max] gi|223452402|gb|ACM89528.1| serine/threonine-specific protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 267/325 (82%), Positives = 290/325 (89%), Gaps = 1/325 (0%)
Query: 7 EGVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGR 66
E + EK + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GR
Sbjct: 54 EDANLNEKSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGR 113
Query: 67 KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQE 125
KVAIK MDQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQE
Sbjct: 114 KVAIKFMDQAGKQGEEEFKVEVELLTRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQE 173
Query: 126 HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185
HLYP + S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILL K FHA
Sbjct: 174 HLYPVSNSIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLGKKFHA 233
Query: 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
KVSDFGLAK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR
Sbjct: 234 KVSDFGLAKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 293
Query: 246 VPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEA 305
VP+D+ +P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAAMCVQPEA
Sbjct: 294 VPVDMKRPPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAMCVQPEA 353
Query: 306 DYRPLMADVVQSLVPLVKYNRSTPK 330
DYRPLMADVVQSLVPLVK RS K
Sbjct: 354 DYRPLMADVVQSLVPLVKTQRSPSK 378
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.917 | 0.805 | 0.820 | 1.1e-140 | |
| TAIR|locus:2010965 | 458 | AT1G54820 [Arabidopsis thalian | 0.851 | 0.652 | 0.596 | 3.4e-93 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.809 | 0.391 | 0.534 | 2e-79 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.817 | 0.257 | 0.537 | 1.2e-77 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.829 | 0.748 | 0.526 | 5.5e-77 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.857 | 0.779 | 0.508 | 1.1e-76 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.811 | 0.625 | 0.527 | 5e-76 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.874 | 0.741 | 0.503 | 1.3e-75 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.817 | 0.759 | 0.527 | 2.7e-75 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.817 | 0.385 | 0.511 | 9.3e-75 |
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
Identities = 265/323 (82%), Positives = 295/323 (91%)
Query: 10 DREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVA 69
D EEKG+ K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKVA
Sbjct: 54 DCEEKGDCQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVA 113
Query: 70 IKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLY 128
IKLMD AGKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY
Sbjct: 114 IKLMDHAGKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLY 173
Query: 129 PANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188
N S SV +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVS
Sbjct: 174 LPNRSGSVPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVS 233
Query: 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
DFGLAK+GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+
Sbjct: 234 DFGLAKVGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPV 293
Query: 249 DVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 308
D+ + +GEGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYR
Sbjct: 294 DMKRATGEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYR 353
Query: 309 PLMADVVQSLVPLVKYNRSTPKI 331
PLMADVVQSLVPLV+ RS K+
Sbjct: 354 PLMADVVQSLVPLVRNRRSASKL 376
|
|
| TAIR|locus:2010965 AT1G54820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 186/312 (59%), Positives = 237/312 (75%)
Query: 27 GLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM----DQAGKQGED 82
G++V+T+K+L AT FS+ +G+G VY+GVLS+G AIK + D A Q +
Sbjct: 131 GVEVYTYKELEIATNNFSEEKKIGNGD---VYKGVLSDGTVAAIKKLHMFNDNASNQKHE 187
Query: 83 E--FKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSN--SVA 137
E F++EV+LL RL+ PYL+ LLGYC+D+ ++L+Y++M NG ++ HL+ N N
Sbjct: 188 ERSFRLEVDLLSRLQCPYLVELLGYCADQNHRILIYEFMPNGTVEHHLHDHNFKNLKDRP 247
Query: 138 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197
LDW RLRIAL+ A+ LEFLHE+ VIHR+FK +NILLD+N AKVSDFGLAK GS
Sbjct: 248 QPLDWGARLRIALDCARALEFLHENTISTVIHRNFKCTNILLDQNNRAKVSDFGLAKTGS 307
Query: 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257
DK G +STRV+GT GY+APEYA TG LTTKSDVYSYG+VLL+LLTGR PID +P G+
Sbjct: 308 DKLNGEISTRVIGTTGYLAPEYASTGKLTTKSDVYSYGIVLLQLLTGRTPIDSRRPRGQD 367
Query: 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317
VLVSWALPRLT+REKI E++DP ++GQYS K++IQVAAIAA+CVQPEA YRPLM DVV S
Sbjct: 368 VLVSWALPRLTNREKISEMVDPTMKGQYSQKDLIQVAAIAAVCVQPEASYRPLMTDVVHS 427
Query: 318 LVPLVK-YNRST 328
L+PLVK +N+ST
Sbjct: 428 LIPLVKAFNKST 439
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 155/290 (53%), Positives = 211/290 (72%)
Query: 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELL 91
++++L AT F ++++G GGFG VYRG+L++G VAIK + G QG+ EF++E+++L
Sbjct: 369 SYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDML 428
Query: 92 GRLRSPYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
RL L+ L+GY S R + LL Y+ + NG L+ L+ G N LDW+TR++I
Sbjct: 429 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNC---PLDWDTRMKI 485
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
AL+AA+GL +LHE P VIHRDFK+SNILL+ NF+AKV+DFGLAK + G H+STRV
Sbjct: 486 ALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRV 545
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268
+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSG+ LV+W P L
Sbjct: 546 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLR 605
Query: 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
D++++ E++D LEG+Y ++ I+V IAA CV PEA RP M +VVQSL
Sbjct: 606 DKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSL 655
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 1.2e-77, P = 1.2e-77
Identities = 157/292 (53%), Positives = 205/292 (70%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEV 88
+ FT ++ AT F +S V+G GGFG VY GV +G KVA+K++ + +QG EF EV
Sbjct: 709 KTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFLAEV 768
Query: 89 ELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
E+L RL L+ L+G C DR + LVY+ + NG ++ HL+ G + +S LDW+ RL+
Sbjct: 769 EMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLH---GIDKASSPLDWDARLK 825
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-SDKAGGHVST 206
IAL AA+GL +LHE SP VIHRDFKSSNILL+ +F KVSDFGLA+ D+ H+ST
Sbjct: 826 IALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHIST 885
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++P G+ LVSW P
Sbjct: 886 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPF 945
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
LT E + I+D +L + S + +VAAIA+MCVQPE +RP M +VVQ+L
Sbjct: 946 LTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQAL 997
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
Identities = 157/298 (52%), Positives = 213/298 (71%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKME 87
++F FK+L +AT FS ++G GGFG VY+G L++ + VA+K +D+ G QG EF E
Sbjct: 71 RIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAE 130
Query: 88 VELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPA-NGSNSVASKLDWETR 145
V +L + P L+ L+GYC D +++LVY++M NG L++HL+ GS S LDW TR
Sbjct: 131 VMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPS----LDWFTR 186
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
+RI AAKGLE+LH++ PPVI+RDFK+SNILL +F++K+SDFGLA++G + HVS
Sbjct: 187 MRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVS 246
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
TRV+GT GY APEYA+TG LT KSDVYS+GVVLLE+++GR ID ++P+ E L+SWA P
Sbjct: 247 TRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEP 306
Query: 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
L DR +I+DP L+G Y +K + Q AIAAMC+Q EA+ RPLM DVV +L L K
Sbjct: 307 LLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLAK 364
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
Identities = 157/309 (50%), Positives = 211/309 (68%)
Query: 12 EEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKV-AI 70
EE + GK ++ +FTF++L AT F+ N +G GGFG VY+G + +V A+
Sbjct: 55 EEIAKLGKGNISA----HIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAV 110
Query: 71 KLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYP 129
K +D+ G QG EF +EV +L L L+ L+GYC+D +++LVY+YM NG L++HL
Sbjct: 111 KQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLE 170
Query: 130 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189
+ + LDW+TR+++A AA+GLE+LHE PPVI+RDFK+SNILLD+ F+ K+SD
Sbjct: 171 L--ARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSD 228
Query: 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
FGLAK+G HVSTRV+GT GY APEYALTG LT KSDVYS+GVV LE++TGR ID
Sbjct: 229 FGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVID 288
Query: 250 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
KP+ E LV+WA P DR K + DP LEG+Y +K + Q A+AAMC+Q EA RP
Sbjct: 289 TTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRP 348
Query: 310 LMADVVQSL 318
+M+DVV +L
Sbjct: 349 MMSDVVTAL 357
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 5.0e-76, P = 5.0e-76
Identities = 153/290 (52%), Positives = 201/290 (69%)
Query: 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVE 89
F F++L +AT F +G GGFG VY+G L S G+ VA+K +D+ G QG EF +EV
Sbjct: 74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133
Query: 90 LLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
+L L P L+ L+GYC+D ++LLVY++M G L++HL+ LDW R++I
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNMRMKI 190
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
A AAKGLEFLH+ +PPVI+RDFKSSNILLD+ FH K+SDFGLAK+G HVSTRV
Sbjct: 191 AAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRV 250
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268
+GT GY APEYA+TG LT KSDVYS+GVV LEL+TGR ID P GE LV+WA P
Sbjct: 251 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFN 310
Query: 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
DR K +++ DP L+G++ + + Q A+A+MC+Q +A RPL+ADVV +L
Sbjct: 311 DRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.3e-75, P = 1.3e-75
Identities = 157/312 (50%), Positives = 210/312 (67%)
Query: 9 VDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRK 67
V+ + K EVT + Q F+F++L +AT F + ++G GGFG VY+G L G
Sbjct: 45 VNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMI 104
Query: 68 VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEH 126
VA+K +D+ G QG EF +EV +L L +L+ L+GYC+D ++LLVY+YM+ G L++H
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 127 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186
L LDW+TR+RIAL AA GLE+LH+ +PPVI+RD K++NILLD F+AK
Sbjct: 165 LLDLTPDQI---PLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAK 221
Query: 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
+SDFGLAK+G HVS+RV+GT GY APEY TG LTTKSDVYS+GVVLLEL+TGR
Sbjct: 222 LSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRR 281
Query: 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEAD 306
ID +P E LV+WA P + + E+ DP+LEG + K + Q A+AAMC+Q EA
Sbjct: 282 VIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEAT 341
Query: 307 YRPLMADVVQSL 318
RPLM+DVV +L
Sbjct: 342 VRPLMSDVVTAL 353
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 2.7e-75, P = 2.7e-75
Identities = 154/292 (52%), Positives = 201/292 (68%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKME 87
Q FTF +L +AT F K ++G GGFG VY+G L S + AIK +D G QG EF +E
Sbjct: 59 QTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVE 118
Query: 88 VELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
V +L L P L+ L+GYC+D ++LLVY+YM G L++HL+ + LDW TR+
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQ---PLDWNTRM 175
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IA AAKGLE+LH+ PPVI+RD K SNILLD ++ K+SDFGLAK+G HVST
Sbjct: 176 KIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVST 235
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GY APEYA+TG LT KSDVYS+GVVLLE++TGR ID ++ +GE LV+WA P
Sbjct: 236 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPL 295
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
DR K ++ DP L+GQY + + Q A+AAMCVQ + + RPL+ADVV +L
Sbjct: 296 FKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTAL 347
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
Identities = 153/299 (51%), Positives = 212/299 (70%)
Query: 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME 87
++ FT +L AT FS V+G GGFG VY+G + +G +VA+KL+ + + + EF E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393
Query: 88 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
VE+L RL L+ L+G C + R + L+Y+ + NG ++ HL+ G+ LDW+ RL
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--EGT------LDWDARL 445
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IAL AA+GL +LHE +P VIHRDFK+SN+LL+ +F KVSDFGLA+ ++ H+ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE-GSQHIST 504
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSGE LV+WA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325
L +RE + +++DPAL G Y+ ++ +VAAIA+MCV E +RP M +VVQ+L L+ YN
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL-KLI-YN 621
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 351 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-51
Identities = 74/198 (37%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G GGFG VY G+KVAIK++ + +E E+E+L +L P ++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
D L LV +Y G L++ L KL + LRI L+ +GLE+LH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL------KENEGKLSEDEILRILLQILEGLEYLHSN--- 111
Query: 166 PVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TG 223
+IHRD K NILLD N K++DFGL+K+ + + ++GT Y+APE L G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKG 169
Query: 224 HLTTKSDVYSYGVVLLEL 241
+ + KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-48
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 47 NVVGHGGFGLVYRGVLSNG----RKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG VY+G L +VA+K + + A ++ +F E ++ +L P ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAAKGLEF 158
LLG C++ L LV +YM G L ++L + S L + L A++ AKG+E+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------KAGGHVSTRVLGTQ 212
L +HRD + N L+ ++ K+SDFGL++ D K GG + R
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271
++APE G T+KSDV+S+GV+L E+ T G P G+ L L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-------PGLSNEEVLEYLRKGY 224
Query: 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ L + + ++ + C Q + + RP +++V+ L
Sbjct: 225 R-LPKPEYCPD---------ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 45/288 (15%)
Query: 44 SKSNVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSP 97
+ +G G FG VY+G L +VA+K L + A +Q +EF E ++ +L P
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ LLG C++ L +V +YM G L +L KL L AL+ A+G+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL------RKNRPKLSLSDLLSFALQIARGM 115
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGT 211
E+L IHRD + N L+ +N K+SDFGL++ D K GG + R +
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-- 170
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270
APE G T+KSDV+S+GV+L E+ T G P G+ L L +
Sbjct: 171 ----APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY-------PGMSNEEVLEYLKNG 219
Query: 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ L + + C + + RP +++V+ L
Sbjct: 220 YR-LPQPPNCPPE---------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 44 SKSNVVGHGGFGLVYRGVLSNG-----RKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSP 97
+ +G G FG VY+G L +VA+K L + A +Q +EF E ++ +L P
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ LLG C++ L +V +YM G L ++L + +L L AL+ A+G+
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-----RKNRPKELSLSDLLSFALQIARGM 116
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGT 211
E+L IHRD + N L+ +N K+SDFGL++ D GG + R
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR---- 169
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270
++APE G T+KSDV+S+GV+L E+ T G P G+ + L L
Sbjct: 170 --WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY-------PGMSNAEVLEYLKKG 220
Query: 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ L + + C + + RP +++V+ L
Sbjct: 221 YR-LPKPPNCPPE---------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 8e-47
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 30/244 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G G FG VY+ G+ VA+K++ + + + E+ +L RL P ++ L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
D+ L LV +Y G L ++L L + +IAL+ +GLE+LH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-------PLSEDEAKKIALQILRGLEYLHSN- 117
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
+IHRD K NILLD+N K++DFGLAK K+ ++T V GT Y+APE L G
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 224 -HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 282
K DV+S GV+L ELLTG+ P L + I I+ P LE
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP-------------FSGENILDQLQLIRRILGPPLE 220
Query: 283 GQYS 286
Sbjct: 221 FDEP 224
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-46
Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLL 100
+ +G G FG VY G+ VAIK++ + K+ + E+++L +L+ P ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEF 158
L D KL LV +Y G L + L S A + LE+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--------YLRQILSALEY 112
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH ++HRD K NILLD++ H K++DFGLA+ G ++T V GT Y+APE
Sbjct: 113 LHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPE 166
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
L D++S GV+L ELLTG+ P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 48 VVGHGGFGLVYRGVL-----SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG VY+G L KVA+K + + A ++ +EF E ++ +L P ++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
LLG C+ L +V +YM G L + L KL + L++AL+ AKG+E+L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR------KHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV----- 215
+HRD + N L+ +N K+SDFGL++ + G +
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWM 171
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
APE G T+KSDV+S+GV+L E+ T G P
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYL 99
+++ ++G G FG VY + G +A+K ++ +G E + + E+ +L L+ P +
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 100 LALLGYCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
+ G D K + +Y++ G L L G KL E +R + +G
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFG------KLP-EPVIRKYTRQILEG 113
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L +LH + ++HRD K +NIL+D + K++DFG AK D G + V GT ++
Sbjct: 114 LAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE +D++S G ++E+ TG+ P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 19/228 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
F+ +G G FG V+ G+ N +VAIK++ + +F+ EV+ L RLR +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 103 LGYCS-DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
CS ++ + M G L L G L + + +A + A+G+ +L E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-----LPVASLIDMACQVAEGMAYLEE 122
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
IHRD + NIL+ ++ KV+DFGLA++ + ++ + APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAAS 177
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268
G +TKSDV+S+G++L E+ T G+VP G+ ++T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPY-------PGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 43 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
F +G GGFG VY+ G++VAIK++ K+ +++ E+++L + + P ++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 102 LLG--YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G D + V ++ + G L++ L S L + E KGLE+L
Sbjct: 62 YYGSYLKKDELWI-VMEFCSGGSLKDLL------KSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H + +IHRD K++NILL + K+ DFGL+ SD ++GT ++APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD---TKARNTMVGTPYWMAPEV 168
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
K+D++S G+ +EL G+ P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYL 99
+ +++G G FG+VY+G+ L G VAIK + + E E++LL L+ P +
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGLE 157
+ +G L ++ +Y NG L++ + E+ + + + + +GL
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP--------ESLVAVYVYQVLQGLA 113
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LHE VIHRD K++NIL K+ K++DFG+A +D + V+GT ++AP
Sbjct: 114 YLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP 168
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E +T SD++S G ++ELLTG P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FGLV+ G RKVAIK + + G E++F E +++ +L P L+ L G C++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
R + LV+++M +G L ++L G K ET L + L+ +G+ +L V
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG------KFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 224
IHRD + N L+ +N KVSDFG+ + D T GT+ + +PE
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWSSPEVFSFSK 177
Query: 225 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 258
++KSDV+S+GV++ E+ + G+ P + N+ + E V
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 50 GHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109
G G FG V+ G + KVA+K + E F E +++ +LR L+ L CS+
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 110 RKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
+ +V +YM+ G L + L G KL + +A + A+G+ +L I
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGK-----KLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT 227
HRD + NIL+ +N K++DFGLA+ I D+ + + APE A G T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTI 183
Query: 228 KSDVYSYGVVLLELLT-GRVP 247
KSDV+S+G++L E++T GRVP
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 74/237 (31%), Positives = 119/237 (50%), Gaps = 22/237 (9%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG+V+ G VAIK++ + G ED+F E +++ +L P L+ L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
+R + +V +YMANG L +L G KL E L + + + +E+L +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG------KLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 224
IHRD + N L+ ++ KVSDFGLA+ D T GT+ + PE
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 225 LTTKSDVYSYGVVLLELLT-GRVPID--VNKPSGEGVLVSWALPRLTD-REKILEIM 277
++KSDV+S+GV++ E+ + G++P + N E V + L R ++ IM
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIM 234
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 4e-30
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 49 VGHGGFGLVY--RGVLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG V R + G+ A+K++ + ++ + E +L R+ P+++ L
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL- 58
Query: 104 GYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+ + KL LV +Y G L HL + E A E LE+LH
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-------RFSEERARFYAAEIVLALEYLH 110
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+I+RD K NILLD + H K++DFGLAK S + G +T GT Y+APE
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC-GTPEYLAPEVL 165
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
L D +S GV+L E+LTG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 42 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSP- 97
+ +G G FG VY + + VA+K++ + + E F E+++L L P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 98 YLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ L + D LV +Y+ G L++ L L L I + L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQILSAL 114
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKI----GSDKAGGHVSTRVLGT 211
E+LH +IHRD K NILLD++ K+ DFGLAK+ GS + + + +GT
Sbjct: 115 EYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 212 QGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 254
GY+APE L + ++ SD++S G+ L ELLTG P + K S
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 74/221 (33%), Positives = 114/221 (51%), Gaps = 25/221 (11%)
Query: 43 FSKSNV-----VGHGGFGLVYRG--VLSNGRK----VAIK-LMDQAGKQGEDEFKMEVEL 90
S V +G G FG VY+G N R VAIK L + A + + EF+ E EL
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 91 LGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKL 140
+ L+ P ++ LLG C+ + ++++Y+A+G L E L +G +V S L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 141 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200
D L IA++ A G+E+L H +HRD + N L+ + K+SDFGL++
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
V ++ L ++ PE L G TT+SD++S+GVVL E+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ G+ +N VA+K + + G +F E +++ +LR P L+ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
+ +V + M G L E+L L + +A + A G+ +L
Sbjct: 73 EEPIYIVTELMKYGSLLEYL-----QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 226
IHRD + N+L+ +N KV+DFGLA+ I D + + APE AL +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFS 182
Query: 227 TKSDVYSYGVVLLELLT-GRVP 247
KSDV+S+G++L E++T GR+P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRL-RSPYLL 100
++G G F V ++ AIK++D + K K+E E+L RL P ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRLNGHPGII 65
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L D L V +Y NG L +++ GS TR A E LE+L
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKC-----TRF-YAAEILLALEYL 118
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK----AGGHVSTRVL------ 209
H +IHRD K NILLDK+ H K++DFG AK+ + +T +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 210 --------GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GT YV+PE SD+++ G ++ ++LTG+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G G FG V G G+KVA+K + F E ++ LR P L+ LLG
Sbjct: 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLG 67
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
L +V +YMA G L ++L + G + + +L AL+ +G+E+L E
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLR-SRGR----AVITLAQQLGFALDVCEGMEYLEEK- 121
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK-AGGHVSTRVLGTQGYVAPEYALT 222
+HRD + N+L+ ++ AKVSDFGLAK S G + + + APE
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTAPEALRE 173
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVP 247
+TKSDV+S+G++L E+ + GRVP
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 31/271 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYL 99
F N +G G FG+V++ V ++ R A+K +D + ++ +E E +L +L S Y+
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+ D+ KL +V +Y NG L + L G + W R ++ GL
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVW----RFFIQILLGLAH 116
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH S ++HRD KS N+ LD + K+ D G+AK+ SD + + ++GT Y++PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
KSDV++ GVVL E TG+ P D N +G L+ KI+ +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALI----------LKIIRGVF 218
Query: 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
P + YS Q+A + C+ + RP
Sbjct: 219 PPVSQMYSQ----QLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ G + KVAIK + Q G + F E L+ +L+ P L+ L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 109 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
++ +YM NG L + L G +KL + +A + A+G+ F+ I
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKL-----IDMAAQIAEGMAFIERKNY---I 124
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAPEYALT 222
HRD +++NIL+ + K++DFGLA++ D +G + APE
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIED-------NEYTAREGAKFPIKWTAPEAINY 177
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVP 247
G T KSDV+S+G++L E++T GR+P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 94/318 (29%), Positives = 148/318 (46%), Gaps = 43/318 (13%)
Query: 28 LQVFTFKQLHSAT-----GGFSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGE 81
LQ F K S T + NV+ G G Y+G + NG + +K ++
Sbjct: 672 LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS 731
Query: 82 DEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKL 140
E+ +G+L+ P ++ L+G C S++ L+++Y+ L E V L
Sbjct: 732 ----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE----------VLRNL 777
Query: 141 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF--HAKVSDFGLAKIGSD 198
WE R +IA+ AK L FLH CSP V+ + I++D H ++S GL
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT--- 834
Query: 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 258
T+ + YVAPE T +T KSD+Y +G++L+ELLTG+ P D + G
Sbjct: 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGS 887
Query: 259 LVSWALPRLTDREKILEIMDPALEGQYSM--KEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
+V WA +D + I DP++ G S+ E+++V +A C + RP DV++
Sbjct: 888 IVEWARYCYSDCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 317 SLVPLVKYNRSTPKISSS 334
+L S + SSS
Sbjct: 947 TL-------ESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 53/287 (18%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLAL 102
+G G FG VY S+G+ +K +D + E E + EV++L +L P ++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 103 LGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASK---LDWETRLRIALEAAKGLEF 158
++ KL V +Y G L + + + LDW +L L++
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH ++HRD K NI L N K+ DFG++K+ S ++ V+GT Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPE 173
Query: 219 ------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272
Y KSD++S G VL EL T + P + L L K
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKHPFE-----------GENLLEL--ALK 214
Query: 273 ILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317
IL+ P + QYS ++ ++ +Q + + RP +A ++QS
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVS------SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 69/220 (31%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 96
K V+G G FG VY+GV + G K VAIK L ++ + E E ++ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
P+++ LLG C + L+ M G L +++ + L+W ++ AKG+
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGM 122
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDK-----AGGHVSTRVLG 210
+L E ++HRD + N+L+ H K++DFGLAK + D+ GG V +
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK--- 176
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 249
++A E L T KSDV+SYGV + EL+T G P +
Sbjct: 177 ---WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 47 NVVGHGGFGLVYRGVLS-NGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG V RG L G+K VAIK L + + +F E ++G+ P ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 102 LLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L G + R ++ + +YM NG L + L +G K + + A G+++L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG------KFTVGQLVGMLRGIASGMKYLS 123
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK------AGGHVSTRVLGTQGY 214
E +HRD + NIL++ N KVSDFGL++ D GG + R +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------W 174
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLT 243
APE T+ SDV+S+G+V+ E+++
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 45 KSNVVGHGGFGLVYRGVLSN-----GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 98
+G G FG V G +VA+K L +Q +F+ E+E+L L
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 99 LLALLGYCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
++ G C R L+ +Y+ +G L+++L + +L L + + KG
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-----LLFSSQICKG 121
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST--RVLGTQG 213
+++L IHRD + NIL++ K+SDFGLAK+ + +
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
Y APE T ++ SDV+S+GV L EL T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 74/289 (25%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 48 VVGHGGFGLVYRGVLS-NGRKVAIK----LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
V+G G G+VY+ G+ A+K D+ ++ + E++ L SPY++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK---QLLRELKTLRSCESPYVVKC 64
Query: 103 LG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 160
G + + +V +YM G L + L E L IA + KGL++LH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP--------EPVLAYIARQILKGLDYLH 116
Query: 161 E--HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
H +IHRD K SN+L++ K++DFG++K+ + + +GT Y++PE
Sbjct: 117 TKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
+ +D++S G+ LLE G+ P P G+ + L + I +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSF--FEL-----MQAICDGPP 220
Query: 279 PAL-EGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324
P+L ++S ++ I + C+Q + RP A+++Q P +K
Sbjct: 221 PSLPAEEFSPEFRDFI------SACLQKDPKKRPSAAELLQH--PFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G+G FG V+ G + KVA+K + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 109 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
+V +YM+ G L + L G L + +A + A G+ ++ I
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRA-----LKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAPEYALT 222
HRD +S+NIL+ K++DFGLA++ D QG + APE AL
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIED-------NEYTARQGAKFPIKWTAPEAALY 177
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVP 247
G T KSDV+S+G++L EL+T GRVP
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 49 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 101
+G G FG+VY G+ +VAIK +++ E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 102 LLGYCSD-RRKLLVYDYMANGGLQEHL---YPANGSNSVASKLDWETRLRIALEAAKGLE 157
LLG S + L+V + MA G L+ +L P +N + +++A E A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA----------KIGSDKAGGHVSTR 207
+L +HRD + N ++ ++ K+ DFG+ K G G + R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG----KGLLPVR 186
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
++APE G TTKSDV+S+GVVL E+ T
Sbjct: 187 ------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 48 VVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G FG V+ G + VA+K L + A +F+ E ELL + ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 101 ALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASK--------LDWETRLRIALE 151
G C++ + V++YM +G L + L ++G ++ K L L+IA++
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTR 207
A G+ +L S +HRD + N L+ + K+ DFG+++ +D + GGH
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH---T 184
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+L + ++ PE + TT+SDV+S+GVVL E+ T G+ P
Sbjct: 185 MLPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 42 GFSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFKM------EVELLGRL 94
F V+G G FG V + +K+ A+K M+ KQ E E +L L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN---KQKCVEKGSVRNVLNERRILQEL 57
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 152
P+L+ L D + LV D + G L+ HL S K E +++ E
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFS-EEQVKFWICEI 109
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
LE+LH +IHRD K NILLD+ H ++DF +A + ++T GT
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA---TKVTPDTLTTSTSGTP 163
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GY+APE + D +S GV E L G+ P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-24
Identities = 81/283 (28%), Positives = 137/283 (48%), Gaps = 51/283 (18%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ G + KVAIK + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 109 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
+V ++M G L + L +G +L + +A + A G+ ++ I
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-----VDMAAQIADGMAYIERM---NYI 124
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 223
HRD +++NIL+ N K++DFGLA++ D + G + + APE AL G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYG 178
Query: 224 HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD---- 278
T KSDV+S+G++L EL+T GRVP P + +RE +LE ++
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP----------------YPGMVNRE-VLEQVERGYR 221
Query: 279 -PALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
P +G S+ E+++ +C + + D RP + +QS +
Sbjct: 222 MPCPQGCPESLHELMK------LCWKKDPDERPTF-EYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-24
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 48 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-Y 105
+G G G VY+ G++VAIK M KQ ++ E+ ++ + P ++ Y
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLHEHCS 164
+V +YM G L + + N V E ++ + E +GLE+LH S
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQ----NFVRMN---EPQIAYVCREVLQGLEYLH---S 134
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
VIHRD KS NILL K+ K++DFG A + + S V+GT ++APE
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKD 192
Query: 225 LTTKSDVYSYGVVLLELLTGRVP 247
K D++S G++ +E+ G P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-24
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 109 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
+V +YM+ G L + L + L + +A + A G+ ++ +
Sbjct: 73 EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 223
HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYG 178
Query: 224 HLTTKSDVYSYGVVLLELLT-GRVP 247
T KSDV+S+G++L EL T GRVP
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 9e-24
Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
F+K +G G FG V++G+ + +KV AIK++D + E ++ + E+ +L + SPY+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 101 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G Y D + ++ +Y+ G + L P LD I E KGL++L
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--------PLDETQIATILREILKGLDYL 117
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H S IHRD K++N+LL ++ K++DFG+A +D +GT ++APE
Sbjct: 118 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEV 172
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
+K+D++S G+ +EL G P P L+ P P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------P 219
Query: 280 ALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
LEG YS +KE ++ C+ E +RP ++++
Sbjct: 220 TLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-23
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 20/216 (9%)
Query: 47 NVVGHGGFGLVYRGVL--SNGRKV--AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLA 101
V+G G FG VY G L S+G+K+ A+K +++ E ++F E ++ P +L+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 102 LLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
LLG C S+ L+V YM +G L+ + + N L + L+ AKG+E+L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA--GGHVSTRVLGTQGYVAP 217
S +HRD + N +LD++F KV+DFGLA+ DK H T ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP--IDVN 251
E T TTKSDV+S+GV+L EL+T P DV+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 98
F+ +G G FG VY+ + + VAIK++D ++ EDE + E++ L + RSPY
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ G KL ++ +Y G + L P KLD I E GLE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLE 112
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL------GT 211
+LHE IHRD K++NILL + K++DFG++ G +++ + GT
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGT 161
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++APE K+D++S G+ +EL G P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 31/212 (14%)
Query: 52 GGFGLVYRGVL----SNGRKVAIKLMDQAGKQGE---DEFKMEVELLGRLRSPYLLALLG 104
G +G V+ L S G AIK++ +A + D+ E ++L + +SPY++ L
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 105 YCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
Y S ++ L LV +Y+ G L L +V S + R+ IA E LE+LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLL------ENVGSLDEDVARIYIA-EIVLALEYLHS 111
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS------TRVLGTQGYV 215
+ +IHRD K NIL+D N H K++DFGL+K+G + +++ R++GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE L + D +S G +L E L G P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-23
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGE-DEFKMEVELLGRLRSPYLLA 101
+ N +G G FG VY V L G +A+K + Q E E+++L L+ P L+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 102 LLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
G R K+ ++ +Y + G L+E L +G LD L+ +GL +LH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELL--EHGRI-----LDEHVIRVYTLQLLEGLAYLH 116
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGYVAP 217
H ++HRD K +NI LD N K+ DFG A + G V + + GT Y+AP
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAP 172
Query: 218 EYALTGHLTTK---SDVYSYGVVLLELLTGRVP 247
E G +D++S G V+LE+ TG+ P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 47 NVVGHGGFGLVYRGVLSNGR------KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+GHG FG VY G+ +VA+K L + +Q E +F ME ++ + +
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 100 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+ L+G +R + ++ + MA G L+ L S L + L A + AKG ++
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 159 LHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLAK--IGSD--KAGGHVSTRVLGT 211
L E+ IHRD + N LL AK++DFG+A+ + + GG R +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG----RAMLP 184
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270
++ PE L G T+K+DV+S+GV+L E+ + G +P P T++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----------------YPGRTNQ 228
Query: 271 EKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
E+M+ G V I C Q + RP A +++ +
Sbjct: 229 ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 49 VGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G FG +Y+G L + + VAIK L D Q EF+ E L+ L P ++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLY----------PANGSNSVASKLDWETRLRIALE 151
LG + + + ++++Y+ G L E L ++ +V S LD L IA++
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
A G+E+L H +H+D + NIL+ + H K+SD GL++ V + L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
++ PE + G ++ SD++S+GVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG VY+GVL +VA+K +F E E+L + P ++ L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 107 SDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
++ + V + + G L L ++L + L+++L+AA G+E+L
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ----GYVAPEYAL 221
IHRD + N L+ +N K+SDFG+++ ++ GG + T G + + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGG-IYTVSDGLKQIPIKWTAPEALN 168
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
G T++SDV+SYG++L E + G P
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRK----VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPY 98
K ++G G FG V++G+ + G VAIK + D++G+Q E + +G L Y
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
++ LLG C LV G L +H+ S L+W ++ AKG+ +
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
L EH ++HR+ + NILL + +++DFG+A + + + ++A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT 243
L G T +SDV+SYGV + E+++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 21/191 (10%)
Query: 68 VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 125
VA+K++ A K ++F EV++L RL+ P ++ LLG C D L ++ +YM NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 126 HL------------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173
L A + + + L +AL+ A G+++L S +HRD
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 174 SSNILLDKNFHAKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDV 231
+ N L+ +N K++DFG+++ + AG + + R + ++A E L G TT SDV
Sbjct: 166 TRNCLVGENLTIKIADFGMSR--NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 232 YSYGVVLLELL 242
+++GV L E+L
Sbjct: 224 WAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG+V G VAIK M + G EDEF E +++ +L L+ L G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
+R + +V +YM+NG L +L + L + + +G+ +L
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEYALTGH 224
IHRD + N L+D KVSDFGL++ D T +G++ V PE L
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 225 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD----- 278
++KSDV+++GV++ E+ + G++P + R + E + ++
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLRLY 221
Query: 279 -PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
P L + +V AI C +A+ RP ++ S+
Sbjct: 222 RPHLASE-------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 80/291 (27%), Positives = 140/291 (48%), Gaps = 38/291 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
F+K +G G FG VY+G+ + ++V AIK++D + E ++ + E+ +L + SPY+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 101 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G Y + ++ +Y+ G + L P + + T LR E KGL++L
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILR---EILKGLDYL 117
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H S IHRD K++N+LL + K++DFG+A +D +GT ++APE
Sbjct: 118 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEV 172
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
K+D++S G+ +EL G P P + V + +P+ + P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIPKNS---------PP 219
Query: 280 ALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328
LEGQYS KE ++ C+ + +RP ++++ + +Y + T
Sbjct: 220 TLEGQYSKPFKEFVEA------CLNKDPRFRPTAKELLKHKF-ITRYTKKT 263
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF----KMEVELLGRLRSP 97
+ K +G G +G VY+ G VA+K + + ++ F E++LL +LR P
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 98 YLLALLGYCSDRRK---LLVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLR-IALE 151
++ L + + K +V++YM + GL + K E++++ +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS---------PEVKFT-ESQIKCYMKQ 108
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
+GL++LH + ++HRD K SNIL++ + K++DFGLA+ + + + RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 212 QGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPI 248
Y PE L G + D++S G +L EL G+ PI
Sbjct: 165 LWYRPPEL-LLGATRYGPEVDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 41/235 (17%)
Query: 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 94
L TG F V+G G +G VY+ G+ VAIK+MD + E+E K E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 95 RSPYLLALLGYCSDRRKLLVY--DYMANG--GLQEHL-----YPANGS--NSVASKLDWE 143
S+ + + ++ G + L GS + V
Sbjct: 60 ------------SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107
Query: 144 TRLR------IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197
RL+ I E +GL +LHE+ VIHRD K NILL KN K+ DFG++
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-QL 163
Query: 198 DKAGGHVSTRVLGTQGYVAPE-----YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
D G +T + GT ++APE +SDV+S G+ +EL G+ P
Sbjct: 164 DSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLALLG 104
V+G G +VY + L N KVAIK +D Q DE + EV+ + + P ++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 105 YCS---DRRKLLVYDYMANGGLQE---HLYPANG--SNSVASKLDWETRLRIALEAAKGL 156
Y S LV Y++ G L + YP G +A T L+ E KGL
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA------TVLK---EVLKGL 115
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG----LAKIGSDKAGGHVSTRVLGTQ 212
E+LH + IHRD K+ NILL ++ K++DFG LA G V +GT
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK--VRKTFVGTP 170
Query: 213 GYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVP 247
++APE H K+D++S+G+ +EL TG P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 70/239 (29%), Positives = 102/239 (42%), Gaps = 29/239 (12%)
Query: 18 GKLEVTTDNGLQVFTFKQLHSA-TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIK-LMDQ 75
L G F ++H G + VL VA+K L
Sbjct: 5 QPLNFVEKLG--EGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL-----VAVKVLRPD 57
Query: 76 AGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGL----QEHLYPA 130
A ++F EV++L RL P + LLG C D ++ +YM NG L Q+H+
Sbjct: 58 ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 131 NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190
+G + L + T L +A + A G+ +L +HRD + N L+ KN+ K++DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADF 174
Query: 191 GLAKIGSDKAGGHVSTRVLGTQGYVAP------EYALTGHLTTKSDVYSYGVVLLELLT 243
G+ S RV G P E L G TTKSDV+++GV L E+LT
Sbjct: 175 GM----SRNLYSSDYYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 49 VGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 103
+GHG FG VY R V VAIK M +GKQ ++++ EV L +LR P +
Sbjct: 23 IGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 104 G-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G Y + LV +Y A+ L+ H P A I A +GL +L
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA----------ICHGALQGLAYL 131
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H H IHRD K+ NILL + K++DFG A + S + +GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEV 182
Query: 220 ALT---GHLTTKSDVYSYGVVLLELLTGRVPI 248
L G K DV+S G+ +EL + P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 4e-20
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSP 97
+ K +G G +G+VY+ G VA+K + E+ E+ LL L+ P
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ LL RKL LV++Y L+++L + L I + +GL
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMD-LKKYL------DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 215
+ H H ++HRD K NIL++++ K++DFGLA+ G T + T Y
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTYTHEVVTLWYR 165
Query: 216 APEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
APE L + H +T D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 49 VGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G GGFG V V + G+ A K +D+ ++GE E ++L ++ S ++++L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHEH 162
+ L LV M G L+ H+Y +V E R A + GLE LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY------NVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
+++RD K N+LLD + + ++SD GLA + GG GT GY+APE
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 223 GHLTTKSDVYSYGVVLLELLTGRVP 247
D ++ G L E++ GR P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 28/220 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKV----AIKLMDQA-GKQGEDEFKMEVELLGRLRS 96
+ V+G G FG VY+G+ + G V AIK++++ G + EF E ++ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
P+L+ LLG C LV M +G L ++++ + L+W ++ AKG+
Sbjct: 69 PHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGM 122
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKA----GGHVSTRVLG 210
+L E ++HRD + N+L+ H K++DFGLA++ G +K GG + +
Sbjct: 123 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK--- 176
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 249
++A E T +SDV+SYGV + EL+T G P D
Sbjct: 177 ---WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-20
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG+V+ G KVAIK +++ G E++F E +++ +L P L+ L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
++ L +V ++M NG L +L G KL + L + + +G+E+L +
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG------KLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 224
IHRD + N L+ KVSDFG+ + D + S+ G + + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSS--GAKFPVKWSPPEVFNFSK 177
Query: 225 LTTKSDVYSYGVVLLELLT-GRVPID 249
++KSDV+S+GV++ E+ T G++P +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-Y 105
+G G +G VY+ + G+ VAIK++ E E+ +L + SPY++ G Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ +V +Y G + + + L E I + KGLE+LH S
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM------KITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 225
IHRD K+ NILL++ AK++DFG++ +D +T V+GT ++APE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNT-VIGTPFWMAPEVIQEIGY 176
Query: 226 TTKSDVYSYGVVLLELLTGRVP 247
K+D++S G+ +E+ G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-20
Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ G +N KVA+K + + G F E L+ L+ L+ L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
+ ++ +YMA G L + L G + KL + + + A+G+ ++
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIERK---NY 124
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALT 222
IHRD +++N+L+ ++ K++DFGLA++ D + G + + APE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINF 178
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281
G T KSDV+S+G++L E++T G++P P +++ + + AL
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP----------------YPGMSNSDVMS-----AL 217
Query: 282 EGQYSMKEV----IQVAAIAAMCVQPEADYRPLMADVVQSLV 319
+ Y M + ++ I C + +A+ RP D +QS++
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTF-DYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL 102
+G G G+V + + G+ +A+K + E K E+++L + SPY++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64
Query: 103 LGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
G ++ + +YM G L + + V ++ +IA+ KGL +LHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILK-----EVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+IHRD K SNIL++ K+ DFG++ ++ + A V GT Y+APE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVPID 249
+ KSD++S G+ L+EL TGR P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 49 VGHGGFGLVYR-GVLSNGRKVAIKLMD----QAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G GGFG V V S R A+K + Q ++ E E+L P+++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 104 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA--LEAAKGLEFLH 160
D++ + ++ +Y G L L G ++ R IA + A E+LH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD-----EYTARFYIACVVLA---FEYLH 110
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYVAPEY 219
+I+RD K N+LLD N + K+ DFG AK K T GT YVAPE
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWTFCGTPEYVAPEI 163
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
L D +S G++L ELLTGR P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 32/218 (14%)
Query: 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRK---VAIKLMDQAG---KQGEDEFKMEVELLGR 93
+K V+G G FG V+RG+L GRK VAIK + + G KQ +D F E ++G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQ 62
Query: 94 LRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
++ L G + + +++ +YM NG L ++L +G S LR
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS---YQLVGMLR---GI 116
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-------KAGGHVS 205
A G+++L + +HRD + NIL++ N KVSDFGL+++ D +GG +
Sbjct: 117 AAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
R + APE T+ SDV+S+G+V+ E+++
Sbjct: 174 IR------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM-----DQAGKQGEDEFKMEVELLGRLRSPY 98
+ ++G G FG VY + GR++A+K + K+ + + E++LL L+
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 99 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKG 155
++ G D L ++ +YM G +++ L A G + +V K R LE G
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYT-----RQILE---G 116
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 214
+E+LH + ++HRD K +NIL D + K+ DFG +K + + + G V GT +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++PE K+DV+S G ++E+LT + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPY 98
+ K VVG G FG+V+ R ++ + V IK + +Q K + E ++L L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 99 LLALL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ + D+ ++V +Y G L E++ S LD +T L ++ L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALH 115
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+H ++HRD K+ NILLDK+ K+ DFG++KI S K+ + V+GT Y++
Sbjct: 116 HVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYIS 169
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLT 243
PE KSD+++ G VL EL +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 32/222 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRK----VAIKLMDQA-GKQGEDEFKMEVELLGRLRS 96
F K V+G G FG VY+G+ + G K VAIK + +A + E E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAK 154
P++ LLG C L+ M G L + Y +++ S+ L+W ++ AK
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNW------CVQIAK 120
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKA-----GGHVSTRV 208
G+ +L E ++HRD + N+L+ H K++DFGLAK +G+D+ GG V +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK- 176
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 249
++A E L T +SDV+SYGV + EL+T G P D
Sbjct: 177 -----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 49 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V+ N VA+K + +A + +F+ E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 103 LGYCSDRRKLL-VYDYMANGGLQEHLYP--------ANGSNSVASKLDWETRLRIALEAA 153
G C++ R LL V++YM +G L L A G + +L L IA + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
G+ +L S +HRD + N L+ + K+ DFG+++ V R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++ PE L TT+SD++S+GVVL E+ T G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 34/212 (16%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V +G+ A+K++ +A KQ + E +L +R P+L+ L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNL 66
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLH 160
G D L LV +Y+ G L HL + VA R A + LE+LH
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-------RFYAA-QVVLALEYLH 118
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR---VLGTQGYVAP 217
+++RD K N+LLD + + K++DFG AK V R + GT Y+AP
Sbjct: 119 -SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAP 167
Query: 218 EYAL-TGHLTTKS-DVYSYGVVLLELLTGRVP 247
E L G+ K+ D ++ G+++ E+L G P
Sbjct: 168 EIILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 48 VVGHGGFGLVYRGVLSN-GRK---VAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG V RG L G++ VAIK + ++G ++ +F E ++G+ P ++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 102 LLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA-AKGLEFL 159
L G + R +++ ++M NG L L +G +V +L L A G+++L
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-------IQLVGMLRGIAAGMKYL 122
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVA 216
E +HRD + NIL++ N KVSDFGL++ D T LG + + A
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLT 243
PE T+ SDV+SYG+V+ E+++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 98
K V+G G FG VY+G+ + +G VAIK L + + E E ++ + SPY
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+ LLG C LV M G L +++ L+W ++ AKG+ +
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKA-----GGHVSTRVLGTQ 212
L E ++HRD + N+L+ H K++DFGLA+ + D+ GG V +
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----- 176
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271
++A E L T +SDV+SYGV + EL+T G P D P+ E +P L ++
Sbjct: 177 -WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE-------IPDLLEKG 227
Query: 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
+ L P + I V I C +++ RP ++V + +
Sbjct: 228 ERLP--QPPI-------CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 71/215 (33%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 47 NVVGHGGFGLVYRG-VLSNGRKV--AIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLA 101
+V+G G FG V + + +G ++ AIK M + A K +F E+E+L +L P ++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 151
LLG C R L L +Y +G L + L PA +NS AS L + L A +
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 208
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ + K G + R
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + Y TT SDV+SYGV+L E+++
Sbjct: 190 MAIESLNYSVY------TTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 49 VGHGGFGLVYRGV--LSNGR--KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+GHG FG V +GV + +G+ +VA+K L + G+ EF E ++ +L P ++ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
G C +LV + G L ++L V+ + A + A G+ +L
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLK-KRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAP 217
+HRD + N+LL AK+SDFG++ +A G S T + AP
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMS-----RALGAGSDYYRATTAGRWPLKWYAP 167
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT 243
E G ++KSDV+SYGV L E +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 53/182 (29%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 68 VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 125
VA+K L + A K ++F E++++ RL+ P ++ LL C L ++ +YM NG L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 126 ----HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181
H + + + T + +A + A G+++L S +HRD + N L+ K
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
N+ K++DFG+++ + R + +++ E L G TT SDV+++GV L E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 242 LT 243
LT
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 27/206 (13%)
Query: 48 VVGHGGFGLVYRGVLSNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRLRSPYLLAL 102
++G G FG V +G + G+KVA+K + QA F E ++ +L L+ L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA-------FLEETAVMTKLHHKNLVRL 64
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
LG +V + M+ G L L + +L L+ +L+ A+G+E+L
Sbjct: 65 LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLE-- 117
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
S ++HRD + NIL+ ++ AKVSDFGLA++GS V L + + APE
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVK-WTAPEALKH 171
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVP 247
++KSDV+SYGV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V G G KVA+K + + A Q F E ++ +LR L+ LLG
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 107 SDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ + L V +YMA G L ++L + S L + L+ +L+ + +E+L +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---A 120
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
+HRD + N+L+ ++ AKVSDFGL K +A T L + + APE
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPEALREKK 175
Query: 225 LTTKSDVYSYGVVLLELLT-GRVP 247
+TKSDV+S+G++L E+ + GRVP
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-19
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 50 GHGGFGLVYR-GVLSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRSPYLLALLGYC 106
G G +G VY+ LS+ + A+K +D + Q E E + E+ +L + P +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAKGLEFLHEHC 163
D KL +V +Y G L + + S + + + RI ++ +GL+ LHE
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAI-----SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
++HRD KS+NILL N K+ D G++K+ +++ +GT Y+APE
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
+ KSD++S G +L E+ T P S + + R K+ P +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF--EARSMQDL-----------RYKVQRGKYPPIPP 223
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317
YS +++ +Q + RP ++ S
Sbjct: 224 IYS-QDLQN---FIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-19
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 38/224 (16%)
Query: 49 VGHGGFGLVYR----GVLSNGRK--VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG V++ G+L VA+K++ ++A + +F+ E L+ P ++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQE---HLYPANGSNSVASK------------LDWETR 145
LLG C+ + + L+++YMA G L E H P + S L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSD---KAG 201
L IA + A G+ +L E +HRD + N L+ +N K++DFGL+ I S KA
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 202 GH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + R ++ PE TT+SDV++YGVVL E+ +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 57 VYRGVLSNGRKVAIKLM--DQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---- 109
+Y+G+ N ++V I+ G K D + E++ L R+ S +L + G+ D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
R L+ +Y G L+E L L ++T+L +A++ KGL L+++ + P
Sbjct: 95 PRLSLILEYCTRGYLREVLD-------KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-- 145
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLT 226
+++ S + L+ +N+ K+ GL KI S +V+ V Y + + T
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYT 200
Query: 227 TKSDVYSYGVVLLELLTGRVPID 249
K D+YS GVVL E+ TG++P +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLALLG 104
+G G +G+VY+ G VAIK + + E K E++LL L P ++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ L LV+++M + G S+ ++ +GL F H H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCHSH 117
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG---GHVSTRVLGTQGYVAPEY 219
++HRD K N+L++ K++DFGLA+ +V TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 220 ALT-GHLTTKSDVYSYGVVLLELLTGR 245
L +T D++S G + ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGED---EFKMEVELLGRLRSPY 98
K ++G G FG VY G+ L +G A+K + G+ G++ + + E+ LL +L+ P
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
++ LG + L ++ + GG L GS + GLE+
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQILLGLEY 117
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-----GTQG 213
LH +HRD K +NIL+D N K++DFG+AK V G+
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 214 YVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 247
++APE G +D++S G +LE+ TG+ P
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 7e-19
Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 47 NVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQ-AGKQGEDEFKMEVELLGRL-RSPYLLA 101
+V+G G FG V R ++ +G K+ AIK++ + A + +F E+E+L +L P ++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 102 LLGYCSDRRKLLV-YDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 151
LLG C +R L + +Y G L + L PA + AS L + L+ A +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 208
A G+++L E IHRD + N+L+ +N +K++DFGL++ + K G + R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + Y TTKSDV+S+GV+L E+++
Sbjct: 185 MAIESLNYSVY------TTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-19
Identities = 70/215 (32%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 47 NVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQ-AGKQGEDEFKMEVELLGRL-RSPYLLA 101
+V+G G FG V + + +G ++ AIK M + A K +F E+E+L +L P ++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 102 LLGYCSDRRKLLV-YDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 151
LLG C R L + +Y +G L + L PA +NS AS L + L A +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 208
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ + K G + R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + Y TT SDV+SYGV+L E+++
Sbjct: 178 MAIESLNYSVY------TTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 84/279 (30%), Positives = 120/279 (43%), Gaps = 57/279 (20%)
Query: 65 GRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPYLLALL--GYCSDRRKLLVYDYMA 119
G +VAIKL+ + E + F+ E L RL P ++ALL G V++Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179
L+E L A+G+ L R+ L+ L H ++HRD K NI++
Sbjct: 63 GRTLREVL-AADGA------LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 180 ---DKNFHAKVSDFGLAKIGS-----DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDV 231
HAKV DFG+ + D A +T VLGT Y APE +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 232 YSYGVVLLELLTGRV----------------PIDVNKPSG-----EGVLVSWAL------ 264
Y++G++ LE LTG+ P+DV+ P G ++ AL
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQ 232
Query: 265 -----PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAA 298
P L +R + LE+ AL G M E AIAA
Sbjct: 233 RAASAPALAERFRALEL--CALVGILRMGEGAGREAIAA 269
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 49 VGHGGFGLV----YRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG V Y + N G VA+K + + + +F+ E+E+L L+ ++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 104 GYC--SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
G C + RR L LV +Y+ G L+++L +LD L A + KG+E+L
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL------QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHVSTRVLGTQGYVAPEY 219
S +HRD + NIL++ K+ DFGL K+ DK V + APE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 220 ALTGHLTTKSDVYSYGVVLLELLT 243
+ SDV+S+GVVL EL T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 49 VGHGGFGLVYRGVLSNGRK---VAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLG 104
+G G FG V +GV +K VAIK++ K DE E E++ +L +PY++ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 161
C +LV + MA+GG P N ++ K D T + + + G+++L
Sbjct: 63 VCEAEALMLVME-MASGG------PLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQ--GYVAPE 218
+HRD + N+LL +AK+SDFGL+K +G+D + + R G + APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPE 168
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT 243
+++SDV+SYG+ + E +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 49 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V+ N VA+K + A +F E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSV-------ASKLDWETRLRIALEAAK 154
G C + L +V++YM +G L + L A+G ++V ++L L IA + A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTRVLG 210
G+ +L S +HRD + N L+ +N K+ DFG+++ +D + GGH +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++ PE + TT+SDV+S GVVL E+ T G+ P
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLAL 102
+G G FG V + S+G+ + K +D G E E + EV +L L+ P ++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 103 LGYCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
DR +Y M G L + + ++ E RI + L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK---YIEEEFIWRILTQLLLALYEC 121
Query: 160 H--EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGY 214
H V+HRD K +NI LD N + K+ DFGLAKI S A +V GT Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYY 176
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++PE KSD++S G ++ EL P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 49 VGHGGFGLVYRGVLSNGRK-VAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG 104
+GHG FG VY S+ + VA+K M +GKQ ++++ EV+ L +L+ P + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 105 -YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
Y + LV +Y A+ L+ H P A I A +GL +LH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------ITHGALQGLAYLH 138
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
H +IHRD K+ NILL + K++DFG A S + +GT ++APE
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVI 189
Query: 221 LT---GHLTTKSDVYSYGVVLLELLTGRVPI 248
L G K DV+S G+ +EL + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 78/297 (26%), Positives = 139/297 (46%), Gaps = 42/297 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEF---KMEVELLGRLRSPY 98
F+K +G G FG V++G+ + ++V AIK++D ++ EDE + E+ +L + SPY
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEITVLSQCDSPY 63
Query: 99 LLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ G Y + ++ +Y+ G + L A D + E KGL+
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--------AGPFDEFQIATMLKEILKGLD 115
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH S IHRD K++N+LL + K++DFG+A +D + +GT ++AP
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 170
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
E +K+D++S G+ +EL G P P + V + +P+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNN--------- 217
Query: 278 DPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKIS 332
P L G++S KE I C+ + +RP ++++ +VK + T ++
Sbjct: 218 PPTLTGEFSKPFKEFIDA------CLNKDPSFRPTAKELLKHKF-IVKNAKKTSYLT 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLG 92
+ K +G G + +VY+ GR VAIK + K GE + E++LL
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI----KLGERKEAKDGINFTALREIKLLQ 57
Query: 93 RLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR---- 147
L+ P ++ LL + LV+++M L E + D L
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIK-----------DKSIVLTPADI 104
Query: 148 --IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHV 204
L +GLE+LH + ++HRD K +N+L+ + K++DFGLA+ GS +
Sbjct: 105 KSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NRKM 159
Query: 205 STRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPI 248
+ +V+ T+ Y APE L G H D++S G + ELL RVP
Sbjct: 160 THQVV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGR----KVAIKLMDQAGKQGED--EFKMEVELLGRLRS 96
++G G FG V G LS KVA+K M + EF E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 97 PYLLALLGYC---SDRRK----LLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRI 148
P ++ L+G C S +K +++ +M +G L L Y G KL +T L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE--KLPLQTLLKF 118
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVS 205
++ A G+E+L + IHRD + N +L ++ V+DFGL+K G G ++
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ ++A E T+KSDV+++GV + E+ T G+ P
Sbjct: 176 KMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLR 95
++K V+G G +G VY G+ + G+ +A+K + A K+ E + + EV+LL L+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYE-KLQEEVDLLKSLK 60
Query: 96 SPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL------RIA 149
++ LG C D + ++ GG S++S L+ L +
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGG------------SISSILNRFGPLPEPVFCKYT 108
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK----IGSDKAGGHVS 205
+ G+ +LH +C V+HRD K +N++L N K+ DFG A+ +G ++
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
+ GT ++APE KSD++S G + E+ TG+ P+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 53/184 (28%), Positives = 98/184 (53%), Gaps = 12/184 (6%)
Query: 68 VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGL-- 123
VA+K++ K ++F E++++ RL++P ++ LLG C SD ++ +YM NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 124 ---QEHLYPA-NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179
Q + +N++ S + L +A++ A G+++L S +HRD + N L+
Sbjct: 107 FLSQREIESTFTHANNIPS-VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 239
++ K++DFG+++ + R + ++A E L G TT SDV+++GV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 240 ELLT 243
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
+G G FG V+ + KVA+K M + G + F E ++ L+ L+ L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 109 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
++ ++MA G L + L GS KL + + + A+G+ F+ + I
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQR---NYI 124
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 223
HRD +++NIL+ + K++DFGLA++ D + G + + APE G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFG 178
Query: 224 HLTTKSDVYSYGVVLLELLT-GRVP 247
T KSDV+S+G++L+E++T GR+P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 47 NVVGHGGFGLVYRG-VLSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
++GHG G VY+ L R +A+K++ + + + E+E+L + SPY++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 105 -YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ + R + ++M G L V K+ RIA+ KGL +L
Sbjct: 67 AFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL---W 112
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
S ++HRD K SN+L++ K+ DFG+ S + ++ +GT Y+APE
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGE 168
Query: 224 HLTTKSDVYSYGVVLLELLTGRVP 247
SDV+S G+ +EL GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 74/218 (33%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 47 NVVGHGGFGLVYRGVL-------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 98
N +G G FG VY G S +VA+K L A Q + EF E L+ P
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ LLG C ++ + M G L +L A L + L I L+ AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 158 FLHE-HCSPPVIHRDFKSSNILL-DKNFHA----KVSDFGLAK--IGSD---KAG-GHVS 205
+L + H IHRD + N L+ +K + A K+ DFGLA+ SD K G G +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
R ++APE L G TT+SDV+S+GV++ E+LT
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 71/218 (32%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSP 97
FS +GHG FG VY R V ++ VAIK M +GKQ ++++ EV L +LR P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 98 YLLALLG-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ G Y + LV +Y A+ L+ H P A + A
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------VTHGAL 125
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL +LH H +IHRD K+ NILL + K+ DFG A I + + +GT
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPY 176
Query: 214 YVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPI 248
++APE L G K DV+S G+ +EL + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 49 VGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL-L 103
+G GGFG V V + G+ A K +D+ K GE +E E+L ++ SP+++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ S LV M G L+ H+Y N L+ E + + + G+ LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIY-----NVGERGLEMERVIHYSAQITCGILHLH--- 112
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
S +++RD K N+LLD + ++SD GLA + G T+ GT GY+APE
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 224 HLTTKSDVYSYGVVLLELLTGRVP 247
+ D ++ G + E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 49 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V+ N VA+K + +F+ E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSV----------ASKLDWETRLRIALE 151
G C D L +V++YM +G L + L A+G +++ +L L IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTR 207
A G+ +L S +HRD + N L+ N K+ DFG+++ +D + GGH
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ ++ PE + TT+SDV+S+GV+L E+ T G+ P
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLR---SP 97
+ + ++G G +G VYRG + GR VA+K+++ + + + EV LL +LR P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 98 YLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+ G Y R ++ +Y G ++ + A + + I E L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVR--------TLMKAGPIAEKYISVIIREVLVAL 114
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSDKAGGHVSTRVLGTQG 213
+++H VIHRD K++NIL+ + K+ DFG+A S K ST V GT
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR----STFV-GTPY 166
Query: 214 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPI-DVNKPSGEGVLVSWALPRLTDRE 271
++APE G TK+D++S G+ + E+ TG P DV+ ++ PRL D
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 47 NVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+ +G G +G VY GV VA+K + + + +EF E ++ ++ P L+ LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
C+ ++ ++M G L ++L N +++ L +A + + +E+L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---K 122
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 219
IHRD + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 176
Query: 220 ALTGHLTTKSDVYSYGVVLLELLT 243
+ KSDV+++GV+L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 37/219 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM-EVELLGRLRSPY 98
F K N +G G +G+VYR ++G VA+K MD + G + E+ LL LR P
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPN 67
Query: 99 LLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLD------WETRLR-I 148
++ L + LV +Y E +AS LD E++++ +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC------EQ--------DLASLLDNMPTPFSESQVKCL 113
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
L+ +GL++LHE+ +IHRD K SN+LL K++DFGLA+ A ++ +V
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKV 169
Query: 209 LGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGR 245
+ T Y APE L T + TT D+++ G +L ELL +
Sbjct: 170 V-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 49 VGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 101
+G G FG+VY G+ K VAIK +++A E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 102 LLGYCSD-RRKLLVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALEAAKGLE 157
LLG S + L++ + M G L+ +L P +N V + + +++A E A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+L+ + +HRD + N ++ ++F K+ DFG+ + + + L +++P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT 243
E G TT SDV+S+GVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSP 97
F+ +GHG FG VY R V +N VAIK M +GKQ ++++ EV+ L R++ P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 98 YLLALLG-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ G Y + LV +Y A+ L+ H P A I A
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------ITHGAL 135
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL +LH H +IHRD K+ NILL + K++DFG A I S + +GT
Sbjct: 136 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPY 186
Query: 214 YVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPI 248
++APE L G K DV+S G+ +EL + P+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 49 VGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G FG VY+G L + VAIK L D+A +EFK E + RL+ P ++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKLDWETRLRIALE 151
LLG + + L +++ Y ++ L E L + +V S L+ + I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLG 210
A G+EFL H V+H+D + N+L+ + K+SD GL + + + + +L
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ +++PE + G + SD++SYGVVL E+ +
Sbjct: 190 IR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 35/279 (12%)
Query: 48 VVGHGGFG--LVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALL 103
V+G G FG +YR + V K ++ ++ + E+ +L L+ P ++A
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 104 GYCSDRRKLLVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ D LL+ ANGG L + + + E L + + ++H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHVSTRVLGTQGYVAPEYAL 221
++HRD K+ NI L K K+ DFG++KI GS+ + V+GT Y++PE
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---VVGTPYYMSPELCQ 174
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281
KSD+++ G VL ELLT + D P LV KI++ +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVV----------KIVQGNYTPV 221
Query: 282 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320
YS E+I + +Q + + RP +V+ +
Sbjct: 222 VSVYS-SELISL---VHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 46/135 (34%), Positives = 61/135 (45%), Gaps = 19/135 (14%)
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+IA KGL +LH +IHRD K SNILL + K+ DFG+ S + ++
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAG 161
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL------- 259
GT Y+APE + SDV+S G+ LLE+ R P P GE L
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPIELLS 218
Query: 260 --VSWALPRLTDREK 272
V+ P L D
Sbjct: 219 YIVNMPNPELKDEPG 233
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 52 GGFGLVY--RGVLSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLR-SPYLLALLGY 105
G FG VY + + G AIK++ D K K E ++ SPY+ L
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ L LV +Y+ NGG L G DW + IA E G+E LH+
Sbjct: 66 FQSKDYLYLVMEYL-NGGDCASLIKTLGGLP----EDW-AKQYIA-EVVLGVEDLHQR-- 116
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
+IHRD K N+L+D+ H K++DFGL++ G + + +GT Y+APE L
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVG 169
Query: 225 LTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
SD +S G V+ E L G P P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 48 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFK---MEVELLG-RLRSPYLLAL 102
++G G FG V+ L + AIK + + +D+ + +E +L P+L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 103 LGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
YC+ + K V +Y+ G L H+ + K D A E GL+FL
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-------KFDLPRATFYAAEIICGLQFL 112
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H S +++RD K NILLD + H K++DFG+ K + G + GT Y+APE
Sbjct: 113 H---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEI 167
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
L T D +S+GV+L E+L G+ P
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-17
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-------FKMEVELLGRL 94
K ++G G FG VY G+ S+G +A+K + +D E+ LL L
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 95 RSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---- 150
+ ++ LG D L ++ GG SVA+ L+ L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGG------------SVAALLNNYGAFEETLVRNF 111
Query: 151 --EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-----IGSDKAGGH 203
+ KGL +LH + +IHRD K +NIL+D K+SDFG++K S K G
Sbjct: 112 VRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+ + G+ ++APE T K+D++S G +++E+LTG+ P
Sbjct: 169 RPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLGRLRS 96
+G G +G+V V GRKVAIK + + F E++LL LR
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 97 PYLLALL-----GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IA 149
++ LL D + +V + M + L+ S + + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT----DDHIQYFL 109
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRV 208
+ +GL++LH S VIHRD K SNIL++ N K+ DFGLA+ + D+ T
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 209 LGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
+ T+ Y APE L+ TK+ D++S G + ELLT +
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 86/310 (27%), Positives = 136/310 (43%), Gaps = 69/310 (22%)
Query: 45 KSNVVGHGGFGLV--YRGVLSN---GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 98
K V+G G FG V Y +N G VA+K L + G+Q +K E+ +L L
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 99 LLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
++ G CS++ L+ +Y+ G L+++L P + KL+ L A + +G
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKH-------KLNLAQLLLFAQQICEG 119
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG-- 213
+ +LH S IHRD + N+LLD + K+ DFGLAK + GH RV G
Sbjct: 120 MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRV-REDGDS 172
Query: 214 ---YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270
+ A E + SDV+S+GV L ELLT + +
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTH------------------CDSKQSPP 214
Query: 271 EKILEIMDPALEGQYSMKEVI-----------------QVAAIAAMCVQPEADYRPLMAD 313
+K E++ P +GQ ++ +I +V + C + EA +RP
Sbjct: 215 KKFEEMIGPK-QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP---- 269
Query: 314 VVQSLVPLVK 323
+SL+P++K
Sbjct: 270 TFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 72/282 (25%), Positives = 137/282 (48%), Gaps = 28/282 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 102 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L Y +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLH 133
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 219
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 187
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 276
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 277 ------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312
+D +E + S KE++Q + +P + PL+A
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLK--IAKPLSSLTPLIA 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 36 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 94
L G F +VG+G +G VY+G + G+ AIK+MD G + E+E K E+ +L +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 95 R-----SPYLLALLGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
+ Y A + D + LV ++ G + + + N+ + L E
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEEWIA 114
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
I E +GL LH+H VIHRD K N+LL +N K+ DFG++ D+ G +T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 170
Query: 207 RVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 248
+GT ++APE KSD++S G+ +E+ G P+
Sbjct: 171 -FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 45 KSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQ----AGKQGE--DEFKMEVELLGRLRS 96
K +G G F Y R V + G +A+K + + +Q E + + E+ L+ RL
Sbjct: 4 KGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 97 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAA 153
P+++ +LG C D L ++MA GG HL G +V + +
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMA-GGSVSHLLSKYGAFKEAVI--------INYTEQLL 113
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLA-KIGSDKAG-GHVSTRVLG 210
+GL +LHE+ +IHRD K +N+L+D +++DFG A ++ + G G ++LG
Sbjct: 114 RGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 211 TQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269
T ++APE L G +S DV+S G V++E+ T + P + K S L+ + + T
Sbjct: 171 TIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATT 228
Query: 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
I E + P L + C++ + + RP ++++
Sbjct: 229 APSIPEHLSPGLRD------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-------EVELLGRL 94
+ + +G G +G+V G KVAIK K E + E+++L R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISPFEHQTFCQRTLREIKILRRF 60
Query: 95 RSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
+ ++ +L + S +V + M L + + + SN ++ LR
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFLYQI-LR- 117
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS--T 206
GL+++H S V+HRD K SN+LL+ N K+ DFGLA+I +D H T
Sbjct: 118 ------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLT 167
Query: 207 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 248
+ T+ Y APE L TK+ D++S G +L E+L+ R P+
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 48 VVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKM-----EVELLGRLRSPYLLA 101
VVG G +G+V + + G VAIK ++ +DE EV++L +LR ++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIVN 64
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L + +L LV++Y+ L+ P G L + + + + +
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLELLEASP-GG-------LPPDAVRSYIWQLLQAIAYC 116
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H H +IHRD K NIL+ ++ K+ DFG A+ + ++ V T+ Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGR 245
+ K DV++ G ++ ELL G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEF------KMEVELLGRLRSPYLL 100
V+G G FG V L ++ A+K++ + +D+ K + L G+ P+L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 101 ALLGYC---SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 156
L + + R V +Y+ G L H+ + + D E R R A E GL
Sbjct: 60 QL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-------RFD-EPRARFYAAEIVLGL 109
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 215
+FLHE +I+RD K N+LLD H K++DFG+ K G G V+T GT Y+
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG---ILGGVTTSTFCGTPDYI 163
Query: 216 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVPID 249
APE L+ + D ++ GV+L E+L G+ P +
Sbjct: 164 APE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 75/260 (28%), Positives = 106/260 (40%), Gaps = 54/260 (20%)
Query: 46 SNVVGHGGFGLV-YRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL-- 102
S V+G G G V +S+G A+K++D G D+ + + E+ L + +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 103 ---LGYCSDRRK-------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
D R LV DY G L++ + +N R E
Sbjct: 97 HEDFAK-KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN------------RTFREH 143
Query: 153 AKGLEFL-------HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
GL F+ H H S +IHRD KS+NILL N K+ DFG +K+ + V
Sbjct: 144 EAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
GT YVAPE + K+D++S GV+L ELLT L
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT--------------------LK 242
Query: 266 RLTDREKILEIMDPALEGQY 285
R D E + E+M L G+Y
Sbjct: 243 RPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRK-VAIKLM---DQAGKQGEDEFKMEVELLGRLRSPY 98
+ VG G FG V+ A+K+M + + E E +L + P+
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ L D+R L ++ +Y+ G L +L + ++ T L A E LE
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-------STGLFYASEIVCALE 115
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH S +++RD K NILLDK H K++DFG AK D+ + + GT Y+AP
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAP 167
Query: 218 E-YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255
E GH D ++ G+++ E+L G P + P G
Sbjct: 168 EVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM----------DQAGKQGEDEFKMEVELLGR 93
K ++G G +G VY + ++ G +A+K + D K + E+E L
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 94 LRSPYLLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-- 150
L ++ LG+ + L ++ +Y+ G S+ S L R L
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGG-------------SIGSCLRTYGRFEEQLVR 111
Query: 151 ----EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
+ +GL +LH S ++HRD K+ N+L+D + K+SDFG++K D +
Sbjct: 112 FFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 207 RVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVP 247
+ G+ ++APE + + K D++S G V+LE+ GR P
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 36 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 94
L G F VVG+G +G VY+G + G+ AIK+MD + E+E K+E+ +L +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69
Query: 95 R-----SPYLLALLGYC---SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
+ Y A + D + LV ++ G + + + G+ A K DW
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDWIAY- 125
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
I E +GL LH H VIHRD K N+LL +N K+ DFG++ D+ G +T
Sbjct: 126 -ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 207 RVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 248
+GT ++APE +SD++S G+ +E+ G P+
Sbjct: 181 -FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 48 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAG---KQGED---EFKMEVELLGRLRSPYLL 100
++G GGFG VY ++ G+ A+K +D+ KQGE ++ + L+ P+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 101 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
+ + + + + D M G L HL + V S E +R A E GLE
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFS----EKEMRFYATEIILGLEH 112
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
+H V++RD K +NILLD++ H ++SD GLA S K H S +GT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS---VGTHGYMAPE 165
Query: 219 YALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNK 252
G + +D +S G +L +LL G P +K
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 35/211 (16%)
Query: 48 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKM-------EVELLGRLRSPYL 99
+VG G +G+V + G+ VAIK + ED+ KM E+ +L +LR L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDD-KMVKKIAMREIRMLKQLRHENL 62
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ L+ +++L LV++++ + L + YP NG LD + + +G+E
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NG-------LDESRVRKYLFQILRGIE 114
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
F H H +IHRD K NIL+ ++ K+ DFG A+ + A G V T + T+ Y AP
Sbjct: 115 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAP 169
Query: 218 EYALTGHLTTKS----DVYSYGVVLLELLTG 244
E L G TK D+++ G ++ E+LTG
Sbjct: 170 EL-LVG--DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 56/184 (30%), Positives = 97/184 (52%), Gaps = 14/184 (7%)
Query: 65 GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---RRKLLVYDYMAN 120
G +VA+K L ++G + K E+E+L L ++ G C++ L+ +++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180
G L+E+L P N +K++ + +L+ A++ KG+++L S +HRD + N+L++
Sbjct: 93 GSLKEYL-PRN-----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 143
Query: 181 KNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 239
K+ DFGL K I +DK V + + APE + SDV+S+GV L
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 240 ELLT 243
ELLT
Sbjct: 204 ELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 50 GHGGFGLVYRGVLSN-GRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
G G FG VY+ G A K++ ++ ++ ED F +E+++L + P ++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAYF 72
Query: 108 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW---ETRLR-IALEAAKGLEFLHEHC 163
KL + +GG +S+ +L+ E ++R + + + L FLH H
Sbjct: 73 YENKLWILIEFCDGG---------ALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
VIHRD K+ NILL + K++DFG+ AK S +GT ++APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 223 GHLTT-----KSDVYSYGVVLLELLTGRVP 247
K+D++S G+ L+EL P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 48 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAG---KQGED---EFKMEVELLGRLRSPYLL 100
++G GGFG VY ++ G+ A+K +D+ KQGE ++ + L+ P+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 101 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
+ + + + + D M G L HL + V S E +R A E GLE
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFS----EAEMRFYAAEIILGLEH 112
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
+H V++RD K +NILLD++ H ++SD GLA S K H S +GT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS---VGTHGYMAPE 165
Query: 219 YALTG-HLTTKSDVYSYGVVLLELLTGRVP 247
G + +D +S G +L +LL G P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 49 VGHGGFGLVYRGVL-SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V+ G L ++ VA+K + + +F E +L + P ++ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCS 164
+ ++ + +V + + G L + +L + +++ AA G+E+L +HC
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL------RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD----KAGGHVSTRVLGTQGYVAPEYA 220
IHRD + N L+ + K+SDFG+++ D GG V + APE
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV----KWTAPEAL 168
Query: 221 LTGHLTTKSDVYSYGVVLLELLT-GRVP 247
G +++SDV+S+G++L E + G VP
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYC 106
++G G FG V++G L + VA+K + Q + +F E +L + P ++ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ R+ + +V + + G L +L + ++ AL+AA G+ +L S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQLVKFALDAAAGMAYLE---SK 112
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 225
IHRD + N L+ +N K+SDFG+++ D + + + + APE G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRY 171
Query: 226 TTKSDVYSYGVVLLELLT 243
+++SDV+SYG++L E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 49 VGHGGFGLVYR-GVLSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLALL 103
+G G G+V++ G VA+K + A ++ E E++ L + PY++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 104 G-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ +LV +YM L E L + + + + KG+ ++H +
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVL-----RDEERPLPEAQVK-SYMRMLLKGVAYMHAN 118
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
++HRD K +N+L+ + K++DFGLA++ S++ S +V T+ Y APE L
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LY 173
Query: 223 G--HLTTKSDVYSYGVVLLELLTGR 245
G D+++ G + ELL G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 48 VVGHGGFGLVY--RGVL--SNGRKVAIKLMDQAGKQGEDEF--KMEVELLGRLRSPYLLA 101
V+G G FG V+ R + G+ A+K++ +A + D KME ++L + P+++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 102 L-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L + ++ + L+ D++ G L L S V + + + +A E A L+ LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEE-DVKFYLA-ELALALDHLH 115
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
S +I+RD K NILLD+ H K++DFGL+K D S GT Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170
Query: 221 -LTGHLTTKSDVYSYGVVLLELLTGRVP 247
GH T +D +S+GV++ E+LTG +P
Sbjct: 171 NRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 48 VVGHGGFGLVYRGVLSNGRK----VAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLL 100
V+G G FG V G L K VAIK + +AG KQ D F E ++G+ P ++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRD-FLSEASIMGQFDHPNII 68
Query: 101 ALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L G + + ++V +YM NG L L +G +V + LR A G+++L
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG---MLR---GIASGMKYL 122
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-------KAGGHVSTRVLGTQ 212
+ +HRD + NIL++ N KVSDFGL+++ D GG + R
Sbjct: 123 SDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR----- 174
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ APE T+ SDV+SYG+V+ E+++
Sbjct: 175 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFK---MEVELLGRLRS-PYLLAL 102
V+G G FG V L +V AIK++ + +D+ E +L P+L AL
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 103 LGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
+C R V +Y+ G L + + K D E R R A E L F
Sbjct: 62 --HCCFQTKDRLFFVMEYVNGGDLMFQI-------QRSRKFD-EPRSRFYAAEVTLALMF 111
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH H VI+RD K NILLD H K++DFG+ K G G +T GT Y+APE
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI--LNGVTTTTFCGTPDYIAPE 166
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251
D ++ GV++ E++ G+ P + +
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-16
Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 87 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
E++++ RSPY+++ G + ++ + ++M G L + + E
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-------DRIYKKGGPIPVEIL 105
Query: 146 LRIALEAAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 204
+IA+ +GL +L+ H ++HRD K SNIL++ K+ DFG+ S + +
Sbjct: 106 GKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSI 158
Query: 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257
+ +GT Y++PE G T KSDV+S G+ ++EL G+ P + +G
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 43 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 99 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+++L Y + LV M G L+ H+Y N D E + A E GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY-----NMGNPGFDEERAVFYAAEITCGLE 116
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVA 216
LH +++RD K NILLD H ++SD GLA +I G + RV GT GY+A
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRV-GTVGYMA 169
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE T D + G ++ E++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 43 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 99 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ L Y + LV M G L+ H+Y N + E L A E GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY-----NMGNPGFEEERALFYAAEILCGLE 116
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVA 216
LH ++RD K NILLD H ++SD GLA KI G + RV GT GY+A
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIRGRV-GTVGYMA 169
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252
PE T D + G ++ E++ G+ P K
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 46 SNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRS---PYL 99
+G G +G VY+ L+ GR VA+K + ++G + E+ LL +L S P +
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 100 LALLGYCS---DRRKL---LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ LL C R+L LV++++ + L +L S L ET + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-----SKCPKPGLPPETIKDLMRQLL 117
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS-TRVLGTQ 212
+G++FLH H ++HRD K NIL+ + K++DFGLA+I S ++ T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF----EMALTSVVVTL 170
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
Y APE L T D++S G + EL
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 48 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAG---KQGEDEFKM-EVELLGRLR-SPY 98
V+G G +G V+ G G+ A+K++ +A K E E ++L +R P+
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 99 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L+ L + +D + L+ DY+ G L HLY E R+ IA E L+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFTES-EVRVYIA-EIVLALD 119
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
LH+ +I+RD K NILLD H ++DFGL+K + + GT Y+AP
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175
Query: 218 EYALTGHLTTKS--DVYSYGVVLLELLTGRVPIDVN 251
E G D +S GV+ ELLTG P V+
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM------EVELLGRLRSPYLLA 101
+G G +G+V++ G+ VAIK ++ ED+ + E+ +L +L+ P L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES----EDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L+ +RKL LV++Y + L E G K +I + + + F H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH 117
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+H IHRD K NIL+ K K+ DFG A+I + G T + T+ Y APE
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPEL- 171
Query: 221 LTGHLT--TKSDVYSYGVVLLELLTG 244
L G DV++ G V ELLTG
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 49 VGHGGFGLVYRGVLS---NGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG V +G+ + + VA+K++ D +DE E ++ +L +PY++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
G C +LV + G L + L + V K + + + G+++L E
Sbjct: 63 GICEAESWMLVMELAELGPLNKFL---QKNKHVTEK----NITELVHQVSMGMKYLEET- 114
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD----KAGGHVSTRVLGTQGYVAPE 218
+HRD + N+LL +AK+SDFGL+K +G+D KA H V + APE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV----KWYAPE 168
Query: 219 YALTGHLTTKSDVYSYGVVLLE 240
++KSDV+S+GV++ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEF------KMEVELLGRLRSPYLL 100
V+G G FG V ++ AIK + + DE K E R P+L+
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 101 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
L + ++ V +Y A G L H++ V S E R A GL++
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFS----EPRAVFYAACVVLGLQY 116
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LHE+ +++RD K N+LLD K++DFGL K G ++ GT ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPE 171
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
T D + GV++ E+L G P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 49 VGHGGFGLVYRG--VLSNGR--KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG+V RG S G+ VA+K L D+F E ++ L L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLY-PANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
G ++V + G L + L A G +++ D+ A++ A G+ +L
Sbjct: 63 GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLE-- 114
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ-GYVAPEYAL 221
S IHRD + NILL + K+ DFGL + +V L + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
T + SDV+ +GV L E+ T G P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG- 104
+G G +G VY+ VL V + + + + E +F ME+++L + SPY++ G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ + + +YM + G + LY + + RI KGL+FL E +
Sbjct: 68 FFIEGAVYMCMEYM-DAGSLDKLY---AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
+IHRD K +N+L++ N K+ DFG+ S ++ +G Q Y+APE +G
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 225 L------TTKSDVYSYGVVLLELLTGRVP 247
T +SDV+S G+ +LE+ GR P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 83/293 (28%), Positives = 123/293 (41%), Gaps = 59/293 (20%)
Query: 49 VGHGGFGLVYRG----VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G+G FG V G +S R V +L A + F EV+ L P +L LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 105 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
C + LLV ++ G L+ +L G + ++ D R+A E A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--VLQRMACEVASGLLWLHQA- 119
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--------IGSDKAGGHVSTRVLGTQGYV 215
IH D N L + K+ D+GLA I D V R ++
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA--VPLR------WL 169
Query: 216 APEYA-------LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP----SGEGVLVSWAL 264
APE L T KS+++S GV + EL T ++P S E VL
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVL----- 219
Query: 265 PRLTDREKILEIMDPALEGQYSMK--EVIQVAAIAAMC-VQPEADYRPLMADV 314
+ RE+ +++ P L+ +YS + EV+Q C + PE RP +V
Sbjct: 220 -KQVVREQDIKLPKPQLDLKYSDRWYEVMQ------FCWLDPET--RPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 43 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 99 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+++L Y + LV M G L+ H+Y + + + A E GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLE 116
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
LH+ +++RD K NILLD + H ++SD GLA + G + RV GT GY+AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAP 170
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252
E T D ++ G +L E++ G+ P K
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 3e-15
Identities = 64/262 (24%), Positives = 130/262 (49%), Gaps = 26/262 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G V+ + ++ G++VAIK ++ + ++ E+ ++ L++P ++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 102 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L + +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV--------TETCMDEAQIAAVCRECLQALEFLH 132
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 219
+ VIHRD KS N+LL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 AN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 276
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246
Query: 277 ------MDPALEGQYSMKEVIQ 292
++ +E + S KE++Q
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 39/288 (13%)
Query: 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLG 92
G F +G G F +VY+ + L +GR VA+K +MD K +D K E++LL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KARQDCLK-EIDLLK 57
Query: 93 RLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIAL 150
+L P ++ L + +L + +A+ G + + + + W+ +++
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
LE +H ++HRD K +N+ + K+ D GL + S K S ++G
Sbjct: 117 ---SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270
T Y++PE KSD++S G +L E+ + P +K + L
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LYSL 216
Query: 271 EKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
K +E D P YS ++ + + C+ P+ + RP ++ V+Q
Sbjct: 217 CKKIEKCDYPPLPADHYSE----ELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+G G +G VY+ ++ G VAIK++ + + E+ +L R P ++A G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 161
R KL +V +Y G LQ+ G S L+IA E KGL +LHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---------ELQIAYVCRETLKGLAYLHE 119
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPE 218
IHRD K +NILL ++ K++DFG+ A++ + ++ R +GT ++APE
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-----IAKRKSFIGTPYWMAPE 171
Query: 219 YA---LTGHLTTKSDVYSYGVVLLELLTGRVP 247
A G K D+++ G+ +EL + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL 103
+ VG G +G V + GRKVAIK + + + + E+ LL + ++ LL
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 104 G-YCSDRRKLLVYD-YMANGGLQEHLYPANGSNSVAS-KLDWETRLRIALEAAKGLEFLH 160
+ D Y+ HL A+ +N V KL + + + +GL+++H
Sbjct: 81 DVFTPASSLEDFQDVYLVT-----HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
S +IHRD K SNI ++++ K+ DFGLA+ D+ G+V+TR Y APE
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 187
Query: 221 LT-GHLTTKSDVYSYGVVLLELLTGRV 246
L H D++S G ++ ELLTG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 72/282 (25%), Positives = 136/282 (48%), Gaps = 28/282 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G VY + ++ G++VAIK M+ + ++ E+ ++ + P ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 102 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L Y +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLH 132
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 219
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 276
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246
Query: 277 ------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312
++ +E + S KE++Q + +P + PL+A
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLK--IAKPLSSLTPLIA 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 21/156 (13%)
Query: 97 PYLLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 152
P+L L +C+ + K V +Y+ G L H+ + + D E R R A E
Sbjct: 56 PFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFD-EARARFYAAEI 105
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
GL+FLH +I+RD K N+LLDK+ H K++DFG+ K + G ++ GT
Sbjct: 106 ICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTP 160
Query: 213 GYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
Y+APE L G +S D +S+GV+L E+L G+ P
Sbjct: 161 DYIAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 9/93 (9%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL+++H S V+HRD K SNIL+++N K+ DFGLA+I + G+VSTR
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 214 YVAPEYALTGH-LTTKSDVYSYGVVLLELLTGR 245
Y APE LT + D++S G + E+L G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 42/112 (37%), Positives = 59/112 (52%), Gaps = 19/112 (16%)
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH--- 203
+IA+ K LE+LH S VIHRD K SN+L+++N K+ DFG++ G+
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVD 156
Query: 204 --VSTRVLGTQGYVAPEY----ALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
T G + Y+APE KSDV+S G+ ++EL TGR P D
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 67/245 (27%), Positives = 98/245 (40%), Gaps = 54/245 (22%)
Query: 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLM--DQAGKQGEDE-FKMEVELLGRLRS 96
F V+G G FG V+ + +V A+K++ K+ + + E ++L S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDW----ETRLRIALE 151
P+++ L D L LV +YM G L L + D R IA E
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL----------IRKDVFPEETARFYIA-E 109
Query: 152 AAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---------------- 194
L+ +H+ IHRD K NIL+D + H K++DFGL K
Sbjct: 110 LVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 195 IGSDKAGGHVSTR-----------VLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELL 242
+ V R +GT Y+APE L G + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
Query: 243 TGRVP 247
G P
Sbjct: 225 YGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 43 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F V+G GGFG V V + G+ A K +++ ++GE E +L ++ S +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 99 LLALLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+++L Y + + LV M G L+ H+Y N D + + A E GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-----NMGNPGFDEQRAIFYAAELCCGL 115
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
E L +++RD K NILLD H ++SD GLA G V RV GT GY+A
Sbjct: 116 EDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRV-GTVGYMA 169
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE T D + G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 48 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFK---MEVELLG-RLRSPYLLAL 102
V+G G FG V L G A+K + + +D+ + +E +L +P+L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 103 LGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
YC+ + K V +++ G L H+ + D A E GL+FL
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFL 112
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRVLGTQGYVA 216
H S +I+RD K N++LD++ H K++DFG+ K G ++A + GT Y+A
Sbjct: 113 H---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-----STFCGTPDYIA 164
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE T D +S+GV+L E+L G+ P
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 87 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
E+++L SPY++ G + SD + ++M G L + L A ++ E
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-------KEAKRIPEEIL 105
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
++++ +GL +L E ++HRD K SNIL++ K+ DFG+ S + ++
Sbjct: 106 GKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMA 159
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
+GT+ Y++PE H + +SD++S G+ L+EL GR PI
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 48 VVGHGGFGLVYRG-VLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G G FG +Y S+ IK +D + + ++ K EV LL +++ P ++
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSN-SVASKLDWETRLRIALEAAKGLEFLHEH 162
+ +L +V +Y G L + + G S L W ++I+L GL+ +H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GLKHIHDR 120
Query: 163 CSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
++HRD KS NI L KN AK+ DFG+A+ +D ++ +GT Y++PE
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQ 175
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251
K+D++S G VL EL T + P + N
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 100
F K + +G G G+V++ +G +A KL+ K ++ E+++L SPY++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 101 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G + SD + ++M G L + L A ++ + ++++ KGL +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
E ++HRD K SNIL++ K+ DFG+ S + ++ +GT+ Y++PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPER 173
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
H + +SD++S G+ L+E+ GR PI
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 60/235 (25%), Positives = 117/235 (49%), Gaps = 18/235 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G VY + ++ G++VAIK M+ + ++ E+ ++ ++P ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 102 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L Y +V +Y+A G L + + + +D + E + L+FLH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALDFLH 132
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 219
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKI 273
K D++S G++ +E++ G P ++ N ++ + P L + E++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 49 VGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G GGFG V + + G+ A K +++ ++G + +E +L ++ S ++++L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ L LV M G L+ H+Y + N + GLE LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP---GFPEPRACFYTAQIISGLEHLHQR- 116
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+I+RD K N+LLD + + ++SD GLA K G K G+ GT G++APE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELL 169
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
D ++ GV L E++ R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 87 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
E+++L SPY++ G + SD + ++M G L + L A ++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPENIL 101
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
+I++ +GL +L E ++HRD K SNIL++ K+ DFG++ D ++
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 155
Query: 206 TRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 248
+GT+ Y++PE L G H T +SD++S G+ L+E+ GR PI
Sbjct: 156 NSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPY 98
F+ V+G G FG V AIK++ + +D+ + +E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
L L C + R V +Y+ G L H+ K + A E + GL
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVGL 114
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 215
FLH +I+RD K N++LD H K++DFG+ K + V+TR GT Y+
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYI 168
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
APE D ++YGV+L E+L G+ P D
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPY 98
G F K VV +GL + KVA+K++ E E M E++++ L +
Sbjct: 45 AGAFGK--VVEATAYGLSKSDAVM---KVAVKMLKPTAHSSEREALMSELKIMSHL-GNH 98
Query: 99 L--LALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
+ LLG C+ L++ +Y G L L S L E L + + AKG
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLR----RKR-ESFLTLEDLLSFSYQVAKG 153
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHV---STRVLGT 211
+ FL S IHRD + N+LL K+ DFGLA+ I +D +V + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYVVKGNARL--P 206
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
++APE T +SDV+SYG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 96 SPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
+P+L+ L + + R LV +Y+ G L H+ KL E A E
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-------QRQRKLPEEHARFYAAEICI 107
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
L FLHE +I+RD K N+LLD + H K++D+G+ K G G ++ GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNY 162
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 48 VVGHGGFGLVYRGVLSN--GR----KVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
+G G FG V + GR VA+K++ + E + E LL ++ P+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 101 ALLGYCS-DRRKLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETR----- 145
L G CS D LL+ +Y G L+ L Y + N +S LD
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 146 ---LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202
+ A + ++G+++L E ++HRD + N+L+ + K+SDFGL++ ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 203 HVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLT 243
++ ++A E +L H+ TT+SDV+S+GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 48 VVGHGGFGLVYRGVL----SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLL 100
++G G FG V +L + GR A+K++ + +DE E +L R P+L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 101 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
AL + + R V +Y G L HL ++ E R R E LE+
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHL--------SRERVFTEERARFYGAEIVSALEY 110
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-SDKAGGHVSTRVLGTQGYVAP 217
LH S V++RD K N++LDK+ H K++DFGL K G SD A GT Y+AP
Sbjct: 111 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAP 164
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E D + GVV+ E++ GR+P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 48 VVGHGGFGLVYRGVL----SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLL 100
++G G FG V +L + G+ A+K++ + +DE E +L R P+L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 101 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 158
AL + + R V +Y G L HL V S E R R E L +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFS----EDRARFYGAEIVSALGY 110
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH S V++RD K N++LDK+ H K++DFGL K + G GT Y+APE
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 165
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
D + GVV+ E++ GR+P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 103
V+G G FG V L +GR A+K++ + +D+ + E +L R+ L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 104 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
C + R V +++ G L H+ + + D E R R A E L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-------RFD-EARARFYAAEITSALMFLH 113
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ +I+RD K N+LLD H K++DFG+ K G G ++ GT Y+APE
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEIL 168
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVPID 249
D ++ GV+L E+L G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 43 FSKSN-----VVGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQG-EDEFKMEVEL 90
F +SN +G G FG V+ + V +K + + + + EF+ E+++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 91 LGRLRSPYLLALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASK---LDWETRL 146
+L ++ LLG C + ++ +Y G L++ L A S K L + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKV 120
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVS 205
+ + A G++ L +HRD + N L+ KVS L+K + + + +
Sbjct: 121 ALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ ++APE +TKSDV+S+GV++ E+ T
Sbjct: 178 ALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 49 VGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRL-RSPYLL 100
+G G FG V + + VA+K L D A ++ + E+E++ + + ++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIAL 150
LLG C+ L +V +Y A+G L++ L + L + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGS-----DKAGGHV 204
+ A+G+EFL S IHRD + N+L+ ++ K++DFGLA+ I G +
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ ++APE T +SDV+S+GV+L E+ T
Sbjct: 197 PVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQ-AGKQGED-EFKM-EVELLGRLRSPY 98
F+ V+G G FG V ++ AIK++ + Q +D E M E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
L L C + R V +Y+ G L H+ K + A E A GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 215
FLH S +I+RD K N++LD H K++DFG+ K + G +TR GT Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYI 168
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
APE D +++GV+L E+L G+ P D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
VG G +G V G +VA+K + Q+ + ++ E+ LL ++ ++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSV-ASKLDWETRLRIALEAAKGLEFLHEHC 163
+ R L ++ + L HL A+ +N V KL + + + +GL+++H
Sbjct: 84 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
S +IHRD K SN+ ++++ K+ DFGLA+ D+ G+V+TR Y APE L
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 224 -HLTTKSDVYSYGVVLLELLTGR 245
H D++S G ++ ELLTGR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 48 VVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL- 102
++G G FG ++ ++G+ A+K++ + +DE E +L R P+L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHE 161
+ + R V +Y+ G L HL ++ E R R E L++LH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL--------SRERVFSEDRTRFYGAEIVSALDYLH- 112
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
S +++RD K N++LDK+ H K++DFGL K G A GT Y+APE
Sbjct: 113 --SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLE 168
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVP 247
D + GVV+ E++ GR+P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 49 VGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YC 106
+G G G+V S GR+VA+K MD +Q + EV ++ + P ++ + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+V +++ G L + + ++++ E + L K L FLH
Sbjct: 87 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIATVCLAVLKALSFLHAQ---G 135
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPEYALTG 223
VIHRD KS +ILL + K+SDFG A++ + V R ++GT ++APE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPEVISRL 190
Query: 224 HLTTKSDVYSYGVVLLELLTGRVP 247
T+ D++S G++++E++ G P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL 99
TG F + + H G G Y + +K I M Q E +L L P++
Sbjct: 28 TGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQV-----QHVAQEKSILMELSHPFI 80
Query: 100 LALL-GYCSDRRKLLVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLE 157
+ ++ + + R + +++ G L HL A N VA E L E
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--------AFE 132
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH S +I+RD K N+LLD H KV+DFG AK D+ + + GT Y+AP
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 218 EYALT-GHLTTKSDVYSYGVVLLELLTGRVP 247
E + GH D ++ GV+L E + G P
Sbjct: 185 EVIQSKGH-GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 8e-14
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRS-PYLLALLGY 105
+G G FG VY G VAIK M + E+ + EV+ L +L P ++ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFLHEHC 163
+ +L V++YM Q L + E+ +R I + +GL +H+H
Sbjct: 67 FRENDELYFVFEYMEGNLYQ--LMKDRKGKPFS-----ESVIRSIIYQILQGLAHIHKH- 118
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGS-----DKAGGHVSTRVLGTQGYVAP 217
HRD K N+L+ K++DFGLA+ I S D +VSTR Y AP
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD----YVSTR-----WYRAP 167
Query: 218 EYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
E L + ++ D+++ G ++ EL T R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 34/172 (19%)
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV--- 204
IA+ K L +L E +IHRD K SNILLD+N + K+ DFG++ G +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--------GQLVDS 161
Query: 205 --STRVLGTQGYVAPEYALTGHLT---TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV- 258
TR G + Y+APE +SDV+S G+ L E+ TG+ P + +
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221
Query: 259 -LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
+V P I+ + E ++S V + +C+ + RP
Sbjct: 222 QVVKGDPP----------ILSNSEEREFSPSFVNFI----NLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G F VYR L + + VA+K +MD +Q D K E++LL +L P ++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ--DCVK-EIDLLKQLNHPNVIK 66
Query: 102 LL-GYCSDRRKLLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L + D +V + G L + + Y + + W + ++ +E +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSAVEHM 122
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H S V+HRD K +N+ + K+ D GL + S K S ++GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
KSD++S G +L E+ + P +K + + +KI + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLFSLCQKIEQCDYP 226
Query: 280 ALEGQ-YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
L + YS K + + +MC+ P+ D RP + V Q
Sbjct: 227 PLPTEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 48 VVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL- 102
++G G FG ++ + GR A+K++ + +DE E +L R P+L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHE 161
+ + R V +Y G L HL V S E R R E L++LH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL----SRERVFS----EDRARFYGAEIVSALDYLHS 113
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
+ V++RD K N++LDK+ H K++DFGL K G K G + T GT Y+APE
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKT-FCGTPEYLAPEVLE 169
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVP 247
D + GVV+ E++ GR+P
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLM--DQAGKQGEDEFKMEV-ELLGRLRSPY 98
F V+G G FG V + ++V A+KL+ + K+ + F E +++ S +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ L D + L +V +YM G L + SN + W R A E L+
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDIPE-KW-ARFYTA-EVVLALD 156
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H S IHRD K N+LLDK+ H K++DFG + D G +GT Y++P
Sbjct: 157 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISP 212
Query: 218 EYALT----GHLTTKSDVYSYGVVLLELLTGRVP 247
E + G+ + D +S GV L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLG 210
K L+++H S VIHRD K SNILL+ + K++DFGLA+ + V T +
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 211 TQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGR 245
T+ Y APE L TK D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL++LH S ++HRD K N+L++ N K+ DFGLA++ H++ V+ TQ
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 214 YVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
Y APE L G H T+ D++S G + ELL R+ P
Sbjct: 170 YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 49 VGHGGFGLVYRGVLSNGRKV-AIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL-L 103
+G G FG V + + +++ A+K + +A + E +L ++ P+++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ S + LV ++ G L HL + ++ + L ALE LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF-YTAELLCALEN------LHKF- 112
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
VI+RD K NILLD H + DFGL K+ + + GT Y+APE L G
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPEL-LLG 167
Query: 224 HLTTKS-DVYSYGVVLLELLTGRVPI---DVNK 252
H TK+ D ++ GV+L E+LTG P +VN+
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 48 VVGHGGFG--LVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-G 104
VVG G FG L+ + V S+ + ++ ++ + E LL +++ P ++A
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ +D +V +Y G L + + G + L W ++ + G++ +HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
V+HRD KS NI L +N K+ DFG A++ + G + T V GT YV PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYV-GTPYYVPPEIWENM 175
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVN 251
KSD++S G +L EL T + P N
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 49 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 101
+G G FG+VY G + +VA+K ++++ E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 102 LLGYCSDRR-KLLVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALEAAKGLE 157
LLG S + L+V + MA+G L+ +L P +N + +++A E A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+L+ + +HRD + N ++ +F K+ DFG+ + + + L ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT 243
E G TT SD++S+GVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 49 VGHGGFGLVYRGVLSN--GRKVAIKLMDQAGKQGEDEFKM---EVELLGR---LRSPYLL 100
+G G FG VY+ V R A+K++ + + E E +L R SP+++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 101 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGLEF 158
L + +D LV DYM+ G L HL G S E R + + E LE
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFS-------EDRAKFYIAELVLALEH 111
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LH++ +++RD K NILLD H + DFGL+K ++ + GT Y+APE
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE 166
Query: 219 YALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L TK D +S GV++ E+ G P
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 98
F ++VG G FG V + G A+K+M ++ ++ F+ E ++L SP+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGL 156
+ L D+ L LV +Y G L L N + D E + L E +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLL------NRYEDQFD-EDMAQFYLAELVLAI 115
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHV-STRVLGTQGY 214
+H+ +HRD K N+L+D+ H K++DFG A++ ++K V S +GT Y
Sbjct: 116 HSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK---MVNSKLPVGTPDY 169
Query: 215 VAPEYALTGHLTTKS------DVYSYGVVLLELLTGRVP 247
+APE T + K D +S GV+ E++ GR P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 97 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
P+L+ L + ++ R V +Y+ G L H+ KL E + E +
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-------QRQRKLPEEHARFYSAEISLA 108
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L +LHE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYI 163
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
APE D ++ GV++ E++ GR P D+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 102
V+G G FG V ++G+ A+K++ + K+ E + M LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
KL V DY+ G L HL + E R R A E A L +LH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQ--------RERSFPEPRARFYAAEIASALGYLH 113
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
S +I+RD K NILLD H ++DFGL K G + + ++ GT Y+APE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVL 168
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
D + G VL E+L G P
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
F K +G G +G+VY+ G VA+K +D + E+ LL L P +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAK 154
+ LL KL LV++++ + L++ + + S + S L + +
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYL---------FQLLQ 111
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLGT 211
GL F H H V+HRD K N+L++ K++DFGLA +A G T + T
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-----RAFGVPVRTYTHEVVT 163
Query: 212 QGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
Y APE L + +T D++S G + E++T R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL+++H S V+HRD K SN+LL+ N K+ DFGLA+ S+K T + T+
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRW 173
Query: 214 YVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPI 248
Y APE L TT DV+S G + ELL GR P+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 52/309 (16%)
Query: 49 VGHGGFGLVY--RGVLSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRS---PYLLA 101
+G G +G V+ R + + GR VA+K + Q G++G + EV +L L + P ++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 102 LLGYCSDRR-----KL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 153
L C+ R KL LV++++ + L +L P G + ET + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-------ETIKDMMFQLL 120
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL+FLH H V+HRD K NIL+ + K++DFGLA+I S + T V+ T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 174
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI-----DVNKPSGEGVLVSWALPRLT 268
Y APE L T D++S G + E+ R P+ DV++
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG-------------- 219
Query: 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328
KIL+++ E + + A + QP + + ++ + L+
Sbjct: 220 ---KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276
Query: 329 PKISSSPSF 337
+IS+ +
Sbjct: 277 KRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLG 104
V+G G +G+V + G KVAIK ++ + D ++ E++LL LR P ++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 105 YC--SDRRKL----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
RR+ +V++ M + L+ +N + + L L + L++
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS-TRVLGTQGYVAP 217
+H + V HRD K NIL + + K+ DFGLA++ + + T + T+ Y AP
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 218 EYALTGHLTTKS----DVYSYGVVLLELLTGR 245
E L G +K D++S G + E+LTG+
Sbjct: 176 E--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-13
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRS 96
+ K +G G FG + +L +G++ IK ++ + + +E + EV +L ++
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK----LDWETRLRIALE 151
P ++ + L +V DY G L + + N V LDW ++ +AL+
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDWFVQICLALK 115
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
H H ++HRD KS NI L K+ K+ DFG+A++ + ++ +GT
Sbjct: 116 --------HVH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGT 164
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
Y++PE KSD+++ G VL E+ T
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 49 VGHGGFGLVYRGVLSNGR---KVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG V G L+ KVA+K M A + ++F E + P ++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 104 GYC---SDRRK----LLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKG 155
G C + +++ +M +G L L Y G L + ++ + A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY--LPTQMLVKFMTDIASG 124
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQ 212
+E+L S IHRD + N +L++N + V+DFGL+K G G ++ +
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++A E TTKSDV+S+GV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
+G G +G VY+ ++ G AIK++ + + E+ ++ + ++A G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 108 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167
R KL + GG + +Y G S S++ + +R E +GL +LH S
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLH---SKGK 127
Query: 168 IHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEYALT---G 223
+HRD K +NILL N H K++DFG+ A+I + A +GT ++APE A G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVERKG 184
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV---SWALPRLTDREK 272
D+++ G+ +EL + P+ P L+ ++ P+L D+ K
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 51/230 (22%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIK-LMDQAGKQGEDEFKM----EVELLGRLRSPYLLALL 103
G G FG VY+ + GR VA+K ++ K G F + E+++L +L+ P ++ L+
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLI 73
Query: 104 GYCSDR------RKLLVY---DYMAN--GGLQE----HLYPANGSNSVASKLDWETRLRI 148
+R ++ VY YM + GL E L + + L+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE------- 126
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGH 203
G+ +LHE+ ++HRD K++NIL+D K++DFGLA+ K GG
Sbjct: 127 ------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 204 VSTR----VLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 248
TR ++ T+ Y PE L TT D++ G V E+ T R PI
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRS---PYLL 100
+G G +G VY+ +G VA+K + + ED + EV LL RL + P ++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 101 ALLGYCSDRRK------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
L+ C+ R LV++++ + L+ +L L ET + + +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-----DKVPPPGLPAETIKDLMRQFLR 119
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GL+FLH +C ++HRD K NIL+ K++DFGLA+I S + T V+ T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWY 173
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELL 242
APE L T D++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 11/111 (9%)
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVS 205
++ + K L +L E VIHRD K SNILLD + + K+ DFG++ ++ KA
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA----K 171
Query: 206 TRVLGTQGYVAPEY----ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252
TR G Y+APE ++DV+S G+ L+EL TG+ P K
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 97 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
P+L+ L + ++ R V ++++ G L H+ KL E + E +
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM-------QRQRKLPEEHARFYSAEISLA 108
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L FLHE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYI 163
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250
APE D ++ GV++ E++ GR P D+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRS 96
F+ ++G G FG V L + +KVA+K++ D +EF E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 97 PYLLALLGYCSDRRK-------LLVYDYMANGGLQEHLYPAN-GSNSVASKLDWETRLRI 148
P ++ L+G R +++ +M +G L L + G L +T +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF--TLPLQTLVRF 118
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 207
++ A G+E+L S IHRD + N +L++N V+DFGL+ KI S
Sbjct: 119 MIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
L + ++A E TT SDV+++GV + E++T G+ P
Sbjct: 176 KLPVK-WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
F + +G G + VY+G + G VA+K + ++G + E+ L+ L+ ++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L KL LV++YM + L++++ ++ V LD T + KG+ F
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYM----DTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST---RVLGTQGYVA 216
HE+ V+HRD K N+L++K K++DFGLA+ G V+T V+ T Y A
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLAR----AFGIPVNTFSNEVV-TLWYRA 168
Query: 217 PEYALTGHL-TTKSDVYSYGVVLLELLTGR 245
P+ L +T D++S G ++ E++TGR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 25/194 (12%)
Query: 67 KVAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL-LVYDYMANGGL 123
KVA+K++ A ++ + E+E++ + + ++ LLG C+ L ++ +Y + G L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 124 QEHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 174
+E+L Y N + +L ++ + A + A+G+E+L S IHRD +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 175 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG-----YVAPEYALTGHLTTKS 229
N+L+ ++ K++DFGLA + H+ T G ++APE T +S
Sbjct: 169 RNVLVTEDNVMKIADFGLA-----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 230 DVYSYGVVLLELLT 243
DV+S+GV+L E+ T
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSN--GRKVAIKLMDQA----GKQGEDEFKMEVELLGRL 94
F V+G G +G V+ R V + G+ A+K++ +A + + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 95 R-SPYLLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
R SP+L+ L + +D + L+ DY+ G L HL S K + E ++ E
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSG-EI 114
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGT 211
LE LH+ +I+RD K NILLD N H ++DFGL+K D+ S GT
Sbjct: 115 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGT 169
Query: 212 QGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251
Y+AP+ GH D +S GV++ ELLTG P V+
Sbjct: 170 IEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLM-----DQAGKQGEDEFKMEVELLGRLRSPYLLA 101
++G G FG VY GR++A+K + Q + + + E++LL LR ++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 102 LLGYCSD--RRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
G D +KL ++ +YM G +++ L A G+ L R + +G+ +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGA------LTENVTRRYTRQILQGVSY 121
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAP 217
LH S ++HRD K +NIL D + K+ DFG +K I + G V GT +++P
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E K+DV+S ++E+LT + P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 102
V+G G FG V K A+K++ + K+ E++ M LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 103 -LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
+ + + V DY+ G L HL + E R R A E A L +LH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ--------RERCFLEPRARFYAAEIASALGYLH 113
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
S +++RD K NILLD H ++DFGL K + G ++ GT Y+APE
Sbjct: 114 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVL 168
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
D + G VL E+L G P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 67/207 (32%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 102
V+G G FG V S+G A+K++ + K+ E M LL L+ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
KL V DY+ G L HL + E R R A E A + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQ--------RERCFLEPRARFYAAEVASAIGYLH 113
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
S +I+RD K NILLD H ++DFGL K G + ++ GT Y+APE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVL 168
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
D + G VL E+L G P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDE---FKMEVELLGRLRS 96
+ + ++G G FG VY + GR++A K + D + E + E++LL L+
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 97 PYLLALLGYCSDR--RKLLVY-DYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEA 152
++ G DR + L ++ +YM G +++ L + SV K TR +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY---TR-----QI 115
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGT 211
+G+ +LH + ++HRD K +NIL D + K+ DFG +K + + G V GT
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+++PE K+DV+S G ++E+LT + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 103
V+G G FG V ++ AIK++ + +D+ + +E +L P L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 104 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
C + R V +Y+ G L + + + A E A GL FLH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH- 118
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
S +I+RD K N++LD H K++DFG+ K + G + GT Y+APE
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVPID 249
D +++GV+L E+L G+ P +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 95
+ K +G G FG V++ + VA+K LM+ K+G F + E+++L L+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEG---FPITALREIKILQLLK 69
Query: 96 SPYLLALLGYCSDRRK---------LLVYDYMAN--GGLQEHLYPANGSNSVASKLDWET 144
++ L+ C + LV+++ + GL ++ K
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGL---------LSNKNVKFTLSE 120
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH- 203
++ GL ++H ++HRD K++NIL+ K+ K++DFGLA+ S
Sbjct: 121 IKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 204 --VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 248
+ RV+ T Y PE L D++ G ++ E+ T R PI
Sbjct: 178 NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 49 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG 104
VG GG+G V+ + G VA+K M ++ +E + E ++L +S +L+ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
D L L +Y+ G + L +N D R +A E + ++ LHE
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSED-HARFYMA-EMFEAVDALHEL- 120
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
IHRD K N L+D + H K++DFGL+K A V+G+ Y+APE
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-----NSVVGSPDYMAPEVLRGK 173
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
D +S G +L E L G P + P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-----SDK 199
R+ A E LE+LH + ++HRD K N+L+ H K++DFGL+KIG ++
Sbjct: 104 RMYFA-ETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 200 AGGHVS--TR------VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GH+ TR V GT Y+APE L D ++ G++L E L G VP
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
V+G G FG V + RKV A+KL+ + + F E +++ SP+++ L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 104 -GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ DR +V +YM G L + + A E L AL+A + F
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL--ALDAIHSMGF---- 163
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
IHRD K N+LLDK+ H K++DFG + +K G +GT Y++PE +
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 223 ----GHLTTKSDVYSYGVVLLELLTGRVP 247
G+ + D +S GV L E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH--VSTRVLGT 211
+GL+++H S VIHRD K SN+L++++ ++ DFG+A+ S H T + T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 212 QGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPI 248
+ Y APE L+ TT D++S G + E+L GR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 48 VVGHGGFGLVYRGV--LSNGRK--VAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG VY+GV K VA+K + E +F E ++ + P+++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE-KFLQEAYIMRQFDHPHIVK 71
Query: 102 LLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
L+G ++ +V + G L+ +L S LD + + + + + L +L
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYS------LDLASLILYSYQLSTALAYLE- 124
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
S +HRD + N+L+ K+ DFGL++ D++ S L + ++APE
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESIN 181
Query: 222 TGHLTTKSDVYSYGVVLLELL 242
T+ SDV+ +GV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 69/251 (27%), Positives = 100/251 (39%), Gaps = 71/251 (28%)
Query: 48 VVGHGGFGLVYRGVL--SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLAL 102
V+G G FG V R V G A+K + ++ K+ + E ++L +P+++ L
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 103 LGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDW----ETRLRIALEAAKG 155
Y S D L L+ +Y+ G + L K D ETR IA E
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIA-ETILA 113
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST--------- 206
++ +H+ IHRD K N+LLD H K+SDFGL G K+ H +
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKS--HRTEFYRILSHAL 167
Query: 207 -------------------------RVL-----GTQGYVAPEYALTGHLTTKSDVYSYGV 236
R L GT Y+APE L + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 237 VLLELLTGRVP 247
++ E+L G P
Sbjct: 228 IMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGRKV-AIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
V+G G FG V + +KV A+KL+ + + F E +++ SP+++ L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 104 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
D + L +V +YM G L N ++ W + A E L+ +H
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL------VNLMSNYDVPEKW-AKFYTA-EVVLALDAIH-- 159
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
S +IHRD K N+LLDK+ H K++DFG + D+ G +GT Y++PE +
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 223 ----GHLTTKSDVYSYGVVLLELLTGRVP 247
G+ + D +S GV L E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 64 NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYCSDRRKLLVYDYMANGG 122
+GR+VA+K+MD +Q + EV ++ + ++ + Y ++ +++ G
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 123 LQEHLYPANGSNSVAS-KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181
L ++ V+ +L+ E + + L +LH S VIHRD KS +ILL
Sbjct: 105 L---------TDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTL 152
Query: 182 NFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPEYALTGHLTTKSDVYSYGVVL 238
+ K+SDFG A+I D V R ++GT ++APE T+ D++S G+++
Sbjct: 153 DGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207
Query: 239 LELLTGRVPIDVNKP-SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIA 297
+E++ G P + P L P+L + KI ++ LE + +E + A
Sbjct: 208 IEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT-REPQERATAQ 266
Query: 298 AMCVQPEADYRPLMADVVQSLVPLVKYNR 326
+ P L + + LVPL++ R
Sbjct: 267 ELLDHPFL----LQTGLPECLVPLIQQYR 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRVLGT 211
GL+++H S V+HRD K N+L++ + K+ DFGLA+ + G + T + T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 212 QGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 248
+ Y APE L+ TK+ DV+S G +L ELL GR P+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSN--GRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 94
F V+G G +G V+ R V + G+ A+K++ +A + + + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 95 R-SPYLLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-E 151
R SP+L+ L + ++ + L+ DY++ G + HLY + + E +R E
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--------EDEVRFYSGE 113
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSDKAGGHVSTRVL 209
LE LH+ +++RD K NILLD H ++DFGL+K + +K +
Sbjct: 114 IILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK---ERTYSFC 167
Query: 210 GTQGYVAPEY--ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GT Y+APE GH D +S G+++ ELLTG P
Sbjct: 168 GTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 21/152 (13%)
Query: 52 GGFGLVYRGVLSNGRKV-AIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYC- 106
G FG VY G N K+ A+K++ +A K + + E + L +SP+++ L Y
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 107 -SDRRKLLVYDYMANGGLQE--HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
S LV +Y+ G ++ H+Y D E ++ E A L++LH H
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIY---------GYFDEEMAVKYISEVALALDYLHRH- 123
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195
+IHRD K N+L+ H K++DFGL+K+
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 49/188 (26%), Positives = 98/188 (52%), Gaps = 15/188 (7%)
Query: 68 VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL-LVYDYMANGGLQ 124
VA+K++ D A ++ + E+E++ + + ++ LLG C+ L ++ +Y + G L+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 125 EHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 175
E+L Y + + ++ ++ + + A+G+E+L S IHRD +
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 176 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 235
N+L+ +N K++DFGLA+ ++ +T ++APE T +SDV+S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 236 VVLLELLT 243
V++ E+ T
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 68 VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKLLVY-DYMANGGLQ 124
VA+K++ D A + + E+E++ + + ++ LLG C+ L V +Y + G L+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 125 EHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 175
E+L Y + +L ++ + A + A+G+E+L S IHRD +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 176 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 235
N+L+ ++ K++DFGLA+ + +T ++APE T +SDV+S+G
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 236 VVLLELLT 243
V+L E+ T
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 49 VGHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPY 98
+G G FG V R K VA+K++ D A + + E+EL+ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 99 LLALLGYCSDRRKLLV-YDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRI 148
++ LLG C+ L V +Y A G L+E L Y + + +L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------KAGG 202
A + A+G+E+L S IHRD + N+L+ ++ K++DFGLA+ D + G
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + ++APE T +SDV+S+G+++ E+ T
Sbjct: 197 RLPVK------WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 42 GFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLR 95
+ S+++ G FG ++ G+L +V +K + D A + E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 96 SPYLLALLGYCSDR--RKLLVYDYMANGGLQEHLY-----PANGSNSVASKLDWETR--L 146
+L +L C + ++Y YM G L+ L AN +++ T+ +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS------TQQLV 120
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD-KAGGH 203
+A++ A G+ +LH+ VIH+D + N ++D+ K++D L++ D G
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
R + ++A E + ++ SDV+S+GV+L EL+T G+ P
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 48 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVE----LLGRLRSPYLLAL 102
V+G G FG V +G+ A+K++ + E K + LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 103 -LGYCSDRRKLLVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLRI-ALEAAKG 155
+ + + V D++ G L HL +P E R R A E A
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-------------EPRARFYAAEIASA 108
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L +LH S +++RD K NILLD H ++DFGL K G ++ +T GT Y+
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYL 163
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE D + G VL E+L G P
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 28/205 (13%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
+G G FG VY+ G A K+++ ++ +++ +E+E+L PY++ LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 108 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLD---WETRLR-IALEAAKGLEFLHEHC 163
KL + GG +++ +LD E +++ I + + L++LH
Sbjct: 80 WDGKLWIMIEFCPGG---------AVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--- 127
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYVAPEYAL 221
S +IHRD K+ N+LL + K++DFG+ S K + R +GT ++APE +
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 222 TGHLTT-----KSDVYSYGVVLLEL 241
+ K+D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL+++H S +IHRD K SN+ ++++ ++ DFGLA+ D+ G+V+TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 214 YVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRV 246
Y APE L H D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 48 VVGHGGFGLVY--RGVL--SNGRKVAIKLMDQA----GKQGEDEFKMEVELLGRLRSPYL 99
V+G GG+G V+ R V G+ A+K++ +A ++ K E +L ++ P++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 100 LALL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK---- 154
+ L+ + + + L+ +Y++ G L HL R I +E
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL----------------EREGIFMEDTACFYL 106
Query: 155 -----GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209
LE LH+ +I+RD K NILLD H K++DFGL K G V+
Sbjct: 107 SEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC 161
Query: 210 GTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 247
GT Y+APE + +GH D +S G ++ ++LTG P
Sbjct: 162 GTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
VG G +G V + G KVAIK + Q+ + ++ E+ LL ++ ++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 105 YCSDRRKL-------LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
+ L LV +M G L +H KL + + + KG
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----------EKLSEDRIQFLVYQMLKG 130
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L+++H + +IHRD K N+ ++++ K+ DFGLA+ + G+V TR Y
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 216 APEYALTG-HLTTKSDVYSYGVVLLELLTGR 245
APE L H T D++S G ++ E+LTG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 34/239 (14%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGY 105
VG G +G VY+ L G A+K++ + G+D + E+ ++ + ++A G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 106 CSDRRKLLV-YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 161
R KL + +Y G LQ+ +Y G S L+IA E +GL +LH
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLS---------ELQIAYVCRETLQGLAYLH- 123
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYVAPEY 219
S +HRD K +NILL N K++DFG+A K ++ R +GT ++APE
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVAA----KITATIAKRKSFIGTPYWMAPEV 177
Query: 220 AL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS---WALPRLTDREK 272
A G D+++ G+ +EL + P+ P L+S + P+L D+ K
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRS 96
++K +G G +G+VY+G G+ VA+K + + E+E E+ LL L+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 153
P ++ L +L L++++++ L+++L P +D E +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY------MDAELVKSYLYQIL 111
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 210
+G+ F H V+HRD K N+L+D K++DFGLA +A G V T +
Sbjct: 112 QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-----RAFGIPVRVYTHEVV 163
Query: 211 TQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGR 245
T Y APE L +T D++S G + E+ T +
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGR--KVAIKLMDQAG--KQGE-DEFKMEVELLGRLRSP 97
F+ +G G FG V N VAIK +++ KQ + D E ++L + P
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLRIALE 151
+ + L G D L LV +++ G L +P N V + ++ + E
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCF--YAAQIVLIFE 145
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR---V 208
+ L +++RD K N+LLDK+ K++DFG AK+ V TR +
Sbjct: 146 YLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTL 188
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
GT Y+APE L +D ++ G+ + E+L G P N+P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRL-R 95
+ K +G G +G VY+ + G+ VA+K + + ++E E+ LL L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 96 SPYLLALLGYCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 149
S Y++ LL K LV++Y+ + L++ + L +T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPG--RPLPAKTIKSFM 116
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRV 208
+ KG+ H+H V+HRD K N+L+DK K++D GL + S + T
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THE 171
Query: 209 LGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTG 244
+ T Y APE L H +T D++S G + E+
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
V+G G +G+VY LS ++AIK + + + E+ L L+ ++ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 107 SDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
S+ ++ + + G L L G K + +T + + +GL++LH++
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 166 PVIHRDFKSSNILLDKNFHA---KVSDFGLAKIGSDKAGGHVSTRVL-GTQGYVAPE--- 218
++HRD K N+L+ N ++ K+SDFG +K AG + T GT Y+APE
Sbjct: 128 QIVHRDIKGDNVLV--NTYSGVVKISDFGTSK---RLAGINPCTETFTGTLQYMAPEVID 182
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
G+ +D++S G ++E+ TG+ P
Sbjct: 183 KGPRGY-GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-----DEFKMEVELLGRLRSPYLLA 101
++G G FG VY GR++A+K + + E + + E++LL L ++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 102 LLGYCSD--RRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
G D R L ++ ++M G +++ L S + + TR + + +G+ +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL------KSYGALTENVTR-KYTRQILEGVSY 121
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAP 217
LH S ++HRD K +NIL D + K+ DFG +K + + G V GT +++P
Sbjct: 122 LH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E K+D++S G ++E+LT + P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEF----- 158
SD + LL+ +Y + G L + + + RL+ L E GL F
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQI---------------KQRLKEHLPFQEYEVGLLFYQIVL 180
Query: 159 -LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
L E S ++HRD KS+NI L K+ DFG +K SD V++ GT Y+AP
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E + K+D++S GV+L ELLT P
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 25/283 (8%)
Query: 49 VGHGGFGLV-YRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYC 106
+G G G+V V S+G+ VA+K MD +Q + EV ++ + ++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+V +++ G L + + ++++ E + L K L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 226
VIHRD KS +ILL + K+SDFG S + S ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 227 TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG--- 283
+ D++S G++++E++ G P P ++ LP + K L + P+L+G
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKGFLD 251
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326
+ +++ Q A A + P A +VPL++ NR
Sbjct: 252 RLLVRDPAQRATAAELLKHPFLA----KAGPPSCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLR 95
F +G G F VYR L +G VA+K LMD + D K E++LL +L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA--DCIK-EIDLLKQLN 60
Query: 96 SPYLLALLGYCSDRRKLLVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 153
P ++ + +L + +A+ G + + + K W + ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLC 116
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
LE +H S V+HRD K +N+ + K+ D GL + S K S ++GT
Sbjct: 117 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273
Y++PE KSD++S G +L E+ + P +K + L S +KI
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-------KKI 220
Query: 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309
+ P L + +E+ Q + MC+ P+ + RP
Sbjct: 221 EQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 45/249 (18%)
Query: 14 KGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKL 72
GE E DN + S + N++G+G FG+VY + + KVAIK
Sbjct: 46 AGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK 98
Query: 73 MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK---------------LLVYDY 117
+ Q + E + ++ L + +L Y +K V+ Y
Sbjct: 99 VLQDPQYKNREL-LIMKNLNHINIIFLKDYY-YTECFKKNEKNIFLNVVMEFIPQTVHKY 156
Query: 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177
M + H P KL + + + L ++H S + HRD K N+
Sbjct: 157 MKHYARNNHALPL-----FLVKL-------YSYQLCRALAYIH---SKFICHRDLKPQNL 201
Query: 178 LLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYG 235
L+D N H K+ DFG AK + G S + ++ Y APE L + TT D++S G
Sbjct: 202 LIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 236 VVLLELLTG 244
++ E++ G
Sbjct: 259 CIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 15/112 (13%)
Query: 138 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IG 196
L E + + + A+G+EFL S IHRD + NILL +N K+ DFGLA+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 197 SD-----KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
D K + + ++APE TT+SDV+S+GV+L E+ +
Sbjct: 225 KDPDYVRKGDARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 18/238 (7%)
Query: 49 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYC 106
+G G G+V + G++VA+K MD +Q + EV ++ ++ + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+V +++ G L + + ++++ E + L + L +LH
Sbjct: 90 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 226
VIHRD KS +ILL + K+SDFG S + S ++GT ++APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYG 196
Query: 227 TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV--LVSWALPRLTDREKILEIMDPALE 282
T+ D++S G++++E++ G P N+P + + + PR+ D K+ ++ L+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLM--DQAG-KQGEDEFKMEVELLGRLRSPYLLALLG 104
+G GG G VY R+VA+K + D + + F E ++ L P ++ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 105 YCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETR----LRIALEAAKGLE 157
CSD VY Y+ L+ L S++ +L +T L I + +E
Sbjct: 70 ICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-----------IGSDKAGGHVST 206
++H S V+HRD K NILL + D+G A I D+ S+
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 207 -----RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+++GT Y+APE L + +D+Y+ GV+L ++LT P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199
LD E L + + AKG+ FL S IHRD + NILL K+ DFGLA+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT------GRVPID 249
+ V ++APE T +SDV+SYG++L E+ + +P+D
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 143 ETRL-RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201
E R+ I ++ L +LH+ ++HRD +NI+L ++ ++DFGLAK K
Sbjct: 112 EERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQP 166
Query: 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 261
T V+GT Y PE K+DV+++G +L ++ T + P ++S
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLS 220
Query: 262 WALPRLTDREKILE-IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
A KI+E + +P EG YS V + C+ P+A+ RP D++Q
Sbjct: 221 LAT-------KIVEAVYEPLPEGMYSE----DVTDVITSCLTPDAEARP---DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 43/222 (19%)
Query: 49 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
+G G GLV+ V S+ ++VA+K + Q E++++ RL ++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 108 DRRKLLVYDYMANGG--LQEHLYPANGSNSVASKLDW-ETRLRIALEAA----------- 153
VY+ + G L E + NSV ++ ET L LE
Sbjct: 67 ------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 154 ----KGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKI----GSDKAGGHV 204
+GL+++H S V+HRD K +N+ ++ ++ K+ DFGLA+I S K G++
Sbjct: 121 YQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK--GYL 175
Query: 205 STRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGR 245
S ++ T+ Y +P L+ + T D+++ G + E+LTG+
Sbjct: 176 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 37/209 (17%)
Query: 50 GHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRS-PYLLALLGYC 106
G G F V + G+ AIK M + K E + E++ L RL P +L L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 107 SDR---RKLLV--------YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
DR R LV Y+ + P L + + K
Sbjct: 68 FDRKTGRLALVFELMDMNLYELIKG-----RKRP----------LPEKRVKSYMYQLLKS 112
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L+ +H + + HRD K NIL+ + K++DFG + K T + T+ Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK---PPYTEYISTRWYR 165
Query: 216 APEYALT-GHLTTKSDVYSYGVVLLELLT 243
APE LT G+ K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 16/115 (13%)
Query: 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD 198
LD + LR + + A+G++FL S IHRD + N+LL AK+ DFGLA+ I +D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 199 -----KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
K + + ++APE T +SDV+SYG++L E+ + G+ P
Sbjct: 266 SNYVVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-----FKMEVELLGRL 94
+ K +G G +G+VY+ G VA+K ++ EDE E+ LL L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKEL 55
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVAS-KLDWETRLRIALEA 152
P ++ LL KL LV++++ + L++++ +S LD +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM------DSSPLTGLDPPLIKSYLYQL 108
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVL 209
+G+ + H H V+HRD K N+L+D+ K++DFGLA +A G T +
Sbjct: 109 LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-----RAFGVPVRTYTHEV 160
Query: 210 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 245
T Y APE L +T D++S G + E++ R
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
GL+++H S +IHRD K N+ ++++ K+ DFGLA+ + G+V TR
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 214 YVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 245
Y APE L H D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMD--QAGKQGEDE-FKMEVELLGRLRSPY 98
F V+G G FG V L N KV A+K+++ + K+ E F+ E ++L + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 99 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ L + + LV DY G L L + + IA+++ L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHVSTRVLGTQGYVA 216
+ +HRD K NIL+D N H +++DFG K+ D G S+ +GT Y++
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYIS 171
Query: 217 PEYALT-----GHLTTKSDVYSYGVVLLELLTGRVP 247
PE G + D +S GV + E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQG 213
G+ LH++ ++HRD K+SN+LL+ K+ DFGLA + GS T+++ T
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL---KPYTQLVVTLW 171
Query: 214 YVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
Y APE L +T D++S G + ELLT +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 49 VGHGGFGLVYRGVLSN---GRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLA 101
+G G +G VY+ N G++ AIK +Q E+ LL L+ +++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-ISQSACREIALLRELKHENVVS 66
Query: 102 LLGYC---SDRRKLLVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L+ +D+ L++DY + Q + S+ + + G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS----MVKSLLWQILNGVH 122
Query: 158 FLHEHCSPPVIHRDFKSSNILL--DKNFHA--KVSDFGLAKI---------GSDKAGGHV 204
+LH + V+HRD K +NIL+ + K+ D GLA++ D
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----- 174
Query: 205 STRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 248
V+ T Y APE L TK+ D+++ G + ELLT PI
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 84/355 (23%), Positives = 132/355 (37%), Gaps = 107/355 (30%)
Query: 48 VVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGEDEFKME-------------- 87
V+GHG FG V S+ VA+K++ + E + M
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 88 VELLGRLRSPY--LLALLGYC----------SDRRKLLVY-------------------- 115
V LLG P L+ ++ +C + R Y
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 116 DYMANGG-----LQEHLYPANGSNSVASKLD--WETRLRI------ALEAAKGLEFLHEH 162
D G +GS + + D W++ L + + + A+G+EFL
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--- 190
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLGTQGYVA 216
S IHRD + NILL +N K+ DFGLA+ I D K + + ++A
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK------WMA 244
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVP---IDVNKPSGEGVLVSWALPRLTD--R 270
PE TT+SDV+S+GV+L E+ + G P + +N+ + RL D R
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTR 295
Query: 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325
+ E P + I C Q + RP + +V+ L L++ N
Sbjct: 296 MRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 49 VGHGGFGLVYRGVLSNG---RKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G+G FG V G +++G +V +K L A Q + +F E + L+ LL LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 105 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
C++ LLV ++ G L+ +L + + D T R+A E A GL LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP--DPTTLQRMACEIALGLLHLHKN- 119
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA--L 221
IH D N LL + K+ D+GL+ + ++ ++APE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 222 TGHL-----TTKSDVYSYGVVLLELL 242
G+L T +S+V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIK---LMDQAGKQGEDEFKM-EVELLGRLRSP 97
+ K +G G +G V++ VA+K L D +G + E+ LL L+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHK 59
Query: 98 YLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ L SD++ LV++Y + L+++ NG +D E + KGL
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNG------DIDPEIVKSFMFQLLKGL 112
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV---STRVLGTQG 213
F H H V+HRD K N+L++KN K++DFGLA+ G V S V+ T
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVV-TLW 164
Query: 214 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPI 248
Y P+ L +T D++S G + EL P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
++G G FG + RG L K VAI L + F E LG+ ++ L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 103 LGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
G + ++ V +YM+NG L L G + L A G+++L E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL------ASGMKYLSE 125
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APE 218
+H+ + +L++ + K+S F ++ DK+ +T + + V APE
Sbjct: 126 M---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT--MSGKSPVLWAAPE 178
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT 243
H ++ SDV+S+G+V+ E+++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 68/265 (25%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG---KQGEDEFKMEVELLGRLRSPY 98
F K +G G FG V + + A+K + +A + K E ++L + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGL-----QEHLYPANGSNSVASKLDWETRLRIALEA 152
++ L D+ L V DY+ G + + ++ +A R IA E
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE----EDLA-------RFYIA-EL 110
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSD----KAGGHV- 204
+E +H+ IHRD K NIL+D++ H K++DFGL + D + G H
Sbjct: 111 TCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 205 ----------------------------STRVL-----GTQGYVAPEYAL-TGHLTTKSD 230
R L GT Y+APE L TG+ T D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCD 226
Query: 231 VYSYGVVLLELLTGRVPIDVNKPSG 255
+S GV+L E+L G+ P + P+
Sbjct: 227 WWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 67/252 (26%), Positives = 102/252 (40%), Gaps = 70/252 (27%)
Query: 43 FSKSNVVGHGGFGLVY----RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLR 95
F K ++G G G V+ +G G+ A+K++D+ ++ K E E+L L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 96 SPYLLALLGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
P+L L Y S + LV DY G L L G ++ E
Sbjct: 60 HPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGK-------------CLSEEV 104
Query: 153 AK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 204
A+ LE+LH +++RD K NILL ++ H +SDF L+K SD V
Sbjct: 105 ARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ-SDVEPPPV 160
Query: 205 STRVL----------------------------GTQGYVAPEY-ALTGHLTTKSDVYSYG 235
S + GT+ Y+APE + GH + D ++ G
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLG 219
Query: 236 VVLLELLTGRVP 247
++L E+L G P
Sbjct: 220 ILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 48 VVGHGGFGLV----YRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLA 101
VVG G +G V +R ++G++ IK ++ A ++ + E +LL +L+ P ++A
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 102 LLGYCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASK-LDWETRLRIALEAAKGLEF 158
LL V + G L L G ++ ++W ++ +AL+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------Y 117
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
LHE ++HRD K+ N+ L + KV D G+A++ ++ +++ ++GT Y++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPE 172
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT 243
KSDV++ G + E+ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 49 VGHGGFGLVYRGVLS--NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLG- 104
+G G +G V++ VL+ NG K A+K++D E E + E +L L P ++ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGM 83
Query: 105 -YCSDRR---KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
Y D + +L + + NGG L G +++ I EA GL+ LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDL--VKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 219
+ IHRD K +NILL K+ DFG+ A++ S + +GT ++APE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEV 195
Query: 220 -----ALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
L + DV+S G+ +EL G P+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 40/211 (18%)
Query: 49 VGHGGFGLVYR------GVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG VY+ GVL+ A K++D ++ +++ +E+++L P ++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 103 L-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLD---WETRLRIAL-EAAKGLE 157
L + + ++ ++ A G + ++V +L+ E ++R+ + + L
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV----------DAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYV 215
+LHE+ +IHRD K+ NIL + K++DFG+ S K + R +GT ++
Sbjct: 118 YLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWM 170
Query: 216 APEYALTGH-----LTTKSDVYSYGVVLLEL 241
APE + K+DV+S G+ L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 15/101 (14%)
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGG 202
+ + AKG+EFL S IHRD + NILL +N K+ DFGLA+ I D K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ + ++APE T +SDV+S+GV+L E+ +
Sbjct: 242 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 10/87 (11%)
Query: 168 IHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHVSTRV-LGTQGYVAPEY--AL-- 221
+HRD K N+LLDKN H +++DFG ++ +D G V + V +GT Y++PE A+
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAVGTPDYISPEILQAMED 180
Query: 222 -TGHLTTKSDVYSYGVVLLELLTGRVP 247
G + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDE-FKM----EVELLGRLRS 96
F +G G +G VY+ + G VA+K + E E F + E+++L +L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 97 PYLLALLGYCSDR------RK-----LLVYDYMANG--GLQEHLYPANGSNSVASKLDWE 143
++ L +D+ +K LV++YM + GL E + + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS----- 120
Query: 144 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203
+ +GL + H+ +HRD K SNILL+ K++DFGLA++ + +
Sbjct: 121 ----FMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 204 VSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 248
+ +V+ T Y PE L + DV+S G +L EL T + PI
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK-PI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 54/295 (18%)
Query: 49 VGHGGFGLVYRGVLSNG----RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G+G FG V + R V +L A + ++EF + + L+ P +L LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 105 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL--RIALEAAKGLEFLHE 161
C + LLV++Y G L+ +L S + + + L R+A E A G+ +H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA- 220
H +H D N L + KV D+G+ + ++APE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 221 ------LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE--- 271
+T T S+V++ GV L EL + +P L+DRE
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQP----------YSHLSDREVLN 219
Query: 272 -----KILEIMDPALEGQYSMK--EVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
+ +++ P LE YS + EV+Q C + R +V + L
Sbjct: 220 HVIKDQQVKLFKPQLELPYSERWYEVLQ------FCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMD--QAGKQGEDE-FKMEVELLGRLRSPY 98
F V+G G FG V + + ++ A+K+++ + K+ E F+ E +L +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ L D L LV DY G L L + +L + E +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLL------SKFEDRLPEDMARFYIAEMVLAIH 116
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H+ +HRD K N+LLD N H +++DFG + + ++ G S+ +GT Y++P
Sbjct: 117 SIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 218 EYALT-----GHLTTKSDVYSYGVVLLELLTGRVP 247
E G + D +S GV + E+L G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHV 204
L + A+G+EFL S +HRD + N+LL + K+ DFGLA+ I D
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ L + ++APE TT SDV+SYG++L E+ +
Sbjct: 297 GSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 17/176 (9%)
Query: 97 PYLLALLGY-CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
P ++ L Y S+ LV + G L H+ S + E R A E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVA 97
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L+ LH ++ RD +NILLD H +++ F D G + Y
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
APE T D +S G +L ELLTG+ ++ + PSG + +P E
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECH-PSGINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 22/229 (9%)
Query: 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELL 91
+ L T + +G G +G VY+ +G A+K++D E E + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNIL 72
Query: 92 GRLRS-PYLLALLG--YCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
L + P ++ G Y +D+ +L + + NGG L G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--VKGLLICGQRLDEAMI 130
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHV 204
I A GL+ LH + +IHRD K +NILL K+ DFG+ A++ S + +
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 205 STRVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 248
S +GT ++APE + DV+S G+ +EL G P+
Sbjct: 188 S---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 43/222 (19%)
Query: 43 FSKSNVVGHGGFGLVYRGV--LSNGRKVAIK--LMDQAGKQGEDE-----FKMEVELLGR 93
+ K +G G +G+VY+ ++N +A+K ++Q EDE E+ LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQ-----EDEGVPSTAIREISLLKE 57
Query: 94 LRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA--- 149
++ ++ L S++R LV++Y+ + L++H+ S D+ R+
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM---------DSSPDFAKNPRLIKTY 107
Query: 150 -LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGG---HV 204
+ +G+ + H H V+HRD K N+L+D+ +A K++DFGLA +A G
Sbjct: 108 LYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-----RAFGIPVRT 159
Query: 205 STRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
T + T Y APE L + H +T D++S G + E++ +
Sbjct: 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 127 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186
L AN + +LD E + + G++ LH S +IHRD K SNI++ + K
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163
Query: 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
+ DFGLA+ + T + T+ Y APE L D++S G ++ EL+ G V
Sbjct: 164 ILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
G++ LH S +IHRD K SNI++ + K+ DFGLA+ + T + T+ Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYY 183
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
APE L D++S G ++ E++ G V
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 49 VGHGGFGLVYRGVLSNGR---KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL--- 102
VG G +G VY+ +G+ + A+K ++ G E+ LL L+ P ++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 103 -LGYCSDRRKLLVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALEAAK 154
L + SDR+ L++DY EH + A+ +N +L + +
Sbjct: 67 FLSH-SDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTR-VL 209
G+ +LH + V+HRD K +NIL+ + K++D G A++ + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 210 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT 243
T Y APE L H T D+++ G + ELLT
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 52/251 (20%)
Query: 43 FSKSNVVGHGGFG---LVYRGVLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS 96
F V+G G FG LV + G A+K++ +A K+ + E ++L S
Sbjct: 3 FESLKVIGRGAFGEVRLVQKK--DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
+++ + D+ L L+ +++ G + L + + + ET+ IA E
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIA-ETVLA 113
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-----------------KIGSD 198
++ +H+ IHRD K N+LLD H K+SDFGL + SD
Sbjct: 114 IDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 199 KAGGHVSTR----------------VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 242
+++++ +GT Y+APE + D +S GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 243 TGRVPIDVNKP 253
G P P
Sbjct: 231 IGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 60/252 (23%), Positives = 98/252 (38%), Gaps = 54/252 (21%)
Query: 43 FSKSNVVGHGGFG---LVYRGVLSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRS 96
F V+G G FG LV + G A+K++ D K+ + E ++L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKK--DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
+++ + D+R L L+ +++ G + L + + A++ + +A++A
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVLAIDAIHQ 119
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG-------------- 201
L F IHRD K N+LLD H K+SDFGL G KA
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPS 169
Query: 202 --------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
++ +GT Y+APE + D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 242 LTGRVPIDVNKP 253
L G P P
Sbjct: 230 LIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD 198
L + + + + A G+EFL S +HRD + N+L+ + K+ DFGLA+ I D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243
+ L + ++APE TT SDV+S+G++L E+ T
Sbjct: 293 SNYISKGSTFLPLK-WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 14/103 (13%)
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST-RV 208
LEA L +LH +IHRD K+ NI LD+ +A + DFG A K H T +
Sbjct: 195 LEA---LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC----KLDAHPDTPQC 244
Query: 209 LGTQGYV---APEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
G G + +PE K+D++S G+VL E+ V +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 10/89 (11%)
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSDKAGGHVSTRVLGTQ 212
G+ ++H+ ++HRD K+ NI L N K+ DFG+++ +GS ++T GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS----CDLATTFTGTP 169
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
Y++PE +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 26/118 (22%)
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 207
+A + G+ +LH ++HRD K SN+L++ + K++DFG+++I + S+
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 208 VLGTQGYVAPE-------------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252
+GT Y++PE YA D++S GV +LE GR P V +
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 61/262 (23%), Positives = 98/262 (37%), Gaps = 60/262 (22%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRSPY 98
F K +G G FG V + A+K + D + K E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ L D+ L V DY+ G + L V ++ + L +A+E+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHKMG 121
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK----------------------- 194
F IHRD K NIL+D + H K++DFGL
Sbjct: 122 F---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 195 -------IGSDKAGGHVST---------------RVLGTQGYVAPEYALTGHLTTKSDVY 232
+ + + G + T ++GT Y+APE L T D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 233 SYGVVLLELLTGRVPIDVNKPS 254
S GV+L E+L G+ P P+
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPT 254
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 12/120 (10%)
Query: 139 KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198
L + L I + +GL +LH +IHRD K+ NI ++ + D G A+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV- 208
Query: 199 KAGGHVSTRVLGTQGYV---APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255
V+ LG G V APE +K+D++S G+VL E+L I + PS
Sbjct: 209 -----VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 64/262 (24%), Positives = 101/262 (38%), Gaps = 74/262 (28%)
Query: 43 FSKSNVVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSP 97
F V+G G FG V R V G+ A+K + ++ +D+ K E ++L SP
Sbjct: 3 FHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWE------TRLRIAL 150
++++L D + L L+ +++ G L L + ++ TR +A
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTML------------IKYDTFSEDVTRFYMA- 108
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL------------------ 192
E +E +H+ IHRD K NIL+D+ H K+SDFGL
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 193 ---AKIGSDKAGGHV-------------------STRVL-----GTQGYVAPEYALTGHL 225
K D + R++ GT Y+APE L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 226 TTKSDVYSYGVVLLELLTGRVP 247
+ D +S G ++ E L G P
Sbjct: 226 GQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 49 VGHGGFGLV---YRGVLSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G G+V Y VL R VAIK + Q + ++ E+ L+ + +++L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
L + ++ L + + L L AN + +LD E + + G++ LH
Sbjct: 82 LNVFTPQKSL---EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
S +IHRD K SNI++ + K+ DFGLA+ + T + T+ Y APE L
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG 192
Query: 223 GHLTTKSDVYSYGVVLLELLTGRV 246
D++S G ++ E++ ++
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 66/271 (24%), Positives = 103/271 (38%), Gaps = 80/271 (29%)
Query: 43 FSKSNVVGHGGFGLV--YRGVLSNG-------RKVAIKLMDQAGKQGEDEFKMEVELLGR 93
F K +G G FG V R V + RK + L +Q K E ++L
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVA-----HVKAERDILAE 57
Query: 94 LRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLR 147
+ +++ L D+ L V DY+ G + L +P + + ++L
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT------ 111
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSD----KA 200
A+E+ + F IHRD K NIL+D++ H K++DFGL + D ++
Sbjct: 112 CAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 201 GGHV--------------------------------------STRVLGTQGYVAPEYALT 222
G HV + ++GT Y+APE L
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 223 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
T D +S GV+L E+L G+ P P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
+ K +G G + VY+G NG+ VA+K++ ++G + E LL L+ ++
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L + L LV++Y+ Q G + KL + +GL ++
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSYI 119
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H+ ++HRD K N+L+ K++DFGLA+ S H + + T Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS--VPSHTYSNEVVTLWYRPPDV 174
Query: 220 AL-TGHLTTKSDVYSYGVVLLELLTG 244
L + +T D++ G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 49 VGHGGFGLV---YRGVLSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G G+V Y +L R VAIK + Q + ++ E+ L+ + ++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
L + ++ L + + + L AN + +LD E + + G++ LH
Sbjct: 89 LNVFTPQKSLEEFQDVY---IVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
S +IHRD K SNI++ + K+ DFGLA+ + T + T+ Y APE L
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG 199
Query: 223 GHLTTKSDVYSYGVVLLELLTGRV 246
D++S G ++ E++ G V
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 52/236 (22%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM---DQAGKQGEDEFKM-----------EVE 89
K +G G +G V + G+ VAIK + + + +D + E++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 90 LLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR- 147
++ ++ ++ L+ Y LV D MA+ + +D + RL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------------DLKKVVDRKIRLTE 118
Query: 148 -----IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAG 201
I L+ GL LH+ +HRD +NI ++ K++DFGLA + G
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 202 GHVS-----------TRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGR 245
+S T + T Y APE + + D++S G + ELLTG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ + +L+ DY+ +G L + L G S A E + I + + L LH+H
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEA-----EVKK-IIRQLVEALNDLHKH-- 128
Query: 165 PPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
+IH D K N+L D + D+GL KI G S GT Y +PE + G
Sbjct: 129 -NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYD-GTLDYFSPE-KIKG 180
Query: 224 HLTTKS-DVYSYGVVLLELLTGRVPIDVNK 252
H S D ++ GV+ ELLTG+ P ++
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 63/290 (21%), Positives = 111/290 (38%), Gaps = 54/290 (18%)
Query: 50 GHGGFGLVYRGVL-------SNGR----KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY 98
G G F +Y+GVL G V +K++ + F L+ +L +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKH 62
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
L+ L G C ++V +Y+ G L L+ + S+ KLD +A + A L +
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD------VAKQLASALHY 116
Query: 159 LHEHCSPPVIHRDFKSSNILLDKN-------FHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
L + ++H + NIL+ + K+SD G+ RV
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-----ITVLSREERVERI 168
Query: 212 QGYVAPEY--ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269
++APE LT +D +S+G LLE+ + + +P L L+
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEP----------LSTLSS 212
Query: 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
EK D + + M + ++A + C + RP +++ L
Sbjct: 213 SEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 49 VGHGGFGLVYRGVLSNGRK---VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL--- 102
VG G +G VY+ +G+ A+K ++ G E+ LL L+ P +++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 103 -LGYCSDRRKLLVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALEAAK 154
L + +DR+ L++DY EH + A+ +N +L + +
Sbjct: 67 FLSH-ADRKVWLLFDY------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTR-VL 209
G+ +LH + V+HRD K +NIL+ + K++D G A++ + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 210 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT 243
T Y APE L H T D+++ G + ELLT
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 37/217 (17%)
Query: 50 GHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGYCS 107
+ + VA+K ++ ED + E+ +L+ P +L +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 108 DRRKL-LVYDYMANGG----LQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFL 159
+L +V MA G L+ H +P G +A IA + L+++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTH-FP-EGLPELA----------IAFILKDVLNALDYI 117
Query: 160 H-EHCSPPVIHRDFKSSNILLDKNFHAKVSDF----GLAKIGSDKAGGHVSTR-VLGTQG 213
H + IHR K+S+ILL + +S + K G + H + +
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 214 YVAPEY---ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+++PE L G+ KSD+YS G+ EL G VP
Sbjct: 174 WLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLLALLGYC 106
+G G + VY+G+ NG+ VA+K++ ++G + E LL L+ ++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ L V++YM Q + G + +L + +GL ++H
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ--- 122
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-- 223
++HRD K N+L+ K++DFGLA+ S + + S V T Y P+ L G
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 224 HLTTKSDVYSYGVVLLELLTGR 245
++ D++ G + +E+L G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRK-VAIKLMDQAGKQGEDEFK----MEVELLGRLRSP 97
F VVG G +G+V + ++ VAIK + + +E K E+++L L+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQE 60
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQ--EHLYPANGSNSVASKLDWETRLRIALEAAK 154
++ L R KL LV++Y+ L+ E + V S + + K
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIK 111
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
+ + H++ ++HRD K N+L+ N K+ DFG A+ S+ + + T + T+ Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWY 167
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
+PE L D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 59/286 (20%), Positives = 119/286 (41%), Gaps = 47/286 (16%)
Query: 49 VGHGGFGLVYRGV---LSNGRK-----VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G F +++G+ + + + V +K++D++ + + F ++ +L +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 101 ALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G C ++V +Y+ G L +L N + W +L +A + A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ------G 213
+ + H + + N+LL + K + K+ SD +S VL +
Sbjct: 117 EDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPG---ISITVLPKEILLERIP 169
Query: 214 YVAPE-YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272
+V PE +L+ +D +S+G L E+ +G +KP D +K
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLS-----------ALDSQK 213
Query: 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
L+ + Q + ++A + C+ E D+RP +++ L
Sbjct: 214 KLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
+ K + +G G + VY+G VA+K + ++G + EV LL L+ ++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L + L LV++Y+ + L+++L + + ++ + +GL +
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYL------DDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H V+HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDI 175
Query: 220 AL-TGHLTTKSDVYSYGVVLLELLTGR 245
L + +T+ D++ G + E+ TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
+ K + +G G + V++G VA+K + ++G + EV LL L+ ++
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L R L LV++Y+ + L+++L ++ + + + +GL +
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSD-LKQYL------DNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H+ ++HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 220 AL-TGHLTTKSDVYSYGVVLLELLTGR 245
L + +T D++ G +L E+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
+ K +G G + V++G VA+K + ++G + EV LL L+ ++
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 101 ALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L +D+ LV++Y+ + L++++ + ++ S + + L + +GL +
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFL---YQILRGLAYC 120
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H V+HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175
Query: 220 AL-TGHLTTKSDVYSYGVVLLELLTGR 245
L + +T+ D++ G + E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 12/104 (11%)
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA----KIGSDKAG 201
L I + +++LHE+ +IHRD K+ NI ++ + DFG A I ++K
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
G GT APE D++S G+VL E+ T
Sbjct: 242 GWA-----GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 38/113 (33%), Positives = 57/113 (50%), Gaps = 22/113 (19%)
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD----------KNFHAKVSDFGLAKIGS 197
I A +GL +LH++ IHR+ K+S+IL+ + ++ V + AK+
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 198 DKAGGHVSTRVLGTQGYVAPEYA---LTGHLTTKSDVYSYGVVLLELLTGRVP 247
D ST VL +++PE L G+ KSD+YS G+ EL TGRVP
Sbjct: 163 DFP--QFSTSVLP---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 24/101 (23%)
Query: 167 VIHRDFKSSNILLDKNFH-----------------AKVSDFGLAK-IGSDKAGGHVSTRV 208
V+HRD K NI L AK+ DFGL+K IG + ++
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSC 201
Query: 209 LGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVP 247
+GT Y +PE L T KSD+++ G ++ EL +G+ P
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 18/100 (18%)
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 207
+ L+ L LH R KS NILL + K+ G + +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL--DGSVAFKTPEQSR----- 65
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++APE T K+D+YS G+ L E L +P
Sbjct: 66 --PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 44/163 (26%)
Query: 94 LRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
LRS ++ + + +Y +M + P L +TR I +
Sbjct: 232 LRSEANTYMI---TQKYDFDLYSFMYDEAFDWKDRP----------LLKQTR-AIMKQLL 277
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+E++H +IHRD K NI L+ + + DFG A +
Sbjct: 278 CAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER------------- 321
Query: 214 YVAPEYALTGHLTTKS-------------DVYSYGVVLLELLT 243
A +Y G + T S D++S G++LL++L+
Sbjct: 322 -EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 14/97 (14%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG--- 210
+GL + H+ V+HRD K N+L+ + K++DFGLA+ S V ++
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS------VPSKTYSNEV 164
Query: 211 -TQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
T Y P+ L + +T D++ G + E+ TGR
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 42/162 (25%), Positives = 62/162 (38%), Gaps = 25/162 (15%)
Query: 87 EVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL--------QEHLYPANGSNSVAS 138
E LL RL P +LALL D GGL + LY G+
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGAR--LR 255
Query: 139 KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198
L +A + ++++H +IHRD K+ N+L++ + DFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312
Query: 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 240
+ GT APE T D++S G+V+ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.41 | |
| PLN02236 | 344 | choline kinase | 97.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.1 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.0 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.27 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.76 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.4 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.0 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.35 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.83 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.7 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=344.14 Aligned_cols=290 Identities=54% Similarity=0.946 Sum_probs=246.9
Q ss_pred CceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEE
Q 018744 27 GLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 106 (351)
....|++.++..++++|.-...||+|+||.||+|...++..+|||.+..........|..|++++.+++|||++++++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67889999999999999999999999999999999888899999988654433145599999999999999999999999
Q ss_pred EcCC--eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 107 SDRR--KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 107 ~~~~--~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
.+.+ .++|+||+.+|+|.+.++..... +++|..+.+|+.++|.||+|||..+.+.++|||||+.|||+|++..
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 8775 68999999999999999764421 7899999999999999999999987667999999999999999999
Q ss_pred EEEeecccccccCCCCCCceeccc-CCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRV-LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
.||+|||++...... ....... .||..|+|||++..+..+.++||||||+++.||+||+.+.+...+........|.
T Consensus 216 aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred EEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 999999999654431 1111112 7899999999999999999999999999999999999988866555555566776
Q ss_pred cccccchhHHHhhcCcccc-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 LPRLTDREKILEIMDPALE-GQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+...+. .+.+++|+.+. ..+.. .....+..+...|++.+|.+||+|.++++.|+.+...
T Consensus 294 ~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 4444444 78899999987 66664 5777899999999999999999999999998666554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=334.01 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=209.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC--eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~v~~ 116 (351)
.+.+..+.||+|..|+||+++++ +++.+|+|++... ++...+++.+|+++++..+||+|+.+++.|.... ..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 36777889999999999999965 6889999999543 3445578999999999999999999999887765 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||++|+|..++... +.+++..+..++.++++||.|||+ + +|+||||||.||||+..|.|||||||.+..
T Consensus 159 YMDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred hcCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 99999999999543 469999999999999999999996 7 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
+... ......||..|||||.+.+..|+.++||||||++++|+++|+.||....+. ....-..+..
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----------~~~~~~Ll~~ 293 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----------YLDIFELLCA 293 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-----------CCCHHHHHHH
Confidence 5543 456678999999999999999999999999999999999999999754211 0111122333
Q ss_pred hcCccccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+++... ...+. ....++++||..||+.||.+|||+.++++|
T Consensus 294 Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 IVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 444222 22333 367789999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.15 Aligned_cols=257 Identities=23% Similarity=0.426 Sum_probs=218.9
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~ 115 (351)
.+|...+.||+|+|+.||.+++ .+|+.||+|++... .....+.+.+|+++.+.++||||++++++|++.+.+ +|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999996 78999999999752 345567788999999999999999999999998665 999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|.|..++|..+++ ..+++++..+..+++||+.||.|||++ +|+|||||..|+|++++.+|||+|||++..
T Consensus 98 ELC~~~sL~el~K-------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHH-------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeee
Confidence 9999999999995 345899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
+.... ......+||+.|.|||++.....+..+||||+||+||.|+.|.+||+... +.+
T Consensus 168 le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------------------vke 225 (592)
T KOG0575|consen 168 LEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------------------VKE 225 (592)
T ss_pred ecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------------------HHH
Confidence 76532 44567899999999999999899999999999999999999999997432 222
Q ss_pred hcCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 018744 276 IMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 331 (351)
Q Consensus 276 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~~ 331 (351)
.+...... .++........+||.++|+.||.+|||+.+|+.+ .+++++-.+.+.
T Consensus 226 ty~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 226 TYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKSGFTPARL 281 (592)
T ss_pred HHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhCCCcCCCC
Confidence 22222222 2233455678899999999999999999999988 777665554444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=336.10 Aligned_cols=264 Identities=32% Similarity=0.517 Sum_probs=218.6
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC--hHHHHHHHHHHhccCCCcceeeeEEEEcCC--eE
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDRR--KL 112 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 112 (351)
........+.+.||+|+||+||++.+.....+++|.+....... .+.|.+|+.+|.+++||||+++++++.+.. .+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 33345566677799999999999999665559999987543322 458999999999999999999999998875 67
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-ceecCCCCCcEEeCCCC-cEEEeec
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-VIHRDFKSSNILLDKNF-HAKVSDF 190 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-i~H~di~p~Nilv~~~~-~v~l~df 190 (351)
+||||+.+|+|..+++.. ....+++..++.++.||++||.|||+. + |+|+||||+||||+.++ ++||+||
T Consensus 117 iVtEy~~~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred EEEEeCCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence 999999999999999653 235899999999999999999999999 8 99999999999999998 9999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccc--cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|+++...... ...+...||..|||||++. ...|+.++||||||+++|||+||..||....+
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------------- 251 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------------- 251 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 9998644321 2234478999999999999 56999999999999999999999999985443
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
............+...+..++..+..|+..||..||+.||++.+++..|+.+...-.
T Consensus 252 -~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 252 -VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 122333333444445555577789999999999999999999999999999887543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=330.80 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.4
Q ss_pred HHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCC-------ChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQ-------GEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
+...+.|.+.+.||+|+||.|-+|. ..+|+.||+|++...... ......+|+++|++++||||++++++++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3456789999999999999999999 558999999998632211 12235689999999999999999999988
Q ss_pred CCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC---Cc
Q 018744 109 RRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FH 184 (351)
Q Consensus 109 ~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~---~~ 184 (351)
.+. |+|+||++||.|.+.+... +.+.+..-..+++||+.|+.|||++ ||+||||||+|||++.+ ..
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 755 7999999999999999543 4567777789999999999999999 99999999999999765 78
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCC---CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL---TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 261 (351)
+||+|||++..... .......+||+.|.|||++.+..+ ..+.|||||||++|-+++|..||.....+.
T Consensus 318 lKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------ 388 (475)
T KOG0615|consen 318 LKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------ 388 (475)
T ss_pred EEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------
Confidence 99999999987653 235567899999999999986543 347799999999999999999997544320
Q ss_pred cccccccchhHHHhhcCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 262 WALPRLTDREKILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
-....+....... ..-....++..+||.+||.+||++|||+.|+|+| .+++
T Consensus 389 ---------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h--pW~~ 441 (475)
T KOG0615|consen 389 ---------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH--PWFK 441 (475)
T ss_pred ---------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC--hhhh
Confidence 0111222221111 1112445688999999999999999999999998 4444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=339.82 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=226.4
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
+......+.+++.+.||+|.||.||+|.+.....+++|.+... ....+.|.+|+.+|++++|++|++++++|..+. .+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 3444445667889999999999999999988789999998654 556678889999999999999999999999876 56
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+..|+|.+++.... ...++....+.++.|||+|++||+++ ++|||||...||||++++.+||+|||+
T Consensus 278 IVtE~m~~GsLl~yLr~~~-----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTRE-----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EEEEecccCcHHHHhhhcC-----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 9999999999999997622 34788999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++...... ........-...|+|||.+..+.+|.+|||||||++||||+| |+.||.+.. ..
T Consensus 350 Ar~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ 411 (468)
T KOG0197|consen 350 ARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NE 411 (468)
T ss_pred ccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HH
Confidence 99432221 112222333457999999999999999999999999999999 999987544 35
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+.+.++.-.+-..+..++..++++|..||+.+|++|||+..+.+.|+++....
T Consensus 412 ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 412 EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 666777777777888889999999999999999999999999999999987643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=323.03 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=207.2
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeE-EEE-cCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLG-YCS-DRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~-~~~-~~~v 114 (351)
.+|+|.+.||.|.||.||++. ..+|..+|.|.++.. +....+....|+.+|++++||||+++++ .+. +.. ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 569999999999999999999 568999999988632 2333466788999999999999999998 333 333 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
||++.+|+|...+..+. +....+++.++|+++.|++.||.++|+. .++ ++||||||.|||++.+|.|||+|||+
T Consensus 99 mE~c~~GDLsqmIk~~K---~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFK---KQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred HHhhcccCHHHHHHHHH---hccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchh
Confidence 99999999999997766 3456799999999999999999999993 224 99999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
++.+.... ......+|||.||+||.+.+..|+.++||||+||++|||+.-..||.+++-
T Consensus 175 ~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------------------- 233 (375)
T KOG0591|consen 175 GRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------------------- 233 (375)
T ss_pred HhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-------------------
Confidence 99866543 334568899999999999999999999999999999999999999986532
Q ss_pred HHhhcCccccCCC---C-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 273 ILEIMDPALEGQY---S-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 273 ~~~~~~~~~~~~~---~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.++..+.-..++ + .-.+.++..+|..|+.+||+.||+...++..+.
T Consensus 234 -~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 234 -LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 222222222233 3 345678999999999999999998655555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=315.71 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=199.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~ 115 (351)
..+|.+.+.||+|.|++||+|++. ++..||||.+..+ .....+.+..|+.+|+.++||||+.+++++...+.+ +||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999954 6889999998765 344556788899999999999999999999887655 999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC------CcEEEee
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN------FHAKVSD 189 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~------~~v~l~d 189 (351)
|||+||+|..++... +.+++.++..++.||+.||++||++ +|+||||||+|||++.. ..+||+|
T Consensus 89 EyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999999654 3799999999999999999999999 99999999999999764 5699999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||+++.+.. .......+|++-|||||++....|+-|+|+||+|+++|+|++|..||+...+.
T Consensus 159 FGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~--------------- 220 (429)
T KOG0595|consen 159 FGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK--------------- 220 (429)
T ss_pred cchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH---------------
Confidence 999998764 33556788999999999999999999999999999999999999999744321
Q ss_pred hhHHHhhc--CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIM--DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
++.... ........+......+.+|+...+..+|.+|.+..+-..+
T Consensus 221 --eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 221 --ELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred --HHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 111100 0111111112222345567777777888888776655433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=327.48 Aligned_cols=276 Identities=24% Similarity=0.311 Sum_probs=216.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHH-HHHHHHHHhccC-CCcceeeeEEEEcCC--eE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-FKMEVELLGRLR-SPYLLALLGYCSDRR--KL 112 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~-~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~ 112 (351)
..-++|.+.+.||.|+||.||+|+ ..+|..||||.++..-..+.+- -.+|++.|++++ ||||+++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345789999999999999999999 5578999999987553332221 246999999998 999999999987765 55
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|||||+. +|..+++.++ ..+++..+..|++||++||+|+|++ |+.|||+||+|||+.....+||+|||+
T Consensus 87 fVfE~Md~-NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred eeHHhhhh-hHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccc
Confidence 99999965 9999997653 5899999999999999999999999 999999999999999888999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc--
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-- 269 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 269 (351)
++...... ..+..+.|.+|+|||++. .+.|+.+.|||++||+++|+++-+..|.+.+...+..++-...+....
T Consensus 157 ARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 157 AREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 98654433 456778899999999875 678999999999999999999999999988776555544333222111
Q ss_pred ---hhHHHhhcCccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 270 ---REKILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 270 ---~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
...+...+.-.+.. ...+....+..+||.+|+.+||++|||+.+++++ .+++-....
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~--pffq~~~~~ 300 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH--PFFQVGRAS 300 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC--ccccccccc
Confidence 12222222211111 1112245689999999999999999999999998 444444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=320.51 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=211.1
Q ss_pred HHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-C
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 110 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 110 (351)
..-.++|.+.+.||+|+|++|++|. ..+++.||||++... .+.-...+..|-++|..| .||.|++++-.|+++ .
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4456899999999999999999999 457999999988532 222345667788999999 899999999998877 5
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.|+|++|+.+|.|.+++... +.+++.....++.+|+.||+|||++ ||+||||||+|||++++++++|.||
T Consensus 149 LYFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence 67999999999999999655 4799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC---------cee--cccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce
Q 018744 191 GLAKIGSDKAGG---------HVS--TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 259 (351)
Q Consensus 191 g~~~~~~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 259 (351)
|.+..+...... ... ...+||..|.+||++..+..++.+|||+|||++|+|+.|..||.+.++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------ 292 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------ 292 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------
Confidence 999876543322 111 336799999999999999999999999999999999999999975543
Q ss_pred eecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 260 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+.+++ +.-.++...+....+||.+.|..||.+|+|+.+|.+|-
T Consensus 293 ----------yliFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 293 ----------YLIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----------HHHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 122333332 22244455556799999999999999999999998874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=307.29 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=208.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
+.|+...++|+|++|.||+++++ +|+.||||.+-... +....-..+|+++|++++|+|++.++++|..... .+|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46889999999999999999955 69999999985332 2233456789999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|++..-|..+-.. ...++...+.+++.|++.|+.|||++ +++||||||+||||+.+|.+||||||+++.+
T Consensus 82 ~~dhTvL~eLe~~-------p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 82 YCDHTVLHELERY-------PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred ecchHHHHHHHhc-------cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhh
Confidence 9998655555422 23688999999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH---
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK--- 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 272 (351)
.. .....+....|.+|+|||.+.+ .+|..+.|||++||++.||++|...|.+.+.......+.........+..
T Consensus 152 ~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 152 SA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred cC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 54 3456678889999999999987 58999999999999999999999999988766444444333332222111
Q ss_pred -----HHhhcCcccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 -----ILEIMDPALE-----GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 -----~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..-+.-+... ....+....-+.+|+..||+.||.+|++-++++.|
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0001111111 11112334478899999999999999999999865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=326.50 Aligned_cols=286 Identities=26% Similarity=0.449 Sum_probs=230.5
Q ss_pred ceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEE
Q 018744 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGY 105 (351)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 105 (351)
....+-+++.+..++..+...||+|.||+||+|+|-+ .||||++...... ..+.|++|+.+|++-+|.||+-+.++
T Consensus 379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cCCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 4444557777888899999999999999999999744 3999998755443 34779999999999999999999999
Q ss_pred EEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 106 ~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
+......+|+.+|+|.+|..+++... .++...+...|++|+++|+.|||.+ +|+|+|||.+|||+.++++|
T Consensus 457 ~~~p~~AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 457 CMNPPLAIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred hcCCceeeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence 99988899999999999999997654 5799999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
+|+|||++..-.............|...|+|||+++. .+|++.+||||||+++|||++|..||.....+ ..+.+.
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmV 605 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMV 605 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEe
Confidence 9999999987555544444556678889999999973 47899999999999999999999999843332 111111
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCCCc
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSF 337 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~~~~~~~~ 337 (351)
...-... +.. ....+++..+.+|+..||+.++++||++.+|+..|+.+++..+...++.|-|+.
T Consensus 606 GrG~l~p--d~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~ 669 (678)
T KOG0193|consen 606 GRGYLMP--DLS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVL 669 (678)
T ss_pred cccccCc--cch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccch
Confidence 1110000 000 112234557999999999999999999999999999999976555555555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=307.83 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=204.8
Q ss_pred HhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
..++|++.+.||.|+||+|+.++ ..+++.||+|+++... ..+.+....|..+|..++||.|++++-.|++. ..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34779999999999999999999 4468999999997442 33456788899999999999999999988876 5569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|++|+.||.|...+. ..+.+++..+.-++..|+.||.|||+. +|+||||||+|||++.+|+++|+|||++
T Consensus 103 Vld~~~GGeLf~hL~-------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ-------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred EEeccCCccHHHHHH-------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence 999999999999993 445799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... .......+||+.|+|||++.+..|+.++|.||||+++|+|++|..||.+.+.. ...
T Consensus 173 k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~ 234 (357)
T KOG0598|consen 173 KEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMY 234 (357)
T ss_pred hhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHH
Confidence 853322 22334578999999999999999999999999999999999999999865531 223
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP----LMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp----t~~eil~~ 317 (351)
..+....+ ...+.-...+.++++..+|+.||++|. .+.+|-+|
T Consensus 235 ~~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 235 DKILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 33333321 122222445788999999999999996 44554443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=317.00 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=207.8
Q ss_pred HHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc----CC-CChHHHHHHHHHHhccC-CCcceeeeEEEEcCC
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA----GK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDRR 110 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 110 (351)
...++|.+.+.||+|+||+|++|. ..++..+|+|++... .. .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999998 447899999977543 12 23456778999999998 999999999998765
Q ss_pred e-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEe
Q 018744 111 K-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVS 188 (351)
Q Consensus 111 ~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~ 188 (351)
. ++||||+.+|.|.+++.. .+++.+..+..+++|++.|++|||++ |++||||||+||+++.+ +++||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEe
Confidence 4 599999999999999954 34788899999999999999999999 99999999999999999 999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCC-CC-CccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|||++.... .........+|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||+..+..
T Consensus 164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------------ 229 (370)
T KOG0583|consen 164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------------ 229 (370)
T ss_pred ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------------
Confidence 999998764 2234556788999999999999876 75 7899999999999999999999853321
Q ss_pred ccchhHHHhhcCccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 267 LTDREKILEIMDPALEGQYSMKE-VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.....+..... .++... ..++..|+.+||..||.+|+|+.+|+++ ..++.
T Consensus 230 ----~l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~~ 280 (370)
T KOG0583|consen 230 ----NLYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQK 280 (370)
T ss_pred ----HHHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhcc
Confidence 11111222111 112222 5678999999999999999999999955 55554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=288.50 Aligned_cols=270 Identities=23% Similarity=0.372 Sum_probs=211.9
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~ 116 (351)
.+|...+.||+|.||.||+|+ ..+|+.||||.+...+.. ......+|++.|+.++|+||+.++++|...+.+ +|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468889999999999999999 568999999998744222 235577899999999999999999999877655 9999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|++. +|...++... ..++...+..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+++.+
T Consensus 82 fm~t-dLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred eccc-cHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 9965 8888886543 4788999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee----------ecc-c
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV----------SWA-L 264 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----------~~~-~ 264 (351)
..+.. .....+.|..|.|||.+.|. .|+...||||.||++.||+.|..-|.+.+...+...+ .|- .
T Consensus 152 ~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 152 GSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 66543 33445778899999998865 7999999999999999999999998877654332211 111 1
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+.+...+.....+.+. ..-+....+..+|+..||..||.+|+|+.|++++ ..+++.
T Consensus 230 ~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~ 287 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSL 287 (318)
T ss_pred cccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcC
Confidence 112222222222222222 1333445577999999999999999999999998 666653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=311.23 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=204.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc-C--CeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-R--RKLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~~~~v~ 115 (351)
..+|...+.||+|+||.||++... +|..+++|.+...+....+.+.+|+.+|.+++||||+++++.... . ...++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 466889999999999999999954 589999998875533336778999999999999999999996332 2 245999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeeccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAK 194 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~ 194 (351)
||+.+|+|.+++...+ .++++..+..+.+|+++||.|||++ |++|+||||+|||++. ++.+||+|||++.
T Consensus 96 Ey~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 9999999999996543 2699999999999999999999999 9999999999999999 7999999999987
Q ss_pred ccCC-CCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 195 IGSD-KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 195 ~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
.... ...........||+.|+|||++.++ ...+++|||||||++.||+||+.||... ......
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---------------~~~~~~ 231 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---------------FEEAEA 231 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---------------cchHHH
Confidence 6553 1112223457799999999999854 3446999999999999999999999742 000111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+..+........++...+....+|+..|+..+|++|||+.++|++.
T Consensus 232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 2222222222355555667899999999999999999999999994
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=319.52 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=204.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 109 (351)
..++|++.+.||+|+||.||+|.+ .++..||+|++..... .....+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999973 1346799999864322 2235688899999999 899999999988654
Q ss_pred -CeEEEEEEccCCChhhhccccCCCC------------------------------------------------------
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------ 134 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~------------------------------------------------------ 134 (351)
..+++|+|+.+|+|.+++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 3468999999999998886432100
Q ss_pred -CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcc
Q 018744 135 -SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213 (351)
Q Consensus 135 -~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 213 (351)
.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++................++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0123578889999999999999999999 999999999999999999999999999875433221112223345678
Q ss_pred cccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHH
Q 018744 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQ 292 (351)
Q Consensus 214 y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (351)
|+|||++.+..++.++|||||||++|+|++ |..||.+.... ......+........+...+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----------------EEFCQRLKDGTRMRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----------------HHHHHHHhcCCCCCCCCCCCHH
Confidence 999999998899999999999999999997 99999753321 0111111111111122233457
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 293 VAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 293 l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+.+++.+||+.||++|||+.++++.|++++..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=305.62 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=211.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 112 (351)
.....+.|++...||.|..+.||+|+ .+.+..|+||++...... +.+.+++|+..++.++||||++++..|..+ ..+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 34455889999999999999999999 667899999999754333 358899999999999999999999987655 567
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||.+|.+|++.+++...-. ..+++..+..++++++.||.|||++ |.+|||||+.||||+++|.|+|+|||.
T Consensus 101 vVmpfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999976542 3599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcee--cccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 193 AKIGSDKAGGHVS--TRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 193 ~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
+..+......... ....|+++|+|||++.. .-|+.|+||||||++..||.+|..||....+.
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------------- 238 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------------- 238 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------------
Confidence 8776553322211 44679999999999653 36899999999999999999999999865542
Q ss_pred chhHHHhhcCc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 269 DREKILEIMDP--------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 269 ~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+..-+.. .+..+........+.+++..||..||.+|||+.+++++ .++++
T Consensus 239 --kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh--~FFk~ 298 (516)
T KOG0582|consen 239 --KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH--AFFKK 298 (516)
T ss_pred --HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc--HHHhh
Confidence 111111111 01111112233479999999999999999999999987 55554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=290.80 Aligned_cols=272 Identities=23% Similarity=0.308 Sum_probs=216.7
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-- 109 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 109 (351)
-+.+.+..++|+|.+.||+|+|+-|+++. ..++..||+|.+...+..+.+...+|++..++++|||+++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 45566778999999999999999999999 567889999999877777788899999999999999999999865322
Q ss_pred ----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 110 ----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 110 ----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
..+++++|+..|+|.+.+..... ...-+++..++.++.++++||.+||... ..++|+||||.||++++.+.+
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCce
Confidence 34699999999999999866542 2346899999999999999999999991 139999999999999999999
Q ss_pred EEeecccccccCCCCCCce-------ecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 186 KVSDFGLAKIGSDKAGGHV-------STRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
+|.|||.+....-...... .....+|..|+|||.+. +...+.++|||||||++|.|+.|..||+......
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 9999999876544322211 11245788999999986 4567899999999999999999999997544322
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.....+ +....+..+-....++.+.+||.+||+.||.+||++.+++..+.+++
T Consensus 249 gSlaLA--------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 GSLALA--------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CeEEEe--------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 211111 11111222222225567999999999999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=309.91 Aligned_cols=264 Identities=26% Similarity=0.375 Sum_probs=206.7
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v 114 (351)
+.|+.+..||+|+||.||+|+ ..+|+.||+|.+..+. +.......+|+.+|+++.||||+++.+...+. ..|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 458888999999999999999 5579999999987654 44456678899999999999999999988765 56799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
+|||+. +|..++.. ..-++++.++..++.||++||.|||.+ |++|||||..||||+.+|.+||+|||+++
T Consensus 197 FeYMdh-DL~GLl~~------p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS------PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred Eecccc-hhhhhhcC------CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999987 66666632 234799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee----------ecc
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV----------SWA 263 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----------~~~ 263 (351)
.+.... ....+..+.|.+|.|||++.|. .|+.+.|+||.||+|.||++|+..|.+.....+..++ .|.
T Consensus 267 ~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 765543 2235667789999999999865 7999999999999999999999999987654222211 122
Q ss_pred cccccchhHHHhhcCccccCCCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 264 LPRLTDREKILEIMDPALEGQYSM-------KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
...+.. ...+.+. ..+.. ..+....+|+..+|..||.+|.|+.++|++ +.+.
T Consensus 346 ~~kLP~----~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~ 404 (560)
T KOG0600|consen 346 VSKLPH----ATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFT 404 (560)
T ss_pred cccCCc----ccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccc
Confidence 111110 0000000 01110 113467889999999999999999999987 5663
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.51 Aligned_cols=268 Identities=28% Similarity=0.455 Sum_probs=226.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
..+..+.+.||+|.||+||+|... ....|+||.++.+... ....|++|++++..++||||++++++|.+++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 356778899999999999999832 3457899999866555 56789999999999999999999999988865
Q ss_pred EEEEEEccCCChhhhccccCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNS-------VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
++|+|||..|+|..|+........ ...+++..+.+.|+.|||.|+.||-++ .+|||||.++|+||.++-.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 599999999999999966543211 134589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
|||+|||+++..-..+.........-..+|||||.+..+.++.+|||||+|++|||+++ |..||.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g------------- 708 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG------------- 708 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-------------
Confidence 99999999986444433333333444568999999999999999999999999999999 9999974
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
+.+.+.+..+.+..+ ...+.+++.++++||..||+.+|++||+++||-..|..+-+.+..
T Consensus 709 ---lSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 709 ---LSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ---cchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 444566666666555 678888999999999999999999999999999999998876544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=314.20 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=209.3
Q ss_pred hcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEE-cCCeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~v~~~ 117 (351)
...|.....||+|..|.||.|. ..+++.||+|.+........+.+.+|+.+|+..+|+||+.+++.+. .++.+.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4678888999999999999999 5578889999997666666677889999999999999999999554 4567899999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
++||+|.+.+. ...+++.++..|++.++.||+|||.+ +|+|+|||.+|||++.+|.+||+|||+|....
T Consensus 352 m~ggsLTDvVt--------~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 352 MEGGSLTDVVT--------KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred cCCCchhhhhh--------cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999883 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......||+.|||||++....|.++.||||||++++||+-|..||-..++......+ ...-
T Consensus 421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------------a~ng 485 (550)
T KOG0578|consen 421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------ATNG 485 (550)
T ss_pred cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------------hhcC
Confidence 5442 345678999999999999999999999999999999999999999765543111111 1111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+ .-..+......+.+|+.+||..|+++|+|+.|+|+|
T Consensus 486 ~P--~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TP--KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CC--CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 112233445579999999999999999999999988
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=315.01 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=212.2
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
+-|++.+.||.|+.|.|-+|++ .+|+..|||++...... ....+.+|+-+|+.+.|||++.+++++++. +.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588999999999999999994 58999999999765322 234577899999999999999999999876 566999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|-|.+++.. .+++++..+.+++.||+.|+.|||.. +++|+||||+|+|++..+++||+|||++..
T Consensus 92 Eyv~gGELFdylv~-------kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-------KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EecCCchhHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec
Confidence 99999999999954 45899999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
.. ........+|.+.|.+||++.|..| ..++||||+|+++|.|++|..||++.+ +.
T Consensus 162 e~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------------------ir 218 (786)
T KOG0588|consen 162 EV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------------------IR 218 (786)
T ss_pred cc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------------------HH
Confidence 32 2344567889999999999999988 578999999999999999999998433 22
Q ss_pred hhcCcccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018744 275 EIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 330 (351)
Q Consensus 275 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~ 330 (351)
.++.+.-. -+++...+.+..+||++||.+||+.|+|++||++| -++......+.
T Consensus 219 ~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH--P~l~g~~~~~~ 274 (786)
T KOG0588|consen 219 VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH--PFLSGYTSLPS 274 (786)
T ss_pred HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC--chhhcCCCCCh
Confidence 22222222 24445666789999999999999999999999999 45554444333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.36 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=211.0
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--------------CCChHHHHHHHHHHhccCC
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--------------KQGEDEFKMEVELLGRLRS 96 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--------------~~~~~~~~~e~~~l~~l~h 96 (351)
.-.+=....|+|++.+.||+|.||.|-+|+. .+++.||+|++.... ....+...+|+.+|+++.|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 3344456679999999999999999999994 478999999985321 1223578889999999999
Q ss_pred CcceeeeEEEEcC---CeEEEEEEccCCChhhhccccCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCceecCC
Q 018744 97 PYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASK-LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF 172 (351)
Q Consensus 97 ~~i~~~~~~~~~~---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di 172 (351)
|||++++++..+. ..|+|++|+..|.+...- ..++ ++..++++++++++.||.|||.+ ||+||||
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCC--------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9999999999764 567999999988665332 1233 89999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCC---CCceecccCCCcccccccccccCC----CCCccceeehHHHHHHHHhCC
Q 018744 173 KSSNILLDKNFHAKVSDFGLAKIGSDKA---GGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGR 245 (351)
Q Consensus 173 ~p~Nilv~~~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~s~~~DiwslG~~l~~lltg~ 245 (351)
||.|+|++++|+|||+|||.+..+.... .........||+.|+|||...++. .+.+.||||+|++||.|+.|.
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 9999999999999999999998653321 112233478999999999987632 357889999999999999999
Q ss_pred CCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 246 VPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 246 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.||-+... -.....++...+..+...+..+.+.+||.+||..||+.|+++.+|..|.+--
T Consensus 317 ~PF~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 317 LPFFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred CCcccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 99964332 2234455555555555556778899999999999999999999999886543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.03 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=215.5
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcCC-cEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeE-EEEc---C
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSNG-RKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLG-YCSD---R 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~-~~~~---~ 109 (351)
+.+...+++|.+.|.+|||+.||+|.+..+ ..||+|++-..++...+.+++|+++++.|+ |+||+.+++ .... .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 344557899999999999999999996554 999999988778888899999999999996 999999999 2221 1
Q ss_pred ----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 110 ----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 110 ----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
+.+++||||.+|.|.+++.++.. ..|++.++++|++++++|+++||.. ...|+|||||.+||||+.+|+.
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence 22499999999999999976542 2499999999999999999999999 4459999999999999999999
Q ss_pred EEeecccccccCCCCCCce-------ecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 186 KVSDFGLAKIGSDKAGGHV-------STRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
||||||.+........... .-...-|+.|+|||.+. +...+.|+|||+|||+||-||....||+....
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 9999999875333221110 11234688999999874 67889999999999999999999999974422
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..++.....-+..+.....+.+||+.||+.||++||++.++++.+-++.....
T Consensus 264 ------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 23344444444445677889999999999999999999999999988876533
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=304.38 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=211.1
Q ss_pred HhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-E
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-L 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~ 113 (351)
...+|++.+.||.|.||+|-+|. +..|+.||||.+..+ ++++.-.+++|++++..++||||+.++++|++.+.+ +
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34689999999999999999999 578999999998744 445556789999999999999999999999998766 9
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||..+|.|.+++ +....+++.....+++||+.|+.|||++ +++|+|||.+|||+|.++++||+|||++
T Consensus 131 vMEYaS~GeLYDYi-------Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 131 VMEYASGGELYDYI-------SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS 200 (668)
T ss_pred EEEecCCccHHHHH-------HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence 99999999999999 4556899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
..+... ......+|++.|.+||++.|.+| .+..|-||||+++|.|..|..||++.+.
T Consensus 201 Nly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------------- 258 (668)
T KOG0611|consen 201 NLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------------- 258 (668)
T ss_pred hhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------------------
Confidence 876543 34566889999999999999888 5789999999999999999999987553
Q ss_pred HHhhcCccccCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 273 ILEIMDPALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 273 ~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
..++.+...+.|. +..+.+..-||++||.+||++|-|+.+|..|-+
T Consensus 259 -k~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 259 -KRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -HHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1222222222222 122335667999999999999999999999853
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.48 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=197.9
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEc--C---CeEEEEEEc
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSD--R---RKLLVYDYM 118 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~---~~~~v~~~~ 118 (351)
..|++|+++.||+|.+ +|+.+|+|.+....... .+.+.+|+.++++++||||+++++++.+ . ..++++||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 67899999987543333 3567799999999999999999998866 2 346999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
.+|+|.+++.. ...+++...+.++.|++.||.+||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 105 ~~g~L~~~l~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 105 TRGYLREVLDK-------EKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CCCcHHHHHhh-------CCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999943 2368889999999999999999997 5 78899999999999999999999999987543
Q ss_pred CCCCCceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......
T Consensus 175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----------------~~~~~~ 233 (283)
T PHA02988 175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----------------KEIYDL 233 (283)
T ss_pred ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----------------HHHHHH
Confidence 321 23457788999999876 6789999999999999999999999974332 111122
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
+.........+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 234 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22222222233345667999999999999999999999999998764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=305.04 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=206.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+..... .....+..|+.+++.++||||+++++++.....++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~ 85 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 85 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCcee
Confidence 367999999999999999999853 333 389998864322 23466888999999999999999999998888889
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++|+.+|+|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 86 v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 999999999999985432 3578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
.................+..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----------------~~ 219 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SE 219 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------------HH
Confidence 86543322222222334567999999999999999999999999999998 9999864321 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
+...+........+......+.+++.+||..+|++|||+.+++..|.++.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 12222221111222233457899999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.81 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=201.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 110 (351)
.++|++.+.||+|+||.||+|.+ .++..+++|++.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999963 235679999986432 22345678899999999 899999999998776 4
Q ss_pred eEEEEEEccCCChhhhccccCCCC--------------------------------------------------------
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSN-------------------------------------------------------- 134 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~-------------------------------------------------------- 134 (351)
.++||||+.+|+|.+++.......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 569999999999998885432100
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCC
Q 018744 135 ------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202 (351)
Q Consensus 135 ------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 202 (351)
.....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0112578899999999999999999999 9999999999999999999999999998765433221
Q ss_pred ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIKEGY 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHHhCc
Confidence 12222334567999999999999999999999999999998 88898643221 11111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
....+...+.++.+|+.+||+.||++|||+.++++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111122245789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.66 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=198.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++.+.+ .+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67999999999999999999964 68899999986432 233456788999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 98 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred cCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999988432 3688899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ....|++.|+|||++.+..++.++|||||||++|+|++|..||....+. .....
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~ 226 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----------------RIYEK 226 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----------------HHHHH
Confidence 53321 2346889999999999888999999999999999999999999643321 11112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
+....+ .++......+.+||.+||+.||.+||+ +.+++.|
T Consensus 227 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 227 ILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222111 112223346889999999999999997 6888877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.22 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=209.2
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
++|.+.+.||+|.||.||+|+. .+.+.||+|.+....+ .+...+++|+++++.++||||+.++++|+.. +.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6799999999999999999994 4788899999865433 3456788999999999999999999999887 4558999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.| +|..++. ..+++++..+..++.+++.||.|||++ +|.|+|+||.||+++.+|.+|+||||+++..
T Consensus 82 ~a~g-~L~~il~-------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILE-------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9987 9999994 446899999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.. +....+...||+.|||||++.+.+|+..+|+|||||++|||++|+.||-. ..+..+
T Consensus 151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------------------~si~~L 208 (808)
T KOG0597|consen 151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------------------RSITQL 208 (808)
T ss_pred cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------------------HHHHHH
Confidence 44 34556778899999999999999999999999999999999999999962 223333
Q ss_pred cCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+...+.. .++......+..|+..+|..||..|.|..+++.|
T Consensus 209 v~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 209 VKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 3333322 2344667789999999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.94 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=198.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999965 68899999986432 123456788999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999998432 3688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----------------~~~~~ 209 (291)
T cd05612 151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----------------GIYEK 209 (291)
T ss_pred ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 4322 12346888999999999888999999999999999999999999754321 11112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
+..... .++......+.+||.+||+.||.+||+ +.+++++
T Consensus 210 i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 221111 122223456899999999999999995 9999888
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=304.23 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=200.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|+||.||++.+. ++..+++|.+..... .....+.+|+++++.++||||+++++++.... .++||+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 688899998864322 23356888999999999999999999887664 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++... ..+++..++.++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 84 HMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99999999998432 36889999999999999999999852 6999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee------------ccc
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS------------WAL 264 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~------------~~~ 264 (351)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 155 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 332 1233468889999999998899999999999999999999999996533210000000 000
Q ss_pred ------------------ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 265 ------------------PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 265 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+..........+................+.+||.+||+.||++|||+.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000111111111111112345799999999999999999999999983
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=300.31 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=198.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC-----------------CcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCccee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN-----------------GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLA 101 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~-----------------~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~ 101 (351)
.++|++.+.||+|+||.||+|.+.+ +..+++|.+...... ....+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 336899988643222 2356888999999999999999
Q ss_pred eeEEEEcCC-eEEEEEEccCCChhhhccccCCC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCce
Q 018744 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGS------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168 (351)
Q Consensus 102 ~~~~~~~~~-~~~v~~~~~~~~L~~~~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 168 (351)
+++++.+.+ .++++||+.+++|.+++...... ......+++..++.++.||+.||.|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 999987664 56999999999999988543211 11123578899999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh--CCC
Q 018744 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRV 246 (351)
Q Consensus 169 H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt--g~~ 246 (351)
|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543322222233445678999999988889999999999999999987 566
Q ss_pred CCCCCCCCCCcceeecccccccchhHHHhhcCc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDP---ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
||....... ........... ......+...+..+.+|+.+||..+|++|||+.+|...|+
T Consensus 241 p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ-------------VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH-------------HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 775432110 00001011100 0001112233457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=304.22 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=199.6
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+..|++++..++||||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 58899999986432 223456778999999999999999999888765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 81 EYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999998432 3688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+..
T Consensus 151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------------~~~i~~ 212 (333)
T cd05600 151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------------WENLKY 212 (333)
T ss_pred ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------------HHHHHh
Confidence 433 22445688999999999988999999999999999999999999975432100 000000
Q ss_pred ---hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 ---IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+...............+.+||.+||..+|.+|||+.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000001234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=307.92 Aligned_cols=266 Identities=25% Similarity=0.393 Sum_probs=202.7
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 109 (351)
...++|.+.+.||+|+||.||+|.+. ++..|++|.+..... .....+.+|+.+++.+ +|+||+++++.+...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34467999999999999999998842 235799999864322 2235678899999999 899999999988776
Q ss_pred C-eEEEEEEccCCChhhhccccCC--------------------------------------------------------
Q 018744 110 R-KLLVYDYMANGGLQEHLYPANG-------------------------------------------------------- 132 (351)
Q Consensus 110 ~-~~~v~~~~~~~~L~~~~~~~~~-------------------------------------------------------- 132 (351)
. .++||+|+.+|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 4 4599999999999988753210
Q ss_pred -------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCcee
Q 018744 133 -------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205 (351)
Q Consensus 133 -------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 205 (351)
......++++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 001123578899999999999999999999 9999999999999999999999999998754332221122
Q ss_pred cccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCC
Q 018744 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ 284 (351)
Q Consensus 206 ~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (351)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..............
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----------------~~~~~~~~~~~~~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----------------SKFYKMVKRGYQMS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----------------HHHHHHHHcccCcc
Confidence 22334567999999988899999999999999999997 99999643221 11111111111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 285 YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11122457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.78 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=197.8
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++..++|++++++.+.+.+.+ .+++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999995 578999999886432 122345678999999999999999999887664 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+|+|...+.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 81 IMNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred ecCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999999988774322 13588999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+...
T Consensus 153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-------------~~~~~~~~ 216 (285)
T cd05631 153 PEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-------------KREEVDRR 216 (285)
T ss_pred CCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-------------hHHHHHHH
Confidence 3221 2234568899999999999999999999999999999999999997544310 00111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
.. .....++......+.+|+.+||+.||++||| +.+++++
T Consensus 217 ~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 217 VK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred hh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11 0111223334457889999999999999997 7888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.86 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=213.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe--EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK--LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~v~ 115 (351)
++|..++.+|.|+||.+++++++ ++..+|+|.+.... ...++....|+.++.+++||||+.+.+.+.+++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 67999999999999999999954 57889999886443 3334567889999999999999999998877654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|++||++.+.+....+ ..+++..++.|+.|++.|+.|||+. .|+|||||+.|||++.++.|+|+|||++..
T Consensus 84 ~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred eecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence 99999999999976552 4689999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......||+.|++||.+.+.+|..++|||||||++|||++-+.+|...+.. .-+..
T Consensus 156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~k 217 (426)
T KOG0589|consen 156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILK 217 (426)
T ss_pred cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHH
Confidence 66644 2446688999999999999999999999999999999999999999865542 22233
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.... ....+.....++..+|..||..+|..||++.++|.+
T Consensus 218 i~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 INRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Hhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33222 345566677789999999999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.84 Aligned_cols=261 Identities=30% Similarity=0.507 Sum_probs=204.6
Q ss_pred cCCCcCceeeecCceEEEEEEEcC-C-----cEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~-~-----~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
++|++.+.||+|++|.||+|.... + ..+++|.+..... .....+.+|+..+..++||||+++++++.... .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 579999999999999999998532 2 5689998864322 22356788999999999999999999987654 56
Q ss_pred EEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 113 LVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
++++|+.+++|.+++...... ......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998653221 01124688999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeec
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 262 (351)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------- 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999875433322222333456778999999988889999999999999999998 9999865332
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
..+...+........+...+..+.+|+.+||+.||.+|||+.+|+++|+++
T Consensus 233 --------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 --------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111122211122223345567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.38 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=207.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.++|++.+.||.|++|.||+|.+.++..+++|.+..........+..|+.+++.++|+|++++++++.... .+++++|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46799999999999999999998778999999997665556678899999999999999999999887765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+.....
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 85 EKGSLLAFLRSPE-----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ccCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999996432 23578999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......
T Consensus 157 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~- 217 (261)
T cd05148 157 DV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----------------HEVYDQI- 217 (261)
T ss_pred cc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----------------HHHHHHH-
Confidence 21 11122334567999999988889999999999999999998 8999964331 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 12222223334456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=298.28 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=196.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
++|++.+.||+|+||.||+|++. +++.+++|++.... ......+.+|+.+++.++|+||+++++++.... .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 57999999999999999999965 67889999886432 223456778999999999999999999887664 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.++.+..+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 81 YVEKNMLELLEE-------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred cCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999876665442 123688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh-----
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE----- 271 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 271 (351)
..... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus 151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 33221 112234678899999999988899999999999999999999999975432111000000000000000
Q ss_pred ---HHHhhcCccccC------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 ---KILEIMDPALEG------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ---~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......+.... .+....+..+.+||.+||+.||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0011134469999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.96 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=191.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+. +++.|++|++..... .....+.+|+++++.++|+||+++++++.... .++|++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 466888999999999999999954 689999999854322 22356888999999999999999999987764 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+.. ..++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 153 ~~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 153 FMDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred cCCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 99999886543 356778889999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
.... .......|+..|+|||++.. ...+.++|||||||++|+|++|..||...... .+ ..
T Consensus 219 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~-------~~ 283 (353)
T PLN00034 219 AQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DW-------AS 283 (353)
T ss_pred cccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cH-------HH
Confidence 3322 11233568899999998743 23456899999999999999999999732211 00 00
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... .............++.+||.+||+.||++|||+.|++++
T Consensus 284 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 LMCAIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000110 001112222344579999999999999999999999998
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=291.31 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=202.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
++|++.+.||.|+||.||+|.+. +++ .+++|.+..... .....+..++..+..+.||||+++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 57899999999999999999953 344 477777753322 223556778888899999999999999877777799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 99999999999995432 3688999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~ 220 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----------------EV 220 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 6543222222233446668999999988889999999999999999998 99999654321 11
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+++........+......+.+++.+||..+|++|||+.++++.|..+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 122211111111112334678899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.03 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=192.6
Q ss_pred ceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|.. .+|+.+|+|++.... ......+..|+.+++.++||||+++++++.... .++||+|+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468899999986432 223345678999999999999999999887765 45999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++.. ...+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 149 (323)
T cd05571 81 ELFFHLSR-------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred cHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence 99988843 24688999999999999999999999 99999999999999999999999999986432211
Q ss_pred CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----------------~~~~~~~~~~- 211 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILMEE- 211 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHcCC-
Confidence 1223456899999999999999999999999999999999999999643211 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..++......+.+||.+||..||++|| ++.+++++
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 122233445789999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.41 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=203.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 111 (351)
.++|.+.+.||+|++|.||+|.+. ++..+++|.+...... ....+.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356899999999999999999853 2478999998654333 346788999999999999999999988766 45
Q ss_pred EEEEEEccCCChhhhccccCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 112 LLVYDYMANGGLQEHLYPANGS-------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+++|+|+.+++|.+++...... ......+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 6999999999999998654321 12234688999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------- 231 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------- 231 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---------
Confidence 99999999875432221112223345678999999999999999999999999999998 99998643321
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.....+.... ....+...+..+.+++.+||..||++|||+.|+++.|+
T Consensus 232 -------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 -------EVIECITQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111111 11122234457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=304.50 Aligned_cols=270 Identities=23% Similarity=0.329 Sum_probs=196.2
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC------CeE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 112 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 112 (351)
+|++.+.||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999954 68999999886422 22345678899999999999999999987532 257
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|++|+. ++|.+++.. ...+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 81 lv~e~~~-~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKA-------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHh-------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999995 588887732 23689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc-
Q 018744 193 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT- 268 (351)
Q Consensus 193 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~- 268 (351)
+......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 8754322211 11234568899999999875 6789999999999999999999999975432110000000000000
Q ss_pred ---------chhHHHhhcCccccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 269 ---------DREKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 269 ---------~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
........+......... ......+.+++.+||..||++|||+.+++++ .+++.
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h--p~f~~ 295 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD--PYFKG 295 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC--chhhh
Confidence 000000001110000000 0123467899999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=293.93 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=206.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 112 (351)
..+|.+.+.||+|+||.||++... ++..+++|.+..........+.+|++++++++|+|++++++++... ..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467999999999999999999842 2456888988655444456788999999999999999999998765 456
Q ss_pred EEEEEccCCChhhhccccCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 113 LVYDYMANGGLQEHLYPANG------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
++++|+.+++|.+++..... .......+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999998854321 011223589999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 265 (351)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----------- 229 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----------- 229 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 999999875433221112223334668999999998889999999999999999998 99998643321
Q ss_pred cccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.....+..... ...+...+..+.+|+.+||+.||.+|||+.++++.|+++.+..
T Consensus 230 -----~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 230 -----EVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -----HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111111111 0111123346899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=288.54 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=206.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYM 118 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~ 118 (351)
..++|++.+.||+|+||.||+|...+++.+++|.+... ......+.+|+.+++.++|+|++++++++.....+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence 45789999999999999999999888899999988643 33456788999999999999999999998777788999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 83 ENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999885432 23688999999999999999999999 999999999999999999999999999876542
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~ 216 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----------------PEVIQNL 216 (260)
T ss_pred CCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----------------HHHHHHH
Confidence 211 11122334567999999988889999999999999999999 9999964332 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
........+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111112222334579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=287.47 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=205.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|++.+.||+|++|.||+|.+.++..+++|.+... ......+.+|+.+++.++|+||+++++++.+...+++++|+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 4679999999999999999999766677999998643 334567888999999999999999999887777789999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 84 KGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCcHHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999995321 23578899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||...+..++.++|||||||++|+|++ |..||...... .....+ .
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----------------~~~~~~-~ 217 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQV-E 217 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----------------HHHHHH-h
Confidence 211 1122335567999999988889999999999999999999 88888643221 111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
...........+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11111223345567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.23 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=202.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
...++|.+++.||+|+||.||+|+ ..+|..+|+|++.... ......++.|=.+|....++.|++++..|++.+ .|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 355889999999999999999999 5579999999997543 233456777888999999999999999998875 56
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||++||++..++.. .+.+++..+..++.+++.||..||++ |++|+||||+|+|||..|++||+|||+
T Consensus 218 LiMEylPGGD~mTLL~~-------~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-------KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEEecCCccHHHHHHh-------cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999943 35799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC--------------------CCce-------------------------ecccCCCcccccccccccCCCCC
Q 018744 193 AKIGSDKA--------------------GGHV-------------------------STRVLGTQGYVAPEYALTGHLTT 227 (351)
Q Consensus 193 ~~~~~~~~--------------------~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~s~ 227 (351)
+..+.... .... ....+|||.|+|||++.+..|..
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 85422100 0000 01246999999999999999999
Q ss_pred ccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc--cccCCCCHHHHHHHHHHHHhccCCCC
Q 018744 228 KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEA 305 (351)
Q Consensus 228 ~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P 305 (351)
.+|.|||||++|||+.|..||....+. .....++.- .+..+-......+..+||.+||. ||
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~----------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQ----------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 999999999999999999999877663 122222221 12222223344678999999999 99
Q ss_pred CCCCC---HHHHHHH
Q 018744 306 DYRPL---MADVVQS 317 (351)
Q Consensus 306 ~~Rpt---~~eil~~ 317 (351)
++|.- +.||.+|
T Consensus 431 ~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKH 445 (550)
T ss_pred HHhcCcccHHHHhcC
Confidence 99996 5666555
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=286.67 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=204.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|++.+.||+|++|.||+|...++..+++|.+.... .....+.+|+.+++.++|++++++++++.....+++|+|+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 46799999999999999999998788889999886543 34567889999999999999999999988777789999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 84 KGSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999985422 23588999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~~ 217 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----------------REVLEQVE 217 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHH
Confidence 211 1112234557999999988889999999999999999999 8999864321 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.......+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111222333445679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=279.69 Aligned_cols=236 Identities=26% Similarity=0.394 Sum_probs=199.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
.+|++.+.||.|+||+|.+++.+ +|..+|+|++....- ...+...+|..+|+.+.||.++++.+.+.+.+ .++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56999999999999999999954 688999999864322 12345667999999999999999998887764 56999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|..||-|.++++. ...+++..+.-++.||+.||.|||+. ++++|||||+|||+|.+|.+|+.|||.+..
T Consensus 124 eyv~GGElFS~Lrk-------~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-------SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred eccCCccHHHHHHh-------cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 99999999999954 34799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ....+||+.|+|||+++...|..+.|.|+||+++|||+.|..||..+++. .....
T Consensus 194 v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~K 252 (355)
T KOG0616|consen 194 VSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEK 252 (355)
T ss_pred ecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHH
Confidence 5443 35688999999999999999999999999999999999999999866642 23334
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 309 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 309 (351)
++...+ .++.-....+.+|+..+|+.|-.+|.
T Consensus 253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 444433 34445556799999999999999993
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.60 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=201.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|.+.+.||+|+||.||+|.+. +++.+|+|++.... ......+..|++++..++|+||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999965 68999999986432 234466888999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 81 EYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999998533 4688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---------------------------CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCC
Q 018744 196 GSDKA---------------------------GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248 (351)
Q Consensus 196 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf 248 (351)
..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 44322 001123356889999999999999999999999999999999999999
Q ss_pred CCCCCCCCcceeecccccccchhHHHhhcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 018744 249 DVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQS 317 (351)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~ 317 (351)
...... .....+.. ..+........+..+.+||.+||. +|.+||+ +.+++++
T Consensus 231 ~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 231 YSDTLQ----------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHH----------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 754321 11112222 111111111135578999999998 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.14 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=201.6
Q ss_pred CCCcCceeeecCceEEEEEEEc-C-CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-N-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.|.+.+.||+|++|.||+|... + +..+++|.+..........+..|+.++..++||||+++++++...+ .++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999843 3 6778888776554444566788999999999999999999887664 56999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+|+|.+++.+.. ....++++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 148 ~gg~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 148 SGGDLNKQIKQRL---KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999998875432 1234688999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
...........|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------------~~~~~~~~~ 285 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----------------REIMQQVLY 285 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHh
Confidence 3322223445689999999999988999999999999999999999999964321 111122211
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ...+......+.++|..||..+|++|||+.+++.+
T Consensus 286 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 GKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111 11222334578999999999999999999998754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=292.57 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=206.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
.+|.+.+.||.|++|.||++.+. ++..+++|.+..........+.+|+..++.++|+||+++++++.... .++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56889999999999999999842 34568888876544444467889999999999999999999987764 569
Q ss_pred EEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 114 VYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
||+|+.+++|.+++...... ......+++..++.++.||+.||+|||++ +++|+||+|+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999998654310 11224589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------- 232 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 99999999875433222222233445678999999998889999999999999999998 99998643321
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
......... .........+..+.+++.+||+.+|++|||+.++++.|.++.+.
T Consensus 233 -------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -------EVIECITQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -------HHHHHHhCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111111 11111223345789999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.74 Aligned_cols=273 Identities=27% Similarity=0.430 Sum_probs=222.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc--CCc----EEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS--NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~--~~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
...+.++.+.||+|.||.||.|... .+. .|++|.+... +.+....|.+|+.++.+++||||+++++++.+. .
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3577888899999999999999843 343 3788888643 344557899999999999999999999999776 4
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++++|||++|+|.+++............++...++.++.|||.|+.||+++ .++||||..+|+|+++...||++||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 5699999999999999987765545567899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|+++...............-...|||||.+..+.++.++||||||+++||++| |..||....+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---------------- 910 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---------------- 910 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----------------
Confidence 99984322221111111223357999999999999999999999999999999 9999975443
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 331 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~~ 331 (351)
...+...+..- +-+.+..++..++++|.+||+.+|++||++..|++.+..+++.....+-.
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~ 971 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYG 971 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccc
Confidence 23333233333 55667778889999999999999999999999999999999986655443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.08 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=198.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-C-CcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-N-GRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~-~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
.++|.+.+.||+|+||.||+|.+. . +..+++|.+... .......+..|+.+++.++||||+++++++.+.. .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 367999999999999999999854 3 368999988532 2233456778999999999999999999988765 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 109 v~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 99999999999998432 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....+. ...
T Consensus 179 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------------~~~ 237 (340)
T PTZ00426 179 KVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----------------LIY 237 (340)
T ss_pred eecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----------------HHH
Confidence 764322 13356889999999999888999999999999999999999999754321 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..+..... .++......+.++|.+||+.||++|+ |+.+++++
T Consensus 238 ~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 238 QKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12222111 12222344688999999999999995 89999887
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=287.32 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=202.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
.++|++.+.||+|+||.||+|.+.. ...+++|.+..... .....+..|+.+++.++|+||+++++++... ..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3679999999999999999998642 35789998864322 2235678899999999999999999988765 4569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++++.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 83 ITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 999999999999985432 3688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------------~~~ 217 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------------QDV 217 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----------------HHH
Confidence 87642222222222334567999999998889999999999999999998 9999853221 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
...+.. ......+...+..+.+++.+||+.+|++||++.+++++|.+++
T Consensus 218 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 218 IKAVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111 1111222334557899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=298.34 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=208.8
Q ss_pred HhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
....|+....||+|.||.||+|. ..+++.||+|++..... .+.+.+..|+.+|..++++||.++++.+..+ ..+++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34568888999999999999999 45789999999975433 3446788899999999999999999977665 445999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.||++.+.+... ..+++..+..+++++..|+.|||.+ +.+|+|||+.||++..+|.++|+|||.+..
T Consensus 91 ey~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred HHhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeee
Confidence 999999999999433 3458888999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......||+.|||||++.+..|+.++||||||++.+||.+|..|+....|......+....
T Consensus 161 l~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~----------- 227 (467)
T KOG0201|consen 161 LTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA----------- 227 (467)
T ss_pred eechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-----------
Confidence 54433 22356789999999999998899999999999999999999999998776632222222111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
-+.+.. .....+.+||..||+.||+.|||+.++++| ++++.
T Consensus 228 --PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh--~FIk~ 268 (467)
T KOG0201|consen 228 --PPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH--KFIKR 268 (467)
T ss_pred --CCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh--HHHHh
Confidence 111222 333458999999999999999999999988 55554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.11 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=203.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
..++|++.+.||+|++|.||+|...+++.+++|.+... ....+.+.+|+.+++.++|+|++++++++.... .++++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 35679999999999999999999777788999998644 334567889999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 83 MKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred ccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999985432 23688999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
...... .........|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~ 216 (261)
T cd05068 155 EDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----------------AEVLQQ 216 (261)
T ss_pred CCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHH
Confidence 321110 111122347999999988889999999999999999999 9999964321 111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111111122233456799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=298.79 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=202.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhcc-CCCcceeeeEEEEcC--
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRL-RSPYLLALLGYCSDR-- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 109 (351)
.++|++.+.||.|+||.||+|... +++.|++|++...... ....+..|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 467999999999999999999632 3478999988643221 234567899999999 799999999987643
Q ss_pred CeEEEEEEccCCChhhhccccCCC------------------------------------------------------CC
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGS------------------------------------------------------NS 135 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~------------------------------------------------------~~ 135 (351)
..+++++|+.+++|.+++...... ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 345899999999999888543210 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccc
Q 018744 136 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215 (351)
Q Consensus 136 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 215 (351)
....+++..+..++.||+.||.|||++ +++|+||||.||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 123688999999999999999999999 99999999999999999999999999987653322212222334566799
Q ss_pred cccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHH
Q 018744 216 APEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVA 294 (351)
Q Consensus 216 aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 294 (351)
|||++.+..++.++|||||||++|+|++ |..||.+.... ......+........+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----------------EEFCRRLKEGTRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----------------HHHHHHHhccCCCCCCccCCHHHH
Confidence 9999999999999999999999999998 99999643221 011111111111111222345789
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 295 AIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 295 ~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+++.+||+.+|++||++.+++++|.+++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=287.41 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=202.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.++|++.+.||+|++|.||+|...++..+++|.+... ....+.+..|+.+++.++|+||+++++.+.... .+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4679999999999999999999777888999987543 334567889999999999999999999887664 46999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSDE-----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999985432 23678889999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----------------~~~~~~- 217 (261)
T cd05072 156 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----------------DVMSAL- 217 (261)
T ss_pred Ccee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----------------HHHHHH-
Confidence 2211 1122334567999999988889999999999999999998 99999643211 111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
............+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111111223345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=283.93 Aligned_cols=270 Identities=22% Similarity=0.271 Sum_probs=207.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC--hHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 113 (351)
.++|+++..|++|+||.||+|+++ +++.||+|.++...+.. .-...+|+.+|.+.+||||+.+.++.... +.|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 466999999999999999999954 78999999987443221 12346799999999999999999988754 4579
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|++. +|.+++.... .++...++..++.|+++|+.|||++ .|+|||||++|+|++..|.+|++|||++
T Consensus 155 VMe~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eHHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 9999987 7888885443 5789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc--------
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL-------- 264 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------- 264 (351)
+.+..+. ...+....|..|.|||++.+. .|+.+.|+||+||++.||+++...|.+.....+...+....
T Consensus 225 R~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 225 REYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 9877653 334667789999999998865 79999999999999999999999998876653322211110
Q ss_pred ccccchhHHH-----hhcCccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 265 PRLTDREKIL-----EIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 265 ~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+....-.... ......+...+... ..+.-++|+..+|..||.+|.|+.+.|++ ..+.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~ 365 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFR 365 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccc
Confidence 1111100000 00000111111111 23567889999999999999999999998 4544
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.93 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=204.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC--
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-- 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 110 (351)
.....++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+..+..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344457999999999999999999984 4789999999864322 23355778999999999999999988664321
Q ss_pred -------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 111 -------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 111 -------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
.++|++|+.+|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG 180 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence 3489999999999998865331 234689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
.++|+|||++................|++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------- 251 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------- 251 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------
Confidence 99999999987654433223334467899999999999999999999999999999999999999743321
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+........ ...+...+..+.+++..||+.||.+|||+.+++.+
T Consensus 252 -------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 -------EVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111111 12233345579999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=289.18 Aligned_cols=255 Identities=21% Similarity=0.327 Sum_probs=199.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. .+..+++|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999743 356889998865422 2234678899999999999999999988765 5569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++++|||.+
T Consensus 84 v~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 999999999999985322 3688999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~~ 217 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------DV 217 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HH
Confidence 54322110 11112234567999999999999999999999999999775 99999643321 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
...+ ........+...+..+.+++..||+.+|++|||+.+|++.|.++
T Consensus 218 ~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 11111122334456799999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=291.14 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=203.8
Q ss_pred CCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+... ..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999842 224578887754322 2235678899999999999999999988765 4569
Q ss_pred EEEEccCCChhhhccccCCC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 114 VYDYMANGGLQEHLYPANGS-----------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~-----------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
+++|+.+++|.+++...... ......+++..++.++.|++.||.|||+. +++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999987543210 01123588999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSG 255 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 255 (351)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999876433322112223345568999999988889999999999999999998 9999964332
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+.+..........+......+.+++.+||+.+|++||++.++++.|++++..
T Consensus 236 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ---------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred ---------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 122222222222222333445799999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.21 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=195.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++||||+++++++.... .++|++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 67999999999999999999954 688999998864322 23346778999999999999999999987765 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+ +|.+++.... ..++...+..++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 8888774322 3578899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec--------cccccc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW--------ALPRLT 268 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~~~ 268 (351)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+............ ..+...
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 155 VPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred CCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 222 12233457889999998875 5689999999999999999999999976543211000000 000000
Q ss_pred chhHHHhhcCccccCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALEGQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..........+...... ......++.+||.+||+.||.+|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 01111111111100000 01123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=286.89 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=202.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
..+|.+.+.||+|++|.||+|.+. .+..+++|.+... ......+.+|+++++.++|+||+++++++.... .+++++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 456889999999999999999954 5888999988643 334567888999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 84 MTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999999884322 23588999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 156 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~ 217 (263)
T cd05052 156 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYEL 217 (263)
T ss_pred cceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHH
Confidence 322111 111223457999999988889999999999999999998 99998643321 11111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
+........+...+..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 218 LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 1111222223334467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.15 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=192.2
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++.+++...+ .++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 6899999998643 2233456778999999999999999999887765 45999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|..++.. ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~- 149 (328)
T cd05593 81 ELFFHLSR-------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA- 149 (328)
T ss_pred CHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence 99888743 23688999999999999999999999 99999999999999999999999999986432211
Q ss_pred CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------------~~~~~~~~~~- 211 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILMED- 211 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----------------HHHHHhccCC-
Confidence 1123356889999999999889999999999999999999999999643321 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..++.....++.+||.+||..||++|| ++.+++++
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 -IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112223345789999999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.23 Aligned_cols=239 Identities=26% Similarity=0.351 Sum_probs=190.4
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||+|+||.||+|.+. +++.+|+|++... .......+..|+.++..++||||+++++++.... .++|++|+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 6889999998642 2333456778999999999999999999887764 4599999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 148 (312)
T cd05585 81 FHHLQR-------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D 148 (312)
T ss_pred HHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence 998843 23688999999999999999999999 99999999999999999999999999987532221 1
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----------------~~~~~~~~~~~~-- 210 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----------------NEMYRKILQEPL-- 210 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----------------HHHHHHHHcCCC--
Confidence 22345688999999999998999999999999999999999999964321 111122222111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPL---MADVVQS 317 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~eil~~ 317 (351)
..+......+.+||.+||+.||++||+ +.+++.+
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 222334457899999999999999985 5666665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=302.14 Aligned_cols=267 Identities=23% Similarity=0.370 Sum_probs=205.0
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccC-CCcceeeeEEEEcC
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 109 (351)
...++|++.+.||+|+||.||+|.+. .+..|++|++..... ...+.+.+|+++++.+. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34578999999999999999999842 134699999864322 23456888999999996 99999999999766
Q ss_pred -CeEEEEEEccCCChhhhccccCCC-------------------------------------------------------
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGS------------------------------------------------------- 133 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~------------------------------------------------------- 133 (351)
..++||||+.+|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 456999999999999887543110
Q ss_pred ----------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 134 ----------------------------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 134 ----------------------------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
......+++..++.++.|++.||.|||+. +++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 00113478889999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcc
Q 018744 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 258 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~ 258 (351)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---- 346 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---- 346 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----
Confidence 9999999999999876433222222223445678999999998889999999999999999997 99998643211
Q ss_pred eeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 259 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+........+...+..+.+++.+||+.+|++|||+.++.+.|.++++
T Consensus 347 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ------------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111111112223345678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.45 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=204.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCc----EEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
.++|++.+.||.|+||.||+|.+ .++. .|++|.+..... .....+..|+.++..++|+||+++++++.....++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 46799999999999999999984 3444 478998864322 22356778999999999999999999998878789
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++++.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 86 ~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 999999999999985432 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~ 219 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----------------RE 219 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HH
Confidence 76543322111222334567999999988889999999999999999998 9999864321 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+...+........+......+.+++.+||+.||++|||+.++++.|.++.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1222222111122233445789999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=287.58 Aligned_cols=272 Identities=24% Similarity=0.321 Sum_probs=211.8
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcc--ccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR- 109 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 109 (351)
.+.......|...+.||.|++|.|+.|.+ .+|+.||+|.+. ..+....++..+|+++|+.++|+||+.+.+++...
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 34455567788889999999999999994 478999999987 44555667788899999999999999999988652
Q ss_pred -----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 110 -----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 110 -----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+.++|++.| +.+|...++. ...++...+..+++|+++||.|+|+. +++||||||.|++++.+..
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~-------~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS-------QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCD 163 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc-------CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCC
Confidence 345788887 5578888843 23599999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
+|+||||+++...........+....|..|.|||++. ...|+.+.||||+||++.||++|+..|.+.+...+...+...
T Consensus 164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 9999999999876543333446678899999999876 568999999999999999999999999998776444433333
Q ss_pred cccccchhHHHhh--------cC---ccccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEI--------MD---PALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~--------~~---~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+.... ..+..+ +. ......+. +.......+|+.+||..||.+|+|++|.|+|
T Consensus 244 lGtP~~-e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 244 LGTPSE-EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cCCCCH-HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222211 111111 11 11111111 1223478899999999999999999999988
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.88 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=203.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|.+.+.||+|++|.||+|.+..+..+++|.+... ....+.+.+|+.+++.++|+|++++++++.....+++|+|+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 3669999999999999999999777677999987543 334567888999999999999999999988777789999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 84 KGSLLDFLKEGD-----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999985432 23578999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||...+..++.++||||||+++|+|++ |..||...... ...... .
T Consensus 156 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~-~ 217 (260)
T cd05069 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----------------EVLEQV-E 217 (260)
T ss_pred ccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHH-H
Confidence 211 1122334567999999988889999999999999999999 99998643221 111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.......+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111112223445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.99 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=206.0
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCS 107 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 107 (351)
+....++|++.+.||+|++|.||++... ....+++|.+..... .....+.+|+++++.+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4455678999999999999999999853 235789998864322 2234577899999999 7999999999887
Q ss_pred cCC-eEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 108 DRR-KLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 108 ~~~-~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
... .+++++|+.+++|..++...... ......+++..++.++.|++.||.|||+. +++|+||+|+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 664 45999999999999998543210 01234689999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGE 256 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 256 (351)
+++.++.++|+|||.+................++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 999999999999999876543322111222334567999999988889999999999999999998 9999864321
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
......+........+......+.+|+.+||..+|++|||+.++++.|++++
T Consensus 241 --------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --------------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111111111222334557899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=295.18 Aligned_cols=241 Identities=26% Similarity=0.368 Sum_probs=191.9
Q ss_pred ceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||++.. .+|..||+|++... .......+..|+.+++.++||||+++++.+...+ .++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998643 1223355677999999999999999999887765 45999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|..++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 149 (323)
T cd05595 81 ELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred cHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence 99888743 23688999999999999999999999 99999999999999999999999999886432211
Q ss_pred CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~~~~~~~ 212 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILMEEI 212 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcCCC
Confidence 1223356889999999999889999999999999999999999999643321 11111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..+......+.+||.+||+.||++|| ++.+++++
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12223345789999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=302.30 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=196.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||.|+||.||+|.+. +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999954 68899999986432 223356778999999999999999999988775 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 81 EYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999998432 3689999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCc------------------------------------eecccCCCcccccccccccCCCCCccceeehHHHHH
Q 018744 196 GSDKAGGH------------------------------------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 239 (351)
Q Consensus 196 ~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~ 239 (351)
........ ......||+.|+|||++.+..++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 32211000 011235899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc--cccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 018744 240 ELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPL---MADV 314 (351)
Q Consensus 240 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ei 314 (351)
+|++|..||....+. .....+... .+...........+.+||.+|+. +|.+|++ +.++
T Consensus 231 el~~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 231 EMLVGYPPFCSDNPQ----------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred HhhcCCCCCCCCCHH----------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 999999999754321 111111110 11101111223468889999997 9999998 9999
Q ss_pred HHH
Q 018744 315 VQS 317 (351)
Q Consensus 315 l~~ 317 (351)
+++
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=301.90 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=193.7
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||++.. .+++.+|+|++... .......+..|+++++.++||||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999985 47889999988532 1223456788999999999999999999988765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998432 3688999999999999999999999 999999999999999999999999999863
Q ss_pred cCCCCCC-----------c----------------------------------eecccCCCcccccccccccCCCCCccc
Q 018744 196 GSDKAGG-----------H----------------------------------VSTRVLGTQGYVAPEYALTGHLTTKSD 230 (351)
Q Consensus 196 ~~~~~~~-----------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~~D 230 (351)
....... . ......|++.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 2211000 0 001235889999999999889999999
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 018744 231 VYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYR 308 (351)
Q Consensus 231 iwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 308 (351)
||||||++|+|++|..||...... .....+.. ..+...........+.+||.+||. +|.+|
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSH----------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHH----------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence 999999999999999999754321 11111111 011101111223468899999998 77665
Q ss_pred ---CCHHHHHHH
Q 018744 309 ---PLMADVVQS 317 (351)
Q Consensus 309 ---pt~~eil~~ 317 (351)
+|+.+++.+
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.26 Aligned_cols=270 Identities=20% Similarity=0.318 Sum_probs=194.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+... ++|++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999965 688999999864332 223456789999999999999999999877654 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+. ++|.+++... ...++...+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 84 YVH-TDLCQYMDKH------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred CCC-cCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 985 5777776432 23588899999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce-eecccccccch--hH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL-VSWALPRLTDR--EK 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~-~~~~~~~~~~~--~~ 272 (351)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+......... ........... ..
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 3221 12234557889999998875 4578899999999999999999999975432100000 00000000000 00
Q ss_pred HHhh--cCc-ccc--CCCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 273 ILEI--MDP-ALE--GQYSM-------KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 273 ~~~~--~~~-~~~--~~~~~-------~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
.... ..+ ... ..... .....+.+|+.+||+.||++|||+.++++| .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h--~~f~ 292 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH--EYFS 292 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC--cccc
Confidence 0000 000 000 00000 012357899999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.36 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=197.0
Q ss_pred eeeecCceEEEEEEE---cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCCC
Q 018744 48 VVGHGGFGLVYRGVL---SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGG 122 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~---~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~ 122 (351)
.||+|+||.||+|.+ .++..+++|++..... ...+.+..|+.+++.+.|+||+++++++.....+++++|+.+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999964 3578899998864332 22356888999999999999999999998888889999999999
Q ss_pred hhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCC
Q 018744 123 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202 (351)
Q Consensus 123 L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 202 (351)
|.+++.. ...+++..++.++.|++.||.+||++ +++|+||+|.||+++.++.++|+|||++.........
T Consensus 82 L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 82 LNKFLQK-------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred HHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999843 23688999999999999999999999 9999999999999999999999999998765433221
Q ss_pred cee-cccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 203 HVS-TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 203 ~~~-~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
... ....++..|+|||.+....++.++|||||||++|+|++ |..||..... ......+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~i~~~ 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----------------NEVTQMIESG 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHCC
Confidence 111 12233468999999988889999999999999999998 9999964322 1112222222
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.....+...+.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22233334556799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=297.66 Aligned_cols=270 Identities=23% Similarity=0.349 Sum_probs=200.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||.|+||.||++.+. ++..+++|.+..... .....+.+|+++++.++|+||+++++++.+.+ .++||+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999965 678889998764322 22356888999999999999999999887764 559999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 84 HMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred cCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999999843 236889999999999999999999742 7999999999999999999999999998654
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee----e--c-------c
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV----S--W-------A 263 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----~--~-------~ 263 (351)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||............ . . .
T Consensus 155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 322 123346788999999999888999999999999999999999999754321000000 0 0 0
Q ss_pred c-----------cc----ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 L-----------PR----LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ~-----------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
. +. .........+...............++.+|+.+||+.||++|||+.+++.+ .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~~ 304 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIKR 304 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHhc
Confidence 0 00 000000000111000000011123468899999999999999999999887 55554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.98 Aligned_cols=249 Identities=32% Similarity=0.546 Sum_probs=191.8
Q ss_pred cCceeeecCceEEEEEEEc-----CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 45 KSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~-----~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
+.+.||.|.||.||+|.+. .+..|++|.+..... .....+.+|++.+++++||||+++++++... ..++|++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999965 356789999954322 2357888999999999999999999999855 45699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +++|++|+++||+++.++.+||+|||++....
T Consensus 83 ~~~g~L~~~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHTC-----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 99999999996541 24689999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
................|+|||.+.+..++.++||||||+++|||++ |..||..... ......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------------~~~~~~~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------------EEIIEKL 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------HHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccccccc
Confidence 3222222333456678999999998889999999999999999999 7888853321 1112222
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
........+...+..+.++|.+||+.+|++|||+.++++.|
T Consensus 219 -~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22222233334556799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.45 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=190.8
Q ss_pred cCCCcCceeeecCceEEEEEEE-c-CCcEEEEEEccccCC--CChHHHHHHHHHHhcc---CCCcceeeeEEEEc-----
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-S-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL---RSPYLLALLGYCSD----- 108 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 108 (351)
++|++.+.||+|+||.||+|.+ . ++..+|+|.+..... .....+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999985 3 467899998864322 2233455677776665 69999999998752
Q ss_pred -CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 -RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 -~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
...+++++++. ++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 151 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEE
Confidence 23569999986 58888885432 23588999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++|..||.+.............. ..
T Consensus 152 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~ 227 (290)
T cd07862 152 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GL 227 (290)
T ss_pred ccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CC
Confidence 999998764332 12234567889999999988889999999999999999999999997654311100000000 00
Q ss_pred cchhHH---HhhcCcccc--C-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKI---LEIMDPALE--G-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~---~~~~~~~~~--~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... ..+....+. . .........+.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000 000000000 0 0001223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.44 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=197.9
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
++|++.+.||+|+||.||++.+.++..+++|.+... ......+..|+.+++.++||||+++++++.... .+++|+|+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 568999999999999999999877778999987533 334567888999999999999999999987664 459999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 83 NGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999885432 3588999999999999999999999 9999999999999999999999999988754322
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+..
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----------------~~~~~i~~ 216 (256)
T cd05114 154 EYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----------------EVVEMISR 216 (256)
T ss_pred cee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHHC
Confidence 111 1112234457999999988889999999999999999999 89999644321 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.. ....+......+.+++.+||+.+|++|||+.++++.|
T Consensus 217 ~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 GF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 10 0111112234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.75 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=194.4
Q ss_pred CCCcCceeeecCceEEEEEEE----cCCcEEEEEEcccc----CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQA----GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~- 111 (351)
+|++.+.||+|+||.||+++. .+++.+++|++... .......+..|+.+++.+ +|++|+.+++++.....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999984 25788999998632 122335677899999999 58999999998877654
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||+|+.+++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence 5999999999999988432 3688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++......... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||........ ..
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------~~ 217 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT------------QS 217 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC------------HH
Confidence 98754332211 12235689999999998865 478899999999999999999999964332100 00
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.....+... ....+......+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 EVSRRILKC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHhcC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 001111111 1122223345688999999999999999 77888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.81 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=199.9
Q ss_pred CCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
|.+.+.||+|+||.||.|... .+..+++|.+...... ....+..|++.++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999853 2367999988643222 2356888999999999999999999875433
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.+++++|+.+++|..++...... .....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 46999999999999888543311 1224689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------------- 222 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------------- 222 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence 999876543322111222334567999999988889999999999999999999 88988643321
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.....+.. ......+......+.+++.+||+.||++|||+.++++.|.+++
T Consensus 223 --~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 223 --EIYDYLRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred --HHHHHHHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111111 1111222334557999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=283.31 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=202.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
++|++.+.||+|+||.||+|... +++.+++|.+..... .....+..|+++++.++|||++++++++.+. ..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999954 788999998754222 2234577899999999999999999988765 455999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++..... ....++...++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 99999999988854321 123578999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ......
T Consensus 156 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------------~~~~~~ 218 (267)
T cd08228 156 FSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LFSLCQ 218 (267)
T ss_pred ccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---------------HHHHHH
Confidence 43322 1112345778899999998888899999999999999999999998643211 011111
Q ss_pred hcCc-cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 276 IMDP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 276 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.+.. ..........+..+.+++.+||+.+|++|||+.++++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111 111111223456799999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.38 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=199.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 111 (351)
.++|.+.+.||+|++|.||+|.+. .+..+++|.+...... ....+..|+.+++.++|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999864 3567888887643222 234578899999999999999999977655 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC---cEEEe
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVS 188 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~v~l~ 188 (351)
+++++|+.+++|.+++............+++..+..++.||+.||.|||+. +++|+||+|+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 699999999999999866543222334689999999999999999999999 999999999999997654 59999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------------- 228 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------------- 228 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence 9999876532221111112223457999999998889999999999999999997 99999743321
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.....+........+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111112223334457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=290.00 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=201.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCC-hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
.+|.+.+.||.|+||.||+|.+. .+..+++|.+....... .+.+..|+.++..++||||+++++++.... .+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45888999999999999999853 24779999987443222 356788999999999999999999987764 45
Q ss_pred EEEEEccCCChhhhccccCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 113 LVYDYMANGGLQEHLYPANG---------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
++++|+.+++|.+++..... .......+++..++.++.|++.||.|||++ +++|+||||.||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 89999999999999853211 011223588899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeec
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 262 (351)
.++|+|||++................++..|+|||.+.++.++.++|||||||++|+|++ |..||.+...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------- 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------- 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999876433322222233445678999999988889999999999999999998 8888864321
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
......+... .....+...+..+.+|+..||+.+|++||++.+|+..|+.
T Consensus 233 -------~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -------QDVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------HHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1112222221 1223334456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=287.01 Aligned_cols=270 Identities=24% Similarity=0.345 Sum_probs=201.3
Q ss_pred CCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce-E--EE
Q 018744 42 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK-L--LV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~-~--~v 114 (351)
.|+-.+.+|+|.||.||.|. ..+++.+|||.+-.+.+ .-.+|+.+|+.+.||||+++.-++... +. + +|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 36668899999999999999 44678999998865433 224599999999999999999877432 12 2 89
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEeecccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLA 193 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~dfg~~ 193 (351)
|||++. +|.+.+++... ....++...+.-+..||++||+|||+. +|+||||||.|+|||.+ |.+||||||.+
T Consensus 101 leymP~-tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHhchH-HHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 999966 88888876432 234688888999999999999999999 99999999999999876 99999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
......... ....++..|+|||.+.+. .|+.+.||||.||++.||+-|+..|.+.+...+...+....+-.. ...
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt-~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT-RED 249 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC-HHH
Confidence 986554422 334467789999998865 799999999999999999999999998665433322222221111 111
Q ss_pred HHhhc-------Ccccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 273 ILEIM-------DPALE-----GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 273 ~~~~~-------~~~~~-----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
+...- .+.+. .-+......++.+|+.++|..+|++|.++.+++.+ .+++..+.+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHhhCc
Confidence 11110 01111 11222334579999999999999999999999977 555544443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=281.48 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=204.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|++|.||+|... +|+.+++|.+.... ......+.+|+++++.++|++++++++.+.+... ++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999965 78999999885322 2234578889999999999999999998877644 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++.... .....++...++.++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 82 ELADAGDLSRMIKHFK---KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred ecCCCCCHHHHHHHhc---ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeee
Confidence 9999999999885432 1234688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
...... ......++..|.|||.+.+..++.++||||||+++|+|++|..||...... .....+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~ 218 (267)
T cd08224 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LYSLCK 218 (267)
T ss_pred ccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------------HHHHHh
Confidence 433221 122345778899999998888999999999999999999999998643211 000111
Q ss_pred hcCccccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 276 IMDPALEGQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 276 ~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
..........+. .....+.++|.+||..+|++|||+.+|++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111111222 44557899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.53 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=200.3
Q ss_pred cCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
.+|++.+.||+|+||.||+|.+ ..+..+++|.+..... .....+.+|+.+++.++||||+++++++.... .++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5689999999999999999984 2457899998864322 22356788999999999999999999887664 569
Q ss_pred EEEEccCCChhhhccccCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 114 VYDYMANGGLQEHLYPANGS----------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
+|+|+.+++|.+++...... ......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999988532210 01123578899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeec
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 262 (351)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------- 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999876533322222233345667999999988889999999999999999998 9999864321
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
..+.+..........+...+..+.+++.+||+.||++||++.+++++|+.
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111112222334578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=296.95 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=192.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|... +++.+|+|++.... ......+..|+.++..++|++|+++++.+.+.. .++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999854 68899999986432 223356778999999999999999999988764 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 81 E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 81 EFLPGGDMMTLLMK-------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 99999999999843 24689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCC---------------------------------ceecccCCCcccccccccccCCCCCccceeehHHHHHHHH
Q 018744 196 GSDKAGG---------------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 242 (351)
Q Consensus 196 ~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~ll 242 (351)
....... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 4321100 0012346899999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc--cccCCCCHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 018744 243 TGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQ--PEADYRPLMADVVQS 317 (351)
Q Consensus 243 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~--~~P~~Rpt~~eil~~ 317 (351)
+|..||....+. .....+... .+...........+.+||.+|+. .++..||++.+++++
T Consensus 231 ~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 231 IGYPPFCSETPQ----------------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hCCCCCCCCCHH----------------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999999754321 111111110 01000001123457778877654 233456899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=282.97 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=199.2
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC-----ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 113 (351)
++|.+.+.||+|++|.||.+.. .+++.+++|.+...... ....+.+|+++++.++||||+++++++.+... ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999995 46889999987643211 23467889999999999999999999877654 59
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++++.+++|.+++... ..++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 82 v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred EEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999999988432 3578899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~ 215 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----------------MAA 215 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----------------HHH
Confidence 75433221111 1234567789999999988899999999999999999999999964321 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.............+......+.+++.+||..+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111112222333445578999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=299.00 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=192.8
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+.|++++.||+|+||.||+|+. .+++.+|+|++.... ......+..|+++++.++|+||+++++.+.+.. .++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 3689999999999999999995 468899999986432 222356778999999999999999999988765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +++|+||||+|||++.++.++|+|||++..
T Consensus 81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 81 DYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999988432 3578899999999999999999999 999999999999999999999999999753
Q ss_pred cCCCCC---------------------------------------------CceecccCCCcccccccccccCCCCCccc
Q 018744 196 GSDKAG---------------------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSD 230 (351)
Q Consensus 196 ~~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~~D 230 (351)
...... ........|++.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 211000 00011245889999999999889999999
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 018744 231 VYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYR 308 (351)
Q Consensus 231 iwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 308 (351)
||||||++|+|++|..||....+. .....+.. ..+...........+.++|.+|+. +|++|
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R 293 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPL----------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDR 293 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHH----------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CHhHc
Confidence 999999999999999999754321 11111111 111111111233467788888764 99999
Q ss_pred CC---HHHHHHH
Q 018744 309 PL---MADVVQS 317 (351)
Q Consensus 309 pt---~~eil~~ 317 (351)
++ +.++++|
T Consensus 294 ~~~~~~~ei~~h 305 (382)
T cd05625 294 LGKNGADEIKAH 305 (382)
T ss_pred CCCCCHHHHhcC
Confidence 97 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.26 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=199.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
+.++|++.+.||+|++|.||.|.+. .+..+++|.+..... .....+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998743 246799998753322 2234577899999999999999999988765 4
Q ss_pred eEEEEEEccCCChhhhccccCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 111 KLLVYDYMANGGLQEHLYPANGS---NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
.+++++|+.+++|.+++...... +.....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 56999999999999998553211 11123567889999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------------ 228 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------------ 228 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence 99999875433221111122334667999999998889999999999999999999 78888643221
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
........... ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ----~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 ----QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111111 1112233457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.51 Aligned_cols=266 Identities=22% Similarity=0.347 Sum_probs=206.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC-----CcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEc--CC
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--RR 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 110 (351)
..++|++.+.||+|+||.||.|.+.. +..+++|.+.... ......+.+|+.+++.++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999654 6788999876432 2234567789999999999999999998765 34
Q ss_pred eEEEEEEccCCChhhhccccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 KLLVYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.+++++++.+++|.+++...... ......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 56899999999999998554211 11224689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||....+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------- 226 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------------- 226 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------------
Confidence 999875433322112222345667999999988889999999999999999999 99999643321
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+...+............+..+.+++.+||..+|++|||+.++++.|.++.+.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 227 ---EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111111111112223345789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=298.97 Aligned_cols=264 Identities=29% Similarity=0.444 Sum_probs=214.3
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc--CC---cEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS--NG---RKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCS 107 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~--~~---~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 107 (351)
+...+++..+.+.||+|+||.||+|... ++ ..||+|...... ......+..|++++++++||||++++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4445578888899999999999999943 22 227999887533 334467889999999999999999999998
Q ss_pred cCCeE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 108 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 108 ~~~~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
.+.++ +|||++.||+|.+++.... ..++..+...++.+.+.||+|||+. +++||||..+|+|++.++.+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 88665 9999999999999995433 2589999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceec-ccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccc
Q 018744 187 VSDFGLAKIGSDKAGGHVST-RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 264 (351)
++|||+++...... ... ...-...|+|||.+..+.++.++||||||+++||+++ |..||.+....
T Consensus 303 ISDFGLs~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------- 369 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------- 369 (474)
T ss_pred eCccccccCCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------
Confidence 99999987643111 111 1234568999999999999999999999999999999 89999765431
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.....+.........+...+..+..++.+||..+|++|||+.++.+.|+.+.+...+
T Consensus 370 ------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 ------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 222233233444455556677889999999999999999999999999999987664
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=283.36 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=198.5
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
++|++.+.||+|++|.||.+.+.++..+++|.+... ......+.+|+.+++.++||||+++++++.... .+++++|+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 568999999999999999999777667999988643 334567889999999999999999999987665 469999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|.||+++.++.++|+|||.+......
T Consensus 83 ~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999885322 2588999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+..
T Consensus 154 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~~~ 216 (256)
T cd05113 154 EY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------------SETVEKVSQ 216 (256)
T ss_pred ce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----------------HHHHHHHhc
Confidence 11 11112234567999999988889999999999999999998 9999864322 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
. .....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 217 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 G-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 111112223457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.37 Aligned_cols=266 Identities=23% Similarity=0.371 Sum_probs=204.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR 110 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 110 (351)
++|.+.+.||+|+||.||++.+. ....+++|.+.... ......+..|+++++.+ +|+||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 67999999999999999999842 22468999886432 22335677899999999 7999999999887664
Q ss_pred -eEEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~ 180 (351)
.+++++|+.+++|.+++....... .....+++..++.++.|++.||+|||++ +++|+||+|+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 559999999999999996543211 1223588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcce
Q 018744 181 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 259 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~ 259 (351)
.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999875433211111112223457999999988889999999999999999998 8888854321
Q ss_pred eecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 260 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..+...+........+......+.+|+.+||..+|++|||+.++++.|++++....
T Consensus 249 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 -----------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred -----------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111111112223344578899999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=291.80 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=192.0
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHH---hccCCCcceeeeEEEEcCC-eEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELL---GRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
|++.+.||+|++|.||+|.+. +++.+++|++.... ....+.+..|..++ +.++||||+++++++.... .++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999954 68999999986432 22334566666555 4667999999999987765 5699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+++|...+.. ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 81 MEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999999999887732 3689999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ....
T Consensus 150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----------------~~~~ 211 (324)
T cd05589 150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----------------EVFD 211 (324)
T ss_pred cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------------HHHH
Confidence 432211 1223456889999999999889999999999999999999999999754321 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.+..... .++...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 212 ~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 2221111 12223345688999999999999999 67788776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.90 Aligned_cols=271 Identities=23% Similarity=0.312 Sum_probs=201.7
Q ss_pred cCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 112 (351)
++|++.+.||+|+||.||++.. .++..+++|.+..........+.+|+++++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5799999999999999999973 25788999998765544456788999999999999999999976432 456
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
++++|+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 9999999999999985322 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceec-ccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVST-RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+............. ...++..|+|||.+.+..++.++||||||+++|+|++|..++............. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN-DKQGQMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc-ccccccchH
Confidence 88654322111111 1223345999999988889999999999999999999887764322110000000 000000111
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.+.+.+............+..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 12222222211122223345799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=285.95 Aligned_cols=269 Identities=25% Similarity=0.361 Sum_probs=201.6
Q ss_pred cCC-CcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC---C
Q 018744 41 GGF-SKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---R 110 (351)
Q Consensus 41 ~~y-~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 110 (351)
++| .+.+.||.|+||.||++.. .++..+++|.+..... .....+.+|+++++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8999999999999988652 3577899999865432 2345678899999999999999999987643 3
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++|+|+.+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df 151 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF 151 (283)
T ss_pred EEEEecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeec
Confidence 4699999999999999842 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...... ...
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~-~~~ 229 (283)
T cd05080 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQG-QMT 229 (283)
T ss_pred ccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hccccc-ccc
Confidence 99876543221111 122234557999999988889999999999999999999999986433211100 000000 001
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.....+..+.......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111222222222223334457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.49 Aligned_cols=250 Identities=25% Similarity=0.329 Sum_probs=193.0
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.|++++.||+|+||.||+|.+ .+++.+|+|++.... ......+..|+++++.++|+||+++++++.+... ++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999995 468899999986432 2234567889999999999999999999887654 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998532 3688899999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCC---------------------------------------------ceecccCCCcccccccccccCCCCCccce
Q 018744 197 SDKAGG---------------------------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDV 231 (351)
Q Consensus 197 ~~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~~Di 231 (351)
...... .......||..|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 110000 00112468899999999998889999999
Q ss_pred eehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC--ccccCCCCHHHHHHHHHHHHhc--cCCCCCC
Q 018744 232 YSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMC--VQPEADY 307 (351)
Q Consensus 232 wslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~--l~~~P~~ 307 (351)
|||||++|+|++|..||....+. .....+.. ..+..........++.+||.+| +..+|..
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPT----------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHH----------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccC
Confidence 99999999999999999754321 11111111 1111111112334677888874 4556666
Q ss_pred CCCHHHHHHH
Q 018744 308 RPLMADVVQS 317 (351)
Q Consensus 308 Rpt~~eil~~ 317 (351)
||++.+++.|
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=292.31 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=192.0
Q ss_pred CceeeecCceEEEEEEE----cCCcEEEEEEcccc----CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQA----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.+.||+|+||.||+++. ..++.+|+|++... .......+..|+.+++.++||||+++++++..+. .++||+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999984 35788999998642 1223345678999999999999999999887764 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 81 YLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999988432 3678889999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----------------~~~~~~~ 212 (323)
T cd05584 151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----------------KKTIDKI 212 (323)
T ss_pred ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----------------HHHHHHH
Confidence 2211 112335688999999999988899999999999999999999999975332 1112222
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..... ..+......+.+||.+||+.+|++|| ++.+++++
T Consensus 213 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 22211 12223345689999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=290.88 Aligned_cols=268 Identities=22% Similarity=0.378 Sum_probs=204.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 109 (351)
.++|.+.+.||+|++|.||++... ....+++|.+..... .....+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467999999999999999999742 245688898764322 2235677899999999 699999999988766
Q ss_pred C-eEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 110 R-KLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 110 ~-~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
. .+++++|+.+++|.+++...... ......+++..+..++.|++.||.|||++ +++|+||+|+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 4 56999999999999998654321 11234688999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcc
Q 018744 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 258 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~ 258 (351)
+.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999876543221111122223457999999988889999999999999999999 8889864332
Q ss_pred eeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 259 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
...............+...+..+.+++.+||+.+|++|||+.++++.|.++......
T Consensus 243 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 243 ------------EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred ------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 111111111111122233445788999999999999999999999999998775433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.61 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=198.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
..++|++.+.||+|+||.||++... +++.+|+|++... .......+..|+.+++.++||||+++++++.+.. .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999954 6889999998632 2233355778999999999999999999887765 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+|+|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++
T Consensus 121 v~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 9999999999998842 2478889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccC----CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------- 253 (370)
T cd05596 190 MKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------------- 253 (370)
T ss_pred eeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---------------
Confidence 7643221 1112345689999999988643 4789999999999999999999999754321
Q ss_pred hhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
.....+........++ ...+..+.+||.+||+.+|++ |+|+.+++++
T Consensus 254 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 -GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1122222211111111 123457889999999999987 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=282.75 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=204.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
...++|++.+.||+|++|.||+|...++..+++|.+... ......+..|+.+++.++|+|++++++++... ..+++++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 345789999999999999999999877788999988643 34557788999999999999999999998774 5569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
++.+++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 82 YMSKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred ccCCCCHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 999999999985432 23688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 154 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----------------~~~~~~ 216 (261)
T cd05034 154 EDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----------------REVLEQ 216 (261)
T ss_pred cchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 43111 11112234557999999998889999999999999999998 9999864321 111111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
+. .......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11 111112222234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=283.96 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=196.1
Q ss_pred CCcCceeeecCceEEEEEEEcC-Cc--EEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------C
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSN-GR--KVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R 110 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~-~~--~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~ 110 (351)
|.+.+.||+|+||.||+|.+.. +. .+++|.+.... ......+..|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999643 33 58899876432 22345678899999999999999999976421 3
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++|+.+++|.+++...... .....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 46999999999999887432211 1234589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------------- 221 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------------- 221 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------------
Confidence 99876543221111122335667999999998889999999999999999999 88888643221
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
...+.+........+......+.+++.+||+.+|++|||+.++++.|++++
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 222 --EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred --HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111110011112233456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=280.83 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=192.3
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
+.||+|+||.||+|.+. +++.+++|.+.... ......+.+|+++++.++|+||+++++++.... .++|++|+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999954 68899999875432 223456888999999999999999999987664 4599999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 81 LTFLRTE------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred HHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence 9998432 23588999999999999999999999 99999999999999999999999999987543221111
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCcccc
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 282 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (351)
.......+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----------------~~~~~~~~~~~~ 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----------------QQTREAIEQGVR 214 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----------------HHHHHHHHcCCC
Confidence 1111223446999999998889999999999999999998 8888853221 111111111122
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 283 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2223334557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.61 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=194.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|+++++.++|+||+++++.+.+.. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 68899999985321 223456788999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... ..+++..+..++.||+.||+|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999998432 3688899999999999999999999 999999999999999999999999998753
Q ss_pred cCCCCC-----------------------------------------CceecccCCCcccccccccccCCCCCccceeeh
Q 018744 196 GSDKAG-----------------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSY 234 (351)
Q Consensus 196 ~~~~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~~Diwsl 234 (351)
...... ........|++.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 211000 000112468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCCC---
Q 018744 235 GVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRP--- 309 (351)
Q Consensus 235 G~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp--- 309 (351)
||++|+|++|..||....+. .....+.. ..+...........+.++|.+|+. +|.+|+
T Consensus 231 Gvilyell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~ 293 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPA----------------ETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKN 293 (376)
T ss_pred cceeeehhhCCCCCCCCCHH----------------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999754421 11111111 011111111233457778888764 999999
Q ss_pred CHHHHHHH
Q 018744 310 LMADVVQS 317 (351)
Q Consensus 310 t~~eil~~ 317 (351)
|+.+++++
T Consensus 294 t~~ell~h 301 (376)
T cd05598 294 GADEIKAH 301 (376)
T ss_pred CHHHHhCC
Confidence 89999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=297.06 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=197.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|.+.+.||+|+||.||++... +++.+|+|++.... ......+..|+.+++.++|+||+++++++.+.+ .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999954 68899999986432 223456788999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 81 EYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred CCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999985432 3689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccc------cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYAL------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
...... .......++..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------------- 215 (330)
T cd05601 152 LTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------------- 215 (330)
T ss_pred CCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---------------
Confidence 543221 1223356889999999986 456789999999999999999999999643321
Q ss_pred hhHHHhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....++... +...........+.+|+..||+ +|.+|||+.+++.+
T Consensus 216 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 -KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111221111 1111111234568899999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=281.84 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=197.5
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
.+|++.+.||+|++|.||++.+.++..+++|++... ......+..|+++++.++|+||+++++++.... .+++++++.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 468999999999999999999877778999988533 334456788999999999999999999887664 459999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ..+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 83 NGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999985332 3688999999999999999999999 9999999999999999999999999988754322
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ..
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~-~~ 215 (256)
T cd05059 154 QYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----------------EVVES-VS 215 (256)
T ss_pred ccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----------------HHHHH-HH
Confidence 111 1111223447999999998889999999999999999999 89999643321 11111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.......+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111112223455799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=289.96 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=193.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+|.+.+.||+|+||.||+|... +++.+++|++.... ......+..|..++..+ +|++|+.+++++...+ .++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999955 57899999986432 22234456677777777 5789999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|...+... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 81 EYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999888432 3688999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----------------~~~~~~ 212 (323)
T cd05616 151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQS 212 (323)
T ss_pred cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 32211 122345688999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
+..... .++......+.+++.+||+.+|++|++. .+++++
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 213 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 222211 2223345578999999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.37 Aligned_cols=244 Identities=27% Similarity=0.420 Sum_probs=203.8
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK 111 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 111 (351)
....++|++.++||+|.||+|+++..+ +++.||||+++.. ...+.+..+.|..++... +||.++.++..|+.+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999954 6889999998754 344567778899998888 49999999999987754
Q ss_pred -EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 112 -LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 112 -~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
++||||..||++..+. ....+++..+.-++..++.||.|||++ ||++||||.+|||+|.+|.+||+||
T Consensus 444 l~fvmey~~Ggdm~~~~--------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred EEEEEEecCCCcEEEEE--------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccc
Confidence 5999999999944444 234799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++...-. .....+..+||+.|+|||++.+..|+.+.|.|+||++||+|+.|..||.+++.+
T Consensus 513 GlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------- 574 (694)
T KOG0694|consen 513 GLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------- 574 (694)
T ss_pred ccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------
Confidence 99985322 333556789999999999999999999999999999999999999999876542
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
+....++... ..|+...+.+...+++++|..+|++|.-+
T Consensus 575 e~FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2233333322 24566677788999999999999999966
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.23 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=204.7
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
+.+.++...-.+.||+|+.|.||+|+. .++.||||.+..-. ..+++-|++|+|+||+.+.++|...- .++|
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 333444455577899999999999997 45779999875332 23789999999999999999998774 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
||||..|.|...++.. .++....+..|..+||.|+.|||.+ .|+|||||.-||||+.+..|||+|||.++
T Consensus 191 MEfCa~GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeccccccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999999543 4788899999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ...-...||..|||||++++.+.+.+.||||||++||||+||..||..-+. ..+.|..
T Consensus 261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGV---------- 323 (904)
T KOG4721|consen 261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGV---------- 323 (904)
T ss_pred hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEec----------
Confidence 65443 233456799999999999999999999999999999999999999974332 1222221
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
-...+.-..+..++..+.-||++||+-.|-.||++.+|+.||+-+
T Consensus 324 --GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 324 --GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 122344456667777899999999999999999999999998654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=290.94 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=193.7
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCC-cceeeeEEEEcCC-eEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSP-YLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~-~~~v~ 115 (351)
+|++.+.||+|+||.||+|... +++.+|+|++... .....+.+..|..++..+.|+ +|+.+++++...+ .++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999954 5788999998643 223445677789999998765 5788888877654 56999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|..++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 81 EYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999999999888432 3688999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.+... ......
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~~~~~ 212 (324)
T cd05587 151 NIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DELFQS 212 (324)
T ss_pred cCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 32211 122345688999999999998999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
+..... .++......+.+++.+||..||.+|++. .+++++
T Consensus 213 i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 213 IMEHNV--SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222111 2222334568899999999999999986 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=280.02 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=196.4
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCCCh
Q 018744 48 VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL 123 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~L 123 (351)
.||+|+||.||+|.+. .+..+++|++..... .....+.+|+.+++.++|+||+++++++.....++|++|+.+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999753 345689998865432 223568889999999999999999999987778899999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 ~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 82 NKFLSGK------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9988532 23689999999999999999999999 99999999999999999999999999987543322111
Q ss_pred e-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 204 V-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 204 ~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+...+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------------PEVMSFIEQGK 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHCCC
Confidence 1 111223467999999988889999999999999999996 9999964321 11222222222
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 22333344567899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.20 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=190.9
Q ss_pred ceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||++.. .+++.+++|++.... ......+..|++++..++||||+++.+++.... .++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468899999986432 223355677899999999999999999887765 45999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
+|..++.. ...+++..++.++.||+.||.|||+ . +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 81 ELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred cHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence 99888743 2368999999999999999999997 7 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----------------~~~~~i~~~~ 212 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILMEE 212 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----------------HHHHHHhcCC
Confidence 1123356889999999999889999999999999999999999999643321 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
. .++......+.+|+.+||+.||++|+ ++.+++++
T Consensus 213 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 I--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 12222345689999999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=284.52 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=198.3
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
+|++.+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+ .+++|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4889999999999999999954 68899999886432 122345677999999999999999999887654 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999998875322 23589999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......++..|+|||++.+..++.++||||+||++|+|++|..||.+.... .....+...
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-------------~~~~~~~~~ 216 (285)
T cd05605 153 PEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-------------VKREEVERR 216 (285)
T ss_pred CCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-------------hHHHHHHHH
Confidence 3221 122346788999999999888999999999999999999999999754321 000111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
+.. ....++...+..+.+|+..||..||++|| ++.+++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 VKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111 11122333455789999999999999999 88899877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=281.24 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=211.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.+.|++.+.||.|..|+||++... ++..+|+|++....-. ...++..|-++|..+.||.++.++..++.++. +++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356888999999999999999954 5789999999754322 33456679999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
||||.||+|..+..... .+.+++..+.-++..++.||+|||-. ||++|||||+||||.++|++.|+||.++.
T Consensus 156 meyCpGGdL~~LrqkQp-----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EecCCCccHHHHHhhCC-----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999986543 35799999999999999999999999 99999999999999999999999998864
Q ss_pred ccCCC--------------------------------C-C---------------------CceecccCCCccccccccc
Q 018744 195 IGSDK--------------------------------A-G---------------------GHVSTRVLGTQGYVAPEYA 220 (351)
Q Consensus 195 ~~~~~--------------------------------~-~---------------------~~~~~~~~~~~~y~aPE~~ 220 (351)
..... . . .......+||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 32110 0 0 0111224588899999999
Q ss_pred ccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhc
Q 018744 221 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMC 300 (351)
Q Consensus 221 ~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 300 (351)
.|.-.+.+.|.|+||+.+|||+.|..||.+.+. ...+.+++.+.+.-.-.+.....+.+||+++
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 999999999999999999999999999987654 4556677777666555556677899999999
Q ss_pred cCCCCCCCCC----HHHHHHH
Q 018744 301 VQPEADYRPL----MADVVQS 317 (351)
Q Consensus 301 l~~~P~~Rpt----~~eil~~ 317 (351)
|..||.+|.. +.||.+|
T Consensus 372 LvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hccChhhhhccccchHHhhcC
Confidence 9999999998 8999887
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=279.98 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=195.9
Q ss_pred ceeeecCceEEEEEEEc-C---CcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS-N---GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~---~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|.+. . +..+++|.+...... ....+..|+.+++.+.|+|++++++++.....+++++|+.++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999843 2 268999998754332 345678899999999999999999998877888999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++... ..+++..++.++.|++.||++||.. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 81 PLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred cHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999432 3688999999999999999999999 999999999999999999999999999876543322
Q ss_pred Ccee-cccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 202 GHVS-TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 202 ~~~~-~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----------------~~~~~~~~~ 213 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------------AEVIAMLES 213 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHc
Confidence 1111 11223457999999988889999999999999999998 9999964321 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 214 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111222233457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=287.66 Aligned_cols=268 Identities=21% Similarity=0.374 Sum_probs=206.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
...+|.+.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3577999999999999999999731 23468999886432 23346688899999999 89999999998877
Q ss_pred CC-eEEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 109 RR-KLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 109 ~~-~~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
.. .+++++|+.+++|.+++....... .....+++..++.++.||+.||.|||++ +++|+||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 64 459999999999999986543211 1124578899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999876543322222222344567999999988889999999999999999998 8888854321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..+...+........+......+.+|+.+||+.+|++|||+.++++.|++++.-..
T Consensus 246 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 11111111111112223345679999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=285.51 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
..+|.+.+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.... .+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467889999999999999999732 35578888887555555567889999999999999999999888764 45
Q ss_pred EEEEEccCCChhhhccccCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 113 LVYDYMANGGLQEHLYPANGS--------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~--------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
++++|+.+++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||+|+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998654310 11123588999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------- 230 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---------- 230 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----------
Confidence 99999999875433221111222334568999999998889999999999999999998 9999853221
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.......... .....+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 231 ------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 ------TEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------HHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111111 111112233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=282.12 Aligned_cols=259 Identities=21% Similarity=0.337 Sum_probs=204.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
.++|.+.+.||.|++|.||+|.+.+ ...+++|...... ....+.+.+|+.+++.++|+|++++++++.+...+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv 84 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV 84 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence 4679999999999999999998532 2468889876443 2334578889999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 85 MELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 99999999999985322 3588999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... .......+...|+|||.+....++.++||||||+++|+|++ |..||...... ...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----------------~~~ 218 (270)
T cd05056 156 YLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----------------DVI 218 (270)
T ss_pred ecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHH
Confidence 5433211 11122233457999999988889999999999999999986 99999644321 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+ ........+...+..+.+++.+||..+|++|||+.++++.|.++.+.+
T Consensus 219 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 219 GRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred HHH-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111 110111122233457999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=292.76 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=201.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC--
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 109 (351)
.++|++.+.||.|+||.||+|.+ .+++.+++|++..... .....+.+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 2467899999864322 2235677899999999 689999999987654
Q ss_pred CeEEEEEEccCCChhhhccccCCCC-------------------------------------------------------
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------- 134 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~------------------------------------------------------- 134 (351)
..+++++|+.+|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 3468999999999999886432100
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccC
Q 018744 135 -----SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209 (351)
Q Consensus 135 -----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 209 (351)
.....+++..+..++.|++.||+|||++ +++|+||||.||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0012467888999999999999999999 99999999999999999999999999987643322111222233
Q ss_pred CCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHH
Q 018744 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMK 288 (351)
Q Consensus 210 ~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (351)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......+........+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----------------HHHHHHHhccCCCCCCCC
Confidence 4567999999988889999999999999999997 99998643211 001111111011111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 289 EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 289 ~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
....+.+++..||+.+|++|||+.+++++|+.+++.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 234688999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=284.33 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
..++|++.+.||+|+||.||+|... .+..+++|.+..... .....+.+|+.++..++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3478999999999999999999853 236799999864322 2234677899999999999999999988766 4
Q ss_pred eEEEEEEccCCChhhhccccCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSN---SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
.+++++|+.+++|.+++....... .....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 569999999999999986543211 1234578899999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------------ 228 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------------ 228 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH------------
Confidence 99999875443322222233445678999999988889999999999999999998 99998643321
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
..............+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 -----EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111111222333567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.39 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=203.8
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
++|++.+.||.|++|.||++.. .+++.+++|.+...... ....+.+|+.+++.++|+||+++++++... ..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5799999999999999999994 57889999987543222 234677899999999999999999988665 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++.... .....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFK---KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 9999999999885432 1234689999999999999999999999 999999999999999999999999998876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 156 ~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~ 219 (267)
T cd08229 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------YSLCKK 219 (267)
T ss_pred cccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH--------------HHHhhh
Confidence 433221 1223457788999999988889999999999999999999999986432210 000111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
+................+.+++.+||..+|++|||+.+|++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111111111234557999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=286.07 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc--EEEEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v 114 (351)
++|++.+.||.|+||.||+|... ++. .+++|.+... .......+..|+.++.++ +||||+++++++.... .+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 68999999999999999999854 333 4677877532 222345678899999999 7999999999887664 5699
Q ss_pred EEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 115 YDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
++|+.+++|.+++...... ......+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999998543211 01223588999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 264 (351)
+|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---------- 225 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------- 225 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 999999986422111 1111222446999999988889999999999999999997 99999643321
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.....+ ........+...+..+.+|+.+||+.+|.+|||+.++++.|.+++...+.
T Consensus 226 ------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 226 ------ELYEKL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------HHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111 11111122223445789999999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=295.72 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=197.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
...++|++.+.||+|+||.||++.+. +++.+|+|++... .......+..|+.+++.++||||+++++++.++. .+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999965 6888999988532 1223455778999999999999999999988765 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||+
T Consensus 120 lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999998842 2478889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccC----CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
+....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------------- 252 (370)
T cd05621 189 CMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------------- 252 (370)
T ss_pred ceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---------------
Confidence 87643221 1122345689999999998753 378899999999999999999999975432
Q ss_pred chhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 269 DREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
......+.........+ ......+.+++..||..++.+ |+|+.++++|
T Consensus 253 -~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 -VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11122222211111111 123456888999999865543 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.35 Aligned_cols=268 Identities=22% Similarity=0.371 Sum_probs=204.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC--------CcEEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
...+|++.+.||+|+||.||.|.+.. +..+++|.+.... ......+.+|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34579999999999999999997421 2358899876432 22346788899999999 79999999998876
Q ss_pred CC-eEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 109 RR-KLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 109 ~~-~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
.. .+++++|+.+++|.+++...... ......+++..+..++.|++.||.|||++ +++|+||+|+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 64 56999999999999998653211 11234588899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 99999999999999875433221111122233457999999998899999999999999999998 8888864321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
......+........+......+.+++.+||+.+|++|||+.++++.|+++...+.
T Consensus 243 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 -------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111111111112222344578999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=287.14 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=201.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 109 (351)
..++|.+.+.||+|+||.||++... .+..+++|.+..... .....+..|+.+++++ +|+||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999731 245789998864322 2235688899999999 799999999988766
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..+++++|+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence 4569999999999999985432 12489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------------- 250 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------------- 250 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------------
Confidence 999876543322112223345678999999998889999999999999999998 99998643221
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
...............+......+.+++.+||+.+|++|||+.++++.|.++
T Consensus 251 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 --SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111111111122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.32 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=203.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYM 118 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~ 118 (351)
..++|++.+.||+|+||.||++....+..+++|.+... ......+.+|+.+++.++|+|++++.+.+.....+++++|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence 35789999999999999999999777778999988643 33456788899999999999999999998887777999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhCC-----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999985432 23578889999999999999999999 999999999999999999999999999876433
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||..... .......
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------------~~~~~~~ 216 (260)
T cd05073 155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------------PEVIRAL 216 (260)
T ss_pred CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHH
Confidence 2211 1112234567999999988889999999999999999998 9999964332 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
............+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111111222334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.35 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=200.3
Q ss_pred ceeeecCceEEEEEEEcC----CcEEEEEEccccCCCC-hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.... +..+++|.+....... ...+..|++.++.++|+|++++++++.... .+++++|+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999543 7889999987543333 577889999999999999999999887754 4599999999
Q ss_pred CChhhhccccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 121 GGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 121 ~~L~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
++|.+++...... ......+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998654210 00125789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----------------EEVLEYLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHHH
Confidence 432222334556778999999988889999999999999999999 6999975421 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
. ......+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1122233344567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=286.55 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=203.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
.++|+..+.||+|++|.||+|.+. ++. .+++|.+...... ....+.+|+.+++.++||||+++++++.....++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 85 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL 85 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence 367889999999999999999853 443 4688877543221 1235778999999999999999999998777779
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++++.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++
T Consensus 86 v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 999999999999885322 3578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----------------~~ 219 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----------------RE 219 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 86543322212222334668999999988889999999999999999997 9999864321 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
...++........+......+.+++..||..+|++||++.++++.|+++.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 111111111111122234578999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=290.80 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=190.2
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+++|++... .......+..|..++..+ +||||+++++++...+ .++||+|+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999998643 223345566788888776 6999999999987765 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~- 149 (320)
T cd05590 81 GDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN- 149 (320)
T ss_pred chHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-
Confidence 9999888432 3688999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
........|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----------------~~~~~~i~~~~ 212 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----------------DDLFEAILNDE 212 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------HHHHHHHhcCC
Confidence 1122345689999999999988999999999999999999999999975432 11111222111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~~ 317 (351)
. ..+......+.+|+.+||+.||++||++ .+++.+
T Consensus 213 ~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 213 V--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1 1122234578999999999999999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.41 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=187.2
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.||+|++.... ......+..|..++... +||||+++++++.... .++||+|+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 68889999986431 22334445566666654 8999999999887664 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~~~~-------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 81 GDLMFHIQS-------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence 999988843 23688999999999999999999999 99999999999999999999999999987533222
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~- 211 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----------------DELFDSILND- 211 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcC-
Confidence 222345689999999999988899999999999999999999999975432 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~ 317 (351)
...++......+.+|+.+||..||++||++. +++++
T Consensus 212 -~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 212 -RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1122223345688999999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.77 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=197.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc-C-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-R-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~~v~~~ 117 (351)
..+|.+.+.||+|++|.||++.. .+..+++|.+... ...+.+.+|+.+++.++|+|++++++++.. . ..+++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35799999999999999999986 4677999988543 235678889999999999999999987543 3 45699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...+++..++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 82 MAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 99999999985432 13578899999999999999999999 99999999999999999999999999887533
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
... .....+..|+|||++.+..++.++|||||||++|+|++ |..||..... ......
T Consensus 154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~ 211 (256)
T cd05082 154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPR 211 (256)
T ss_pred ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHH
Confidence 221 22233457999999988889999999999999999998 9999863221 111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
+............+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111111222233455789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=282.46 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=198.2
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.. .+++.+++|++..........+.+|+.++..++||||+++++++.... .++|++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 46799999999999999999995 468889999987554455567888999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++... .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999988432 3688999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
.... ......++..|+|||.+. ...++.++|||||||++|+|++|..||....+..........
T Consensus 158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06646 158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------- 224 (267)
T ss_pred cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence 3211 112345778899999874 345788999999999999999999998643322111000000
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+.. ......+..+.+|+.+||..+|++|||+.++++++
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000000 00112235789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=290.12 Aligned_cols=241 Identities=27% Similarity=0.391 Sum_probs=190.9
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|... +++.+++|++.... ......+..|.+++..+ +||||+++++++.... .++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57899999986432 23334566788888866 7999999999988765 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|...+... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 81 GDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence 9999888432 3688999999999999999999999 99999999999999999999999999987532221
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----------------~~~~~i~~~~ 212 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----------------DLFESILHDD 212 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 1223456889999999999889999999999999999999999999754321 1122222111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRP-------LMADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-------t~~eil~~ 317 (351)
. ..+......+.+++..||..||++|| ++.+++++
T Consensus 213 ~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 V--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 11222345688999999999999999 88888877
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=289.30 Aligned_cols=238 Identities=27% Similarity=0.381 Sum_probs=188.2
Q ss_pred CceeeecCceEEEEEEE----cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 46 SNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.+.||+|+||.||+++. .+|+.+++|++..... .....+..|+++++.++||||+++++++.... .++|++|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999874 3578999999864322 22345667999999999999999999887765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 81 RGGDLFTRLSK-------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999988843 23689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 151 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----------------~~~~~~i~~ 212 (318)
T cd05582 151 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----------------KETMTMILK 212 (318)
T ss_pred CC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----------------HHHHHHHHc
Confidence 21 122335688899999999988889999999999999999999999975332 111122222
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 313 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e 313 (351)
... ..+......+.+||.+||+.||++|||+.+
T Consensus 213 ~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 122233456889999999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.48 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=201.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
.++|++.+.||.|++|.||+|... |+.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+. ..+++++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 468999999999999999999874 78899999875533 456788899999999999999999998755 456999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 83 AKGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred CCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999985432 12689999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. .....+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...+
T Consensus 155 ~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~ 212 (256)
T cd05039 155 GQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPHV 212 (256)
T ss_pred cc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHH
Confidence 21 12233557999999988889999999999999999997 9999863321 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
........+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111122223346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.35 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=194.6
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||+|++|.||+|.+ .+++.+++|.+..... .....+.+|++++..++||||+++++.+.... .+++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688999999999999999995 4788999998864322 22356788999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|..+. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 81 MDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred CCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 9999886543 467889999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......... ..........
T Consensus 147 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~ 213 (279)
T cd06619 147 NS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MPLQLLQCIV 213 (279)
T ss_pred cc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------chHHHHHHHh
Confidence 32 1233567889999999998889999999999999999999999996432211000 0001111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..............+.+++.+||+.+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111111233468999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=306.58 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=190.6
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------C-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~- 110 (351)
.++|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999995 46889999987532 12345699999999999999998876321 1
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEe
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVS 188 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~ 188 (351)
.++||+|+.+ +|.+++.... .....+++..++.++.||+.||+|||+. +++||||||+||+++.++ .++|+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA---RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 2379999875 6766664332 1234689999999999999999999999 999999999999998654 69999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+................
T Consensus 214 DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~- 289 (440)
T PTZ00036 214 DFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT- 289 (440)
T ss_pred ccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-
Confidence 999997643321 12234678899999988754 6899999999999999999999999765432111000000000
Q ss_pred cchhHHHhh-------c-----CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEI-------M-----DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~-------~-----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......... . ...+...++...+.++.+||.+||..||.+|||+.|+++|
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000 0 0000011111234578999999999999999999999987
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=290.08 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=191.7
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+|+|++.... ......+..|..++..+ +||||+++++++.+.. .++||+|+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999954 68899999986432 22345577899999888 6999999999988765 4699999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 81 GDLMFHMQR-------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150 (329)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence 999888743 24689999999999999999999999 99999999999999999999999999986422111
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..........+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~ 221 (329)
T cd05588 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-------QNTEDYLFQVILEKQ 221 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-------ccchHHHHHHHHcCC
Confidence 12234568899999999999999999999999999999999999996432211000 000001111122221
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPL------MADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt------~~eil~~ 317 (351)
. ..+......+.++|.+||+.||.+||| +.++++|
T Consensus 222 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 I--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 122233456889999999999999997 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.74 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=199.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC-----------------CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCccee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN-----------------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLA 101 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~-----------------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 101 (351)
.++|++.+.||+|+||.||+|.... +..+++|.+..... .....+.+|++++..++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999988532 24578898764322 23456788999999999999999
Q ss_pred eeEEEEcC-CeEEEEEEccCCChhhhccccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 102 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 102 ~~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
+++++..+ ..+++++++.+++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99988775 456999999999999998554311 01123689999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh--CCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPS 254 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt--g~~pf~~~~~~ 254 (351)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999875433322222233445678999999988889999999999999999998 6777753221
Q ss_pred CCcceeecccccccchhHHHhhc------CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 255 GEGVLVSWALPRLTDREKILEIM------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
...+.... ........+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus 240 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ---------------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---------------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 01111110 001111112223457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.34 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=204.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
..+|++.+.||+|+||.||+|.+. ++. .+++|.+..... .....+.+|+..+..++|+|++++++++.....++
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQL 85 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEE
Confidence 367899999999999999999853 333 588888764432 22356788999999999999999999998877889
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++|+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+
T Consensus 86 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999985432 3588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
................++..|+|||.+....++.++|+||||+++|+|++ |..||..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~ 219 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------------VE 219 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------------HH
Confidence 76543322222222223457999999988889999999999999999998 9999965332 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+...+........+......+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 220 IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1111111111122222345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=283.45 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=192.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||+|+||.||++.+. +++.+++|.+..... .....+..|+.+++.++|+||+++.+++.... .++||+|+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999954 688999999864322 12345677999999999999999999887664 5599999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
...+.... .....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~ 152 (280)
T cd05608 81 RYHIYNVD---EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--S 152 (280)
T ss_pred HHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--c
Confidence 88774432 1234689999999999999999999999 99999999999999999999999999987543322 1
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ............. .
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------------~~~~~~~~~~~~~--~ 218 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV------------ENKELKQRILNDS--V 218 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch------------hHHHHHHhhcccC--C
Confidence 1233467889999999999999999999999999999999999997533210 0011111111111 1
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.++...+..+.+++.+||+.||++|| |+.+++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 22233455789999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.59 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=200.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
...+|++.+.||+|++|.||+|.. .+++.+++|.+..........+.+|+.+++.+.|+|++++++.+... ..++|++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346899999999999999999995 46889999988765555567788899999999999999999987665 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 98 ~~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 98 YLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred ccCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 9999999998832 2478899999999999999999999 9999999999999999999999999988754
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......++..|+|||.+.+..++.++|||||||++|+|++|..||....+.... ....
T Consensus 167 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~---------------~~~~ 229 (296)
T cd06654 167 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---------------YLIA 229 (296)
T ss_pred cccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH---------------HHHh
Confidence 3321 1122345778899999998888899999999999999999999999654331100 0000
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.........+......+.+++.+||..+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11111111122344568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.15 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=190.3
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|... +++.+++|++... .......+..|+.++..+ +||||+++++++.... .++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6789999998643 222345567788888776 7999999999887664 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 81 GDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence 999888743 24689999999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH-HhhcCc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI-LEIMDP 279 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 279 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||......... .......+ ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i~~~ 220 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVILEK 220 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHHhcC
Confidence 1223456889999999999999999999999999999999999999632211000 00001111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPL------MADVVQS 317 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt------~~eil~~ 317 (351)
.. ..+......+.+||.+||+.||++||| +.++++|
T Consensus 221 ~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 QI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 223334456889999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.32 Aligned_cols=264 Identities=20% Similarity=0.247 Sum_probs=194.1
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+ .+++.+|+|... ...+.+|+.+++.++||||+++++++.... .++++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46899999999999999999995 468899999653 234578999999999999999999887664 4588888
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|..++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 165 ~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 165 YK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 75 6787777332 3588999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce----eecc---c---c-c
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL----VSWA---L---P-R 266 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~----~~~~---~---~-~ 266 (351)
... ........||+.|+|||++.+..++.++|||||||++|+|++|..||-.......... .... . + .
T Consensus 234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 211 1122345689999999999988999999999999999999999988754321110000 0000 0 0 0
Q ss_pred --ccchhHHHhhc----Cccc---cCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 267 --LTDREKILEIM----DPAL---EGQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 267 --~~~~~~~~~~~----~~~~---~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
........... .... .... ....+.++.+||.+||+.||++|||+.|++++ .+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h--p~f~ 380 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF--AAFQ 380 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC--hhhc
Confidence 00000001000 0000 0000 01234578999999999999999999999987 4554
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.85 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=199.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CC---cEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~---~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
+.|++.+.||.|+||.||+|... ++ ..+++|.+... .......+..|+.+++.++||||+++.+++.++. .+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 56889999999999999999954 33 36999988643 2223457888999999999999999999987665 4699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++.... ..+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 84 TEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999885432 3588999999999999999999999 99999999999999999999999999887
Q ss_pred ccCCCCCCceecccCC---CcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 195 IGSDKAGGHVSTRVLG---TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
...............+ +..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----------------- 217 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------- 217 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----------------
Confidence 5433222111111111 346999999998889999999999999999887 9999864321
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
...............+.+.+..+.+++.+||..+|++||++.++++.|++++
T Consensus 218 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 218 QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred HHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1111111111111222334557899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=284.50 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=201.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR- 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 109 (351)
...++|++.+.||+|+||.||+|... .+..+++|.+..... .....+.+|+..++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34578999999999999999999743 245789998753322 1223567799999999999999999988765
Q ss_pred CeEEEEEEccCCChhhhccccCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSN---SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
..+++|+|+.+|+|.+++....... .....++...+..++.|++.||.|||++ +++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 4569999999999999996543211 1124567788999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 265 (351)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------------ 227 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------------ 227 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 999999875433221111122334567999999998889999999999999999998 7888864321
Q ss_pred cccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+.+... ...+...+..+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus 228 ----~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 228 ----EQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ----HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 111111111111 11122234579999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.81 Aligned_cols=268 Identities=22% Similarity=0.359 Sum_probs=198.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-----------------CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCccee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-----------------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLA 101 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-----------------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 101 (351)
.++|++.+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998632 23458889886442 223467889999999999999999
Q ss_pred eeEEEEcC-CeEEEEEEccCCChhhhccccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 102 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 102 ~~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
+++++... ..+++++|+.+++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99988765 456999999999999998654321 11223578889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh--CCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPS 254 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt--g~~pf~~~~~~ 254 (351)
|+++.++.++|+|||++................++..|++||...++.++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433221111222334567999999888889999999999999999998 77888643221
Q ss_pred CCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 255 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
... ..................+...+..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVI----------ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH----------HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 00000000000000011112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.22 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=207.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
....+|++.+.||+|++|.||++.. .+++.+++|.+........+.+..|+.+++.++|+|++++++++.... .++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3458899999999999999999995 478999999987655555567888999999999999999999887664 56999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++.. ..+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 96 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 96 EYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred cccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999998832 2578889999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+....... +.
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~------------ 229 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-AT------------ 229 (297)
T ss_pred ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-cc------------
Confidence 433221 122345778899999998888999999999999999999999999754432111000 00
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 330 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~ 330 (351)
........+......+.+|+.+||..+|++|||+.+++++ .+++..++.++
T Consensus 230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~~~~~~~~ 280 (297)
T cd06656 230 --NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH--PFLKLAKPLSS 280 (297)
T ss_pred --CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--chhcccccccc
Confidence 0000001112234468899999999999999999999997 66665555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.81 Aligned_cols=265 Identities=29% Similarity=0.436 Sum_probs=201.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCc--EEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~--~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~ 113 (351)
.++|++.+.||.|+||.||+|.+. ++. .+++|.+.... ......+.+|++++..+ +|+||+++++++... ..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 478999999999999999999954 444 35666664322 22335678899999999 899999999998766 4569
Q ss_pred EEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 114 VYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+++|+.+++|.+++...... ......+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 99999999999998654311 01224688999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------- 230 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------- 230 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---------
Confidence 9999999886321111 1111223457999999988889999999999999999998 99998643321
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
..............+...+..+.+|+.+||+.+|++|||+.++++.|.+++.....
T Consensus 231 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 231 --------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred --------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 11111111111111222345689999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=276.38 Aligned_cols=269 Identities=22% Similarity=0.265 Sum_probs=200.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCc-ceeeeEEEEcCC-----
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPY-LLALLGYCSDRR----- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 110 (351)
...|..++.||+|+||+||+|+. .+|+.||+|.+..... .......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35577788899999999999994 4789999999875433 24456678999999999999 999999987655
Q ss_pred -e-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 111 -K-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 111 -~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
. ++|++|.+. +|..++....... ..++...+..++.||+.||+|||++ +|+||||||.||+|+.+|.+||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence 3 488998855 8888886544211 3567789999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||+++....+. ...+...+|..|+|||++.+. .|+...||||+||+++||+++...|.+.........+-......
T Consensus 163 DFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 163 DFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred ccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 999998654333 234566788899999999877 79999999999999999999999998766531111100000000
Q ss_pred cch--hHHHhhcCc--cccCC-----CCHHH---HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDR--EKILEIMDP--ALEGQ-----YSMKE---VIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~--~~~~~~~~~--~~~~~-----~~~~~---~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ..+..+.+- ..... ..... ..+..+++.+||+.+|.+|.|++.+++|
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000000000 00000 00000 1367889999999999999999999998
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.19 Aligned_cols=271 Identities=21% Similarity=0.329 Sum_probs=200.6
Q ss_pred cCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
.-|++.+.||+|+||.||++.. .++..+++|.+.... ......+.+|+.+++.++|+|++++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999973 257789999986442 22345788899999999999999999988764 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++|+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence 69999999999999884321 3588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++........... .....++..|+|||.+.+..++.++|||||||++|+|+++..|+.............. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMTVT 233 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccccHH
Confidence 9886544322111 1234456679999999888899999999999999999998766532111000000000 0000000
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
... ..+............+..+.+|+.+||+.+|++|||+.++++.|+.++
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 234 RLV-RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHH-HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 111 111111111112234557999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.30 Aligned_cols=268 Identities=22% Similarity=0.364 Sum_probs=205.1
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccC-CCcceeeeEEEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLR-SPYLLALLGYCS 107 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 107 (351)
.....++|.+.+.||+|+||.||+|.+. .+..|++|++...... ....+..|++++..+. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445577999999999999999999853 3467999999754222 2346888999999997 999999999887
Q ss_pred cC-CeEEEEEEccCCChhhhccccCCCC----------------------------------------------------
Q 018744 108 DR-RKLLVYDYMANGGLQEHLYPANGSN---------------------------------------------------- 134 (351)
Q Consensus 108 ~~-~~~~v~~~~~~~~L~~~~~~~~~~~---------------------------------------------------- 134 (351)
.. ..++|+||+.+|+|.++++......
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 75 4569999999999999886432100
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCC
Q 018744 135 ---------------------------------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 175 (351)
Q Consensus 135 ---------------------------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~ 175 (351)
.....+++..++.++.||+.||.|||+. +++|+||||.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 0113467788999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCC
Q 018744 176 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPS 254 (351)
Q Consensus 176 Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~ 254 (351)
||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999876433221111223345678999999998889999999999999999998 8889864321
Q ss_pred CCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 255 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.......+........+......+.+++.+||..+|.+||++.+|++.|++++
T Consensus 348 ---------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ---------------NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111111111222233457999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.55 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=205.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
..+|++.+.||.|++|.||++.. .+++.+++|.+..........+.+|+.+++.++|+|++++++++... ..++|++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999985 47899999998765555567788899999999999999999988765 45699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|..++.. ..+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 98 LAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred cCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999998832 2578999999999999999999999 99999999999999999999999999887543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+. .....+.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----------------~~~~~~~ 228 (296)
T cd06655 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------------RALYLIA 228 (296)
T ss_pred cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Confidence 3221 123345778899999998888999999999999999999999999754321 1111111
Q ss_pred C-ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 278 D-PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 278 ~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
. .......+...+..+.++|.+||..+|++|||+.+++.+ .+++..++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~--~~~~~~~~ 277 (296)
T cd06655 229 TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH--PFLKLAKP 277 (296)
T ss_pred hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhhhccc
Confidence 0 000011122234468899999999999999999999987 66665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.70 Aligned_cols=241 Identities=26% Similarity=0.404 Sum_probs=191.0
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+|+|++... .......+..|..++..+ +||||+++++++.... .++||+|+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 5789999998643 223345567788888877 6999999999887765 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 81 GDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150 (318)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence 9999888432 3689999999999999999999999 99999999999999999999999999886422211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......++..|+|||++.+..++.++|||||||++|+|++|..||..... ......+....
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----------------~~~~~~i~~~~ 212 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSILEDE 212 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----------------HHHHHHHHcCC
Confidence 112334578899999999999999999999999999999999999964331 11111121111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
. .++...+..+.+||.+||..||++|||+ .+++++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 V--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 1222334578999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.87 Aligned_cols=264 Identities=21% Similarity=0.288 Sum_probs=194.3
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 109 (351)
...++|++.+.||+|+||.||++.+. +|..+++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999954 6889999998633 223345677899999999999999999988643
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..+++|+|+.+ +|...+. ..++...+..++.|++.||.|||++ +++|+||||+||+++.++.++|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl 164 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 164 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEE
Confidence 24699999976 5555542 2478889999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||.+.+...............
T Consensus 165 ~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 165 LDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred ecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999998653221 12233567889999999999999999999999999999999999997654211000000000000
Q ss_pred cc------hhHHHhhcCcc--cc----------------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TD------REKILEIMDPA--LE----------------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~------~~~~~~~~~~~--~~----------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ........... .. ..........+.+||.+||..||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000000 00 00001123468899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=277.84 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=197.3
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCCh---------HHHHHHHHHHhccCCCcceeeeEEEEcCC-
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGE---------DEFKMEVELLGRLRSPYLLALLGYCSDRR- 110 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 110 (351)
+|++...||.|++|.||+|... +++.+++|.+........ ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999854 578899998864433221 45778999999999999999999887664
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++|+.+++|.+++... ..++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence 45999999999999999432 4688899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCc----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 191 GLAKIGSDKAGGH----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 191 g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|.+.......... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------- 217 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------------- 217 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------------
Confidence 9987654221111 11223467889999999888889999999999999999999999964321
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+..... ......+...+..+.++|.+||+.+|++||++.+++++
T Consensus 218 ---~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 218 ---LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111111 11122233445678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.42 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
+..+....++|++.+.||+|+||.||++.+. +++.+|+|++... .......+.+|..+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999965 6889999998532 12233457789999999999999999998877
Q ss_pred CC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 RR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 ~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
.. .++||+|+.+++|.+++.. ..++...+..++.||+.||.|||++ +++|+||||+||+++.++.++|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEE
Confidence 65 4599999999999998842 2478889999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccC----CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
+|||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 184 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------- 253 (371)
T cd05622 184 ADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------- 253 (371)
T ss_pred EeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------
Confidence 9999987653321 1122345689999999998753 3789999999999999999999999754321
Q ss_pred cccccchhHHHhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQSL 318 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~l 318 (351)
.....++... +...........+.++|..||..++.+ |+++.+++++.
T Consensus 254 -------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1122222211 111111233456888999999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.46 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=199.7
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||+|++|.||+|... +++.+++|.+... .......+..|+++++.++|||++++++.+.+.. .+++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4888999999999999999954 6889999988643 2233466788999999999999999999887664 5699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...++...++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 81 AENGDLHKLLKMQR-----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred CCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999999986432 24688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|..||..... ........
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~ 214 (256)
T cd08529 153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----------------GALILKII 214 (256)
T ss_pred Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHH
Confidence 3221 12234577889999999988899999999999999999999999964431 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ...........+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 112222345579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.42 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=188.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||+|+||.||++... +|+.+++|.+..... .....+..|+++++.++||||+++.+++.... .+++|+|+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999954 689999998853221 12234566999999999999999999887664 5599999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 81 KYHIYNVG-----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred HHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence 88875332 23578899999999999999999999 99999999999999999999999999987643321
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ................
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~ 217 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV------------AKEELKRRTLEDEVKF 217 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh------------hHHHHHHHhhcccccc
Confidence 2234567889999999998889999999999999999999999996432210 0001111111111110
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
........+.+|+..||+.||++||+++|+++.+
T Consensus 218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0112345689999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.62 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=199.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|++.+.||.|+||.||++.. .++.+++|.+... .....+.+|+.+++.++|+|++++++++.....+++++|+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~ 81 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS 81 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence 36799999999999999999875 6778999988643 23467888999999999999999999998888889999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 82 KGNLVNFLRTRG-----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999985432 23578999999999999999999999 9999999999999999999999999998753321
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
. .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .......
T Consensus 154 ~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~ 211 (254)
T cd05083 154 V-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----------------EVKECVE 211 (254)
T ss_pred C-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----------------HHHHHHh
Confidence 1 22233457999999988889999999999999999998 99998643321 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
...........+..+.+++.+||+.+|++||++.++++.|++
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111112222344678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.74 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=198.1
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
+|++.+.||.|++|.||++.+. +++.+++|.+... .......+..|+.+++.++|+|++++++.+..+. .+++++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999954 6889999988532 2233466788999999999999999999887764 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...++...++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQR-----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999998875322 23578899999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......++..|+|||++.+..++.++|+||||+++|+|++|..||...+.. .....+..
T Consensus 153 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----------------~~~~~~~~ 214 (255)
T cd08219 153 PG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----------------NLILKVCQ 214 (255)
T ss_pred cc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----------------HHHHHHhc
Confidence 22 1123355788899999998888999999999999999999999999643321 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ....+...+..+.+|+.+||+.||++|||+.+++..
T Consensus 215 ~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 111223344568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=292.94 Aligned_cols=261 Identities=24% Similarity=0.284 Sum_probs=199.3
Q ss_pred CCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-C-----CcceeeeEEEEcC-CeEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-S-----PYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~-~~~~ 113 (351)
+|.+.+.||+|+||.|.+|. .++++.||||++++. ..-.++...|+.+|..++ | -|+++++++|.-. +.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999999 557999999999754 444566778999999996 4 3999999998766 5567
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC--CCcEEEeecc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFG 191 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~--~~~v~l~dfg 191 (351)
|+|.+ ..+|.++++.. ....++...+..++.||+.||.+||.. +|+|+||||+|||+.. ...|||+|||
T Consensus 266 VfELL-~~NLYellK~n-----~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-----KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eehhh-hhhHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 77776 55999999653 345699999999999999999999999 9999999999999954 4479999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc-------
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL------- 264 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------- 264 (351)
++....... .....+..|+|||++.|..|+.+.|||||||+++||++|...|.+.+.......+....
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998654432 25567778999999999999999999999999999999999998876652211110000
Q ss_pred ------------------c--cccc------hhHHHh----hcCcccc--------CCCCHHHHHHHHHHHHhccCCCCC
Q 018744 265 ------------------P--RLTD------REKILE----IMDPALE--------GQYSMKEVIQVAAIAAMCVQPEAD 306 (351)
Q Consensus 265 ------------------~--~~~~------~~~~~~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~P~ 306 (351)
. .... ...... ....... ..........+.+|+.+||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0 0000 000000 0111000 011113345789999999999999
Q ss_pred CCCCHHHHHHH
Q 018744 307 YRPLMADVVQS 317 (351)
Q Consensus 307 ~Rpt~~eil~~ 317 (351)
+|+|..+.+.|
T Consensus 492 ~R~tp~qal~H 502 (586)
T KOG0667|consen 492 ERITPAQALNH 502 (586)
T ss_pred hcCCHHHHhcC
Confidence 99999999988
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.66 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=186.5
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHH-HHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVE-LLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+++|++.... ......+..|.. +++.++||||+++++.+.+.. .++||+|+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 122233444444 567789999999999887664 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~- 149 (323)
T cd05575 81 GELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH- 149 (323)
T ss_pred CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-
Confidence 999988843 24688999999999999999999999 9999999999999999999999999998643221
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
........|++.|+|||++.+..++.++|||||||++|+|++|..||...+. ......+....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----------------~~~~~~i~~~~ 212 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----------------AEMYDNILNKP 212 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----------------HHHHHHHHcCC
Confidence 1122345688999999999998999999999999999999999999974332 11112222221
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA----DVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~----eil~~ 317 (351)
. ......+..+.++|.+||+.||.+||++. +++++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 213 L--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1 11222355789999999999999999984 65554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.26 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=194.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 109 (351)
...++|++.+.||+|+||.||++.+. .++.+++|++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 44689999999999999999999954 6888999998643 223345677899999999999999999977543
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..++||+|+.+ +|...+. ..++...++.++.|++.||+|||++ +++|+||||+||+++.++.++|
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 167 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 167 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEE
Confidence 34699999965 6666652 2477889999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...+............. .
T Consensus 168 ~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~ 243 (364)
T cd07875 168 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG-T 243 (364)
T ss_pred EeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-C
Confidence 9999987543321 22334678899999999999999999999999999999999999976543111000000000 0
Q ss_pred cchh-------HHHhh---------------cCccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDRE-------KILEI---------------MDPAL---EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~-------~~~~~---------------~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... .+... ..... ...........+.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00000 00000 000011123468899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=276.11 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
.++|++.+.||.|++|.||+|... +++.+++|.+..........+.+|+.+++.++|||++++++++.+.. .+++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999954 57889999987665556678899999999999999999999887665 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ..++...++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999885431 4688999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCceecccCCCcccccccccccC---CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+. ....
T Consensus 153 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----------------~~~~ 214 (262)
T cd06613 153 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----------------RALF 214 (262)
T ss_pred hhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHH
Confidence 321 112334567789999998766 7889999999999999999999999643321 1111
Q ss_pred hhcCc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDP---ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ..........+..+.+++.+||..+|.+|||+.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 215 LISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111 00111223345679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=293.76 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=194.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||++... +++.+|+|++... .......+..|..++..++|++|+++++.+.+.. .++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999954 6889999998632 2233456788999999999999999999888765 46999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 81 EFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred eCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 999999999998432 3688999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCC---------------------------------ceecccCCCcccccccccccCCCCCccceeehHHHHHHHH
Q 018744 196 GSDKAGG---------------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 242 (351)
Q Consensus 196 ~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~ll 242 (351)
....... .......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 4221100 0011346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc--cccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 018744 243 TGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPL---MADVVQS 317 (351)
Q Consensus 243 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~eil~~ 317 (351)
+|..||....+. .....+... .+...........+.+||.+|+. ||.+|++ +.++++|
T Consensus 231 tG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 231 IGYPPFCSETPQ----------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred cCCCCCCCCCHH----------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 999999754431 111111111 11000011123467888888775 9999995 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.69 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=196.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC---------------CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN---------------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALL 103 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~---------------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 103 (351)
.++|++.+.||+|+||.||++.... ...+++|.+..... .....+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987532 23488998864322 2235688899999999999999999
Q ss_pred EEEEcC-CeEEEEEEccCCChhhhccccCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 104 GYCSDR-RKLLVYDYMANGGLQEHLYPANGS-----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 104 ~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
+++... ..+++|+|+.+++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||+|+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 988765 456999999999999988543210 01112468899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh--CCCCCCCCCCCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPSG 255 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt--g~~pf~~~~~~~ 255 (351)
+++.++.++|+|||++................++..|+|||.+.++.++.++||||||+++|+|++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433221112223344668999999988889999999999999999998 667775322110
Q ss_pred CcceeecccccccchhHHHhhcC---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 256 EGVLVSWALPRLTDREKILEIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.......... .......+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus 241 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 -------------VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -------------HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0000000000 000011112234579999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.11 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=197.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
.+.|++.+.||.|++|.||+|... ++..+++|.+..........+..|+.+++.++|+|++++++.+..+ ..++||+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 477999999999999999999964 5889999998765555556788899999999999999999987655 45699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|..++.... ..+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 91 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999988774322 3588999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... .......++..|+|||++. ...++.++|||||||++|+|++|..||....+. ..
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~ 223 (292)
T cd06644 162 KTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RV 223 (292)
T ss_pred ccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----------------HH
Confidence 221 1123345678899999885 345678999999999999999999998643321 11
Q ss_pred HHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......... ....+......+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111100 011122334468899999999999999999999886
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.72 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=200.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 111 (351)
.++|++.+.||.|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|||++++++++... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 467889998864322 2235688899999999999999999988766 45
Q ss_pred EEEEEEccCCChhhhccccCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 112 LLVYDYMANGGLQEHLYPANGS---------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
+++++|+.+++|.+++...... ......+++..++.++.|++.||.+||++ +++|+||+|.|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 6999999999999998643211 11123578899999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSG 255 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 255 (351)
|+++.++.++|+|||.+.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875433221111222334557999999988889999999999999999998 88888533211
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.....+.+... ...+...+..+.+|+.+||+.+|++|||+.|++..|++
T Consensus 240 ---------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ---------------EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---------------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111111 11122334579999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=308.86 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=204.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+++++.++||||+++++++.+.+ .+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999965 6889999998643222 2356788999999999999999999987764 45999
Q ss_pred EEccCCChhhhccccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 116 DYMANGGLQEHLYPANGSN----SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+|+++++|.+++....... .....++...++.++.||+.||+|||++ +++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886432111 1123567788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC----------------CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 192 LAKIGSDKAG----------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 192 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
++........ ........|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9876521110 001122468999999999999999999999999999999999999996532210
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhccCC
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~l~~~~~~~~~ 327 (351)
. . .................+..+.+++.+||..||++|| ++.++++.|+..+.....
T Consensus 239 i-----------~----~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 I-----------S----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred h-----------h----hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 0 0 0000000000000112334688999999999999996 567788888888775443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.34 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=197.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC------
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR------ 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------ 109 (351)
.+.+.|++.+.||.|+||.||+|... +++.+++|.+... ......+..|+.+++.+ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46688999999999999999999954 6888999998644 33456778899999998 699999999988642
Q ss_pred -CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
..+++++|+.+++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 3469999999999999985432 23688999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
|||++....... .......++..|+|||++. +..++.++|||||||++|+|++|..||....+.
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--------- 222 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--------- 222 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---------
Confidence 999987643322 1123355788899999886 335788999999999999999999999643221
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...................+..+.+|+.+||..+|.+|||+.+++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 223 -------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -------HHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00011111111111111233468999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=274.53 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=194.3
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCChh
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQ 124 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L~ 124 (351)
+.||.|++|.||++.+..++.+++|.+...... ....+..|+++++.++|+||+++++++.+.. .+++++++.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766899999988654333 3457888999999999999999999887664 56999999999999
Q ss_pred hhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCce
Q 018744 125 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 204 (351)
Q Consensus 125 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 204 (351)
+++.... ..++...++.++.+++.+|.+||++ +++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 81 TFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 9885322 3578899999999999999999999 999999999999999999999999999875432211111
Q ss_pred ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......+..|+|||.+.+..++.++||||||+++|+|++ |..||...... ............
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----------------~~~~~~~~~~~~ 214 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------QTRERIESGYRM 214 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----------------HHHHHHhcCCCC
Confidence 112223456999999988889999999999999999999 88888654321 111111111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 222334557999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.12 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=204.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEcc--ccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcCCeE-E
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRRKL-L 113 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~-~ 113 (351)
+....|++.+.||+||.+.||++...+.+.+++|.+. ..+.+...-+..|+.+|.+++ |.+|+.+++|-..++.+ +
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3457799999999999999999997777778887654 445566788999999999995 89999999998766554 6
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|||+- ..+|...+.+..+ -++...+..+..||+.|+.++|.+ ||||.||||.|+|+ -.|.+||+|||++
T Consensus 438 vmE~G-d~DL~kiL~k~~~------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA 506 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIA 506 (677)
T ss_pred Eeecc-cccHHHHHHhccC------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechh
Confidence 77765 5589999976653 234348889999999999999999 99999999999988 4569999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccC-----------CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
..............++||+.||+||.+... ..++++|||||||+||+|+.|+.||..-..
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------- 577 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------- 577 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence 988887777778889999999999998632 256899999999999999999999962111
Q ss_pred ccccccchhHHHhhcCccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+..+.++.-.-+++.- ....+.+++..||..||++|||..++|++
T Consensus 578 ------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12345566666443333321 11239999999999999999999999987
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=283.74 Aligned_cols=258 Identities=26% Similarity=0.333 Sum_probs=201.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|++|.||+|... +++.+++|.+...... ....+..|+++++.++|+||+++++.+.... .++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999955 5899999998654322 3356788999999999999999999887664 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 81 DYCPGGELFRLLQRQP-----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EecCCCCHHHHHHhCC-----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 9999999999885322 24689999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCc---------------------------eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCC
Q 018744 196 GSDKAGGH---------------------------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248 (351)
Q Consensus 196 ~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf 248 (351)
........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 43221100 011235678899999999888999999999999999999999999
Q ss_pred CCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHHHHHhhhc
Q 018744 249 DVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL----MADVVQSLVPLVKY 324 (351)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt----~~eil~~l~~~~~~ 324 (351)
...+.. ...................+..+.+++.+||..+|++||| +.+++.+ .+++.
T Consensus 233 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~--~~~~~ 294 (316)
T cd05574 233 KGSNRD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH--PFFRG 294 (316)
T ss_pred CCCchH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC--chhhc
Confidence 754421 1122222222211111224567999999999999999999 7888775 34443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.28 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=208.0
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|.+.+.||.|-||.||+|+ .+++-.+++|++... ......++++|+++-..++||||++++++|.++.. |+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 669999999999999999999 557888999998643 23345678999999999999999999999988855 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||...|.+...+.... ...+++...+.++.|++.|+.|+|.. +++||||||+|+|++.++.++++|||.+..
T Consensus 102 Eya~~gel~k~L~~~~-----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EecCCchHHHHHHhcc-----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999996433 34688899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.+. ......+||..|.+||...+..++...|+|++|++.||++.|..||.... .......
T Consensus 174 ~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----------------~~etYkr 233 (281)
T KOG0580|consen 174 APS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----------------HSETYKR 233 (281)
T ss_pred cCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----------------hHHHHHH
Confidence 432 23456789999999999999999999999999999999999999997432 1223333
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+..-.+ .++........+||..|+..+|.+|.+..|++.+=
T Consensus 234 I~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 234 IRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 332222 23344556789999999999999999999999873
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=275.61 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=195.9
Q ss_pred ceeeecCceEEEEEEEcC--C--cEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLSN--G--RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~--~--~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~ 121 (351)
+.||+|++|.||+|.+.+ + ..+++|.+..... ...+.+..|+..+++++|+||+++++++.+...+++++++.++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999998543 3 2589999876544 4456788999999999999999999998885566999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++..... ..+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 81 SLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999854321 3689999999999999999999999 999999999999999999999999999887544222
Q ss_pred Cc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 202 GH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 202 ~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+...
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~~~~~~~~~~ 216 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----------------SQILKKIDKE 216 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhc
Confidence 11 1122345678999999988889999999999999999998 9999853321 1111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111122234467999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=280.48 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=196.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.|++.+.||+|+||.||++.+. +++.+++|.+...... ....+..|+.+++.++|++++++++.+.+.+ .+++++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999954 6889999988643222 2245667999999999999999999887654 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~g~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 81 LMNGGDLKFHIYHMG-----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred ecCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999998885432 13588999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-------------~~~~~~~~~ 216 (285)
T cd05630 153 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-------------IKREEVERL 216 (285)
T ss_pred CCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-------------chHHHHHhh
Confidence 3221 122346888999999999888999999999999999999999999753321 001111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
... ....++......+.+|+.+||+.||++||| +.+++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 217 VKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111 111122233456899999999999999999 8899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.32 Aligned_cols=241 Identities=28% Similarity=0.401 Sum_probs=187.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhc-cCCCcceeeeEEEEcCCe-EEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGR-LRSPYLLALLGYCSDRRK-LLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~-~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+|+|++.... ......+..|..++.. ++||||+++++++.+... ++||+|+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999986431 2233445667777775 489999999999877654 599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
|+|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 81 GDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence 9999988432 3688899999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~i~~~- 211 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----------------ELFQSIRMD- 211 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC-
Confidence 1223456888999999999888999999999999999999999999753321 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~ 317 (351)
...++......+.+++.+||+.||++||++. +++++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 212 -NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 0112222345688999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.62 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=196.9
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++||||+++++.+... ..+++++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46899999999999999999995 46889999998765444556678899999999999999999988765 45599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 88 CGGGSLQDIYHV-------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred cCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999998843 23689999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
... .......++..|+|||.+. ...++.++|+|||||++|+|++|..||....+........ ..
T Consensus 158 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-----------~~ 224 (267)
T cd06645 158 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-----------KS 224 (267)
T ss_pred Ccc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-----------cc
Confidence 321 1123456788999999874 4568889999999999999999999985433210000000 00
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+.... ....+..+.+++.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000000 01123468899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=277.44 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=199.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CC---cEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v 114 (351)
++|+..+.||+|++|.||+|... ++ ..+++|.+.... ......+..|+++++.++|+|++++.+++... ..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 57888999999999999999954 33 368889886442 22345678899999999999999999988765 45699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+++.+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 85 TEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999985322 3688999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceec-ccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 195 IGSDKAGGHVST-RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 195 ~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
............ ....+..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----------------~~~ 219 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----------------HEV 219 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----------------HHH
Confidence 654322111111 1122346999999988889999999999999999998 9999853321 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
...+. ...........+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 220 ~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 220 MKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11111 11111222234457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=284.09 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=197.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||+|+||.||++.+. ++..+++|.+..... .....+.+|+++++.++||||+++++.+.... .+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999954 678889898764322 22355778999999999999999999887654 5599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
+.+++|.+++... ..+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 81 MDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 9999999998432 468899999999999999999997 6 8999999999999999999999999988653
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc---------
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL--------- 267 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------- 267 (351)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+...............
T Consensus 151 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 151 IDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 222 1233467889999999988889999999999999999999999996543211100000000000
Q ss_pred -----------cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 -----------TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........................++.+|+.+||..+|++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111111100000001234568999999999999999999999988
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=286.73 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=190.7
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|... +++.+++|++.... ......+..|..++..+ +|++|+.+++++.... .++||+|+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 67889999986432 22345577899998888 6999999999887665 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~-------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 81 GDLMFHMQR-------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG 150 (327)
T ss_pred CcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence 999888743 23689999999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH-HhhcCc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI-LEIMDP 279 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 279 (351)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~----------~~~~~~~~~~~~~ 218 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM----------NTEDYLFQVILEK 218 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc----------ccHHHHHHHHHhC
Confidence 1223456899999999999999999999999999999999999999643321110 001111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 317 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~~ 317 (351)
.. ..+...+..+.+++.+||+.||++|+++ .++++|
T Consensus 219 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 219 PI--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11 1222334568899999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=276.21 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=196.8
Q ss_pred CCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC------ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
+|++.+.||.|+||.||+|...+++.+++|.+...... ....+.+|+++++.++|+||+++++++.+.. .+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58899999999999999999878899999988643221 1245778999999999999999999987765 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++... ..+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 81 MEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 9999999999998432 3578999999999999999999999 99999999999999999999999999887
Q ss_pred ccCCCCC----CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 195 IGSDKAG----GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 195 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
....... ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------------- 214 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---------------- 214 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----------------
Confidence 5422111 11122345788899999999888999999999999999999999999643221
Q ss_pred hHHHhhcCc-cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......... ......+......+.++|.+||+.+|++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 215 AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000010000 01111222344568999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.94 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=187.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. ++..+|+|.+.... ......+..|..++... +||+|+++++++.+.. .++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999986431 22344556677777654 8999999999887765 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 g~L~~~i~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 149 (316)
T cd05620 81 GDLMFHIQD-------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG- 149 (316)
T ss_pred CcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-
Confidence 999988843 23688999999999999999999999 9999999999999999999999999998643211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----------------~~~~~~~~~~ 212 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----------------ELFESIRVDT 212 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCC
Confidence 11223456899999999999999999999999999999999999999754321 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~ 317 (351)
..++......+.+||.+||+.||++||++. ++++|
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 213 --PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 111222344688999999999999999985 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=285.26 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=211.5
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccC-CCcceeeeEEEEcCCe
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLR-SPYLLALLGYCSDRRK 111 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 111 (351)
......|++.+.||.|.||.||++... +|+.+|+|.+...... +...+.+|+.+|+.++ ||||+.+.+++++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345578999999999999999999965 5999999999754332 3468899999999998 9999999999998865
Q ss_pred E-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC----CCcEE
Q 018744 112 L-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----NFHAK 186 (351)
Q Consensus 112 ~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~----~~~v~ 186 (351)
+ +|||++.||.|.+.+... .+++..+..++.|++.++.|||+. |++|+||||+|+|+.. ++.++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEE
Confidence 4 999999999999999543 289999999999999999999999 9999999999999943 35799
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++|||++..... .......+||+.|+|||++....|+...||||+|+++|.|++|..||.+....
T Consensus 180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~------------ 244 (382)
T KOG0032|consen 180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF------------ 244 (382)
T ss_pred EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh------------
Confidence 999999987655 44567789999999999999999999999999999999999999999865532
Q ss_pred ccchhHHHhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+.... +...+-......+.+||+.|+..||.+|+|+.++|+|
T Consensus 245 ----~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 245 ----EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2222222222 2333334556789999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=303.25 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=218.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-C---CcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-E
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-N---GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-L 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~---~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~ 113 (351)
.+...|.+.||.|.||.|++|+.+ . ...||||.++.-. +..+..|..|+.++-++.||||+.+.++......+ +
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 355678999999999999999944 2 3568999997443 33456799999999999999999999999888766 9
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|+|||++|+|+.|+.+.. +++...++..|++.|+.|+.||-+. +++||||..+||||+.+..+|++|||++
T Consensus 708 iTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999996544 4688899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCC--CcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 194 KIGSDKAGGHVSTRVLG--TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+.++... ....+...| ..+|+|||.+....++.++||||+|++|||.++ |..||=... +.
T Consensus 779 Rvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQ 841 (996)
T KOG0196|consen 779 RVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQ 841 (996)
T ss_pred eecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hH
Confidence 9765544 121222222 348999999999999999999999999999877 999985322 23
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
. +-+-+++..+-+.+++++..|.+|+..||+.|-.+||.+.+|+.+|++++.+-..
T Consensus 842 d-VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 842 D-VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred H-HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 3 3344555566677889999999999999999999999999999999999986433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.32 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=189.2
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhcc---CCCcceeeeEEEEcC------
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL---RSPYLLALLGYCSDR------ 109 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~------ 109 (351)
+|++.+.||+|++|.||+|.+. +++.+++|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999954 688999998864322 1223455677766655 699999999987542
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..+++++++.+ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 24699999875 7888774332 23589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||................. ...
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~ 227 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPP 227 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCC
Confidence 99987643322 12234578889999999988899999999999999999999999965432110000000000 000
Q ss_pred hhHHH-------hhcCcccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKIL-------EIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~-------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ....+... ..........+.+|+.+||+.||++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00000000 00011223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=272.68 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=201.6
Q ss_pred hcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
.++|.+-..||.|.|+.|+++. ..+|+.+++|++..+ ...+.+.+.+|+.+-+.++||||+.+++.+.+. -.++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4679999999999999999988 557999999987533 233567889999999999999999999977665 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC---CCCcEEEeeccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGL 192 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~---~~~~v~l~dfg~ 192 (351)
+.++|+.|..-+.+.. -+++..+-.+++||+++|.|+|.+ +|+|||+||+|+++. ...-+||+|||+
T Consensus 90 e~m~G~dl~~eIV~R~-------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE-------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred ecccchHHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 9999999877775432 477888999999999999999999 999999999999994 345699999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+..+. ....-....||+.|+|||++...+|+.++|||+.|+++|-|+.|+.||.+.+. ..
T Consensus 160 Ai~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------------~r 219 (355)
T KOG0033|consen 160 AIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HR 219 (355)
T ss_pred EEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------------HH
Confidence 98765 23345567899999999999999999999999999999999999999975432 12
Q ss_pred HH-hhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 IL-EIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~-~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+. .+..... ..++-+...++..+|+++||..||.+|+|+.|.|.|
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 22 2222111 122223445678999999999999999999998865
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=285.95 Aligned_cols=237 Identities=27% Similarity=0.351 Sum_probs=183.3
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHH-HHHHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKME-VELLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|++. +++.+++|++.... ......+..| ..+++.++|+||+++++++...+ .++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57789999986432 1122233333 34567789999999999887665 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~ 150 (325)
T cd05602 81 GELFYHLQR-------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150 (325)
T ss_pred CcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence 999998843 23578889999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~~ 212 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNILNKP 212 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----------------HHHHHHHhCC
Confidence 1223456889999999999999999999999999999999999999643321 1112222211
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 313 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e 313 (351)
. .........+.+++.+||+.||.+||++.+
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 213 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred c--CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1 112233456899999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.39 Aligned_cols=250 Identities=31% Similarity=0.510 Sum_probs=195.6
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChH--HHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
|++++.||+|+||.||++... +++.+|+|++......... ....|+.+++.++|+||+++++++.+.. .+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678999999999999999965 5668999998654332222 2345899999999999999999997664 55999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++. ....++...++.++.|+++||.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-- 148 (260)
T PF00069_consen 81 PGGSLQDYLQ-------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-- 148 (260)
T ss_dssp TTEBHHHHHH-------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--
T ss_pred cccccccccc-------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--
Confidence 9999999995 224689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
...........++..|+|||++. +..++.++||||||+++|+|++|..||..... ...........
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-------------~~~~~~~~~~~ 215 (260)
T PF00069_consen 149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-------------DDQLEIIEKIL 215 (260)
T ss_dssp TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-------------HHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------------hhhhhhhhhcc
Confidence 11223345566788999999998 78899999999999999999999999974310 00011111111
Q ss_pred CccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......... ......+.+++..||+.||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110110 0112679999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=276.67 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=199.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-C---CcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-N---GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~---~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. + +..+++|.+.... ......+..|+.+++.++||||+++++++..++ .++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 367899999999999999999853 2 3368899875432 122356788999999999999999999887654 458
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++|+.+++|.+++.... ..+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 999999999999985332 3588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCcee-cccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 194 KIGSDKAGGHVS-TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 194 ~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
............ ....++..|+|||.+.+..++.++|+|||||++|++++ |..||...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----------------~ 217 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----------------D 217 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----------------H
Confidence 765432211111 11222457999999998889999999999999999887 99998643321 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
....+.+ ......+...+..+.+++.+||+.+|.+|||+.++++.|.+++
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 218 VIKAIEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 1111111 1111222234557899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=278.20 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=198.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+..|+.+++.++|+|++++.+++.+.. .++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999954 68899999986543 233456788999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.. ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 81 CGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999842 2688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+. .....+.
T Consensus 150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----------------~~~~~~~ 211 (274)
T cd06609 150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----------------RVLFLIP 211 (274)
T ss_pred ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----------------HHHHHhh
Confidence 432 1223345777899999999888999999999999999999999999643321 0011111
Q ss_pred CccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... .+..+.+++.+||..+|++|||+.+++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 -KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111111 44568999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.20 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=194.2
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC------eE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------KL 112 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 112 (351)
+|++.+.||+|+||.||++.+ .+++.+|+|.+... .......+.+|+++++.++|+||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478999999999999999995 47899999988643 2223456788999999999999999999887654 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|++|+. ++|.+.+.. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-------PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 8888886 577777632 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch-
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR- 270 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 270 (351)
+........ .......++..|+|||++.+. .++.++|||||||++|+|++|..||....+.................
T Consensus 150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 876433221 122334568889999998764 57899999999999999999999997654321111000000000000
Q ss_pred ------hHHHhhcCccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 ------EKILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ------~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+....... .........+.+||.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 0111124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.73 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=194.8
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC----
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---- 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 109 (351)
....++|++.+.||+|+||.||++.+. .++.+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 345689999999999999999999954 68899999886432 22335677899999999999999999987543
Q ss_pred ---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 110 ---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 110 ---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
..+++|+|+.+ ++...+. ..++...++.++.|++.||.|||++ +++|+||||+||+++.++.++
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEE
Confidence 24699999976 5655552 2478889999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+.+..............
T Consensus 160 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987543321 223356788999999999889999999999999999999999999764421100000000000
Q ss_pred -c-cc----hhHHHhhcCc---------------c-c--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 -L-TD----REKILEIMDP---------------A-L--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 -~-~~----~~~~~~~~~~---------------~-~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. .. ........+. . . ...........+.+||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00 0000000000 0 0 000111123468899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=284.84 Aligned_cols=236 Identities=27% Similarity=0.369 Sum_probs=182.7
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHH-HHHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEV-ELLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|.+. +++.+++|++.... ......+..|. .+++.++||||+++++++.+.+ .++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986321 12223344444 4678889999999999887664 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|...+.. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 81 GELFFHLQR-------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150 (321)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence 999887732 24688899999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+. ......+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~i~~~~ 212 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----------------SQMYDNILHKP 212 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----------------HHHHHHHhcCC
Confidence 122345688999999999988899999999999999999999999965331 11111222211
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 312 (351)
. ..+......+.+++.+||+.||.+||++.
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 22223445788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=282.27 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=193.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||++... +++.+++|++... .......+..|..++..++|++|+++++.+.+.. .++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999954 5788999998532 2223345778999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+|+|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999995432 3688999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
..... ........|+..|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---------------- 214 (332)
T cd05623 152 LMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------- 214 (332)
T ss_pred cccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----------------
Confidence 32221 11223356899999999986 346789999999999999999999999754321
Q ss_pred hHHHhhcCccccCCCC---HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
.....+........++ ......+.+|+.+|+..++++ |+++.+++++
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111222111111111 123457888999988665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=278.40 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=205.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-----CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEc--C-Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~~ 111 (351)
..|++.+.||+|+||.||+|.+. ++..+++|.+...... ....+.+|+++++.++|+||+++++++.. . ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56888999999999999999843 3678999998754332 35678899999999999999999998876 2 35
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++|+.+++|.+++.... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 69999999999999985322 2589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
.+........... .....++..|+|||.+.+..++.++|||||||++|+|++|..||............. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~ 232 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIV 232 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccH
Confidence 9887543221111 112234456999999988889999999999999999999999986433221100000 0000111
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
....+.+........+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222222222222334446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=274.24 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
.++|++.+.||.|++|.||+|.+. +++.+++|.+..... ...+.+|+++++.++|+|++++++.+... ..++++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 368999999999999999999965 478999999864422 67889999999999999999999988766 45599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 80 CGAGSVSDIMKIT------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred CCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999998432 24689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||++.+..++.++||||||+++|+|++|..||....+.. ......
T Consensus 151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----------------~~~~~~ 212 (256)
T cd06612 151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------------AIFMIP 212 (256)
T ss_pred cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----------------hhhhhc
Confidence 3321 1233446778999999988889999999999999999999999997533211 000100
Q ss_pred Cc-cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ......+......+.+++.+||+.+|++|||+.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 00011122334578999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=273.42 Aligned_cols=249 Identities=21% Similarity=0.375 Sum_probs=198.7
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC--eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~v~~ 116 (351)
+|++.+.||.|++|.||.+.+. +++.+++|.+..... ...+.+..|+++++.++|+|++++.+.+...+ .+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999954 578899999864322 23456788999999999999999998876433 469999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.... ...+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 81 FCEGGDLYHKLKEQK-----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ccCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999885422 23589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...+. ......+
T Consensus 153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----------------~~~~~~~ 214 (257)
T cd08223 153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----------------NSLVYRI 214 (257)
T ss_pred cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHH
Confidence 3322 122345578899999999988899999999999999999999999864321 1111112
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+ ...+......+.+++.+||+.+|++|||+.+++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 215 IEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111 12233445679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=310.56 Aligned_cols=259 Identities=19% Similarity=0.318 Sum_probs=196.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--- 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 109 (351)
.....++|++.+.||.|+||.||+|.+. ++..+++|++.... ......+..|+.++..++||||+++++++...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445688999999999999999999954 57788999886432 22345688899999999999999999987543
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----CCCceecCCCCCcEEeCC----
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----SPPVIHRDFKSSNILLDK---- 181 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----~~~i~H~di~p~Nilv~~---- 181 (351)
..++||+|+.+++|.+++..... ....+++..++.|+.||+.||.|||+.. ..+|+|+||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 34699999999999999854321 2246899999999999999999999851 025999999999999954
Q ss_pred -------------CCcEEEeecccccccCCCCCCceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCC
Q 018744 182 -------------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRV 246 (351)
Q Consensus 182 -------------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~ 246 (351)
.+.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999987543321 1234568999999999864 457899999999999999999999
Q ss_pred CCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
||...... ..+...+....... ....+..+.+||..||..+|.+|||+.+++.+
T Consensus 242 PF~~~~~~----------------~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 242 PFHKANNF----------------SQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCcCCcH----------------HHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99643211 11111111111000 11224578999999999999999999999975
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=273.36 Aligned_cols=250 Identities=29% Similarity=0.475 Sum_probs=197.1
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
.+|++.+.||.|++|.||++.+.++..+++|.+... ......+..|+++++.++||+++++++++.... .+++++|+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 578999999999999999999777788999988643 334567888999999999999999999887654 459999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ..+++..++.++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 83 HGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999998884322 3578999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||..... ......+..
T Consensus 154 ~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~~~~ 216 (256)
T cd05112 154 QYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----------------SEVVETINA 216 (256)
T ss_pred ccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----------------HHHHHHHhC
Confidence 111 1112224457999999988889999999999999999998 9999864331 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
......+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 217 -~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 -GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111111111235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=274.94 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=194.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-----CChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
.+|++.+.||+|++|.||+|... ++..+++|.+..... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999954 688999998753321 1224577899999999999999999987653 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++|+.+++|.+++... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 5899999999999998432 3578899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++.......... ......++..|+|||.+.+..++.++|||||||++|+|++|..||..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------------~ 215 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------------M 215 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----------------H
Confidence 987543321111 11224477889999999888899999999999999999999999964321 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+............+......+.+++ +||..+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 216 AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 112222211112233333445677787 6777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=278.12 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=195.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
.|++.+.||.|++|.||++... ++..+++|.+..........+.+|+++++.++|+|++++++++.... .+++++|+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3788999999999999999955 57788889886554444567788999999999999999999887664 459999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|..++... ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~~~l~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 86 GGAVDAVMLEL------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred CCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 99998887432 23689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 200 AGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
. .......++..|+|||++. +..++.++|||||||++|+|++|..||....+ .....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----------------~~~~~ 218 (282)
T cd06643 157 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----------------MRVLL 218 (282)
T ss_pred c--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----------------HHHHH
Confidence 1 1123345788999999874 34577899999999999999999999864322 11111
Q ss_pred hhcCcc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... .....+...+..+.+||.+||+.+|++|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111100 0011122234578999999999999999999999877
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=284.40 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=192.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccC-CCcceeeeEEEEcCC-eEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+|.+.+.||+|+||.||+|... +++.||+|++... .......+..|..++..+. |++|+++.+++...+ .++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999954 6889999998643 1223355677888888885 567788888877665 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|..++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 81 EYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999888432 3689999999999999999999999 999999999999999999999999999874
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~~~~~ 212 (323)
T cd05615 151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----------------DELFQS 212 (323)
T ss_pred cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 32211 112334588999999999988899999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
+..... .++......+.+++.+||+.+|.+|++. .+++++
T Consensus 213 i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 213 IMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 222111 2222334578899999999999999984 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=282.91 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=194.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++++++..+. .++|++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999954 678899998864322 23345678999999999999999999987664 5599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+ +|.+++.... ..++...+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++....
T Consensus 86 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 875 7777764322 3578899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc--------ccc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------RLT 268 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~~~ 268 (351)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||................. ...
T Consensus 156 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 156 VPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred CCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 322 11223456888999998865 4678999999999999999999999976543211000000000 000
Q ss_pred chhHHHhhcCccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALEG----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........-.+.... ........++.+||.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000000 0001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=290.45 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=216.1
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc---CCc--EEEEEEccc-cCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS---NGR--KVAIKLMDQ-AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~--~~~vk~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
.....+..+..+.||.|.||.||.|.+- .|+ .||||.-+. ......+.|..|+.+++++.||||++++++|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 3445566778889999999999999832 333 467777665 3344567899999999999999999999999999
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..++|||.+..|-|..++.... ..++..+...+++||+.||+|||+. +++||||..+||||...-.|||+|
T Consensus 464 P~WivmEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 9999999999999999996543 4688899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||+++........... ...-...|+|||.+.-..++.++|||.||+++||++. |..||.+-.+.
T Consensus 535 FGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------------- 599 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------------- 599 (974)
T ss_pred cchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------------
Confidence 9999987665433322 2233457999999999999999999999999999888 99999764432
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
++--.++..-+.+.++.++..|+.|+.+||..+|.+||++.++...|.+++.
T Consensus 600 ---DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 ---DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111223333446677888899999999999999999999999999988887
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=278.67 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=201.7
Q ss_pred eeHHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
..++.+..+.++|++.+.||+|++|.||++... +++.+++|++... ......+..|+.+++.+ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445677778899999999999999999999854 6788999987542 22235677899999999 69999999998732
Q ss_pred ------CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 109 ------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 109 ------~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
...+++|+|+++++|.+++.... .....+++..++.++.|++.||.|||+. +++|+||+|+||+++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh---ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 23579999999999998875321 1224688999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+.++|+|||++....... .......++..|+|||++.. ..++.++|||||||++|+|++|..||....+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred CCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 999999999987643321 12233457889999998753 4578899999999999999999999865432110
Q ss_pred ceeecccccccchhHHHhhcCcc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 258 VLVSWALPRLTDREKILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
........ .....+......+.+|+.+||+.+|++|||+.+++++.
T Consensus 238 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 ---------------LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---------------HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000 00001111234688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.87 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=192.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+++.. +++.+|+|++... .......+..|..++..++|+||+++++++.+.. .++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999954 6889999998632 2233456788999999999999999999887765 55999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|.+++... ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 999999999998532 23688999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---------------- 214 (331)
T cd05597 152 LLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------- 214 (331)
T ss_pred cCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----------------
Confidence 433211 11223458899999999863 45788999999999999999999999653321
Q ss_pred hHHHhhcCccccCCC---CHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEAD--YRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~P~--~Rpt~~eil~~ 317 (351)
.....+......... ....+..+.+|+.+||..+++ .|+++.+++++
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111111000001 112345688899998865444 37899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=279.59 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=199.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
.++|++.+.||.|++|.||++.+. ++..+++|.+..........+..|+++++.++|+|++++++++.... .++|++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999954 68899999987654445567888999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999885432 3689999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... .......++..|+|||.+. ...++.++||||||+++|+|++|..||...... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----------------~~ 216 (280)
T cd06611 155 STL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----------------RV 216 (280)
T ss_pred ccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----------------HH
Confidence 321 1122345788899999875 334678999999999999999999999754321 11
Q ss_pred HHhhcCcc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+.... .....+......+.+++..||+.+|.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111110 0001122334568899999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=277.55 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=195.3
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.|+..+.||.|+||.||.+.+ .+++.+++|.+.... ......+.+|+++++.++|++++.+.+.+..++ .+++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999995 468899999885432 122345677999999999999999998877664 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|..++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 81 IMNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred eccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999998885432 23689999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+...
T Consensus 153 ~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-------------~~~~~~~~~ 216 (285)
T cd05632 153 PEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-------------VKREEVDRR 216 (285)
T ss_pred CCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHHh
Confidence 3221 112346788999999998888999999999999999999999999743321 000111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
.... ...+.......+.+|+..||+.||++||| +.+++.+
T Consensus 217 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 217 VLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred hhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1000 11122233456889999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=285.55 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=183.4
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHH-HHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVE-LLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|... +|+.+++|++.... ......+..|.. +++.++||||+++++++...+ .++||+|+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999954 68899999986431 222233444444 567789999999999887664 5599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|...+.. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 81 GELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150 (325)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence 999888743 24689999999999999999999999 99999999999999999999999999986432211
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~~~~~~ 212 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----------------EMYDNILHKP 212 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 1223456889999999999999999999999999999999999999654321 1112222221
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 312 (351)
+ .........+.+++.+||..+|.+||++.
T Consensus 213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 213 L--VLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred c--cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 1 11122345688999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=280.76 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=193.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+++.. +++.+|+|++... .......+..|..++..++|++|+.+++++.+.+ .++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 6788999988532 1223345778899999999999999999988765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred eCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999995422 3688899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
...... .......|+..|+|||++.+ +.++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------------- 214 (331)
T cd05624 152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------- 214 (331)
T ss_pred ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------------
Confidence 433221 11233568999999999875 46788999999999999999999999643321
Q ss_pred hHHHhhcCccccCCCC---HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
.....+........++ ...+..+.+++.+||...+.+ |+++.+++++
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111111111101111 123457889999999866544 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=275.38 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=194.0
Q ss_pred ceeeecCceEEEEEEEcC-------CcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 47 NVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~-------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
+.||.|++|.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++... ..+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2578889875432 23356788899999999999999999988765 45699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-----cEEEeeccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-----HAKVSDFGL 192 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-----~v~l~dfg~ 192 (351)
+.+++|.+++............+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865432211234578899999999999999999999 999999999999998877 899999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+................++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----------------~ 220 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------------Q 220 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----------------H
Confidence 875433222122223345678999999998899999999999999999998 9999863321 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.....+........+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111111222334567899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=276.27 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=199.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 112 (351)
++|++.+.||.|+||.||+|+.. ..+.+++|.+...... ....+..|++++++++|+|++++++++.+. ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67999999999999999999953 2456888987654332 346788899999999999999999998775 456
Q ss_pred EEEEEccCCChhhhccccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 113 LVYDYMANGGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
++++|+.+++|.+++...... ......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644311 11122689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|.+....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---------------- 224 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---------------- 224 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----------------
Confidence 9876432211 111122344567999999988888999999999999999999 8888853221
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
...........+........+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111222112222222234457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.55 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=196.8
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-----CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-----QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
+|+..+.||+|++|.||+|... +++.+++|.+..... .....+..|+.+++.++|+|++++++++.+.. .+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999965 788999998864332 23456888999999999999999999887764 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++.. ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 81 LELVPGGSLAKLLKK-------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred EEecCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccce
Confidence 999999999999843 23588999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCC-CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||...... ...
T Consensus 151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----------------~~~ 211 (258)
T cd06632 151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----------------AAV 211 (258)
T ss_pred eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----------------HHH
Confidence 643322 223455778899999987766 899999999999999999999999643210 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............+......+.+++.+||+.+|++|||+.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 212 FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11111011112222334578899999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=276.04 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=198.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-----
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR----- 110 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----- 110 (351)
.+.++|++.+.||.|++|.||+|... +++.+++|++.... .....+..|+.+++.+ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999964 67889999886543 3446788999999999 6999999999986543
Q ss_pred --eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 111 --KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 111 --~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
.+++++|+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 469999999999999885432 1124688999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
|||.+....... .......++..|+|||++.. ..++.++||||||+++|+|++|..||......
T Consensus 156 d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------- 224 (275)
T cd06608 156 DFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------- 224 (275)
T ss_pred CCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---------
Confidence 999987543321 11233457888999998753 34678899999999999999999999643211
Q ss_pred cccccchhHHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+..... ...........+.+|+.+||..||++|||+.+++++
T Consensus 225 -------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 -------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111111 111112244578999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.04 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=196.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-----CChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
++|++.+.||+|++|.||.+... ++..+++|.+..... .....+.+|+.+++.+.|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999954 688999998753221 1234678899999999999999999988653 24
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++|+.+++|.+++... ..+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence 4899999999999988432 3578889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
.+.......... ......++..|+|||.+.+..++.++|||||||++|+|++|..||..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------------~ 215 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----------------M 215 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----------------H
Confidence 887543321111 12234577889999999888889999999999999999999999963221 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+......+.+++.+||. +|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11222222222233344555678899999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.70 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=200.2
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~ 115 (351)
+|++.+.||.|++|.||++.+ .++..+++|.+..... .....+..|+.+++.++|+|++++++++... ..++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999984 4678899998864322 2335677899999999999999999977543 346999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-----EHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
+|+.+++|.+++.... ....++++..++.++.||+.||.+|| +. +++|+||+|+||+++.++.++|+||
T Consensus 81 e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 81 EYCEGGDLAQLIQKCK---KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred hhccCCCHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecc
Confidence 9999999999985532 12357899999999999999999999 77 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------- 215 (265)
T cd08217 155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----------------- 215 (265)
T ss_pred cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----------------
Confidence 99887544321 12334578899999999888899999999999999999999999974331
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+......+.+++.+||+.+|++|||+.+|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11111111111223334455679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.09 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=200.7
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 109 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 109 (351)
+..++..+.++|.+.+.||+|++|.||++.. .+++.+++|++... ......+..|+.+++.+ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3355556678999999999999999999995 46889999988543 22345677899999998 799999999987643
Q ss_pred ------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 110 ------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 110 ------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
..++|++|+.+++|.+++.... .....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLL---ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 3569999999999999885422 1224688999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccC-----CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 258 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 258 (351)
.++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|..||....+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---- 239 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---- 239 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----
Confidence 999999999876433221 12234577889999987643 3688999999999999999999999643321
Q ss_pred eeecccccccchhHHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 259 LVSWALPRLTDREKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..+..... ....+......+.+||.+||+.+|++||++.+++++
T Consensus 240 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 ------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111100 001122234468999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.51 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=200.2
Q ss_pred CCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
+|++.+.||.|++|.||.++ ..+++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+... +++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999998 4468889999876432 3334567889999999999999999999877654 589999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 81 ANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred cCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 99999999985432 23688999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+.
T Consensus 153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------------~~~~~~~~ 214 (256)
T cd08221 153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----------------LNLVVKIV 214 (256)
T ss_pred cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHH
Confidence 3321 22335578899999999888889999999999999999999999964332 11111222
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
..... ......+..+.+++.+||..+|++|||+.++++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 QGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 11233445789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=277.27 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=199.4
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEc-
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD- 108 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 108 (351)
+..++..+.+.|++.+.||.|+||.||+|.+ .+++.+++|++.... .....+..|+.++..+ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455666778999999999999999999995 468899999885432 3345677899999988 69999999998742
Q ss_pred ------CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 109 ------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 109 ------~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
...+++|+|+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 23469999999999999885432 23578889999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+.++|+|||++........ ......++..|+|||.+. +..++.++|||||||++|+|++|..||....+.
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--- 232 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--- 232 (282)
T ss_pred CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---
Confidence 9999999999875432211 122345788899999875 345788999999999999999999999643321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...................+..+.+||.+||+.||.+|||+.+++++
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 233 -------------RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -------------hhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00111111111111111234579999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=298.18 Aligned_cols=267 Identities=18% Similarity=0.270 Sum_probs=189.8
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCC------CcceeeeEEE
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS------PYLLALLGYC 106 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~ 106 (351)
+++....++|++.+.||+|+||.||+|.+. .++.||+|++.... .....+..|+.++..++| .+++.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344445688999999999999999999954 67889999985432 223445667777777654 4588888888
Q ss_pred EcC--CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCC
Q 018744 107 SDR--RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 107 ~~~--~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~ 183 (351)
... ..++|++++ +++|.+++... ..+++..++.++.||+.||.|||+ . +++|+||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 754 345777766 67888877432 368999999999999999999997 6 999999999999998665
Q ss_pred ----------------cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCC
Q 018744 184 ----------------HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247 (351)
Q Consensus 184 ----------------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~p 247 (351)
.+||+|||.+..... ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998753222 12345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcceeecccccccc-------hhHHHhhcCc--cccCCCC---------------HHHHHHHHHHHHhccCC
Q 018744 248 IDVNKPSGEGVLVSWALPRLTD-------REKILEIMDP--ALEGQYS---------------MKEVIQVAAIAAMCVQP 303 (351)
Q Consensus 248 f~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~--~~~~~~~---------------~~~~~~l~~li~~~l~~ 303 (351)
|.+................... ......+... .+..... ......+.+||.+||+.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9765432111000000000000 0000000000 0000000 01134578999999999
Q ss_pred CCCCCCCHHHHHHH
Q 018744 304 EADYRPLMADVVQS 317 (351)
Q Consensus 304 ~P~~Rpt~~eil~~ 317 (351)
||++|||+.|+++|
T Consensus 425 dP~~R~ta~e~L~H 438 (467)
T PTZ00284 425 DRQKRLNARQMTTH 438 (467)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=269.90 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=191.7
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCChh
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQ 124 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L~ 124 (351)
+.||.|++|.||+|...++..+++|.+...... ....+.+|+++++.++||||+++++++.... .+++++|+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999778889999988643322 2245778999999999999999999987764 45999999999999
Q ss_pred hhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCce
Q 018744 125 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 204 (351)
Q Consensus 125 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 204 (351)
+++.... ..+++..++.++.|++.+|.+||++ +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 150 (250)
T cd05085 81 SFLRKKK------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SS 150 (250)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-cc
Confidence 9884322 3578999999999999999999999 999999999999999999999999999865322211 11
Q ss_pred ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 205 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..... .......
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----------------~~~~~-~~~~~~~ 213 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----------------QAREQ-VEKGYRM 213 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHH-HHcCCCC
Confidence 111233457999999988889999999999999999998 99999643221 11111 1111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 222234457999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.77 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=203.0
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEEEccCCChhh
Q 018744 48 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 125 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~~~~~~~L~~ 125 (351)
+||.|.+|+||.|++. +...+|||-+...+....+-+..|+.+.+.++|.||+++++.+.++..+ +.||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999955 5678999999888788888899999999999999999999998877766 9999999999999
Q ss_pred hccccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-CCCcEEEeecccccccCCCCCC
Q 018744 126 HLYPANGSNSVASKL--DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGG 202 (351)
Q Consensus 126 ~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-~~~~v~l~dfg~~~~~~~~~~~ 202 (351)
++...++ ++ ++.++..+-.||++||.|||++ .|+|||||-+||+|+ -.|.+||+|||.+..+.... .
T Consensus 662 LLrskWG------PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P 731 (1226)
T KOG4279|consen 662 LLRSKWG------PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-P 731 (1226)
T ss_pred HHHhccC------CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-c
Confidence 9987774 45 8899999999999999999999 999999999999995 57899999999998754422 1
Q ss_pred ceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 203 HVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 203 ~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
+ .....||..|||||++..+ -|..++|||||||++.||.||++||--.... ..-+...---+
T Consensus 732 ~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGmyK 795 (1226)
T KOG4279|consen 732 C-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGMYK 795 (1226)
T ss_pred c-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhccee
Confidence 1 2335689999999999866 4889999999999999999999999522211 00011111122
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+++.....+...||.+|+..+|.+||++.++|+-
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 3456777888899999999999999999999999864
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=270.43 Aligned_cols=250 Identities=29% Similarity=0.497 Sum_probs=197.1
Q ss_pred CCcCceeeecCceEEEEEEEcC-----CcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
+++.+.||.|+||.||++.+.. +..+++|.+...... ....+..|+..+..++|+|++++++++.+. ..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678899999999999999643 378999998654333 456788999999999999999999988775 455999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++..... ..+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999854321 1289999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~ 214 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----------------EEVL 214 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence 544321111 12335678999999988889999999999999999998 8888864221 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
...........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 215 EYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111111122223456799999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.78 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=197.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc---CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
..+|.+.+.||.|+||.||++... .+..+++|.+... ....+|+++++.++||||+++++++.... .+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999742 4577899987532 23457999999999999999999887664 45888
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++. ++|..++. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 166 e~~~-~~l~~~l~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 166 PKYK-CDLFTYVD-------RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred hhcC-CCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 8875 57777772 224689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc----------cc
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA----------LP 265 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~----------~~ 265 (351)
..............|+..|+|||++.+..++.++|||||||++|+|++|..||.+............. .+
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54433222233456899999999999989999999999999999999999999765543211100000 00
Q ss_pred cccch---hHHHhhcCccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 266 RLTDR---EKILEIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 266 ~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
..... ..... ........+. .....++.++|.+||..||++|||+.+++.+ .++.
T Consensus 315 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~--p~f~ 379 (392)
T PHA03207 315 QNGSTNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL--PLFT 379 (392)
T ss_pred CccchhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC--chhh
Confidence 00000 00000 1111111111 0123468889999999999999999999988 4544
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=273.55 Aligned_cols=250 Identities=23% Similarity=0.418 Sum_probs=195.0
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC----------ChHHHHHHHHHHhccCCCcceeeeEEEEcCC
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ----------GEDEFKMEVELLGRLRSPYLLALLGYCSDRR 110 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 110 (351)
+|.+.+.||.|++|.||+|... +++.+++|.+...... ..+.+..|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999854 6889999987532111 1235778999999999999999999987764
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++|++|+.+++|.+++... ..++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence 45999999999999998432 4688899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCC--CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
||++................++..|+|||.+.... ++.++|+||||+++|+|++|..||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------------- 218 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------------- 218 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------------
Confidence 99987644322222223345778899999987654 789999999999999999999998633211
Q ss_pred cchhHHHhhc----CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEIM----DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+.. ...+........+..+.+++.+||+.+|++|||+.+++++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 ---AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111 1111111222334579999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=277.66 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=193.7
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
+|++.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|||++++++++.++ ..++|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999954 68899999886432 22345678899999999999999999998765 45599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLP----KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCC----CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 58888774432 124689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce----------eeccccc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL----------VSWALPR 266 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~----------~~~~~~~ 266 (351)
... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||........... ..|. .
T Consensus 153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 228 (285)
T cd07861 153 IPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP--G 228 (285)
T ss_pred CCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh--c
Confidence 321 112234567889999988654 468899999999999999999999975432100000 0000 0
Q ss_pred ccchhHHHhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
................. ......+.++.++|.+||..||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000000 0001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.51 Aligned_cols=253 Identities=30% Similarity=0.460 Sum_probs=192.0
Q ss_pred ceeeecCceEEEEEEEc-CCc--EEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~~--~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||+|+||.||+|... ++. .+++|.+.... ......+..|++++.++ +||||+++++++.... .+++|+|+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999964 343 46788776322 23345688899999999 7999999999887664 5699999999
Q ss_pred CChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 121 GGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 121 ~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999998643210 01223578999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---------------- 218 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------------- 218 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----------------
Confidence 875322111 1111223456999999988889999999999999999997 99999643211
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
..............+......+.+++.+||+.+|.+|||+.+++..|.+++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111111111122233456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.06 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=190.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC------
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 109 (351)
..++|++.+.||.|+||.||+|.+ .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999995 468899999886432 12234567899999999999999999877532
Q ss_pred -CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
..+++++++ +++|..++. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 234666665 778887773 23589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+............ ..
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~ 234 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV-GT 234 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh-CC
Confidence 99998764332 233467889999999876 568999999999999999999999996543210000000000 00
Q ss_pred cchhH--------HHhhcCccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREK--------ILEIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~--------~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ....... +..... ......+.+|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000 000000 0112347899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.73 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=188.8
Q ss_pred ceeeecCceEEEEEEEc----CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEc--CCeEEEEEEcc
Q 018744 47 NVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--RRKLLVYDYMA 119 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~~~~~ 119 (351)
+.||+|+||.||+|.+. .+..+++|.+.... ......+..|+.+++.++|||++++++++.. ...+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 23568999875322 2234677889999999999999999997753 34569999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ...++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999985322 2456778889999999999999999 9999999999999999999999999998754322
Q ss_pred CCCc--eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhC-CCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 200 AGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 200 ~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......++..|+|||.+.+..++.++|||||||++|+|++| ..||..... ......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----------------~~~~~~ 214 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----------------FDITVY 214 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHH
Confidence 1111 11123345679999999888899999999999999999995 555643221 111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+........+...+..+.+++.+||..+|++||++.++++.|++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111111112234568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=273.22 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=195.9
Q ss_pred CCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
|.+.+.||+|++|.||+|.+. ++..+++|++..... ...+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999843 467899998864322 23456788999999999999999999875431
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.+++++|+.+++|..++...... .....++...++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 24788999999998887432211 1123578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||++................++..|++||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------------- 222 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------------- 222 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------------
Confidence 999876433221111222334567999999988888999999999999999999 88888643321
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
..............+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 ---EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111100001111223345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=273.00 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=199.1
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC------ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
+|+..+.||+|++|.||.+.. .+++.+++|.+...... ....+..|+++++.++|+|++++++++.+.. .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999994 57889999988643211 2356788999999999999999999987765 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGL 192 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~ 192 (351)
+++|+.+++|.+++... .++++..++.++.|++.||.+||++ +++|+||+|.||+++.++ .++|+|||.
T Consensus 81 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred EEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 99999999999988432 3688999999999999999999999 999999999999998775 599999999
Q ss_pred ccccCCCCCCc--eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 193 AKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+.......... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------------~~~ 217 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-------------NHL 217 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-------------chH
Confidence 87654332111 112345778899999998888999999999999999999999999643321 001
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+......+.+++.+||..+|++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11112111122233444455679999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=292.18 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=190.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
..+|.+.+.||.|+||.||++.+. .++.|++|... ...+.+|+.+++.++|+||+++++++... ..++++++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 57889999642 22356799999999999999999987665 45689998
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|..++... ...+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++....
T Consensus 242 ~~-~~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 242 YR-SDLYTYLGAR------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred cC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 85 6788777432 23689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCC-CCcc-------eeecc------
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS-GEGV-------LVSWA------ 263 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~-------~~~~~------ 263 (351)
............|+..|+|||++.+..++.++|||||||++|+|++|..++-..... .... .....
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 322222223356899999999999999999999999999999999977654322111 0000 00000
Q ss_pred cccccchhHHHhhcC---ccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEIMD---PALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+............. ........ ......+.+||.+||+.||.+|||+.|+|++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000000000 00000000 0112368889999999999999999999987
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.27 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=204.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
..+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++.+... ..++|++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 378999999999999999999854 6788999998655455556788899999999999999999988765 55699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.. ..+++..+..++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred CCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 999999998842 2578889999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ . .
T Consensus 167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--~-------------~ 229 (293)
T cd06647 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--A-------------T 229 (293)
T ss_pred cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--h-------------c
Confidence 3221 123345778899999998888899999999999999999999999754432110000 0 0
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
...............+.+++.+||..+|++||++.+++.+ .+++..+.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h--~~~~~~~~ 277 (293)
T cd06647 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH--PFLKIAKP 277 (293)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--HHHhcCcc
Confidence 0000011122234468899999999999999999999988 56665553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.20 Aligned_cols=248 Identities=25% Similarity=0.436 Sum_probs=199.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.+.|+..+.||.|++|.||.|.+. ++..+++|.+.... ......+.+|+.+++.+.|+|++++++.+.+.. .++|++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 356888999999999999999964 68899999886432 223456788999999999999999999887764 559999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.. .+++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 83 YLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred cCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 9999999998832 3578889999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....+. .....
T Consensus 152 ~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------------~~~~~ 212 (277)
T cd06640 152 TDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----------------RVLFL 212 (277)
T ss_pred cCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------------hHhhh
Confidence 3322 1122345677899999998888999999999999999999999999643321 00111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.............+..+.+++.+||+.+|++||++.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11111223334556679999999999999999999999888
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=281.12 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=193.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++|+||+++++++.... .++|++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999954 68899999886432 233346778999999999999999999987765 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 86 ~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58888774322 3578899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+................ .......
T Consensus 156 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (301)
T cd07873 156 IPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGI 232 (301)
T ss_pred CCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhh
Confidence 322 112234567889999988654 578899999999999999999999975432100000000000000 0000000
Q ss_pred cC---------ccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MD---------PALEG----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~---------~~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+. +.... .........+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00000 0001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=270.72 Aligned_cols=249 Identities=21% Similarity=0.381 Sum_probs=198.2
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||.|+||.+|.+.. .+++.+++|.+.... ......+.+|+.+++.++|+||+++.+++.... .+++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999995 468899999886432 223456888999999999999999999987764 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... ...+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 81 CEGGDLYKKINAQR-----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 99999999885322 12578899999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|..||..... ........
T Consensus 153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------------~~~~~~~~ 214 (256)
T cd08218 153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----------------KNLVLKII 214 (256)
T ss_pred cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----------------HHHHHHHh
Confidence 3221 11234467789999999888899999999999999999999999863221 11111221
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... ...+.....++.++|.+||+.+|++||++.+++++
T Consensus 215 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 215 RGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 12223345579999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=273.74 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=195.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
++|++.+.||+|++|.||+|... +++.+++|.+..... ...+.+.+|+.+++.++|+|++++++++.... .+++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999965 688999998864322 23356788999999999999999999887764 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.++.|..++.. ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 81 YCDHTVLNELEKN-------PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred ccCccHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999888877632 23589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc-cchhH--
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-TDREK-- 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-- 272 (351)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................... .....
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 44321 1223446778999999876 457899999999999999999999997544321100000000000 00000
Q ss_pred -----HHhhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 -----ILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 -----~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+......+ ...+..+.+|+.+||+.+|++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000 1124578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=270.22 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=197.0
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|.+.+.||+|++|.||++... +++.+++|.+...... ..+.+..|+.+++.++|+||+++++++...+ .+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5889999999999999999954 6889999998755443 4577889999999999999999999887665 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 81 CSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred CCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 9999999998432 3578889999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCCce--ecccCCCcccccccccccCC---CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 198 DKAGGHV--STRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 198 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
....... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||...... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------------~~~ 215 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------------FQI 215 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------------HHH
Confidence 4332211 12345678899999988765 889999999999999999999999643210 000
Q ss_pred HHhhcCccccCCCCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSM--KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+.. ......+. .....+.+++.+||+.+|++|||+.+++.+
T Consensus 216 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 216 MFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 11111111 124568899999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=272.05 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=196.2
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
+.+.++......||+|+||.||+|.+. ++..+++|.+..........+.+|+.+++.++|+||+++++++...+. +++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566666778999999999999954 678899998876555555678899999999999999999998877654 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKL--DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg 191 (351)
++|+.+++|.+++.... ..+ +...+..++.|++.||+|||+. +++|+||+|+||+++. ++.++|+|||
T Consensus 84 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 84 MEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999985432 233 7888899999999999999999 9999999999999976 6799999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
.+....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.......
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-------------- 218 (268)
T cd06624 155 TSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-------------- 218 (268)
T ss_pred hheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--------------
Confidence 987543221 112234577889999998654 37889999999999999999999986322110
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+......+.+++.+||+.+|++|||+.+++++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 219 -AAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000000001112233344578999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.22 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|++|.||+|... +++.+++|.+..... .....+..|+..+..++|+|++++++++.... .+++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999965 589999999865443 34567889999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
+.+++|.+++... ..++...++.++.|+++++.+||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 81 MDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999433 468999999999999999999999 9 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........+
T Consensus 151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------------~~~~~~~~~ 215 (264)
T cd06623 151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-------------SFFELMQAI 215 (264)
T ss_pred ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-------------CHHHHHHHH
Confidence 433211 12345677899999998888999999999999999999999999754320 001111121
Q ss_pred cCccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ........ .+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 CDG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred hcC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 211 11122222 45679999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=270.49 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=200.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+.... .++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999954 67889999886432 224567889999999999999999999877664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++..... ...+++..++.++.|++.||++||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 81 LSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred cCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999999999854321 23689999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCCCc--eecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 198 DKAGGH--VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... ......++..|+|||.+... .++.++|+||||+++|+|++|..||....+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~ 217 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----------------VLM 217 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----------------hHH
Confidence 433221 22334578889999998766 78999999999999999999999997543310 011
Q ss_pred hhcC---ccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMD---PALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~---~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+... ..+.... ....+..+.+++..||..||++|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 218 LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 1111111 11334578899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.33 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=187.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
....+|++.+.||+|+||.||+|... +++.+++|+.... ....|+.+++.++|+||+++++++.... .++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999964 5778999975322 2245899999999999999999887665 45888
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++. ++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 137 e~~~-~~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 137 PHYS-SDLYTYLTKR------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EccC-CcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 8885 5777777432 24689999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCC-CCCCCCCCCccee--------------
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLV-------------- 260 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~p-f~~~~~~~~~~~~-------------- 260 (351)
..... ......|+..|+|||++.+..++.++|||||||++|+|+++..+ |............
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 207 PVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred cccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 32211 12335588899999999998999999999999999999985444 4332211000000
Q ss_pred --ecccccccchhHHHhhcCc--cccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 261 --SWALPRLTDREKILEIMDP--ALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+............+. .....+. ......+.+||.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000000111000 0000000 0123356779999999999999999999987
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=271.18 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=195.4
Q ss_pred CCCcCceeeecCceEEEEEEEcC--CcEEEEEEccccC----------CCChHHHHHHHHHHhc-cCCCcceeeeEEEEc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAG----------KQGEDEFKMEVELLGR-LRSPYLLALLGYCSD 108 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vk~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 108 (351)
+|++.+.||+|++|.||.+.+.. ++.+++|.+.... ......+..|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999654 6789999875321 1122445668887765 699999999998876
Q ss_pred C-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEE
Q 018744 109 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 109 ~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
. ..++++||+.+++|.+++.... .....+++..++.++.|++.+|.+||+ . +++|+||+|+||+++.++.++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEE
Confidence 5 4559999999999998874422 122468999999999999999999996 5 899999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------------ 219 (269)
T cd08528 155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------------ 219 (269)
T ss_pred Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------------
Confidence 99999987644432 233456788899999999888999999999999999999999998643211
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.....+................+.+++.+||+.||++||++.++.+++.
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 ----SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111111111123457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.59 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|++|.||++.+. +++.+++|++.... ......+.+|+++++.++||||+++++.+.... .++|++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467999999999999999999954 68889999876432 233467888999999999999999999887764 469999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|+.+++|..++.. .+.+++..+..++.+++.+|.|||+ . +++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 84 FMDCGSLDRIYKK-------GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred cCCCCCHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999988743 2368899999999999999999996 5 899999999999999999999999998764
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||............. .........
T Consensus 154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (284)
T cd06620 154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP-----MGILDLLQQ 224 (284)
T ss_pred hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh-----hHHHHHHHH
Confidence 32211 123467889999999988889999999999999999999999997544321100000 000011111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
..............+..+.+|+.+||+.||++|||+.+++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111111122455789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=274.94 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=197.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|++|.||++.+. +++.+++|++.... ......+.+|+++++.++||||+++++++.+.. .++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999954 68899999886432 223456788999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..++...+..++.|++.||.+||+. +++|+||+|.||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 81 EYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 999999999998432 4688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......
T Consensus 151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~ 209 (290)
T cd05580 151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----------------IQIYEK 209 (290)
T ss_pred cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 4332 2334578889999999888889999999999999999999999964331 111111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
+.... ...+......+.+++.+||..||.+|+ ++++++++
T Consensus 210 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11111 112222345789999999999999999 88888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.45 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=199.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||.|++|.||++.+. +++.+++|.+.... ......+.+|+++++.++||||+++++.+.... .++++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999965 68889999886543 233456788999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
+.+++|.+++.... ..++...++.++.|++.||++||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 81 MDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred cCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 99999999985432 468899999999999999999999 8 9999999999999999999999999988654
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .........
T Consensus 152 ~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~ 216 (265)
T cd06605 152 VNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-----------GIFELLQYI 216 (265)
T ss_pred HHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-----------cHHHHHHHH
Confidence 3221 1125577789999999888999999999999999999999999964432100 001111122
Q ss_pred cCccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ...+.. ....+.++|.+||..+|++|||+.+++.+
T Consensus 217 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 217 VNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 22111 111222 45578999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.16 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=195.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+.|+..+.||.|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|+||+++++.+.... .++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777888999999999999854 57889999886432 223456888999999999999999999887664 5699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.. ..+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 84 LGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred cCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 999999988832 3578899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+.. ... ..
T Consensus 153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----------------~~~-~~ 213 (277)
T cd06642 153 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----------------VLF-LI 213 (277)
T ss_pred Ccc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----------------HHh-hh
Confidence 321 11122456778999999998889999999999999999999999986433210 000 01
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............+..+.+++.+||+.+|++|||+.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1111111222334568999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=270.40 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=185.2
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|.+. .+..+++|.+..... .....+.+|+.+++.++||||+++++++.+.. .++||||+.++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999854 345789998764432 22346778999999999999999999887664 46999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++...... .....++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 81 DLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred cHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999998654321 123466778889999999999999999 999999999999999999999999999865332221
Q ss_pred CceecccCCCcccccccccccC-------CCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 202 GHVSTRVLGTQGYVAPEYALTG-------HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~-------~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
........++..|+|||++.+. .++.++||||||+++|+|++ |..||....+... . ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~---------~~~~ 223 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---L---------TYTV 223 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---H---------HHHh
Confidence 1122234466789999988642 35789999999999999996 9999964332100 0 0000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
...................+.+++..|| .+|++|||+.+|+..|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000000011111122345788999999 58999999999997763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=285.97 Aligned_cols=265 Identities=23% Similarity=0.388 Sum_probs=225.0
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcC-CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
+.++-...+.+..++||-|.||.||.|.|+. .-.++||.++. +.+....|..|+.+++.++|||+++++++|.-+-.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455556677788899999999999999875 45688998854 57788999999999999999999999999987755
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
|+|+|||..|+|.+++..-+ ...++...++.|+.||+.|+.||... +++||||...|+||.++..||++|||
T Consensus 339 YIiTEfM~yGNLLdYLRecn-----r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-----RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-----hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 49999999999999996543 23577788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+++........... ...-...|.|||.+....++.++|||+||++|||+.| |..||.+-+ .
T Consensus 411 LsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------l 472 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------L 472 (1157)
T ss_pred hhhhhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------H
Confidence 99875443211111 1122447999999999999999999999999999999 999996433 4
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.++..+++...+...+..++..+++||+.||+++|.+||+++|+-+.++.++..+
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 5677888888888888899999999999999999999999999999998887653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=268.05 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=196.6
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ......+..|+++++.++|+|++++++.+.... .++|+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999995 468889999886432 233467888999999999999999999887654 5699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~dfg~~~~~ 196 (351)
+.+++|.+++.... ...+++..++.++.+++.+|.+||++ +++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 81 APGGTLAEYIQKRC-----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred CCCCCHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999999995432 23588999999999999999999999 99999999999999754 46899999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.. ......
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----------------~~~~~~ 213 (256)
T cd08220 153 SSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----------------ALVLKI 213 (256)
T ss_pred CCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----------------HHHHHH
Confidence 4322 112345678899999998888899999999999999999999999654321 111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ...+......+.+++.+||..+|++|||+.+++++
T Consensus 214 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 MSGTF-APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HhcCC-CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111 11222334578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=268.26 Aligned_cols=238 Identities=19% Similarity=0.367 Sum_probs=183.6
Q ss_pred ceeeecCceEEEEEEEcC-------------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeE
Q 018744 47 NVVGHGGFGLVYRGVLSN-------------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~-------------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 112 (351)
+.||+|+||.||.|.... ...+++|.+..........+..++.+++.++||||+++++++... ..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 235888887655444455778899999999999999999988765 456
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-------E
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-------A 185 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~-------v 185 (351)
++++|+.+++|..++.... ..+++..++.++.||+.||+|||+. +++|+||+|+||+++.++. +
T Consensus 81 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999988874322 3689999999999999999999999 9999999999999976654 8
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHH-hCCCCCCCCCCCCCcceeecc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELL-TGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~ 263 (351)
+++|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------- 216 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------- 216 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---------
Confidence 99999987643221 2234667899999886 567899999999999999998 488887643211
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
........... .......++.+||.+||+.||++||++.+|++.|
T Consensus 217 --------~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 --------EKERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HHHHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01111111111 1111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.99 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=203.2
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC--C-eEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR--R-KLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~-~~~v~ 115 (351)
+|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++.+++++|+||+++++.+... . .++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999965 688999998865432 3456788999999999999999999988776 3 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++... ..+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 999999999998432 2789999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..............++..|+|||.+.+...+.++||||||+++|+|++|..||...... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~ 215 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------------MAALYK 215 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHHHh
Confidence 65543221234456788999999998888999999999999999999999999754310 111112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.........+......+.+++.+||..+|++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 221112223333445679999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=273.16 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=196.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
++|++.+.||+|++|.||++.+. ++..+++|.+... .......+.+|+.+++.++|+||+++++.+... ..+++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46899999999999999999965 7899999988643 222235678899999999999999999977665 45599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
+.+++|..++.... ....+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 81 MDAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred cCCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999988885421 12368999999999999999999996 5 8999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCcccccccccccC------CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ...
T Consensus 154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------------~~~ 216 (286)
T cd06622 154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------------NIF 216 (286)
T ss_pred cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------------hHH
Confidence 3221 2234467789999988543 3578999999999999999999999642211 000
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..+.... ....+.....++.++|.+||..+|++||++.+++.+
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 217 AQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111122111 122333456678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=278.07 Aligned_cols=265 Identities=18% Similarity=0.225 Sum_probs=189.0
Q ss_pred cCceeeec--CceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 45 KSNVVGHG--GFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 45 ~~~~lg~G--~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
+.++||+| ++++||++.. .+|+.+++|.+..... .....+..|+.+++.++||||+++++++..++ .++|++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6889999984 5789999999864322 22356778999999999999999999887664 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 82 AYGSAKDLICTHF-----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred CCCcHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999999985432 13588999999999999999999999 999999999999999999999999986543221
Q ss_pred CCCC-----ceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc-eeecccccccc-
Q 018744 199 KAGG-----HVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPRLTD- 269 (351)
Q Consensus 199 ~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~- 269 (351)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 1100 01122345667999999876 458899999999999999999999997432210000 00000000000
Q ss_pred ----hhHH-------------Hh--h-------cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 ----REKI-------------LE--I-------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ----~~~~-------------~~--~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... .. . ................+.+|+.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00 0 00000001111234578899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.88 Aligned_cols=240 Identities=25% Similarity=0.313 Sum_probs=181.7
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhcc---CCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRL---RSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
||+|+||.||+|++. +++.+|+|++..... ........|..++... .||+|+++++++.... .++||+|+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999954 689999999864321 1222334456666554 6999999999887664 5699999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|..++.. ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~-------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 81 GELFWHLQK-------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN 150 (330)
T ss_pred ChHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence 999988843 24688999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... .....+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~ 212 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----------------QMYRNIAFG 212 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----------------HHHHHHHcC
Confidence 122345688999999998754 5789999999999999999999999653321 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRP----LMADVVQS 317 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp----t~~eil~~ 317 (351)
..... .......+.+|+.+||+.||++|| ++.+++++
T Consensus 213 ~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 213 KVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 11000 011234688999999999999998 57777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=273.15 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=196.0
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||.|++|.||+|.+. +|+.+++|.+.... ......+.+|+.+++.++|+|++++++++.... .++|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999954 68899999986543 223467888999999999999999999887764 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+ +++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 81 M-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred c-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9 999999885432 4689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc--------cccc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL--------PRLT 268 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~ 268 (351)
.... .......++..|+|||.+.+. .++.++|||||||++|+|++|..+|................ +...
T Consensus 151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 4321 112335678889999988654 46899999999999999999988886543210000000000 0000
Q ss_pred chhHHHhhcCccc-c---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPAL-E---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~-~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.-.....+..... . .....+....+.+|+.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 0 00001223678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.42 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=158.5
Q ss_pred CceeeecCceEEEEEEEc---CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEEEEEcc
Q 018744 46 SNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYDYMA 119 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~~~~~ 119 (351)
.+.||+|+||.||+|... +++.+++|.+... .....+.+|+.+++.++||||+++++++... ..+++++++.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999854 4678999988543 2234567899999999999999999988543 2358888875
Q ss_pred CCChhhhccccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe----CCCCcEEEeecccc
Q 018744 120 NGGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLA 193 (351)
Q Consensus 120 ~~~L~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----~~~~~v~l~dfg~~ 193 (351)
++|..++...... ......+++..+..++.||+.||.|||++ +++|+||||+||++ +.++.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4777776432211 11223589999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCC-ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCC
Q 018744 194 KIGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253 (351)
Q Consensus 194 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~ 253 (351)
......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 765432211 11234567889999999876 4589999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=276.46 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=198.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
.|.....||.|+||.||.+... ++..+++|.+..........+.+|+..++.++|+|++++++.+... ..+++++|+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999954 6889999998655444456788899999999999999999987665 4569999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.. ..+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 103 GGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9999988732 3578899999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+.. ....+......
T Consensus 172 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------------~~~~~~~~~~~ 236 (292)
T cd06658 172 VP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------------AMRRIRDNLPP 236 (292)
T ss_pred cc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHhcCCC
Confidence 21 1223457888999999988889999999999999999999999996433210 00011111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+.. .......+.+++..||..||++|||+.+++++ .++.....
T Consensus 237 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~--~~~~~~~~ 280 (292)
T cd06658 237 RVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH--PFLKLAGP 280 (292)
T ss_pred cccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhhccCC
Confidence 1111 11234468889999999999999999999986 55554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=269.81 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=197.7
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-CCChHHHHHHHHHHhccC---CCcceeeeEEEEcCC-eEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLR---SPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-~~~v~ 115 (351)
.|++.+.||.|++|.||+|.+ .+++.+++|.+.... ......+.+|+.+++.++ |||++++++++.+.. .++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999995 578899999886432 333456788999999986 999999999887664 55999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++.. ..+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 99999999988732 2688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... .......++..|+|||.+.++ .++.++|+||||+++|+|++|..||........... ..
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------~~ 215 (277)
T cd06917 151 LNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------------IP 215 (277)
T ss_pred cCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------------cc
Confidence 54433 112334578889999988754 568999999999999999999999975432110000 00
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
....+.+.. .....++.+++.+||+.||++|||+.+++.+ .+++..
T Consensus 216 ~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~--~~~~~~ 261 (277)
T cd06917 216 KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS--KWIKAH 261 (277)
T ss_pred cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC--hHhhcc
Confidence 000011111 0134468999999999999999999999986 555543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.02 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=196.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
++|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+++++.++|+||+++++++.... .+++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999965 6889999988643 2333467888999999999999999999887654 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.++.+..+... ...++...++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 81 YVERTLLELLEAS-------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred cCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9998766655522 23588999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc------
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD------ 269 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 269 (351)
..... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.....................
T Consensus 151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 44322 122334567889999999887 7899999999999999999999999754321100000000000000
Q ss_pred --hhHHH-----hhcCc-cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 --REKIL-----EIMDP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 --~~~~~-----~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ..... .+...++...+..+.+||.+||..+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00000 00001111225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=270.14 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=182.6
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|... ....+++|.+..... .....+.+|+..++.++|+||+++++.+.... .+++|+|+.++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999999743 235678887754322 22345778999999999999999999887664 56999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++...... .....++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 81 DLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred cHHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 999998654321 122356788899999999999999999 999999999999999999999999999864322211
Q ss_pred CceecccCCCccccccccccc-------CCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 202 GHVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~-------~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
........++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.. ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------------~~~~~~ 223 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------------VLKQVV 223 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------------HHHHHh
Confidence 111223345567999998742 356889999999999999999 788886432110 000000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
...................+.+++..|| .||++|||+.+|++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 224 REQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred hccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000000111112233445777888898 4999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=271.19 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=197.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~ 115 (351)
++|...+.||.|++|.||++... +++.+++|.+..... .....+.+|+++++.++||||+++++++.+. ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999964 688899998864322 2345688899999999999999999987543 356999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++..... ....++...++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999999888643221 224688899999999999999999999 999999999999999999999999999765
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||......... . ......+..
T Consensus 155 ~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~-------~~~~~~~~~ 222 (287)
T cd06621 155 LVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-P-------IELLSYIVN 222 (287)
T ss_pred ccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-h-------HHHHHHHhc
Confidence 43221 12344677899999999889999999999999999999999999754321000 0 000000111
Q ss_pred hcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+..... ......+.+++.+||..+|++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01111111111 1234578999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=269.62 Aligned_cols=247 Identities=27% Similarity=0.349 Sum_probs=198.1
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
+|++.+.||.|++|.||+|.+. ++..+++|.+..... ...+.+.+|+++++.++||||+++++.+.+.. .+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999965 688999998864322 23567888999999999999999999887664 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|..++... .++++..++.++.|+++||.|||++ +++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 81 LLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 99999999998432 4688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~ 213 (258)
T cd05578 151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--------------RDQIRAK 213 (258)
T ss_pred CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--------------HHHHHHH
Confidence 4332 2233557778999999988889999999999999999999999997554310 0111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM--ADVVQ 316 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~--~eil~ 316 (351)
... .....+...+..+.++|.+||+.||.+||++ .++++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 110 1122233344679999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.93 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=199.8
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
.|++.+.||+|++|.||++... ++..+++|++..........+.+|++.++.++|++++++++++... ..+++++|+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999965 6889999998765544567888999999999999999999988766 4559999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.... ..+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999885432 4689999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .........
T Consensus 152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~ 212 (253)
T cd05122 152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----------------KALFKIATN 212 (253)
T ss_pred cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----------------HHHHHHHhc
Confidence 21 23455778899999998888899999999999999999999999643211 111111110
Q ss_pred cccCCCCHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 280 ALEGQYSMK--EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 280 ~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........ ....+.+++.+||+.||++|||+.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 -GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111111 24579999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.56 Aligned_cols=265 Identities=23% Similarity=0.343 Sum_probs=194.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
++|++.+.||+|++|.||+|.+. +++.+++|.+...... ....+.+|+++++.++|+||+++++++.... .+++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 57999999999999999999965 5889999987643222 2456788999999999999999999887664 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.++.|..+... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 81 FVDHTVLDDLEKY-------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred cCCccHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999888877632 23588999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc------
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD------ 269 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 269 (351)
.... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.....................
T Consensus 151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 151 AAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred cCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 3322 11223456788999998875 45688999999999999999999998644321000000000000000
Q ss_pred --hhHHHhhcCccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 --REKILEIMDPALEGQ-----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 --~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.........+..... .....+..+.+|+.+||+.+|++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000 011234579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.10 Aligned_cols=237 Identities=24% Similarity=0.433 Sum_probs=185.5
Q ss_pred ceeeecCceEEEEEEEcC-C----------cEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEE
Q 018744 47 NVVGHGGFGLVYRGVLSN-G----------RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 115 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~-~----------~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 115 (351)
+.||+|+||.||+|.+.. + ..+++|.+...... ...+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 468999999999999653 3 24777876544332 57788899999999999999999988776678999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-------cEEEe
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-------HAKVS 188 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-------~v~l~ 188 (351)
+|+.+++|.+++.... ..+++..+..++.||+.||+|||++ +++|+||||+||+++.++ .++|+
T Consensus 80 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 80 EYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999985432 2688999999999999999999999 999999999999998887 79999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 265 (351)
|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.......
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---------- 214 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---------- 214 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----------
Confidence 9999875433 1223456679999998876 78999999999999999999 577775432110
Q ss_pred cccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
...... .. ...+......+.+++.+||..+|.+|||+.++++.|
T Consensus 215 ----~~~~~~--~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 ----KERFYQ--DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----HHHHHh--cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 00 001111115789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.57 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=195.9
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-----ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
+|.+.+.||.|++|.||+|.+. +++.+++|.+...... ....+..|+++++.++|+||+++++++.+.. .++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999954 6889999998654322 2345677999999999999999999988764 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+ +++|.+++.... ..+++..++.++.||++||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred Eccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeee
Confidence 9999 889999884321 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch--h
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR--E 271 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 271 (351)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..+|...................... .
T Consensus 151 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 151 SFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred eccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 654422 11223345678999998864 467889999999999999999988876544311000000000000000 0
Q ss_pred HHH---hhcCccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 272 KIL---EIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 272 ~~~---~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
... ........... .......+.++|.+||+.+|++|||+.+++++ .++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~ 286 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFS 286 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--cccc
Confidence 000 00000000000 11224578999999999999999999999986 5555
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=273.77 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=194.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|.+.+.||.|+||.||++... .++.+++|.+..... .....+..|+++++.++||||+++++.+.... .++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999954 578999998864422 22346778999999999999999999887765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|.||+++.++.++|+|||++..
T Consensus 81 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998432 3688999999999999999999999 999999999999999999999999998764
Q ss_pred cCCCCCC-------------ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 196 GSDKAGG-------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 196 ~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------- 222 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------- 222 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence 2111100 0011234677899999998888999999999999999999999999643321
Q ss_pred ccccccchhHHHhhcCccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQ-YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.............. .....+..+.++|.+||+.+|++||+..++++.|..
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 --------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111111100 011234568999999999999999996555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=275.01 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=195.6
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
..|.....||.|+||.||.|... +++.+++|.+..........+.+|+.+++.+.|||++++++++..+ ..+++++|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34555668999999999999954 6889999998755555566788899999999999999999987665 456999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|..++.. ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 101 ~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 101 QGGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99999887732 3578999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||....+. .....+..
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~ 231 (297)
T cd06659 170 DV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----------------QAMKRLRD 231 (297)
T ss_pred cc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhc
Confidence 21 1123355788999999999888999999999999999999999999643321 00111100
Q ss_pred ccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 279 PAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 279 ~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ...........+.+++.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 232 SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 000111223468899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.84 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=214.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc--CCc--EEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS--NGR--KVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~--~~~--~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 115 (351)
++..+.++||+|.||.|++|.|. +|+ .||||.+...... ....|.+|+.++.+|+|+|++++++++.+.-..+|+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ 189 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVF 189 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHh
Confidence 34566788999999999999965 343 5799999765544 568899999999999999999999999987777999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|.+..|+|.+.+... ....+....+..++.||+.|+.||..+ ++|||||...|+++...-.|||+|||+.+.
T Consensus 190 ELaplGSLldrLrka-----~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA-----KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhcccchHHHHHhhc-----cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 999999999999762 224677889999999999999999999 999999999999998888999999999998
Q ss_pred cCCCCCCceecc-cCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 196 GSDKAGGHVSTR-VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 196 ~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
+........... ..-...|+|||.+....++.++|||++|+++|||++ |..||.+.. ...+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qI 324 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQI 324 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHH
Confidence 766554333332 334457999999999999999999999999999999 999997654 3456
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.+.+|..-.-..+..+++++++++..||..+|.+|||+..|.+.+
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 666776666667778889999999999999999999999997543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=279.26 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=195.9
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC----
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---- 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 109 (351)
....++|++.+.||+|++|.||+|... +++.+++|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 345689999999999999999999954 7899999988532 222335677899999999999999999987543
Q ss_pred ---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 110 ---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 110 ---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
..++|++|+.+ +|.+.+. ..++...+..++.|++.||++||++ +++|+||||+||+++.++.++
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQ---------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence 34799999964 7777662 1278889999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+..............
T Consensus 159 L~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 159 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred EccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999997643322 122345678899999999999999999999999999999999999754321000000000000
Q ss_pred cc---------------------chhHHHhhcCccc----cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LT---------------------DREKILEIMDPAL----EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~---------------------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ............. ...........+.++|.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000000000 000011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=274.64 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=212.1
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
+-|-+.+.||+|.|+.|-+|+ .-+|..||||++.... ......+..|+.-++.++||||++++++.... ..|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 568889999999999999999 4489999999996432 23345677899999999999999999998766 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe-CCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv-~~~~~v~l~dfg~~~~ 195 (351)
.-++|+|.+++.... ..+++....+++.||+.|+.|||+. .++|+||||+||++ ..-|-|||.|||++..
T Consensus 98 LGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred ecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999996543 4689999999999999999999999 89999999999877 5678999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCC-CccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
+.... .....+|...|.|||++.|..|. ++.||||||+++|-|.+|+.||+-.+ +.+.+.
T Consensus 169 f~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLT 229 (864)
T KOG4717|consen 169 FQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLT 229 (864)
T ss_pred CCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhh
Confidence 55432 34567889999999999999885 67899999999999999999997332 234444
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+++-+. ..+.-...++++||..||..||++|-|+++|..+ .+++....
T Consensus 230 mImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~--~Wlq~~D~ 278 (864)
T KOG4717|consen 230 MIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST--SWLQAGDR 278 (864)
T ss_pred hhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc--ccccCCCC
Confidence 5555433 4556677789999999999999999999999987 55665444
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.46 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|.+.+.||.|++|.||++.+. ++..+++|.+..... .....+..|++.++.++|+|++++.+.+.... .++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999964 688999999875433 34566888999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+++++|.+++..... ....+++..++.++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 81 ADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred cCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 999999998865421 125789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......
T Consensus 155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~ 216 (258)
T cd08215 155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------ELALKIL 216 (258)
T ss_pred cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HHHHHHh
Confidence 432 1223346788899999998888999999999999999999999998643321 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... ....+......+.+++.+||+.+|++|||+.+++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 KGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 112222344578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.27 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=190.2
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||.|++|.||+|.+. +|+.+++|.+..... .....+.+|+++++.++|+|++++++++.+.. .+++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999964 688999998864322 22345677999999999999999999887664 4589999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|.+++... ...+++..++.++.||++||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSC------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 86 4777776432 24689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc-eeecccccccc--hhHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPRLTD--REKI 273 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~--~~~~ 273 (351)
... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||.......... ........... -...
T Consensus 151 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 151 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 322 112234567889999988764 47899999999999999999998864322110000 00000000000 0000
Q ss_pred HhhcCccccC---------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEG---------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+..... .........+.+||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000000 0011224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.36 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=200.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
..+.|++...||.|++|.||++.+. ++..+++|++..... ....+..|++.++.++|+|++++++.+... ..+++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4577999999999999999999965 688999999865433 456788899999999999999999988765 4559999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 96 ~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 96 YMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred ccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999995432 3689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+. .....+
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----------------~~~~~~ 228 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----------------RALFLI 228 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Confidence 33221 112334677899999998888999999999999999999999998643321 111111
Q ss_pred cCccccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... ......+..+.++|.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111 1111234578999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=272.43 Aligned_cols=266 Identities=21% Similarity=0.313 Sum_probs=192.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|++|.||+|... +++.|++|.+...... ....+.+|+++++.++|+||+++++++.+.. .++|++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 378999999999999999999965 6889999998643322 2245667999999999999999999987764 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 84 YLDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred cCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 9975 8888874332 3678999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............+.............
T Consensus 154 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 154 SVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 32211 1122345778999998875 45788999999999999999999999654311000000000000000000000
Q ss_pred h------cC--------ccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 I------MD--------PALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~------~~--------~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. .. ..+.... .......+.+++.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00 0000000 00011467899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=268.05 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=188.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHH-HhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVEL-LGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
++|++.+.||+|+||.||++.+. +|+.+|+|.+..... .....+..|... ++..+|||++++++++... ..+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 689999998864322 222344445554 5667899999999988765 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|++ ++|.+++..... ....+++..++.++.|++.||.|||++. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 81 VMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 986 578777644321 2246899999999999999999999742 7999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCccccccccccc----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ...
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~ 216 (283)
T cd06617 155 VDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------------FQQ 216 (283)
T ss_pred cccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------------HHH
Confidence 3211 1223456778999998864 45688999999999999999999999632211 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+................+..+.++|.+||..+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112111111111111234578999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.27 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc-----CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
++|++.+.||+|++|.||+|.+ .++..+++|.+... .......+.+|+++++.++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999995 46889999987432 122335678899999999999999999988654 24
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++++.+++|.+++... ..+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence 5899999999999988422 3578899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++......... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~ 215 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------------M 215 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------------H
Confidence 98764332111 111234577889999999888889999999999999999999999963221 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+............+......+.+++.+||. +|..|||+.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 12222222222233444555679999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=266.83 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=196.1
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+-|++.+.||.|+||.||+|.+ .++..+++|.+.... ......+.+|+..++.++|+||+++++.+..+. .++|++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4578899999999999999985 467899999875432 223356788999999999999999999887764 5699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|..++.. ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 84 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 999999988832 3588999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ..... .
T Consensus 153 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~-~ 213 (277)
T cd06641 153 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----------------KVLFL-I 213 (277)
T ss_pred cch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----------------HHHHH-H
Confidence 322 1122345677899999998888899999999999999999999998643211 01111 1
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............+..+.+++.+||+.+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111222334568999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.74 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=199.1
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
.|.-.+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.+.|+|++++++++... ..+++++|+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455567999999999999995 46889999988655444456688899999999999999999987665 4569999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|.+++.. ..++...++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 100 ~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 100 GGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred CCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 9999998843 3578899999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+. .....+...
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----------------~~~~~~~~~ 230 (285)
T cd06648 169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------QAMKRIRDN 230 (285)
T ss_pred Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----------------HHHHHHHhc
Confidence 21 112345788899999998888999999999999999999999999643321 011111110
Q ss_pred c-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 280 A-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 280 ~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
. .........+..+.+++.+||+.+|++|||+.+++++ .+++..+
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~--~~~~~~~ 276 (285)
T cd06648 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH--PFLAKAG 276 (285)
T ss_pred CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC--cccccCC
Confidence 0 0001111234579999999999999999999999986 5555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=264.77 Aligned_cols=242 Identities=26% Similarity=0.330 Sum_probs=193.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~~~~L 123 (351)
||.|++|.||++... +++.+++|++..... ...+.+.+|+.+++.++|+||+++++.+.++ ..+++++|+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 588999999864322 2346688899999999999999999988766 45699999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++... ..++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--- 147 (262)
T cd05572 81 WTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--- 147 (262)
T ss_pred HHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence 9998432 3588999999999999999999999 99999999999999999999999999987654432
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...............
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~ 213 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--------------PMEIYNDILKGNGKL 213 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--------------HHHHHHHHhccCCCC
Confidence 122345778899999988888899999999999999999999999754321 011122222111222
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
.++......+.++|.+||..+|++||| ++|++++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 233333568999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.59 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=182.1
Q ss_pred ceeeecCceEEEEEEEcCC---cEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLSNG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+.... .+++|+|+.++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999974332 345666665332 223467888999999999999999999987664 46999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++..... .....+...++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 81 DLKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred cHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 99999865321 123467778899999999999999999 999999999999999999999999998754222111
Q ss_pred CceecccCCCccccccccccc-------CCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 202 GHVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~-------~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
........++..|+|||++.. ..++.++||||||+++|+|++ |..||........ .. .. .....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~----~~-~~~~~ 226 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LN----HV-IKDQQ 226 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HH-Hhhcc
Confidence 112233456778999998753 235789999999999999997 6778753221000 00 00 00000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
....++.+.. .....+.+++..|| .+|++|||+.++++.|.
T Consensus 227 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0111122221 23346788999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.41 Aligned_cols=267 Identities=20% Similarity=0.311 Sum_probs=192.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+.++|++.+.||+|++|.||+|.. .+++.+++|.+...... ....+.+|+.+++.++|+||+++++++.... .++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 46889999998644322 2345678999999999999999999887764 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+. +++.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 83 e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 83 EYMH-TDLAQYMIQH------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred eccc-CCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9995 6777666332 13577888999999999999999999 999999999999999999999999998875
Q ss_pred cCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH--
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK-- 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 272 (351)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............+..........
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 153 KSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred cCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 33322 112334467889999998754 5788999999999999999999999754321110000000000000000
Q ss_pred -HH-------hhcCccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 -IL-------EIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 -~~-------~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ........... .......+.+++.+|+..||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000000000 00113468899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=256.07 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=201.1
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCC----CCh----HHHHHHHHHHhcc-CCCcceeeeEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK----QGE----DEFKMEVELLGRL-RSPYLLALLGY 105 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~----~~~----~~~~~e~~~l~~l-~h~~i~~~~~~ 105 (351)
-....+.|.-.+.||.|..+.|-++. ..+|..+++|++..... ... +.-..|+.+|+++ .||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34455788999999999999998888 45788898898752211 112 2334689999998 69999999999
Q ss_pred EEcCCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 106 CSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 106 ~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
++.+.. ++|++.+..|-|.+++ ++...++++....+++|+.+++.|||.+ +|+|+||||+|||++++-+
T Consensus 92 yes~sF~FlVFdl~prGELFDyL-------ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYL-------TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMN 161 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHh-------hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccc
Confidence 988764 4999999999999999 4456799999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCccccccccccc------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 258 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 258 (351)
++|+|||++..+... ......+||++|+|||.+.. .-|+...|+|++|++||.|+.|+.||-....
T Consensus 162 i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----- 233 (411)
T KOG0599|consen 162 IKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----- 233 (411)
T ss_pred eEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----
Confidence 999999999876553 34567899999999998852 3578899999999999999999999942211
Q ss_pred eeecccccccchhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 259 LVSWALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+ -.+..++.....-.-+ .+......+||.+||++||.+|.|++|+|.|
T Consensus 234 --------m---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 --------M---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred --------H---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0 0112223222211111 2345578899999999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.88 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=210.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC-hHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~ 115 (351)
.+.....+.++||+|.||.|.++....+.+||+|.++...... ++.|.+|+++|.+++||||+.++++|..++.+ +++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4457789999999999999999998778999999998654443 47899999999999999999999999876554 999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||++.|+|.+++...... .+.......|+.||+.|++||.+. +++||||.+.|+|+++++++|++|||+++-
T Consensus 615 EYmEnGDLnqFl~aheap-----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP-----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHhcCcHHHHHHhccCc-----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 999999999999554321 234455667999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh--CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
+-........+...-..+|+|||.+..+.++.++|+|+||+++||+++ ...||..... ...+
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----------------e~vv 750 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----------------EQVV 750 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----------------HHHH
Confidence 655555555555666779999999999999999999999999999765 8888863221 1111
Q ss_pred H---hhcC---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 274 L---EIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 274 ~---~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
. +.++ .......+.-++..++++|..||+.+-++|||++++..+|.+.
T Consensus 751 en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 1111 1112233455677899999999999999999999999887654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=264.69 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=199.8
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+..|+++++.++|+||+++.+++.+. ..+++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999854 67899999886432 22335667899999999999999999887665 44599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.... .....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 81 APFGDLSKAISKRK---KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred cCCCCHHHHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 99999999885532 1224689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. .......
T Consensus 155 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------------~~~~~~~ 213 (256)
T cd08530 155 KN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----------------QDLRYKV 213 (256)
T ss_pred cC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHH
Confidence 43 12234577889999999988899999999999999999999999964332 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........+.....++.+++.+||+.+|++|||+.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111122333556679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.48 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=191.8
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||.|++|.||+|... +++.+++|.+..... .....+..|+++++.++||||+++++++.+.. .+++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999964 688999998864322 22356788999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 57888774432 24688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc--------c
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL--------T 268 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------~ 268 (351)
... .......++..|+|||.+.+. .++.++||||||+++|+|+||..||................... .
T Consensus 152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 152 VPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 322 112233457789999988764 46889999999999999999999996543210000000000000 0
Q ss_pred chhHHHhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........+...... .........+.++|.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000 0001123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=267.24 Aligned_cols=247 Identities=29% Similarity=0.384 Sum_probs=192.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.+.|.+.+.||+|++|.||+|... +++.+++|.+....... ...+.+|+++++.++|||++++.+++.+.. .++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 366999999999999999999954 68899999886433322 245778999999999999999999987664 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+. +++.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~e~~~-g~l~~~~~~~------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 94 MEYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred HHhhC-CCHHHHHHHc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcce
Confidence 99986 5666666322 23589999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
..... ....++..|+|||++. ...++.++||||||+++|+|++|..||...... .
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----------------~ 221 (307)
T cd06607 164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------S 221 (307)
T ss_pred ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----------------H
Confidence 54322 2235677899999874 456888999999999999999999998643321 0
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+.............+..+.+++.+||+.+|++|||+.+++.+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 01111111111111223445789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=271.76 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=157.0
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~~~~~~ 120 (351)
..||+|+||.||+|... ++..+++|.+... .....+.+|+.+++.++||||+++++++... ..+++++|+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999954 4578999988543 2234577899999999999999999987532 34588999765
Q ss_pred CChhhhccccCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe----CCCCcEEEeeccccc
Q 018744 121 GGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAK 194 (351)
Q Consensus 121 ~~L~~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----~~~~~v~l~dfg~~~ 194 (351)
+|.+++..... .......+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.++|+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 67766643221 112234688999999999999999999999 99999999999999 566789999999997
Q ss_pred ccCCCCCC-ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 195 IGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 195 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
........ .......++..|+|||++.+ ..++.++|||||||++|+|+||..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65433211 11223457889999999876 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=266.86 Aligned_cols=237 Identities=22% Similarity=0.379 Sum_probs=180.8
Q ss_pred eeeecCceEEEEEEEcC-------------------------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceee
Q 018744 48 VVGHGGFGLVYRGVLSN-------------------------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~-------------------------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 102 (351)
.||+|+||.||+|.... ...+++|++..........+..++.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999987321 13478888865433334567788999999999999999
Q ss_pred eEEEEcC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 103 LGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 103 ~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
++++... ..++||+|+.+++|..++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 9998765 456999999999999888432 23688999999999999999999999 9999999999999975
Q ss_pred CC-------cEEEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHH-hCCCCCCCCC
Q 018744 182 NF-------HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELL-TGRVPIDVNK 252 (351)
Q Consensus 182 ~~-------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~ll-tg~~pf~~~~ 252 (351)
.+ .++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 43 3899999987542211 22345677999998875 56899999999999999995 5999986543
Q ss_pred CCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 253 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+. .......... ..+......+.++|.+||+.+|++|||+.++++.|
T Consensus 227 ~~-----------------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PS-----------------EKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hH-----------------HHHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 21 0011111111 11111223688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=265.10 Aligned_cols=241 Identities=28% Similarity=0.387 Sum_probs=182.8
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHh---ccCCCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 48 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLG---RLRSPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
.||+|+||.||++... +++.+++|.+..... .....+..+..+++ ...|++++.+.+.+... ..++||+|+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999954 688999998854321 11122334443333 34789999999988765 4569999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|..++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 81 GGDLHYHLSQ-------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (279)
T ss_pred CCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence 9999988843 23689999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
......++..|+|||.+. +..++.++|||||||++|+|++|..||...... ....+....
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~- 211 (279)
T cd05633 151 ----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------------DKHEIDRMT- 211 (279)
T ss_pred ----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--------------CHHHHHHHh-
Confidence 122346888999999886 456889999999999999999999999643321 011111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.......+...+..+.++|.+||+.||++|| |++++++|
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111223334456799999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.49 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=194.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 113 (351)
.++|++.+.||.|++|.||+|.+. +++.+++|.+...... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999965 5888999988644322 223466799999999999999999987654 4569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++|+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 v~e~~~~-~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~ 153 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLA 153 (293)
T ss_pred EehhcCc-CHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCce
Confidence 9999874 8888874322 2589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc---
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD--- 269 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 269 (351)
....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.....................
T Consensus 154 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 154 REYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred eeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 7654432 112334567789999988754 4688999999999999999999999754321100000000000000
Q ss_pred --------h--hHHHhhcCccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 --------R--EKILEIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 --------~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. ..........+...++.. ....+.++|.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000000011111111 24568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=266.89 Aligned_cols=238 Identities=23% Similarity=0.417 Sum_probs=182.9
Q ss_pred ceeeecCceEEEEEEEc-CC-------cEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEE
Q 018744 47 NVVGHGGFGLVYRGVLS-NG-------RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~-~~-------~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~ 117 (351)
+.||.|+||.||+|... .+ ..+++|.+........+.+..|..+++.++|||++++++++... ..++||+|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999853 22 34777877544444446778899999999999999999988764 56799999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc--------EEEee
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--------AKVSD 189 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~--------v~l~d 189 (351)
+.+|+|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++. ++++|
T Consensus 81 ~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 81 VKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999985432 2578899999999999999999999 9999999999999977655 69999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCC-CCCCCCCCCCCcceeecccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGR-VPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
||.+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+.
T Consensus 152 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------------- 212 (258)
T cd05078 152 PGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------------- 212 (258)
T ss_pred cccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------------
Confidence 998764322 122446778999999886 45789999999999999999984 565432211
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
......... ...+......+.+|+.+||+.+|++|||+.++++.|
T Consensus 213 ----~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 213 ----KKLQFYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----HHHHHHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 001111111 112222335689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=260.63 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=198.2
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+++++.++|+|++++++++.+.. .++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999854 678899999875543 34467889999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++... ..+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 81 AENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred CCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 9999999988432 4689999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
..... .....++..|+|||...+..++.++|||+||+++|+|++|..||...... .......
T Consensus 151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~ 212 (254)
T cd06627 151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----------------AALFRIV 212 (254)
T ss_pred CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHh
Confidence 43321 23345778899999988877899999999999999999999998643210 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......+......+.+++.+||..+|++|||+.+++.+
T Consensus 213 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 213 -QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 011112222334578999999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=274.77 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=194.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC------C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 110 (351)
.++|.+.+.||.|++|.||+|.. .++..+++|.+... .......+..|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999995 46899999988643 223345667899999999999999999977543 2
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++|+. ++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-------SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 579999986 678887732 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc----
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP---- 265 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~---- 265 (351)
|++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.............
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9987653321 12233456788999998765 4689999999999999999999999975432100000000000
Q ss_pred ---cccchhHHHhhcCc---cccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 266 ---RLTDREKILEIMDP---ALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 266 ---~~~~~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.............. .... ......+..+.+||.+||+.+|++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000000 0000 0011234568999999999999999999999999
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.26 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=192.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC------Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 111 (351)
.++|++.+.||+|++|.||+|.+ .+|+.|++|.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999985 468899999986422 22345677899999999999999999877543 24
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++++.+ +|.+.+.. ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~~-~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEehhccc-CHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 688888864 77766622 3588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc-eecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 192 LAKIGSDKAGGH-VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 192 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
++.......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+........ ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~-~~~~~~~~ 230 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI-LGVLGTPS 230 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCC
Confidence 987643322111 1123457888999998754 46889999999999999999999999654321000000 00000000
Q ss_pred hhHHHhhcCcc---------ccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPA---------LEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~---------~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+.... .....+ ......+.+++.+||+.+|++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111100000 000000 1123468899999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.66 Aligned_cols=252 Identities=29% Similarity=0.391 Sum_probs=194.9
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+.|...+.||+|+||.||++.+ .++..+++|.+...... ....+..|+++++.++|+|++++++++.+++ .++|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4488899999999999999995 46889999988643222 2346778999999999999999999887664 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+ ++.+.+... ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 105 e~~~g-~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 105 EYCLG-SASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred eCCCC-CHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 99965 777666432 23588999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... .....++..|+|||.+. ++.++.++|||||||++|+|++|..||..... ...
T Consensus 175 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----------------~~~ 232 (317)
T cd06635 175 ASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSA 232 (317)
T ss_pred cCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----------------HHH
Confidence 332 12345777899999874 45688999999999999999999999864321 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+................+.+++.+||+.+|.+||++.+++++...+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1111111111111223345689999999999999999999999986654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=270.88 Aligned_cols=270 Identities=21% Similarity=0.252 Sum_probs=194.1
Q ss_pred CCCcCceeeecCceEEEEEEEc---CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcC--C-eE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--R-KL 112 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~-~~ 112 (351)
+|.+.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.++..++||||+++++++.+. . .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999954 47899999987532 33346677899999999999999999998766 3 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC----CCcEEEe
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----NFHAKVS 188 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~----~~~v~l~ 188 (351)
+|++++.+ ++.+++...... ....++...++.++.|++.||.|||+. +++|+||+|+||+++. ++.++|+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 89999875 666665432211 123688999999999999999999999 9999999999999999 9999999
Q ss_pred ecccccccCCCCCCc-eecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc---
Q 018744 189 DFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA--- 263 (351)
Q Consensus 189 dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--- 263 (351)
|||++.......... ......++..|+|||++.+. .++.++|||||||++|+|++|..||...............
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 999987654432211 12234567889999988764 5789999999999999999999999865543200000000
Q ss_pred --------cccccchh------HHHhhcCccccCCCC---------H--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 --------LPRLTDRE------KILEIMDPALEGQYS---------M--KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 --------~~~~~~~~------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+...... ......+......++ . .....+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 000000000000111 0 223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=273.43 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=196.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 111 (351)
..+|++.+.||.|++|.||+|... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999954 68999999986432 23345677899999999999999999877532 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|++|+. ++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-------DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEehhh-hhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 69999985 588888732 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC--ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc-
Q 018744 192 LAKIGSDKAGG--HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL- 267 (351)
Q Consensus 192 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~- 267 (351)
++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 98764332211 11223467888999998765 468899999999999999999999997544321100000000000
Q ss_pred ------cchhHHHhhcCccc-cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 ------TDREKILEIMDPAL-EGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ------~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+....+... .... ....+..+.++|.+||+.+|.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000111111000 0011 11235679999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=266.28 Aligned_cols=269 Identities=22% Similarity=0.252 Sum_probs=192.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccC-CCcceeeeEEEEcCC------
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLR-SPYLLALLGYCSDRR------ 110 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~------ 110 (351)
++|++.+.||+|++|.||+|.+. +++.+++|.+..... .....+.+|+.+++.+. |+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999954 688999998764322 22356778999999995 699999999886543
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEee
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSD 189 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~d 189 (351)
.+++++|+.+ +|.+++...... ....+++..++.++.||+.||.|||++ +++|+||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 4799999986 788887543321 124689999999999999999999999 9999999999999998 88999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....................
T Consensus 155 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 155 LGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred cccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999875433221 1122345778999998865 4578999999999999999999999975432110000000000000
Q ss_pred -----chhHHHhhc-----CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 -----DREKILEIM-----DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 -----~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......... .+.............+.+||.+||..||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 0000000011234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=266.38 Aligned_cols=270 Identities=25% Similarity=0.289 Sum_probs=194.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 113 (351)
.++|++.+.||.|++|.||+|.+. +|+.|++|.+...... ....+.+|+.+++.++|+|++++++++... ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999954 6899999988643222 123456799999999999999999988654 3469
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|++|+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 86 v~e~~~~-~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEecCCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 9999865 7887774322 4689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch--
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR-- 270 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 270 (351)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..................
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 156 RTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 76543321 1122334677999998865 467899999999999999999999997544321100000000000000
Q ss_pred ------hH--HHhhcCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 271 ------EK--ILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 271 ------~~--~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
.. ........... .........+.+||.+||+.||++|||+.+++.+ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~ 294 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFK 294 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhc
Confidence 00 00000000000 0000124467889999999999999999999987 4454
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=267.45 Aligned_cols=269 Identities=20% Similarity=0.272 Sum_probs=191.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcC------
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 109 (351)
..++|++.+.||+|++|.||+|... +++.+++|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4468999999999999999999954 6889999988543222 223456799999999999999999987643
Q ss_pred ---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 110 ---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 110 ---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
..+++++|+.+ +|.+.+... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK 159 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence 23699999865 777776322 23689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCC--ceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 187 VSDFGLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
|+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+..........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999998765432221 111234467789999988654 4688999999999999999999999765432100000000
Q ss_pred c--------ccccchhHHHhhcCc-c----ccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 L--------PRLTDREKILEIMDP-A----LEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~--------~~~~~~~~~~~~~~~-~----~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. +.............+ . ..... .......+.+||.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 000000000000000 0 00000 00012357789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=263.25 Aligned_cols=243 Identities=28% Similarity=0.452 Sum_probs=188.9
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||.|++|.||++.+. +++.+++|.+..... .....+..|+++++.++|+|++++++.+.... .+++++++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 688999999999965 589999999864433 33456788999999999999999998877654 5699999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC--
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG-- 201 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~-- 201 (351)
.+++... ..+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 81 ASLLENV-------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred HHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence 9998432 3689999999999999999999999 999999999999999999999999999876433211
Q ss_pred ----CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 202 ----GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 202 ----~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
........++..|+|||.+.+...+.++||||||+++|+|++|..||....+ ......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~~~ 214 (265)
T cd05579 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEIFQNIL 214 (265)
T ss_pred cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHh
Confidence 1122334567789999999888889999999999999999999999964332 11111222
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+.+++.+||+.+|++|||+..+.+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 215 NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 1111111111125678999999999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=275.69 Aligned_cols=245 Identities=31% Similarity=0.415 Sum_probs=197.4
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCCh---HHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGE---DEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
..|+-.+.||.|+||.||.|++ .+.+.|+||.+.....+.. +.+.+|+..|++++|||++.+.+++..++. ++||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466788999999999999995 4678899999875544443 567789999999999999999998876654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+||-| +-.+++.- ..+++-+..|..|+.+.+.||+|||++ +.+|+|||..|||+++.|.|||+|||.+..
T Consensus 106 EYClG-SAsDlleV------hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV------HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHhc-cHHHHHHH------HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhh
Confidence 99965 66666632 235789999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... ....+||+.|||||++. .+.|+-+.||||||++..+|...++|+-..+. +..-..
T Consensus 176 ~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------------MSALYH 236 (948)
T KOG0577|consen 176 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------MSALYH 236 (948)
T ss_pred cCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------------HHHHHH
Confidence 433 35678999999999986 67899999999999999999999999753332 111111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+...-.+.+ ...+....++.|+..||+.-|.+|||..+++.|
T Consensus 237 IAQNesPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 237 IAQNESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhcCCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111222 134556689999999999999999999999887
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.20 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=189.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||+|+||.||++... +|+.+++|.+.... ......+..|+++++.++|||++++++.+...+ .++|++|+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886432 223345677999999999999999999887654 5699999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 149 (277)
T cd05577 81 KYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--- 149 (277)
T ss_pred HHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence 998854321 3688999999999999999999999 99999999999999999999999999887543311
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+...... ...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~-~~~ 215 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-------------EKEELKRRTLE-MAV 215 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-------------cHHHHHhcccc-ccc
Confidence 1223456778999999988889999999999999999999999997543210 01111111110 111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..+......+.++|.+||+.+|++|| ++.+++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 22223355789999999999999999 77777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=267.36 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=198.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v 114 (351)
++|.+.+.||.|++|.||++... +++.+++|++.... ......+..|+++++.++ |+||+++++++... ..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999954 78999999986422 222356778999999998 99999999988665 45699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+++.+++|.+++... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 81 LEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 9999999999998533 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCC------------------ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 195 IGSDKAGG------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 195 ~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
........ .......++..|+|||.+.+..++.++||||||+++++|++|..||.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--- 227 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--- 227 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---
Confidence 65443211 112233467889999998888899999999999999999999999974331
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM----ADVVQS 317 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~----~eil~~ 317 (351)
......... .....+...+..+.+++.+||+.+|++|||+ .+++.+
T Consensus 228 -------------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 -------------YLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -------------HHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111111 1122233335578999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=261.11 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=196.5
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
+|++.+.||.|++|.||++... ++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.... .+++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999954 57889999886432 233456788999999999999999999887664 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-EEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-AKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~-v~l~dfg~~~~~ 196 (351)
+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 81 CDGGDLMKRINRQR-----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999999885432 12578999999999999999999999 9999999999999988764 699999988765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 153 ~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~ 214 (257)
T cd08225 153 NDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----------------HQLVLKI 214 (257)
T ss_pred cCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------HHHHHHH
Confidence 4322 112234578889999999888899999999999999999999999864321 1112222
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... .........+.+++.+||..+|++|||+.+++.+
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 CQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred hcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 221111 1122334579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=266.17 Aligned_cols=264 Identities=21% Similarity=0.268 Sum_probs=191.7
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
|++.+.||.|++|.||+|.+. +|..+++|++..... .....+.+|+++++.++|+|++++++++.+.. .+++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999954 689999998864432 22356778999999999999999999887764 45899998
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
. ++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 81 D-LDLKKYMDSSP-----LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred C-cCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 5 68888874322 13689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch-------
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR------- 270 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 270 (351)
... ......++..|+|||++.+. .++.++||||||+++|+|++|..||......................
T Consensus 152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 221 11223457789999987654 57889999999999999999999997543211000000000000000
Q ss_pred -hHHHhhcCcc---ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 -EKILEIMDPA---LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 -~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... ............+.++|.+||+.+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 0000111223568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=271.96 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=196.9
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC------CeE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 112 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 112 (351)
+|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|+||+++.+++... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999964 58899999886543 33446788899999999999999999988665 356
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
++++|+. ++|.+++.. ...+++..++.++.|++.||.+||+. +++|+||+|.||+++.++.++|+|||+
T Consensus 81 lv~e~~~-~~l~~~l~~-------~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 81 IVTELME-TDLHKVIKS-------PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred EEecchh-hhHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 8999887 478887742 23789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc---
Q 018744 193 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL--- 267 (351)
Q Consensus 193 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~--- 267 (351)
+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 9875443210 112334567889999999877 78999999999999999999999997654211000000000000
Q ss_pred ----cchhHHHhhcC---cccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 ----TDREKILEIMD---PALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ----~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.........+. .... .......+..+.++|.+||+.+|++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 0000 00011234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=259.10 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=190.3
Q ss_pred HHHHHHHhcCCCcCcee--eecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 33 FKQLHSATGGFSKSNVV--GHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~l--g~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
+.+.....++|.+.+.+ |+|+||.||++.. .++..+++|.+........ |......+ +|+|++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556788888877 9999999999995 4688899998864322211 22222222 69999999998876
Q ss_pred CC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEE
Q 018744 109 RR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAK 186 (351)
Q Consensus 109 ~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~ 186 (351)
.+ .++|+||+.+++|.+++... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++ .++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEE
Confidence 54 56999999999999998432 3789999999999999999999999 999999999999999988 999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~----------- 213 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE----------- 213 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-----------
Confidence 9999988754322 22357788999999998889999999999999999999999997433210
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~ 317 (351)
.............. ......+..+.+||.+||+.+|.+||+ +.+++++
T Consensus 214 -~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 214 -LDLESLLKRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -hhHHHHHHhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111111111111 122234567999999999999999996 5998865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=253.89 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=200.0
Q ss_pred HhcCCCcC-ceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-----C
Q 018744 39 ATGGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-----R 110 (351)
Q Consensus 39 ~~~~y~~~-~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~ 110 (351)
..++|++. ++||-|-.|+|..+.+ .+++++|+|++.. ....++|+++.-.. .||||+.+++++++. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45678775 4799999999999885 4799999999853 23456788877666 699999999998764 2
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEE
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKV 187 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l 187 (351)
..+|||.++||.|.+.+.+.+. ..+++..+..|+.||+.|+.|||+. +|.||||||+|+|... +..+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 3489999999999999966542 4699999999999999999999999 9999999999999954 567999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... .....+.|+.|.|||++....|+.++|+||+|+++|-|++|..||....-. .+
T Consensus 206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----ai------- 271 (400)
T KOG0604|consen 206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AI------- 271 (400)
T ss_pred cccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cC-------
Confidence 9999998654322 234567799999999999999999999999999999999999999643221 00
Q ss_pred cchhHHHhhcCccccCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 268 TDREKILEIMDPALEGQYS----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
..+....+..... .++ ...++...++|+.+|+.+|.+|.|+.+++.+ .++.+...
T Consensus 272 -spgMk~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h--pwi~~~~~ 330 (400)
T KOG0604|consen 272 -SPGMKRRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH--PWINQYEA 330 (400)
T ss_pred -ChhHHhHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC--chhccccc
Confidence 0111111211111 122 2335678889999999999999999999988 55555444
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=272.44 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=189.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|.+.+.||+|++|.||+|.+. +++.+++|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999954 68999999886432 22235577899999999999999999987643
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..+++++++.. +|..+. ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred eEEEEeccccc-CHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 23688888754 565544 12578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+............. ....
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~ 234 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV-TGVP 234 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCC
Confidence 9998754321 123456778999999876 46889999999999999999999999764421100000000 0000
Q ss_pred chhHHHhh-----------cCccccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEI-----------MDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~-----------~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........ .......... ......+.+||.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000000000 1123468899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.69 Aligned_cols=259 Identities=23% Similarity=0.268 Sum_probs=187.1
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccC-CCcceeeeEEEEcC---CeEEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLVYD 116 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~---~~~~v~~ 116 (351)
|++.+.||+|++|.||+|... +++.+++|.+...... ......+|+..+..+. |+|++++++++.+. ..++|++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999954 6889999988653222 2223346888888885 99999999988765 4459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+ ++.+.+... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||.+...
T Consensus 81 ~~~~-~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMDM-NLYELIKGR------KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCCc-cHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 9974 777776432 13689999999999999999999999 9999999999999999 99999999998765
Q ss_pred CCCCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ......++..|+|||.+. +..++.++|||||||++|+|++|..||...+................ .....
T Consensus 150 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 224 (282)
T cd07831 150 YSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD--AEVLK 224 (282)
T ss_pred ccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCC--HHHHH
Confidence 3322 112345678899999765 45678899999999999999999999976543110000000000000 00000
Q ss_pred hcCcc--ccCC-----------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPA--LEGQ-----------YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~--~~~~-----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... .... .....+..+.++|.+||+.+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 0000 011235689999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.82 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=194.1
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
+|++.+.||.|++|.||+|.+. ++..+++|.+..... .....+..|+.+++.++|+|++++++++.+.. .++|++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999965 688999998875433 23456778999999999999999999987764 46999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~-~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHG----VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcC----CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 75 7888774432 124689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. .......++..|++||.+.+. .++.++||||||+++|+|++|..||...+............. .........+.
T Consensus 153 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (284)
T cd07836 153 PV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGIS 229 (284)
T ss_pred Cc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHh
Confidence 21 112234567789999988654 568899999999999999999999976543210000000000 00000000000
Q ss_pred C-ccccC-----------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 278 D-PALEG-----------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 278 ~-~~~~~-----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. +.+.. .........+.+++..||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 00000 0011224568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=280.70 Aligned_cols=250 Identities=21% Similarity=0.384 Sum_probs=204.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeE-EEEcCCeEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~v~~~~ 118 (351)
+-|.|++.||-|+||+||+|..+ ++-..|.|++...+......+.-|+++|....||+|+++++ ||.++..+++.+||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45889999999999999999965 45556788888777888888999999999999999999998 55666778999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.||-+...+.... ..+.+.++.-+++|++.||.|||++ +|+|+|||..|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred CCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999886544 4789999999999999999999999 999999999999999999999999999864222
Q ss_pred CCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
. ........||+.|||||+.. ..+|..++||||||+++.+|..+.+|....++. ..+
T Consensus 183 t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVl 244 (1187)
T KOG0579|consen 183 T--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVL 244 (1187)
T ss_pred H--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHH
Confidence 1 12234567999999999875 458999999999999999999999997643331 222
Q ss_pred HhhcCcccc-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+-..... --.+......+.+|+..||..||..||++.++++|
T Consensus 245 lKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 245 LKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 222221111 12234455689999999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.03 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=195.9
Q ss_pred CceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEccCCCh
Q 018744 46 SNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 123 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~~~~L 123 (351)
...||+|++|.||++.. .+++.+++|.+..........+.+|+.+++.++|+|++++++.+... ..+++++|+.+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 46889999988655444556788899999999999999999988765 45699999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++.. ..+++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 105 ~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-- 171 (292)
T cd06657 105 TDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 171 (292)
T ss_pred HHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence 987732 2578899999999999999999999 999999999999999999999999998765433221
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.......+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------------~~~~~~~~~~~~~~~~ 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------KAMKMIRDNLPPKLKN 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHhhCCcccCC
Confidence 122345778899999998888899999999999999999999999643321 0000111111111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.......+.+++.+||..+|.+||++.+++++ .++....
T Consensus 239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred --cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccC
Confidence 11233468899999999999999999999986 5555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=259.21 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=201.7
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEE-cC----CcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVL-SN----GRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~----~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
.......|++.+.||+|++|.||+|.. ++ ...+|+|.++.. ........-+|+.+++.++|+|++.+..++..
T Consensus 19 rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 19 RVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred hHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 334557899999999999999999962 22 236899988643 22333556779999999999999999998865
Q ss_pred C--CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC----
Q 018744 109 R--RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---- 182 (351)
Q Consensus 109 ~--~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~---- 182 (351)
. ..+++++|.+. +|...++..... ....++...+..++.||+.|+.|||++ -++||||||.||+|..+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~--~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRAS--KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccc--hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence 3 34589999877 788887665432 335899999999999999999999999 99999999999999877
Q ss_pred CcEEEeecccccccCCCCCCc-eecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce-
Q 018744 183 FHAKVSDFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL- 259 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~- 259 (351)
|.|||+|+|+++.+..+.... .....+.|..|.|||++.|. .|+++.|||++||++.||+|....|.+.........
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 999999999999877655433 23345678899999998865 799999999999999999999999987654322110
Q ss_pred ----------------eecccccccchhHHHhhcCccccCCCCHH------------HHHHHHHHHHhccCCCCCCCCCH
Q 018744 260 ----------------VSWALPRLTDREKILEIMDPALEGQYSMK------------EVIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 260 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
.+...+.+.+-......+..... .+..+ ...+..+|+..||+.||.+|.|+
T Consensus 253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~-~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR-HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHH-hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 00000000000000000000000 00000 01247789999999999999999
Q ss_pred HHHHHH
Q 018744 312 ADVVQS 317 (351)
Q Consensus 312 ~eil~~ 317 (351)
.+.+++
T Consensus 332 ~qAleh 337 (438)
T KOG0666|consen 332 EQALEH 337 (438)
T ss_pred HHHhcc
Confidence 999998
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=271.29 Aligned_cols=267 Identities=23% Similarity=0.300 Sum_probs=194.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC---Ce
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~---~~ 111 (351)
..++|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+.+++.+ +|+||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999965 6888999987532 222334566799999999 999999999987643 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|++++. ++|..++.. ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g 152 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA--------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG 152 (337)
T ss_pred EEEecccc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence 69999997 488887732 2578889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 192 LAKIGSDKAGG---HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 192 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 98765443221 12223457888999998764 467889999999999999999999996543221100000000000
Q ss_pred cc-------hhHHHhhcCccccCC------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TD-------REKILEIMDPALEGQ------YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~-------~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. .......++...... .....+..+.++|.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 000000111000000 001134578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=262.35 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=193.0
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYD 116 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~~ 116 (351)
|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+..|+++++.++|+|++++++++.+. ..+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 58899999987553 23345677899999999999999999988765 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+ +|.+++.... ..+++..++.++.|++.||++||+. +++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9975 7888874321 3689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch--hHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR--EKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~ 273 (351)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...................... ...
T Consensus 151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 44321 11233445778999998765 457899999999999999999999997544211000000000000000 000
Q ss_pred -----Hhhc------CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 -----LEIM------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 -----~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... ...+...+....+..+.+++.+||+.+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0000000000124578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=265.15 Aligned_cols=248 Identities=29% Similarity=0.382 Sum_probs=191.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.+.|...+.||.|++|.||+|+.. ++..+++|.+..... .....+.+|+++++.++|+|++++.+++.... .++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345888899999999999999954 678899998753222 22345778999999999999999999887664 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+. +++.+.+... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~e~~~-~~l~~~~~~~------~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 94 MEYCL-GSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred EEccC-CCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccce
Confidence 99996 5777766432 23588999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
..... ....++..|+|||.+. ...++.++|||||||++|+|++|..||..... ..
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~ 221 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MS 221 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH----------------HH
Confidence 54321 2345677899999874 35678899999999999999999999854221 01
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.....................+.+||.+||..+|++||++.+++++-.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111111111111112234457899999999999999999999998843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.37 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=190.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
++|++.+.||.|.+|.||+|.+. +++.+++|.+..... .....+..|+++++.++|+|++++++++.+. ..++|++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999965 688999998864322 2335678899999999999999999998776 4559999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~~ 195 (351)
|+. ++|.+++.... ...+++..++.++.||+.||.|||++ +++|+||+|+||+++. ++.++|+|||++..
T Consensus 82 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred ccc-ccHHHHHHhCC-----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 986 47777763322 12467889999999999999999999 9999999999999985 56799999999875
Q ss_pred cCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc--------c
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------R 266 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~ 266 (351)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................. .
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 43321 11233456778999998865 4578999999999999999999999975432100000000000 0
Q ss_pred ccchhHHHhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
................. .........+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000 0011123468899999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=261.46 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=208.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeE-EEEcCCeEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~v~~~~ 118 (351)
+-|-++++||+|++|.||+|.++ +|..+++|.+.. ..+.+.+.+|+.++.+...++++++++ ||...+.++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 44778889999999999999954 799999999864 456788999999999999999999999 66777899999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
..|++.+.+..++ +++++..+..+++..+.||+|||.. .-+|||||..|||++.+|..||+|||.+-.+..
T Consensus 111 GAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 111 GAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred CCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 9999999996544 6899999999999999999999999 999999999999999999999999999875443
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......||+.|+|||++..--|..++||||||++..+|..|+.||..--|......+....
T Consensus 182 TM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P-------------- 245 (502)
T KOG0574|consen 182 TM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP-------------- 245 (502)
T ss_pred hH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC--------------
Confidence 22 22345779999999999998889999999999999999999999997654432222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...-..+...+.++.+|+++||-.+|++|-|+.++++|
T Consensus 246 -PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 -PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11112233445678999999999999999999999988
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=265.49 Aligned_cols=259 Identities=15% Similarity=0.187 Sum_probs=179.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCCCChH-----------HHHHHHHHHhccCCCcceeee
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGED-----------EFKMEVELLGRLRSPYLLALL 103 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~~ 103 (351)
..++|.+.+.||+|+||.||+|.+.+ +..+++|+.......... ....++..+..+.|++++.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34789999999999999999999543 445666754433222111 111233445566899999999
Q ss_pred EEEEcCC-----eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 104 GYCSDRR-----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 104 ~~~~~~~-----~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
+...... .+++++++. .++.+.+... ...++..++.++.|++.||.|||+. +++||||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil 158 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM 158 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 8654432 134555443 3555554221 2356788999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCC-----ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCC
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~ 253 (351)
++.++.++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999998765322111 111234689999999999999999999999999999999999999975432
Q ss_pred CCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 254 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.... .. .........+...... ....+..+.+++..||+.+|++||++.++++.|
T Consensus 239 ~~~~--~~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 239 NGNL--IH-----AAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred chHH--HH-----HhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100 00 0000011111111111 112245689999999999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=261.28 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=194.1
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
|.+.+.||.|++|.||++... +++.+++|.+...... ....+..|+.+++.++|+|++++++++.... .+++++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999954 6889999988644322 3456778999999999999999999887664 45999998
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+ ++..++.... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 81 DT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 75 7877774322 4689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc--------cccc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------RLTD 269 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~~~~ 269 (351)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+............. ....
T Consensus 151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 32 112234567789999998876 789999999999999999999999965442110000000000 0000
Q ss_pred --hhHHHhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 --REKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 --~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........... ............+.++|.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 0001112345689999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=267.65 Aligned_cols=273 Identities=22% Similarity=0.317 Sum_probs=195.8
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR- 109 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 109 (351)
.++-.+.++|.+.+.||+|+||.||++.. .+++.|++|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556679999999999999999999984 478899999886432 22235677899999999999999999987542
Q ss_pred -----C-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 110 -----R-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 110 -----~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
. .++++++ .+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++
T Consensus 90 ~~~~~~~~~lv~~~-~~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 90 SLEEFNDVYLVTHL-MGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccEEEEehh-cccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 1 2355554 47788877632 3588999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee-e
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-S 261 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~ 261 (351)
.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ .
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754321 233456788999998866 46788999999999999999999999643321000000 0
Q ss_pred -------cccccccc--hhHHHhhcCccccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 262 -------WALPRLTD--REKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 262 -------~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
........ .......+.......+. ......+.+||.+||+.||.+|||+.+++.+ .++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~f~~~ 306 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQY 306 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC--hhhhhc
Confidence 00000000 00000000000000000 0123468899999999999999999999988 455543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=266.89 Aligned_cols=275 Identities=20% Similarity=0.224 Sum_probs=194.1
Q ss_pred HHhcCCCc-CceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC--------------hHHHHHHHHHHhccCCCccee
Q 018744 38 SATGGFSK-SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--------------EDEFKMEVELLGRLRSPYLLA 101 (351)
Q Consensus 38 ~~~~~y~~-~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~ 101 (351)
...++|.. .+.||.|++|.||+|.+. +++.+++|.+....... ...+.+|+++++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 34577875 567999999999999954 68899999885432211 124678999999999999999
Q ss_pred eeEEEEcCCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC
Q 018744 102 LLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180 (351)
Q Consensus 102 ~~~~~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~ 180 (351)
+++++..... +++++++. ++|.+++.. ...++...+..++.|++.||.+||+. +++|+||+|+||+++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~ 153 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDR-------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFIN 153 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEEC
Confidence 9998876654 58999986 588888732 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC------------CceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCC
Q 018744 181 KNFHAKVSDFGLAKIGSDKAG------------GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVP 247 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~p 247 (351)
.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999876541110 1111223457789999998764 468999999999999999999999
Q ss_pred CCCCCCCCCcceeecccccccch--hHHHhh-----cCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 248 IDVNKPSGEGVLVSWALPRLTDR--EKILEI-----MDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 248 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
|...................... .....+ ....... .........+.++|.+||+.+|++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 97554311000000000000000 000000 0000000 0001123468899999999999999999999986
Q ss_pred HHHhhhcc
Q 018744 318 LVPLVKYN 325 (351)
Q Consensus 318 l~~~~~~~ 325 (351)
.+++..
T Consensus 314 --~~~~~~ 319 (335)
T PTZ00024 314 --EYFKSD 319 (335)
T ss_pred --cccCCC
Confidence 555533
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.02 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=194.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 109 (351)
..+|++.+.||.|++|.||+|.. .++..+++|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999995 46889999998766555667788899999999999999999866543
Q ss_pred ------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-CC
Q 018744 110 ------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KN 182 (351)
Q Consensus 110 ------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-~~ 182 (351)
..+++++|+. ++|.+++.. ..+++..++.++.||+.||.|||+. +++|+||+|+||+++ .+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 2468999986 578777732 3588999999999999999999999 999999999999997 45
Q ss_pred CcEEEeecccccccCCCCCCc-eecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 183 FHAKVSDFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
+.++|+|||.+.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+.......
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 678999999987643322111 1122356778999998654 56788999999999999999999999754321110000
Q ss_pred eccccccc--chhHHH----hhcC-ccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 261 SWALPRLT--DREKIL----EIMD-PALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 261 ~~~~~~~~--~~~~~~----~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
....+... ...... .... .......+ ......+.+|+.+||+.||++|||+.+++.+ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--~~~~ 304 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH--PYMS 304 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC--Cccc
Confidence 00000000 000000 0000 00000000 1123468899999999999999999999987 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.67 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=188.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
++|...+.||+|+||.||++.+. +++.+++|.+..... .....+..|+.++.++. |+||+++++++..+ ..+++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35677889999999999999954 688999998864332 23456778999999996 99999999987665 4558888
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
++.. ++.++...... .....+++..+..++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~-~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 84 LMDI-SLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred cccC-CHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 8754 55444321100 112468999999999999999999996 5 899999999999999999999999999865
Q ss_pred cCCCCCCceecccCCCcccccccccccC---CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|..||...... ...
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~ 219 (288)
T cd06616 158 LVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---------------FDQ 219 (288)
T ss_pred hccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---------------HHH
Confidence 43321 11233577889999998765 6889999999999999999999999643210 011
Q ss_pred HHhhcC---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..... +.+........+..+.+|+.+||+.+|++|||+.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111111112345579999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.64 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=192.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC----
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR---- 110 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 110 (351)
...++|++.+.||.|++|.||+|... +++.+++|.+..... .....+..|+.+++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999965 588999999864322 22345677999999999999999999886543
Q ss_pred -------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 111 -------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 111 -------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
.+++++|+.+ ++...+... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 4699999876 666666322 23689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
.++|+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..............
T Consensus 154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999876543321 11122345667999998764 3568899999999999999999999975332100000000
Q ss_pred ccccccc--hhHHHhh-----cC------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 263 ALPRLTD--REKILEI-----MD------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 263 ~~~~~~~--~~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... ...+.+. .+ ....... ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0000000 00 0000000 0123568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.90 Aligned_cols=263 Identities=29% Similarity=0.552 Sum_probs=200.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
....|.....||+|+||.||+|.. .++..|++|.+....... ..|++.+++++||||+++++++.+. ..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345688889999999999999996 578899999886432221 3468899999999999999999766 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+++|+|.+++. .+++..+..++.|++.||+|||..+.++++|+||||+||+++.++..++. ++.....
T Consensus 764 y~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 764 YIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999993 47889999999999999999995444499999999999999998887765 5543321
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.. .....++..|+|||++.+..++.++|||||||++|||++|+.||+..... ......|..... ........
T Consensus 833 ~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~ 904 (968)
T PLN00113 833 CT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCY-SDCHLDMW 904 (968)
T ss_pred cc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhc-Cccchhhe
Confidence 11 12235678999999999999999999999999999999999999543221 111111211111 11122334
Q ss_pred cCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 277 MDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 277 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+++.+.. .....+...+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 4444432 23445666889999999999999999999999999998774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=259.82 Aligned_cols=288 Identities=24% Similarity=0.366 Sum_probs=215.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhc--cCCCcceeeeEEEEcC-----CeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR-----RKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~-----~~~ 112 (351)
.....+.+.||+|.||.||+|.. +++.||||++.. ...+.+..|-+++.. ++|+||+.+++.-... +.+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45577888999999999999997 448999999964 345567777777665 5899999999876433 456
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCceecCCCCCcEEeCCCCcEE
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------SPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
+|++|.+.|+|.+++.. ..++|....+|+..|++||+|||... ...|+|||||.+||||.+|+++.
T Consensus 285 LVt~fh~kGsL~dyL~~--------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred EEeeeccCCcHHHHHHh--------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 99999999999999943 36899999999999999999999764 35799999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCC-CC-----CccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LT-----TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s-----~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
|+|||++..+.............||.+|||||++.+.. .. .+.||||+|.++|||++...-+............
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 99999999877655444445588999999999987542 22 4689999999999999988777532211122222
Q ss_pred ecccccccchhHHHhhc-CccccCCCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCCCCC
Q 018744 261 SWALPRLTDREKILEIM-DPALEGQYSMK-----EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSS 334 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~~~~~ 334 (351)
.......+.-+.+.+++ .++.+..++.. ....+++.+..||..||+-|.|+.=+-+.+.++..-.+. +...++
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~-~~~~s~ 515 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED-SSGESS 515 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc-cCCccc
Confidence 22333333344444433 23333333322 234789999999999999999999999999998875544 344444
Q ss_pred CCcccC
Q 018744 335 PSFHAS 340 (351)
Q Consensus 335 ~~~~~~ 340 (351)
++...+
T Consensus 516 ~~~~~~ 521 (534)
T KOG3653|consen 516 SSLVTP 521 (534)
T ss_pred cccCCC
Confidence 444333
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=267.20 Aligned_cols=273 Identities=22% Similarity=0.299 Sum_probs=196.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC--
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-- 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 110 (351)
+....++|++.+.||+|++|.||++.. .++..+++|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334567899999999999999999984 468899999885322 222345778999999999999999999886542
Q ss_pred -----eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 111 -----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 111 -----~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
.++|++++ +++|..++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 36899988 6788877732 3588999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 264 (351)
+|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998754322 123456778999998875 457899999999999999999999997543210000000000
Q ss_pred cc--------c--cchhHHHhhcCccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 265 PR--------L--TDREKILEIMDPALEGQ---YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 265 ~~--------~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.. . .........+....... ........+.++|.+||+.||++|||+.+++.+ .+++..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~--~~~~~~~~ 306 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH--PYFEEFHD 306 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC--ccHhhhcC
Confidence 00 0 00000000000000000 001123368899999999999999999999976 55554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=266.42 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=187.6
Q ss_pred ceeeec--CceEEEEEEE-cCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHG--GFGLVYRGVL-SNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G--~~g~v~~~~~-~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
..||.| +++.||++.+ .+++.|++|++...... ..+.+.+|+.+++.++||||+++++++..+. .+++++|+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999996 47899999998643222 2356788999999999999999999998765 4599999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
+++.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 84 GSANSLLKTYF-----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred CCHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 99999885532 12588999999999999999999999 99999999999999999999999997654322111
Q ss_pred CCc-----eecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc-ee------eccccc
Q 018744 201 GGH-----VSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LV------SWALPR 266 (351)
Q Consensus 201 ~~~-----~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~------~~~~~~ 266 (351)
... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......... .. .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 100 01112345569999998764 47899999999999999999999997543210000 00 000000
Q ss_pred ccch-----------------hHHH-----hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDR-----------------EKIL-----EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~-----------------~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... .... ......+...........+.+|+++||..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0000 0011111122223455689999999999999999999999977
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=261.34 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=196.9
Q ss_pred CCCcCceeeecCceEEEEEEE----cCCcEEEEEEccccC----CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~- 111 (351)
+|++.+.||.|++|.||++.. .++..+++|.+.... ......+..|+.++..+ +|++|+++++.+.....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999884 256789999886321 22335677899999999 59999999988876644
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|++|+.+++|.+++.. ...+++..+..++.|++.+|.+||+. +++|+||+|.||+++.++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred EEEEecCCCCcHHHHHhh-------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence 599999999999998843 23588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCC--CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
++........ .......++..|+|||.+.+.. .+.++||||||+++|+|++|..||........ .
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------------~ 217 (288)
T cd05583 151 LSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS------------Q 217 (288)
T ss_pred cccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch------------H
Confidence 9876433221 1122345778899999987654 78899999999999999999999964322100 0
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
........... ...+......+.+++.+||+.+|++|||+.++.+.|+-..-++..+
T Consensus 218 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 218 SEISRRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHHHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00011111111 1222233456899999999999999999887777665554444433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=264.16 Aligned_cols=265 Identities=27% Similarity=0.382 Sum_probs=211.6
Q ss_pred ceeeeHHHHHHHh-cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceee
Q 018744 28 LQVFTFKQLHSAT-GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL 102 (351)
Q Consensus 28 ~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~ 102 (351)
+.++++-|.-..+ +.|+.-+.||.|+||.|+-++ ..+|+.+|.|.+..+ ..........|-.+|.+++.+.|+.+
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 4556665554443 778889999999999999998 457999999877532 33445567789999999999999998
Q ss_pred eEEEEcC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 103 LGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 103 ~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
--.++.. ..++|+..|+||+|.-.+.+.+. ..+++..+.-++.+|+.||.+||+. +||+||+||+|||+|+
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd 322 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDD 322 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeecc
Confidence 7777665 56699999999999999976653 4699999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee
Q 018744 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 182 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 261 (351)
.|+++|+|+|++....... ......||.+|||||++.++.|+.+.|.|||||++|+|+.|+.||.....
T Consensus 323 ~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-------- 391 (591)
T KOG0986|consen 323 HGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-------- 391 (591)
T ss_pred CCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------
Confidence 9999999999998654432 23445899999999999999999999999999999999999999975432
Q ss_pred cccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 262 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
....+.+..... .-...++...+.+..++.+.+|..||++|.- +.++.+|
T Consensus 392 -----Kvk~eEvdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 392 -----KVKREEVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred -----hhhHHHHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 111222222111 1123556677778999999999999999984 4566666
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=256.28 Aligned_cols=238 Identities=25% Similarity=0.364 Sum_probs=180.6
Q ss_pred ceeeecCceEEEEEEE-cCCcEEEEEEccccCCCCh---HHHHHHHHH-HhccCCCcceeeeEEEEcCC-eEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGE---DEFKMEVEL-LGRLRSPYLLALLGYCSDRR-KLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~---~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~ 120 (351)
+.||.|++|.||+|.. .+++.+++|.+........ ..+..|..+ .....|+|++++++++...+ .++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999995 4688999999864322111 223334443 34458999999999987664 5699999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 149 (260)
T cd05611 82 GDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-- 149 (260)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence 9999998432 3688999999999999999999999 999999999999999999999999998875322
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~ 209 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----------------AVFDNILSRR 209 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhcc
Confidence 23345777899999998888899999999999999999999999643321 1111111111
Q ss_pred c--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 281 L--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 281 ~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
. ........+..+.+++.+||+.+|++|||+.++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 1 11111234567999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.02 Aligned_cols=268 Identities=23% Similarity=0.284 Sum_probs=189.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|++.+.||+|++|.||+|.+. +++.+++|.+...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999954 6889999988643322 224567899999999999999999876432
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..+++++|+.+ ++...+... ...+++..++.++.|+++||.|||++ +++|+||+|+||+++.++.++|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 23588888865 566655322 23689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCce---------ecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 188 SDFGLAKIGSDKAGGHV---------STRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+|||++........... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999876433221111 1123457789999987654 5789999999999999999999999754432110
Q ss_pred ceeecccccc-----cchhHHHhhcCccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 258 VLVSWALPRL-----TDREKILEIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 258 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... .....+............+ ......+.+++.+||+.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000000 0000000000000000000 0112468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.62 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=196.7
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-C-C----cceeeeEEEEcCCe-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-S-P----YLLALLGYCSDRRK- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~~- 111 (351)
.++|.++..+|+|.||.|..+.+ ..+..+|+|+++... .-.+..+-|+++|.++. + | .++.+.+|++-..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 68999999999999999999984 357899999997542 23345566999999993 2 2 35666667876644
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC----------
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---------- 181 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---------- 181 (351)
++|++.+ |.++.+++.. ....+++...+..|+.|+++++++||+. +++|.||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~-----N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-----NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred EEEEecc-ChhHHHHhcc-----CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 5777776 5689999843 2345799999999999999999999999 9999999999999931
Q ss_pred ----------CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 182 ----------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 182 ----------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
+..|+++|||.++...... .....|..|.|||++.+-.+|.++||||+||+|+|+++|...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3459999999998654433 4556788899999999999999999999999999999999999877
Q ss_pred CCCCCcceeecccccccch------------------------hHHHhhcCccc----cCCCCHHHHHHHHHHHHhccCC
Q 018744 252 KPSGEGVLVSWALPRLTDR------------------------EKILEIMDPAL----EGQYSMKEVIQVAAIAAMCVQP 303 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~ 303 (351)
+......+......+++.. +......+... .......+...|.+|++.||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 6432211111111111100 00000111000 0111234456899999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhh
Q 018744 304 EADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 304 ~P~~Rpt~~eil~~l~~~~~ 323 (351)
||.+|+|+.|++.| .+++
T Consensus 393 DP~~RiTl~EAL~H--pFF~ 410 (415)
T KOG0671|consen 393 DPARRITLREALSH--PFFA 410 (415)
T ss_pred CccccccHHHHhcC--HHhh
Confidence 99999999999987 4444
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.20 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=193.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--C
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--R 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 110 (351)
+..+.++|++.+.||.|+||.||+|... ++..+++|.+... .......+..|+++++.++|||++++.+++... .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999954 7889999987532 222345677899999999999999999988653 4
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++++ +++|..++.. ..++...+..++.|++.||.+||+. +++|+||+|.||+++.++.++|+||
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcc
Confidence 56888887 5688877732 3578888899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc---
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR--- 266 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--- 266 (351)
|.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..................
T Consensus 153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 998753221 123456778999998765 56899999999999999999999999654321000000000000
Q ss_pred -----ccchhHHHhhcCccccCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 -----LTDREKILEIMDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 -----~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........-..........+. .....+.++|.+||+.+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000111111 123578999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=249.15 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=193.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc-CCCChHHHHHHHHHHhccC-CCcceeeeEEEEcCCeE-EE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRRKL-LV 114 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~-~v 114 (351)
..++..++..||+|..|.||++.. .+|...|||.+... +..+..++.+.+.++..-. +|+|++++++|..+.-+ +.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 346677888999999999999995 46889999988644 3344466777787776654 89999999998765433 55
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+.|. ..+..++... ..++++..+-++...++.||.||...| +++|||+||+|||+|+.|++||||||++-
T Consensus 170 MelMs-~C~ekLlkri------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRI------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHHH-HHHHHHHHHh------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccc
Confidence 55553 3444444332 246899999999999999999998887 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
.+.. +...+...|.+.|||||.+.- ..|..++||||||++++||.||..||.+.+.+ ..
T Consensus 241 rlvd---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe 302 (391)
T KOG0983|consen 241 RLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FE 302 (391)
T ss_pred eeec---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HH
Confidence 6433 223456778889999999873 46888999999999999999999999875542 12
Q ss_pred HHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+..+++... .-+.....+..+.+|+..||..|+.+||...+++++
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222222111 111122356689999999999999999999999987
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=282.33 Aligned_cols=273 Identities=18% Similarity=0.213 Sum_probs=182.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc--CCcEEEEEE--------------cc---ccCCCChHHHHHHHHHHhccCCCc
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKL--------------MD---QAGKQGEDEFKMEVELLGRLRSPY 98 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vk~--------------~~---~~~~~~~~~~~~e~~~l~~l~h~~ 98 (351)
...++|++.+.||+|+||.||++... .+...+.|. +. .........+.+|+.+++.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998743 222222221 10 011122345778999999999999
Q ss_pred ceeeeEEEEcCCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 99 LLALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 99 i~~~~~~~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
|+++++++...+. +++++++. ++|..++...... .........+..++.||+.||.|||++ +++|+||||+||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 9999999987654 57777774 4666666432211 112344667888999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCC-CCCCCCCCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGE 256 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~p-f~~~~~~~~ 256 (351)
|++.++.++|+|||++........ .......|+..|+|||++.+..++.++|||||||++|+|++|..+ |........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999976543221 112235689999999999998999999999999999999997754 432211100
Q ss_pred cceeecc------cccccc-hhHHHhhcCcccc----CCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 257 GVLVSWA------LPRLTD-REKILEIMDPALE----GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 257 ~~~~~~~------~~~~~~-~~~~~~~~~~~~~----~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... ...+.. ...+.+.+..... .... .....++.++|.+||+.||++|||+.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 000000 0011111100000 0000 0112357788999999999999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=256.86 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=189.1
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhcc---CCCcceeeeEEEEcCC------
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRL---RSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~------ 110 (351)
|++.+.||.|++|.||+|.+. ++..+++|.+...... ....+.+|+.+++.+ .|+|++++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 5899999998643222 223455677766655 5999999999987654
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++++.+ +|.+++.... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 4589999875 7888774322 12588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc----
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR---- 266 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~---- 266 (351)
|.+....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||..................
T Consensus 152 g~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 152 GLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred CcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 9987654332 112234677899999999888999999999999999999999999754321000000000000
Q ss_pred --ccchhHHHhhcCcccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 --LTDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 --~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
................ ..........+.+++.+||+.||++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000000000 01111234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=257.08 Aligned_cols=241 Identities=27% Similarity=0.386 Sum_probs=182.1
Q ss_pred eeeecCceEEEEEEE-cCCcEEEEEEccccCCC---ChHHHHHHH---HHHhccCCCcceeeeEEEEcCC-eEEEEEEcc
Q 018744 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEV---ELLGRLRSPYLLALLGYCSDRR-KLLVYDYMA 119 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~---~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~ 119 (351)
.||+|+||.||+|.. .+++.+++|.+...... ....+..+. ..++...||+++.+.+.+...+ .++|++|+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999995 46889999988643211 111223333 3444457999999999887765 459999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+++|..++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 81 GGDLHYHLSQ-------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (278)
T ss_pred CCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence 9999988832 24689999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
......++..|+|||.+.++ .++.++||||+|+++|+|++|..||........ .......
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~- 211 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMT- 211 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--------------HHHHHHh-
Confidence 12234678899999998754 688999999999999999999999975422100 0111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.......+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 212 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011122222345799999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=260.34 Aligned_cols=243 Identities=30% Similarity=0.421 Sum_probs=187.8
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
|...+.||+|++|.||+|... ++..+++|.+...... ....+..|+++++.++|+|++++++++.+.. .+++++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 677788999999999999954 6889999988643222 2245778999999999999999999987765 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. +++.+++... ..++++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~------~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 85 5677766332 23688999999999999999999999 99999999999999999999999999876422
Q ss_pred CCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
. .....++..|+|||.+. +..++.++||||||+++|+|++|..||...+.. ....
T Consensus 173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----------------~~~~ 230 (313)
T cd06633 173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALY 230 (313)
T ss_pred C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHH
Confidence 1 12345778899999874 456888999999999999999999998654321 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..................+.+|+.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111111223468899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=261.83 Aligned_cols=271 Identities=18% Similarity=0.217 Sum_probs=188.8
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCC
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 121 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~ 121 (351)
+.+.+|.|+++.++.+.. +++.+|+|++... .......+..|+++++.++|+||+++++++.+.+ .+++++|+.++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334444444444444333 6899999998654 3344567889999999999999999999887664 45999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+||+.+........
T Consensus 85 ~l~~~l~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 85 SCEDLLKTHF-----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 9999985432 23588899999999999999999999 999999999999999999999999998765432111
Q ss_pred -----CceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc-eeecccccccchhH-
Q 018744 202 -----GHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPRLTDREK- 272 (351)
Q Consensus 202 -----~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~- 272 (351)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 011122346678999999875 357899999999999999999999997543211000 00000000000000
Q ss_pred ------HH--------hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 273 ------IL--------EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 273 ------~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.. ..................+.+|+..||+.||++|||+.+++++ .+++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--p~~~~~~ 302 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH--SFFKQCK 302 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC--chHhhhc
Confidence 00 0000001112223345678999999999999999999999997 4455443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=256.16 Aligned_cols=250 Identities=20% Similarity=0.329 Sum_probs=191.1
Q ss_pred CCCcCceeeecCceEEEEEEEcC-CcEEEEEEcccc-----CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v 114 (351)
+|.+.+.||+|++|.||++.+.. +..+++|++... .......+..|+.+++.++|||++++++++.+. ..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999998543 444555554321 122334566789999999999999999987665 45699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++.... .....+++..++.++.|++.||.+||+. +++|+||+|+||+++. +.++|+|||.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~ 153 (260)
T cd08222 81 TEYCEGRDLDCKLEELK---HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSR 153 (260)
T ss_pred EEeCCCCCHHHHHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCcee
Confidence 99999999998885432 1234689999999999999999999999 9999999999999975 579999999887
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .....
T Consensus 154 ~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------------~~~~~ 215 (260)
T cd08222 154 LLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------------LSVVL 215 (260)
T ss_pred ecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------HHHHH
Confidence 643321 122234567889999998888888999999999999999999999863221 11111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... ......+...+..+.++|.+||+.+|++||++.+++++
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 11122334455679999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=272.79 Aligned_cols=249 Identities=23% Similarity=0.412 Sum_probs=192.7
Q ss_pred cCceeeecCceEEEEEEEc-CCcEEEEEEcc----ccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe---EEEEE
Q 018744 45 KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMD----QAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK---LLVYD 116 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~v~~ 116 (351)
+...||+|+|.+||+|.+. +|-.||=..++ ..++...++|..|+++|+.|+|+||+++++.+.+... .+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3557999999999999964 46555432222 1234455889999999999999999999998876543 39999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~~ 195 (351)
.+..|+|..|.+.. +.++...+..|++||+.||.|||++ .+.|+|||||-+||||++ -|.|||+|+|++..
T Consensus 124 L~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred cccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 99999999999654 4788999999999999999999999 669999999999999975 58999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .....|||.|||||+.. ..|....||||||+++.||.|+..||.--. +..++..
T Consensus 196 ~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----------------n~AQIYK 254 (632)
T KOG0584|consen 196 LRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----------------NPAQIYK 254 (632)
T ss_pred hhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----------------CHHHHHH
Confidence 65533 33478999999999765 789999999999999999999999996222 2222222
Q ss_pred hcCccccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 276 IMDPALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 276 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
-+...... .+.--...++.+||.+||.. .++|||+.|+|.+ .++...
T Consensus 255 KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d--~Ff~~d 302 (632)
T KOG0584|consen 255 KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD--PFFDED 302 (632)
T ss_pred HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC--hhhccc
Confidence 11111100 00001123689999999998 9999999999987 555543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.96 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=192.3
Q ss_pred CCCcCceeeecCceEEEEEEE----cCCcEEEEEEccccC----CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~- 111 (351)
+|++.+.||.|+||.||.|.. .+|..+++|++.... ....+.+..|+.++..+ +|++|+++++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999985 368889999986432 12235677899999999 58999999998877654
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|++|+.+++|.+++... ..+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence 5999999999999988432 3678899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ..
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------------~~ 217 (290)
T cd05613 151 LSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN------------SQ 217 (290)
T ss_pred cceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc------------cH
Confidence 9876433211 111234577889999998753 46789999999999999999999996432110 00
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.......... ...++......+.+++.+||..+|++|| ++.+++.+
T Consensus 218 ~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 218 AEISRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111111111 1122233445688999999999999997 77888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.10 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=202.2
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~ 116 (351)
-+|.-...||.|.||.||.|. ..+|...|+|.+... .......+.+|..+|..++|||+++++++-...+.+ +.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 567778899999999999999 457999999977533 233446688899999999999999999988766544 9999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
||.+|+|.+.+.... -.++.....+-.|++.|++|||++ ||||+||||.||+++.+|.+|++|||.+...
T Consensus 1315 yC~~GsLa~ll~~gr-------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HhccCcHHHHHHhcc-------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999995443 456666677889999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--ceecccCCCcccccccccccCC---CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 197 SDKAGG--HVSTRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 197 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
...... .......||+.|||||++.+.. ...++|||||||++.||+||+.||...+.. -
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----------------~ 1448 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----------------W 1448 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----------------h
Confidence 554211 1123467999999999998643 467899999999999999999999744331 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+--.+...-....+......-.+||.+||..||++|.++.|++++ .+-+.++.
T Consensus 1449 aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~--~f~~~~~d 1502 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH--AFGKSCTD 1502 (1509)
T ss_pred HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh--hccccccc
Confidence 1111111112223334455567889999999999999999999988 44444444
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=254.82 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=190.6
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEEEEc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
|.+.+.||.|++|.||+|... +++.+++|.+...... ......+|+..++.++ |+|++++++++.++ ..++|++|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999965 5788999988643221 2233456889999998 99999999988765 456999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
+++|.+.+.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 -~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 778888875432 23689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc-----chhH
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-----DREK 272 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~ 272 (351)
.. ......++..|+|||.+. +..++.++|+||||+++++|++|..||.................... ....
T Consensus 152 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 152 RP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 22 122345677899999875 44578999999999999999999999965543211000000000000 0000
Q ss_pred HHhhcCccccCC-------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQ-------YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............ ........+.+++++||+.+|++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 001113568999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=257.45 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=188.9
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~ 113 (351)
...++|++.+.||+|++|.||+|.+. +++.+++|.+..... .....+..|+.++... .|+||+++++++.+.. .++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34578999999999999999999975 488999999864322 2234455577666666 4999999999987664 558
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+++++. +++.+++.... ..+++..+..++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||+
T Consensus 92 v~e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred EeeccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcccc
Confidence 888874 46766664322 368899999999999999999996 6 899999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCC----CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
+....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......
T Consensus 162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------- 224 (296)
T cd06618 162 SGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------------- 224 (296)
T ss_pred chhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--------------
Confidence 87543321 112334677899999987543 788999999999999999999999642211
Q ss_pred chhHHHhhcCcccc-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......+..... ..........+.+|+.+||+.||++|||+.+++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 -FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111111111110 01111234578999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.19 Aligned_cols=268 Identities=21% Similarity=0.257 Sum_probs=189.1
Q ss_pred CCCcCceeeecCceEEEEEEEc-C--CcEEEEEEccccC--CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-----C
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-N--GRKVAIKLMDQAG--KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-----R 110 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~--~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~ 110 (351)
+|++.+.||+|+||.||++... . +..+++|.+.... ......+..|+.+++.+ +|+||+++++..... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999954 4 7789999886422 22245677899999999 599999999864321 2
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++++ +++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~e~~-~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS-------GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred EEEEEecc-cCCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 34566665 4688888732 24688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC--ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 191 GLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 191 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|.+......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+............. .
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 228 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-T 228 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-C
Confidence 998765432211 11123467888999998765 4688999999999999999999999975432100000000000 0
Q ss_pred cchhHHH-----------hhcCccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 268 TDREKIL-----------EIMDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 268 ~~~~~~~-----------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
....... ..........+ .......+.+|+.+||+.||++|||+.+++.+ .++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~ 296 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLA 296 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhh
Confidence 0000000 00000000000 01123468899999999999999999999877 4444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=251.09 Aligned_cols=238 Identities=28% Similarity=0.375 Sum_probs=189.1
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
||.|++|.||.+... +++.+++|.+...... ....+..|+.+++.++|+|++++++.+..+. .+++++++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 5889999988644322 3356788999999999999999999887664 5699999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~ 148 (250)
T cd05123 81 FSHLSKE-------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S 148 (250)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence 9998432 3688999999999999999999999 99999999999999999999999999987643321 1
Q ss_pred eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 204 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||...+. ......+... ..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~~~~~--~~ 210 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----------------KEIYEKILKD--PL 210 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHhcC--CC
Confidence 22345567789999999888889999999999999999999999964331 1111122211 11
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH---HHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLM---ADVVQ 316 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~---~eil~ 316 (351)
..+...+..+.+++.+||..||++|||+ .++++
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2223335678999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=259.52 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=193.2
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
|++.+.||+|.+|.||+|... +++.+++|.+.... ......+..|+.+++.++|+|++++++++.+. ..+++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999955 58999999987543 33345677899999999999999999988765 456999998
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
. ++|.+++.... ..+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 7 58999885432 3689999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH----
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI---- 273 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 273 (351)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||................. .......
T Consensus 151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 227 (282)
T cd07829 151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG-TPTEESWPGVT 227 (282)
T ss_pred Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC-CCcHHHHHhhc
Confidence 221 12233456779999998766 789999999999999999999999975442100000000000 0000000
Q ss_pred -----HhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 -----LEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 -----~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... .........+.+++.+||..+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 0001124579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=266.68 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=207.0
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
...|.+.+.||+|.|+.|.+|++ .++..||+|.+.... ....+.+.+|++++..++||||++++++.+.. ..++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 36799999999999999999994 478999999986432 23335577899999999999999999999865 567999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|.+.+++.... .+.+..+..++.|++.|++|||++ .++|+|||++||+++.+-+++|+|||++..
T Consensus 135 eya~~ge~~~yl~~~g-------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EeccCchhHHHHHhcc-------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 9999999999996544 566688999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
+... ......+|++.|.|||++.+..| .+..|+||+|+++|.|+.|.+||++... .
T Consensus 205 ~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k 261 (596)
T KOG0586|consen 205 FDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------K 261 (596)
T ss_pred eccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------c
Confidence 6643 35566889999999999998766 6789999999999999999999986442 2
Q ss_pred hhcCccccCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 275 EIMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 275 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
++-...+...+ +.-...++.++|+++|-.+|.+|++..++.++-+-...
T Consensus 262 ~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 262 ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 22222222222 22234468889999999999999999999888654433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=268.96 Aligned_cols=274 Identities=23% Similarity=0.344 Sum_probs=202.6
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~~ 111 (351)
..|.-.+.||.|+||.||+++ ..+|+.+|+|.+... ....++...+|++++++++|+||+++.++-++. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345667889999999999999 558999999998643 334556778899999999999999999876543 35
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--C--CCcEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--K--NFHAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~--~--~~~v~l 187 (351)
+++||||.+|+|...+.... ....+++..++.++.+++.||.|||.+ +|+||||||.||++. + ....||
T Consensus 93 vlvmEyC~gGsL~~~L~~PE----N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE----NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc----cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEee
Confidence 69999999999999996543 456899999999999999999999999 999999999999993 2 334799
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||.++.++... ......||..|++||+.. .+.|+...|.|||||++|+..||..||..........-..|...-
T Consensus 166 tDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 166 TDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred ecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 9999999765543 567788999999999888 488999999999999999999999999654332111111111100
Q ss_pred ccc-----------hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhhc
Q 018744 267 LTD-----------REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP--LMADVVQSLVPLVKY 324 (351)
Q Consensus 267 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp--t~~eil~~l~~~~~~ 324 (351)
... ++.+..-..-.............+...+..+|..+|.+|- ...+....+..+++.
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 000 0000000000001122334455677778888888888887 555665555555553
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=248.80 Aligned_cols=239 Identities=27% Similarity=0.380 Sum_probs=192.2
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
++|.+.+.||.|.||+|.+++. .+++.+|+|+++..- ..+...-..|-.+|..-+||.+..+.-.++.. ..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 7799999999999999999994 479999999986432 22223344588999999999988887666655 556999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|..||.|.-.+. ....+++....-+-..|+.||.|||++ +|+.+|||.+|.+++.+|++|+.|||++..
T Consensus 248 eyanGGeLf~HLs-------rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 248 EYANGGELFFHLS-------RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEccCceEeeehh-------hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999887773 334688888888999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
. ..........+||+.|+|||++....|..+.|.|.+|+++|+|++|+.||...+. +.+.+
T Consensus 318 ~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----------------~kLFe 378 (516)
T KOG0690|consen 318 E--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----------------EKLFE 378 (516)
T ss_pred c--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----------------hHHHH
Confidence 2 2223445668899999999999999999999999999999999999999975543 12222
Q ss_pred h-cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 018744 276 I-MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 310 (351)
Q Consensus 276 ~-~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt 310 (351)
+ +-..+ .++.....+...|+..+|..||++|..
T Consensus 379 LIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 379 LILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred HHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 2 11111 333344456788999999999999984
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=263.78 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=192.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-----
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR----- 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 110 (351)
..++|++.+.||+|++|.||+|.+. ++..+++|.+... .......+.+|+.+++.+.|+|++++.+++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999964 6789999987542 1223355677999999999999999998765443
Q ss_pred --eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 111 --KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 111 --~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
.++|++++ +++|.+++.. ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 45888887 6688888742 3689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...................
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 99998764332 233456778999998865 367899999999999999999999997543311000000000000
Q ss_pred cc-------hhHHHhhcCc---cccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TD-------REKILEIMDP---ALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~-------~~~~~~~~~~---~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. .......+.. .....+. ......+.++|.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000000000 0000000 1124578999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.06 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=206.3
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
.+++...++|.|+++||+|+||.|.+++. .+++.||+|++... ...+..-|+.|-.+|..-+.+=|+.++-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 44556678999999999999999999995 46889999998752 344556788888888888888888887777665
Q ss_pred -CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
+.|+||+|+.||+|..++. ....+++..+..++..|+.||..||+. |+|||||||+|||++..|+++|+
T Consensus 148 ~~LYlVMdY~pGGDlltLlS-------k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS-------KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cceEEEEecccCchHHHHHh-------hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeec
Confidence 6679999999999999993 344799999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccc----c-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL----T-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
|||.|..... .+.-.....+|||.|.+||++. + +.|+..+|.||+|+++|||+.|..||..+...
T Consensus 218 DFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--------- 287 (1317)
T KOG0612|consen 218 DFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--------- 287 (1317)
T ss_pred cchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---------
Confidence 9999976543 2334556688999999999986 3 57999999999999999999999999744321
Q ss_pred cccccchhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPL---MADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt---~~eil~~ 317 (351)
+....+++-.-.-.+| .+.+.+..+||...+. +|+.|.. +.++..|
T Consensus 288 -------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 288 -------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1112222221111222 3456678899999887 8899998 8888877
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=271.97 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=218.0
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCc----EEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
...+.+++||+|+||+||+|.| +.|+ +|++|++... .......+..|+-.+.++.|||++++++++..+...+|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlv 775 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLV 775 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHH
Confidence 3456678999999999999984 4444 5788887543 33345778899999999999999999999998887899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
+.|+..|+|.+++...+ ..+-.+..+.|..||++|+.|||.+ +++||||..+||||..-..+|+.|||++.
T Consensus 776 tq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhh
Confidence 99999999999997644 4688899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...............-.+.|+|-|.+....++.++||||||+++||++| |..|+.+... ..+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI 909 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEI 909 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHh
Confidence 8766554443333444567999999999999999999999999999999 9999975442 456
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.++++...+-..++.+..+++.++.+||..|++.||+++++.+.+.++.+.
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 666666666677778888999999999999999999999999998776553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=251.66 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=201.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhc--cCCCcceeeeEEEEcC----
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR---- 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---- 109 (351)
.+....+.++.+.||+|.||.||+|.| .|+.||||++.. .+...+.+|.+++.. ++|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345567899999999999999999999 678899999853 334556678888876 4999999998754322
Q ss_pred -CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCceecCCCCCcEEeCCCC
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-----CSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~i~H~di~p~Nilv~~~~ 183 (351)
+.++|++|.+.|+|.+++.. ..++....++++..++.||+|||.. ..+.|+|||||.+||||..++
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 45699999999999999943 4689999999999999999999965 245899999999999999999
Q ss_pred cEEEeecccccccCCCCC--CceecccCCCcccccccccccCC-----CC-CccceeehHHHHHHHHhCC----------
Q 018744 184 HAKVSDFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALTGH-----LT-TKSDVYSYGVVLLELLTGR---------- 245 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-----~s-~~~DiwslG~~l~~lltg~---------- 245 (351)
.+.|+|+|++........ .......+||.+|||||++.... -+ ..+||||||.++||++-..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999987555432 22345578999999999987532 12 3689999999999997643
Q ss_pred CCCCCCCCCCCcceeecccccccchhHHHhhc----CccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 246 VPIDVNKPSGEGVLVSWALPRLTDREKILEIM----DPALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 246 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
.||.+..+. +........-+. .+.+...+ ..+....+.++|+.||..||.-|.|+-.+.+.|.+
T Consensus 434 ~Pyyd~Vp~-----------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 434 LPYYDVVPS-----------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred CCcccCCCC-----------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 344322221 111111111112 22222222 23556789999999999999999999999999999
Q ss_pred hhh
Q 018744 321 LVK 323 (351)
Q Consensus 321 ~~~ 323 (351)
+.+
T Consensus 503 l~~ 505 (513)
T KOG2052|consen 503 LSN 505 (513)
T ss_pred Hhc
Confidence 885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=226.88 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=199.4
Q ss_pred CCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDY 117 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~~ 117 (351)
+|.-.++||+|.+|+|++|+ +.+++.|++|.+..+ ++.......+|+-+|+.++|.||++++++...+... +|+++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999999 567899999988743 344457788899999999999999999998877655 99999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
|+. .|..++-.- .+.++...+..++.|+++||.++|++ ++.|+|+||.|.+++.+|.+||+|||+++.+.
T Consensus 83 cdq-dlkkyfdsl------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred hhH-HHHHHHHhc------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 965 788777433 35789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh--HH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE--KI 273 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 273 (351)
-+. .-......|..|.+|.++.+. -|+.+.|+||.||++.|+.. |...|.+.+-..+...+.+......++. .+
T Consensus 153 ipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred Cce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 543 112335568899999999865 68999999999999999998 8888877655433222222222111111 11
Q ss_pred HhhcCccccCCCCH---------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEGQYSM---------KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+.+-.....++. .....=++|+..+|.-+|.+|++++..+++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11222111112211 112245779999999999999999998876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.04 Aligned_cols=274 Identities=23% Similarity=0.312 Sum_probs=225.1
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEEcC------CcEEEEEEccc-cCCCChHHHHHHHHHHhccCCCcceeeeE
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQ-AGKQGEDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vk~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
...++.....+++..-.+-+|.||.||.|.|.+ .+.+.+|.+++ ++......+..|.-++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345667777888889999999999999997543 23455666653 34444567888999999999999999999
Q ss_pred EEEcC--CeEEEEEEccCCChhhhccccCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 105 YCSDR--RKLLVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 105 ~~~~~--~~~~v~~~~~~~~L~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
++.+. ..+.++.+..-|+|+.++..-++ ..+....+...++..++.|++.|++|||++ +++|.||..+|.+|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 87654 45789999999999999964322 222344677888999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCccee
Q 018744 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 182 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 260 (351)
...|||+|=.+++.+...+..+..........||+||.+.+..|+.++|+||||+++|||+| |+.|+..-+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-------- 503 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-------- 503 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--------
Confidence 99999999999998888777777777777889999999999999999999999999999999 999986333
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..++...+....+-..+.+++.+|+.++.-||...|++||++.++...|.++..+-
T Consensus 504 ---------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 504 ---------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ---------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 23444444444455566778889999999999999999999999999999887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=263.07 Aligned_cols=240 Identities=22% Similarity=0.276 Sum_probs=192.4
Q ss_pred HhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-CeEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
..+.|.+...+|.|+|+.|-.+. ..+++.+++|++..... ...+|+.++... +|+||++..+++.+. +.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46789999999999999998887 45788899999865422 123356555444 799999999999887 556999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe-CCCCcEEEeeccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DKNFHAKVSDFGLAK 194 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv-~~~~~v~l~dfg~~~ 194 (351)
+.+.++-+.+.+... +.....+..|+++|+.|+.|||.+ |++||||||+|||+ ++.++++|+|||.+.
T Consensus 396 e~l~g~ell~ri~~~--------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK--------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred hhccccHHHHHHHhc--------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 999999888877432 233367778999999999999999 99999999999999 699999999999988
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ....+-|..|.|||++....|+.++|+||||+++|+|++|+.||.....+ .
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ 520 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------I 520 (612)
T ss_pred hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------H
Confidence 65443 23445677899999999999999999999999999999999999754321 1
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
++........+....+....+|+.+||+.||.+||++.++..+
T Consensus 521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2222222233334556678999999999999999999999988
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=245.04 Aligned_cols=218 Identities=22% Similarity=0.209 Sum_probs=169.9
Q ss_pred cCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCChhhhccc
Q 018744 52 GGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYP 129 (351)
Q Consensus 52 G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L~~~~~~ 129 (351)
|.++.||++++. +++.+++|.+.... ....+...+....|||++++++++.+.. .++++||+.+++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999954 68899999986532 2233445555567999999999887664 4599999999999998843
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccC
Q 018744 130 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209 (351)
Q Consensus 130 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 209 (351)
. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+....... ....
T Consensus 79 ~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~ 143 (237)
T cd05576 79 F-------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA 143 (237)
T ss_pred h-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence 2 3588999999999999999999999 99999999999999999999999999876543321 2234
Q ss_pred CCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHH
Q 018744 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKE 289 (351)
Q Consensus 210 ~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (351)
++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .... .....+...
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~~----~~~~~~~~~ 201 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INTH----TTLNIPEWV 201 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------cccc----cccCCcccC
Confidence 456799999998888899999999999999999999887532110 0000 000111223
Q ss_pred HHHHHHHHHhccCCCCCCCCCH
Q 018744 290 VIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 290 ~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
...+.++|.+||+.||++|||+
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCC
Confidence 3468899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=271.59 Aligned_cols=269 Identities=25% Similarity=0.427 Sum_probs=210.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc----C----CcEEEEEEccccC-CCChHHHHHHHHHHhcc-CCCcceeeeEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS----N----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGY 105 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 105 (351)
+....++..+.+.||+|.||.|++|... . ...||+|.+.... ..+...+..|+++++.+ .|+||+.+++.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4455566777889999999999999822 1 3458999886432 34457788999999999 69999999999
Q ss_pred EEcC-CeEEEEEEccCCChhhhccccC-CCCCCC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCC
Q 018744 106 CSDR-RKLLVYDYMANGGLQEHLYPAN-GSNSVA--------SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 175 (351)
Q Consensus 106 ~~~~-~~~~v~~~~~~~~L~~~~~~~~-~~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~ 175 (351)
+... ..++|.||+..|+|.+++...+ ...... ..++...++.++.||+.|++||++. +++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 9875 4569999999999999997765 111111 2389999999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCCCceeccc-CCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCC
Q 018744 176 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV-LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKP 253 (351)
Q Consensus 176 Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~ 253 (351)
|||+..+..+|++|||+++.............. .-...|+|||.+....++.++||||||+++||+++ |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999854333322211111 12336999999999999999999999999999999 9999964211
Q ss_pred CCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 254 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
...+.+.+....+...+..+..+++++++.||+.+|++||++.++.+.+...+.
T Consensus 528 ----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 ----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 122233444444445555667789999999999999999999999999999765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=240.81 Aligned_cols=268 Identities=22% Similarity=0.349 Sum_probs=202.0
Q ss_pred eeeeHHHHHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEE
Q 018744 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYC 106 (351)
Q Consensus 29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 106 (351)
...+|+++-.-. ...||+|+++.|-.+. ..+|..|+||++.......+.++.+|++++...+ |+||+.++++|
T Consensus 71 ~~g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 71 LSGKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred ccchHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 334455544333 3469999999999988 7789999999998777777888889999999985 99999999999
Q ss_pred EcCCeE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-
Q 018744 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH- 184 (351)
Q Consensus 107 ~~~~~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~- 184 (351)
+++..+ +|||.+.||+|...+.+. .-+++..+..+..+|+.||.+||.. ||.|+||||+|||-..-..
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 988765 999999999999999544 4689999999999999999999999 9999999999999965443
Q ss_pred --EEEeecccccccCC--CCC---CceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 185 --AKVSDFGLAKIGSD--KAG---GHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 185 --v~l~dfg~~~~~~~--~~~---~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
||||||.+..-... ... .-.....+|+..|||||+.. ...|+.++|.||||+++|-|++|..||.+.-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 89999987643211 111 11123466888999999864 2368999999999999999999999998765
Q ss_pred CCCCcceeeccccccc--chhHHH-hhcCccccCCCCHHH----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 253 PSGEGVLVSWALPRLT--DREKIL-EIMDPALEGQYSMKE----VIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
-..-++ .....= ....+. .+-+.. -.++..+ +....+|++.+|..++.+|.++..++.+
T Consensus 296 g~dCGW----drGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 296 GADCGW----DRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCcCCc----cCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 432222 111100 011111 121111 1333333 3467789999999999999999998874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=278.12 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=180.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-Ce----
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK---- 111 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~---- 111 (351)
-.++|+....||+|+||.||+++.+ +|+.||||.+... +......+.+|+..|.+++||||++++..+.+. ..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888999999999999999966 8999999998754 334456788899999999999999997532110 00
Q ss_pred --------------------------------------------------------------------------------
Q 018744 112 -------------------------------------------------------------------------------- 111 (351)
Q Consensus 112 -------------------------------------------------------------------------------- 111 (351)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------------------EEEEEEccCCChhhhccccCCCCCCCCCC--CHHHHHHHHHHHHH
Q 018744 112 -----------------------------------LLVYDYMANGGLQEHLYPANGSNSVASKL--DWETRLRIALEAAK 154 (351)
Q Consensus 112 -----------------------------------~~v~~~~~~~~L~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~ 154 (351)
|+=|+||+..++.+++.. ..+ .....|.++++|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--------N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--------NHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh--------cccchhhHHHHHHHHHHHH
Confidence 011222222222222110 011 25678999999999
Q ss_pred HHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC----------------CCCCCceecccCCCccccccc
Q 018744 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS----------------DKAGGHVSTRVLGTQGYVAPE 218 (351)
Q Consensus 155 ~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE 218 (351)
||+|+|++ |++||||||.|||+++++.|||+|||++.... ...+....+...||.-|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999 99999999999999999999999999987611 011111234567999999999
Q ss_pred ccccC---CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCC--CCHHHHHHH
Q 018744 219 YALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ--YSMKEVIQV 293 (351)
Q Consensus 219 ~~~~~---~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 293 (351)
++.+. .|+.|+|+||||+++|||+. ||.. .++.-..+..+.+..+..+ +..+....-
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T---------------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT---------------SMERASILTNLRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCc---------------hHHHHHHHHhcccCCCCCCcccccccchHH
Confidence 98754 59999999999999999985 4531 1222233444444444333 223344456
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHH
Q 018744 294 AAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 294 ~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+|++|++.||++|||+.|+|..
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhc
Confidence 789999999999999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=272.88 Aligned_cols=145 Identities=30% Similarity=0.475 Sum_probs=126.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...... ....+..|+.++..++|+||+++++++.... .++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999965 6889999998643322 2356778999999999999999998887654 5699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... ..+++..++.++.||+.||.|||.. +++|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998432 3578889999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=255.05 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=199.9
Q ss_pred eHHHHHHHhcCCCc--CceeeecCceEEEEEE-EcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEE
Q 018744 32 TFKQLHSATGGFSK--SNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYC 106 (351)
Q Consensus 32 ~~~~~~~~~~~y~~--~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 106 (351)
.+++-..+..-|+| .+.||+|.||+||-|+ .++|+.||||++..-. ......++.|+.+|.++.||.|+.+...|
T Consensus 553 qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ 632 (888)
T KOG4236|consen 553 QIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF 632 (888)
T ss_pred hhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence 34444444555655 6789999999999999 4589999999986432 23347789999999999999999999999
Q ss_pred EcCCeE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---C
Q 018744 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---N 182 (351)
Q Consensus 107 ~~~~~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~ 182 (351)
+..+.+ .|||.+.|.-|.-.+. ++.+.+++..-..++.||+.||.|||.. +|+|+||||+|||+.. .
T Consensus 633 ET~ervFVVMEKl~GDMLEMILS------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 633 ETPERVFVVMEKLHGDMLEMILS------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPF 703 (888)
T ss_pred cCCceEEEEehhhcchHHHHHHH------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCC
Confidence 988766 7888887655555552 3345788888889999999999999999 9999999999999954 5
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
..+||||||.++...+.. ......||+.|+|||+++++-|..+-|+||+|+++|--+.|..||.-....
T Consensus 704 PQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-------- 772 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-------- 772 (888)
T ss_pred Cceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--------
Confidence 679999999999866543 345578999999999999999999999999999999999999999632211
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
..++++.--.....++ .+......+||..+|++.-.+|.|....+++-
T Consensus 773 -------ndQIQNAaFMyPp~PW-~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 773 -------NDQIQNAAFMYPPNPW-SEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred -------hHHhhccccccCCCch-hhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1111111100000111 23344678899999999999999998777663
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=248.81 Aligned_cols=285 Identities=22% Similarity=0.327 Sum_probs=211.3
Q ss_pred CccceEEecCCCceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc
Q 018744 16 ESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 94 (351)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l 94 (351)
++|.-..|-.++++...+.++.. .++|.+.++||.|.|++||+|.+ .+.+.||+|+.+.+ ..-.+....|+++|+.+
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v 131 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQV 131 (590)
T ss_pred cccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHH
Confidence 45556667778999999988653 36899999999999999999994 46778899998644 33345677899999998
Q ss_pred C-----C---CcceeeeEEEEcC-----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 018744 95 R-----S---PYLLALLGYCSDR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161 (351)
Q Consensus 95 ~-----h---~~i~~~~~~~~~~-----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 161 (351)
+ | .+|+++++.|.-. +.++|+|++ |.+|..++.... ...++...+..|++||+.||.|||+
T Consensus 132 ~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-----YrGlpl~~VK~I~~qvL~GLdYLH~ 205 (590)
T KOG1290|consen 132 REGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-----YRGLPLSCVKEICRQVLTGLDYLHR 205 (590)
T ss_pred HhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-----CCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 4 2 4789999988532 345888887 668888886543 4578999999999999999999999
Q ss_pred CCCCCceecCCCCCcEEeC-------------------------------------------------------------
Q 018744 162 HCSPPVIHRDFKSSNILLD------------------------------------------------------------- 180 (351)
Q Consensus 162 ~~~~~i~H~di~p~Nilv~------------------------------------------------------------- 180 (351)
.+ ||+|.||||+|||+.
T Consensus 206 ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~ 283 (590)
T KOG1290|consen 206 EC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKK 283 (590)
T ss_pred hc--CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhh
Confidence 99 999999999999993
Q ss_pred -----------------------------------------------------C--------------------------
Q 018744 181 -----------------------------------------------------K-------------------------- 181 (351)
Q Consensus 181 -----------------------------------------------------~-------------------------- 181 (351)
.
T Consensus 284 ~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~ 363 (590)
T KOG1290|consen 284 LEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDG 363 (590)
T ss_pred hhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccc
Confidence 0
Q ss_pred --------------------------CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehH
Q 018744 182 --------------------------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 235 (351)
Q Consensus 182 --------------------------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG 235 (351)
+-+|||+|||.+.-+.. ..+....|..|+|||++.+..|+..+||||++
T Consensus 364 ~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~A 438 (590)
T KOG1290|consen 364 SLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTA 438 (590)
T ss_pred cccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHH
Confidence 00156666665543222 23445568889999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccee-------------eccc-------ccccc-hhH-----------HHhhcCccccC
Q 018744 236 VVLLELLTGRVPIDVNKPSGEGVLV-------------SWAL-------PRLTD-REK-----------ILEIMDPALEG 283 (351)
Q Consensus 236 ~~l~~lltg~~pf~~~~~~~~~~~~-------------~~~~-------~~~~~-~~~-----------~~~~~~~~~~~ 283 (351)
|++|||+||...|+...-.....-. .+.+ +.+.+ .+. +.+++.. .-
T Consensus 439 C~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e--KY 516 (590)
T KOG1290|consen 439 CMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE--KY 516 (590)
T ss_pred HHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHH--Hh
Confidence 9999999999999875543221100 0000 00111 111 1111111 12
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.++.+...++.+|+.-||+.+|++|||+.+.++|
T Consensus 517 ~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 517 EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred CCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 4566778899999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=236.99 Aligned_cols=236 Identities=28% Similarity=0.418 Sum_probs=189.2
Q ss_pred CceEEEEEEEc-CCcEEEEEEccccCCCC-hHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEccCCChhhhccc
Q 018744 53 GFGLVYRGVLS-NGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYP 129 (351)
Q Consensus 53 ~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~~~~L~~~~~~ 129 (351)
+||.||+|.+. +++.+++|++....... ...+..|++.++.++|+|++++++.+... ..+++++++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999965 58999999987655544 67889999999999999999999988765 55699999999999998843
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccC
Q 018744 130 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209 (351)
Q Consensus 130 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 209 (351)
.. .++...++.++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~ 147 (244)
T smart00220 81 RG-------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV 147 (244)
T ss_pred cc-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence 22 388899999999999999999999 99999999999999999999999999988754432 223455
Q ss_pred CCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHH-
Q 018744 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMK- 288 (351)
Q Consensus 210 ~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 288 (351)
++..|++||.+.+..++.++|||+||+++++|++|..||..... .....+.............
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 211 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----------------LLELFKKIGKPKPPFPPPEW 211 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------------HHHHHHHHhccCCCCccccc
Confidence 77789999999888889999999999999999999999864211 1112222211111111111
Q ss_pred -HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 289 -EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 289 -~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+.+++.+||..+|++||++.+++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 44579999999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=259.40 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred eeHHHHHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEE-
Q 018744 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCS- 107 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~- 107 (351)
..++.+......|+|...||.|.+|.||+++ ..+++..++|+...... ..+.+..|+++|+.. .|||++.+++++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455566667889999999999999999999 45788899998865433 345677799999998 5999999999874
Q ss_pred -----cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 108 -----DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 108 -----~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
.++.++|||+|.+|+..++++... ...+.+..+..|++.++.|+.+||.+ .++|+|||-.|||++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN 159 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc
Confidence 345679999999999999996543 45799999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+.|||+|||.+..+.... .......||+.|||||++.. ..|+..+|+||||++..||.-|.+|+-..-|....
T Consensus 160 ~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred CcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 999999999987655433 22345679999999999964 35778999999999999999999998654432111
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.-...+......+.....++.+||..||..|-++||++.++++|
T Consensus 238 ---------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ---------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111122222333345667789999999999999999999998876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=241.28 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=194.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCCh--------HHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGE--------DEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
...++|-+..+||+|+|+.||+|.+- ..+.+|+|+-..+ ..+. ....+|+.+.+.+.||.|+++++++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN-K~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN-KNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhc-cchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34568999999999999999999944 5667778875432 2222 235579999999999999999998853
Q ss_pred -C-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC---CCC
Q 018744 109 -R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNF 183 (351)
Q Consensus 109 -~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~---~~~ 183 (351)
. ..|-|+||++|.+|.-++++. +.+++..+..|+.||+.||.||... ...|+|-||||.|||+. ..|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 3 456999999999999999554 4789999999999999999999988 66899999999999994 457
Q ss_pred cEEEeecccccccCCCCCCc-----eecccCCCcccccccccccC----CCCCccceeehHHHHHHHHhCCCCCCCCCCC
Q 018744 184 HAKVSDFGLAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 254 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~ 254 (351)
.+||.|||++...+...... ......||.+|++||.+.-+ ..+.+.||||+|+++|+.+.|+.||+....+
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 89999999998865544332 23345689999999988633 4678999999999999999999999754432
Q ss_pred CCcceeecccccccchhHHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 255 GEGVLVSWALPRLTDREKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. .-....++...- .-+..+-.......||++||...-++|....++...
T Consensus 691 Qd-------------ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 691 QD-------------ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HH-------------HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 00 000001111111 111112233467889999999999999998887654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=258.36 Aligned_cols=271 Identities=18% Similarity=0.190 Sum_probs=167.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-C----CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEE-------E
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-N----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY-------C 106 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-------~ 106 (351)
..++|.+.+.||+|+||.||+|.+. + +..+|+|.+...... +.... +.++...+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence 5578999999999999999999954 4 688999987533221 11111 11111122222221111 1
Q ss_pred EcCCeEEEEEEccCCChhhhccccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC
Q 018744 107 SDRRKLLVYDYMANGGLQEHLYPANGSN-------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173 (351)
Q Consensus 107 ~~~~~~~v~~~~~~~~L~~~~~~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~ 173 (351)
.....++|++|+.+++|.+++....... ..........+..++.||+.||.|||++ +++|+|||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 2335679999999999998885432100 0011123456778999999999999999 99999999
Q ss_pred CCcEEeCC-CCcEEEeecccccccCCCCCCceecccCCCcccccccccccC----------------------CCCCccc
Q 018744 174 SSNILLDK-NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----------------------HLTTKSD 230 (351)
Q Consensus 174 p~Nilv~~-~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~s~~~D 230 (351)
|+|||++. ++.++|+|||++........ .......+++.|+|||.+... .+..++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 67999999999975433221 122345678899999965422 2344569
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCC------HHHHHHHHHHHHhccCCC
Q 018744 231 VYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYS------MKEVIQVAAIAAMCVQPE 304 (351)
Q Consensus 231 iwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~ 304 (351)
||||||++|+|+++..+++......... ..... ................... ........+||.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~---l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQ---LKRND-YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHH---HHhcC-CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999776653211000000 00000 0000000111111000000 001123558999999999
Q ss_pred CCCCCCHHHHHHHHHHhhh
Q 018744 305 ADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 305 P~~Rpt~~eil~~l~~~~~ 323 (351)
|++|||+.++++| .+++
T Consensus 438 P~kR~ta~e~L~H--pff~ 454 (566)
T PLN03225 438 GRQRISAKAALAH--PYFD 454 (566)
T ss_pred cccCCCHHHHhCC--cCcC
Confidence 9999999999998 4444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=230.10 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=202.3
Q ss_pred HhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccc---cCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~ 112 (351)
..++|.+.++||+|++++|.+++ .++.+.+++|+++. ++.++.+....|-.++... +||.++.++..++.+. .+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34789999999999999999999 45788899998863 4455667777888888887 6899999999887664 56
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|.||.+||+|--.+. ...++++..+..+...|+.||.|||++ ||+.+|||.+||+++..|++||.|+|+
T Consensus 328 fvieyv~ggdlmfhmq-------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ-------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred EEEEEecCcceeeehh-------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence 9999999998877773 335899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc-chh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-DRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 271 (351)
+...-. ........+||+.|.|||++++..|..+.|.|+||+++++|+.|+.||+.-..+.. ... ++.
T Consensus 398 cke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~---------d~ntedy 466 (593)
T KOG0695|consen 398 CKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP---------DMNTEDY 466 (593)
T ss_pred hhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc---------ccchhHH
Confidence 975322 23345668899999999999999999999999999999999999999974322110 111 122
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL------MADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt------~~eil~~ 317 (351)
...-+++..++ .+...+.....++...|+.||.+|.. +.++.+|
T Consensus 467 lfqvilekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 467 LFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred HHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 23334444442 33334445667889999999999973 4555544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-34 Score=236.57 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=191.0
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEE-EcCCeEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYC-SDRRKLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~v~~ 116 (351)
.+.+-...||.|+||+|++-.+ ++|+..|||.+...+. .+..++..|.+...+- ++|||+++++.+ .+++.++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4455567899999999999884 5799999999975433 4556777788776665 689999999965 5556667888
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
.|+ .+|..+..... ......++++.+.+|....+.||.||.... .++|||+||+|||++..|.+||||||++-.+
T Consensus 144 LMd-~SlDklYk~vy--~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVY--SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHh-hhHHHHHHHHH--HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 774 46655442211 123346899999999999999999998765 8999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
.. +...+...|...|+|||.+.. .-|..++||||||+++||+.||+.|+..++.. -.++.
T Consensus 219 v~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---------------feql~ 280 (361)
T KOG1006|consen 219 VD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---------------FEQLC 280 (361)
T ss_pred HH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---------------HHHHH
Confidence 33 223455678889999999873 34899999999999999999999999876542 11111
Q ss_pred hhcC---ccccCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMD---PALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~---~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.++. +.+..... ......+..+|..||..|-++||...+++++
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2111 11111111 2345579999999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=230.43 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=194.2
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.+.|.-..+||+|.||.||+|+. ++|+.|++|++-.. .+.-.....+|+++|..+.|+|++.++++|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45677788899999999999994 46788888765322 222335567799999999999999999877432
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..++||.+|+. +|..++.. ....++..++.+++.++..||.|+|+. .++|||+|+.|++|+.+|.++|
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN------RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC------ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEe
Confidence 23588888876 56666622 224789999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCc--eecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee---
Q 018744 188 SDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS--- 261 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~--- 261 (351)
+|||+++.+....+.. ..+....|..|++||.+.| ..|+++.|||+.||++.+|.++.+.+.+...+.....+.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 9999997654433322 2344566889999998876 479999999999999999999999998876542221111
Q ss_pred -----cccccccchhH----------------HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 262 -----WALPRLTDREK----------------ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 262 -----~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+...+-.. +.+.+.+... ..+..+|+..+|..||.+|+.+.+++.+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k-------d~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK-------DDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC-------ChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111111111 1122221111 2257789999999999999999999887
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=236.24 Aligned_cols=243 Identities=27% Similarity=0.391 Sum_probs=191.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-CeE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~ 112 (351)
-..+|.++.+||.|+||+|.+|.. .+.+.+|||+++.+- ..+.+--..|-++|... +-|.++.++..++.- ..+
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 346799999999999999999984 467899999886431 11112223356666555 356777777766654 567
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+.||+|--.+.+. +++.+..+.-++..|+-||-+||++ ||++||||.+||+++.+|++||.|||+
T Consensus 427 FVMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eEEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence 999999999998888554 4677788889999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+... ..........+||+.|+|||++...+|+.+.|.||+|+++|||+.|+.||++.+. ...
T Consensus 497 cKEn--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------------~el 558 (683)
T KOG0696|consen 497 CKEN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DEL 558 (683)
T ss_pred cccc--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------HHH
Confidence 9742 2223344567899999999999999999999999999999999999999997664 233
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
...+++... .|+-..+.+...++...|...|.+|...
T Consensus 559 F~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 559 FQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 444554433 3444555677889999999999999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=244.29 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=202.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCc-EEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGR-KVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
..++.++-.||-|+||.|=+++..+.. .+|+|+++.. +....+.+..|-.++...+.|.|++++..|.++.. |++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356777888999999999999864433 4788877533 33344566778999999999999999998887754 489
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
||-|-||.|+..+... +.++..+..-++.++.+|+.|||++ +|++|||||+|.+++.+|-+||.|||++.
T Consensus 499 mEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred HHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHH
Confidence 9999999999999654 3688889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .....+||+.|.|||++.+.-...+.|.||||+++|||++|.+||.+.++. .....+.
T Consensus 569 ki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------------ktYn~IL 632 (732)
T KOG0614|consen 569 KIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------------KTYNLIL 632 (732)
T ss_pred HhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------------HHHHHHH
Confidence 765533 334578999999999999999999999999999999999999999887753 1122222
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQSL 318 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~l 318 (351)
.-++ ...++........+||+++.+.+|.+|.- +.+|..|.
T Consensus 633 kGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 633 KGID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hhhh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 2222 22444445556788999999999999997 67887775
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=221.75 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=196.1
Q ss_pred hcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC---CeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~---~~~~v 114 (351)
.++|++++++|+|-++.|+.|. ..+++++++|+++.. ....+.+|+++|..+. +|||++++++..+. ...++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4789999999999999999999 557889999999643 3467889999999997 99999999998765 33499
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLA 193 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~ 193 (351)
+|+.++.+...+. ..++...+...+.+++.||.|||+. ||.|||+||.|++++. .-.++|+|+|++
T Consensus 114 FE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 9999998877766 4688889999999999999999999 9999999999999975 456999999999
Q ss_pred cccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCC-CCCCCCCCcceeeccccc-----
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPI-DVNKPSGEGVLVSWALPR----- 266 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf-~~~~~~~~~~~~~~~~~~----- 266 (351)
..+.... ...-...+..|-.||++.. ..|..+-|+|||||++..|+..+.|| .+.++..+...+.....-
T Consensus 181 EFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 181 EFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred hhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 8765533 1222344566889998864 56889999999999999999988887 444444333332222211
Q ss_pred ------ccchhHHHhhcCccccCCCCH--------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 ------LTDREKILEIMDPALEGQYSM--------KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ------~~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.-+....+++....+..+.. -...+..+|+..+|..|-.+|+|++|...|
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111122222222221111110 012468899999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=240.69 Aligned_cols=275 Identities=22% Similarity=0.245 Sum_probs=203.8
Q ss_pred CCceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCC------Cc
Q 018744 26 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS------PY 98 (351)
Q Consensus 26 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h------~~ 98 (351)
.++..+.+.|+. -++|.+....|.|-|++|.+|.+. .|+.||||+|.++..+- ..=..|+++|++|+. -|
T Consensus 419 EGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 419 EGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhH
Confidence 457777777765 577999999999999999999954 47899999998764432 333569999999963 37
Q ss_pred ceeeeEEEE-cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 99 LLALLGYCS-DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 99 i~~~~~~~~-~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
++.++..|. ..+.|+|||-+ ..+|...+..++. ...|....+..++.|+..||..|-.. |++|.||||+||
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 777776554 45677898887 4589999987763 34688899999999999999999999 999999999999
Q ss_pred EeCC-CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 178 LLDK-NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 178 lv~~-~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
||++ ...+||||||.+....... .+....+..|.|||++.|-.|+...|+||+||+||||+||+..|.+......
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred EeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 9976 4568999999987644322 2333445579999999999999999999999999999999999988654311
Q ss_pred cceee-----------------------------cccccccc------------hhHHHhhcCccccCCCC---HHHHHH
Q 018744 257 GVLVS-----------------------------WALPRLTD------------REKILEIMDPALEGQYS---MKEVIQ 292 (351)
Q Consensus 257 ~~~~~-----------------------------~~~~~~~~------------~~~~~~~~~~~~~~~~~---~~~~~~ 292 (351)
.-..+ ........ ...+...+.. ...++ ......
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~--~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA--VQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc--cCCCCchhHHHHHH
Confidence 00000 00000000 0111111110 11122 334568
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 293 VAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 293 l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.+|+..||..||++|.|..+.|.|
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=243.80 Aligned_cols=269 Identities=18% Similarity=0.253 Sum_probs=177.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-----------------cCCcEEEEEEccccCCCChHH--------------HHHH
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-----------------SNGRKVAIKLMDQAGKQGEDE--------------FKME 87 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-----------------~~~~~~~vk~~~~~~~~~~~~--------------~~~e 87 (351)
..++|.+.++||+|+||.||+|.. ..++.|++|.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999863 234679999986443222222 2335
Q ss_pred HHHHhccCCCcc-----eeeeEEEE---------cCCeEEEEEEccCCChhhhccccCCC-----------------CCC
Q 018744 88 VELLGRLRSPYL-----LALLGYCS---------DRRKLLVYDYMANGGLQEHLYPANGS-----------------NSV 136 (351)
Q Consensus 88 ~~~l~~l~h~~i-----~~~~~~~~---------~~~~~~v~~~~~~~~L~~~~~~~~~~-----------------~~~ 136 (351)
+.++.+++|.++ +.+++++. ....++|++|+.+++|.+++....+. ...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666665543 55566553 23567999999999999988643210 011
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccc
Q 018744 137 ASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216 (351)
Q Consensus 137 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 216 (351)
...+++..++.++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 23457788999999999999999999 999999999999999999999999999865332211 11112334788999
Q ss_pred ccccccCC--------------------C--CCccceeehHHHHHHHHhCCC-CCCCCCCCCCcceeecccccccchhH-
Q 018744 217 PEYALTGH--------------------L--TTKSDVYSYGVVLLELLTGRV-PIDVNKPSGEGVLVSWALPRLTDREK- 272 (351)
Q Consensus 217 PE~~~~~~--------------------~--s~~~DiwslG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~- 272 (351)
||.+.... + ..+.||||+||++|+|++|.. ||........ ..........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~------~~~~~~~~~~~ 452 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT------ELRQYDNDLNR 452 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh------HHhhccchHHH
Confidence 99875322 1 134699999999999999875 6643211100 0000000000
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEA---DYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P---~~Rpt~~eil~~ 317 (351)
..........-...........+|+.+||..+| .+|+|+.|+|+|
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000111111112234568899999999766 689999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=223.27 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=192.6
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe------
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK------ 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 111 (351)
.+.+-.+-||-|+||.||.+.++ +|+.+++|.+.+. +-.....+-+|+++|+.++|.|++..+++....+.
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45667889999999999999965 7899999988632 22334567779999999999999999988765532
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+.++|.+ ..+|...+. +...++...+.-+++||++||.|||+. +|.||||||.|.+|+.+..+||||||
T Consensus 133 YV~TELm-QSDLHKIIV-------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV-------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHHHHH-Hhhhhheec-------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 2344443 446777773 345788889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+++..+... ....+....|..|.|||++.|. .|+.+.||||+||++.||+..+..|....+......+........-.
T Consensus 202 LARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 202 LARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred cccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 998754433 2334555678889999999865 79999999999999999999999998766643222211111000000
Q ss_pred ------hHHH-hhcCcccc-----CCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 271 ------EKIL-EIMDPALE-----GQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 271 ------~~~~-~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+... .++..... .-| +.....+-..++..++..||.+|.+..+.+.++
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000 01111000 000 012233566788899999999999999998775
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=233.75 Aligned_cols=204 Identities=27% Similarity=0.397 Sum_probs=169.7
Q ss_pred cCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
.-|..++.||-|+||.|.+++ ..+...||.|.+..++- ......+.|-.+|.....+-|++++-.|.++ ..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346678889999999999998 55677899998865432 2234466688899999999999999988877 566999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.||++-+++.+.+ -+.+..+..++..+..|+.+.|+. |++||||||+|||||.+|++||.|||+|+-
T Consensus 709 dYIPGGDmMSLLIrmg-------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred eccCCccHHHHHHHhc-------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence 9999999999997654 588888999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCCc----------------------------------------eecccCCCcccccccccccCCCCCccceeehH
Q 018744 196 GSDKAGGH----------------------------------------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 235 (351)
Q Consensus 196 ~~~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG 235 (351)
+....... .....+||+.|+|||++...-|+..+|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 32111100 01124589999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCC
Q 018744 236 VVLLELLTGRVPIDVNKPS 254 (351)
Q Consensus 236 ~~l~~lltg~~pf~~~~~~ 254 (351)
++||+|+.|..||-...+.
T Consensus 859 vil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HHHHHHhhCCCCccCCCCC
Confidence 9999999999999876664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=244.67 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=178.9
Q ss_pred CceeeecCceEE-EEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCeE-EEEEEccCCC
Q 018744 46 SNVVGHGGFGLV-YRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL-LVYDYMANGG 122 (351)
Q Consensus 46 ~~~lg~G~~g~v-~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~-~v~~~~~~~~ 122 (351)
.+.+|.|+.|++ |+|.. .|+.||||.+-. .....+.+|+..|+.- .||||+++++.-.+.+.. +..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 456888988764 88887 668999998742 3345678899999988 699999999988777654 555655 559
Q ss_pred hhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-----CCcEEEeecccccccC
Q 018744 123 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLAKIGS 197 (351)
Q Consensus 123 L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-----~~~v~l~dfg~~~~~~ 197 (351)
|.+++.... ... ........+.++.|++.||++||+. +|+||||||.||||+. ..+++|+|||++....
T Consensus 589 L~dlie~~~-~d~--~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 589 LQDLIESSG-LDV--EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HHHHHhccc-cch--hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 999996641 110 0111145678899999999999999 9999999999999965 3568999999998876
Q ss_pred CCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 198 DKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 198 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
...... ......||-+|.|||++.....+.+.|||||||++|+.++ |.+||+...... .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------------------~N 724 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------------------AN 724 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------------------hh
Confidence 644332 2344668999999999998888889999999999999988 699997533210 01
Q ss_pred hcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
++... +..-.+.... ...+||.+|++.+|..||++.+++.|
T Consensus 725 Il~~~~~L~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 725 ILTGNYTLVHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hhcCccceeeeccCchH-HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11100 0000001111 67889999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=208.46 Aligned_cols=210 Identities=36% Similarity=0.615 Sum_probs=178.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEccCCChhh
Q 018744 49 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQE 125 (351)
Q Consensus 49 lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~~~~L~~ 125 (351)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.++|++++++++++... ..+++++++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999998754332 346788999999999999999999998875 4569999999999999
Q ss_pred hccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecccccccCCCCCCce
Q 018744 126 HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGSDKAGGHV 204 (351)
Q Consensus 126 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~~~~~~~~~~~ 204 (351)
++.... ..++...++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (215)
T cd00180 81 LLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L 149 (215)
T ss_pred HHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence 984331 3588999999999999999999999 9999999999999998 89999999999876544321 1
Q ss_pred ecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccC
Q 018744 205 STRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283 (351)
Q Consensus 205 ~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (351)
.....+...|++||.+... .++.++|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334567789999998877 788999999999999999
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
..+.+++..|++.+|++||++.++++++
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2588899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=218.42 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=194.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccc--cCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
..+|.-.+.++.|.- .|..|.+. .++++++|.... .+.....+..+|...+..++|+||++++.++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888899988 66666643 688899997752 2344556677899999999999999999988543
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
+.++|||++.. +|...+. -.++-.++..++.|++.|+.|||+. ||+||||||+||++..++.+|++|
T Consensus 95 e~y~v~e~m~~-nl~~vi~---------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 33589999865 7877774 1466789999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++...... ...+....+..|.|||++.+-.+....||||+||++.||++|+..|.+.+......+.....+....
T Consensus 162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 9999864332 3456677788999999999888999999999999999999999999876654332222111111000
Q ss_pred --hhHHH-------------------hhc-CccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 --REKIL-------------------EIM-DPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 --~~~~~-------------------~~~-~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..++. +++ |..+.. ..+......+++++.+||-.||++|.|+.++|.|
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000 000 000000 0011224468889999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=204.07 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=161.7
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEE-EEcCCe
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGY-CSDRRK 111 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~ 111 (351)
+...-+.......||+|++|.|-..+ ..+|...|+|.+... +.+...+..+|+.+...- .+|.++.+++. +.+.+-
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 33444566667889999999998877 458999999988633 222334455566665543 68999999984 455566
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++.||.++ .+|..+..+.- .....+++..+-+|+..++.||.|||++- .++|||+||.|||++.+|.||+||||
T Consensus 121 wIcME~M~-tSldkfy~~v~---~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVL---KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHH---hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 68888774 47776654432 23356899999999999999999999985 89999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCccccccccccc----CCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALT----GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
.+-.+.... ..+...|...|+|||.+.. ..|+.++||||||++++||.+++.||..+.
T Consensus 195 IsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 195 ISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 997654432 3344667888999998863 368999999999999999999999997654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=226.54 Aligned_cols=196 Identities=22% Similarity=0.358 Sum_probs=161.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC-CcEEEEEEccccCC--------CChHHHHHHHHHHhccC---CCcceeeeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLR---SPYLLALLGYCS 107 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 107 (351)
...|+..+.||+|+||.|++|.++. ...|++|.+....- .....+..|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3569999999999999999999764 55688898753210 11123556999999997 999999999999
Q ss_pred cCCeE-EEEEEc-cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 108 DRRKL-LVYDYM-ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 108 ~~~~~-~v~~~~-~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
+++.| ++++.. ++-+|.+++ .....+++..+..|+.|++.|+++||++ ||+|||||-+||.++.+|-+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I-------E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI-------EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh-------hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence 98777 566654 344677777 3345789999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCC
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPID 249 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~ 249 (351)
||+|||.+...... .....+||..|.|||++.|..| ...-|||+||+++|.+.....||.
T Consensus 710 klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998764443 2455779999999999998877 567899999999999999888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=203.65 Aligned_cols=197 Identities=31% Similarity=0.476 Sum_probs=167.2
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
|.+.+.||.|++|.||++... +++.+++|.+...... ....+.+|++.++.++|+|++++++++... ..+++++++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 677889999999999999965 4889999999765444 567888999999999999999999988765 4569999999
Q ss_pred CCChhhhccccCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 120 NGGLQEHLYPANGSNSVASK-LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
+++|.+++.... . +++..++.++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.....
T Consensus 81 ~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 81 GGDLFDYLRKKG-------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred CCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 999999985432 3 78999999999999999999999 999999999999999999999999999887544
Q ss_pred CCCCceecccCCCccccccccc-ccCCCCCccceeehHHHHHHHHhCCCCCCC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~s~~~DiwslG~~l~~lltg~~pf~~ 250 (351)
.... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3211 12334566789999998 566778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=208.71 Aligned_cols=267 Identities=24% Similarity=0.359 Sum_probs=195.2
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 110 (351)
++-..+.|.++.+||+|.|++||++... .++.|++|.+...+ ....+..|+++|..+ .+.||+++.+.+..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455688999999999999999999832 46789999886433 345688899999999 4889999999998776
Q ss_pred eE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEe
Q 018744 111 KL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVS 188 (351)
Q Consensus 111 ~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~ 188 (351)
.+ +|++|++.....++.. .++...+..+++.++.||.++|.+ ||+|+||||.|++.+. .+.-.|+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred eeEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 55 9999999999888883 567889999999999999999999 9999999999999964 5678999
Q ss_pred ecccccccCC----------------C-----------------CCCce---------ecccCCCccccccccccc-CCC
Q 018744 189 DFGLAKIGSD----------------K-----------------AGGHV---------STRVLGTQGYVAPEYALT-GHL 225 (351)
Q Consensus 189 dfg~~~~~~~----------------~-----------------~~~~~---------~~~~~~~~~y~aPE~~~~-~~~ 225 (351)
|||++..... . .+... .....||++|.|||++.. ..-
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 9999872100 0 00000 011348999999999875 456
Q ss_pred CCccceeehHHHHHHHHhCCCCCCCCCCCCCcc---------------------eeecccccccchhH----HHhh-cCc
Q 018744 226 TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV---------------------LVSWALPRLTDREK----ILEI-MDP 279 (351)
Q Consensus 226 s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~---------------------~~~~~~~~~~~~~~----~~~~-~~~ 279 (351)
+.+.||||.|+++..++++..||-....+.... ..-|.......... ...+ ...
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 889999999999999999999996654442211 11111000000000 0011 011
Q ss_pred ccc--------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 280 ALE--------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 280 ~~~--------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
... .....-.+..+.+|+.+||..||.+|.|+++.|.|
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 111 11112224479999999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=201.68 Aligned_cols=242 Identities=18% Similarity=0.328 Sum_probs=174.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEE-EEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGY-CSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~-~~~v~~ 116 (351)
+.|.|.+.||+|.||.+.++.+. ++..+|+|.+... ......|.+|...--.+ .|.||+..+++ |+..+ .++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 67999999999999999999954 6788999988643 34456777787766556 48899988874 34444 449999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe--CCCCcEEEeeccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAK 194 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv--~~~~~v~l~dfg~~~ 194 (351)
|++.|+|.+-+.. ..+-+.....++.|++.||.|+|+. +++|||||.+|||| .+.-+|||||||..+
T Consensus 103 ~aP~gdL~snv~~--------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA--------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred cCccchhhhhcCc--------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999988843 3466778889999999999999999 99999999999999 344589999999987
Q ss_pred ccCCCCCCceecccCCCccccccccccc---C--CCCCccceeehHHHHHHHHhCCCCCCCCCCCC--Ccceeecccccc
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALT---G--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG--EGVLVSWALPRL 267 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~ 267 (351)
..+.. .....-+..|.+||+... + ...+.+|||.||+++|.++||+.||+...... ......|..+.
T Consensus 172 k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk- 245 (378)
T KOG1345|consen 172 KVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK- 245 (378)
T ss_pred ccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-
Confidence 53332 233344567999997642 2 34688999999999999999999997322110 00011111111
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
.+.+...+. .....+..+.++-|..++++|=-.
T Consensus 246 ----------~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki 278 (378)
T KOG1345|consen 246 ----------NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKI 278 (378)
T ss_pred ----------CccCchhhc-ccCHHHHHHHHHhcCCcccccchh
Confidence 111111000 123357778899999999999333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=193.80 Aligned_cols=168 Identities=21% Similarity=0.209 Sum_probs=125.7
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 200 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 200 (351)
|+|.+++... ...+++..++.++.|++.||.|||++ + ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~- 62 (176)
T smart00750 1 VSLADILEVR------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE- 62 (176)
T ss_pred CcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-
Confidence 5777877432 23699999999999999999999999 6 999999999999999 9988754332
Q ss_pred CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCcc
Q 018744 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280 (351)
Q Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
...+++.|+|||++.+..++.++|||||||++|+|++|..||........ ....+.......
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~------------~~~~~~~~~~~~ 124 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA------------ILEILLNGMPAD 124 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH------------HHHHHHHHhccC
Confidence 12578899999999999999999999999999999999999964322100 000111111111
Q ss_pred -ccC-CCCHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 281 -LEG-QYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 281 -~~~-~~~~~~~~--~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
... ........ .+.+++.+||..+|++|||+.++++++..+...
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 125 DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000 11112222 589999999999999999999999999877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=222.94 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=203.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEE-cCCeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~v~~ 116 (351)
...+|...+.+|+|.+|.||++++ .+++..++|+++.....+..-+..|+-+++.-+||||+.+++.+. ....++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 347899999999999999999994 478999999998777777778888999999999999999999665 446679999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+|+|.+..+ ...++++.++..+++..++++.|||+. +=+|||||-.||++++.|.+++.|||.+...
T Consensus 93 ycgggslQdiy~-------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 93 YCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred ecCCCcccceee-------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 999999999874 335899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
.... .......||+.|+|||+.. .+-|...+|||++|++..++---+.|--..-+.... .-..
T Consensus 163 tati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l------------~LmT 228 (829)
T KOG0576|consen 163 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL------------FLMT 228 (829)
T ss_pred hhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH------------HHhh
Confidence 3221 2234567999999999864 567899999999999999998766653211110000 0000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-----------HHHhhhccCCCC
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS-----------LVPLVKYNRSTP 329 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~-----------l~~~~~~~~~~~ 329 (351)
...+++.-. .-......-+.+|++.||..+|++|||++-+|.| ..+++++.+.+.
T Consensus 229 kS~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 229 KSGFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred ccCCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 011111110 1111234468889999999999999999887754 245555555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=232.21 Aligned_cols=192 Identities=18% Similarity=0.227 Sum_probs=130.4
Q ss_pred CcceeeeEEEE-------c-CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCce
Q 018744 97 PYLLALLGYCS-------D-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168 (351)
Q Consensus 97 ~~i~~~~~~~~-------~-~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 168 (351)
.||..+++++. . ...++++|++ +++|.+++... ...++...++.++.||++||.|||++ +|+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP------DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc------cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 46666666551 1 1223566665 66999999532 24589999999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcE-------------------EEeecccccccCCCCC--------------CceecccCCCcccc
Q 018744 169 HRDFKSSNILLDKNFHA-------------------KVSDFGLAKIGSDKAG--------------GHVSTRVLGTQGYV 215 (351)
Q Consensus 169 H~di~p~Nilv~~~~~v-------------------~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~ 215 (351)
||||||+||||+..+.+ +++|||+++....... ........+|+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999655544 4555555432111000 00001134678899
Q ss_pred cccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHH
Q 018744 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAA 295 (351)
Q Consensus 216 aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 295 (351)
|||++.+..++.++|||||||++|||++|..|+..... ....+....+. ............
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~------------------~~~~~~~~~~~-~~~~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR------------------TMSSLRHRVLP-PQILLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH------------------HHHHHHHhhcC-hhhhhcCHHHHH
Confidence 99999999999999999999999999998887642110 01111100110 111112234567
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 018744 296 IAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 296 li~~~l~~~P~~Rpt~~eil~~ 317 (351)
++.+||+.+|.+|||+.+++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-23 Score=188.30 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=192.9
Q ss_pred CCCcCceeeecCceEEEEEEEcCC--cEEEEEEccccCCCChHHHHHHHHHHhccCC----CcceeeeEEEE-cC-CeEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSNG--RKVAIKLMDQAGKQGEDEFKMEVELLGRLRS----PYLLALLGYCS-DR-RKLL 113 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~~-~~-~~~~ 113 (351)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++... .. ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 4788888765433333367789999988862 68888888873 44 3456
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-----CcEEEe
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-----FHAKVS 188 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-----~~v~l~ 188 (351)
||..+ |.+|.++..... ...++..+++.++.|++.+|.+||+. |++||||||.|+++... ..++|.
T Consensus 99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 66655 779998774332 35799999999999999999999999 99999999999999754 469999
Q ss_pred eccccc--ccCCCCCCc-----e-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 189 DFGLAK--IGSDKAGGH-----V-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 189 dfg~~~--~~~~~~~~~-----~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
|||+++ ......... . .....||..|+++..+.+...+.+.|+||+++++.+|+.|..||........
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---- 245 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---- 245 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----
Confidence 999998 332222111 1 2235599999999999999999999999999999999999999965432111
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
....................+..+.++...+-..+..++|....+...|++.....
T Consensus 246 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 ---------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111111111111122334555666666688999999999999998888865
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=216.10 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=185.7
Q ss_pred ceeeeHHHHHHHhc-CCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC-CCChHHHHHHHHH--HhccCCCcceeee
Q 018744 28 LQVFTFKQLHSATG-GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG-KQGEDEFKMEVEL--LGRLRSPYLLALL 103 (351)
Q Consensus 28 ~~~~~~~~~~~~~~-~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~-~~~~~~~~~e~~~--l~~l~h~~i~~~~ 103 (351)
.+..+++....... +|..++.||++.|-+|.+|++..|. +++|++-... .-..+.+.+.++- ...+++||++++.
T Consensus 9 sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfq 87 (1431)
T KOG1240|consen 9 SQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQ 87 (1431)
T ss_pred cccchHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchH
Confidence 34444444444443 7888999999999999999987877 8889875443 4445555554433 4455899999998
Q ss_pred EEEEcCCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 104 GYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 104 ~~~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
.+...... ++|-.|.. .+|.+.+ +.+.-+..-+...++.|++.||..+|+. |++|||||.+||||+.-
T Consensus 88 k~~~t~kAAylvRqyvk-hnLyDRl-------STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSW 156 (1431)
T KOG1240|consen 88 KVLVTDKAAYLVRQYVK-HNLYDRL-------STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSW 156 (1431)
T ss_pred HHHHhhHHHHHHHHHHh-hhhhhhh-------ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeee
Confidence 77554433 35555554 4788888 4455677888889999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCC-CCC----CceecccCCCcccccccccccC-----------CCCCccceeehHHHHHHHHh-CC
Q 018744 183 FHAKVSDFGLAKIGSD-KAG----GHVSTRVLGTQGYVAPEYALTG-----------HLTTKSDVYSYGVVLLELLT-GR 245 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~-~~~----~~~~~~~~~~~~y~aPE~~~~~-----------~~s~~~DiwslG~~l~~llt-g~ 245 (351)
+-+.|+||......-- .++ .........-.+|.|||.+... ..+++.||||+||+++||++ |.
T Consensus 157 NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 157 NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 9999999987644211 111 1123334456689999987531 26789999999999999998 89
Q ss_pred CCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 246 VPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 246 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.+|.... ...+......+.+.+.+.++. ..++.||..|++.||++|.++++.|+..
T Consensus 237 PlF~LSQ------L~aYr~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 237 PLFTLSQ------LLAYRSGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred CcccHHH------HHhHhccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 9986322 112221112222222222211 1588999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=189.20 Aligned_cols=183 Identities=19% Similarity=0.166 Sum_probs=137.0
Q ss_pred eeHHHHHHHhcCCCcCceeeecCceEEEEEEEc--CCcEEEEEEccccC-----CCChHHHHHHHHHHhccCCCcceeee
Q 018744 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKLMDQAG-----KQGEDEFKMEVELLGRLRSPYLLALL 103 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~ 103 (351)
.+.++.....++|.+.+.||+|+||.||+|.+. +++.+++|.+.... ......+.+|+++|+.++|+|+++.+
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 345667778899999999999999999999854 56777999864221 11245688999999999999998533
Q ss_pred EEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCC-CCCcEEeCCC
Q 018744 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF-KSSNILLDKN 182 (351)
Q Consensus 104 ~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di-~p~Nilv~~~ 182 (351)
.. ....++||+|+.+++|.... +.. ...++.|++++|.+||++ |++|||| ||+||+++.+
T Consensus 88 ~~--~~~~~LVmE~~~G~~L~~~~-----------~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 88 LA--TGKDGLVRGWTEGVPLHLAR-----------PHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD 148 (365)
T ss_pred EE--cCCcEEEEEccCCCCHHHhC-----------ccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC
Confidence 22 24568999999999886321 011 145788999999999999 9999999 9999999999
Q ss_pred CcEEEeecccccccCCCCCCce------ecccCCCcccccccccccC------CCCCcccee
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHV------STRVLGTQGYVAPEYALTG------HLTTKSDVY 232 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~------~~s~~~Diw 232 (351)
+.++|+|||++........... .....++..|.|||.+... ..+..+|.|
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999999987654321111 1234577789999988633 234456666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=178.52 Aligned_cols=249 Identities=20% Similarity=0.349 Sum_probs=189.6
Q ss_pred CCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
+..+..+|.+...|.+|+|+|+. ..++.|++.... ....+.|..|.-.|+.+.||||+++++.|... +..++..|+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34556778999999999999955 456678775332 22336788899999999999999999999876 566999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe--eccccccc
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS--DFGLAKIG 196 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~--dfg~~~~~ 196 (351)
..|+|.+.++... .--.+..++.+++.++++|++|||+.. +-+..--|+...++|+++.+.+|+ |--++.
T Consensus 270 p~gslynvlhe~t-----~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT-----SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred cchHHHHHHhcCc-----cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--
Confidence 9999999997543 234677889999999999999999984 234444689999999998877663 222111
Q ss_pred CCCCCCceecccCCCcccccccccccCC---CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
......-.+.|++||.++..+ .-.++|+|||++++|||.|...||....+...+.++.
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 111223356799999998654 3468999999999999999999998776643322222
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
-+.++-..++.....+.+|+.-|++.||.+||.+..++-.|+++.
T Consensus 403 ----leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ----LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 223344566667778999999999999999999999999888764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=204.55 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=182.1
Q ss_pred CcCceeeecCceEEEEEEE-cCCcEEEEEEcc-----ccCCCChH-HHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEE
Q 018744 44 SKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMD-----QAGKQGED-EFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 44 ~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~-----~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~ 115 (351)
...+.+|.|.+|.++.+.. ...+.+..|.+. ........ .+..|+.+-..+.|+|++..+..+.+...+ ..|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4577899999997777663 233334444332 11111111 155577777788999997777665544333 458
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+ +|..++.. ...+....+-.++.|++.|+.|+|+. |+.|+|+|++|++++.+|.++++|||.+..
T Consensus 401 E~~~~-Dlf~~~~~-------~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-------NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hcccH-HHHHHHhc-------ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 99999 89888832 24688889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--ceecccCCCcccccccccccCCCCC-ccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGG--HVSTRVLGTQGYVAPEYALTGHLTT-KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~-~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
....... .......|...|+|||++.+..|.+ ..||||.|+++..|.+|+.||.................+...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~--- 546 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI--- 546 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc---
Confidence 6555444 4556678999999999999988865 579999999999999999999765443221100000000000
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..-........+...+.+|.+||+++|.+|.|+.+|++.
T Consensus 547 ------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 ------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000011112334567889999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-22 Score=169.30 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=188.4
Q ss_pred hcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
+-.|++.++||+|.||.++.|. .-++++||||.-...+ .+-+++.|+...+.|. .++|..++-+-.++ +.++|++
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4569999999999999999999 4589999999876543 3457788999998884 68888777555544 3457877
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-----CCcEEEeecc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFG 191 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-----~~~v~l~dfg 191 (351)
.+ |-+|.+++--= ...++.++++.++.||+.-++++|.+ .++.|||||+|+||.. ...+.++|||
T Consensus 105 LL-GPSLEDLFD~C------gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC------GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hh-CcCHHHHHHHh------cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence 76 66888877321 23689999999999999999999999 9999999999999953 3459999999
Q ss_pred cccccCCCCCCcee-----cccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 192 LAKIGSDKAGGHVS-----TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 192 ~~~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++..+..+...... ....||.+||+-..+.+..-|.+.|+-|||-++++++-|.+||.+....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~------------ 242 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD------------ 242 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc------------
Confidence 99887665443322 2356999999999999999999999999999999999999999876542
Q ss_pred ccchhHHHhhcCccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 267 LTDREKILEIMDPALEGQ---YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+.+-+.+-... .....+.++..-++-.-+.+=.+-|...-+..-+.+++.
T Consensus 243 -tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 243 -TNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred -chHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11122222222111110 011223344444544445566667777666555555443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=167.52 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=163.8
Q ss_pred HHhcCCCcCceeeecCceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCC-CcceeeeEEEEcC-CeEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~v 114 (351)
...++|.+++.||+|+||.+|+|. ..+|..||+|+-..... ...+..|.++.+.+++ ..|..+..+..+. ..++|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999999 66899999999765433 2456779999999975 5666666665554 44588
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~dfg 191 (351)
|+.+ |.+|.+++.-- ...++..+++.++-|++.-++|+|.+ +++|+||||+|+|..- ...+.|+|||
T Consensus 90 MdLL-GPsLEdLfnfC------~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC------SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred eecc-CccHHHHHHHH------hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 8877 66888887322 23588899999999999999999999 9999999999999953 4579999999
Q ss_pred cccccCCCCCCce-----ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCC
Q 018744 192 LAKIGSDKAGGHV-----STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253 (351)
Q Consensus 192 ~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~ 253 (351)
++..+........ .....||..|.+-..+.+-..+.+.|+-|+|+++.++.-|..||++...
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9987644332221 2345689999999888888889999999999999999999999987654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=168.41 Aligned_cols=171 Identities=16% Similarity=0.161 Sum_probs=131.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHH---------HHHHHHHHhccCCCcceeeeEEEEc
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE---------FKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
...++|++.+.||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4469999999999999999999665 56789999996443332222 5788999999999999999887542
Q ss_pred C---------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 109 R---------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 109 ~---------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
. ..+++|||++|.+|.++. .++. ..+.+++.++..||+. |++|+|++|.||++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-----------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 2 357999999999998764 1222 2456999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHH
Q 018744 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 242 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~ll 242 (351)
+.+| ++|+|||........... ...+....+..++|+|+||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988 999999987654221100 00233445667999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-21 Score=172.26 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=194.0
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCC-cceeeeEEEEcCCe-EEEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSP-YLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~-~~v~~~ 117 (351)
|.+.+.||.|+|+.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+..... ++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999975 77888988654333 256788899999999988 79999999866654 799999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~~~~~ 196 (351)
+.++++.+++...... ..+.......++.|++.++.++|+. +++|+|+||+||+++..+ .++++|||.+...
T Consensus 80 ~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 80 VDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred CCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999666332210 3688999999999999999999999 999999999999999988 7999999998754
Q ss_pred CCCCCCc----eecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 197 SDKAGGH----VSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 197 ~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
....... ......++..|++||.+.+ ..++...|+|++|++++++++|..||...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------~~~~~~ 223 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------SATSQT 223 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------ccHHHH
Confidence 4433221 2456778999999999987 57889999999999999999999997654421 000000
Q ss_pred hhHHHhhcCccccCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYS----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+.....+....... ......+.+++..|+..+|..|.+..+....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00011111110111111 1123468889999999999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=158.95 Aligned_cols=142 Identities=17% Similarity=0.195 Sum_probs=108.9
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEccccCCC--C-------h-----------------HHHHHHHHHHhccCCCc
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--G-------E-----------------DEFKMEVELLGRLRSPY 98 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~ 98 (351)
+...||+|++|.||+|...+|+.||+|++...... . . .....|++.+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35689999999999999778999999998643211 1 0 12234899999998777
Q ss_pred ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCceecCCCCCcE
Q 018744 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL-HEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 99 i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~di~p~Ni 177 (351)
+.....+ .....++||||+.++++..... ....++...++.++.|++.+|.++ |+. |++|+||||+||
T Consensus 81 v~~p~~~-~~~~~~iVmE~i~g~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPI-LLKSHVLVMEFIGDDGWAAPRL-------KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNL 149 (190)
T ss_pred CCCCcEE-EecCCEEEEEEeCCCCCcchhh-------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence 6433322 2334589999999876654432 123688899999999999999999 788 999999999999
Q ss_pred EeCCCCcEEEeecccccccCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~ 198 (351)
+++ ++.++|+|||++.....
T Consensus 150 li~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 150 LYH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred EEE-CCcEEEEEccccccCCC
Confidence 998 47899999999875433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=173.44 Aligned_cols=235 Identities=19% Similarity=0.296 Sum_probs=144.8
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhccC----------CCcceeeeEEEE-
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLR----------SPYLLALLGYCS- 107 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~- 107 (351)
+...+.||.|+++.||.+.+. +++.+++|++...... ..+.+++|.-....+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455778999999999999965 5899999987643322 2344555544443322 223333333221
Q ss_pred --------cC---------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceec
Q 018744 108 --------DR---------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHR 170 (351)
Q Consensus 108 --------~~---------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~ 170 (351)
.. +.+++|+.+ .++|.+++............+.....+.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 223566665 5577777533221111122344555667779999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccccc--------CCCCCccceeehHHHHHHHH
Q 018744 171 DFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--------GHLTTKSDVYSYGVVLLELL 242 (351)
Q Consensus 171 di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~~DiwslG~~l~~ll 242 (351)
||+|+|++++.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999998876533311 11334567999997643 24688999999999999999
Q ss_pred hCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 018744 243 TGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 308 (351)
Q Consensus 243 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 308 (351)
+|..||+...+...... .+ ..+. +.++.+..||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999985443211000 11 1333 666779999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=151.52 Aligned_cols=142 Identities=16% Similarity=0.152 Sum_probs=110.0
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC--------------------------hHHHHHHHHHHhccCCCc
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--------------------------EDEFKMEVELLGRLRSPY 98 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~ 98 (351)
+.+.||+|++|.||+|...+|+.||+|++....... ...+..|+..+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999997689999999986542110 112356889999998888
Q ss_pred ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcE
Q 018744 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNI 177 (351)
Q Consensus 99 i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Ni 177 (351)
+.....+... ..++||||+.++++...... ...++...+..++.|++.++.++|+ . |++|+||||+||
T Consensus 81 i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~-------~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK-KNVLVMEFIGDDGSPAPRLK-------DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec-CCEEEEEEecCCCchhhhhh-------hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence 7444433332 35899999998755433211 1356788899999999999999999 8 999999999999
Q ss_pred EeCCCCcEEEeecccccccCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~ 198 (351)
+++ ++.++|+|||++.....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 998 78999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=148.85 Aligned_cols=186 Identities=20% Similarity=0.125 Sum_probs=136.7
Q ss_pred CcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC----hHHHHHHHHHHhccC-CCcceeeeEEEEcCCeEEEEEEc
Q 018744 44 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG----EDEFKMEVELLGRLR-SPYLLALLGYCSDRRKLLVYDYM 118 (351)
Q Consensus 44 ~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~v~~~~ 118 (351)
-++..|++|+||+|+++.. .+.+++.+.+.....-. ...+.+|+++|+.+. +++++.++++ ...+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeee
Confidence 4577899999999997776 67888878775442211 125788999999995 5788888886 4468999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCC-CCCcEEeCCCCcEEEeecccccccC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF-KSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di-~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
.|.+|..... . ....++.|++.+|.++|++ |++|+|| ||.||+++.++.++|+|||++....
T Consensus 81 ~G~~L~~~~~-----------~---~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP-----------R---GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh-----------h---hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9988864431 0 1135778999999999999 9999999 7999999999999999999998644
Q ss_pred CCCCC----ce-------ecccCCCcccccccccccC-CCC-CccceeehHHHHHHHHhCCCCCCC
Q 018744 198 DKAGG----HV-------STRVLGTQGYVAPEYALTG-HLT-TKSDVYSYGVVLLELLTGRVPIDV 250 (351)
Q Consensus 198 ~~~~~----~~-------~~~~~~~~~y~aPE~~~~~-~~s-~~~DiwslG~~l~~lltg~~pf~~ 250 (351)
..... .. ......++.+++|+...-- ..+ .+.+.++-|+-+|.++|+..++-.
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 33211 00 1112246667777643321 233 566888999999999998888643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=179.44 Aligned_cols=203 Identities=21% Similarity=0.251 Sum_probs=156.2
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC---CCcceeeeEEEE-
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCS- 107 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~- 107 (351)
...+...-.+.|.|.+.||.|++|.||+|...+|+.+|+|+-...+.-+. .+ -.+++.+|+ -+.|+.+.....
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-YI--~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-YI--CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-ee--hHHHHHhhchhhhcchHHHHHHHcc
Confidence 33445566788999999999999999999977799999998765443221 11 122223333 233444433222
Q ss_pred cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-------
Q 018744 108 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD------- 180 (351)
Q Consensus 108 ~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~------- 180 (351)
.+..++|++|.+.|+|.+++. ..+-+++..+..+..||+..+.+||.. +|+||||||+|+++.
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred CCcceeeeeccccccHHHhhc-------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCC
Confidence 234479999999999999995 335789999999999999999999999 999999999999993
Q ss_pred CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCC
Q 018744 181 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~p 247 (351)
+.-.++|+|||.+--...-.........++|..+-.+|...|..+++..|.|.|+.+++.|+.|..-
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2345999999998554333333455667788899999999999999999999999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-21 Score=175.33 Aligned_cols=231 Identities=25% Similarity=0.333 Sum_probs=180.2
Q ss_pred eeeecCceEEEEEE----EcCCcEEEEEEccccCCCC--hHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEEEEcc
Q 018744 48 VVGHGGFGLVYRGV----LSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMA 119 (351)
Q Consensus 48 ~lg~G~~g~v~~~~----~~~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~~~~~ 119 (351)
.+|.|.+|.|++++ ...+..+++|+........ ......|-.++...+ ||.++.++-.++.+ ..++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999877 2346778888775432211 113344677777776 89999998877665 4568999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+|.|...+.. ...+.+.........++.+++++|+. +++|+|+|++||+++.+|++++.|||.+...-..
T Consensus 81 gg~lft~l~~-------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRLSK-------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhcccc-------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9988888743 34677888888999999999999999 9999999999999999999999999998764332
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
. ..+|+..|+|||++. ....+.|.||||+++|+|++|..||.. .....++..
T Consensus 151 ~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~ 202 (612)
T KOG0603|consen 151 K------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA 202 (612)
T ss_pred h------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh
Confidence 2 128899999999988 457899999999999999999999973 233344433
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHH
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM--ADVVQSL 318 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~--~eil~~l 318 (351)
. ..++........+++..++..+|.+|.-. ..+.++.
T Consensus 203 ~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 203 E--LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred c--cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 3 35667777889999999999999999976 3444444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=158.68 Aligned_cols=195 Identities=21% Similarity=0.214 Sum_probs=133.1
Q ss_pred CCCcceeeeEEEEcC----------------------------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHH
Q 018744 95 RSPYLLALLGYCSDR----------------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146 (351)
Q Consensus 95 ~h~~i~~~~~~~~~~----------------------------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~ 146 (351)
.||||+.+...|.++ ..|+||..+. .+|..++... ..+.....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--------~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--------HRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--------CCchHHHH
Confidence 499999998765321 2245665554 3777777432 35667788
Q ss_pred HHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe--CC--CCcEEEeecccccccCCCCCCc----eecccCCCccccccc
Q 018744 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DK--NFHAKVSDFGLAKIGSDKAGGH----VSTRVLGTQGYVAPE 218 (351)
Q Consensus 147 ~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv--~~--~~~v~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE 218 (351)
-++.|+++|+.|||++ |+.|+|+|.+||++ ++ -..+.++|||++-......-.. ..-...|...-+|||
T Consensus 345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 8999999999999999 99999999999999 33 3458999999986433211111 112244677899999
Q ss_pred ccccCC------CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHH
Q 018744 219 YALTGH------LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQ 292 (351)
Q Consensus 219 ~~~~~~------~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (351)
+....+ .-.++|.|+.|.+.||+++...||...... ..+-.. ..+.--...+...+..
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem------------~L~~r~----Yqe~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM------------LLDTRT----YQESQLPALPSRVPPV 485 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh------------eechhh----hhhhhCCCCcccCChH
Confidence 886322 124899999999999999999999753221 000001 1111112334445557
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 293 VAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 293 l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.+|+...|+.||++|++..-....
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhH
Confidence 8999999999999999997544433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=161.28 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=159.3
Q ss_pred HhccCCCcceeeeEEEEcCC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc-e
Q 018744 91 LGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV-I 168 (351)
Q Consensus 91 l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i-~ 168 (351)
|+.+.|.|+.++++.+.++. .+.|.+++..|+|.+.+... .-++++.....++++++.||.|||.. .+ .
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~------~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE------DIKLDYFFILSFIRDISKGLAYLHNS---PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc------ccCccHHHHHHHHHHHHHHHHHHhcC---ccee
Confidence 45678999999999887774 45999999999999999542 34789999999999999999999998 44 9
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccC-------CCCCccceeehHHHHHHH
Q 018744 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-------HLTTKSDVYSYGVVLLEL 241 (351)
Q Consensus 169 H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~s~~~DiwslG~~l~~l 241 (351)
|+.++..|.+++....+||.|||+.................-..-|.|||.+.+. ..+.++||||||++++|+
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999998765431111111122234469999998753 246789999999999999
Q ss_pred HhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC---ccccCCCC-H-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 242 LTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD---PALEGQYS-M-KEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 242 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
++...||......... .+.+..+.+ ..+..... . +....+..++..||..+|.+||++.++-.
T Consensus 152 ~~r~~~~~~~~~~~~~------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDP------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HhccCccccccccCCh------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9999999754332110 111111111 11111111 1 22336889999999999999999999999
Q ss_pred HHHHhhhcc
Q 018744 317 SLVPLVKYN 325 (351)
Q Consensus 317 ~l~~~~~~~ 325 (351)
.++.+.+..
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 988888754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=148.10 Aligned_cols=148 Identities=16% Similarity=0.147 Sum_probs=112.0
Q ss_pred HhcCCCcCceeeecCceEEEEEE--EcCCcEEEEEEccccCCCC------------------------hHHHHHHHHHHh
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQG------------------------EDEFKMEVELLG 92 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~--~~~~~~~~vk~~~~~~~~~------------------------~~~~~~e~~~l~ 92 (351)
-+--|.+.+.||.|++|.||+|. ..+|+.||+|++....... ...+..|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33458999999999999999998 4579999999986432110 123567999999
Q ss_pred ccCCCcceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-ceecC
Q 018744 93 RLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-VIHRD 171 (351)
Q Consensus 93 ~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-i~H~d 171 (351)
.+.+.. +.+..++.....++||+|+.+.+|...... ...+....+..++.|++.++.+||+. + ++|+|
T Consensus 106 ~L~~~~-i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D 174 (237)
T smart00090 106 RLYEAG-VPVPKPIAWRRNVLVMEFIGGDGLPAPRLK-------DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGD 174 (237)
T ss_pred HHHhcC-CCCCeeeEecCceEEEEEecCCcccccccc-------cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence 997532 222222333456899999999887765422 12355667789999999999999999 9 99999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCC
Q 018744 172 FKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 172 i~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
|+|+||+++ ++.++|+|||.+.....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccCC
Confidence 999999999 78999999998875433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-17 Score=139.69 Aligned_cols=135 Identities=18% Similarity=0.252 Sum_probs=103.0
Q ss_pred CcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-----CCCcceeeeEEEEcCC---e-E-E
Q 018744 44 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-----RSPYLLALLGYCSDRR---K-L-L 113 (351)
Q Consensus 44 ~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~-~ 113 (351)
.-.+.||+|+++.||. ++.....++|++........+.+.+|+.+++.+ .||||++++++++++. . + +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433233468888655444567789999999999 5799999999998763 2 3 6
Q ss_pred EEEE--ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCceecCCCCCcEEeCC----CCcEE
Q 018744 114 VYDY--MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL-EFLHEHCSPPVIHRDFKSSNILLDK----NFHAK 186 (351)
Q Consensus 114 v~~~--~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~i~H~di~p~Nilv~~----~~~v~ 186 (351)
|++| +.+++|.+++.+. .+++. ..++.+++.++ .|||++ +|+|+||||+||+++. ++.++
T Consensus 83 I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 7888 4578999999431 24444 35577777777 999999 9999999999999963 34799
Q ss_pred Eeecccc
Q 018744 187 VSDFGLA 193 (351)
Q Consensus 187 l~dfg~~ 193 (351)
|+|++.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=137.29 Aligned_cols=148 Identities=20% Similarity=0.157 Sum_probs=113.9
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC----------------------ChHHHHHHHH
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ----------------------GEDEFKMEVE 89 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~----------------------~~~~~~~e~~ 89 (351)
..+++......|.+.+.||.|++|.||++...+|+.+++|++...... ....+..|+.
T Consensus 6 ~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 6 ALHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred HHHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 345566666669999999999999999999878999999986532210 0112556888
Q ss_pred HHhccCCCc--ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 018744 90 LLGRLRSPY--LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167 (351)
Q Consensus 90 ~l~~l~h~~--i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 167 (351)
++..+.+++ ++..+ .....+++|+|+.+++|..... ......++.+++.++.++|+. ++
T Consensus 86 ~l~~l~~~~i~v~~~~---~~~~~~lv~e~~~g~~L~~~~~-------------~~~~~~~~~~i~~~l~~lh~~---gi 146 (198)
T cd05144 86 ALKALYEEGFPVPKPI---DWNRHAVVMEYIDGVELYRVRV-------------LEDPEEVLDEILEEIVKAYKH---GI 146 (198)
T ss_pred HHHHHHHcCCCCCcee---ecCCceEEEEEeCCcchhhccc-------------cccHHHHHHHHHHHHHHHHHC---CC
Confidence 888887764 33333 3345589999999998876541 023567889999999999999 99
Q ss_pred eecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 168 ~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
+|+||+|.||+++.++.++|+|||.+.....
T Consensus 147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-18 Score=162.93 Aligned_cols=215 Identities=23% Similarity=0.336 Sum_probs=143.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
......++|..++.+..|++|.||++++. +.+++++|+-+++ - +.+. ++.....|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhhc--cccccCCccee-------------
Confidence 34445588999999999999999999965 5778888542211 1 1111 22222233222
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
-+..+|...+ ++++.. ++.+++|||+- +++|+|+||+|.+|+.-|++|+.|||++
T Consensus 136 ----gDc~tllk~~----------g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 ----GDCATLLKNI----------GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ----chhhhhcccC----------CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 1122222222 233332 27899999999 9999999999999999999999999997
Q ss_pred cccCCCCCC-------------ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 194 KIGSDKAGG-------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 194 ~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
......... ......+||+.|.|||++...-|....|.|+||+++|+++-|+.||.++.+..-
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---- 266 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---- 266 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH----
Confidence 652211110 112235799999999999988899999999999999999999999988755200
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 310 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt 310 (351)
....+.+.+ .+... ....+.+..+++.++|+.+|.+|.-
T Consensus 267 --------fg~visd~i-~wpE~--dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 267 --------FGQVISDDI-EWPEE--DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred --------Hhhhhhhhc-ccccc--CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 001111111 00000 1122346888999999999999983
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.9e-18 Score=154.26 Aligned_cols=173 Identities=22% Similarity=0.347 Sum_probs=129.1
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++.|+++...+|.+++.... .....++...+.++.|++.++.| + +.+|+|++|.||+...+..++|+||
T Consensus 331 lyI~Mn~c~~~tledWl~rr~----~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRR----TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCC----cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence 458999999999999996443 23457788999999999999999 6 8999999999999999999999999
Q ss_pred ccccccCCCC----CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccc
Q 018744 191 GLAKIGSDKA----GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 191 g~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 265 (351)
|+........ .....+...||..|++||.+.+..|+.+.|||+||++++|++. =...|.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------------- 464 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------------- 464 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------------
Confidence 9987654433 1223456789999999999999999999999999999999987 232221
Q ss_pred cccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 018744 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 313 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e 313 (351)
......++.+..+......+.+ .-+.|+.+++...|.+||++.+
T Consensus 465 ---r~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 465 ---RIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 1111222222222211111111 2457999999999999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-16 Score=133.64 Aligned_cols=133 Identities=22% Similarity=0.332 Sum_probs=107.2
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCCC--------hHHHHHHHHHHhccCCCcceeeeEEE-EcCCeEEEEEE
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--------EDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDY 117 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~v~~~ 117 (351)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|+++.....++ .....+++|+|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 66778889765332211 13466799999999988876665554 34466799999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
++|++|.+++... .. .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988321 11 7889999999999999999 999999999999999 78999999998753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.1e-16 Score=148.82 Aligned_cols=145 Identities=19% Similarity=0.287 Sum_probs=112.1
Q ss_pred eeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEE-ccccCC-------CChHHHHHHHHHHhccCCCcceee
Q 018744 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKL-MDQAGK-------QGEDEFKMEVELLGRLRSPYLLAL 102 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~-~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~ 102 (351)
.++.........|...+.||+|+||.||++.+.... +++|. +..... ...+.+.+|+++++.++|++++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 344444555566778899999999999999875443 44343 221111 112457789999999999998876
Q ss_pred eEEEEc-CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 103 LGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 103 ~~~~~~-~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
..+... ...++||+|+++++|.+++. ....++.+++++|.+||+. +++|+||||+||++ .
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~ 462 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-R 462 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-E
Confidence 665544 45679999999999998882 3567899999999999999 99999999999999 6
Q ss_pred CCcEEEeecccccc
Q 018744 182 NFHAKVSDFGLAKI 195 (351)
Q Consensus 182 ~~~v~l~dfg~~~~ 195 (351)
++.++|+|||++..
T Consensus 463 ~~~~~liDFGla~~ 476 (535)
T PRK09605 463 DDRLYLIDFGLGKY 476 (535)
T ss_pred CCcEEEEeCccccc
Confidence 77999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.4e-16 Score=129.05 Aligned_cols=129 Identities=24% Similarity=0.371 Sum_probs=100.3
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEccccCCC--C------hHHHHHHHHHHhccCCCcceeeeEE-EEcCCeEEEEEEc
Q 018744 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--G------EDEFKMEVELLGRLRSPYLLALLGY-CSDRRKLLVYDYM 118 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~------~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~v~~~~ 118 (351)
.||+|++|.||++.+ .+..+++|........ . ...+.+|+++++.++++++....-+ ......+++|+++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 5678999986433211 1 2456679999999988765433333 2344567999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988873211 0 7899999999999999 999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.2e-15 Score=122.09 Aligned_cols=137 Identities=20% Similarity=0.221 Sum_probs=96.2
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEccccCCCCh--HH----------------------HHHHHHHHhccCCCc--
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE--DE----------------------FKMEVELLGRLRSPY-- 98 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~-- 98 (351)
+.+.||+|++|.||+|...+++.|++|++........ .. ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3567999999999999977899999998764322111 11 123555555553332
Q ss_pred ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcE
Q 018744 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNI 177 (351)
Q Consensus 99 i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Ni 177 (351)
+.++++. ...+++++|+.++.+........ .. ...+..++.+++.++.++|. . +++|+||+|+||
T Consensus 81 ~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~-------~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL---NRHVLVMEFIGGDGIPAPRLKDV-------RL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNI 146 (187)
T ss_pred CCceEec---CCCEEEEEEeCCCCccChhhhhh-------hh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence 3333332 34589999999865432211000 01 15678899999999999999 8 999999999999
Q ss_pred EeCCCCcEEEeeccccccc
Q 018744 178 LLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~ 196 (351)
+++ ++.++|+|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 889999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-14 Score=113.43 Aligned_cols=134 Identities=21% Similarity=0.185 Sum_probs=108.3
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCC--CcceeeeEEEEcC-CeEEEEEEccCC
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDR-RKLLVYDYMANG 121 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~-~~~~v~~~~~~~ 121 (351)
+++.|+.|.++.||++...+ ..+++|....... ...+..|+..++.+++ .++++++.+.... ..+++++|+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56789999999999999754 7799998864432 4567889999999976 4888888777653 457999999887
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.+..+ +......++.+++.+++.+|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus 79 ~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 65543 3456677899999999999986334799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-16 Score=150.39 Aligned_cols=255 Identities=22% Similarity=0.259 Sum_probs=185.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC--CcEEEEEEccccC--CCChHHHHHHHHHHhccC-CCcceeeeEEEEcCCe-EE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-~~ 113 (351)
...|.+.+.||+|.++.+-++.... ...++.|.+.... ......+..|..+-..+. |.|++.+++...+.+. ++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4678999999999999998887433 3445555554332 222344555777777776 9999999998877654 48
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCceecCCCCCcEEeCCCC-cEEEeecc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNF-HAKVSDFG 191 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg 191 (351)
++++..++++...+... .....+....-..+.|+..++.|+| .. ++.|+||+|+|.+++..+ .+++.|||
T Consensus 99 ~~~~s~g~~~f~~i~~~-----~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-----DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccCcccccccccccccC-----CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence 88888888887777311 1113455667788999999999999 88 999999999999999999 99999999
Q ss_pred cccccCC-CCCCceecccCC-CcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 192 LAKIGSD-KAGGHVSTRVLG-TQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 192 ~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
++..+.. ..........+| ++.|.|||...+. ...+..|+||.|+++..+++|..|+.......... .
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~-------- 241 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-S-------- 241 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-e--------
Confidence 9998777 444555566778 9999999998874 55788999999999999999999997544321100 0
Q ss_pred chhHHHhhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... .............+++..++..+|..|.+.+++...
T Consensus 242 ------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 242 ------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------eecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0111100 001111222346778899999999999999888644
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-14 Score=122.10 Aligned_cols=133 Identities=21% Similarity=0.208 Sum_probs=99.9
Q ss_pred ceee-ecCceEEEEEEEcCCcEEEEEEccccC-------------CCChHHHHHHHHHHhccCCCcc--eeeeEEEEcCC
Q 018744 47 NVVG-HGGFGLVYRGVLSNGRKVAIKLMDQAG-------------KQGEDEFKMEVELLGRLRSPYL--LALLGYCSDRR 110 (351)
Q Consensus 47 ~~lg-~G~~g~v~~~~~~~~~~~~vk~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~ 110 (351)
..|| .|+.|++|.+... +..+++|.+.... ......+.+|++++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 7888999988874 6778888774211 1223457789999999988775 66666543321
Q ss_pred -----eEEEEEEccC-CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 111 -----KLLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 111 -----~~~v~~~~~~-~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
.++|++++++ .+|.+++.. ..++.. .+.+++.+|.+||+. |++|+||+|.|||++.++.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK 180 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence 2489999997 688877732 134433 357899999999999 9999999999999998889
Q ss_pred EEEeecccccc
Q 018744 185 AKVSDFGLAKI 195 (351)
Q Consensus 185 v~l~dfg~~~~ 195 (351)
++|+|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-14 Score=121.91 Aligned_cols=206 Identities=20% Similarity=0.312 Sum_probs=140.9
Q ss_pred HHHHhccCCCcceeeeEEEEcCC------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 018744 88 VELLGRLRSPYLLALLGYCSDRR------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161 (351)
Q Consensus 88 ~~~l~~l~h~~i~~~~~~~~~~~------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 161 (351)
..-|-.+.|.|+++++.|+.+.. .+++++|+..|++..+++.... ..+.+......+|+.||..||.|||+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~---~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK---NQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH---hhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 34444556999999999886542 3599999999999999976542 23467888888999999999999999
Q ss_pred CCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc---eecccCCCcccccccccccCCCCCccceeehHHHH
Q 018744 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH---VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVL 238 (351)
Q Consensus 162 ~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l 238 (351)
- .+.++|+++..+.|++..+|-++++- +............ ......+.+.|.+||.=...+.+-++|||+||...
T Consensus 195 ~-~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 195 C-DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred c-CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 7 67899999999999999998888742 2211111111111 11223457789999976666778899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 239 LELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 239 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.+|..+..--...... ......+.+... .+... .-+.++..|++..|..||++++++-|.
T Consensus 273 lemailEiq~tnseS~------------~~~ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESK------------VEVEENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHheeccCCCcce------------eehhhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 9998876542211110 000011111110 00011 124488899999999999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=127.01 Aligned_cols=249 Identities=21% Similarity=0.214 Sum_probs=177.5
Q ss_pred cCCCcCceeee--cCceEEEEEEE--c-CCcEEEEEEcc--ccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCeE
Q 018744 41 GGFSKSNVVGH--GGFGLVYRGVL--S-NGRKVAIKLMD--QAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~--G~~g~v~~~~~--~-~~~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 112 (351)
..+.+.+.+|. |.+|.+|.+.. . ++..+++|.-. .........=.+++.....+ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 55788999999 99999999985 3 56778888632 22222222223466666666 488999988888888777
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEE
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK----GLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKV 187 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l 187 (351)
+++....+.+|..+.+.-. .-++...+|..+.+... |+.++|.. +++|.|++|.||+...+ ..+++
T Consensus 194 fiqtE~~~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred eeeeccccchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 7777777788888885332 34778889999999999 99999999 99999999999999998 88999
Q ss_pred eecccccccCCCCCCce---ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc
Q 018744 188 SDFGLAKIGSDKAGGHV---STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 264 (351)
+|||+............ .....+...|++||+. .+.++.++||++||.++.+..++..+...... ..|.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~- 336 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS- 336 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc-
Confidence 99999877555432221 2223677889999965 55678999999999999999887766543211 1111
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
..+ ...+..++-......+...+.+|+..+|-.|++.+.+..
T Consensus 337 ---~~r-------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ---QLR-------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccc-------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 001111222222335666999999999999999776653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-12 Score=121.10 Aligned_cols=165 Identities=19% Similarity=0.273 Sum_probs=124.2
Q ss_pred EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEccCCChhhhccccCCCCCCCCCC
Q 018744 62 LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKL 140 (351)
Q Consensus 62 ~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l 140 (351)
..++.++.+......+......+.+.++-|+.++||||+++++.++.+ ..|+|+|.+. .|..++. .+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk----------~l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK----------EL 101 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH----------Hh
Confidence 446778888887665554556788899999999999999999987665 4568888875 4666663 23
Q ss_pred CHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccc
Q 018744 141 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220 (351)
Q Consensus 141 ~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (351)
....+..-+.||+.||.+||+.+ +++|++|+...|+|+..|.-+|++|..+........ .......-..|..|+.+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence 35667778899999999998665 999999999999999999999999988754332221 11222223346777654
Q ss_pred ccCCCCCccceeehHHHHHHHHhC
Q 018744 221 LTGHLTTKSDVYSYGVVLLELLTG 244 (351)
Q Consensus 221 ~~~~~s~~~DiwslG~~l~~lltg 244 (351)
.... ...|.|.|||++++++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4322 567999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=106.06 Aligned_cols=131 Identities=17% Similarity=0.119 Sum_probs=94.8
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcce-eeeEEEEcCCeEEEEEEccCCChh
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYMANGGLQ 124 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~v~~~~~~~~L~ 124 (351)
++.|+.|.++.||++... +..+++|+...... ....+..|+..++.+.+.+++ +++.+ .....++||+++++.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCccc
Confidence 456889999999999874 67899998754322 223456789999888654444 34433 344568999999998776
Q ss_pred hhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 125 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC--SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 125 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
... . .....+.+++++|+.||... ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 0 11345678999999999981 11249999999999998 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.9e-11 Score=104.16 Aligned_cols=270 Identities=19% Similarity=0.214 Sum_probs=164.8
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEE------EEcCCe-E-E
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGY------CSDRRK-L-L 113 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~~~-~-~ 113 (351)
....+.||+|+-+.+|..-.- ...|.|++......... .....|... .||-+..-+.| -.+... + +
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 456788999999999875522 22466887643332211 123333333 45533221111 112222 2 7
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+|..+.+..-...+.....+.......+|..++.+++.++.+.+.||.. |.+-||++++|+||++++.|.|.|-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 7777766533222322222224455688999999999999999999999 9999999999999999999999987655
Q ss_pred cccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcce---eeccc
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL---VSWAL 264 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~---~~~~~ 264 (351)
... .+........|...|++||.-+ +..-+...|.|.||+++|+++. |.+||.+-........ .....
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 543 2333445677888999999754 3345678899999999999988 5999976433211100 00000
Q ss_pred ccccchhHHHhhcCccccCCCC-HHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHhhhc
Q 018744 265 PRLTDREKILEIMDPALEGQYS-MKEVIQVAAIAAMCVQP--EADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~--~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+....+...-+.+.. ...+ .-.+.++..|..+|+.. ++.-|||++-++..|..+..+
T Consensus 242 g~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111111000011111 1111 12234567788888864 356899999999888777655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-11 Score=114.92 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=95.1
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCCh------------------------------H----------HHH
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE------------------------------D----------EFK 85 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~------------------------------~----------~~~ 85 (351)
.+.||+|++|.||+|+..+|+.||||+......... + .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999988999999998753211000 0 122
Q ss_pred HHHHHHhcc----CCCcceeeeEEEE--cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHH-HHHH
Q 018744 86 MEVELLGRL----RSPYLLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-GLEF 158 (351)
Q Consensus 86 ~e~~~l~~l----~h~~i~~~~~~~~--~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-~l~~ 158 (351)
.|+..+..+ ++.+-+.+-.++. ....+++|||++|++|.+...... ...+ ...++..++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~------~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE------AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh------cCCC---HHHHHHHHHHHHHHH
Confidence 333333333 2333333333332 345689999999999988763211 0112 2345555555 4678
Q ss_pred HHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 159 LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+|.. |++|+|++|.||+++.++.++++|||++....
T Consensus 273 l~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8988 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.6e-11 Score=97.60 Aligned_cols=138 Identities=15% Similarity=0.186 Sum_probs=97.8
Q ss_pred CceeeecCceEEEEEEEcC-------CcEEEEEEcccc-------------C---------CCChHHH----HHHHHHHh
Q 018744 46 SNVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQA-------------G---------KQGEDEF----KMEVELLG 92 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~-------~~~~~vk~~~~~-------------~---------~~~~~~~----~~e~~~l~ 92 (351)
...||.|--+.||.|...+ +..+|+|+.... + ......+ .+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999998432 478999976311 0 0112222 37888998
Q ss_pred ccCC--CcceeeeEEEEcCCeEEEEEEccCCChhh-hccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCce
Q 018744 93 RLRS--PYLLALLGYCSDRRKLLVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLEFL-HEHCSPPVI 168 (351)
Q Consensus 93 ~l~h--~~i~~~~~~~~~~~~~~v~~~~~~~~L~~-~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~i~ 168 (351)
++.. -+++.++++ ...++||+|+.++.+.. .+.. ..++......++.+++.+|..| |+. +++
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~---glV 147 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKEC---NLV 147 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 8853 455555654 56789999998753321 1211 1244556677889999999999 888 999
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 169 H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
||||++.||+++ ++.++|+|||.+.....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999999997 46899999998875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=106.35 Aligned_cols=220 Identities=15% Similarity=0.167 Sum_probs=153.4
Q ss_pred CceEEEEEE-EcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEE-----cCCeEEEEEEccC-CChhh
Q 018744 53 GFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-----DRRKLLVYDYMAN-GGLQE 125 (351)
Q Consensus 53 ~~g~v~~~~-~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~v~~~~~~-~~L~~ 125 (351)
...+.|++. .-+|..|++|+++.+..+.......-+++|+++.|+|++++.+++. +...++|+.|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346678888 4489999999996655555555566799999999999999998775 3456799999864 35555
Q ss_pred hccccCC-C-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 126 HLYPANG-S-------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 126 ~~~~~~~-~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+...... . .....+.++..+|.++.|+..||.++|+. |+.-+-|.+.+|+++++.+++++.+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4432211 1 23445688999999999999999999999 99999999999999999999999999887654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .+| +.+ -.+-|.=.||.+++.|.||...--..+. ..+.-
T Consensus 445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-------------------~~~s~ 486 (655)
T KOG3741|consen 445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDS-------------------TQSSH 486 (655)
T ss_pred CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccc-------------------hHHHH
Confidence 432 111 111 1345777899999999998654211110 00000
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
..........++++++.-....++.+ -++.+++.++
T Consensus 487 ----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 ----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 11222333446777777777777765 6777777654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-10 Score=109.72 Aligned_cols=147 Identities=14% Similarity=0.115 Sum_probs=93.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC-CcEEEEEEccccCCC--------------------------C--------hHH-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQ--------------------------G--------EDE- 83 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~~~~~~--------------------------~--------~~~- 83 (351)
...|.. +.||+|++|.||+|+..+ |+.||||+....-.. . .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999766 999999998633100 0 011
Q ss_pred -----HHHHHHHHhcc----CCCcceeeeEEEE--cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHH
Q 018744 84 -----FKMEVELLGRL----RSPYLLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152 (351)
Q Consensus 84 -----~~~e~~~l~~l----~h~~i~~~~~~~~--~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 152 (351)
+.+|+.-+.++ .+.+.+.+-.++. ....++||||++|+.+.+.-.-.. .+.....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 22233333333 2344444444443 346689999999999977431110 00001123333344444444
Q ss_pred HHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEEeecccccccCC
Q 018744 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVSDFGLAKIGSD 198 (351)
Q Consensus 153 ~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l~dfg~~~~~~~ 198 (351)
... |++|+|++|.||+++.++ .++++|||++.....
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 346 999999999999999888 999999999876544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.6e-10 Score=88.81 Aligned_cols=129 Identities=22% Similarity=0.326 Sum_probs=93.5
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEcccc-CCC-------ChHHHHHHHHHHhccCCCcceeeeEEE-EcCCeEEEEEEc
Q 018744 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQA-GKQ-------GEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYM 118 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~~~~~~vk~~~~~-~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~v~~~~ 118 (351)
.+++|+-+.++.+.+. |.++++|.-..+ ... ...+-.+|+.++.++.--.|....-+. ......++|+|.
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4778999999999763 344676743222 111 113345689999988655543333333 334557999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|..|.+.+... ...++..+-.-+.-||.. |++||||.++||++.+++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888322 256778888889999999 999999999999997764 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-09 Score=92.81 Aligned_cols=141 Identities=22% Similarity=0.320 Sum_probs=105.8
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCC--cceeeeEEEEcC----CeEEEEEEcc
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSP--YLLALLGYCSDR----RKLLVYDYMA 119 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~v~~~~~ 119 (351)
+.|+.|..+.+|++...+|..+++|....... .....+..|++++..+.+. ++.+++.+.... ..+++|+++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56889999999999876668899998754322 1345678899999998753 456677766553 3479999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------------ 163 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------ 163 (351)
|.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 84 GRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9888776521 23566677777888888888887531
Q ss_pred -----------------CCCceecCCCCCcEEeCC--CCcEEEeecccccc
Q 018744 164 -----------------SPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 195 (351)
Q Consensus 164 -----------------~~~i~H~di~p~Nilv~~--~~~v~l~dfg~~~~ 195 (351)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 125799999999999988 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-09 Score=86.79 Aligned_cols=142 Identities=20% Similarity=0.286 Sum_probs=99.3
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEc-cccCCC-------ChHHHHHHHHHHhccCCCcceeeeE-EEEcCCeEEEE
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLM-DQAGKQ-------GEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVY 115 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~-~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~v~ 115 (351)
....+.+|+-+.|+++.+ .|+.++||.- ....+. ...+...|+++|.++.--.|.-..- ++......++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567788999999999998 5667777743 222121 2244567899988876444433322 44455668999
Q ss_pred EEccC-CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC---cEEEeecc
Q 018744 116 DYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFG 191 (351)
Q Consensus 116 ~~~~~-~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~v~l~dfg 191 (351)
||+++ .++.+++...-. ..........++..|-+.+.-||.. +++||||..+||++..++ .+.++|||
T Consensus 90 E~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred EeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence 99977 467777643321 1223333478899999999999999 999999999999995544 35899999
Q ss_pred cccc
Q 018744 192 LAKI 195 (351)
Q Consensus 192 ~~~~ 195 (351)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.2e-09 Score=86.54 Aligned_cols=126 Identities=25% Similarity=0.317 Sum_probs=81.2
Q ss_pred EEEEEEEcCCcEEEEEEccccC--------------C--------CC----hHHHHHHHHHHhccCCC--cceeeeEEEE
Q 018744 56 LVYRGVLSNGRKVAIKLMDQAG--------------K--------QG----EDEFKMEVELLGRLRSP--YLLALLGYCS 107 (351)
Q Consensus 56 ~v~~~~~~~~~~~~vk~~~~~~--------------~--------~~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 107 (351)
.||.|...+|..+|+|+..... . .. .....+|++.|..+..- +++.++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999764210 0 01 12456799999999765 45555544
Q ss_pred cCCeEEEEEEcc--CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 108 DRRKLLVYDYMA--NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF-LHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 108 ~~~~~~v~~~~~--~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
...++||||+. |..+..+... .++......++.+++..+.. +|.. |++||||++.||+++++ .
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~---------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDV---------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHC---------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred -eCCEEEEEecCCCccchhhHHhc---------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 35689999998 5555443311 11123455677777775555 5788 99999999999999887 9
Q ss_pred EEEeecccccccC
Q 018744 185 AKVSDFGLAKIGS 197 (351)
Q Consensus 185 v~l~dfg~~~~~~ 197 (351)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.6e-10 Score=108.73 Aligned_cols=153 Identities=22% Similarity=0.252 Sum_probs=106.7
Q ss_pred HHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCcee-------cccCCCcccccccccc
Q 018744 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS-------TRVLGTQGYVAPEYAL 221 (351)
Q Consensus 149 ~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~ 221 (351)
+.+++.|+.++|+.. +++|++|.|++|+++..+..||++|+.+............ ........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344559999999986 9999999999999999999999999987654432211111 1123456799999999
Q ss_pred cCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhc
Q 018744 222 TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMC 300 (351)
Q Consensus 222 ~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 300 (351)
+...+.++|+||+|+++|.++. |...+....... ........+..-...+..+.+.++++=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~--------------~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL--------------SYSFSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc--------------hhhhhhcccccccccccccCcHHHHHHHHHH
Confidence 9888999999999999999995 655554332110 0111111111222233345556788888999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 018744 301 VQPEADYRPLMADVVQS 317 (351)
Q Consensus 301 l~~~P~~Rpt~~eil~~ 317 (351)
+..++.-||++..+...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999977766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=89.70 Aligned_cols=148 Identities=22% Similarity=0.177 Sum_probs=105.0
Q ss_pred eeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC----------------------CCChHHHHHH
Q 018744 30 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----------------------KQGEDEFKME 87 (351)
Q Consensus 30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~----------------------~~~~~~~~~e 87 (351)
......+..-..=+.+...||.|--|.||.|..+.|.++++|.-..-. ...+....+|
T Consensus 80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE 159 (304)
T COG0478 80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE 159 (304)
T ss_pred HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence 333444444444566788999999999999999999999999532100 0112346679
Q ss_pred HHHHhccCCC--cceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 018744 88 VELLGRLRSP--YLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165 (351)
Q Consensus 88 ~~~l~~l~h~--~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 165 (351)
.++|..+... .+++.++ -+.+++||++.+|-.|...- ++......++..|++.+..+-..
T Consensus 160 f~~L~~L~~~G~~VP~P~~---~nRHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~--- 221 (304)
T COG0478 160 FEALQRLYPEGVKVPKPIA---WNRHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRR--- 221 (304)
T ss_pred HHHHHHhhhcCCCCCCccc---cccceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHc---
Confidence 9999988654 5555543 34568999999986555433 12344455666666667766677
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 166 ~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|++|||+++-||+|+++|.++++||--+..
T Consensus 222 GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 222 GIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CccccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999999965543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-09 Score=100.96 Aligned_cols=245 Identities=18% Similarity=0.199 Sum_probs=162.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEE--cCCcEEEEEEccccCCCChHHH--HHHHHHHhcc-CCCcceeee-EEEEcCCeE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL--SNGRKVAIKLMDQAGKQGEDEF--KMEVELLGRL-RSPYLLALL-GYCSDRRKL 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~--~~~~~~~vk~~~~~~~~~~~~~--~~e~~~l~~l-~h~~i~~~~-~~~~~~~~~ 112 (351)
-..+|..+..||.|.|+.++.... .++..|++|-..+........+ ..|+-+...+ .|.+++... .|....+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788899999999999998773 3577788887654433333221 2244444444 366666544 455666667
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEeecc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFG 191 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~dfg 191 (351)
+=-||++++++..... ....++...++.+..|++.++.++|+. .++|+|++|.||++..+ +..+++||+
T Consensus 343 ip~e~~~~~s~~l~~~-------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV-------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred CchhhhcCcchhhhhH-------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 7778888888766652 122467778899999999999999999 99999999999999875 788999999
Q ss_pred cccccCCCCCCceecccCCCcccc--cccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYV--APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
+...+.... ........+. +++......+-.+.|+++||..+.+.+++...-....
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------------- 470 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------------- 470 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------------
Confidence 886422211 1122223334 4444446678899999999999999998765422110
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
....+...... .. ......+..+...+...++..||.+.++..+..
T Consensus 471 --~~~~i~~~~~p-~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 471 --QSLTIRSGDTP-NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --cceeeeccccc-CC-CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 01111111010 01 111145666788889999999999888766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.9e-08 Score=85.70 Aligned_cols=139 Identities=17% Similarity=0.113 Sum_probs=95.4
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCC-----------CChHHHHHHHHHHhccCCCcc--eeeeEEEEc-----
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-----------QGEDEFKMEVELLGRLRSPYL--LALLGYCSD----- 108 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~----- 108 (351)
+.+-......|.+... +|+.+.+|....... .....+.+|+..+..+...+| +.++.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444455666555 567899996632221 111246778888888753333 344445432
Q ss_pred -CCeEEEEEEccCC-ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-----
Q 018744 109 -RRKLLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----- 181 (351)
Q Consensus 109 -~~~~~v~~~~~~~-~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~----- 181 (351)
...++|++++++. +|.+++.... ..+.+......++.+++..+..||.. |++|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 2357999999886 7888873211 12345667788999999999999999 9999999999999974
Q ss_pred --CCcEEEeeccccc
Q 018744 182 --NFHAKVSDFGLAK 194 (351)
Q Consensus 182 --~~~v~l~dfg~~~ 194 (351)
++.+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 5689999998775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.7e-10 Score=109.29 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=160.2
Q ss_pred HHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEc-CCeE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKL 112 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 112 (351)
+....+.+.+-+.+|.++.++.+.- ..|.....++...... ...+.++.+-.++-...+|.++....-+.. ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 4456788888899999999988873 3343344443322211 111112222222222223333322222222 2345
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+++++..++.|...++... ..+.......+..+..++.+||.. .+.|+|++|.|.+...++...+.+|+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence 8999999999988885543 344445555667788999999998 899999999999999999999999973
Q ss_pred ccccCCC-------------------------C----CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh
Q 018744 193 AKIGSDK-------------------------A----GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243 (351)
Q Consensus 193 ~~~~~~~-------------------------~----~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt 243 (351)
....... . .........+++.|.+||...+......+|.|++|.++++.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 2211000 0 0011223458999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 018744 244 GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMA 312 (351)
Q Consensus 244 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rpt~~ 312 (351)
|..||....++ ....++......+.. +........+++...+..+|.+|..+.
T Consensus 1031 g~pp~na~tpq----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQ----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchh----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999865543 111222222221111 123344677788889999999999877
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=78.54 Aligned_cols=105 Identities=25% Similarity=0.298 Sum_probs=79.5
Q ss_pred hHHHHHHHHHHhccCCC--cceeeeEEEEcC-----CeEEEEEEccCC-ChhhhccccCCCCCCCCCCCHHHHHHHHHHH
Q 018744 81 EDEFKMEVELLGRLRSP--YLLALLGYCSDR-----RKLLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEA 152 (351)
Q Consensus 81 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~-----~~~~v~~~~~~~-~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 152 (351)
.....+|+..+..+... ..+..+++.+.. ..++|++++++. +|.+++.... ..+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHH
Confidence 34567788877777432 345555555442 236899999874 7888884322 24556778899999
Q ss_pred HHHHHHHHcCCCCCceecCCCCCcEEeCCCC---cEEEeecccccc
Q 018744 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFGLAKI 195 (351)
Q Consensus 153 ~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~v~l~dfg~~~~ 195 (351)
+..++.||.. |++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999998887 899999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.6e-07 Score=74.49 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=89.8
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHH---------HHHHHHhccC---CCcceeeeEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---------MEVELLGRLR---SPYLLALLGY 105 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~i~~~~~~ 105 (351)
...++|.+.+.+.......|.+... +|..+++|..........+.+. +.+..+..++ ......++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4458899999999888887777665 5688999987654333222222 2233233332 2222222222
Q ss_pred EE------cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 106 CS------DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 106 ~~------~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
.+ ....++++||++|..|.+.. .++. .+...+.+++..||+. |++|||..|.|+++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-----------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch-----------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEE
Confidence 21 12345899999998776654 1222 2445677889999999 99999999999999
Q ss_pred CCCCcEEEeeccccc
Q 018744 180 DKNFHAKVSDFGLAK 194 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~ 194 (351)
+++ .++++||+...
T Consensus 169 ~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKR 182 (229)
T ss_pred ECC-cEEEEECcccc
Confidence 865 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.7e-07 Score=75.09 Aligned_cols=138 Identities=17% Similarity=0.128 Sum_probs=97.0
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEccccC------CCChHHHHHHHHHHhccCCC--cceeeeEEEE---cC---CeEE
Q 018744 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAG------KQGEDEFKMEVELLGRLRSP--YLLALLGYCS---DR---RKLL 113 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~---~~~~ 113 (351)
.-++|+.+-|++....+ ..+-+|.-.+.- +-....|.+|+..+..+..- .+..+. ++. .. ..++
T Consensus 25 N~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 34568999998877643 467777654211 22456788899999998532 244444 332 11 2358
Q ss_pred EEEEccC-CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc--EEEeec
Q 018744 114 VYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVSDF 190 (351)
Q Consensus 114 v~~~~~~-~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~--v~l~df 190 (351)
|++.+.+ .+|.+++.... ..+.+......++.+++.+++.||+. |+.|+|+.+.||+++.++. +.++||
T Consensus 103 VTe~L~g~~~L~~~l~~~~-----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA-----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EEEeCCCCccHHHHHhcCC-----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 9997764 36766663321 12456777789999999999999999 9999999999999986667 999999
Q ss_pred ccccc
Q 018744 191 GLAKI 195 (351)
Q Consensus 191 g~~~~ 195 (351)
.-++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 76653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.9e-06 Score=72.62 Aligned_cols=160 Identities=19% Similarity=0.218 Sum_probs=107.1
Q ss_pred cCCCceeeeHHHHHHHhcCCCcCceeee---cCceEEEEEEEcCCcEEEEEEccccCCC-------------------Ch
Q 018744 24 TDNGLQVFTFKQLHSATGGFSKSNVVGH---GGFGLVYRGVLSNGRKVAIKLMDQAGKQ-------------------GE 81 (351)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~---G~~g~v~~~~~~~~~~~~vk~~~~~~~~-------------------~~ 81 (351)
....+-..+...+....++..+....|. |--+.||+|...++..+|+|++...... ..
T Consensus 28 ~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r 107 (268)
T COG1718 28 VDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR 107 (268)
T ss_pred hhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence 3345566677888888888888776664 5667888888778899999987532111 11
Q ss_pred -----HHHHHHHHHHhccC--CCcceeeeEEEEcCCeEEEEEEccCCC-hhhhccccCCCCCCCCCCCHHHHHHHHHHHH
Q 018744 82 -----DEFKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAA 153 (351)
Q Consensus 82 -----~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~v~~~~~~~~-L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 153 (351)
....+|+.-|+++. +-.+++.+.+. +.++||+++.... -.-.+ ....+.......+..+++
T Consensus 108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~L--------kDv~~e~~e~~~~~~~~v 176 (268)
T COG1718 108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRL--------KDVPLELEEAEGLYEDVV 176 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCc--------ccCCcCchhHHHHHHHHH
Confidence 12335666666663 33344444333 4479999986541 11111 111223335677788888
Q ss_pred HHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 154 KGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 154 ~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
+.+.-|-. . +++|+||+.-|||+. ++.+.++|++-+....+
T Consensus 177 ~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 177 EYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 88888887 5 999999999999999 77999999998775443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.6e-07 Score=84.19 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=91.7
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCC--------------------------Ch--------HH------HHH
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--------------------------GE--------DE------FKM 86 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--------------------------~~--------~~------~~~ 86 (351)
.-|+.++.|.||.|..++|+.||||+....-.. .. +. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999989999999986432110 00 01 223
Q ss_pred HHHHHhcc----CCCcceeeeEEEE--cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018744 87 EVELLGRL----RSPYLLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160 (351)
Q Consensus 87 e~~~l~~l----~h~~i~~~~~~~~--~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 160 (351)
|+.-+..+ +...-+.+-.++- ....+++|||++|..+.+...... ..++.+.+...+.++.- ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k~ia~~~~~~f~--~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRKELAELLVRAFL--RQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCCHHHHHHHHHHHHH--HHHH
Confidence 33333333 2232244444443 356789999999999988852221 23444444444333322 2233
Q ss_pred cCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 161 ~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.. |++|+|..|.||+|+.+|++.+.|||+......
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 34 999999999999999999999999999875443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.2e-06 Score=72.17 Aligned_cols=71 Identities=20% Similarity=0.260 Sum_probs=50.6
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC--cceeeeEEEEcCCe-EEEEEEccCCC
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YLLALLGYCSDRRK-LLVYDYMANGG 122 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~-~~v~~~~~~~~ 122 (351)
..|+.|..+.||+. .+..+++|..... .......+|+++++.+..- .+.+++.+...... .++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 2456888987642 2345568899999888543 34666777665544 48999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.3e-06 Score=65.80 Aligned_cols=131 Identities=15% Similarity=0.184 Sum_probs=90.6
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCCC
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGG 122 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~ 122 (351)
....+.|+.|.+|.||++.+.+ ..+++|+-..+ .....+..|+++|..++--++.+=+-.+. ..++.|+|.+|-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg--~~~i~me~i~G~~ 98 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG--EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec--hhhhhhhhhcCcc
Confidence 3457789999999999999854 57788875433 34567888999999998766544332222 2255699999988
Q ss_pred hhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC-CCcEEeCCCCcEEEeecccccc
Q 018744 123 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK-SSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 123 L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~-p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|.+.... .+- +-+..+++.-.-|-.. ||-|+.|+ |...++.+++.+.|+||..++.
T Consensus 99 L~~~~~~----------~~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG----------GDR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc----------ccH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7766521 122 2344456666666777 99999998 4444454555999999988763
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.1e-05 Score=67.26 Aligned_cols=77 Identities=16% Similarity=0.273 Sum_probs=53.9
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC--cceeeeEEEEcC----CeEEEEEEcc
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YLLALLGYCSDR----RKLLVYDYMA 119 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~v~~~~~ 119 (351)
++.|+.|..+.+|++...+ ..+++|..... .....+..|..+++.+... .+..++.+.... ..+++++++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4578999999999999866 68999986533 3345677888888887432 355666543222 2368999999
Q ss_pred CCChhh
Q 018744 120 NGGLQE 125 (351)
Q Consensus 120 ~~~L~~ 125 (351)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.3e-05 Score=66.85 Aligned_cols=74 Identities=22% Similarity=0.168 Sum_probs=50.3
Q ss_pred eeecCc-eEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEEEEccCCChhh
Q 018744 49 VGHGGF-GLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMANGGLQE 125 (351)
Q Consensus 49 lg~G~~-g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~~~~~~~~L~~ 125 (351)
|..|.. +.||+.... +..+++|+..... ...+..|+++++.+. +-.+.+++.+.... ..++||++++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 455555 788888754 4678889875432 334667888888874 34456666666543 4679999999887764
Q ss_pred h
Q 018744 126 H 126 (351)
Q Consensus 126 ~ 126 (351)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=66.04 Aligned_cols=103 Identities=26% Similarity=0.287 Sum_probs=81.4
Q ss_pred HHHHHHhccCC-CcceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 018744 86 MEVELLGRLRS-PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164 (351)
Q Consensus 86 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 164 (351)
.|.-++..+++ +++++++|.|. .+++.|+...+++....... ......+|..+.+++.++++.+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l----~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPL----SQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCcccccccccc----ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 47888888876 69999999985 48899999877554321000 011257899999999999999999999655
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
..+...|++++|+-++++++++++|......
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 5788999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.6e-05 Score=67.11 Aligned_cols=140 Identities=13% Similarity=0.063 Sum_probs=78.4
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEccCCChhhh
Q 018744 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMANGGLQEH 126 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~~~~~L~~~ 126 (351)
.+..|-.+.+|+... +++.+++|........-.-....|+++++.+....+ .+++... ...+|++|++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVITLD 78 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCcccccc
Confidence 356677888998874 567899998654322211124668888888864333 3333332 24789999998765432
Q ss_pred -----------------ccccCCCCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHcC-----CCCCceecCCCC
Q 018744 127 -----------------LYPANGSNSVASKLDWE-TRLRIALEA---------AKGLEFLHEH-----CSPPVIHRDFKS 174 (351)
Q Consensus 127 -----------------~~~~~~~~~~~~~l~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~i~H~di~p 174 (351)
++... ....+++.. .+.....++ ...+..+-.. ....++|+|+.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQP---RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 11111 111122221 111111111 1112222111 022689999999
Q ss_pred CcEEeCCCCcEEEeecccccc
Q 018744 175 SNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 175 ~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.||++++++ +.|+||+.+..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999998876 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00014 Score=73.97 Aligned_cols=78 Identities=15% Similarity=0.284 Sum_probs=56.2
Q ss_pred CceeeecCceEEEEEEEcCC---cEEEEEEccccC-CCChHHHHHHHHHHhccC-CCcc--eeeeEEEEcC----CeEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSNG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLR-SPYL--LALLGYCSDR----RKLLV 114 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~----~~~~v 114 (351)
++.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ ++++.++.+. ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56688899999999876543 468888765432 223456788999999985 5554 7777777653 46799
Q ss_pred EEEccCCCh
Q 018744 115 YDYMANGGL 123 (351)
Q Consensus 115 ~~~~~~~~L 123 (351)
|++++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.6e-05 Score=67.91 Aligned_cols=143 Identities=15% Similarity=0.201 Sum_probs=97.8
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEcccc-----CC---------------------CChHHHHHHHHHHhccCCCc
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA-----GK---------------------QGEDEFKMEVELLGRLRSPY 98 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~-----~~---------------------~~~~~~~~e~~~l~~l~h~~ 98 (351)
+.+.|..|--+.||.|...+|..+|||+++-. ++ +....+..|..-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45567778889999999888999999986411 00 01122345666677776555
Q ss_pred ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 99 i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
+++-.-..-..+++||+++.......-. -....++...+..+-.+++.-+.-|.+.+ ++||.||+--|+|
T Consensus 228 -IP~PePIlLk~hVLVM~FlGrdgw~aPk-------LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 228 -IPCPEPILLKNHVLVMEFLGRDGWAAPK-------LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred -CCCCCceeeecceEeeeeccCCCCcCcc-------cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 3333334445668999998643221111 12234667778888899999999998887 9999999999999
Q ss_pred eCCCCcEEEeecccccccCC
Q 018744 179 LDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~ 198 (351)
+. +|.++++|.+-+.....
T Consensus 298 yh-dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred EE-CCEEEEEEccccccCCC
Confidence 95 45899999987654333
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00025 Score=58.89 Aligned_cols=128 Identities=19% Similarity=0.283 Sum_probs=85.4
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccC----------------CCChHHHHHHHHHHhccC------CCcceeee
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----------------KQGEDEFKMEVELLGRLR------SPYLLALL 103 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~ 103 (351)
...||+|+.-.||. ++++...+||+..... ....+...+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45689999888875 4455668889886554 122455566666666555 78999999
Q ss_pred EEEEcCCeE-EEEEEccC------CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 104 GYCSDRRKL-LVYDYMAN------GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 104 ~~~~~~~~~-~v~~~~~~------~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
++.+.+... +|+|...+ -+|.+++.. ..++. . +...+-+...+|-++ .|+.+|++|.|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--------~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~N 148 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE--------GGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHN 148 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc--------CCccH-H---HHHHHHHHHHHHHHc---CCeecCCCccc
Confidence 999887544 88887642 246666622 23444 3 333444556677777 89999999999
Q ss_pred EEeCCC---C-cEEEeec
Q 018744 177 ILLDKN---F-HAKVSDF 190 (351)
Q Consensus 177 ilv~~~---~-~v~l~df 190 (351)
|++... . .+.|+|-
T Consensus 149 Iv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred EEEEecCCCceEEEEEeC
Confidence 999432 2 5777763
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00013 Score=62.72 Aligned_cols=72 Identities=19% Similarity=0.249 Sum_probs=44.3
Q ss_pred ceeeecCce-EEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC---cceeeeEEEEcC----CeEEEEEEc
Q 018744 47 NVVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCSDR----RKLLVYDYM 118 (351)
Q Consensus 47 ~~lg~G~~g-~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~----~~~~v~~~~ 118 (351)
+.++.|+.. .||+. +..+++|.... ......+..|++++..+... .+..+++..... ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 48875 23578887543 22345788899999887532 334444433221 236899999
Q ss_pred cCCChh
Q 018744 119 ANGGLQ 124 (351)
Q Consensus 119 ~~~~L~ 124 (351)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00017 Score=61.93 Aligned_cols=74 Identities=12% Similarity=0.083 Sum_probs=47.7
Q ss_pred CceeeecCceEEEEEEEcC--CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEccCCC
Q 018744 46 SNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMANGG 122 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~--~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~~~~~ 122 (351)
++.|..|-...+|++...+ +..+++|+....... ......|+.+++.+...++ ++++.... ..++++|++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEeeCCCc
Confidence 3467788889999988654 678999987543222 1223468888888854333 33333322 358999998876
Q ss_pred h
Q 018744 123 L 123 (351)
Q Consensus 123 L 123 (351)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00014 Score=68.90 Aligned_cols=142 Identities=18% Similarity=0.177 Sum_probs=88.6
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCC-----------------------h--------HH------HHHHH
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-----------------------E--------DE------FKMEV 88 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~-----------------------~--------~~------~~~e~ 88 (351)
.+-|+..+.|.|++|+.++|+.||||+-+..-+.. . .. |..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35688999999999998889999999754221100 0 00 11222
Q ss_pred H----HHhccCCCc---ceeeeEEEE--cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018744 89 E----LLGRLRSPY---LLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159 (351)
Q Consensus 89 ~----~l~~l~h~~---i~~~~~~~~--~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 159 (351)
+ ..+.+.|-+ -+.+-.++- ....+++|||++|..+.+.-.-.. ..++...+...+.+...-+-+.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK------RGISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH------cCCCHHHHHHHHHHHHHHHHHh
Confidence 2 122223333 122223332 235689999999998877743222 2455555555554443333333
Q ss_pred HcCCCCCceecCCCCCcEEeC----CCCcEEEeecccccccCC
Q 018744 160 HEHCSPPVIHRDFKSSNILLD----KNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 160 H~~~~~~i~H~di~p~Nilv~----~~~~v~l~dfg~~~~~~~ 198 (351)
| |++|+|=.|.||++. .++.+.+.|||+......
T Consensus 320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 899999999999998 477899999999875433
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.5e-05 Score=69.79 Aligned_cols=145 Identities=18% Similarity=0.121 Sum_probs=98.8
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC------------------CCC----hHHHHHHHHHH
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG------------------KQG----EDEFKMEVELL 91 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~------------------~~~----~~~~~~e~~~l 91 (351)
..+..-..-+.+...||-|--+.+|.+.+..|++.++|.-..-. -.+ +-...+|+..+
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 33333334577888999999999999999899999999532100 001 11234577777
Q ss_pred hccCCCcceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecC
Q 018744 92 GRLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRD 171 (351)
Q Consensus 92 ~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d 171 (351)
+.+.... .++-..+....+++||+.+.+.+|...-+-. ....+...+...+..|..+ |++|||
T Consensus 165 kaL~e~g-fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~-------------d~~~ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 165 KALYERG-FPVPKPIDHNRHCVVMELVDGYPLRQVRHVE-------------DPPTLYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHHHcC-CCCCCcccccceeeHHHhhcccceeeeeecC-------------ChHHHHHHHHHHHHHHHHc---Cceecc
Confidence 7764321 1222233445568999999998877654221 2234555566677788888 999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccc
Q 018744 172 FKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 172 i~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.+--||+|++++.++++||.-+..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred cchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999965543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00042 Score=61.75 Aligned_cols=78 Identities=10% Similarity=0.099 Sum_probs=56.2
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCC---CcceeeeEEEEc----CCeEEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS---PYLLALLGYCSD----RRKLLVY 115 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~----~~~~~v~ 115 (351)
..-.+.|+.|..+.||.....++ .+++|..+. ......+..|++.|+.+.- -.++++++++.. +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33456799999999999876555 467777432 1234578889999998853 367788877653 3468999
Q ss_pred EEccCCCh
Q 018744 116 DYMANGGL 123 (351)
Q Consensus 116 ~~~~~~~L 123 (351)
+++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00064 Score=61.33 Aligned_cols=164 Identities=15% Similarity=0.144 Sum_probs=86.6
Q ss_pred CceeeeHHHHHHHhcCCCc-----CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC--cc
Q 018744 27 GLQVFTFKQLHSATGGFSK-----SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YL 99 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~--~i 99 (351)
++...+.+++......|-+ .+.|+.|....+|+....+| .+++|++.. .....+..++.++..+... .+
T Consensus 3 vyt~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpv 78 (319)
T PRK05231 3 VYTDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPV 78 (319)
T ss_pred ccccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCC
Confidence 3455666777666667765 34456677788999886555 688898751 2234444455555555321 13
Q ss_pred eeeeEE-------EEcCCeEEEEEEccCCChhh-----------hc---cccCCC----CCCCCCCCH-HHHHH------
Q 018744 100 LALLGY-------CSDRRKLLVYDYMANGGLQE-----------HL---YPANGS----NSVASKLDW-ETRLR------ 147 (351)
Q Consensus 100 ~~~~~~-------~~~~~~~~v~~~~~~~~L~~-----------~~---~~~~~~----~~~~~~l~~-~~~~~------ 147 (351)
.+++.. ...+..++++++++|..+.. .+ +..... ......+.+ ...+.
T Consensus 79 P~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 158 (319)
T PRK05231 79 PAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFL 158 (319)
T ss_pred CcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhcc
Confidence 333321 12334579999998875421 11 111100 000001111 11111
Q ss_pred ------HHHH-HHHHHHHHHcC----CCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 148 ------IALE-AAKGLEFLHEH----CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 148 ------i~~q-i~~~l~~LH~~----~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
.+.+ +...+..+... -..+++|+|+.+.||+++++...-++||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 159 ADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11222233211 13489999999999999876556899998765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=6.3e-06 Score=77.79 Aligned_cols=188 Identities=16% Similarity=0.148 Sum_probs=128.7
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc-ceeeeEEEEcCC-eEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.-|...+.++.++++++++.+.-..+....+.+... -..+-++++|.+++||| .+..++-++.+. .++.++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 445556678888888888887433333445555332 33455899999999999 444444333333 34778887
Q ss_pred cCC-ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 119 ANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 119 ~~~-~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
..+ +....+ ......+...+....++.-.++++++|+. .-+|+| ||+..+ +..++++|+....+.
T Consensus 317 s~~rs~~~~~------~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 317 STGRSSALEM------TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred cCCccccccC------ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccC
Confidence 766 221111 11222344556667777778899999987 568887 766655 578999999887665
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCC
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 250 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~ 250 (351)
... ......+++.++|||+..++.+....|.|++|.-..+|.-|..|-..
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 543 23445678899999999999999999999999988888878777543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00057 Score=62.96 Aligned_cols=76 Identities=18% Similarity=0.267 Sum_probs=52.9
Q ss_pred CceeeecCceEEEEEEEcCC-cEEEEEEcccc------C-CCChHHHHHHHHHHhccC--C-CcceeeeEEEEcCCeEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSNG-RKVAIKLMDQA------G-KQGEDEFKMEVELLGRLR--S-PYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~-~~~~vk~~~~~------~-~~~~~~~~~e~~~l~~l~--h-~~i~~~~~~~~~~~~~~v 114 (351)
.+.||.|.+..||++...+| +.++||.-... . ....++...|.+.|+.+. . .++++++.+ ..+..++|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-D~~~~~lV 109 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-DEELAVTV 109 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-CCCCCEEE
Confidence 35789999999999997766 48999974311 1 234566777888888863 2 345556655 44556899
Q ss_pred EEEccCCC
Q 018744 115 YDYMANGG 122 (351)
Q Consensus 115 ~~~~~~~~ 122 (351)
|+++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99987644
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.74 E-value=6.7e-05 Score=75.61 Aligned_cols=194 Identities=18% Similarity=0.211 Sum_probs=132.0
Q ss_pred HHHHHHHhccCCCcceeeeEEEEcCC--eE---EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018744 85 KMEVELLGRLRSPYLLALLGYCSDRR--KL---LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159 (351)
Q Consensus 85 ~~e~~~l~~l~h~~i~~~~~~~~~~~--~~---~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 159 (351)
..|.+.+.+..|+|+..+..|..... .+ ...+++...++...+. .-...+..+...+..++.+|+.++
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-------~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-------SVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-------hccccCHHHHHHHHHHHhhhHHHH
Confidence 34777888889999999988765431 11 4556666666666662 234678889999999999999999
Q ss_pred HcCCCCCceecCCCCC---cEEeCCCCcEEEe--ecccccccCCCCCCceecccCCCcccccccccccCCCC--Ccccee
Q 018744 160 HEHCSPPVIHRDFKSS---NILLDKNFHAKVS--DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT--TKSDVY 232 (351)
Q Consensus 160 H~~~~~~i~H~di~p~---Nilv~~~~~v~l~--dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s--~~~Diw 232 (351)
|+. .+.|.-+... +..++..+.+..+ ||+.+..+..... .........+.++|......++ ...|+|
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHH
Confidence 998 6666666555 5555666777777 8887765444332 2223344567888877766554 447999
Q ss_pred ehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 018744 233 SYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312 (351)
Q Consensus 233 slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 312 (351)
.+|.....+..|..+-... .....++.... .. .+.++...|+..++++|+++.
T Consensus 377 ~lgll~~~~~~~~~i~~~~-------------------~~~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKS-------------------AVPVSLLDVLS----TS----ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHhhhhhcCcccccc-------------------cchhhhhcccc----ch----hhhhhhhhhcchhhhhccchh
Confidence 9999999998876543210 11111121111 10 467788999999999999999
Q ss_pred HHHHHH
Q 018744 313 DVVQSL 318 (351)
Q Consensus 313 eil~~l 318 (351)
+++.+.
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 999883
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0007 Score=60.76 Aligned_cols=164 Identities=17% Similarity=0.213 Sum_probs=89.5
Q ss_pred ceeeeHHHHHHHhcCCCc-----CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc--ce
Q 018744 28 LQVFTFKQLHSATGGFSK-----SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LL 100 (351)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~ 100 (351)
+...+.+++....++|.+ .+.++.|....+|++...++ .+++|+.... .....+..+.+++..+...+ ++
T Consensus 4 ~~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp 80 (307)
T TIGR00938 4 YTSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVP 80 (307)
T ss_pred cccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 344555666666666755 34566777789999876444 6888976432 12344556677776664222 33
Q ss_pred eeeEEE-------EcCCeEEEEEEccCCChhhh--------------ccccCCC---CCCC-CCC-CHHHHH--------
Q 018744 101 ALLGYC-------SDRRKLLVYDYMANGGLQEH--------------LYPANGS---NSVA-SKL-DWETRL-------- 146 (351)
Q Consensus 101 ~~~~~~-------~~~~~~~v~~~~~~~~L~~~--------------~~~~~~~---~~~~-~~l-~~~~~~-------- 146 (351)
+++... ..+..+++++|++|..+... ++..... .... ... .|....
T Consensus 81 ~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (307)
T TIGR00938 81 KPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAP 160 (307)
T ss_pred ccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccc
Confidence 333311 12345689999988654211 1111100 0000 000 010000
Q ss_pred ----HHHHHHHHHHHHHHc----CCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 147 ----RIALEAAKGLEFLHE----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 147 ----~i~~qi~~~l~~LH~----~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
.....+...+.++.. ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 161 ~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 161 QLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011122334444432 113489999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00051 Score=61.22 Aligned_cols=145 Identities=19% Similarity=0.186 Sum_probs=81.4
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc--ceeeeEE-------EEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGY-------CSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-------~~~~~~~~v~~ 116 (351)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..+...+ +.+++.. ...+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4456677778999987644 4689898754 23445666788777774322 3343321 11234568999
Q ss_pred EccCCChhhh--------------ccccC----CCCCCCCCCCHHHHH----------HHHHHHHHHHHHHHcC----CC
Q 018744 117 YMANGGLQEH--------------LYPAN----GSNSVASKLDWETRL----------RIALEAAKGLEFLHEH----CS 164 (351)
Q Consensus 117 ~~~~~~L~~~--------------~~~~~----~~~~~~~~l~~~~~~----------~i~~qi~~~l~~LH~~----~~ 164 (351)
+++|..+... ++... ..........+.... .....+..++.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9988765321 11110 000000011111100 0111223344444431 12
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00068 Score=60.63 Aligned_cols=74 Identities=20% Similarity=0.252 Sum_probs=47.1
Q ss_pred ceeeecCceEEEEEEEcC-------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEc
Q 018744 47 NVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYM 118 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~-------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~ 118 (351)
+.|..|-...+|++...+ ++.+++|+..... ........|++++..+...++ .+++.++. ...|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---~~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP---NGRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC---CCchhhee
Confidence 456667778889888544 5789999975432 222345668888888753333 34444443 24588888
Q ss_pred cCCChh
Q 018744 119 ANGGLQ 124 (351)
Q Consensus 119 ~~~~L~ 124 (351)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0018 Score=56.99 Aligned_cols=30 Identities=27% Similarity=0.525 Sum_probs=25.3
Q ss_pred CceecCCCCCcEEeCCCCc-EEEeecccccc
Q 018744 166 PVIHRDFKSSNILLDKNFH-AKVSDFGLAKI 195 (351)
Q Consensus 166 ~i~H~di~p~Nilv~~~~~-v~l~dfg~~~~ 195 (351)
.++|+|+.+.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999987555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0024 Score=56.89 Aligned_cols=143 Identities=20% Similarity=0.273 Sum_probs=91.4
Q ss_pred CCCcCceeeecCceEEEEEEEcCCcEEEEEEcc--ccCCCChHHHHHHHHHHhccCC--CcceeeeEEEEcCC---eEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDRR---KLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~v 114 (351)
...+++.+..|....+|..... ++.++++ .. ...........+|+.+++.+.- ..+...++.|.++. .++|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3445555655655666666643 7889999 33 1223334556778888888743 33455556665544 4799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHH-HHHHHHHHHHHcCC------------------------------
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA-LEAAKGLEFLHEHC------------------------------ 163 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~-~qi~~~l~~LH~~~------------------------------ 163 (351)
|++.+|..+.+..... +.. ...+ -.+++.|+.||+-.
T Consensus 104 ~~~veGe~~~~~~~~~----------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~ 171 (321)
T COG3173 104 MEWVEGEVVWSALPPE----------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKK 171 (321)
T ss_pred EEEecceeccCcCCcc----------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHH
Confidence 9999987555444211 111 1122 36666777776652
Q ss_pred -------------------------CCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 164 -------------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 164 -------------------------~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
...++|||+.+.|++++.++-+-++||+.+...+.
T Consensus 172 ~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 172 ELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 11499999999999999888899999999876433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0032 Score=52.10 Aligned_cols=141 Identities=26% Similarity=0.395 Sum_probs=90.0
Q ss_pred ceEEecCCCceeeeHHHHHHHhcCCCcCceeeecCc-eEEEEEEEcCCcEEEEEEcccc---CC----------------
Q 018744 19 KLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGF-GLVYRGVLSNGRKVAIKLMDQA---GK---------------- 78 (351)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~-g~v~~~~~~~~~~~~vk~~~~~---~~---------------- 78 (351)
+++.-..+...+|+... ..+++.+.||.|.- |.||++.. +|+.||+|++... ..
T Consensus 20 plp~~~gPKL~~F~~h~-----~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~ 93 (207)
T PF13095_consen 20 PLPQCPGPKLEPFTHHG-----DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLST 93 (207)
T ss_pred ccccCCCCCcCCcCCCC-----CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccch
Confidence 33333444455555522 78999999999999 99999998 5679999993211 10
Q ss_pred --CChHHHHHHHHHHhccC---CCcc--eeeeEEEEcC--C-----------------eEEEEEEccCCChhhhccccCC
Q 018744 79 --QGEDEFKMEVELLGRLR---SPYL--LALLGYCSDR--R-----------------KLLVYDYMANGGLQEHLYPANG 132 (351)
Q Consensus 79 --~~~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~--~-----------------~~~v~~~~~~~~L~~~~~~~~~ 132 (351)
.-...|..|-+...+++ +.++ +++++|..-. . ..+|.+|.....
T Consensus 94 ~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------- 163 (207)
T PF13095_consen 94 PAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------- 163 (207)
T ss_pred hhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------
Confidence 01123566777666664 4455 8888876211 0 114444443321
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 133 SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 133 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
.+.. .-+.+|.+-+..+|+. ||+-+|+++.|.. .-+|+|||.+
T Consensus 164 ------~~~~----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 ------PLQI----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ------ccch----hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 1222 3355667778889999 9999999999965 3478999854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0024 Score=58.24 Aligned_cols=143 Identities=17% Similarity=0.193 Sum_probs=79.7
Q ss_pred ceeeecCceEEEEEEEcC-----CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEccC
Q 018744 47 NVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMAN 120 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~-----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~~~ 120 (351)
..|..|-...+|++...+ ++.+++|+.........++ ..|..+++.+...++ .++++.+... .|.+|+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc---eEEEeeCC
Confidence 345567888999987432 3679999886543332232 568888888754333 3445554332 57888877
Q ss_pred CChhhh-----------------ccccCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-
Q 018744 121 GGLQEH-----------------LYPANGSNSVASKLDWETRLRIALEA-----------------AKGLEFL----HE- 161 (351)
Q Consensus 121 ~~L~~~-----------------~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~~l~~L----H~- 161 (351)
.++... +++...... .....+..+..++.++ ...+..| ..
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~-~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGP-KNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 665421 122111100 0011122333332221 1111111 11
Q ss_pred CCCCCceecCCCCCcEEeCC-CCcEEEeeccccc
Q 018744 162 HCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAK 194 (351)
Q Consensus 162 ~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~ 194 (351)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11237899999999999976 4689999998765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0046 Score=55.95 Aligned_cols=74 Identities=20% Similarity=0.198 Sum_probs=49.4
Q ss_pred eeeecCceEEEEEEEcCC-cEEEEEEcc----c---cCCCChHHHHHHHHHHhccC--CCcceeeeEEEEcCCeEEEEEE
Q 018744 48 VVGHGGFGLVYRGVLSNG-RKVAIKLMD----Q---AGKQGEDEFKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYDY 117 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~~~-~~~~vk~~~----~---~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~v~~~ 117 (351)
.+|.|....||++..++| +.++||.-. . .-+...++...|.+.|+... .|..++-+-++..+...++||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 579999999999997654 578888532 1 11344566677888887763 3544444445555566799999
Q ss_pred ccCC
Q 018744 118 MANG 121 (351)
Q Consensus 118 ~~~~ 121 (351)
+...
T Consensus 82 L~~~ 85 (370)
T TIGR01767 82 LSHH 85 (370)
T ss_pred Cccc
Confidence 8543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0063 Score=53.76 Aligned_cols=72 Identities=21% Similarity=0.319 Sum_probs=44.6
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC---CCcceeeeEEEEcC-CeEEEEEEccCC
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVYDYMANG 121 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-~~~~v~~~~~~~ 121 (351)
.+.++.|....+|+.. .+++.+.+|+-. ......+..|++-|+.+. .-.+++++.+.... ..+++++|++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568888999999887 567788889765 233457788888888883 34677777776543 558999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.013 Score=54.01 Aligned_cols=74 Identities=20% Similarity=0.228 Sum_probs=50.3
Q ss_pred cCceeeecCceEEEEEEEcCCcEEEEEEccc----cCC---CChHHHHHHHHHHhccC---CCcceeeeEEEEcCCeEEE
Q 018744 45 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQ----AGK---QGEDEFKMEVELLGRLR---SPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~----~~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~v 114 (351)
-.+.||.|....||+.... +..++||.-.. ... ....+...|++.|+.+. -.++++++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-CCCEEE
Confidence 3567899999999998864 45688886541 111 23444555777777664 246777887776 445789
Q ss_pred EEEccC
Q 018744 115 YDYMAN 120 (351)
Q Consensus 115 ~~~~~~ 120 (351)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.012 Score=52.83 Aligned_cols=54 Identities=26% Similarity=0.386 Sum_probs=48.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 139 KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 139 ~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.-.+.++..++.+.+..++-+.... ..-|+|+.-.||+|+ .|+|.|+||-+++.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 4567889999999999999998876 789999999999999 89999999999884
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0055 Score=56.16 Aligned_cols=75 Identities=16% Similarity=0.209 Sum_probs=50.7
Q ss_pred CceeeecCceEEEEEEEcC-CcEEEEEEcc----c--cCCCChHHHHHHHHHHhccC--CCcceeeeEEEEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSN-GRKVAIKLMD----Q--AGKQGEDEFKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~----~--~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~v~~ 116 (351)
.+.||.|...-||++...+ ++.++||.-. . .=+.+.++...|++.|+... .|..++-+-++..+...+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 4578999999999999743 5678888532 1 11345577777999998774 454444444555555678898
Q ss_pred EccC
Q 018744 117 YMAN 120 (351)
Q Consensus 117 ~~~~ 120 (351)
++..
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 8854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=53.76 Aligned_cols=145 Identities=14% Similarity=0.194 Sum_probs=77.5
Q ss_pred CceeeecCceEEEEEEEcC----CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEccC
Q 018744 46 SNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMAN 120 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~~~ 120 (351)
++.|..|-...+|+....+ +..+++|+....... .-.-..|..+++.+..-++ .+++.++. .. +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G-~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG-MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc-EeehhhcC
Confidence 3445557778889886432 247999988654332 2223558888888865444 34455543 22 47888876
Q ss_pred CChhhh-----------------ccccCCCCCCCCCCCHHHHHHHHHHH-------------------------HHHHHH
Q 018744 121 GGLQEH-----------------LYPANGSNSVASKLDWETRLRIALEA-------------------------AKGLEF 158 (351)
Q Consensus 121 ~~L~~~-----------------~~~~~~~~~~~~~l~~~~~~~i~~qi-------------------------~~~l~~ 158 (351)
.++... ++...... ......+..+..++.++ +..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~-~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPG-SKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCC-CCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 655221 12211110 00011122222222221 111222
Q ss_pred HHcC--CCCCceecCCCCCcEEeCC-CCcEEEeecccccc
Q 018744 159 LHEH--CSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 195 (351)
Q Consensus 159 LH~~--~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~~ 195 (351)
+... ...-++|+|+.+.||++++ ++.++++||+.+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 2211 0114899999999999974 57899999987653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0061 Score=51.41 Aligned_cols=29 Identities=34% Similarity=0.515 Sum_probs=20.9
Q ss_pred CceecCCCCCcEEe-CCCCcEEEeeccccc
Q 018744 166 PVIHRDFKSSNILL-DKNFHAKVSDFGLAK 194 (351)
Q Consensus 166 ~i~H~di~p~Nilv-~~~~~v~l~dfg~~~ 194 (351)
.++|+|+.+.||++ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 68999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.018 Score=48.16 Aligned_cols=89 Identities=18% Similarity=0.135 Sum_probs=57.5
Q ss_pred ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018744 80 GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158 (351)
Q Consensus 80 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 158 (351)
....+..++.++.++. .|+++..- +...+ ++.|.|..-.. . ..-.+... +.+|.-
T Consensus 101 ~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------------~---~~N~i~ag-i~~L~~ 156 (308)
T PF07387_consen 101 NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------------N---FSNFITAG-IKDLMD 156 (308)
T ss_pred chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------------c---hhHHHHHh-HHHHHH
Confidence 3455677888887765 45555522 23334 88888764211 1 11111111 345666
Q ss_pred HHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 159 LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
.|+. ..+.+|||..|+||+-+..|.+||.|-++.
T Consensus 157 fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 157 FHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred hhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 7754 448999999999999999999999998764
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.041 Score=49.35 Aligned_cols=31 Identities=19% Similarity=0.275 Sum_probs=27.8
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.+++|+|+.++|+++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4899999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.28 Score=44.34 Aligned_cols=96 Identities=15% Similarity=0.119 Sum_probs=57.3
Q ss_pred CceeeeHHHHHHHhcCCCcC--c--eeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc--ce
Q 018744 27 GLQVFTFKQLHSATGGFSKS--N--VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LL 100 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~--~--~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~ 100 (351)
++...+.+.+..+.+.+-+. . ..-.+.-..||+....++..+++|+.... ......+..|.+.+..+.... ++
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCC
Confidence 46667777777777777543 1 12234457789988777888999987532 334566777877777663211 22
Q ss_pred eee---E--EEE-cCCeEEEEEEccCCCh
Q 018744 101 ALL---G--YCS-DRRKLLVYDYMANGGL 123 (351)
Q Consensus 101 ~~~---~--~~~-~~~~~~v~~~~~~~~L 123 (351)
... + +.. ++..+.++++..|...
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 211 1 111 2334578888877643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.00026 Score=73.47 Aligned_cols=158 Identities=14% Similarity=0.025 Sum_probs=111.8
Q ss_pred HHHHHhccCCCcceeeeEEEEcC---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 018744 87 EVELLGRLRSPYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163 (351)
Q Consensus 87 e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 163 (351)
|...++...|+++.....-.... ..+.+++++..|.+.+.+..+.. +...++..-+.....+.+....-+|++.
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e---e~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE---ESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc---cCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34445556777766555433322 34578888999999888865542 2334555555444444466666666663
Q ss_pred --CCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHH
Q 018744 164 --SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 241 (351)
Q Consensus 164 --~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~l 241 (351)
+...+|.++++.|.++..+-.++++++|+.+...+ .....+...+++.|++|++...-.++.++|+|..|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23578999999999999999999999999873222 22334556677789999988877888889999999999999
Q ss_pred HhCCCCCC
Q 018744 242 LTGRVPID 249 (351)
Q Consensus 242 ltg~~pf~ 249 (351)
..|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 99988873
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.13 Score=47.61 Aligned_cols=75 Identities=13% Similarity=0.229 Sum_probs=43.8
Q ss_pred CceeeecCceEEEEEEEcCC--cE-----EEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSNG--RK-----VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDY 117 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~--~~-----~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~ 117 (351)
++.|..|-...+|++...++ .. |+++.......... .-..|+.+++.+...++ .++++.+. ..++.+|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~---~g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG---DFTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC---CEEEEEE
Confidence 44555688889999874432 22 44444322211111 22458889888865544 44444443 2689999
Q ss_pred ccCCChh
Q 018744 118 MANGGLQ 124 (351)
Q Consensus 118 ~~~~~L~ 124 (351)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.5 Score=42.70 Aligned_cols=164 Identities=19% Similarity=0.252 Sum_probs=88.2
Q ss_pred CceeeeHHHHHHHhcCCCcCc-----eeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc--
Q 018744 27 GLQVFTFKQLHSATGGFSKSN-----VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-- 99 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~~-----~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-- 99 (351)
.+....-.+..-+...|.+.- .|.+ .-..+|+....+|+. ++|+.... .....+..|...+..+.-..+
T Consensus 7 ~~~~~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v 82 (331)
T COG2334 7 VFTPLTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPV 82 (331)
T ss_pred cccCcChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCC
Confidence 344444455555555555432 2333 456788888766665 88988654 455677778888887732111
Q ss_pred -ee---eeE---EEEcC--CeEEEEEEccCCChhh-h--------------ccccCCCC-----CCCCCCCHH-------
Q 018744 100 -LA---LLG---YCSDR--RKLLVYDYMANGGLQE-H--------------LYPANGSN-----SVASKLDWE------- 143 (351)
Q Consensus 100 -~~---~~~---~~~~~--~~~~v~~~~~~~~L~~-~--------------~~~~~~~~-----~~~~~l~~~------- 143 (351)
++ .-+ ..... ..+-+++|++|..+.. . ++...... .......|.
T Consensus 83 ~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~ 162 (331)
T COG2334 83 PAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRAL 162 (331)
T ss_pred CCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhh
Confidence 11 111 11122 4458999998887772 1 11111000 000011111
Q ss_pred ------HHHHHHHHHHHHHHHHHcC----CCCC---ceecCCCCCcEEeCCCCc-EEEeeccccc
Q 018744 144 ------TRLRIALEAAKGLEFLHEH----CSPP---VIHRDFKSSNILLDKNFH-AKVSDFGLAK 194 (351)
Q Consensus 144 ------~~~~i~~qi~~~l~~LH~~----~~~~---i~H~di~p~Nilv~~~~~-v~l~dfg~~~ 194 (351)
.-.....++...+..+.+. -..+ ++|+|+.|.||+++.+.. +-++||+.+.
T Consensus 163 ~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 163 LRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 0001222233333333322 1223 899999999999998875 8899998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.26 Score=46.45 Aligned_cols=75 Identities=15% Similarity=0.130 Sum_probs=45.8
Q ss_pred cCceeeecCceEEEEEEEcC---------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcce-eeeEEEEcCCeEEE
Q 018744 45 KSNVVGHGGFGLVYRGVLSN---------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLV 114 (351)
Q Consensus 45 ~~~~lg~G~~g~v~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~v 114 (351)
-++.|..|-.-.+|++...+ ++.|++++.......-. .-..|..+++.+...++. ++++.+. ...+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS---GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC---CCEE
Confidence 34556678788888887432 46789998865433322 234577777777544442 3444432 3567
Q ss_pred EEEccCCCh
Q 018744 115 YDYMANGGL 123 (351)
Q Consensus 115 ~~~~~~~~L 123 (351)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888887644
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.75 Score=48.28 Aligned_cols=31 Identities=39% Similarity=0.473 Sum_probs=25.9
Q ss_pred CCceecCCCCCcEEeCCCC--cEE-Eeecccccc
Q 018744 165 PPVIHRDFKSSNILLDKNF--HAK-VSDFGLAKI 195 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~~--~v~-l~dfg~~~~ 195 (351)
.+++|+|+.+.||+++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3799999999999998775 555 999997753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.76 Score=39.02 Aligned_cols=74 Identities=19% Similarity=0.234 Sum_probs=45.9
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCC---CcceeeeEEEEcC-CeEEEEEEccCCC
Q 018744 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS---PYLLALLGYCSDR-RKLLVYDYMANGG 122 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~-~~~~v~~~~~~~~ 122 (351)
+.+.-|..-..|...+ +..++.+|+-. ..-...|..|+.-|+.+.- -.+.+++.+-.+. +.++|++|++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444555555566554 44567778642 3334567777777777643 4566666655444 5679999998766
Q ss_pred hh
Q 018744 123 LQ 124 (351)
Q Consensus 123 L~ 124 (351)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.14 Score=45.87 Aligned_cols=29 Identities=31% Similarity=0.431 Sum_probs=25.2
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 38999999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.062 Score=50.61 Aligned_cols=47 Identities=15% Similarity=0.202 Sum_probs=34.7
Q ss_pred HHHHHHHHHHhccCCCcceeeeEEEEcCC--eEEEEEEccCCChhhhccc
Q 018744 82 DEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLVYDYMANGGLQEHLYP 129 (351)
Q Consensus 82 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~v~~~~~~~~L~~~~~~ 129 (351)
..+.....+++.++|+|....+++..... .++|++++ +.+|.+....
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 45566788999999999999998876552 34666666 5588887743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 351 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-57 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-163
Identities = 119/291 (40%), Positives = 170/291 (58%), Gaps = 8/291 (2%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEV 88
L AT F ++GHG FG VY+GVL +G KVA+K QG +EF+ E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 89 ELLGRLRSPYLLALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
E L R P+L++L+G+C +R + +L+Y YM NG L+ HLY GS+ + WE RL
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLE 143
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 207
I + AA+GL +LH +IHRD KS NILLD+NF K++DFG++K G++ H+ST
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267
V GT GY+ PEY + G LT KSDVYS+GVVL E+L R I + P L WA+
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ ++ +I+DP L + + + + A C+ ++ RP M DV+ L
Sbjct: 261 NNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-156
Identities = 124/295 (42%), Positives = 181/295 (61%), Gaps = 9/295 (3%)
Query: 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-EDEFKM 86
L+ F+ ++L A+ FS N++G GGFG VY+G L++G VA+K + + QG E +F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 87 EVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
EVE++ LL L G+C +LLVY YMANG + L LDW R
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR---ERPESQPPLDWPKR 133
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
RIAL +A+GL +LH+HC P +IHRD K++NILLD+ F A V DFGLAK+ K HV+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 192
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE--GVLVSWA 263
T V GT G++APEY TG + K+DV+ YGV+LLEL+TG+ D+ + + + +L+ W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
L ++ K+ ++D L+G Y +EV Q+ +A +C Q RP M++VV+ L
Sbjct: 253 KGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-155
Identities = 109/318 (34%), Positives = 174/318 (54%), Gaps = 24/318 (7%)
Query: 16 ESGKLEVTTDNGLQVFTFKQLHSATGGFSK------SNVVGHGGFGLVYRGVLSNGRKVA 69
E+ LEV+ F+F +L + T F + N +G GGFG+VY+G + N VA
Sbjct: 1 ENKSLEVSDTR-FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVA 58
Query: 70 IK----LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQ 124
+K ++D ++ + +F E++++ + + L+ LLG+ SD LVY YM NG L
Sbjct: 59 VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 125 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184
+ L +G+ L W R +IA AA G+ FLHE+ IHRD KS+NILLD+ F
Sbjct: 119 DRLSCLDGT----PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFT 171
Query: 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
AK+SDFGLA+ A +++R++GT Y+APE L G +T KSD+YS+GVVLLE++TG
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITG 230
Query: 245 RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPE 304
+D ++ +L+ + + I + +D + V + ++A+ C+ +
Sbjct: 231 LPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK 287
Query: 305 ADYRPLMADVVQSLVPLV 322
+ RP + V Q L +
Sbjct: 288 KNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 7e-85
Identities = 73/328 (22%), Positives = 121/328 (36%), Gaps = 33/328 (10%)
Query: 18 GKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG 77
G +G+ + L+ + V G FG V++ L VA+K+
Sbjct: 2 GHHHHHHSSGVD-LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 78 KQGEDEFKMEVELLGRLRSPYLLALLGYC-----SDRRKLLVYDYMANGGLQEHLYPANG 132
KQ + + EV L ++ +L +G D L+ + G L + L
Sbjct: 60 KQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---- 114
Query: 133 SNSVASKLDWETRLRIALEAAKGLEFLHEH-------CSPPVIHRDFKSSNILLDKNFHA 185
A+ + W IA A+GL +LHE P + HRD KS N+LL N A
Sbjct: 115 ----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT-----KSDVYSYGVVLLE 240
++DFGLA + +GT+ Y+APE + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 241 LLTGRVPIDVNKPSGEGVLVS--WALPRLTDREKI--LEIMDPALEGQYSMKEVI-QVAA 295
L + D P L D +++ + P L + + +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 296 IAAMCVQPEADYRPLMADVVQSLVPLVK 323
C +A+ R V + + + +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-68
Identities = 90/292 (30%), Positives = 143/292 (48%), Gaps = 29/292 (9%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+G G FG V+R +G VA+K++ + +EF EV ++ RLR P ++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
+ L +V +Y++ G L L+ + +LD RL +A + AKG+ +LH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH----KSGAREQLDERRRLSMAYDVAKGMNYLH-NR 156
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
+PP++HR+ KS N+L+DK + KV DFGL+++ + S GT ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
KSDVYS+GV+L EL T + P P+ V A+ R +I ++P +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 335
AAI C E RP A ++ L PL+K + P + S
Sbjct: 269 ----------AAIIEGCWTNEPWKRPSFATIMDLLRPLIK--SAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-67
Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 33/295 (11%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
VVG G FG+V + + VAIK ++ + F +E+ L R+ P ++ L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ + LV +Y G L L+ + L+ ++G+ +LH
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 166 PVIHRDFKSSNILLDKNF-HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
+IHRD K N+LL K+ DFG A T G+ ++APE +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSN 179
Query: 225 LTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
+ K DV+S+G++L E++T R P ++ P+ + WA+ R +++ + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAVHN-GTRPPLIKNLPKPI-- 233
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 338
+ ++ C + RP M ++V+ + L++Y + P H
Sbjct: 234 ----ESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-67
Identities = 68/349 (19%), Positives = 115/349 (32%), Gaps = 59/349 (16%)
Query: 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE- 89
+ ++G G +G VY+G L + R VA+K+ F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 90 -LLGRLRSPYLLALLGYC------SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW 142
+ + + + LLV +Y NG L ++L DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--------LHTSDW 110
Query: 143 ETRLRIALEAAKGLEFLHE------HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI- 195
+ R+A +GL +LH H P + HRD S N+L+ + +SDFGL+
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 196 -----GSDKAGGHVSTRVLGTQGYVAPEYA-------LTGHLTTKSDVYSYGVVLLELLT 243
+ + +GT Y+APE + D+Y+ G++ E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 244 GRVPIDVNKPSGEGVL----VSWALPRLTD----------REKILEIMDPALEGQYSMKE 289
+ + E + P D R K E S+KE
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 290 VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 338
I+ C +A+ R + + L+ +S + H
Sbjct: 291 TIE------DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 8e-63
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 42/287 (14%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED-------EFKMEVELLGRLRSPY 98
+G GGFGLV++G + + VAIK + +GE EF+ EV ++ L P
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
++ L G + +V +++ G L L + W +LR+ L+ A G+E+
Sbjct: 85 IVKLYGLMHNP-PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALGIEY 137
Query: 159 LHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+ + +PP++HRD +S NI L AKV+DFGL++ + +LG
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQ 191
Query: 214 YVAPEYALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
++APE T K+D YS+ ++L +LTG P D + + R
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIREEGLRP 249
Query: 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
I E P L + VI+ +C + RP + +V+ L
Sbjct: 250 TIPEDCPPRL------RNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-61
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 34/283 (12%)
Query: 49 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG VY+G VA+K+++ + FK EV +L + R +L +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+ + +V + L HL+ + K + + + IA + A+G+++LH +
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE---YALTG 223
+IHRD KS+NI L ++ K+ DFGLA S +G H ++ G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI---MDPA 280
+ +SDVY++G+VL EL+TG++P + + + R + + ++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
+ + A C++ + D RP ++ + L +
Sbjct: 258 M------------KRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-61
Identities = 71/311 (22%), Positives = 110/311 (35%), Gaps = 48/311 (15%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYLLALLG 104
++G G FG VY G +VAI+L+D + FK EV + R ++ +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 105 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
C L ++ L + A LD +IA E KG+ +LH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS---TRVLGTQGYVAPE-- 218
+ ++H+D KS N+ D ++DFGL I G G ++APE
Sbjct: 148 AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 219 -------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
+ SDV++ G + EL P +P+ + W +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPN 262
Query: 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 331
M + + I C E + RP ++ L L K NR
Sbjct: 263 LSQIGMGKEI------------SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR---- 306
Query: 332 SSSPSFHASRS 342
S P H +S
Sbjct: 307 LSHPG-HFWKS 316
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-60
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 40/281 (14%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 104
+ G +++G G + +K++ + +F E L P +L +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 105 YCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
C L+ +M G L L+ +D ++ AL+ A+G+ FLH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-----VVDQSQAVKFALDMARGMAFLH- 128
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
P + S ++++D++ A++S + S + +VAPE AL
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-AL 180
Query: 222 TG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
+D++S+ V+L EL+T VP G+ V+ R T I +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----IPPGI 236
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
P + + + +C+ + RP +V L
Sbjct: 237 SPHV------------SKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-60
Identities = 77/285 (27%), Positives = 120/285 (42%), Gaps = 42/285 (14%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLM----DQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
++G GGFG VYR G +VA+K D+ Q + + E +L L+ P ++AL
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
G C L LV ++ G L L ++ + + A++ A+G+ +LH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHD 123
Query: 162 HCSPPVIHRDFKSSNILLDKNFH--------AKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
P+IHRD KSSNIL+ + K++DFGLA+ + G
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYA 179
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273
++APE + SDV+SYGV+L ELLTG VP V++ + I
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLA---VAYGVAMNKLALPI 235
Query: 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
A + C P+ RP +++ L
Sbjct: 236 PSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-56
Identities = 72/310 (23%), Positives = 118/310 (38%), Gaps = 54/310 (17%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE--LLGRLRSPYLLALLG 104
+G G +G V+ G G KVA+K+ E + E E +R +L +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 105 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L+ DY NG L ++L ++ LD ++ L++A + GL L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLCHL 150
Query: 160 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 212
H P + HRD KS NIL+ KN ++D GLA +GT+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 213 GYVAPEYALTGHL-------TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
Y+ PE L L +D+YS+G++L E+ V + + + LP
Sbjct: 211 RYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE--------YQLP 261
Query: 266 --RLTDREKILEIMD---------PALEGQYSMKEVI-QVAAIAAMCVQPEADYRPLMAD 313
L + E M P+ ++S E + Q+ + C R
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 314 VVQSLVPLVK 323
V ++L + +
Sbjct: 322 VKKTLAKMSE 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
V+G G FG + G + +K + + ++ + F EV+++ L P +L +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
++L + +Y+ G L+ + + + W R+ A + A G+ +LH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS------QYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------------KAGGHVSTRVLGTQ 212
+IHRD S N L+ +N + V+DFGLA++ D K V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272
++APE K DV+S+G+VL E++ P ++ R
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---RGFLDRY 243
Query: 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
P+ I C + + RP + L L
Sbjct: 244 CPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-55
Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 52/307 (16%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL--LGRLRSPYLLALLG 104
VG G +G V+RG G VA+K+ + E + E EL LR +L +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 105 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
R L+ Y G L ++L + LD + LRI L A GL L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------LTTLDTVSCLRIVLSIASGLAHL 121
Query: 160 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 212
H P + HRD KS NIL+ KN ++D GLA + S + +GT+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 213 GYVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP- 265
Y+APE + D++++G+VL E+ V G++ + P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPPF 233
Query: 266 -RLTDREKILEIMD---------PALEGQYSMKEVI-QVAAIAAMCVQPEADYRPLMADV 314
+ + E M P + ++ + +A + C R +
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 315 VQSLVPL 321
++L +
Sbjct: 294 KKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-53
Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 54/310 (17%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE--LLGRLRSPYLLALLG 104
+G G FG V+RG G +VA+K+ + E + E E LR +L +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 105 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
+ LV DY +G L ++L + E +++AL A GL L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHL 155
Query: 160 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 212
H P + HRD KS NIL+ KN ++D GLA + +GT+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 213 GYVAPEYALTGHL-------TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
Y+APE L + ++D+Y+ G+V E+ +++ LP
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLP 266
Query: 266 --RLTDREKILEIMD---------PALEGQYSMKEVIQ-VAAIAAMCVQPEADYRPLMAD 313
L + +E M P + ++ E ++ +A I C R
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 314 VVQSLVPLVK 323
+ ++L L +
Sbjct: 327 IKKTLSQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 50 GHGGFGLVYRGVL-SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
G G FG V+ G L ++ VA+K + + +F E +L + P ++ L+G C+
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 108 DRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
++ +V + + G L + ++L +T L++ +AA G+E+L
Sbjct: 183 QKQPIYIVMELVQGGDFLTFL------RTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY----VAPEYALT 222
IHRD + N L+ + K+SDFG+++ +D V G + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWTAPEALNY 289
Query: 223 GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281
G +++SDV+S+G++L E + G P P L++++ +
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP----------------YPNLSNQQTREFVEK--- 330
Query: 282 EGQYSMKE----VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326
G + V + C E RP + + Q L + K +R
Sbjct: 331 -G-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V+ G + KVA+K + + G D F E L+ +L+ L+ L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+ ++ +YM NG L + L +G KL L +A + A+G+ F+ E
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 221
IHRD +++NIL+ K++DFGLA++ D + G + + APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAIN 183
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
G T KSDV+S+G++L E++T GR+P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V+ + KVA+K M + G + F E ++ L+ L+ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+ ++ ++MA G L + L GS KL + + + A+G+ F+ +
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQRN--- 304
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEYALTG 223
IHRD +++NIL+ + K++DFGLA++ D T G + + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFG 360
Query: 224 HLTTKSDVYSYGVVLLELLT-GRVP 247
T KSDV+S+G++L+E++T GR+P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG+V G VAIK++ + G EDEF E +++ L L+ L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 107 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ +R ++ +YMANG L +L + + + L + + + +E+L
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYA 220
+HRD + N L++ KVSDFGL++ D G R + PE
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVL 193
Query: 221 LTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ ++KSD++++GV++ E+ + G++P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
S+ +V +YM+ G L + L G +L + +A + A G+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERMN--- 300
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 221
+HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAAL 354
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
G T KSDV+S+G++L EL T GRVP
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 38 SATGGFSKSN-VVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGR 93
S G F K + +G G F VY+G+ +VA + + K FK E E+L
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81
Query: 94 LRSPYLLALLGYCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
L+ P ++ K LV + M +G L+ + +
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFK------VMKIKVLRSW 134
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTR 207
+ KGL+FLH +PP+IHRD K NI + K+ D GLA + +
Sbjct: 135 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKA 189
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
V+GT ++APE + DVY++G+ +LE+ T P
Sbjct: 190 VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-38
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FGLV+ G N KVAIK + + G E++F E E++ +L P L+ L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 107 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
++ LV ++M +G L ++L + ET L + L+ +G+ +L E C
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYA 220
VIHRD + N L+ +N KVSDFG+ + D G + + +PE
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVF 177
Query: 221 LTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++KSDV+S+GV++ E+ + G++P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 8e-38
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 96
F K V+G G FG VY+G+ + VAIK L + + E E ++ + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
P++ LLG C L+ M G L +++ + L+W ++ AKG+
Sbjct: 77 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 210
+L + ++HRD + N+L+ H K++DFGLAK +G++ GG V +
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++A E L T +SDV+SYGV + EL+T G P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 107 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
S+ +V +YM+ G L + L G +L + +A + A G+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERMN--- 383
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 221
+HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAAL 437
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
G T KSDV+S+G++L EL T GRVP
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 96
K V+G G FG V++GV + V IK + D++G+Q + +G L
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+++ LLG C LV Y+ G L +H+ G+ L+W ++ AKG+
Sbjct: 75 AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGM 128
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 210
+L EH ++HR+ + N+LL +V+DFG+A + D + +
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK--- 182
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++A E G T +SDV+SYGV + EL+T G P
Sbjct: 183 ---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
+G G FG+V G VA+K++ + G EDEF E + + +L P L+ G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 108 DRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 166
+V +Y++NG L +L S L+ L + + +G+ FL H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL------RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--- 124
Query: 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 221
IHRD + N L+D++ KVSDFG+ + D G + + APE
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFH 178
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
++KSDV+++G+++ E+ + G++P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLG 104
+G G FG V G G KVA+K + K F E ++ +LR L+ LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 105 YCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ + L V +YMA G L ++L S L + L+ +L+ + +E+L +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYAL 221
+HRD + N+L+ ++ AKVSDFGL K S + G + + + APE
Sbjct: 137 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 187
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
+TKSDV+S+G++L E+ + GRVP
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 48 VVGHGGFGLVYRGVLSNGR----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
++G G FG VY GV +N + VA+K +++F E ++ L P+++ L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+G + ++ + G L +L + L T + +L+ K + +L
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV------- 215
+HRD NIL+ K+ DFGL+ R + + Y
Sbjct: 133 N---CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRL 176
Query: 216 -----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+PE TT SDV+ + V + E+L+ G+ P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 47 NVVGHGGFGLVYRGVLSNGR-KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+ +G G +G VY GV VA+K + + +EF E ++ ++ P L+ LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
C+ ++ ++M G L ++L N ++ L +A + + +E+L +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 219
IHRD + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 183
Query: 220 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ KSDV+++GV+L E+ T G P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLG 104
+G G FG V G G KVA+K + K F E ++ +LR L+ LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 105 YCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ + L V +YMA G L ++L S L + L+ +L+ + +E+L +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYAL 221
+HRD + N+L+ ++ AKVSDFGL K S + G + + + APE
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 359
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVP 247
+TKSDV+S+G++L E+ + GRVP
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 47/310 (15%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 98
F +G G F VYR L +G VA+K + E++LL +L P
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 99 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ + +L + + G L + + T + ++ LE
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H V+HRD K +N+ + K+ D GL + S K + V GT Y++P
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSP 205
Query: 218 E------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
E Y KSD++S G +L E+ + P +K + + +
Sbjct: 206 ERIHENGY------NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-----------K 248
Query: 272 KILE-IMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328
KI + P YS +++++ MC+ P+ + RP + V V + +
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVN------MCINPDPEKRPDVTYVYD--VAKRMHACTA 300
Query: 329 PKISSSPSFH 338
+ H
Sbjct: 301 SSLEHHHHHH 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-36
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGR-----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG VY+G+L VAIK L ++ +F E ++G+ ++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L G S + +++ +YM NG L + L +G + + + A G+++L
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAGMKYLA 164
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 217
+HRD + NIL++ N KVSDFGL+++ D +T G + + AP
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAP 219
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E T+ SDV+S+G+V+ E++T G P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 41/287 (14%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G GGF V L +G A+K + +Q +E + E ++ P +L L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 107 SDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
R L+ + G L + + L + L + L +GLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-------GTQGY 214
+ HRD K +NILL + D G G L T Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 215 VAPE-YALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
APE +++ H + ++DV+S G VL ++ G P D+ G+ V +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----------- 258
Query: 272 KILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
+ + ++S + +++ + + RP + ++
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLS 299
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-36
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 48 VVGHGGFGLVYRGVLSNGR---KVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V +G + VA+K++ + +DE E ++ +L +PY++ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+G C +LV + G L ++L + + + + + + G+++L E
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEY 219
+HRD + N+LL +AK+SDFGL+K + + + V APE
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPEC 191
Query: 220 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++KSDV+S+GV++ E + G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 50 GHGGFGLVYRGVLSNGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
G G FG V +GV +K VAIK L K +E E +++ +L +PY++ L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
C +LV + G L + L ++ + + + G+++L E
Sbjct: 79 CQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD------KAGGHVSTRVLGTQGYVAPE 218
+HRD + N+LL +AK+SDFGL+K +G+D ++ G + + APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPE 183
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+++SDV+SYGV + E L+ G+ P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 47 NVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G FG V + G +VA+K L ++G + K E+E+L L ++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 101 ALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
G C++ L+ +++ +G L+E+L P N + K++ + +L+ A++ KG++
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKN-----KINLKQQLKYAVQICKGMD 140
Query: 158 FLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 215
+L +HRD + N+L++ K+ DFGL K I +DK V V
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPV 193
Query: 216 ---APEYALTGHLTTKSDVYSYGVVLLELLT 243
APE + SDV+S+GV L ELLT
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 47 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+ +G G FG V + G VA+K + +G + +F+ E+++L L S +++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 102 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
G + LV +Y+ +G L++ L + + +LD L + + KG+E+
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRA-----RLDASRLLLYSSQICKGMEY 142
Query: 159 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDK------AGGHVSTRVLG 210
L C +HRD + NIL++ H K++DFGLAK + DK G
Sbjct: 143 LGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF--- 195
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ APE + +SDV+S+GVVL EL T
Sbjct: 196 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 96
F K V+G G FG VY+G+ + VAIK L + + E E ++ + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
P++ LLG C L+ M G L +++ + L+W ++ AKG+
Sbjct: 77 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 210
+L + ++HRD + N+L+ H K++DFGLAK +G++ GG V +
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++A E L T +SDV+SYGV + EL+T G P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 47 NVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+ +G G +G VY GV VA+K + + +EF E ++ ++ P L+ LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
C+ ++ ++M G L ++L N ++ L +A + + +E+L +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 219
IHR+ + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 390
Query: 220 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ KSDV+++GV+L E+ T G P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 48 VVGHGGFGLVYRGVL----SNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G FG+V RG VA+K + + + D+F EV + L L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 101 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L G +V + G L + L G + + + A++ A+G+ +L
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYLE 138
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 217
IHRD + N+LL K+ DFGL + +V + AP
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E T + SD + +GV L E+ T G+ P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 47 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG V + G VA+K + + ++ +F+ E+E+L L+ ++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 102 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
G C + L+ +Y+ G L+++L + ++D L+ + KG+E+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKE-----RIDHIKLLQYTSQICKGMEY 129
Query: 159 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV- 215
L IHRD + NIL++ K+ DFGL K + DK V + +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPIF 182
Query: 216 --APEYALTGHLTTKSDVYSYGVVLLELLT 243
APE + SDV+S+GVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-35
Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 47 NVVGHGGFGLVYRGVLSN-----GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G FG V G VA+K L AG Q +K E+++L L +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 101 ALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
G C D LV +Y+ G L+++L + L A + +G+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------RHSIGLAQLLLFAQQICEGMA 148
Query: 158 FLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 215
+LH H IHRD + N+LLD + K+ DFGLAK + V G
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-----GDS 199
Query: 216 -----APEYALTGHLTTKSDVYSYGVVLLELLT 243
APE SDV+S+GV L ELLT
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V++G+ + VAIK + ++F E + + P+++ L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+G ++ ++ + G L+ L S +AS + + A + + L +L
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALAYLESK 135
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAP 217
+HRD + N+L+ N K+ DFGL++ D + G + + ++AP
Sbjct: 136 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAP 186
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E T+ SDV+ +GV + E+L G P
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+G G FG+VY GV K VAIK + + A + EF E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 100 LALLGYCSDRRKLL-VYDYMANGGLQEHL---YPANGSNSVASKLDWETRLRIALEAAKG 155
+ LLG S + L + + M G L+ +L PA +N V + +++A E A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY- 214
+ +L+ + +HRD + N ++ ++F K+ DFG+ R + Y
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDIYETDYY 194
Query: 215 ------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++PE G TT SDV+S+GVVL E+ T P
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 48 VVGHGGFGLVYRGVLSNGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G FG V +GV +K VAIK L K +E E +++ +L +PY++ L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
G C +LV + G L + L ++ + + + G+++L E
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD------KAGGHVSTRVLGTQGYVA 216
+HR+ + N+LL +AK+SDFGL+K +G+D ++ G + + A
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYA 507
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
PE +++SDV+SYGV + E L+ G+ P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 47 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G FG V + G VA+K + + ++ +F+ E+E+L L+ ++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 102 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
G C + L+ +Y+ G L+++L + ++D L+ + KG+E+
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKE-----RIDHIKLLQYTSQICKGMEY 160
Query: 159 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV- 215
L IHRD + NIL++ K+ DFGL K + DK V + +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESPIF 213
Query: 216 --APEYALTGHLTTKSDVYSYGVVLLELLT 243
APE + SDV+S+GVVL EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
VVG G FG V G L K VAIK L ++ +F E ++G+ P ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L G + + ++V +YM NG L L + + + + A G+++L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYLS 164
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 217
+ +HRD + NIL++ N KVSDFGL ++ D +TR G + + +P
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSP 219
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E T+ SDV+SYG+VL E+++ G P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 40/231 (17%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
F + V+G G FG V + + R AIK + ++ EV LL L Y++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 102 LLG-YCSDRRKL-------------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
+ R + + +Y NG L + ++ N + R
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWR 120
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD--------- 198
+ + + L ++H +IHRD K NI +D++ + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 199 ----KAGGHVSTRVLGTQGYVAPE-YALTGHLTTKSDVYSYGVVLLELLTG 244
+ ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 65/324 (20%), Positives = 121/324 (37%), Gaps = 54/324 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 98
+ + +G G FG +GR+ IK ++ + E + EV +L ++ P
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPN 84
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ + L +V DY G L + + G + L ++ L+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLALK 139
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H+ ++HRD KS NI L K+ ++ DFG+A++ + + ++ +GT Y++P
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSP 194
Query: 218 E------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
E Y KSD+++ G VL EL T + + LV
Sbjct: 195 EICENKPY------NNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVL---------- 235
Query: 272 KILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP-----LMADVVQSLVPLVKY 324
KI+ P + YS ++ ++ + RP L + +
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 325 NRSTPKISSSPSFHASRSPAFPDK 348
+ + +F S P K
Sbjct: 290 PQLIAEEFCLKTFSKFGSQPIPAK 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-34
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 46/228 (20%)
Query: 50 GHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
G G FG V+ N VA+K + +F+ E ELL L+ +++
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 104 GYCSDRR-KLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIALEAA 153
G C D ++V++YM +G L + L +L L IA + A
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
G+ +L +HRD + N L+ N K+ DFG++ R + +
Sbjct: 144 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVYSTD 187
Query: 214 Y-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
Y + PE + TT+SDV+S+GV+L E+ T G+ P
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 47 NVVGHGGFGLVYRGVL----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
++G G G V G L VAIK L ++ +F E ++G+ P ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L G + R ++V +YM NG L L +G + + + G+ +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGMRYLS 168
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 217
+ +HRD + N+L+D N KVSDFGL+++ D +T G + + AP
Sbjct: 169 DLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAP 223
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E ++ SDV+S+GVV+ E+L G P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 105
G G FG VY + +A+K++ Q K G E + + EVE+ LR P +L L GY
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
D ++ L+ +Y G + L SK D + E A L + H
Sbjct: 78 FHDATRVYLILEYAPLGTVYREL-------QKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
VIHRD K N+LL K++DFG + A T + GT Y+ PE
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 225 LTTKSDVYSYGVVLLELLTGRVPID 249
K D++S GV+ E L G+ P +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 26/220 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 98
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
++ L Y + + + N L L +D R + +
Sbjct: 71 IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVHT 123
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
+H+H ++H D K +N L+ K+ DFG+A V +GT Y+ PE
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 219 -----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++ KSDV+S G +L + G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 49/233 (21%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+G FG VY+G L VAIK L D+A +EF+ E L RL+ P +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 100 LALLGYCSDRR-KLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 149
+ LLG + + +++ Y ++G L E L + +V S L+ + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 150 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
+ A G+E+L H +H+D + N+L+ + K+SD GL R
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177
Query: 209 LGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ Y +APE + G + SD++SYGVVL E+ + G P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG VY G L + A+K L +F E ++ P +L+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 102 LLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
LLG C L+V YM +G L+ + + + + L+ AKG+++L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 160 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD---KAGGHVSTR--VLGTQ 212
+HRD + N +LD+ F KV+DFGLA+ + + V
Sbjct: 145 ASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
A E T TTKSDV+S+GV+L EL+T G P
Sbjct: 200 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLAL 102
+G GG V+ L + R VA+K++ D F+ E + L P ++A+
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 103 LGYCSDRRKLLVYDYMA----NGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
Y+ +G L++ ++ G + + + + +A + L
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEG------PMTPKRAIEVIADACQALN 130
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST-RVLGTQGYVA 216
F H++ +IHRD K +NI++ KV DFG+A+ +D T V+GT Y++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE A + +SDVYS G VL E+LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G FG V+ N VA+K + +A + +F+ E ELL L+ +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 101 ALLGYCSDRR-KLLVYDYMANGGLQEHL--------YPANGSNSVASKLDWETRLRIALE 151
G C++ R L+V++YM +G L L A G + L L +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
A G+ +L +HRD + N L+ + K+ DFG++ R + +
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIYS 210
Query: 212 QGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
Y + PE L TT+SDV+S+GVVL E+ T G+ P
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLAL 102
+G GG VY KVAIK + E E F+ EV +L +++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 103 LGYCSDRRKLLVYDYMANGGLQ----EHLYPANGSN-----SVASKLDWETRLRIALEAA 153
+ D E++ G L +T + +
Sbjct: 76 -----------MIDVDEEDDCYYLVMEYI---EGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
G++ H+ ++HRD K NIL+D N K+ DFG+AK S+ + + VLGT
Sbjct: 122 DGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y +PE A +D+YS G+VL E+L G P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 47 NVVGHGGFGLVYRGVLSNGR----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG+VY G + + AIK L Q + F E L+ L P +LA
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 102 LLGYCSDRR--KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
L+G ++ YM +G L + + + N L + L+ A+G+E+L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDL-----ISFGLQVARGMEYL 140
Query: 160 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--------IGSDKAGGHVSTRVLG 210
E +HRD + N +LD++F KV+DFGLA+ + +
Sbjct: 141 AEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK--- 193
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ A E T TTKSDV+S+GV+L ELLT G P
Sbjct: 194 ---WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 28/221 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 98
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ L Y + + +V + N L L +D R + +
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVH 141
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H+H ++H D K +N L+ K+ DFG+A V +GT Y+ P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 218 E-----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E ++ KSDV+S G +L + G+ P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 46/220 (20%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 50 GHGGFGLVYRGVLSNGRKVAIKLMD-----------------QAGKQGEDEFKMEVELLG 92
G F + + + A+K + + K D+FK E++++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 93 RLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IAL 150
+++ Y L G ++ ++ ++Y+YM N + + + + ++ I
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
++H + + HRD K SNIL+DKN K+SDFG ++ D + G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR-G 212
Query: 211 TQGYVAPEYALTGHLTT---KSDVYSYGVVLLELLTGRVP 247
T ++ PE + + K D++S G+ L + VP
Sbjct: 213 TYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 48 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V++G+ + VAIK + ++F E + + P+++ L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+G ++ ++ + G L+ L LD + + A + + L +L
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKF------SLDLASLILYAYQLSTALAYLESK 510
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAP 217
+HRD + N+L+ N K+ DFGL++ D + G + + ++AP
Sbjct: 511 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAP 561
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
E T+ SDV+ +GV + E+L G P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 60/275 (21%), Positives = 99/275 (36%), Gaps = 44/275 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRL-RSPY 98
F + + +GHG +G V++ +GR A+K + G + EV ++ + P
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ L + L L + LQ+H S L + L
Sbjct: 119 CVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS------LPEAQVWGYLRDTLLALA 171
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
LH ++H D K +NI L K+ DFGL G V G Y+AP
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE-I 276
E L G T +DV+S G+ +LE+ P G +++ +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNMEL-----PHG-----------GEGWQQLRQGY 268
Query: 277 MDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 309
+ P S ++ V+ M ++P+ R
Sbjct: 269 LPPEFTAGLSSELRSVLV------MMLEPDPKLRA 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 26/220 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 98
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
++ L Y + + + N L L +D R + +
Sbjct: 118 IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVHT 170
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
+H+H ++H D K +N L+ K+ DFG+A V +G Y+ PE
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 219 -----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
++ KSDV+S G +L + G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 47 NVVGHGGFGLVYRGVLSNG---RKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYLLA 101
+V+G G FG V + + AIK M + A K +F E+E+L +L P ++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIALE 151
LLG C R L L +Y +G L + L +NS AS L + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD---KAGGHVSTRV 208
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ K G + R
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++A E TT SDV+SYGV+L E+++ G P
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 47 NVVGHGGFGLVYRGVLSNGR----KVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 100
++G G FG V G L KVA+K M D + ++ +EF E + P ++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 101 ALLGYCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
LLG C + + +++ +M G L +L + + + +T L+ ++ A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
G+E+L +HRD + N +L + V+DFGL+ + + + Y
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSGDY 202
Query: 215 -------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+A E T+KSDV+++GV + E+ T G P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-33
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+GHG FG VY G +S VA+K L + +Q E +F ME ++ + +
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 100 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+ +G + ++ + MA G L+ L S S L L +A + A G ++
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 159 LHE-HCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQG 213
L E H IHRD + N LL AK+ DFG+A+ I S G
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------SYYRKGGCA 205
Query: 214 YV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ PE + G T+K+D +S+GV+L E+ + G +P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 66/318 (20%), Positives = 117/318 (36%), Gaps = 74/318 (23%)
Query: 50 GHGGFGLVYRGVLSNGR--------KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
G G F +++GV +V +K++D+A + + F ++ +L +L+
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
G C +LV +++ G L +L ++ KL+ A + A + FL
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV------AKQLAAAMHFLE 130
Query: 161 EHCSPPVIHRDFKSSNILLDK--------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
E+ +IH + + NILL + K+SD G++ VL
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175
Query: 213 GY------VAPEYALTG-HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 264
V PE +L +D +S+G L E+ + G P L
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP----------------L 219
Query: 265 PRLTDREKILEIMD----PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320
L + K+ D PA + ++A + C+ E D+RP +++ L
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAA-------ELANLINNCMDYEPDHRPSFRAIIRDLNS 272
Query: 321 LVKYNRSTPKISSSPSFH 338
L P+ S H
Sbjct: 273 LF-TPDLVPRGSHHHHHH 289
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLA 101
+VG GG G VY R VA+KLM + D + E GRL+ P+++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 102 LLGYCSDRRKLLVYDYMANGGLQEHLYPA----NGSN-----SVASKLDWETRLRIALEA 152
++D+ G + LY NG + L + I +
Sbjct: 99 ------------IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
L+ H HRD K NIL+ + A + DFG+A +D+ + +GT
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTL 199
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y+APE H T ++D+Y+ VL E LTG P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 46/229 (20%)
Query: 47 NVVGHGGFGLVYRGVLSNG----RKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 100
++G G FG V L KVA+K++ D +EF E + P++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 101 ALLGYCSDR-------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
L+G +++ +M +G L L A+ L +T +R ++ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVRFMVDIA 147
Query: 154 KGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
G+E+L + IHRD + N +L ++ V+DFGL+ R + +
Sbjct: 148 CGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYSG 190
Query: 213 GY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
Y +A E T SDV+++GV + E++T G+ P
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 103
V+G G +G+VY G LSN ++AIK + + + E+ L L+ ++ L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 104 GYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFLHE 161
G S+ + ++ + + G L L G D E + + +GL++LH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK-----DNEQTIGFYTKQILEGLKYLHD 140
Query: 162 HCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 218
+ ++HRD K N+L++ + K+SDFG +K + + GT Y+APE
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 219 -YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
G+ +D++S G ++E+ TG+ P
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKPP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG VY G L + A+K L +F E ++ P +L+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 102 LLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
LLG C L+V YM +G L+ + + + + L+ AKG++FL
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 208
Query: 160 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV--- 215
+HRD + N +LD+ F KV+DFGLA+ DK V + T +
Sbjct: 209 ASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVK 261
Query: 216 --APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
A E T TTKSDV+S+GV+L EL+T G P
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 37/228 (16%)
Query: 47 NVVGHGGFGLVYRGVLSN------GRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PY 98
+G G FG V R VA+K++ + A E+++L +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 99 LLALLGYCSDRRK--LLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLR 147
++ LLG C+ +++ ++ G L +L Y + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 148 IALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVS 205
+ + AKG+EFL C IHRD + NILL + K+ DFGLA I D
Sbjct: 153 YSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKD------P 202
Query: 206 TRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
V + APE T +SDV+S+GV+L E+ + G P
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 61/299 (20%), Positives = 118/299 (39%), Gaps = 65/299 (21%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
F + ++G GGFG V++ +G+ IK + ++ + EV+ L +L ++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVH 68
Query: 102 LLGY--------------CSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWET 144
G S + ++ ++ G L++ + G KLD
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-----KLDKVL 123
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGG 202
L + + KG++++H +I+RD K SNI L K+ DFGL K
Sbjct: 124 ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 261
TR GT Y++PE + + D+Y+ G++L ELL + +K
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------- 226
Query: 262 WALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
++ D + + K ++Q + + + RP ++++++L
Sbjct: 227 ----------FFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEILRTL 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALL 103
+G G FG VY N +A+K++ Q K+G E + + E+E+ LR P +L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 104 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
Y DR+++ L+ ++ G L + L + D + E A L + HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL-------QKHGRFDEQRSATFMEELADALHYCHER 133
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL----GTQGYVAPE 218
VIHRD K N+L+ K++DFG + H + GT Y+ PE
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSV--------HAPSLRRRTMCGTLDYLPPE 182
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
K D++ GV+ E L G P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-32
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+GHG FG VY G +S VA+K L + +Q E +F ME ++ + +
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 100 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+ +G + ++ + MA G L+ L S S L L +A + A G ++
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 159 LHE-HCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQG 213
L E H IHRD + N LL AK+ DFG+A+ I G
Sbjct: 197 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------GYYRKGGCA 246
Query: 214 YV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ PE + G T+K+D +S+GV+L E+ + G +P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 67/321 (20%), Positives = 115/321 (35%), Gaps = 54/321 (16%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 105
V+ GGF VY + +GR+ A+K + ++ EV + +L P ++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 106 CSDRRK--------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
S ++ L+ + G L E L L +T L+I + + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG----PLSCDTVLKIFYQTCRAVQ 150
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-------- 209
+H PP+IHRD K N+LL K+ DFG A S S +
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 210 --GTQGYVAPE-YALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264
T Y PE L + K D+++ G +L L + P + L
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-----DGAKL----- 259
Query: 265 PRLTDREKIL--EIMDPALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321
+I+ + P + QY+ +I+ +Q + R +A+VV L +
Sbjct: 260 -------RIVNGKYSIPPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEI 306
Query: 322 VKYNRSTPKISSSPSFHASRS 342
PK + +
Sbjct: 307 AAARNVNPKSPITELLEQNGG 327
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 52/236 (22%)
Query: 47 NVVGHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS- 96
+G G FG V K VA+K++ D A ++ + E+E++ +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRL 146
++ LLG C+ L ++ +Y + G L+E+L Y + + ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 147 RIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 205
+ A+G+E+L C IHRD + N+L+ +N K++DFGLA
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA------------ 204
Query: 206 TRVLGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
R + Y +APE T +SDV+S+GV++ E+ T G P
Sbjct: 205 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 64/233 (27%), Positives = 86/233 (36%), Gaps = 52/233 (22%)
Query: 50 GHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRS-PYLLA 101
G G FG V K VA+K L A + E+++L L + ++
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 102 LLGYCSDRRKLLV-YDYMANGGLQEHL-----------YPANGSNSVASKLDWETRLRIA 149
LLG C+ LV +Y G L L LD E L +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 150 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
+ AKG+ FL +C IHRD + NILL K+ DFGLA R
Sbjct: 152 YQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA-------------RD 194
Query: 209 LGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ +APE T +SDV+SYG+ L EL + G P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 42/289 (14%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLG 104
+G G +G + S+G+ + K +D ++ + EV LL L+ P ++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 105 YCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
DR +Y +Y G L + LD E LR+ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 162 HCSPP--VIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGYVA 216
V+HRD K +N+ LD + K+ DFGLA+I + A T V GT Y++
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFV-GTPYYMS 184
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276
PE KSD++S G +L EL P L KI E
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----------QKELA--GKIREG 231
Query: 277 MDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
+ +YS + E+I + + +RP + +++++ PL+
Sbjct: 232 KFRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILEN--PLIL 272
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 44/253 (17%), Positives = 79/253 (31%), Gaps = 31/253 (12%)
Query: 47 NVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS---P 97
+++G G F VY N +K +K+ A EF + +L+ RL+
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQH 127
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+ + LV + + G L + + + + A+ +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE--KVMPQGLVISFAMRMLYMI 185
Query: 157 EFLHEHCSPPVIHRDFKSSNILL-----------DKNFHAKVSDFGLAKIGSDKAGGHVS 205
E +H+ +IH D K N +L D + + D G + G +
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 206 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
T T G+ E + D + + +L G + V GE
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT-YMKVKNEGGECKPEG-LFR 300
Query: 266 RLTDREKILEIMD 278
RL + E
Sbjct: 301 RLPHLDMWNEFFH 313
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 105
G G F VYR + G +VAIK++D K G + EV++ +L+ P +L L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
D + LV + NG + +L S + E R + G+ +LH H
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-----ENEAR-HFMHQIITGMLYLHSHG- 132
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
++HRD SN+LL +N + K++DFGLA T + GT Y++PE T
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-LCGTPNYISPE-IATRS 187
Query: 225 L-TTKSDVYSYGVVLLELLTGRVPID 249
+SDV+S G + LL GR P D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 50 GHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYL 99
G G FG V K VA+K++ D A ++ + E+E++ + +
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 149
+ LLG C+ L ++ +Y + G L+E+L Y + + ++ ++ +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 150 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 207
+ A+G+E+L C IHRD + N+L+ +N K++DFGLA I +
Sbjct: 210 YQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI------DYY 259
Query: 208 VLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
T G + APE T +SDV+S+GV++ E+ T G P
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 37/277 (13%), Positives = 74/277 (26%), Gaps = 44/277 (15%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGG----FSKSNVVGHGGFGLVYRGV-LSNG 65
E +S + + + ++ S G + V+G G
Sbjct: 44 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 103
Query: 66 RKVAIKLMDQAGKQGEDE---FKMEVELLGRLRS-------------------------P 97
+ + + + K EV L LR
Sbjct: 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 98 YLLALLGYCSDRRKLLVYDYM--ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
++ + D L + LQ +S L RL++ L+ +
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L LH + ++H + +I+LD+ ++ F A R
Sbjct: 224 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETT 279
Query: 216 APEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVP 247
A +T D ++ G+ + + +P
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+ VG G FG V+R G + A+K + E E+ L SP ++
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVP 114
Query: 102 LLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFL 159
L G + + ++ + + G L + + L E R +A +GLE+L
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG-------CLP-EDRALYYLGQALEGLEYL 166
Query: 160 HEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAK-IGSDKAGGHVSTR--VLGTQGYV 215
H ++H D K+ N+LL + A + DFG A + D G + T + GT+ ++
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 216 APE-YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE K D++S ++L +L G P
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 45/213 (21%), Positives = 75/213 (35%), Gaps = 37/213 (17%)
Query: 48 VVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQGEDE-FKMEVELLGRLRSPYLLALLG 104
+ HGG G +Y + NGR V +K + +G E + L + P ++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ--- 143
Query: 105 YCSDRRKLLVYDYMANGGLQEHLYP------ANGSN---SVASKLDWETRLRIALEAAKG 155
+++++ + G + S KL + LE
Sbjct: 144 ---------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPA 194
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 214
L +LH +++ D K NI+L + K+ D G I S + GT G+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGF 243
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE T +D+Y+ G L L
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 28/283 (9%), Positives = 60/283 (21%), Gaps = 44/283 (15%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKS----NVVGHGGFGLVYRGV-LSNG 65
K + +E T + S + + G +V+ +
Sbjct: 28 EALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERL 87
Query: 66 RKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPYLLALLGYC---------------- 106
A+K+ + E RL
Sbjct: 88 EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP 147
Query: 107 --------SDRRKLLVYDYM--ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
D M A+ L+ + + + +
Sbjct: 148 FAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
L ++H F N+ + + + D G Y
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL-----WKVGTRGPASSVPVTYAP 259
Query: 217 PEYALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257
E+ T + + G+ + + +P + P +G
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 50 GHGGFGLVYRGVL--------SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYL 99
G G FG V + KVA+K++ A ++ + E+E++ + +
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 149
+ LLG C+ L ++ +Y + G L+E+L Y N S++ +L + + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 150 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 207
+ A+G+E+L C IHRD + N+L+ ++ K++DFGLA I
Sbjct: 198 YQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI------DYY 247
Query: 208 VLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
T G + APE T +SDV+S+GV+L E+ T G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 50 GHGGFGLVYRGVLSNGRK------VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
G G FG V + + + VA+K++ + A + E +L ++ P+++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 103 LGYCSDRR-KLLVYDYMANGGLQEHL-----------------YPANGSNSVASKLDWET 144
G CS LL+ +Y G L+ L ++ + L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 145 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 202
+ A + ++G+++L E +HRD + NIL+ + K+SDFGL+ + +
Sbjct: 152 LISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDVYEE---- 203
Query: 203 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ V +QG + A E TT+SDV+S+GV+L E++T G P
Sbjct: 204 --DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 105
G GGF + A K++ K ++ ME+ + L +++ G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAKGLEFLHEH 162
D + +V + L E K + E R + G ++LH +
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELH--------KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
VIHRD K N+ L+++ K+ DFGLA K+ D G + GT Y+APE L
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPE-VL 213
Query: 222 TGHL-TTKSDVYSYGVVLLELLTGRVPID 249
+ + + DV+S G ++ LL G+ P +
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 67/308 (21%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
F +G GGFG+V+ + AIK + ++ ++ EV+ L +L P ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 101 ALLGYCSD----------RRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
+ K+ +Y L++ + + + L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLH 122
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI----------GS 197
I L+ A+ +EFLH ++HRD K SNI + KV DFGL +
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257
T +GT+ Y++PE + K D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------------- 225
Query: 258 VLVSWALPRLTDREKILEIMD------PALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 309
P T E++ + D P L Q ++Q + P RP
Sbjct: 226 -------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ------DMLSPSPMERP 272
Query: 310 LMADVVQS 317
+++++
Sbjct: 273 EAINIIEN 280
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 47 NVVGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRS-PY 98
+G G FG V KVA+K L A ++ E++++ L
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 99 LLALLGYCSDRRKLLV-YDYMANGGLQEHL-------YPANGSNSVASKLDWETRLRIAL 150
++ LLG C+ +LV +Y G L L S L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 151 EAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRV 208
+ A+G+ FL +C IHRD + N+LL AK+ DFGLA I +D S +
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND------SNYI 221
Query: 209 LGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ + APE T +SDV+SYG++L E+ + G P
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 105
G GGF + A K++ K ++ ME+ + L +++ G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLD-WETRLRIALEAAKGLEFLHEHC 163
D + +V + L E L E R + G ++LH +
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEPEAR-YYLRQIVLGCQYLHRNR 135
Query: 164 SPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
VIHRD K N+ L+++ K+ DFGLA K+ D G + GT Y+APE L+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPE-VLS 188
Query: 223 GHL-TTKSDVYSYGVVLLELLTGRVPID 249
+ + DV+S G ++ LL G+ P +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 22/224 (9%)
Query: 40 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSP 97
G + +G GGFG V R + G +VAIK Q + + + +E++++ +L P
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 98 YLLALL-------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 150
+++ + LL +Y G L+++L L +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPIRTLLS 128
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA---KVSDFGLAKIGSDKAGGHVSTR 207
+ + L +LHE+ +IHRD K NI+L K+ D G AK G + T
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTE 182
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251
+GT Y+APE T D +S+G + E +TG P N
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 50 GHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
G G FG V++ VA+K L ++A + +F+ E L+ +P ++ L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 103 LGYCSDRR-KLLVYDYMANGGLQEHL-----------------YPANGSNSVASKLDWET 144
LG C+ + L+++YMA G L E L A S+ L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 145 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 202
+L IA + A G+ +L E +HRD + N L+ +N K++DFGL+ I S
Sbjct: 176 QLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIYSA---- 227
Query: 203 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
+ PE TT+SDV++YGVVL E+ + G P
Sbjct: 228 --DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 50 GHGGFGLVYRGVLSNGRK------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYLLA 101
G G FG V K VA+K++ ++A + E++++ +L S ++
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 102 LLGYCSDRRKLLV-YDYMANGGLQEHL----------------YPANGSNSVASKLDWET 144
LLG C+ + + ++Y G L +L + L +E
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 145 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 202
L A + AKG+EFL C +HRD + N+L+ K+ DFGLA I SD
Sbjct: 174 LLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMSD---- 225
Query: 203 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
S V+ + APE G T KSDV+SYG++L E+ + G P
Sbjct: 226 --SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPY 98
F ++G G F V + R+ AIK++++ E++ E +++ RL P+
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 156
+ L D KL Y NG L +++ D ET R E L
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-------SFD-ETCTRFYTAEIVSAL 143
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
E+LH +IHRD K NILL+++ H +++DFG AK+ S ++ + +GT YV+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 217 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
PE LT KS D+++ G ++ +L+ G P
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 29/250 (11%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNG 65
SG+ + LQ + S G S+ +G G +G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 66 RKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGG 122
+ AIK++ + EV +L L P ++ L + D+R LV + G
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 123 LQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL- 179
L + + + A+ + ++ L + +LH+H ++HRD K N+LL
Sbjct: 123 LFDEII-HRMKFNEVDAAVI-----IKQVLSG---VTYLHKHN---IVHRDLKPENLLLE 170
Query: 180 --DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVV 237
+K+ K+ DFGL+ + + LGT Y+APE L K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 238 LLELLTGRVP 247
L LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-29
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLL 100
+ S+++G G V+RG G AIK+ + + D E E+L +L ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 101 ALLGY---CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L + R K+L+ ++ G L L S A L L + + G+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 158 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
L E+ ++HR+ K NI+ D K++DFG A+ D + GT+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEE 180
Query: 214 YVAPE--------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y+ P+ D++S GV TG +P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLL 100
+ S+++G G V+RG G AIK+ + + D E E+L +L ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 101 ALLGY---CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L + R K+L+ ++ G L L S A L L + + G+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 158 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
L E+ ++HR+ K NI+ D K++DFG A+ D + GT+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY-GTEE 180
Query: 214 YVAPE--------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y+ P+ D++S GV TG +P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 34/242 (14%), Positives = 68/242 (28%), Gaps = 51/242 (21%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLR-------- 95
V+G G + + + + K EV L LR
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 96 -----------------SPYLLALLGYCSDRRKLLVYDYM--ANGGLQEHLYPANGSNSV 136
++ + D L + LQ +S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 137 ASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196
L RL++ L+ + L LH + ++H + +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 197 SDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGR 245
+ ++G+ PE +T D ++ G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 246 VP 247
+P
Sbjct: 311 LP 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L +L +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLH 133
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ VIHRD KS NILL + K++DFG + + + ++GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
K D++S G++ +E++ G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 33/227 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLA 101
++G+G G V GR VA+K M D ME++LL P ++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+ R L + + N LQ+ + N S+ + + + A G+ LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 161 EHCSPPVIHRDFKSSNILLD-------------KNFHAKVSDFGLAKI---GSDKAGGHV 204
+IHRD K NIL+ +N +SDFGL K G ++
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 205 STRVLGTQGYVAPE-------YALTGHLTTKSDVYSYGVVLLELLTG 244
+ GT G+ APE LT D++S G V +L+
Sbjct: 190 NNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLA 101
F +V+GHG G + + + R VA+K + + EV+LL P ++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
DR+ + + A LQE++ + ++ + + + GL LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE------PITLLQQTTSGLAHLH 135
Query: 161 EHCSPPVIHRDFKSSNILL-----DKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 214
++HRD K NIL+ A +SDFGL K + + + V GT+G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 215 VAPEY---ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+APE + T D++S G V +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 43 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F V+G GGFG V+ + + G+ A K +++ ++G +E ++L ++ S +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
+++L Y + LV M G ++ H+Y + N E R + G
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ----EPRAIFYTAQIVSG 301
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
LE LH+ +I+RD K N+LLD + + ++SD GLA GT G++
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFM 356
Query: 216 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
APE L G S D ++ GV L E++ R P
Sbjct: 357 APE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL 102
V+G G FG V G++ A+K++ + K ++ EV+LL +L P ++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFL 159
+ D+ LV + G L + + + S A+++ +R L + ++
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARI-----IRQVLSG---ITYM 142
Query: 160 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
H++ ++HRD K N+LL K+ + ++ DFGL+ +GT Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIA 196
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE L G K DV+S GV+L LL+G P
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G G+V +GR+VA+K+MD +Q + EV ++ + ++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+ +L ++ +++ G L + + +L+ E + + L +LH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLH 158
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAP 217
+ VIHRD KS +ILL + K+SDFG A+I D R ++GT ++AP
Sbjct: 159 ---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAP 210
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E T+ D++S G++++E++ G P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 61/284 (21%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
F+K +G G FG V++G+ + VAIK++D + E ++ + E+ +L + SPY+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 101 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G Y D + ++ +Y+ G + L P LD I E KGL++L
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYL 135
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H IHRD K++N+LL ++ K++DFG+A +D + +GT ++APE
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 190
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP------------IDVNKPSGEGVLVSWALPRL 267
+K+D++S G+ +EL G P I N P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------- 236
Query: 268 TDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 309
P LEG YS +KE + C+ E +RP
Sbjct: 237 -----------PTLEGNYSKPLKEFV------EACLNKEPSFRP 263
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
+ V+G G +V KVAIK ++ Q DE E++ + + P ++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 101 ALLGYCS--DRRKL-LVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKGL 156
+ Y S + +L LV ++ G + + + + + LD T I E +GL
Sbjct: 77 SY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQG 213
E+LH++ IHRD K+ NILL ++ +++DFG+ A + + R +GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 214 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
++APE K+D++S+G+ +EL TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD----QAGKQGEDEFKMEVELLGRLRSPYLLAL-- 102
G G +G V + + A+K++ + GE K E++LL RLR ++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 103 -LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK------- 154
L ++ +V +Y G+QE L +SV K R + +A
Sbjct: 74 VLYNEEKQKMYMVMEY-CVCGMQEML------DSVPEK-----RFPVC-QAHGYFCQLID 120
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GLE+LH ++H+D K N+LL K+S G+A+ A G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 215 VAPEYALTGHLT---TKSDVYSYGVVLLELLTGRVPID 249
PE G T K D++S GV L + TG P +
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIK-------------LMDQAGKQGEDEFKMEVELLG 92
+G G +G V + + AIK ++ ++ +E E+ LL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 93 RLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIA 149
L P ++ L D++ LV ++ G L E + A+ + ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAANI-----MKQI 155
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVST 206
L + +LH+H ++HRD K NILL + + K+ DFGL+ S +
Sbjct: 156 LSG---ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLR 206
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
LGT Y+APE L K DV+S GV++ LL G P
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 43 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
+++L Y + LV M G L+ H+Y + + E R A E G
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP----EARAVFYAAEICCG 298
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
LE LH +++RD K NILLD + H ++SD GLA + G + RV GT GY+
Sbjct: 299 LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYM 352
Query: 216 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
APE + T S D ++ G +L E++ G+ P
Sbjct: 353 APE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 98
FS +GHG FG VY + N VAIK M +GKQ ++++ EV L +LR P
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 99 LLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ G Y + LV +Y G + L L + A +GL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK------PLQEVEIAAVTHGALQGLA 168
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYV 215
+LH H +IHRD K+ NILL + K+ DFG A ++ +GT ++
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWM 217
Query: 216 APEYALT---GHLTTKSDVYSYGVVLLELLTGRVP 247
APE L G K DV+S G+ +EL + P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 42/220 (19%), Positives = 82/220 (37%), Gaps = 25/220 (11%)
Query: 43 FSKSNVVGHG--GFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSP 97
+ V+G G V G V ++ ++ + + E+ + P
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 98 YLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKG 155
++ + +D +V +MA G ++ + ++ E + L K
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI-----CTHFMDGMN-ELAIAYILQGVLKA 140
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG----LAKIGSDKAGGHVSTRVL-G 210
L+++H +HR K+S+IL+ + +S + G + H +
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 211 TQGYVAPE---YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+++PE L G+ KSD+YS G+ EL G VP
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVP 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALL 103
++G G FG V + ++ A+K++++A + +D EVELL +L P ++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 104 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLH 160
D +V + G L + + S A+++ ++ + ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI-----IKQVFSG---ITYMH 138
Query: 161 EHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+H ++HRD K NILL +K+ K+ DFGL+ +GT Y+AP
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAP 192
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E L G K DV+S GV+L LL+G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
F +G G +G VY+ + G+ VAIK + + E E+ ++ + SP+++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
G L +V +Y G + + + N L + I KGLE+LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK------TLTEDEIATILQSTLKGLEYLH 142
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
IHRD K+ NILL+ HAK++DFG+A +D + V+GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 48/212 (22%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+ +G G FG VY+ G A K+++ ++ +++ +E+E+L PY++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 102 LLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
LLG Y D + ++ ++ G + + + L + + + L FLH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEALNFLH 134
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+IHRD K+ N+L+ +++DFG++ S +GT ++APE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVV 189
Query: 221 LTGHLT-----TKSDVYSYGVVLLELLTGRVP 247
+ + K+D++S G+ L+E+ P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 74/341 (21%), Positives = 132/341 (38%), Gaps = 48/341 (14%)
Query: 5 AFEGVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-S 63
E ++ +E+ + +LE +V K F K + +G G G+V++
Sbjct: 3 KLEELELDEQ-QRKRLEAFLTQKQKVGELKDDD-----FEKISELGAGNGGVVFKVSHKP 56
Query: 64 NGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMA 119
+G +A KL+ + E+++L SPY++ G + SD + ++M
Sbjct: 57 SGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114
Query: 120 NGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178
G L + + G E L ++++ KGL +L E ++HRD K SNIL
Sbjct: 115 GGSL-DQVLKKAGRIP-------EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNIL 164
Query: 179 LDKNFHAKVSDFGLAKIGSD-KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVV 237
++ K+ DFG++ D A V GT+ Y++PE H + +SD++S G+
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLS 219
Query: 238 LLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIA 297
L+E+ GR PI ++ + ++ M
Sbjct: 220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD--------- 270
Query: 298 AMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 338
+P L+ +V P + P S F
Sbjct: 271 ---SRPPMAIFELLDYIVNEPPPKL------PSGVFSLEFQ 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 58/246 (23%), Positives = 88/246 (35%), Gaps = 49/246 (19%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRLRSPYLLA 101
+G G +G+V + AIK+M+ Q + + K EV L+ +L P +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---------- 150
L D + + LV + G L + L ++ +D
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 151 ----------------EAAK-------GLEFLHEHCSPPVIHRDFKSSNILL--DKNFHA 185
+ L +LH + HRD K N L +K+F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 186 KVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVAPE--YALTGHLTTKSDVYSYGVVLLEL 241
K+ DFGL+K + + T GT +VAPE K D +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 242 LTGRVP 247
L G VP
Sbjct: 270 LMGAVP 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 53/296 (17%), Positives = 98/296 (33%), Gaps = 65/296 (21%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRL-RSPY 98
F + +G G FG V++ V +G AIK AG E EV L + +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 99 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGL 156
++ ++ +L+ +Y G L + + S E L+ + L+ +GL
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK----EAELKDLLLQVGRGL 128
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKN-------------------FHAKVSDFGLAKIGS 197
++H ++H D K SNI + + K+ D G S
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 198 DKAGGHVSTRVLGTQGYVAPE--YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255
G ++A E HL K+D+++ + ++
Sbjct: 186 S-----PQVEE-GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGDQ-- 236
Query: 256 EGVLVSWALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 309
W +I + P + S E++ + + P+ + RP
Sbjct: 237 ------WH--------EIRQGRLPRIPQVLSQEFTELL------KVMIHPDPERRP 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 43 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS-- 96
FS ++G GGFG VY G+ A+K +D+ KQGE E +L + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 97 -PYLLALLGYC-SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 152
P+++ + Y KL + D M G L HL +G S E +R A E
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS-------EADMRFYAAEI 301
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
GLE +H V++RD K +NILLD++ H ++SD GLA S V GT
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASV-GTH 354
Query: 213 GYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
GY+APE G S D +S G +L +LL G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 53/251 (21%), Positives = 104/251 (41%), Gaps = 32/251 (12%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNG 65
+ + + + ++ + + + + G +G G FG+V+R V + G
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 66 RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGL- 123
R K ++ + K E+ ++ +L P L+ L D+ ++ L+ ++++ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 124 -----QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178
+++ S + +R A E GL+ +HEH ++H D K NI+
Sbjct: 137 DRIAAEDYKM----SEAEVINY-----MRQACE---GLKHMHEH---SIVHLDIKPENIM 181
Query: 179 L--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGV 236
K K+ DFGLA + + T + APE + +D+++ GV
Sbjct: 182 CETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 237 VLLELLTGRVP 247
+ LL+G P
Sbjct: 239 LGYVLLSGLSP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 104
++G G FG V + ++ A+K++++A + +D EVELL +L P ++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 105 YCSDRRKL-LVYDYMANGGL-----QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
D +V + G L + + S A+++ ++ + +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARI-----IKQVFSG---ITY 136
Query: 159 LHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
+H+H ++HRD K NILL +K+ K+ DFGL+ +GT Y+
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYI 190
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
APE L G K DV+S GV+L LL+G P
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
V+G G F V+ G+ A+K + ++ + + E+ +L +++ ++ L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 107 SDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
LV ++ G L + + AS + ++ L A +++L
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVY-----TEKDASLV-----IQQVLSA---VKYL 122
Query: 160 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
HE+ ++HRD K N+L ++N ++DFGL+K+ + + + GT GYVA
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVA 175
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE + D +S GV+ LL G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD---------QAGKQGEDEFKMEVELLGRLRS- 96
++G G +V R + ++ A+K++D + ++ + EV++L ++
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIA 149
P ++ L LV+D M G L + L S K+ +R
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-----SEKETRKI-----MRAL 133
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209
LE + LH+ ++HRD K NILLD + + K++DFG + G V
Sbjct: 134 LEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVC 184
Query: 210 GTQGYVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GT Y+APE + D++S GV++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G +G V V + A K + + + D FK E+E++ L P ++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHC 163
D + LV + G L E + A+++ ++ L A + + H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARI-----MKDVLSA---VAYCHKL- 125
Query: 164 SPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
V HRD K N L + K+ DFGLA G + +GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQ-V 179
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
L G + D +S GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRL-RSPYLLAL 102
+G G +G V + V +G+ +A+K + E E K M+++++ R PY++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 160
G + + M+ + Y S + + E L +I L K L L
Sbjct: 87 YGALFREGDCWICMELMS-TSF-DKFYKYVYS-VLDDVIP-EEILGKITLATVKALNHLK 142
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 218
E+ +IHRD K SNILLD++ + K+ DFG++ D TR G + Y+APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 197
Query: 219 --YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL---VSWALPRLTDREKI 273
A +SDV+S G+ L EL TGR P + L V P+L++ E
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQVVKGDPPQLSNSE-- 254
Query: 274 LEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 309
E ++S + +C+ + RP
Sbjct: 255 --------EREFSPSFINFV------NLCLTKDESKRP 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+G G FG V+ S+G + IK ++ + ++ + E+E+L L P ++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
D + +V + G L E + A S+ ++ + A L + H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ-- 143
Query: 165 PPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
V+H+D K NIL + K+ DFGLA++ ST GT Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPE-VF 198
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVP 247
+T K D++S GVV+ LLTG +P
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLL 100
F +VG+G +G VY+G + G+ AIK+MD G E+E K E+ +L + +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 101 ALLG------YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
G +L LV ++ G + + + G+ L E I E
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREIL 139
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL LH+H VIHRD K N+LL +N K+ DFG++ G + +GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 214 YVAPEYALTGHLT-----TKSDVYSYGVVLLELLTGRVP 247
++APE KSD++S G+ +E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 40/251 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 105
+G G F + + V + + A+K++ K+ E + E+ L P ++ L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFLHEH 162
D+ LV + + G L E + S + AS + +R + A + +H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYI-----MRKLVSA---VSHMHDV 125
Query: 163 CSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
V+HRD K N+L + N K+ DFG A++ T Y APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPE- 179
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
L + +S D++S GV+L +L+G+VP + R +EIM
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTCTSAVEIMK 226
Query: 279 PALEGQYSMKE 289
+G +S +
Sbjct: 227 KIKKGDFSFEG 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCS 107
G G +G V V VA+K++D + K E+ + L ++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 108 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFL 159
+ L +Y + G L + + P + +A + G+ +L
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI-------------GMPEP-DAQRFFHQLMAGVVYL 121
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 220 ALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
L DV+S G+VL +L G +P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 56/247 (22%), Positives = 101/247 (40%), Gaps = 24/247 (9%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNG 65
R + S + + + + + + +G G FG+V+R + G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182
Query: 66 RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQ 124
A K + + ++ + E++ + LR P L+ L D ++ ++Y++M+ G L
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 125 EHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DK 181
E + + S A + +R + GL +HE+ +H D K NI+ K
Sbjct: 243 EKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTK 291
Query: 182 NFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 240
+ K+ DFGL V GT + APE A + +D++S GV+
Sbjct: 292 RSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 241 LLTGRVP 247
LL+G P
Sbjct: 349 LLSGLSP 355
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 48 VVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLAL 102
+G G FG V + + A+K M++ +E E++++ L P+L+ L
Sbjct: 22 AIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 103 LGYCS--DRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEF 158
+ S D + +V D + G L+ HL +L I E L++
Sbjct: 81 --WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFIC-ELVMALDY 130
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
L +IHRD K NILLD++ H ++DF +A + T + GT+ Y+APE
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPE 184
Query: 219 ----YALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
G+ + + D +S GV ELL GR P
Sbjct: 185 MFSSRKGAGY--SFAVDWWSLGVTAYELLRGRRP 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD--------QAGKQGEDEFKMEVELLGRLRS-P 97
V+G G +V R V + G + A+K+M+ + ++ + + E +L ++ P
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIAL 150
+++ L+ + LV+D M G L + L S + +R L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL-----SEKETRSI-----MRSLL 210
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
EA + FLH + ++HRD K NILLD N ++SDFG + G + G
Sbjct: 211 EA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCG 261
Query: 211 TQGYVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
T GY+APE + D+++ GV+L LL G P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 104
+G G F +V R V + G + A K+++ D + E + +L+ P ++ L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 105 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ LV+D + G L +E S + AS ++ LE+ +
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFY-----SEADASHC-----IQQILES---IA 119
Query: 158 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
+ H + ++HR+ K N+LL K K++DFGLA +D GT GY
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGY 173
Query: 215 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
++PE L + D+++ GV+L LL G P
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
SK+ ++G G FG V++ + G K+A K++ G + ++E K E+ ++ +L L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 102 LLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAK 154
L + + LV +Y+ G L + + + ++ E
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL----TELDTILF-----MKQICE--- 198
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILL-DKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
G+ +H+ ++H D K NIL +++ K+ DFGLA+ GT
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTP 252
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
++APE ++ +D++S GV+ LL+G
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDE--FKMEVELLGRLRSPYLLA 101
V+G G F +V R + G++ A+K++D A G K E + L+ P+++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 102 LLGYCSDRRKL-LVYDYMANG---------GLQEHLYPANGSNSVASKLDWETRLRIALE 151
LL S L +V+++M +Y S +VAS +R LE
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY----SEAVASHY-----MRQILE 141
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRV 208
A L + H++ +IHRD K +LL + + K+ FG+A + G V+
Sbjct: 142 A---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGR 193
Query: 209 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+GT ++APE DV+ GV+L LL+G +P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-FKMEVELLGRLRSPYLLALLGYCS 107
G G +G V V VA+K++D E K E+ + L ++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 108 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFL 159
+ L +Y + G L + + P + +A + G+ +L
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI-------------GMPEP-DAQRFFHQLMAGVVYL 121
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 220 ALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
L DV+S G+VL +L G +P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRL-RSPYLLAL 102
+G G G V++ G +A+K M ++G ++E K M+++++ + PY++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 160
G + + + M ++ G E L ++ + K L +L
Sbjct: 90 FGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP-------ERILGKMTVAIVKALYYLK 141
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 218
E VIHRD K SNILLD+ K+ DFG++ D R G Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERI 196
Query: 219 ---YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
++DV+S G+ L+EL TG+ P K
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 39/262 (14%)
Query: 45 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLAL 102
+ +V+G G V + L ++ A+K++++ EVE+L + + +L L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFL 159
+ + + + LV++ M G + H++ + AS + ++ A L+FL
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVV-----VQDVASA---LDFL 127
Query: 160 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKI------GSDKAGGHVSTRVLG 210
H + HRD K NIL ++ K+ DF L S + + T G
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 211 TQGYVAPEYALTGHLTT------KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264
+ Y+APE + + D++S GV+L LL+G P S G A
Sbjct: 184 SAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 265 PRLTDREKILEIMDPALEGQYS 286
P + + + EG+Y
Sbjct: 243 PACQN-----MLFESIQEGKYE 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLGYC 106
G G F V + GR+VAIK++D+ K+ EV ++ L P ++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 107 SDRRKL-LV---------YDY-MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
+ L L+ +DY +A+G ++E E R +
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----------------EAR-SKFRQIVSA 126
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
+++ H+ ++HRD K+ N+LLD + + K++DFG + + GG + G Y
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYA 180
Query: 216 APEYALTGHLTT--KSDVYSYGVVLLELLTGRVPID 249
APE G + DV+S GV+L L++G +P D
Sbjct: 181 APE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG--KQGEDE-FKMEVELLGRLRSPY 98
F V+G G F V + +V A+K+M++ K+GE F+ E ++L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 99 LLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAK 154
+ L + + D L LV +Y G L L ++ R E
Sbjct: 123 ITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS------KFGERIP-AEMARFYLAEIVM 173
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQG 213
++ +H +HRD K NILLD+ H +++DFG +A G V + V GT
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL--RADGTVRSLVAVGTPD 228
Query: 214 YVAPEYALTGHLTTKSDVY-------SYGVVLLELLTGRVP 247
Y++PE + Y + GV E+ G+ P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 49/254 (19%)
Query: 24 TDNGLQVFTFKQL-----HSATGGFSK----SNVVGHGGFGLVYRGV-LSNGRKVAIK-- 71
+ + +VF F L S +G G G V +KVAI+
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 72 ----LMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL-- 123
+ ++ + + E+E+L +L P ++ + + +V + M G L
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228
Query: 124 ----QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179
+ L + L A +++LHE+ +IHRD K N+LL
Sbjct: 229 KVVGNKRL-----KEATCKLY-----FYQMLLA---VQYLHENG---IIHRDLKPENVLL 272
Query: 180 ---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE---YALTGHLTTKSDVYS 233
+++ K++DFG +KI + + + GT Y+APE T D +S
Sbjct: 273 SSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 234 YGVVLLELLTGRVP 247
GV+L L+G P
Sbjct: 330 LGVILFICLSGYPP 343
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSP 97
F + +G G FG V +G A+K++D+ KQ E E +L + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFP 101
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
+L+ L D L +V +Y+A G + HL + E R A +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFS-EPHARFYAAQIVLT 153
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGY 214
E+LH +I+RD K N+L+D+ + +V+DFG AK + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEA 204
Query: 215 VAPEYALT-GHLTTKS-DVYSYGVVLLELLTGRVP 247
+APE L+ G+ K+ D ++ GV++ E+ G P
Sbjct: 205 LAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAG--KQGEDE-FKMEVELLGRLRSP 97
F V+G G FG V + + + A+K++++ K+ E F+ E ++L S
Sbjct: 76 FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 98 YLLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAA 153
++ L + + D L LV DY G L L +L E R E
Sbjct: 135 WITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFED------RLP-EEMARFYLAEMV 185
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
++ +H+ +HRD K NIL+D N H +++DFG + S V GT
Sbjct: 186 IAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241
Query: 214 YVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y++PE + + D +S GV + E+L G P
Sbjct: 242 YISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETP 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 35/214 (16%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM--EVELLGRLRSPYLLALLGY 105
G G FG V G G KVA+K+++ Q + + K+ E++ L R P+++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 157
S +V +Y++ G L +++ +G R+ EA + ++
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYIC-KHG------------RVEEM-EARRLFQQILSAVD 125
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+ H H V+HRD K N+LLD + +AK++DFGL+ + SD G + T G+ Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAP 179
Query: 218 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
E ++G L + D++S GV+L LL G +P D
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 104
+G G F +V R V + G + A K+++ D + E + +L+ P ++ L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 105 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ LV+D + G L +E S + AS ++ LE+ +
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFY-----SEADASHC-----IQQILES---IA 142
Query: 158 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
+ H + ++HR+ K N+LL K K++DFGLA +D GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGY 196
Query: 215 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
++PE L + D+++ GV+L LL G P
Sbjct: 197 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVE-LLGRLRSPYLLA 101
+G G +G+V + + +G+ +A+K + E K M+++ + + P+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFL 159
G + + + M + L + E L +IA+ K LE L
Sbjct: 71 FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGKIAVSIVKALEHL 125
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE- 218
H S VIHRD K SN+L++ K+ DFG++ D G + Y+APE
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPER 180
Query: 219 ---YALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
+ KSD++S G+ ++EL R P D
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRS--PYLL 100
G GGFG VY G+ +S+ VAIK + D MEV LL ++ S ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 101 ALLGYCSDRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
LL + L+ + L + + G L E + + +
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFIT-ERG------ALQEELARSFFWQVLEAVRH 164
Query: 159 LHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
H V+HRD K NIL+D N K+ DFG + D + GT+ Y P
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPP 217
Query: 218 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
E+ + H + V+S G++L +++ G +P +
Sbjct: 218 EW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 35/214 (16%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALLGY 105
G G FG V G G KVA+K++++ + D + E++ L R P+++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 157
S + +V +Y++ G L +++ NG RL E+ + G++
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYIC-KNG------------RLDEK-ESRRLFQQILSGVD 130
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+ H H V+HRD K N+LLD + +AK++DFGL+ + SD G + T G+ Y AP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAP 184
Query: 218 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
E ++G L + D++S GV+L LL G +P D
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRS----PY 98
G GGFG V+ G L++ +VAIK ++ + +EV LL ++ + P
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 99 LLALLGYCSDRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
++ LL + + LV + L +++ G L + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKG------PLGEGPSRCFFGQVVAAI 152
Query: 157 EFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
+ H V+HRD K NIL+D + AK+ DFG + D + GT+ Y
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD-GTRVYS 205
Query: 216 APEYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
PE+ ++ H + V+S G++L +++ G +P +
Sbjct: 206 PPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 40/221 (18%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDE--FKMEVELLGRLRSPY 98
+G G G V +KVAIK + ++ + + E+E+L +L P
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 99 LLALLGYCSDRRKLLVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEA 152
++ + + +V + M G L + L + L A
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL-----KEATCKLY-----FYQMLLA 126
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209
+++LHE+ +IHRD K N+LL +++ K++DFG +KI + + +
Sbjct: 127 ---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC 177
Query: 210 GTQGYVAPE---YALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GT Y+APE T D +S GV+L L+G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 51/264 (19%), Positives = 91/264 (34%), Gaps = 53/264 (20%)
Query: 73 MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPAN 131
+ D +++ + + + L S + L + L++ +
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 132 GSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191
+ L I ++ A+ +EFLH ++HRD K SNI + KV DFG
Sbjct: 157 SLED----REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 192 LAKI----------GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 241
L + T +GT+ Y++PE + + K D++S G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 242 LTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD------PALEGQYS--MKEVIQV 293
L T E++ I D P L Q ++Q
Sbjct: 270 LY---------------------SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ- 307
Query: 294 AAIAAMCVQPEADYRPLMADVVQS 317
+ P RP D++++
Sbjct: 308 -----DMLSPSPTERPEATDIIEN 326
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 104
+G G F +V R V + G++ A +++ D + E + L+ P ++ L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 105 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
S+ L++D + G L +E+ S + AS ++ LEA +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYY-----SEADASHC-----IQQILEA---VL 124
Query: 158 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
H+ V+HR+ K N+LL K K++DFGLA + GT GY
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 179
Query: 215 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
++PE L D+++ GV+L LL G P
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-23
Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 94
F +G G FG V+ L NGR A+K++ + KQ E E +L +
Sbjct: 8 FQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIV 63
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEA 152
P+++ + G D +++ ++ DY+ G L L + N VA + A E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAA-EV 115
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GT 211
LE+LH +I+RD K NILLDKN H K++DFG AK D T L GT
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGT 166
Query: 212 QGYVAPEYALT-GHLTTKS-DVYSYGVVLLELLTGRVP 247
Y+APE T + KS D +S+G+++ E+L G P
Sbjct: 167 PDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-23
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKM------EVELLGRLRSPYLL 100
G G FG V+ V ++V +K + + + E E+ +L R+ ++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 101 ALLGYCSDRRKL-LVYDYMANGG-----LQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
+L ++ LV + +G + H +LD I +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-----------PRLDEPLASYIFRQLVS 141
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
+ +L +IHRD K NI++ ++F K+ DFG A G T GT Y
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195
Query: 215 VAPEYALTGHLTT--KSDVYSYGVVLLELLTGRVPID 249
APE L G+ + +++S GV L L+ P
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 58/275 (21%)
Query: 33 FKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKME 87
+QLH + F+ +G G + + R + + + A+K++D++ + +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---- 65
Query: 88 VELLGRLRS-PYLLALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASK 139
+E+L R P ++ L D + + +V + M G L Q+ S AS
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-----SEREASA 120
Query: 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKI 195
+ L + +E+LH V+HRD K SNIL D++ + ++ DFG AK
Sbjct: 121 V-----LFTITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPS 254
+A + T +VAPE L + D++S GV+L +LTG P
Sbjct: 170 L--RAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF------ 220
Query: 255 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKE 289
P T EI+ G++S+
Sbjct: 221 -------ANGPDDTPE----EILARIGSGKFSLSG 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-23
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG+V+R V S+ + K + G + K E+ +L R +L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHC 163
+L +++++++ + E + + + + E L+FLH H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH- 121
Query: 164 SPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
+ H D + NI+ ++ K+ +FG A+ G + Y APE
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQ 176
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVP 247
++T +D++S G ++ LL+G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMD------QAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G F +V + S G + A K + +E + EV +L ++ ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 157
L +R + L+ + ++ G L + L S S A+ ++ L+ G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF-----IKQILD---GVN 129
Query: 158 FLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+LH + H D K NI+L DKN K+ DFGLA D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
+VAPE L ++D++S GV+ LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 43 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAG--KQGEDE-FKMEVELLGRLRSP 97
+ V+G G FG V R S + A+KL+ + K+ + F E +++ SP
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+++ L D R L +V +YM G L + + A R A E L
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTA-EVVLAL 181
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 215
+ +H IHRD K N+LLDK+ H K++DFG + + G V GT Y+
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYI 236
Query: 216 APEYALTGHLT---TKS-DVYSYGVVLLELLTGRVP 247
+PE + + D +S GV L E+L G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 30/245 (12%)
Query: 11 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVA 69
L + F + T +G G F +V + + S G++ A
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTS-----KELGRGKFAVVRQCISKSTGQEYA 58
Query: 70 IKLMD--QAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDRRKL-LVYDYMANGGLQE 125
K + + G+ E E+ +L +S P ++ L + ++ L+ +Y A G +
Sbjct: 59 AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS 118
Query: 126 HLYPANG---SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--- 179
P S + +L ++ LE G+ +LH++ ++H D K NILL
Sbjct: 119 LCLPELAEMVSENDVIRL-----IKQILE---GVYYLHQNN---IVHLDLKPQNILLSSI 167
Query: 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 239
K+ DFG+++ + + GT Y+APE +TT +D+++ G++
Sbjct: 168 YPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 240 ELLTG 244
LLT
Sbjct: 225 MLLTH 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-23
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 48 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLA 101
V+G G FG V+ + A+K++ +A + KME ++L + P+++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 102 LLGYCS--DRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 156
L + + KL L+ D++ GG L L S E ++ E A L
Sbjct: 91 L--HYAFQTEGKLYLILDFL-RGGDLFTRL-------SKEVMFT-EEDVKFYLAELALAL 139
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+ LH +I+RD K NILLD+ H K++DFGL+K D + GT Y+A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMA 194
Query: 217 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
PE + T+S D +S+GV++ E+LTG +P
Sbjct: 195 PE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G +VYR + A+K++ + + + E+ +L RL P ++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 107 SDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
++ LV + + G L + + S A+ ++ LEA + +L
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYY-----SERDAADA-----VKQILEA---VAYL 164
Query: 160 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
HE+ ++HRD K N+L + K++DFGL+KI + V GT GY A
Sbjct: 165 HENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCA 218
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE + D++S G++ LL G P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM--EVELLGRLRSPYLLALLGY 105
G G FG V +KVA+K + Q K+ + ++ E+ L LR P+++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 157
+ + +V +Y A G L +++ R+ E + +E
Sbjct: 78 ITTPTDIVMVIEY-AGGELFDYIV-EKK------------RMTED-EGRRFFQQIICAIE 122
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+ H H ++HRD K N+LLD N + K++DFGL+ I +D G + T G+ Y AP
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSC-GSPNYAAP 176
Query: 218 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 249
E + G L + DV+S G+VL +L GR+P D
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE------DEFKMEVELLGRLRSPYLL 100
+G G F +V + G++ A K + + +E + EV +L +R P ++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 157
L ++ + L+ + ++ G L + L S + A++ L+ L+ G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQF-----LKQILD---GVH 122
Query: 158 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+LH + H D K NI+L N K+ DFG+A +AG GT
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPE 176
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
+VAPE L ++D++S GV+ LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G F +V + S G + A K +E + EV +L ++ P ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 157
L +R + L+ + ++ G L + L S S A+ ++ L+ G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF-----IKQILD---GVN 129
Query: 158 FLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+LH + H D K NI+L DKN K+ DFGLA D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
+VAPE L ++D++S GV+ LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALL 103
++G G FG V + GR A+K++ + +DE E +L R P+L AL
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 104 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
Y + R V +Y G L HL S E R R E LE+LH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHL-------SRERVFT-EERARFYGAEIVSALEYLH 122
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
V++RD K N++LDK+ H K++DFGL K G G GT Y+APE
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPE-V 176
Query: 221 LTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L + ++ D + GVV+ E++ GR+P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 48/234 (20%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKM---------------- 86
G G +G+V ++ A+K L+ QAG +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 87 ----EVELLGRLRSPYLLAL---LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASK 139
E+ +L +L P ++ L L ++ +V++ + G + E P
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLK------P 133
Query: 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199
L + + KG+E+LH +IHRD K SN+L+ ++ H K++DFG++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKG 189
Query: 200 AGGHVSTRVLGTQGYVAPEYALTGHLT----TKSDVYSYGVVLLELLTGRVPID 249
+ +S V GT ++APE +L+ DV++ GV L + G+ P
Sbjct: 190 SDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALL 103
++G G FG V + GR A+K++ + +DE E +L R P+L AL
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 104 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 160
Y + R V +Y G L HL S E R R E L++LH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHL-------SRERVFS-EDRARFYGAEIVSALDYLH 265
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ V++RD K N++LDK+ H K++DFGL K G G GT Y+APE
Sbjct: 266 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPE-V 320
Query: 221 LTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L + ++ D + GVV+ E++ GR+P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLLA 101
++ V+G+G FG+V++ L +VAIK + Q + FK E++++ ++ P ++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVD 96
Query: 102 LL------GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA- 153
L G D L LV +Y+ E +Y A +L+ +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRA---------SRHYAKLKQTMPMLL 142
Query: 154 ---------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAK--IGSDKAG 201
+ L ++H + HRD K N+LLD K+ DFG AK I +
Sbjct: 143 IKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 202 GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 245
++ +R Y APE + TT D++S G V+ EL+ G+
Sbjct: 200 SYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 48 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQA---GKQGEDEF-KMEVELLGRLRSPYL 99
V+G GG+G V+ + G+ A+K++ +A + K E +L ++ P++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 100 LALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 156
+ L+ Y + + L+ +Y++ G L L E E + L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQL-------EREGIFM-EDTACFYLAEISMAL 134
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
LH+ +I+RD K NI+L+ H K++DFGL K G V+ GT Y+A
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMA 189
Query: 217 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
PE L ++ D +S G ++ ++LTG P
Sbjct: 190 PE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 54/217 (24%), Positives = 82/217 (37%), Gaps = 43/217 (19%)
Query: 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108
G G FG+ VA+K +++ G ++ + E+ LR P ++
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 109 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFLH 160
L ++ +Y + G L E + G R EA G+ + H
Sbjct: 88 PTHLAIIMEYASGGELYERIC-NAG------------RFSED-EARFFFQQLLSGVSYCH 133
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHA--KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
+ HRD K N LLD + K+ DFG +K + V GT Y+APE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTV-GTPAYIAPE 187
Query: 219 ------YALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
Y G +DV+S GV L +L G P +
Sbjct: 188 VLLRQEYD--G---KIADVWSCGVTLYVMLVGAYPFE 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLL 100
+G G F +V + S G + A K ++ + EV +L ++ P ++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 ALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAA 153
L ++ + L+ + +A G L +E L + A++ L+ L
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEEATEF-----LKQILNG- 126
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 209
+ +LH + H D K NI+L K+ DFGLA G+ +
Sbjct: 127 --VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIF 178
Query: 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
GT +VAPE L ++D++S GV+ LL+G P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
++ + V+G+G FG+VY+ L +G VAIK + Q + FK E++++ +L ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 101 ALLG--YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
L Y S +K LV DY+ E +Y ++ + + +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRV-------ARHYSRAKQTLPVIYV 158
Query: 154 K--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAK--IGSDKAGG 202
K L ++H + HRD K N+LLD + K+ DFG AK + +
Sbjct: 159 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 203 HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 248
++ +R Y APE T+ DV+S G VL ELL G+ PI
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVE--------LLGRLRSPY 98
V+G G FG V A+K++ K+ +VE L + P+
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
L L C + R V +Y+ G L H+ + E A E A G
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFK-EPHAVFYAAEIAIG 454
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L FL +I+RD K N++LD H K++DFG+ K G + GT Y+
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYI 509
Query: 216 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
APE + KS D +++GV+L E+L G+ P
Sbjct: 510 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 48 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAGKQGEDEF----KMEVELLGRL-RSPY 98
V+G G +G V+ G+ A+K++ +A + + + E ++L + +SP+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 99 LLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAK 154
L+ L + + KL L+ DY+ G L HL S + E ++I E
Sbjct: 121 LVTL--HYAFQTETKLHLILDYINGGELFTHL-------SQRERFT-EHEVQIYVGEIVL 170
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
LE LH+ +I+RD K NILLD N H ++DFGL+K GT Y
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 215 VAPE---YALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
+AP+ +GH K+ D +S GV++ ELLTG P
Sbjct: 227 MAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 31 FTFKQLHSATGGFSK-----SNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF 84
F+ + V+G G G V G+K A+KL+ + K
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----A 68
Query: 85 KMEVELLGRLRS-PYLLALLGYCSDRRK-----LLVYDYMANGGLQEHLYPANGSNS--- 135
+ EV+ + P+++ +L + L++ + M G L + G +
Sbjct: 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTE 127
Query: 136 -VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFG 191
A+++ +R A ++FLH H + HRD K N+L +K+ K++DFG
Sbjct: 128 REAAEI-----MRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
AK + + T T YVAPE D++S GV++ LL G P
Sbjct: 177 FAKETTQ---NALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 63/277 (22%), Positives = 96/277 (34%), Gaps = 85/277 (30%)
Query: 47 NVVGHGGFGLVYRGVL------SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PY 98
+G G FG V + R VA+K++ + A E+++L +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 99 LLALLGYCSDRRKLL-------------------------------------VYDYMANG 121
++ LLG C+ L Y
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 122 GLQEHLYPANGSNSVASKLDWETR------------------------LRIALEAAKGLE 157
L+ L S S AS E + + + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLGT 211
FL S IHRD + NILL + K+ DFGLA+ I D K + +
Sbjct: 208 FL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 260
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247
++APE T +SDV+S+GV+L E+ + G P
Sbjct: 261 --WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVE--------LLGRLRSPY 98
++G G FG V+ + AIK + K+ +VE L P+
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 99 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 155
L + + V +Y+ G L H+ + K D +R A E G
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH-------KFD-LSRATFYAAEIILG 130
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
L+FLH +++RD K NILLDK+ H K++DFG+ K G + GT Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYI 185
Query: 216 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
APE L G S D +S+GV+L E+L G+ P
Sbjct: 186 APE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 102
V+G G + V L R A+K++ + +++ ++ E P+L+ L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 103 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 159
C ++ R V +Y+ G L H+ KL E R + E + L +L
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLP-EEHARFYSAEISLALNYL 126
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
HE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+APE
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPE- 180
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L G S D ++ GV++ E++ GR P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-20
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 102
V+G G FG V + G A+K++ + +D+ + E L P+L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 103 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 159
C + R V +++ G L H+ + + D E R R A E L FL
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFD-EARARFYAAEIISALMFL 140
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H+ +I+RD K N+LLD H K++DFG+ K G G + GT Y+APE
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPE- 194
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L L + D ++ GV+L E+L G P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 102
V+G G FG V A+K++ + +D+ + VE L + P+L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 103 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 159
C + R V +Y+ G L H+ + E A E A GL FL
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFK-EPHAVFYAAEIAIGLFFL 137
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
+I+RD K N++LD H K++DFG+ K G + GT Y+APE
Sbjct: 138 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPE- 191
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
+ KS D +++GV+L E+L G+ P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 102
V+G G FG V + A+K++ + + E K + E LL ++ P+L+ L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 103 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 159
+ + + V DY+ G L HL E R R A E A L +L
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHL-------QRERCFL-EPRARFYAAEIASALGYL 155
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H +++RD K NILLD H ++DFGL K + ++ GT Y+APE
Sbjct: 156 HSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGTPEYLAPE- 209
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L ++ D + G VL E+L G P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 94
+ +VG G +G+V + GR VAIK L +D+ K E++LL +L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLKQL 81
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
R L+ LL C +++ LV++++ + + + L + LD++ + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL------ELFPNGLDYQVVQKYLFQII 134
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 210
G+ F H H +IHRD K NIL+ ++ K+ DFG A+ + V+TR
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--- 188
Query: 211 TQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
Y APE + DV++ G ++ E+ G
Sbjct: 189 --WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 48 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 102
V+G G + V L R A++++ + +++ ++ E P+L+ L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 103 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 159
C ++ R V +Y+ G L H+ KL E R + E + L +L
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLP-EEHARFYSAEISLALNYL 169
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
HE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+APE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPE- 223
Query: 220 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 247
L G S D ++ GV++ E++ GR P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 8e-19
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 94
+ K +G G +G V++ VA+K +D +DE E+ LL L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLKEL 58
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ ++ L +KL LV+++ + L+++ +S LD E +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF------DSCNGDLDPEIVKSFLFQLL 111
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
KGL F H V+HRD K N+L+++N K+++FGLA+ S V+ T
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV-TLW 166
Query: 214 YVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 248
Y P+ +T D++S G + EL P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-19
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 94
+ K +G G FG V++ G+KVA+K LM+ E E F + E+++L L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-----EKEGFPITALREIKILQLL 73
Query: 95 RSPYLLALLGYCSDRRKL---------LVYDYMAN--GGLQEHLYPANGSNSVASKLDWE 143
+ ++ L+ C + LV+D+ + GL ++ K
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---------LVKFTLS 124
Query: 144 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKA 200
R+ GL ++H + ++HRD K++N+L+ ++ K++DFGLA+ + +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 201 GGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 248
+ RV+ T Y PE L D++ G ++ E+ T PI
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-19
Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 45/229 (19%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
F + G G FG V G G VAIK + D + E ++ L L P +
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIMQDLAVLHHPNI 81
Query: 100 LALLG--YCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALE 151
+ L Y R +V +Y+ + L+ + + ++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRC-------CRNYYRRQVAPPPI 129
Query: 152 AAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKI-GSDKAG 201
K + LH S V HRD K N+L+++ K+ DFG AK +
Sbjct: 130 LIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 202 GH-VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 248
+ +R Y APE H TT D++S G + E++ G PI
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 95
F + +G+G + VY+G+ + G VA+K +D E+ E+ L+ L+
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAIREISLMKELK 61
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
++ L KL LV+++M N + + L+ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSR----TVGNTPRGLELNLVKYFQWQL 117
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
+GL F HE+ ++HRD K N+L++K K+ DFGLA+ S+ V+ T
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVV-TL 172
Query: 213 GYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
Y AP+ L G +T D++S G +L E++TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 94
+ K +G G +G+V++ G+ VAIK L + +D K E+ +L +L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLKQL 59
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ P L+ LL +R+L LV++Y + + L + + I +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL------DRYQRGVPEHLVKSITWQTL 112
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 210
+ + F H+H IHRD K NIL+ K+ K+ DFG A++ + + V+TR
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR--- 166
Query: 211 TQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
Y +PE L G DV++ G V ELL+G
Sbjct: 167 --WYRSPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 36/207 (17%), Positives = 58/207 (28%), Gaps = 50/207 (24%)
Query: 48 VVGHGGFGLVYRG---VLSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPYLLA 101
G ++ L R+VA+ +D G +D E L R+ P +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 102 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+L R L+V +++ G LQE + +R A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA---------DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
V S + + + G V VL +
Sbjct: 147 RA---GVALSIDHPSRVRVSID-------------------GDV---VLAYPATMPDA-- 179
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP 247
+ D+ G L LL R P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-18
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRLR 95
+ K VG G +G+VY+ S GR VA+K +D EDE E+ LL L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-----EDEGIPSTAIREISLLKELH 77
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
P +++L+ R L LV+++M L++ L + + L + +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL------DENKTGLQDSQIKIYLYQLLR 130
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
G+ H+H ++HRD K N+L++ + K++DFGLA+ + V+ T Y
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWY 185
Query: 215 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
AP+ L G +T D++S G + E++TG+
Sbjct: 186 RAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 95
+ K + +G G F VY+ + + VAIK + + +D E++LL L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-SEAKDGINRTALREIKLLQELS 70
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
P ++ LL + + LV+D+M L+ + + L L +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII------KDNSLVLTPSHIKAYMLMTLQ 123
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GLE+LH+H ++HRD K +N+LLD+N K++DFGLAK + +V+ T+ Y
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV-TRWY 178
Query: 215 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
APE L G D+++ G +L ELL
Sbjct: 179 RAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-18
Identities = 50/213 (23%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRLR 95
+ +G G +G+VY+ + G A+K +++ EDE E+ +L L+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK-----EDEGIPSTTIREISILKELK 58
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
++ L +++L LV++++ + L++ L + L+ T L+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL------DVCEGGLESVTAKSFLLQLLN 111
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
G+ + H+ V+HRD K N+L+++ K++DFGLA+ + ++ T Y
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWY 166
Query: 215 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
AP+ L G +T D++S G + E++ G
Sbjct: 167 RAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 47/228 (20%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 95
+ +G G +G VY+ +G VA+K + G + EV LL RL
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRLE 69
Query: 96 S---PYLLALL-----GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
+ P ++ L+ K+ LV++++ + + + LD
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQ--------DLRTYLDKAPPP 115
Query: 147 RIALEAAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GS 197
+ E K GL+FLH +C ++HRD K NIL+ K++DFGLA+I
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
A ++ V+ T Y APE L T D++S G + E+ +
Sbjct: 173 QMA---LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 52/244 (21%), Positives = 92/244 (37%), Gaps = 54/244 (22%)
Query: 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 100
+S +G G FG+V +G++ A+K + Q + +K E++++ L ++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63
Query: 101 ALLGY----CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALE----- 151
L+ Y + K N ++ N SV L + +E
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 152 --------------------------AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185
+ + F+H S + HRD K N+L++ +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 186 -KVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLEL 241
K+ DFG AK S+ + ++ +R Y APE L T D++S G V EL
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 242 LTGR 245
+ G+
Sbjct: 236 ILGK 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 43 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 95
+ K + +G G + VY+G VA+K ++ E+ EV LL L+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-----EEGAPCTAIREVSLLKDLK 58
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
++ L + L LV++Y+ + L+++L + + ++ + +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL------DDCGNIINMHNVKLFLFQLLR 111
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GL + H V+HRD K N+L+++ K++DFGLA+ S + V+ T Y
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWY 166
Query: 215 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 245
P+ L G +T+ D++ G + E+ TGR
Sbjct: 167 RPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 105
V+G G G V + K A+K++ + + EVEL R P+++ ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 106 CSDRRK-----LLVYDYMANGGLQEHLYPANGSNS----VASKLDWETRLRIALEAAKGL 156
+ L+V + + G L + G + AS++ ++ EA +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEI-----MKSIGEA---I 174
Query: 157 EFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
++LH + HRD K N+L N K++DFG AK + ++T T
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPY 228
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
YVAPE D++S GV++ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL 103
VG G +G V + +G KVAIK + + + + E+ LL ++ ++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 104 GYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+ L LV +M + + K E + + KGL
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM----------QTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+++H S V+HRD K N+ ++++ K+ DFGLA+ + G+V TR Y A
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRA 191
Query: 217 PEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
PE L+ ++ D++S G ++ E+LTG+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLGRLRS 96
+G G G+V R VAIK + + F+ E+ L+ +
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNH 120
Query: 97 PYLLALL-------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 149
+++LL + LV + M AN + +LD E +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM----------DANLCQVIQMELDHERMSYLL 170
Query: 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG--GHVSTR 207
+ G++ LH S +IHRD K SNI++ + K+ DFGLA+ +V TR
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
Y APE L D++S G ++ E++ ++
Sbjct: 228 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 44/209 (21%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS----PYLLALL 103
+G G + V+ + ++N KV +K++ K+ + K E+++L LR L ++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 104 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 163
R LV++++ N + LY + + E K L++ H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYM---------YEILKALDYCHSMG 150
Query: 164 SPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYA 220
++HRD K N+++D ++ ++ D+GLA+ V++R + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 221 LTGHLTTKS-DVYSYGVVLLELLTGRVPI 248
+ + S D++S G +L ++ + P
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 55/237 (23%), Positives = 84/237 (35%), Gaps = 41/237 (17%)
Query: 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE--FKM---- 86
+LH+ ++ + G +G V GV S G VAIK + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 87 -----EVELLGRLRSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNS 135
E+ LL P +L L + + LV + M + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM----------RTDLAQV 123
Query: 136 VASKLDWETRLRIAL---EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192
+ + + I GL LH V+HRD NILL N + DF L
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 193 AKIGSDKAG--GHVSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
A+ + A +V+ R Y APE + TK D++S G V+ E+ +
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYL 99
+ +G G G+V R VAIK + + + + E+ L+ + +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 100 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
+ LL + ++ L +V + M AN + +LD E + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELM----------DANLCQVIQMELDHERMSYLLYQM 136
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA--GGHVSTRVLG 210
G++ LH S +IHRD K SNI++ + K+ DFGLA+ +V TR
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 191
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
Y APE L D++S G ++ E++ G V
Sbjct: 192 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
KGL ++H + +IHRD K N+ ++++ K+ DFGLA+ + G+V TR
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 214 YVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
Y APE L T++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 49 VGHGGFGLVYRGV---LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLA 101
VG G +G VY+ + + A+K + M E+ LL L+ P +++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK------QIEGTGISMSACREIALLRELKHPNVIS 82
Query: 102 LLGYCSDR--RKL-LVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALE 151
L RK+ L++DY EH + A+ +N +L + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA----KVSDFGLAKIGSD--KAGGHVS 205
G+ +LH + V+HRD K +NIL+ K++D G A++ + K +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 206 TRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 248
V+ T Y APE L H T D+++ G + ELLT PI
Sbjct: 194 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 43 FSKSNVVGHGGFGLVYRG--VLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGR 93
+ +G G +G V++ + + GR VA+K + +E + EV +L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----GEEGMPLSTIREVAVLRH 67
Query: 94 LRS---PYLLALLGYCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWET 144
L + P ++ L C+ R LV++++ + + + LD
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--------DLTTYLDKVP 113
Query: 145 RLRIALEAAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI- 195
+ E K GL+FLH H V+HRD K NIL+ + K++DFGLA+I
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 245
A +++ V+ T Y APE L T D++S G + E+ +
Sbjct: 171 SFQMA---LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 9/94 (9%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
+GL+++H S +IHRD K SN+ ++++ K+ DFGLA+ +D+ G+V+TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 214 YVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
Y APE L ++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 94
+ + +G G +G VY+ + VAIK ++ E+E EV LL L
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-----EEEGVPGTAIREVSLLKEL 90
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALE 151
+ ++ L +L L+++Y N + + + S +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV-IKS---------FLYQ 140
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-----KVSDFGLAKIGSDKAGGHVST 206
G+ F H +HRD K N+LL + + K+ DFGLA+ +
Sbjct: 141 LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-TH 196
Query: 207 RVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 245
++ T Y PE L + H +T D++S + E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 15/100 (15%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG------GHVSTR 207
+GL+++H S V+HRD K SN+LL+ K+ DFGLA++ +V+TR
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 208 VLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
Y APE L TKS D++S G +L E+L+ R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 37/218 (16%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+G G FG+++ G L N ++VAIK Q DE++ L G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG---CTGIPNVYYF 74
Query: 106 CSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ +LV D + G E L + K +T A + ++ +HE
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 165 PPVIHRDFKSSNILLDKNFHAK-----VSDFGLAKIGSDKAGG-HVSTR----VLGTQGY 214
+++RD K N L+ + V DFG+ K D H+ R + GT
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT--- 181
Query: 215 VAPEYA-LTGHLTT----KSDVYSYGVVLLELLTGRVP 247
Y + HL + D+ + G V + L G +P
Sbjct: 182 --ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ- 212
+ ++ LH VIHRD K SN+L++ N KV DFGLA+I + A + +
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 213 -GYV------APEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
+V APE LT +++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 37/218 (16%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+G G FG + G L VAIKL M Q E++ +L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 106 CSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+ +V + + G E L+ + +T L IA++ +E++H
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLF-----DLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 165 PPVIHRDFKSSNILLDKNFHAKVS-----DFGLAKIGSDKAGG-HVSTR----VLGTQGY 214
+I+RD K N L+ + + DF LAK D H+ R + GT
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT--- 180
Query: 215 VAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 247
Y + HL + + D+ + G + + L G +P
Sbjct: 181 --ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYC 106
+G G FG +Y G ++ G +VAIKL K + +E ++ ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 107 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
++ ++V + + G E L+ N + K +T L +A + +E++H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLF-----NFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 166 PVIHRDFKSSNILLDKNFHAK---VSDFGLAKIGSDKAGG-HVSTR----VLGTQGYVAP 217
IHRD K N L+ + DFGLAK D H+ R + GT Y A
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 218 EYALTGH-LTTKSDVYSYGVVLLELLTGRVP 247
G + + D+ S G VL+ G +P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 52/246 (21%), Positives = 90/246 (36%), Gaps = 73/246 (29%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL- 103
++G G +G VY + + VAIK +++ + D ++ E+ +L RL+S Y++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 104 -----GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET------RLRIALEA 152
+V + ++ + I L
Sbjct: 93 LIIPDDLLKFDELYIVLEIA------------------------DSDLKKLFKTPIFLTE 128
Query: 153 A----------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202
G F+H +IHRD K +N LL+++ KV DFGLA+ + +
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 203 HVSTRVLGTQ--------------GYV------APEYALTGHLTTKS-DVYSYGVVLLEL 241
++ + + +V APE L TKS D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 242 LTGRVP 247
L
Sbjct: 246 LNMLQS 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 16/101 (15%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAG------GHVST 206
+GL+++H S V+HRD K +N+ ++ ++ K+ DFGLA+I + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 207 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
+ Y +P L+ + TK+ D+++ G + E+LTG+
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYC 106
+G G FG +Y G + +VAIKL + K + E ++ L+ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 107 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+ +LV D + G E L+ N + KL +T L +A + +EF+H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLF-----NFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 166 PVIHRDFKSSNILLDKNFHAK---VSDFGLAKIGSDKAGG-HVSTR----VLGTQGYVAP 217
+HRD K N L+ A + DFGLAK D + H+ R + GT Y A
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 218 EYALTGH-LTTKSDVYSYGVVLLELLTGRVP 247
G + + D+ S G VL+ L G +P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 45/226 (19%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G F V+ + N VA+K++ + K + + E++LL R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVND---ADNTKED 81
Query: 107 SDRRKLLV--YDY-MANGGLQEHL-----------------YPANGSNSVASKLDWETRL 146
S ++ D+ G H+ Y G + K
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK------- 134
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD------KNFHAKVSDFGLAKIGSDKA 200
+I+ + GL+++H C +IH D K N+L++ K++D G A +
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 201 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
+ TR Y +PE L +D++S ++ EL+TG
Sbjct: 193 TNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 48/271 (17%), Positives = 86/271 (31%), Gaps = 92/271 (33%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLG 92
+ +++G G +G V R VAIK + F+ E+ +L
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILN 107
Query: 93 RLRSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
RL +++ +L +V + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------------------DSDF 143
Query: 147 ------RIALEAA----------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190
+ L G++++H S ++HRD K +N L++++ KV DF
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 191 GLAKIGSDKAGGHVSTRVLGTQ-------------------GYV------APEYALTGHL 225
GLA+ G+ + + G+V APE L
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 226 TTKS-DVYSYGVVLLELLTGRVPIDVNKPSG 255
T++ DV+S G + ELL
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 23/113 (20%)
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ- 212
K +++LH S ++HRD K SNILL+ H KV+DFGL++ + + + +
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 213 ------------GYV------APEYALTGHLTTKS-DVYSYGVVLLELLTGRV 246
YV APE L TK D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 49/233 (21%)
Query: 49 VGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKM-----EVELLGRLRSP 97
+G GGFG +Y + + +K+ E K + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 98 YLLALLG-----------YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 146
L LG + ++ D G + +Y AN + +T L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK-----RFSRKTVL 155
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGG-H 203
+++L LE++HEH +H D K+SN+LL+ +V D+GLA +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 204 VSTR----VLGTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 247
+ GT E+ + H + + D+ G +++ LTG +P
Sbjct: 213 YAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 61/217 (28%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 105
V+G G G V + K A+K++ + + EVEL R P+++ ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 106 CSDRRK-----LLVYDYMANGGL-------QEHLYPANGSNSVASKLDWETRLRIALEAA 153
+ L+V + + G L + + + AS++ ++ EA
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF----TEREASEI-----MKSIGEA- 129
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
+++LH + HRD K N+L N K++DFG AK G
Sbjct: 130 --IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------TTG 172
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+ Y D++S GV++ LL G P
Sbjct: 173 -EKY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 50/232 (21%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVA---IKLMDQAGKQGEDEFKMEVELLG-----RLRSPYL 99
+G GGFGL+Y + K A +K+ Q E K + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 100 LALLG-----------YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
L LG + + +V + + G + + NG T L++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGGHV-- 204
+ LE++HE+ +H D K++N+LL +V +D+GL+ G H
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP-NGNHKQY 212
Query: 205 ---STRVL-GTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 247
+ GT E+ L H + +SDV G +L L G++P
Sbjct: 213 QENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 49 VGHGGFGLVYRGV---------LSNGRKVAIKLMDQAGKQ-GEDEF------KMEVELLG 92
G++Y +K ++KL + G+ E F ++V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 93 RLRSPYLLAL-----LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
+L S LLA+ G D+ + LV + G + + + ++ + + L+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER----SVLQ 163
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGGHVS 205
+A LEFLHE+ +H + + NI +D ++V + +G A +G HV+
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHVA 219
Query: 206 TR------VLGTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 247
G E+ + H + +SD+ S G +L+ L G +P
Sbjct: 220 YVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 1e-11
Identities = 40/258 (15%), Positives = 69/258 (26%), Gaps = 56/258 (21%)
Query: 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM---DQAGKQGE---- 81
F T + +G G FG V++ + + VAIK++ G
Sbjct: 9 GPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 82 -DEFKMEVELLGRL---------RSPYLLALLGYCSDRRK-----LLVYDYMANGGLQEH 126
+E E+ + L R+ + L + L +D+ + +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 127 LYPANGSNS------------------VASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168
P + T I + L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG-------HVSTRVLGTQGYV-----A 216
HRD N+LL K K+ K + + G + +R+ V
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 217 PEYALTGHLTTKSDVYSY 234
E TG + D+Y
Sbjct: 245 DEDLFTGDGDYQFDIYRL 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 43/220 (19%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSP- 97
+++G G FG V + VAIK++ +QA ++EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEVRLLELMNKHD 111
Query: 98 -----YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYP---ANGSNSVASKLDWETRLRI 148
Y++ L + R L LV++ L +LY V+ L TR +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGVSLNL---TR-KF 162
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVST 206
A + L FL +IH D K NILL K K+ DFG + + ++ +
Sbjct: 163 AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
R Y +PE L D++S G +L+E+ TG
Sbjct: 222 RF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 55/224 (24%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLR---- 95
V+G G FG V + + VA+K++ QA E+ +L LR
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEIRILEHLRKQDK 155
Query: 96 --SPYLLALLGYCSDRRKL-LV--------YDYMANGGLQEHLYPANGSNSVASKLDWET 144
+ ++ +L + R + + Y+ + Q G + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ-------GFSLPLVR----- 203
Query: 145 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA--KVSDFGLAKIGSDKAGG 202
+ A + L+ LH++ +IH D K NILL + + KV DFG + +
Sbjct: 204 --KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
++ +R Y APE L D++S G +L ELLTG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 49/277 (17%), Positives = 85/277 (30%), Gaps = 89/277 (32%)
Query: 49 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--------PYL 99
+G G F V+ + + VA+K++ A E E+ LL +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 100 LALLGY-----------CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 148
+ LL C +V++ + HL ++ L +I
Sbjct: 104 VQLLDDFKISGVNGTHIC------MVFEVL-----GHHLLKWIIKSNYQ-GLPLPCVKKI 151
Query: 149 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----------------------------- 179
+ +GL++LH C +IH D K NILL
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 180 --------------------DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
+ K++D G A + TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256
+ T +D++S + EL TG + +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 49/240 (20%), Positives = 81/240 (33%), Gaps = 69/240 (28%)
Query: 48 VVGHGGFGLVYRGV--LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSPY 98
+G G FG V + +VA+K++ + A ++E+ +L +++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLEINVLKKIKE-- 75
Query: 99 LLALLGYCSDRRKLLV--YDY--------MANGGLQEHLY---PANGSNSVASKLDWETR 145
+ + L V D+ +A L ++ + N R
Sbjct: 76 ------KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH---VR 126
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-------------------K 186
+A + L FLHE+ + H D K NIL + +
Sbjct: 127 -HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246
V+DFG A + V+TR Y PE L DV+S G +L E G
Sbjct: 183 VADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 54/244 (22%), Positives = 86/244 (35%), Gaps = 77/244 (31%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRS--- 96
+G G FG V + N + A+K++ A K+E ++L ++++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEADILKKIQNDDI 93
Query: 97 --PYLLALLGY-------C--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 145
++ G C + +Y+ + N N + +
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR----------NNYNGFHIED---IK 140
Query: 146 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-------------------- 185
+E K L +L + + H D K NILLD +
Sbjct: 141 -LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 186 -----KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 240
K+ DFG A SD G ++TR Y APE L SD++S+G VL E
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 241 LLTG 244
L TG
Sbjct: 252 LYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 54/240 (22%), Positives = 85/240 (35%), Gaps = 73/240 (30%)
Query: 48 VVGHGGFGLVYRGV--LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSP- 97
+G G FG V + + GR VA+K++ + A + E+++L L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSEIQVLEHLNTTD 72
Query: 98 ----YLLALLGYCSDRRK-------LL---VYDYMANGGLQEHLYPANGSNSVASKLDWE 143
+ + + LL YD++ NG
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE----------NGFLPFRLDH--- 119
Query: 144 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA------------------ 185
R ++A + K + FLH + + H D K NIL ++ +
Sbjct: 120 IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 186 -KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 244
KV DFG A + VSTR Y APE L + DV+S G +L+E G
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 1e-04
Identities = 51/349 (14%), Positives = 107/349 (30%), Gaps = 109/349 (31%)
Query: 4 FAFEGVDREEKGESGKLEVTTD------NGLQVFT---------FKQLHSATGGFSKS-N 47
F + E++ S + + N QVF + +L A + N
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 48 VVGHG--GFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
V+ G G G + + A+ + Q + +FK+ + L L
Sbjct: 153 VLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKI-----------FWLN-LKN 191
Query: 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG-LEFLHEHCS 164
C+ +L + + L N S+ D + +++ + + + L L
Sbjct: 192 CNSPETVLE--------MLQKLLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRRL----- 237
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSD-FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
+ + +++ ++L +AK + F L S ++L
Sbjct: 238 --LKSKPYENCLLVLLNVQNAKAWNAFNL------------SCKIL-------------- 269
Query: 224 HLTTK-SDVYSYGVVLLELLTGRVPID-----VNKPSGEGVLVSWA------LPRLTDRE 271
LTT+ V L T + +D + + +L+ + LPR
Sbjct: 270 -LTTRFKQVTD---FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 272 KILEI-M-------DPALEGQYSMKEVIQVAAIAAMCV--QPEADYRPL 310
+ + A + ++ I + A+YR +
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.35 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.69 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=392.09 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=214.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
.++|.+.+.||+|+||.||+|.+. ++..||||++...+....+.|.+|++++++++||||+++++++.+++ .+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367999999999999999999853 46789999997655555677999999999999999999999998764 56
Q ss_pred EEEEEccCCChhhhccccCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 113 LVYDYMANGGLQEHLYPANG------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
+||||+++|+|.+++..... .......+++..++.++.||+.||+|||++ +++||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 99999999999999965421 112345799999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 265 (351)
|+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------------ 236 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------ 236 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------------
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999999976544332223334568899999999999999999999999999999999 9999975432
Q ss_pred cccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 266 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...+..+.. ......+...+.++.+||.+||+.||++|||+.+|++.|+++.+.+
T Consensus 237 ----~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 237 ----NEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ----HHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111112211 1112333445567999999999999999999999999999988754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-55 Score=387.05 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=205.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 115 (351)
...+++++.+.||+|+||.||+|.+.+ .+|||+++.... ...+.|.+|+.++++++||||+++++++.++..++||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm 110 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT 110 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence 345788999999999999999998643 589999864322 2346788999999999999999999999888888999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+++|+|.+++.... .++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 111 Ey~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp ECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999995432 4699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
..............||+.|+|||++.+ +.|+.++|||||||++|||+||..||...... ..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----------------~~ 245 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR----------------DQ 245 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------------HH
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH----------------HH
Confidence 554443334455789999999999864 45899999999999999999999999754321 11
Q ss_pred HHhhcC----ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 273 ILEIMD----PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 273 ~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+...+. .......+...+..+.+||.+||+.||++|||+.+|+++|+.+..
T Consensus 246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111111 101112233455679999999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=391.90 Aligned_cols=265 Identities=28% Similarity=0.402 Sum_probs=208.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
.++|.+.+.||+|+||.||+|.+. ++..||||++...+....+.|.+|+++|++++||||+++++++.+.. .+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356888899999999999999853 47789999997665555678999999999999999999999998764 56
Q ss_pred EEEEEccCCChhhhccccCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 113 LVYDYMANGGLQEHLYPANGS--------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~--------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+||||+++|+|.+++...... .....++++..++.++.||+.||+|||++ +++||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999999764321 12335799999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 263 (351)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---------- 266 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---------- 266 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----------
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----------
Confidence 99999999986544433334455678999999999999999999999999999999999 9999975332
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+..+. .......+...+..+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 267 ------~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 ------TEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------HHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111111 1112233344556799999999999999999999999999998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=385.14 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=212.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-e
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 111 (351)
.+++++.+.||+|+||.||+|.+. +++.||||++.... ....+.|.+|+.++++++||||+++++++.+.. .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 356788999999999999999852 46789999996443 334578999999999999999999999998764 5
Q ss_pred EEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 112 LLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
++||||+.+|+|.+++....... .....+++..++.++.||+.||+|||++ +++||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 69999999999999996543211 1234689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceee
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 261 (351)
+.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.+...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------- 253 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 253 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------
Confidence 9999999999986544333333455678999999999999999999999999999999998 8999975432
Q ss_pred cccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 262 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
..+...+......+.+..++..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus 254 ---------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 ---------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ---------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1122222222222344556678999999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=384.64 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=210.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
+.|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+++ .++||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 69999999997666666778899999999999999999999998765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
++|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||++.....
T Consensus 154 ~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 154 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 99999998843 3589999999999999999999999 999999999999999999999999999987544
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ..+..+.+
T Consensus 223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~~i~~ 284 (346)
T 4fih_A 223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKMIRD 284 (346)
T ss_dssp SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHH
T ss_pred CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHHHc
Confidence 32 2234578999999999999999999999999999999999999999754321 11111111
Q ss_pred cc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 279 PA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 279 ~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.. .........+.++.+||.+||..||++|||+.|+++| .+++..
T Consensus 285 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~~ 330 (346)
T 4fih_A 285 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKA 330 (346)
T ss_dssp SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGC
T ss_pred CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcCC
Confidence 10 0111122334578999999999999999999999998 555543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=382.40 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=208.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++... .....+.+.+|+++++.++||||+++++++++++. ++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999954 7899999998632 34456788999999999999999999999988765 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 112 Ey~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999543 4799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+. ......
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~ 245 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------GLIFAK 245 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHH
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 6554444445567899999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
+..... .++...+.++.+||.+||..||++|||+.|++.
T Consensus 246 i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 246 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 222111 222333457899999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=389.05 Aligned_cols=250 Identities=21% Similarity=0.388 Sum_probs=199.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.. .++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 689999999864322 23467889999999999999999999998775 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++...
T Consensus 104 y~~gg~L~~~i~~~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp CCTTCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CCCCCcHHHHHHHcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 999999999995432 23578999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+. ...+..+
T Consensus 176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i 237 (350)
T 4b9d_A 176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----------------KNLVLKI 237 (350)
T ss_dssp CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHH
T ss_pred cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHH
Confidence 321 1122345799999999999999999999999999999999999999975432 1112222
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ...+...+.++.+||.+||..||++|||+.|++++
T Consensus 238 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 238 ISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22111 11222344579999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=377.68 Aligned_cols=256 Identities=22% Similarity=0.234 Sum_probs=205.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.+.|++.+.||+|+||.||+|++. +|+.||+|++..... ..+|+.+++.++||||+++++++.++.. ++||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999964 689999999964322 1359999999999999999999987754 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAKIG 196 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~~~~~ 196 (351)
+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.+| .+||+|||++...
T Consensus 132 ~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp CTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 9999999999543 3699999999999999999999999 999999999999999887 6999999999876
Q ss_pred CCCCCCc---eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 197 SDKAGGH---VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....... ..+
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------------~~i 268 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------------LKI 268 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------------HHH
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------------HHH
Confidence 4432111 123357999999999999999999999999999999999999999765432111 001
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.. .+......+...+..+.+||.+||..||++|||+.|++++|..++...
T Consensus 269 ~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 269 AS--EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp HH--SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred Hc--CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 11 000001223334457899999999999999999999999999888753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=387.79 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=210.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
+.|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+.+ .++||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 69999999997666666778899999999999999999999988765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
++|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||++.....
T Consensus 231 ~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 231 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999998843 3589999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ..-..+.....
T Consensus 300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------------~~~~~i~~~~~ 364 (423)
T 4fie_A 300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------KAMKMIRDNLP 364 (423)
T ss_dssp SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHHHHSCC
T ss_pred CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------HHHHHHHcCCC
Confidence 32 2234567999999999999999999999999999999999999999754321 00011111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+ ......+.++.+||.+||..||++|||+.|+++| .+++..
T Consensus 365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~~ 407 (423)
T 4fie_A 365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKA 407 (423)
T ss_dssp CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGC
T ss_pred CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcCC
Confidence 111 1112234578999999999999999999999998 555543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=367.16 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=191.2
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|.+ .+|+.||+|++... .......+.+|+++++.++||||+++++++.+++. ++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 47999999998643 23345678899999999999999999999988755 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+ +|+|.+++... .++++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 93 Ey~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred eCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCee
Confidence 998 67899988543 4799999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+. .....
T Consensus 162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----------------~~~~~ 222 (275)
T 3hyh_A 162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----------------PVLFK 222 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHH
T ss_pred cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----------------HHHHH
Confidence 43322 2345679999999999998876 5799999999999999999999975331 11111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
.+..... .++...+.++.+||.+||+.||++|||+.|+++| .+++
T Consensus 223 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k 267 (275)
T 3hyh_A 223 NISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFK 267 (275)
T ss_dssp HHHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHH
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--cccc
Confidence 1111111 1222334568999999999999999999999997 4554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=384.34 Aligned_cols=275 Identities=23% Similarity=0.336 Sum_probs=219.7
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEcC------CcEEEEEEccccCC-CChHHHHHHHHHHhccCC-CcceeeeE
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRS-PYLLALLG 104 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~ 104 (351)
.+.+....++|++.+.||+|+||.||+|.+.. ++.||+|.+..... ...+.+.+|+++|.++.| |||+++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455667899999999999999999998532 35799999864332 234568899999999965 89999999
Q ss_pred EEEcC--CeEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC
Q 018744 105 YCSDR--RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173 (351)
Q Consensus 105 ~~~~~--~~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~ 173 (351)
+|... ..++||||+++|+|.+++...... ......+++..+..++.||+.||.|||++ +++|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 98653 357999999999999999654321 11234689999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCC
Q 018744 174 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNK 252 (351)
Q Consensus 174 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~ 252 (351)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655444444555678999999999999999999999999999999998 999997543
Q ss_pred CCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 253 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.. ..+...+........+...+.++.+||.+||+.||++|||+.+|+++|.++++.+.
T Consensus 293 ~~----------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 293 ID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp CS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 21 11222222222223333445679999999999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=369.30 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=194.7
Q ss_pred CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----CeEEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RKLLV 114 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~v 114 (351)
|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ..++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999964 68899999986432 22346688999999999999999999988642 24699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCC-CCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDK-NFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~-~~~v~l~dfg 191 (351)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||
T Consensus 108 mEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCc
Confidence 9999999999999543 4789999999999999999999998 7 999999999999974 7899999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||...... .
T Consensus 178 la~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~ 236 (290)
T 3fpq_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----------------A 236 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------H
T ss_pred CCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----------------H
Confidence 99753322 2345679999999998865 5999999999999999999999999643321 1
Q ss_pred HHHh-hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILE-IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+.. +.........+...+.++.+||.+||..||++|||+.|+++|
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 111111111111122368899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=371.76 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=195.6
Q ss_pred cCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.++. .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999852 47889999986321 122345778999999999999999999998775 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++
T Consensus 104 vmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999543 4799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+. ....
T Consensus 174 ~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~ 235 (304)
T 3ubd_A 174 KESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----------------KETM 235 (304)
T ss_dssp EC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHH
T ss_pred eeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----------------HHHH
Confidence 7543322 223456799999999999999999999999999999999999999975432 1112
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
..+....+ .++...+.++.+||.+||+.||++|||+ +|+++|
T Consensus 236 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 236 TMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 22222211 2233345578999999999999999984 677776
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=360.03 Aligned_cols=272 Identities=24% Similarity=0.323 Sum_probs=202.0
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHH--HHHHHHhccCCCcceeeeEEEEcCC-----eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK--MEVELLGRLRSPYLLALLGYCSDRR-----KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 113 (351)
++|.+.+.||+|+||.||+|.+ +|+.||||++.... ...+. .|+..+..++||||+++++++.+.+ .++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 5688899999999999999998 68899999986432 23333 3555566789999999999987542 469
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-----CSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||++ +..+++||||||+|||++.++.+||+
T Consensus 79 V~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 9999999999999953 2588999999999999999999975 23489999999999999999999999
Q ss_pred ecccccccCCCCCCc--eecccCCCcccccccccccC------CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 189 DFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 189 dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||.......... .
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~ 229 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-Y 229 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-T
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-h
Confidence 999998654433211 12345799999999998754 36789999999999999999998886543321100 0
Q ss_pred ecccccccchhHHHhhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...............+....+....+ .+....+.+|+.+||+.||++|||+.+|++.|+++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00000111111122223333332222 245568899999999999999999999999999988753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=361.06 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=190.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCC--------
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-------- 110 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 110 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999964 6899999998654332 3356889999999999999999999886433
Q ss_pred -----eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 111 -----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 111 -----~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
.++||||+.+|+|.+++..... ....++..++.++.||+.||+|||++ +++||||||+|||++.++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT----IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS----GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC----CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 3699999999999999965431 23456778999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCc----------eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 186 KVSDFGLAKIGSDKAGGH----------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
||+|||++.......... .....+||+.|+|||++.+..|+.++|||||||++|+|++ ||....
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--- 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--- 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---
Confidence 999999998754432111 1223579999999999999999999999999999999996 774211
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSM---KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
.....+..+.. ..++. .....+.+||.+||+.||++|||+.|++++ .+++
T Consensus 232 ------------~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~ 284 (299)
T 4g31_A 232 ------------ERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFE 284 (299)
T ss_dssp ------------HHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGC
T ss_pred ------------HHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhC
Confidence 00111112111 12222 233457889999999999999999999986 4454
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=357.87 Aligned_cols=273 Identities=22% Similarity=0.302 Sum_probs=201.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEc-------CC
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSD-------RR 110 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 110 (351)
++|++.+.||+|+||.||+|++. +|+.||||++...... ....+.+|+++|+.++||||+++++++.. ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 7999999999643222 23567789999999999999999998754 24
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||||+. |+|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-------~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-------SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEeCCC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 579999996 578888843 34799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC--CCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 191 GLAKIGSDKA--GGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 191 g~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|++....... ........+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998653322 12233456899999999998875 56999999999999999999999997654321100000000000
Q ss_pred c-------chhHHHhhcCccc-cCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 268 T-------DREKILEIMDPAL-EGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 268 ~-------~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
. ........+.... ....+. ....++.+||.+||..||++|||+.|+++| .+++..+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~~ 352 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLAKYH 352 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGTTTC
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhCcCC
Confidence 0 0000000000000 001111 123468899999999999999999999998 5665433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=351.94 Aligned_cols=199 Identities=25% Similarity=0.363 Sum_probs=167.4
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK 111 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 111 (351)
....++|++.+.||+|+||.||+|++. +++.||+|.+... .....+.+|+++|+.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999853 4678999988543 3456678899999998 69999999999987755
Q ss_pred -EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEee
Q 018744 112 -LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSD 189 (351)
Q Consensus 112 -~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~d 189 (351)
++||||+++|+|.+++ ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~----------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL----------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEEEECCCCCCHHHHH----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEeCCCcccHHHHH----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 5999999999999998 2588999999999999999999999 99999999999999876 8999999
Q ss_pred cccccccCCCCCC--------------------------ceecccCCCcccccccccccC-CCCCccceeehHHHHHHHH
Q 018744 190 FGLAKIGSDKAGG--------------------------HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELL 242 (351)
Q Consensus 190 fg~~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~ll 242 (351)
||+++........ ......+||+.|+|||++.+. .|+.++||||+||++|+|+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 9999754332110 112235699999999999875 5899999999999999999
Q ss_pred hCCCCCCC
Q 018744 243 TGRVPIDV 250 (351)
Q Consensus 243 tg~~pf~~ 250 (351)
+|..||..
T Consensus 242 ~G~~Pf~~ 249 (361)
T 4f9c_A 242 SGRYPFYK 249 (361)
T ss_dssp HTCSSSSC
T ss_pred HCCCCCCC
Confidence 99999954
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=345.70 Aligned_cols=290 Identities=40% Similarity=0.709 Sum_probs=233.8
Q ss_pred eeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 29 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
..++..++....++|++.+.||+|+||.||+|.+.+++.+++|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34455566667799999999999999999999987899999999876666666788999999999999999999999876
Q ss_pred C-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 ~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
. ..++|++|+.+++|.+++.... .....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSD---LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSC---CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEE
T ss_pred CCeEEEEEEcCCCCcHHHHHhccC---CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEE
Confidence 5 4569999999999999985443 1224689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++................|+..|+|||++.+..++.++|||||||++|+|++|..||....+........|... .
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~ 259 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-S 259 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH-H
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh-c
Confidence 999999865443333333445688999999999999999999999999999999999999986554322221111110 0
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.....+...+++.+...........+.+++.+||+.||++|||+.+++++|+.+++-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 0111122344455555667888899999999999999999999999999999998743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=368.10 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=208.6
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~~ 118 (351)
++|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+... ++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999964 799999999876555556778899999999999999999999988755 5999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC--CcEEEeeccccccc
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN--FHAKVSDFGLAKIG 196 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~--~~v~l~dfg~~~~~ 196 (351)
.+|+|.+++... ...+++..+..++.||+.||.|||++ +++||||||+|||++.+ +.+||+|||++...
T Consensus 237 ~gg~L~~~i~~~------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 237 SGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCBHHHHHTCT------TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred CCCcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999988532 24689999999999999999999999 99999999999999754 89999999999875
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+... ...+..+
T Consensus 308 ~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----------------~~~~~~i 368 (573)
T 3uto_A 308 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DETLRNV 368 (573)
T ss_dssp CTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHHH
T ss_pred cCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHH
Confidence 443 233456799999999999999999999999999999999999999975432 1122222
Q ss_pred cCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 277 MDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 277 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..... ........+..+.+||.+||..||++|||+.|+++| .+++.
T Consensus 369 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H--pw~~~ 416 (573)
T 3uto_A 369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLTP 416 (573)
T ss_dssp HTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTSC
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cCcCC
Confidence 22111 111112234568899999999999999999999987 44443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=337.59 Aligned_cols=293 Identities=42% Similarity=0.720 Sum_probs=234.5
Q ss_pred CCceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeE
Q 018744 26 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 26 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
.....++..++..+.++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 45678899999999999999999999999999999987899999999864432 22346889999999999999999999
Q ss_pred EEEcC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 105 YCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 105 ~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
++... ..++|++|+.+++|.+++..... ....+++..++.++.|++.||.|||+++..+++|+||||+||+++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 99766 45699999999999999965442 234699999999999999999999998666899999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC--Ccceee
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG--EGVLVS 261 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~--~~~~~~ 261 (351)
.++|+|||++....... ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 172 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999998654332 223344568999999999998889999999999999999999999996321110 011111
Q ss_pred cccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 262 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+.. ............+..+...+.......+.+++.+||+.||++|||+.+++++|++...
T Consensus 251 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 251 WVK-GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp HHT-TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHH-HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 110 1111222334455556667778888999999999999999999999999999986433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=361.46 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=198.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHH---HHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKM---EVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
.++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.. ++.+++.++||||+++++++.+.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999965 6999999998532 1223333333 4667777899999999999988755
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||||+.||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 268 ylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence 5999999999999999543 4699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+...... .
T Consensus 338 lA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------------~ 400 (689)
T 3v5w_A 338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------H 400 (689)
T ss_dssp TCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-------------H
T ss_pred eeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------------H
Confidence 998654322 244689999999999974 5799999999999999999999999975432100 0
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
.....+.... ..++...+.++.+||.+||..||++|++ +.||++|
T Consensus 401 ~i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 401 EIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1111111111 1223334457899999999999999998 6888887
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.88 Aligned_cols=269 Identities=30% Similarity=0.467 Sum_probs=203.9
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR- 110 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 110 (351)
..+....++|++.+.||+|+||.||+|.+ .++.+|+|++...... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444568899999999999999999987 6788999998654322 2356788999999999999999999997764
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCCCCcEEEe
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~~~~v~l~ 188 (351)
.++||+|+.+++|.+++.... ....+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.++|+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT----HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred eEEEEecCCCCcHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 569999999999999995432 112489999999999999999999999 9 9999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------------- 244 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------------- 244 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---------------
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------
Confidence 999987533321 122345689999999999999999999999999999999999999975432
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
................+...+..+.+||.+||+.||++|||+.++++.|+.+++...++
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 245 -AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 11111111111122233334457899999999999999999999999999999865443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.57 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=208.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ .++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 47899999999999999999995 578999999997766667788899999999999999999999887665 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 99 ~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp CTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999843 2588999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....+. .....+.
T Consensus 168 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~~~ 229 (297)
T 3fxz_A 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIA 229 (297)
T ss_dssp STT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHH
T ss_pred Ccc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Confidence 332 2234467899999999999999999999999999999999999999754321 1111110
Q ss_pred -CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 278 -DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 278 -~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
........+...+..+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--~~~~~ 275 (297)
T 3fxz_A 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH--QFLKI 275 (297)
T ss_dssp HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhcc
Confidence 0011111222334568999999999999999999999987 45553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=335.31 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=206.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcE----EEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRK----VAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~----~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
++|++.+.||+|+||.||+|.+. +++. +++|.+.... ......+.+|+.+++.++||||+++++++.+...++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 67999999999999999999954 4443 7788775332 3334566779999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 93 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 99999999999985432 3688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~ 226 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----------------EV 226 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----------------HH
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----------------HH
Confidence 7655444444455667789999999999999999999999999999999 99999754421 11
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+........+...+..+.+++.+||..||++|||+.+++++|+++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111122222334588899999999999999999999999998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.59 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=208.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999964 34469999986432 22345688899999999999999999999776 4569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 128 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 999999999999985432 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 194 KIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~ 261 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------------R 261 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------H
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------H
Confidence 8754432221 2223445678999999998999999999999999999999 9999964331 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+...+........+...+..+.+||..||..||++|||+.++++.|+.+++....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 12222222222233334456799999999999999999999999999999985443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=332.54 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=206.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
++|++.+.||+|+||.||+|.+. +++ ++++|.+... .......+.+|+.+++.++||||+++++++.....+++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 67999999999999999999954 444 3588877533 33455778999999999999999999999999888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++++.+|+|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 99999999999996533 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...............++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEI 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGH
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----------------HHH
Confidence 7655443333344556778999999999999999999999999999999 9999975432 112
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+........+......+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 222222222233334455799999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=331.23 Aligned_cols=275 Identities=23% Similarity=0.304 Sum_probs=210.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-----eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-----KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ........|+.+++.++||||+++++++.... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 478999999999999999999874 7899999986432 22334556888899999999999999987643 4799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCCceecCCCCCcEEeCCCCcEEE
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-------CSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
|+|+.+|+|.+++.. ..+++..++.++.|++.||.|||+. ++.+++|+||||+||+++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999943 2589999999999999999999975 1337999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccC-----CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
+|||++................|++.|+|||++.+. .++.++|||||||++|+|++|..||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999776554433334446789999999998863 456788999999999999999999987554322211111
Q ss_pred ccccccchhHHHh-hcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 263 ALPRLTDREKILE-IMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 263 ~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.. .......... ........... ......+.+||.+||+.||++|||+.++++.|+++.+..
T Consensus 253 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IG-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HC-SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hc-cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 1111111211 22222222111 244567999999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=325.49 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=210.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
++|++.+.||+|+||.||+|.+. +++.+++|.+...+....+.+.+|+++++.++||||+++++++.+.. .++||+|+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 67999999999999999999964 68999999886655555677889999999999999999999987765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 90 KGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp TTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999996532 4689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCc------------eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 199 KAGGH------------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 199 ~~~~~------------~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------ 234 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence 32211 011456899999999999999999999999999999999999998754432111100
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
........... ...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 235 -----~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 -----NVRGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -----CHHHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----hhhccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01111111111 1122358899999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=319.94 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=210.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.++|++.+.||+|+||.||+|.+.+++.+++|++... ....+.+.+|+++++.++||||+++++++.+.. .++||+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4679999999999999999999888889999999643 345677899999999999999999999998764 56999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999985432 4689999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----------------~~~~~~~~ 221 (269)
T 4hcu_A 159 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDIS 221 (269)
T ss_dssp HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHH
T ss_pred cc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----------------HHHHHHHh
Confidence 21 111223445678999999998999999999999999999999 9999975332 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
. ......+...+..+.+++.+||+.||++|||+.+++++|+++.+.+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 222 T-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp T-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred c-CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 1 1111222223456899999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=334.59 Aligned_cols=267 Identities=21% Similarity=0.368 Sum_probs=211.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 109 (351)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367999999999999999999852 345799999864422 2335688899999999 899999999999766
Q ss_pred -CeEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
..++||||+.+|+|.+++...... ......+++..++.++.||+.||.|||++ +++|+||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 456999999999999999654321 01224689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcc
Q 018744 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 258 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~ 258 (351)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999986554332222334556788999999999999999999999999999999 99999753321
Q ss_pred eeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 259 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.+...+........+...+..+.+||.+||+.||++|||+.++++.|++++....
T Consensus 313 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 -------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111111111222333445579999999999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=327.38 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=201.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+... ++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999965 789999999864332 223567889999999999999999999988755 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 86 YCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp CCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999843 34689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.............|++.|+|||++.+..+ +.++|||||||++|+|++|..||....... .....
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~~~~ 220 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYSD 220 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---------------HHHHH
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---------------HHHHH
Confidence 43332233345678999999999987765 778999999999999999999997544320 01111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.................+.+||.+||..||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111111111112234468899999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=318.03 Aligned_cols=285 Identities=35% Similarity=0.590 Sum_probs=226.1
Q ss_pred CceeeeHHHHHHHhcCCCcC------ceeeecCceEEEEEEEcCCcEEEEEEccccC----CCChHHHHHHHHHHhccCC
Q 018744 27 GLQVFTFKQLHSATGGFSKS------NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRS 96 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h 96 (351)
....+++.++..+.++|... +.||+|+||.||+|.. +++.+++|++.... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 56889999999999998877 8999999999999987 67889999886432 2234678899999999999
Q ss_pred CcceeeeEEEEcC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCC
Q 018744 97 PYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 175 (351)
Q Consensus 97 ~~i~~~~~~~~~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~ 175 (351)
|||+++++++.+. ..+++++|+.+++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||+|+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~ 162 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA 162 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence 9999999999766 4569999999999999985432 224689999999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 176 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 176 Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
||+++.++.++|+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999987554433333445678999999998765 57899999999999999999999997644321
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
........ .......+...++..+ ..........+.+++.+||+.||++|||+.+++++|+++..
T Consensus 242 ~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLDIKEE--IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTHHHHH--HHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHH--hhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11000000 0000111223333333 34566777889999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=328.13 Aligned_cols=270 Identities=21% Similarity=0.317 Sum_probs=198.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcC-Cc---EEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSN-GR---KVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~---~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
+....++|++.+.||+|+||.||+|.+.. +. .+|+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33445789999999999999999999543 32 7999998654 233346788999999999999999999998765
Q ss_pred Ce-------EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC
Q 018744 110 RK-------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 110 ~~-------~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~ 182 (351)
.. +++++|+.+++|.+++...... .....+++..++.++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 32 7999999999999998654321 1223689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceee
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~ 261 (351)
+.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------- 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------- 246 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------
Confidence 9999999999976544332233334556778999999999999999999999999999999 99999754321
Q ss_pred cccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 262 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.....+... .....+...+..+.+|+.+||+.||++|||+.++++.|++++....
T Consensus 247 ---------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 247 ---------EIYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---------GHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---------HHHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 111111111 1112223344579999999999999999999999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.83 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=209.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
..++|++.+.||+|+||.||+|.+.++..+|+|++... ......+.+|+.+++.++||||+++++++.+.. .++||++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34789999999999999999999888888999999654 345677889999999999999999999998764 5699999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp CTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred cCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999999985432 3589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||..... .......
T Consensus 156 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~ 218 (268)
T 3sxs_A 156 DDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----------------SEVVLKV 218 (268)
T ss_dssp TTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHHHHHH
T ss_pred hhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----------------HHHHHHH
Confidence 332 112233445678999999998899999999999999999999 9999964332 1111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.. ......+...+..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 219 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 219 SQ-GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HT-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred Hc-CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11 1111112223346899999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=323.71 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=210.8
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
..+....++|++.+.||+|+||.||++.+.++..+++|++... ....+.+.+|+++++.++||||+++++++.+.. .+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 3444556889999999999999999999888889999999654 345677889999999999999999999998764 56
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+|+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 96 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence 9999999999999995432 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 167 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----------------~~ 229 (283)
T 3gen_A 167 SRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SE 229 (283)
T ss_dssp GGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HH
T ss_pred cccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----------------hH
Confidence 87643321 111223445678999999998899999999999999999998 9999974332 11
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
....+. .......+...+..+.+++.+||+.||++|||+.+++++|.++++..
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 230 TAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111111 11112222233457899999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.31 Aligned_cols=253 Identities=20% Similarity=0.355 Sum_probs=205.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+++++.++||||+++++++.... .++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 347899999999999999999996 579999999986432 223456788999999999999999999998765 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 93 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp ECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 9999999999998543 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCC-CccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ......|++.|+|||++.+..+. .++|||||||++|+|++|..||.+... ....
T Consensus 163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~ 223 (328)
T 3fe3_A 163 EFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----------------KELR 223 (328)
T ss_dssp GGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHH
T ss_pred ecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----------------HHHH
Confidence 654322 23456789999999999887765 789999999999999999999975432 1111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+..... ..+...+..+.+|+.+||..||.+|||+.+++++ .+++.
T Consensus 224 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h--~~~~~ 270 (328)
T 3fe3_A 224 ERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD--RWINA 270 (328)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC--TTTTT
T ss_pred HHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC--HhhcC
Confidence 11111111 1222234568899999999999999999999987 44443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=336.73 Aligned_cols=266 Identities=25% Similarity=0.366 Sum_probs=211.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 111 (351)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 477999999999999999999942 46689999986432 22334678899999999999999999999776 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC---cEEEe
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVS 188 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~v~l~ 188 (351)
++||+|+.+++|.+++............+++..++.++.||+.||+|||++ +++||||||+||+++.++ .++|+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 799999999999999977654444445799999999999999999999999 999999999999998555 49999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------------- 292 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------------- 292 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------
Confidence 9999975433222222334557889999999999999999999999999999998 9999975332
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+...+........+...+..+.+|+.+||+.||++|||+.+++++|+.+.+..
T Consensus 293 ---~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 293 ---QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ---HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1122221111112223334456899999999999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.38 Aligned_cols=279 Identities=23% Similarity=0.332 Sum_probs=218.9
Q ss_pred ceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcc
Q 018744 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYL 99 (351)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i 99 (351)
...+....+....++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|++++..+ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34455566667779999999999999999999983 2457899999864322 2235688999999999 78999
Q ss_pred eeeeEEEEcCC--eEEEEEEccCCChhhhccccCCCC-------------------------------------------
Q 018744 100 LALLGYCSDRR--KLLVYDYMANGGLQEHLYPANGSN------------------------------------------- 134 (351)
Q Consensus 100 ~~~~~~~~~~~--~~~v~~~~~~~~L~~~~~~~~~~~------------------------------------------- 134 (351)
+++++++.+.. .++||+|+.+|+|.+++.......
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999987653 569999999999999986543210
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 135 ----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 135 ----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.....+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 0022389999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
...........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... ..+...+
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~ 309 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRL 309 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHH
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----------------HHHHHHH
Confidence 443344455667889999999999999999999999999999998 99999754431 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
........+...+..+.+++.+||+.||++|||+.+++++|+++++.+
T Consensus 310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111111222233456899999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.37 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=209.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 112 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 112 (351)
+....++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445578999999999999999999975 689999999864322 1224577899999999999999999999876 456
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 189 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9999999999999985432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------------~ 322 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------------Q 322 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------H
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------H
Confidence 875433211111111234567999999998899999999999999999998 9999974331 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.....+........+...+..+.+||.+||+.||++|||+.++++.|+++.+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 122222222222233334557899999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.69 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=204.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcE----EEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRK----VAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~----~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. +++. +++|.+... .......+.+|+.+++.++||||+++++++.....++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 378999999999999999999954 4443 577776533 3445678899999999999999999999999988889
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
+++++.+++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 94 v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred EEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999986533 3689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
................++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~ 227 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 227 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------H
Confidence 87654433333344556778999999999999999999999999999999 99999754321 1
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+...+........+...+..+.++|.+||..||.+|||+.++++.|.++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1222222222223333455799999999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.82 Aligned_cols=272 Identities=22% Similarity=0.358 Sum_probs=216.7
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCS 107 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 107 (351)
...++|++.+.||+|+||.||+|.+. .+..+|+|++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999852 235799999864422 2235688899999999 8999999999998
Q ss_pred cC-CeEEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 108 DR-RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 108 ~~-~~~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
.. ..++||+|+.+++|.+++....... .....+++..++.++.||+.||.|||+. +++|+||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 76 4569999999999999996654211 1234699999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGE 256 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 256 (351)
+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999986655433333444567788999999999999999999999999999999 9999964331
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 329 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~ 329 (351)
..+...+........+...+..+.+|+.+||+.||++|||+.+++++|++++.......
T Consensus 300 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 --------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp --------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred --------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 11222222222222233344579999999999999999999999999999998665443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.66 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=213.1
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
....++|++.+.||+|+||.||+|.+ .++..+++|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 33457899999999999999999985 2357899999864322 2336688899999999999999999998766
Q ss_pred -CeEEEEEEccCCChhhhccccCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecC
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSN-----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRD 171 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d 171 (351)
..++|++|+.+++|.+++....... .....+++..++.++.||+.||.|||++ +++|+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 4569999999999999996543210 0123488999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCC
Q 018744 172 FKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDV 250 (351)
Q Consensus 172 i~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~ 250 (351)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986554433223334556778999999999899999999999999999999 9999975
Q ss_pred CCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.... .+...+........+...+..+.+++.+||+.||++|||+.+++++|++++...
T Consensus 256 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 256 IPPE-----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp CCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCHH-----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 4321 111111111122223334457999999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=330.90 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=198.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999854 56789999986432 223456889999999999999999999998764 569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||+.+++|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 124 v~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 999999999999995432 3689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 194 KIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------------~ 257 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------------Q 257 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------H
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------H
Confidence 7654332111 1112234668999999999999999999999999999998 9999964321 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+...+........+...+..+.+++.+||+.||++|||+.++++.|+++++..
T Consensus 258 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 122222222222333344567999999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=322.61 Aligned_cols=269 Identities=25% Similarity=0.382 Sum_probs=213.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 109 (351)
..++|++.+.||+|+||.||+|.+ .+++.+++|++..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 347899999999999999999984 2467899999864432 2346688999999999 899999999999766
Q ss_pred CeEEEEEEccCCChhhhccccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGS-----------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~-----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
..++|++|+.+++|.+++...... ......+++..++.++.||+.||.|||++ +++|+||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 456999999999999998654321 01123589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 254 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---
Confidence 99999999999999987655443333444556778999999999999999999999999999999 99999754321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
......+........+...+..+.+++.+||..||.+|||+.+++++|++++....
T Consensus 255 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 11111111111112222334578999999999999999999999999999988643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=326.91 Aligned_cols=271 Identities=23% Similarity=0.365 Sum_probs=211.0
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
....++|++.+.||+|+||.||+|.+ .++..||+|++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33457899999999999999999995 24567999998643 233457788999999999 89999999999877
Q ss_pred C-CeEEEEEEccCCChhhhccccCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecC
Q 018744 109 R-RKLLVYDYMANGGLQEHLYPANGSN----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRD 171 (351)
Q Consensus 109 ~-~~~~v~~~~~~~~L~~~~~~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d 171 (351)
. ..++||+|+.+++|.+++....... .....+++..++.++.||+.||.|||++ +++|+|
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 6 4569999999999999996543210 0113489999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCC
Q 018744 172 FKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDV 250 (351)
Q Consensus 172 i~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~ 250 (351)
|||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986554443334445567788999999999999999999999999999998 9999975
Q ss_pred CCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.... ......+........+...+..+.+|+.+||..||.+|||+.+++++|+.++....
T Consensus 278 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 4321 11122222222222233345579999999999999999999999999999887644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=317.83 Aligned_cols=258 Identities=28% Similarity=0.523 Sum_probs=196.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+.. .+++|++...... ..+.+.+|+.+++.++||||++++++......++|++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e 99 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 99 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEE
Confidence 35789999999999999999998533 5999998644322 2356889999999999999999999888888889999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 100 WCEGSSLYHHLHAS------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ecCCCcHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999998533 24689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
.............|+..|+|||++. +..++.++||||||+++|+|++|..||...... ..+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~ 234 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----------------DQI 234 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----------------HHH
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----------------HHH
Confidence 4433333344567899999999986 567888999999999999999999999753321 111
Q ss_pred HhhcC----ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 274 LEIMD----PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 274 ~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
..... ...........+..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11110 000111222344579999999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.94 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=204.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+... ++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999965 6899999998643 34456778889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++.
T Consensus 84 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 9999999999988533 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .....
T Consensus 154 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~ 215 (337)
T 1o6l_A 154 EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ERLFE 215 (337)
T ss_dssp CSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHH
T ss_pred hcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----------------HHHHH
Confidence 532221 223446689999999999999999999999999999999999999964331 11111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.+..... .++...+..+.+||.+||+.||++|| ++.++++|
T Consensus 216 ~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 216 LILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 2211111 22223445789999999999999999 89999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=313.95 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=213.9
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEE
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~ 116 (351)
....++|++.+.||+|+||.||+|...++..+++|.+... ....+.+.+|+++++.++||||+++++++.++..++|++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 3345789999999999999999999888889999998654 345678899999999999999999999998888889999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
++.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 88 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp CCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999994321 12689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 160 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------------~~~~~~ 222 (279)
T 1qpc_A 160 EDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVIQN 222 (279)
T ss_dssp SSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHH
T ss_pred cCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----------------HHHHHH
Confidence 4322 111223446778999999998889999999999999999999 9999964321 111111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
+. .......+...+..+.+++.+||..||++|||+.++++.|++++....
T Consensus 223 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 223 LE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred Hh-cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11 111112223334579999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.15 Aligned_cols=275 Identities=22% Similarity=0.303 Sum_probs=207.9
Q ss_pred hcCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 37899999999999999999983 26789999999765555556788999999999999999999998543 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||+|+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 79999999999999995432 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||............... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK-QGQMIV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC-CTHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc-ccchhH
Confidence 99865443221 1222344667799999999999999999999999999999999998642210000000000 000000
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
......+........+...+..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111122222222233344556799999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=317.85 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=205.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+. ++..+++|.+....... ...+.+|+.+++.++||||+++++++.+... ++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 478999999999999999999954 68899999985443333 3567889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... .++++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp EECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 9999999999998543 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.... ....
T Consensus 160 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------------~~~~ 222 (294)
T 4eqm_A 160 ALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----------------SIAI 222 (294)
T ss_dssp TC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----------------HHHH
T ss_pred cccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHH
Confidence 643322 11223456899999999999999999999999999999999999999754321 1111
Q ss_pred hhcCccc---cCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhccCC
Q 018744 275 EIMDPAL---EGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 275 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~l~~~~~~~~~ 327 (351)
....... ........+..+.++|.+||..||++|| ++.++.+.|..++...+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 223 KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred HHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 1111111 0111122345689999999999999999 899999999988876554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=318.34 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=211.7
Q ss_pred eeeeHHHHHHHhcC----------CCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCC
Q 018744 29 QVFTFKQLHSATGG----------FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP 97 (351)
Q Consensus 29 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~ 97 (351)
..++.+++..+.+. |...+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35777888877765 777889999999999999965 7999999999766666678889999999999999
Q ss_pred cceeeeEEEEcCC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 98 YLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 98 ~i~~~~~~~~~~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
||+++++++.... .++||+|+.+++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 9999999887664 5699999999999998842 3589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
|+++.++.++|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-- 247 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-- 247 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999999876543221 223457899999999999999999999999999999999999999644321
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+.....+.+ ......+..+.+|+.+||..||++|||+.+++++
T Consensus 248 -----------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 -----------QAMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -----------HHHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011111111111 1111233468999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=330.04 Aligned_cols=278 Identities=25% Similarity=0.348 Sum_probs=211.0
Q ss_pred cCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc--C-CeE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~~~ 112 (351)
++|++.+.||+|+||.||+|.+ .+++.|++|++........+.+.+|+++++.++||||+++++++.. . ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999983 3678899999976555555678899999999999999999998863 2 345
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+|+.+++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 9999999999999995432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHH
Confidence 98764433221 12234577789999999999999999999999999999999999864321100000 0000011111
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 329 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~ 329 (351)
.+...+........+...+..+.+||.+||+.||++|||+.+++++|+.+........
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 2222222223333344455679999999999999999999999999999988765543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=314.67 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=204.2
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCCh-------HHHHHHHHHHhccCCCcceeeeEEEEcCCe
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGE-------DEFKMEVELLGRLRSPYLLALLGYCSDRRK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 111 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 37899999999999999999996 4789999999864433221 56888999999999999999999987655
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCCCCc-----
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFH----- 184 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~~~~----- 184 (351)
++||+|+.+++|.+++.... ..+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence 79999999999988885432 4689999999999999999999999 8 999999999999988776
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccc--cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
++|+|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------- 234 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-------- 234 (287)
T ss_dssp EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--------
T ss_pred EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--------
Confidence 99999999874332 234567899999999984 456788999999999999999999999754321
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.................+...+..+.++|.+||+.||++|||+.++++.|+++
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 ------KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00111111222222233334456799999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=313.40 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=196.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC----CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v 114 (351)
.++|++.+.||+|+||.||+|.+ .++.+++|++..... ...+.+.+|+++++.++||||+++++++.+. ..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 47899999999999999999997 478899999864322 2346788999999999999999999999766 45699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---ceecCCCCCcEEeCC--------CC
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP---VIHRDFKSSNILLDK--------NF 183 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~---i~H~di~p~Nilv~~--------~~ 183 (351)
|+|+.+++|.+++. ...+++..++.++.|++.||.|||++ + ++|+||||+||+++. ++
T Consensus 85 ~e~~~~~~L~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--------GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp EECCTTEEHHHHHT--------SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred EEcCCCCCHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCc
Confidence 99999999999883 23689999999999999999999999 8 899999999999985 77
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
.++|+|||++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------- 219 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------- 219 (271)
T ss_dssp CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----------
T ss_pred ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------
Confidence 89999999987543322 2245688999999999999999999999999999999999999974331
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
................+...+..+.+++.+||+.||++|||+.+++++|+++
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 ------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1122222222233333344456799999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.62 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=203.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC------ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
.++|++.+.||+|+||.||+|.+. +|+.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 478999999999999999999965 6899999998644322 34678899999999999999999999987754
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l 187 (351)
++||+|+.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++ .++|
T Consensus 91 ~lv~e~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-------CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 599999999999999943 34689999999999999999999999 999999999999998776 7999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 161 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------------- 223 (361)
T 2yab_A 161 IDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 223 (361)
T ss_dssp CCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------------
T ss_pred EecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------------
Confidence 9999998654422 23445689999999999998999999999999999999999999975432
Q ss_pred cchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+..... .++. ..+..+.+||.+||..||++|||+.++++|
T Consensus 224 --~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 224 --QETLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --HHHHHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111222222111 1121 123468999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=324.41 Aligned_cols=280 Identities=23% Similarity=0.331 Sum_probs=218.6
Q ss_pred ceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCCC-ChHHHHHHHHHHhcc-CCCcc
Q 018744 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRL-RSPYL 99 (351)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i 99 (351)
...+.........++|++.+.||+|+||.||+|.+ .+++.|++|++...... ....+.+|+.++..+ +||||
T Consensus 14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 33445556666678999999999999999999984 24678999998654222 235678899999999 78999
Q ss_pred eeeeEEEEcC--CeEEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCce
Q 018744 100 LALLGYCSDR--RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 168 (351)
Q Consensus 100 ~~~~~~~~~~--~~~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 168 (351)
+++++++... ..+++++|+.+++|.+++....... .....+++..++.++.|++.||.|||++ +++
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 9999998764 3579999999999999996543210 0122388999999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCC
Q 018744 169 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 247 (351)
Q Consensus 169 H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~p 247 (351)
|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986555443334445567888999999999999999999999999999998 9999
Q ss_pred CCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 248 IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 248 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
|...... ......+........+...+..+.+++.+||+.||.+|||+.+++++|+++++.+.
T Consensus 251 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 251 YPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp STTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred Ccccchh----------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 9754321 11111111111111222234568999999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=313.62 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=209.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999965 58999999987433 34457788999999999999999999998764 34699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe----CCCCcEEEeec
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDF 190 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----~~~~~v~l~df 190 (351)
|+|+.+++|.+++..... ...+++..++.++.||+.||.|||++ +++|+||||+||++ +.++.++|+||
T Consensus 88 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EeCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 999999999999965431 22489999999999999999999999 99999999999999 78888999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccc--------cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL--------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
|++....... ......++..|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 161 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----- 232 (319)
T 4euu_A 161 GAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----- 232 (319)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-----
T ss_pred CCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-----
Confidence 9998654432 223456899999999886 467899999999999999999999999643321100
Q ss_pred ccccccchhHHHhhc-----------------------CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 263 ALPRLTDREKILEIM-----------------------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
...+..++ ...............+.+|+.+||+.||++|||+.|++++..
T Consensus 233 -------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 233 -------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp -------HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred -------HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 00111111 011122445677888999999999999999999999999987
Q ss_pred Hhhh
Q 018744 320 PLVK 323 (351)
Q Consensus 320 ~~~~ 323 (351)
+-.-
T Consensus 306 d~~~ 309 (319)
T 4euu_A 306 DILH 309 (319)
T ss_dssp HHTC
T ss_pred HHhh
Confidence 5543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=316.98 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=199.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
..++|++.+.||+|+||.||+|.+.. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 34789999999999999999998642 45689998864322 23456888999999999999999999998888889
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 999999999999985432 3689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----------------~~ 226 (281)
T 1mp8_A 164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DV 226 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GH
T ss_pred cccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----------------HH
Confidence 76543221 11223445678999999998899999999999999999997 99999754321 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...+... .....+...+..+.+++.+||+.||++|||+.++++.|+++++..
T Consensus 227 ~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 227 IGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 111223334457899999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=316.44 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=194.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--------------------------CChHHHHHHHHHHh
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--------------------------QGEDEFKMEVELLG 92 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--------------------------~~~~~~~~e~~~l~ 92 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 378999999999999999999964 688999999864321 12356788999999
Q ss_pred ccCCCcceeeeEEEEcC---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcee
Q 018744 93 RLRSPYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIH 169 (351)
Q Consensus 93 ~l~h~~i~~~~~~~~~~---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H 169 (351)
.++||||+++++++.+. ..++||||+.+++|.+++. ...+++..++.++.||+.||.|||++ +++|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH 160 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIH 160 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 99999999999999752 3569999999999988652 24689999999999999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCC---CCCccceeehHHHHHHHHhCCC
Q 018744 170 RDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRV 246 (351)
Q Consensus 170 ~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~s~~~DiwslG~~l~~lltg~~ 246 (351)
+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999998654322 2234467899999999987654 4778999999999999999999
Q ss_pred CCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
||..... ......+.............+..+.+||.+||+.||++|||+.+++++
T Consensus 239 pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 239 PFMDERI----------------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCCSSH----------------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCccH----------------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9964321 011111111111111112233468999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=324.83 Aligned_cols=269 Identities=24% Similarity=0.387 Sum_probs=210.4
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
....++|++.+.||+|+||.||+|.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345589999999999999999999964 347899999874422 2235688999999999999999999999766
Q ss_pred -CeEEEEEEccCCChhhhccccCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecC
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSN-----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRD 171 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d 171 (351)
..++||+|+.+++|.+++....... .....+++..++.++.||+.||.|||++ +++|+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 4569999999999999986542110 0125789999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCC
Q 018744 172 FKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDV 250 (351)
Q Consensus 172 i~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~ 250 (351)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999876543322222344567888999999998899999999999999999999 9999964
Q ss_pred CCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 251 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
... ......+.+... ...+...+..+.+|+.+||+.||++|||+.+++++|+++....
T Consensus 280 ~~~----------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAH----------------EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCH----------------HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCh----------------HHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 331 111112211111 1222334457999999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.53 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=216.5
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL 112 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 112 (351)
.+.+....++|++.+.||+|+||.||+|.+.++..||+|.+... ....+.+.+|+.+++.++||||+++++++.....+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 258 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY 258 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccE
Confidence 34455566889999999999999999999888889999999754 34678899999999999999999999999877888
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+|+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+|||++.++.+||+|||+
T Consensus 259 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999995432 12578899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+... .
T Consensus 331 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----------------~ 392 (454)
T 1qcf_A 331 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------------P 392 (454)
T ss_dssp GGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------H
T ss_pred ceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----------------H
Confidence 97643211 001122345678999999998899999999999999999999 9999974331 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+...+........+...+..+.+||.+||+.||++|||+.+|++.|+++....
T Consensus 393 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111111111122223344567999999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=334.60 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=211.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
.+....++|++.+.||+|+||.||+|.+..+..||+|++... ....+.+.+|+.+++.++||||+++++++.+...++|
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv 256 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 256 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEE
Confidence 344456789999999999999999999887788999999754 3456788999999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 257 ~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp ECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ehhhcCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 99999999999995422 13588999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+... ..+
T Consensus 329 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~ 390 (452)
T 1fmk_A 329 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REV 390 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHH
T ss_pred ecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 654321 111223445678999999998999999999999999999999 9999964331 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...+........+...+..+.+||.+||+.||++|||+.++++.|++++...
T Consensus 391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1111122222333445567999999999999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=325.00 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=193.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
..++|++.+.||+|+||.||+++.. +++.||+|++... ......+.+|+.+++.++||||+++++++.+... ++||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999965 7899999998654 3334678899999999999999999999987654 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc--EEEeeccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVSDFGLAK 194 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~--v~l~dfg~~~ 194 (351)
|+.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++. ++|+|||++.
T Consensus 97 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 97 YASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred eCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999998543 3689999999999999999999999 9999999999999987665 9999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCc-cceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTK-SDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~-~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
..... .......|++.|+|||++.+..++.+ +|||||||++|+|++|..||........ ....+
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~~~ 231 (361)
T 3uc3_A 167 SSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------------YRKTI 231 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------------HHHHH
T ss_pred ccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------------HHHHH
Confidence 43221 12234568999999999988777655 8999999999999999999975433111 11122
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+.............+..+.+||.+||..||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22222222111111233568899999999999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.37 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=200.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|++.+.||+|+||.||+|.+ .++.+++|.+.. ....+.+.+|+.+++.++||||+++++++.+ ..++||+|+.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-PVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEEEEEcCC
Confidence 36799999999999999999997 468899999853 3345678899999999999999999998774 4689999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-EEEeecccccccCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-AKVSDFGLAKIGSD 198 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~-v~l~dfg~~~~~~~ 198 (351)
+++|.+++.... ....++...++.++.|++.||.|||+.+..+++|+||||+||+++.++. ++|+|||++.....
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSS----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999996432 1235788999999999999999999932229999999999999988876 79999999875432
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
. .....|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------~~~~~~~~~~ 219 (307)
T 2eva_A 159 H-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--------------AFRIMWAVHN 219 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--------------HHHHHHHHHT
T ss_pred c-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--------------HHHHHHHHhc
Confidence 2 23345889999999999989999999999999999999999999643211 0000001110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
..........+..+.+++.+||+.||++|||+.++++.|+.+.+.-..
T Consensus 220 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 220 -GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp -TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred -CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 011111222344689999999999999999999999999999876443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.03 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=211.5
Q ss_pred hcCCCcCc-eeeecCceEEEEEEEc---CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 40 TGGFSKSN-VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 40 ~~~y~~~~-~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
.++|.+.+ .||+|+||.||+|.+. ++..+++|++..... .....+.+|+++++.++||||+++++++..+..++|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 35677776 9999999999999843 577899999875422 234668889999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++++.+++|.+++... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhC------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccccee
Confidence 9999999999998532 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 195 IGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 195 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~ 221 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PE 221 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------------HH
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----------------HH
Confidence 754432211 1223446788999999998889999999999999999998 9999975432 11
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
....+........+...+..+.++|.+||..||++|||+.+++++|++++.....
T Consensus 222 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 222 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111111111223334456799999999999999999999999999999887554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=314.25 Aligned_cols=270 Identities=22% Similarity=0.294 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+.+++.+|+|++...... ....+.+|+++++.++||||+++++++.+.. .++||+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4789999999999999999999888999999998643222 2366888999999999999999999998765 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+ +|.+.+... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 100 FMEK-DLKKVLDEN------KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp CCSE-EHHHHHHTC------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CCCC-CHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 9985 777777432 23589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc--------cc
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------RL 267 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~~ 267 (351)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... ..
T Consensus 170 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 170 GIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred CCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 4322 22344567999999999876 5689999999999999999999999976554321111000000 00
Q ss_pred cchhHHHhhcCccccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 268 TDREKILEIMDPALEGQ----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
................. .......++.+||.+||+.||++|||+.|++++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~ 305 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH--PYFK 305 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC--cccc
Confidence 00000000000000000 001123468899999999999999999999987 4444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.74 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=209.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
.++|++.+.||+|+||.||+|.+.+++.+++|++... ....+.+.+|+++++.++||||+++++++.+. ..+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4689999999999999999999888889999999654 33457789999999999999999999999776 456999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+++|.+++.... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999985432 3688999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus 157 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~i~ 219 (267)
T 3t9t_A 157 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEVVEDIS 219 (267)
T ss_dssp HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHH
T ss_pred cc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----------------HHHHHHHh
Confidence 11 111223446678999999998899999999999999999999 8999974331 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.. .....+...+..+.+++.+||+.||++|||+.+++++|+++...
T Consensus 220 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 220 TG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC-CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11 11112222345689999999999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.70 Aligned_cols=269 Identities=21% Similarity=0.375 Sum_probs=210.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc--------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999853 467899999864322 2345688899999999 89999999999977
Q ss_pred C-CeEEEEEEccCCChhhhccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 109 R-RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 109 ~-~~~~v~~~~~~~~L~~~~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
. ..++|++|+.+++|.+++....... .....+++..++.++.||+.||.|||+. +++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 6 4569999999999999996543211 1123589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999986554332222334456778999999998889999999999999999999 9999964321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
..+...+........+...+..+.+++.+||+.||.+|||+.++++.|++++.....
T Consensus 266 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111111111111122233445789999999999999999999999999999986554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=330.63 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=207.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4578999999999999999999974 6799999987542 557889999999999999999999997655 4579999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+|+|.+++.... ...++...++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 268 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp CCTTCBHHHHHHHHC-----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999996542 12478999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ....++..|+|||++.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~ 398 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPR 398 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----------------THHHH
T ss_pred cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHH
Confidence 3221 22356778999999999999999999999999999998 99999754431 11111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+ ........+...+..+.+||.+||+.||++|||+.++++.|+++...
T Consensus 399 i-~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 399 V-EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1 11112223334456799999999999999999999999999998875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.44 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=202.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+. +++.+++|.+... ......+.+|+.+++.++||||+++++++.+... ++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999965 6889999998643 3334568889999999999999999999987654 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC--CCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~--~~~v~l~dfg~~~~ 195 (351)
+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++. ++.++|+|||++..
T Consensus 83 ~~g~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 83 ISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCBHHHHHTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 9999999998432 23689999999999999999999999 9999999999999987 78999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~~~~~ 214 (321)
T 1tki_A 154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIEN 214 (321)
T ss_dssp CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHH
T ss_pred CCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----------------HHHHHH
Confidence 54322 23445689999999999988899999999999999999999999974332 111222
Q ss_pred hcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 276 IMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 276 ~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+..... ..+. ..+..+.+||.+||..||++|||+.+++++-
T Consensus 215 i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 215 IMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 222111 1111 1234789999999999999999999999973
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.71 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=209.2
Q ss_pred HHHhcCCCcCc-eeeecCceEEEEEEE---cCCcEEEEEEccccCCCC--hHHHHHHHHHHhccCCCcceeeeEEEEcCC
Q 018744 37 HSATGGFSKSN-VVGHGGFGLVYRGVL---SNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDRR 110 (351)
Q Consensus 37 ~~~~~~y~~~~-~lg~G~~g~v~~~~~---~~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 110 (351)
....++|.+.+ .||+|+||.||+|.+ .+++.+++|++....... .+.+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 91 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 91 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCC
Confidence 33457788888 999999999999963 246789999987543222 467889999999999999999999998778
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++|++++.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+||
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 88999999999999999542 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 191 GLAKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 191 g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|++........... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------- 226 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------- 226 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------------
Confidence 99986544332111 122345678999999998889999999999999999999 9999975332
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..+...+........+...+..+.++|.+||+.||++|||+.++++.|++++....
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 227 --SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11112111111222333445579999999999999999999999999999988643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=317.69 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=201.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC------CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-e
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 111 (351)
.++|++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999965 689999999864322 13577889999999999999999999998775 4
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l 187 (351)
++||+|+.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++ .++|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-------SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEEEcCCCCCHHHHHHh-------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 599999999999999943 34689999999999999999999999 999999999999998877 7999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 222 (326)
T 2y0a_A 160 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 222 (326)
T ss_dssp CCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------------
T ss_pred EECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------------
Confidence 9999998654322 22345689999999999988999999999999999999999999964331
Q ss_pred cchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+.... ..... ..+..+.+||.+||..||++|||+.+++++
T Consensus 223 --~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 223 --QETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --HHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111110 01111 123468899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.07 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=203.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|..+++.++||||+++++++.+... ++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999965 6899999998642 23455678889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.+|.++|+|||++.
T Consensus 85 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcce
Confidence 9999999999999543 3689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .....
T Consensus 155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~~ 213 (318)
T 1fot_A 155 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYE 213 (318)
T ss_dssp ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHH
T ss_pred ecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHH
Confidence 64432 2345789999999999999999999999999999999999999964331 11222
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.++...+ .++......+.+||.+||..||++|| ++.++++|
T Consensus 214 ~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 214 KILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 2222221 22233345789999999999999999 89999877
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=313.18 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=206.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 113 (351)
..++|++.+.||+|+||.||+|.+.. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 34789999999999999999998532 23599999865422 23466888999999999999999999999888899
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|++++.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 90 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp EEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred EEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 999999999999995432 3589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----------------~ 222 (281)
T 3cc6_A 161 RYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----------------D 222 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----------------G
T ss_pred cccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----------------H
Confidence 76543221 11233456778999999998899999999999999999998 99999643321 0
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
....+........+...+..+.+++.+||..||++|||+.+++++|+++.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 11111111111122223456899999999999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=321.17 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=194.6
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-----
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR----- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 110 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++....... ...+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999996 578899999997543333 246788999999999999999999886542
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred cEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 27999999999999998543 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|++......... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------------- 225 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------------- 225 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------------
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---------------
Confidence 999765443221 1223356899999999999999999999999999999999999999754321
Q ss_pred hhHHHhhcCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH-HHHHhhh
Q 018744 270 REKILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ-SLVPLVK 323 (351)
Q Consensus 270 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~-~l~~~~~ 323 (351)
............. ......+..+.+||.+||+.||++||++.+++. .+.+...
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 226 -SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1111111110000 000112346899999999999999997766654 4444443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=315.87 Aligned_cols=272 Identities=22% Similarity=0.312 Sum_probs=202.6
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEE
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCS 107 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 107 (351)
..+....++|++.+.||+|+||.||+|... ++..+++|.+...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444455688999999999999999999843 3457999998644322 2356888999999999999999999987
Q ss_pred cCC------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 108 DRR------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 108 ~~~------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
+.. .+++++|+.+++|.+++...... .....+++..++.++.||+.||.|||++ +++|+||||+||+++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 643 37999999999999998543211 1235699999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCccee
Q 018744 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 182 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 260 (351)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 256 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------ 256 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------
Confidence 99999999999876544332222334456778999999999999999999999999999999 89999654321
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.....+... .....+...+..+.+++.+||..||++|||+.+++++|+++++..+
T Consensus 257 ----------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 257 ----------EMYDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ----------GHHHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----------HHHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111111111 1112222334579999999999999999999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=311.26 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=198.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhc--cCCCcceeeeEEEEcC-----CeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR-----RKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~-----~~~ 112 (351)
.++|++.+.||+|+||.||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++... ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999998 6889999998643 34455667777766 7899999999986432 346
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCceecCCCCCcEEeCCCCc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--------EHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+|++|+.+++|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||+||+++.++.
T Consensus 83 lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred EehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 99999999999999932 36899999999999999999999 88 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCce--ecccCCCcccccccccccC------CCCCccceeehHHHHHHHHhC----------CC
Q 018744 185 AKVSDFGLAKIGSDKAGGHV--STRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTG----------RV 246 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~------~~s~~~DiwslG~~l~~lltg----------~~ 246 (351)
++|+|||++........... .....|++.|+|||++.+. .++.++|||||||++|+|++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999999876544332211 2234689999999999876 455799999999999999999 66
Q ss_pred CCCCCCCCCCcceeecccccccchhHHHhhc-CccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 018744 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIM-DPALEGQ-----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 320 (351)
Q Consensus 247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~ 320 (351)
||....+.. .......... ....... .....+..+.+|+.+||+.||++|||+.++++.|++
T Consensus 232 pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 232 PFYDVVPND------------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTTSCSS------------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCCCC------------cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 664332211 0111111111 1111111 223466789999999999999999999999999987
Q ss_pred h
Q 018744 321 L 321 (351)
Q Consensus 321 ~ 321 (351)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=308.14 Aligned_cols=252 Identities=20% Similarity=0.319 Sum_probs=204.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. ++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999984 78899999875432 2235688899999999999999999999765 44799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
++|+.+++|.+++.... ...+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.++|+||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCS-----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccc
Confidence 99999999999996432 12589999999999999999999999 8 99999999999999999999999987
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCC---ccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT---KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~---~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
...... ....+++.|+|||++.+..++. ++|||||||++|+|++|..||.....
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------- 216 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------------- 216 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----------------
T ss_pred eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----------------
Confidence 654222 3346788999999998765544 79999999999999999999974332
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
................+...+..+.+++..||+.||++|||+.++++.|+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 217 MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111222222222223333445579999999999999999999999999998864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=324.16 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=199.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-E
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-L 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~ 112 (351)
..++|++.+.||+|+||.||+|++. +++.||+|++... .......+..|..++..+ +||||+++++++.+... +
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4588999999999999999999965 6899999998642 234456678899999988 79999999999987754 5
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+|+.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.++|+|||+
T Consensus 101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccc
Confidence 999999999999998543 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ...
T Consensus 171 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~ 232 (353)
T 3txo_A 171 CKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----------------DDL 232 (353)
T ss_dssp CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHH
T ss_pred eeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----------------HHH
Confidence 8753222 1223456799999999999988899999999999999999999999975432 112
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~~ 317 (351)
...+..... .++......+.+||.+||..||++||++ .++++|
T Consensus 233 ~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 233 FEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 222222221 2222344568999999999999999998 778776
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=314.98 Aligned_cols=273 Identities=22% Similarity=0.356 Sum_probs=189.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..... ++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999954 68999999986443 3344678899999999999999999999987754 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+. ++|.+++...... .....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 83 e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp ECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9998 5888888543311 1234689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee----------cc-
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS----------WA- 263 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~----------~~- 263 (351)
..... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+........... |.
T Consensus 158 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 158 FGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred cCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence 54322 12234568899999999876 468999999999999999999999997543210000000 00
Q ss_pred ---cccc------cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 ---LPRL------TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+.. .....+...+.+..... ....+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~ 299 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALHH--PWFAE 299 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGG
T ss_pred hhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhCC--hhhhc
Confidence 0000 00000001111111111 23468999999999999999999999987 44444
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.70 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=201.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++..... ++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 37899999999999999999996 57899999998532 23344678899999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+ +|+|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 88 ~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp ECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 9998 67888888543 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...............
T Consensus 157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 223 (336)
T 3h4j_B 157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC---------- 223 (336)
T ss_dssp TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS----------
T ss_pred eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC----------
Confidence 643322 2344568999999999988776 68999999999999999999999764432111100000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
....+...+..+.+||.+||..||.+|||+.|++++ .+++
T Consensus 224 --------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h--p~~~ 263 (336)
T 3h4j_B 224 --------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD--PWFN 263 (336)
T ss_dssp --------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC--HHHH
T ss_pred --------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC--hhhc
Confidence 001122233468899999999999999999999988 4444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=311.64 Aligned_cols=263 Identities=18% Similarity=0.241 Sum_probs=208.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+|+.+++.+ +|++++++++++.+... ++|++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 47899999999999999999995 578999999885432 334577899999999 79999999999877654 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-----EEEeecc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-----AKVSDFG 191 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~-----v~l~dfg 191 (351)
++ +++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++. ++|+|||
T Consensus 87 ~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99 999999995432 3589999999999999999999999 9999999999999987766 9999999
Q ss_pred cccccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 192 LAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 192 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++.......... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---------- 226 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---------- 226 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH----------
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc----------
Confidence 998765433221 22445689999999999999999999999999999999999999976443211
Q ss_pred ccchhHHHhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 267 LTDREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
......+....... ......+..+.+++.+||+.||++|||+.++++.|+++++....
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 227 ---KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp ---HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 01111111000000 00011234689999999999999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=316.98 Aligned_cols=258 Identities=19% Similarity=0.251 Sum_probs=206.9
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+..|+.+++.+ +||||+++++++..... ++||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 47899999999999999999995 5789999999864432 34578899999999 89999999999887755 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc-----EEEeecc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-----AKVSDFG 191 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~-----v~l~dfg 191 (351)
++ +++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||
T Consensus 86 ~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 86 LL-GPSLEDLFDLC------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred eC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 99 99999998543 24689999999999999999999999 9999999999999998887 9999999
Q ss_pred cccccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 192 LAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 192 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---------- 225 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---------- 225 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH----------
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH----------
Confidence 998754433221 12346789999999999999999999999999999999999999976532110
Q ss_pred ccchhHHHhhcCccccCCCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 267 LTDREKILEIMDPALEGQYSMK-----EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
......+..... ..+.. .+ .+.+++..||+.||.+||++.+|++.|+++.+..
T Consensus 226 ---~~~~~~i~~~~~--~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 226 ---KERYQKIGDTKR--ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ---HHHHHHHHHHHH--HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHHHhhhc--cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 011111110000 00111 12 7999999999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=307.49 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=202.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
..++|++.+.||+|++|.||+|.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+... ++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999965 689999999864433 334678899999999999999999999887654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..
T Consensus 85 e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 85 EYCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp ECCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCcHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 99999999999843 24689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..............++..|+|||++.+..+ +.++||||||+++|+|++|..||....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~ 219 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYS 219 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---------------HHHH
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---------------HHHH
Confidence 543322222344568899999999987665 778999999999999999999997544310 0111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...............+..+.+||.+||..||++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1111111111111234468899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=324.92 Aligned_cols=270 Identities=21% Similarity=0.285 Sum_probs=206.6
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc----
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---- 108 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 108 (351)
+.+....++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 33444568899999999999999999996 5789999999866555556778899999999999999999998862
Q ss_pred -CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 -RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 -~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
...++|++|+.+++|.+++..... ....+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEE
Confidence 144699999999999999865321 234689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCce-------ecccCCCcccccccccccCC---CCCccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 188 SDFGLAKIGSDKAGGHV-------STRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~---~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+|||++........... .....|+..|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~- 254 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD- 254 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-
Confidence 99998765332111000 11234688999999987553 68899999999999999999999953211000
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..................+..+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus 255 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 255 --------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00000111111111223345799999999999999999999999999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.10 Aligned_cols=268 Identities=25% Similarity=0.366 Sum_probs=207.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
..++|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347899999999999999999983 246789999986332 22345678899999999999999999999876 4
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEE
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKV 187 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l 187 (351)
.++||+|+.+++|.+++............+++..++.++.|++.||.|||+. +++|+||+|+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 5699999999999999976654333445699999999999999999999999 9999999999999984 446999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------- 251 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------- 251 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------------
Confidence 99999876444332233344567889999999998899999999999999999998 9999964321
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
......+........+...+..+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 252 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 252 ----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11111111111112222334578999999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=312.33 Aligned_cols=272 Identities=22% Similarity=0.335 Sum_probs=208.6
Q ss_pred cCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
++|++.+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5699999999999999999983 36889999998743 334457789999999999999999999998764 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||+|+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 69999999999999985432 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++......... .......++..|+|||++.+..++.++|||||||++|+|++|..|+............ ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~ 249 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG--PTHGQMTV 249 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC--SCCGGGHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC--CcccccCH
Confidence 99875543322 1233455777899999999999999999999999999999999986422100000000 00001111
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+........+...+..+.+||.+||+.||.+|||+.++++.|+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 12222222222223334445679999999999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=322.89 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=203.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+. +++.+|+|++..........+.+|+.+++.++||||+++++++.+... ++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999965 688999999865444445678899999999999999999999987754 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--CCCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~--~~~~v~l~dfg~~~~ 195 (351)
+.+++|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++ .++.++|+|||++..
T Consensus 130 ~~gg~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 130 LSGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp CCCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 9999999988532 23689999999999999999999999 999999999999997 457899999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------------~~~~~~ 261 (387)
T 1kob_A 201 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LETLQN 261 (387)
T ss_dssp CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHH
T ss_pred cCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 54322 23345689999999999999999999999999999999999999975432 111111
Q ss_pred hcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.. ...........+..+.+||.+||..||++|||+.+++++
T Consensus 262 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 262 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111 111111112334578999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=310.86 Aligned_cols=265 Identities=19% Similarity=0.300 Sum_probs=195.1
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||+|+||.||+|.+.+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.... .++||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998789999999986432 233467888999999999999999999998764 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+ +|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 976 8888875332 4689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc--ccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR--LTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 274 (351)
... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.................. ........
T Consensus 152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 152 IPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 321 122345678999999998764 5899999999999999999999999754321000000000000 00000000
Q ss_pred h--hcCcccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 E--IMDPALE-------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~--~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. ..++... .......+..+.+||.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000000 00111223468899999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=316.67 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=201.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC-----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
.++|++.+.||+|+||.||+|.+.. +..+++|.+..... .....+.+|+.+++.++||||+++++++.... .+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3677888999999999999998542 23599999864322 22346788999999999999999999998764 56
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+++.+++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 123 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 9999999999999985432 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 193 AKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 193 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------------~ 257 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------H 257 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------H
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------------H
Confidence 97654332111 1222345678999999998899999999999999999999 9999964321 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.....+. .......+...+..+.+++.+||+.||++|||+.++++.|+++++....
T Consensus 258 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 258 EVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHHHHHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1111111 1111222333455799999999999999999999999999999876443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.03 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=213.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
...++|++.+.||+|+||.||+|.+. ++..+++|.+... ....+.+.+|+.+++.++||||+++++++.+.. .++|+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34578999999999999999999965 5888999998643 444577889999999999999999999998764 46999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp ECCTTEEHHHHHHHCC-----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EcCCCCcHHHHHHhcc-----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999996532 24689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 161 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----------------~~~~ 222 (288)
T 3kfa_A 161 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVY 222 (288)
T ss_dssp SCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHH
T ss_pred ccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence 54332 122333456778999999998999999999999999999999 9999975432 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+........+...+..+.+|+.+||..||++|||+.++++.|++++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 222222222233334457999999999999999999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=319.69 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=201.0
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 113 (351)
...++|++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+... ++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999965 689999999864432 223567889999999999999999999987754 59
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC---CcEEEeec
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHAKVSDF 190 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~---~~v~l~df 190 (351)
||+|+.+++|.+.+.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.+ +.++|+||
T Consensus 106 v~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EECCCCSCBHHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999998843 24689999999999999999999999 99999999999999764 45999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+. .
T Consensus 176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----------------~ 236 (362)
T 2bdw_A 176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------------H 236 (362)
T ss_dssp TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 9997654322 22346789999999999998999999999999999999999999964331 1
Q ss_pred hHHHhhcCccccCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+......... ....+..+.+||.+||..||++|||+.+++++
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111111000 11234568999999999999999999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=327.40 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=200.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
..++|++.+.||+|+||.||+|.+. +|+.+++|++..... ...+.+.+|+.+++.++||||+++++++.+... ++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999954 688999999864332 223567889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC---CCCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~---~~~~v~l~dfg 191 (351)
|+|+.+|+|.+.+... ..+++..++.++.||+.||.|||++ +++|+||||+||+++ .++.++|+|||
T Consensus 89 ~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp ECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 9999999999988543 4689999999999999999999999 999999999999998 56789999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... ..
T Consensus 159 ~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----------------~~ 220 (444)
T 3soa_A 159 LAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----------------HR 220 (444)
T ss_dssp SCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HH
T ss_pred eeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----------------HH
Confidence 997654322 222346789999999999998999999999999999999999999964331 11
Q ss_pred HHHhhcCcccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+...... .......+..+.+||.+||..||++|||+.+++++
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111111111 11111234568999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=319.72 Aligned_cols=273 Identities=26% Similarity=0.344 Sum_probs=209.4
Q ss_pred CCcCceeeecCceEEEEEEEc-----CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 113 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~-----~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 113 (351)
|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.+. ..++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999988632 678899999875422 2345688999999999999999999998763 3469
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+++|.+++.. ..+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++
T Consensus 113 v~e~~~~~~L~~~l~~--------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR--------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EECCCTTCBHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEecccCCcHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 9999999999999943 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||......... ...+. ........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIA-QGQMTVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSC-CHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhccc-ccchhHHH
Confidence 8765433211 223355777899999999989999999999999999999999998642110000 00000 00001111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
+...+........+...+..+.+||.+||+.||++|||+.++++.|+++.+.-..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 22233333333334445567999999999999999999999999999998875543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=323.02 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=200.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC---CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~ 113 (351)
.++|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+..|..++..+ +||||+++++++.+.. .++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 478999999999999999999965 67889999986432 23335677899999887 8999999999998775 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.++|+|||++
T Consensus 131 V~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeeccee
Confidence 99999999999988543 3689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........
T Consensus 201 ~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~~~~ 271 (396)
T 4dc2_A 201 KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLF 271 (396)
T ss_dssp BCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHH
T ss_pred eecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHHHHH
Confidence 753222 123345679999999999999999999999999999999999999996543211000 00001111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~~ 317 (351)
..+....+ .++...+..+.+||.+||+.||++||++ .++++|
T Consensus 272 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 272 QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 12222111 2233344578999999999999999995 677766
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=315.53 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=197.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 110 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999975 78999999986433 334467889999999999999999999875432
Q ss_pred ---------------------------------------------------eEEEEEEccCCChhhhccccCCCCCCCCC
Q 018744 111 ---------------------------------------------------KLLVYDYMANGGLQEHLYPANGSNSVASK 139 (351)
Q Consensus 111 ---------------------------------------------------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~ 139 (351)
.+++|+|+.+++|.+++..... ...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~ 160 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LED 160 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GGG
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----ccc
Confidence 4699999999999999965432 234
Q ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCC----------ceecccC
Q 018744 140 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG----------HVSTRVL 209 (351)
Q Consensus 140 l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~----------~~~~~~~ 209 (351)
.++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++......... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 57778999999999999999999 9999999999999999999999999999876543221 1123356
Q ss_pred CCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHH
Q 018744 210 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKE 289 (351)
Q Consensus 210 ~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (351)
|++.|+|||++.+..++.++|||||||++|+|++|..|+.. ............. .......
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------------------~~~~~~~~~~~~~-~~~~~~~ 298 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------------------RVRIITDVRNLKF-PLLFTQK 298 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------------------HHHHHHHHHTTCC-CHHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------------------HHHHHHHhhccCC-CcccccC
Confidence 89999999999999999999999999999999998766421 0011111111110 1111233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 290 VIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 290 ~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+.+||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 4578899999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=334.48 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=212.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
...++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34577999999999999999999976 4889999999654 44578899999999999999999999999876 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+|||++.++.+||+|||++..
T Consensus 296 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp ECCTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EccCCCCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999996532 23588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+... ..+.
T Consensus 368 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----------------~~~~ 429 (495)
T 1opk_A 368 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVY 429 (495)
T ss_dssp CTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHH
T ss_pred ccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence 53321 111223345678999999998899999999999999999999 9999975432 1112
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+.+........+...+..+.+||.+||+.||++|||+.++++.|+.++..
T Consensus 430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 22222222233344456799999999999999999999999999988754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=319.01 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=201.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-----CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999964 6899999998532 2234677899999999999999999999987765 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc---EEEee
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSD 189 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~---v~l~d 189 (351)
+||||+.+++|.+.+..... ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++. ++|+|
T Consensus 103 lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence 99999999999888754321 123589999999999999999999999 9999999999999976554 99999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 177 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------------- 238 (351)
T 3c0i_A 177 FGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------------- 238 (351)
T ss_dssp CTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----------------
T ss_pred CcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----------------
Confidence 99998654422 223445789999999999999999999999999999999999999964211
Q ss_pred hhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+..... .... ..+..+.+||.+||..||++|||+.+++++
T Consensus 239 -~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 239 -RLFEGIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -HHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111111 1111 123478999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=321.29 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=201.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999955 6889999998532 3445677889999999999999999999998775 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+|+|..++.. ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++.
T Consensus 94 ~e~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-------NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp ECCCTTEEHHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999853 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...
T Consensus 164 ~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-------------~~~ 227 (384)
T 4fr4_A 164 MLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-------------SKE 227 (384)
T ss_dssp ECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-------------HHH
T ss_pred eccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-------------HHH
Confidence 65432 22345678999999999874 458999999999999999999999997543211 011
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~ 317 (351)
....+.... ..++...+..+.+||.+||+.||++||+ +.+++++
T Consensus 228 ~~~~~~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 228 IVHTFETTV--VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHhhcc--cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 111111111 1222333457899999999999999998 7777664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.62 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=197.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--CChHHHHHHHHHHhccCC--CcceeeeEEEEcCCeE-E
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRS--PYLLALLGYCSDRRKL-L 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~-~ 113 (351)
..++|++.+.||+|+||.||++.+.+++.||+|++..... .....+.+|+.++..++| +||+++++++.....+ +
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3467999999999999999999988899999999864322 223568889999999976 9999999999887655 7
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+ +.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++ ++.++|+|||++
T Consensus 87 v~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEe-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccc
Confidence 777 6788999999543 4689999999999999999999999 999999999999997 578999999999
Q ss_pred cccCCCCCCceecccCCCccccccccccc-----------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
................|++.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------- 225 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------- 225 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------
Confidence 86554433333445678999999999865 6788999999999999999999999963221
Q ss_pred ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.........+......++......+.+||.+||..||++|||+.+++++-
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 226 ------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11223333333333333333345789999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=318.81 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=203.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999965 6899999998532 2345577888999999999999999999998765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 121 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence 999999999999543 3689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~ 249 (350)
T 1rdq_E 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEK 249 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHH
T ss_pred ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----------------HHHHHH
Confidence 5432 2345689999999999999999999999999999999999999974332 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
+....+ .++...+..+.+||.+||+.||++||+ +.++++|
T Consensus 250 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 222111 222233457899999999999999998 8999887
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=312.90 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=199.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC---ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
..++|++.+.||+|+||.||+|.. .+++.+++|++...... ....+.+|+.+++.++||||+++++++.... .++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446899999999999999999995 47899999998753322 2356788999999999999999999987664 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|++++.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 110 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 9999999999999854321 224689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..||.+.... .....
T Consensus 184 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~~ 247 (310)
T 2wqm_A 184 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------------LYSLC 247 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--------------HHHHH
T ss_pred eeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--------------HHHHH
Confidence 7543322 1123356788999999999989999999999999999999999999643221 00111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 328 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~ 328 (351)
..+.............+..+.+|+.+||+.||++|||+.++++.|+++......+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 248 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1111111111111223456899999999999999999999999999999876653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=309.21 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=194.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.++.. ++||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999965 6889999998644322 23667889999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+ ++.+.+... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~-~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSE-EHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCC-CHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9976 555555332 24689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceecccCCCcccccccccccCC-CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc-c--ccccchhH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA-L--PRLTDREK 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~--~~~~~~~~ 272 (351)
.... .......++..|+|||++.+.. ++.++|||||||++|+|++|..||............... . +.......
T Consensus 152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 4322 2234456789999999988765 799999999999999999988886322110000000000 0 00000000
Q ss_pred HHhhcC---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMD---------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+ ..............+.+||.+||+.||++|||+.|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 000001111234568899999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=320.49 Aligned_cols=272 Identities=25% Similarity=0.379 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEE
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGY 105 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 105 (351)
.+++....++|++.+.||+|+||.||+|.+. +++.+++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455566789999999999999999999853 367899999864322 223457889999999999999999999
Q ss_pred EEcC-CeEEEEEEccCCChhhhccccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC
Q 018744 106 CSDR-RKLLVYDYMANGGLQEHLYPANG---SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 106 ~~~~-~~~~v~~~~~~~~L~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~ 181 (351)
+.+. ..++||+++.+++|.+++..... .......+++..++.++.|++.||.|||++ +++|+||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 9776 45699999999999999865321 011124578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCccee
Q 018744 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 182 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~ 260 (351)
++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------- 246 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------- 246 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------
Confidence 99999999999875433322222233456778999999999999999999999999999999 8999964331
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
......+..... ...+...+..+.+||.+||..||++|||+.+++++|++++..
T Consensus 247 ---------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 ---------EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ---------HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---------HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111111111111 122233445689999999999999999999999999988664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=324.80 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=203.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|.+.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.... .++|+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999965 7899999998633 2334567889999999999999999999998765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 96 E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 96 EYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECCSSEEHHHHTTS-------SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999943 34699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||..... .....
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----------------~~~~~ 226 (476)
T 2y94_A 166 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----------------PTLFK 226 (476)
T ss_dssp CCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----------------HHHHH
T ss_pred ccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----------------HHHHH
Confidence 54322 2344578999999999988765 6899999999999999999999975432 11122
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.+..... ..+...+..+.+||.+||..||++|||+.+++++
T Consensus 227 ~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 2222211 1112233468999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.90 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=203.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++||||+++++++.+... ++||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999965 577899999877666777889999999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg~~ 193 (351)
|+.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||+|+||++ +.++.++|+|||++
T Consensus 87 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 87 LCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp CCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999988543 3689999999999999999999999 99999999999999 78899999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... ......+++.|+|||++.+. ++.++||||||+++|+|++|..||..... ....
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~ 216 (277)
T 3f3z_A 157 ARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD----------------SEVM 216 (277)
T ss_dssp EECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHH
T ss_pred eeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH----------------HHHH
Confidence 7654322 23445689999999988654 89999999999999999999999974331 1111
Q ss_pred HhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..... ..+. ..+..+.+||.+||+.||++|||+.+++++
T Consensus 217 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 217 LKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 1111 123578999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.26 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=214.4
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
.+....++|++.+.||+|+||.||+|.+..+..||+|++... ....+.+.+|+.+++.++|+||+++++++.+...++|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv 339 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 339 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence 334456788999999999999999999887788999999754 3456789999999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++.
T Consensus 340 ~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp ECCCTTEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eehhcCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999999995422 13588999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+... ..+
T Consensus 412 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~ 473 (535)
T 2h8h_A 412 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REV 473 (535)
T ss_dssp TCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHH
T ss_pred ecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 543211 001122345678999999998999999999999999999999 9999964331 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...+........+...+..+.+||.+||+.||++|||+.+|++.|++++...
T Consensus 474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1111112222233344567999999999999999999999999999988643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.57 Aligned_cols=269 Identities=25% Similarity=0.291 Sum_probs=205.7
Q ss_pred eeeHHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc-----CCCChHHHHHHHHHHhccCCCcceeee
Q 018744 30 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALL 103 (351)
Q Consensus 30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~ 103 (351)
..+...+....++|++.+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++||||++++
T Consensus 15 ~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp CCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 3445566777899999999999999999999964 6889999988533 234457788999999999999999999
Q ss_pred EEEEcCCe-EEEEEEccCCChhhhccccCCCC---------------------------------CCCCCCCHHHHHHHH
Q 018744 104 GYCSDRRK-LLVYDYMANGGLQEHLYPANGSN---------------------------------SVASKLDWETRLRIA 149 (351)
Q Consensus 104 ~~~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~---------------------------------~~~~~l~~~~~~~i~ 149 (351)
+++.+... ++||||+.+++|.+++....... .....+++..++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 99987754 59999999999999985321100 011234678899999
Q ss_pred HHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC--cEEEeecccccccCCCCCCc--eecccCCCccccccccccc--C
Q 018744 150 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF--HAKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALT--G 223 (351)
Q Consensus 150 ~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~--~v~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~ 223 (351)
.||+.||.|||+. +++|+||||+||+++.++ .++|+|||++.......... ......|++.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 9999999999999 999999999999998766 89999999997653322211 2344668999999999875 6
Q ss_pred CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCC--HHHHHHHHHHHHhcc
Q 018744 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCV 301 (351)
Q Consensus 224 ~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l 301 (351)
.++.++|||||||++|+|++|..||..... ......+.........+ ...+..+.+||.+||
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVND----------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----------------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHc
Confidence 788999999999999999999999964332 12222222222111111 123457899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 018744 302 QPEADYRPLMADVVQS 317 (351)
Q Consensus 302 ~~~P~~Rpt~~eil~~ 317 (351)
+.||.+|||+.+++++
T Consensus 316 ~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 316 NRNVDERFDAMRALQH 331 (345)
T ss_dssp CSCTTTSCCHHHHHHS
T ss_pred CCChhHCCCHHHHhcC
Confidence 9999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=307.04 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=202.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+. ++..+++|++... .......+.+|+.+++.++||||+++++++.+... ++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367999999999999999999955 5778999988532 22345678889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence 9999999999998543 3689999999999999999999999 99999999999999999999999999885
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....
T Consensus 158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~ 217 (279)
T 3fdn_A 158 HAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------------ETYK 217 (279)
T ss_dssp CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHH
T ss_pred cCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----------------HHHH
Confidence 43322 223456889999999999999999999999999999999999999743311 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+... ....+...+..+.+||.+||+.||++|||+.+++++ .+++....
T Consensus 218 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~~~~ 266 (279)
T 3fdn_A 218 RISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITANSS 266 (279)
T ss_dssp HHHHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHHHCS
T ss_pred HHHhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC--ccccCCcc
Confidence 11110 111222234568899999999999999999999998 55555443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=319.20 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=202.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 110 (351)
.....++|++.+.||+|+||.||+|.+. +++.||+|++... .......+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3445689999999999999999999965 6889999998643 234556778899999877 8999999999998775
Q ss_pred e-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 K-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 ~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
. ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~D 161 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIAD 161 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeE
Confidence 4 5999999999999998543 3689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 162 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------------- 223 (345)
T 1xjd_A 162 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---------------- 223 (345)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------
T ss_pred ChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----------------
Confidence 99987532221 223456789999999999999999999999999999999999999975432
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~ 317 (351)
......+.... ..++...+..+.+||.+||..||++||++. ++++|
T Consensus 224 ~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 224 EELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11111111111 112223345789999999999999999998 77655
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=322.87 Aligned_cols=272 Identities=17% Similarity=0.221 Sum_probs=201.5
Q ss_pred HHhcCCCcCceeeec--CceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 38 SATGGFSKSNVVGHG--GFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G--~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
...++|++.+.||+| +||.||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345789999999999 99999999965 689999999864432 223567789999999999999999999887654
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||+|+.+++|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF-----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEEEccCCCCHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccc
Confidence 59999999999999986532 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-----CCceecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec-c
Q 018744 192 LAKIGSDKA-----GGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW-A 263 (351)
Q Consensus 192 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-~ 263 (351)
.+....... .........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+............ .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 876432211 1111233468889999999987 5789999999999999999999999976543311110000 0
Q ss_pred cccccc------------------hhHHHhhcC---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 264 LPRLTD------------------REKILEIMD---------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 264 ~~~~~~------------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
.+.... ......... ..............+.+||.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000 000000000 00000112223457999999999999999999999998
Q ss_pred H
Q 018744 317 S 317 (351)
Q Consensus 317 ~ 317 (351)
+
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=314.34 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=193.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE----cCCcEEEEEEccccC----CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
.++|++.+.||+|+||.||+|+. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999996 478999999986432 22345577899999999999999999999876 4
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||+|+.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeC
Confidence 56999999999999998543 3688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 166 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~ 227 (327)
T 3a62_A 166 GLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----------------K 227 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------H
T ss_pred CcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 9987532221 122345689999999999988899999999999999999999999975332 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
.....+..... ..+......+.+||.+||..||++|| ++.++++|
T Consensus 228 ~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 228 KTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11222222111 12223345789999999999999999 78888887
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=312.60 Aligned_cols=271 Identities=25% Similarity=0.364 Sum_probs=211.5
Q ss_pred eeeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhc--cCCCcceeeeEEEE
Q 018744 30 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCS 107 (351)
Q Consensus 30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 107 (351)
..+...-....++|++.+.||+|+||.||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 334444556678999999999999999999998 5889999998543 34567778888887 68999999999987
Q ss_pred cC-----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCceecCCCC
Q 018744 108 DR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--------EHCSPPVIHRDFKS 174 (351)
Q Consensus 108 ~~-----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~di~p 174 (351)
.. ..++|++|+.+++|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp 175 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKS 175 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSG
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCH
Confidence 65 35699999999999999943 25889999999999999999999 78 999999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCCCc--eecccCCCcccccccccccC------CCCCccceeehHHHHHHHHhC--
Q 018744 175 SNILLDKNFHAKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTG-- 244 (351)
Q Consensus 175 ~Nilv~~~~~v~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~s~~~DiwslG~~l~~lltg-- 244 (351)
+||+++.++.++|+|||++.......... ......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999997654433211 12345689999999998765 234689999999999999999
Q ss_pred --------CCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCH
Q 018744 245 --------RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLM 311 (351)
Q Consensus 245 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~ 311 (351)
..||....+.. .........+....+....+ ......+.+|+.+||+.||++|||+
T Consensus 256 ~~~~~~~~~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSD-----------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSS-----------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred cCCcccccccCccccCcCc-----------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 66765432210 00111111222222222222 3566789999999999999999999
Q ss_pred HHHHHHHHHhhhccC
Q 018744 312 ADVVQSLVPLVKYNR 326 (351)
Q Consensus 312 ~eil~~l~~~~~~~~ 326 (351)
.+++++|+++.++..
T Consensus 325 ~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 325 LRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhc
Confidence 999999999988643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.64 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=203.0
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCCCh
Q 018744 48 VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL 123 (351)
Q Consensus 48 ~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~~L 123 (351)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++..+..++||||+.+|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999853 45679999997543 3456789999999999999999999999998888899999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCc
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 203 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 203 (351)
.+++... ...+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++..........
T Consensus 423 ~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 423 HKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9998532 24689999999999999999999999 99999999999999999999999999998654322111
Q ss_pred -eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 204 -VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 204 -~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+...+....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~ 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGK 556 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----------------HHHHHHHHTTC
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 1122335578999999999999999999999999999998 9999975432 11112121112
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 282 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
....+...+..+.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 223334455679999999999999999999999999999887643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=317.05 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=187.8
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+... ++||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999965 57899999986432 34567889999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~dfg~~ 193 (351)
|+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||++
T Consensus 129 ~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 129 LVTGGELFDRIVE-------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp CCCSCBHHHHHTT-------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred eCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999843 24689999999999999999999999 9999999999999975 889999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~ 260 (349)
T 2w4o_A 199 KIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---------------QFMF 260 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---------------HHHH
T ss_pred cccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---------------HHHH
Confidence 7643321 223456899999999999989999999999999999999999999643321 1111
Q ss_pred HhhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..... ........+..+.+||.+||..||++|||+.+++++
T Consensus 261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12222111 111112334578999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=325.25 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=196.0
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--CChHHHHHHHHHHhccC--CCcceeeeEEEEcCCeE-EEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLR--SPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~-~v~ 115 (351)
.+|++.+.||+|+||.||+|....++.||+|++..... .....+.+|+.+++.++ ||||+++++++.....+ +||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 56999999999999999999987799999999864322 23466889999999996 59999999998877554 788
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
| +.+++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++ ++.++|+|||++..
T Consensus 136 E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp E-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred e-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 8 6788999998543 3688899999999999999999999 999999999999995 57999999999986
Q ss_pred cCCCCCCceecccCCCccccccccccc-----------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 264 (351)
..............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------- 272 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------- 272 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----------
Confidence 544332223345679999999999865 3688999999999999999999999964221
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+..+++.......+......+.+||.+||..||++|||+.+++++-
T Consensus 273 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 273 ----QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ----HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11223333333332223322345789999999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=311.75 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=199.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CC-------cEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NG-------RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~-------~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 110 (351)
.++|++.+.||+|+||.||+|.+. ++ ..+++|++........+.+.+|+.+++.++||||+++++++.+. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999854 33 46999998766666678899999999999999999999999766 4
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc------
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH------ 184 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~------ 184 (351)
.++||+|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 569999999999999995432 3489999999999999999999999 9999999999999988877
Q ss_pred --EEEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCC-CCCCCCCCCCccee
Q 018744 185 --AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRV-PIDVNKPSGEGVLV 260 (351)
Q Consensus 185 --v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~-pf~~~~~~~~~~~~ 260 (351)
++|+|||++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|.. ||.....
T Consensus 158 ~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------- 224 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------- 224 (289)
T ss_dssp CEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred ceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------
Confidence 99999999864322 123446788999999987 678999999999999999999544 4432211
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.......... ...+...+..+.+|+.+||+.||++|||+.+++++|++++...-
T Consensus 225 ----------~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 225 ----------QRKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ----------HHHHHHHHTT--CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ----------HHHHHHhhcc--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111111000 01111113358899999999999999999999999999988433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.04 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=191.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEc-------
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSD------- 108 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~------- 108 (351)
....+|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.++..+. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 33468999999999999999999964 68999999986554445567888999999996 9999999998841
Q ss_pred -CC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeCCCCc
Q 018744 109 -RR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 109 -~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~~~~~ 184 (351)
.. .+++++++. |+|.+++.... ....+++..++.++.||+.||.|||+. + ++|+||||+||+++.++.
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence 22 358888885 68888885432 124699999999999999999999999 8 999999999999999999
Q ss_pred EEEeecccccccCCCCCCc----------eecccCCCccccccccc---ccCCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 185 AKVSDFGLAKIGSDKAGGH----------VSTRVLGTQGYVAPEYA---LTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
++|+|||++.......... ......+++.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998654432211 11134588899999998 4667889999999999999999999999643
Q ss_pred CCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 018744 252 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 331 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~~~ 331 (351)
... ..................+.+||.+||+.||++|||+.+++++|+.+.......+..
T Consensus 257 ~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 257 AKL--------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred hHH--------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 321 001111111111111234788999999999999999999999999998875554444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=319.65 Aligned_cols=272 Identities=23% Similarity=0.363 Sum_probs=212.2
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEcC-C-----cEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEE
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYC 106 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~-----~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 106 (351)
......++|++.+.||+|+||.||+|.+.. + ..+++|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556889999999999999999999542 2 4799999864322 2345688899999999 899999999999
Q ss_pred EcC-CeEEEEEEccCCChhhhccccCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 107 SDR-RKLLVYDYMANGGLQEHLYPANGS-------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 107 ~~~-~~~~v~~~~~~~~L~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
... ..++||+|+.+++|.+++...... ......+++..++.++.|++.||.|||++ +++|+||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 776 456999999999999998543210 00124689999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--- 273 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--- 273 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---
Confidence 99999999999999986544433333344556778999999999999999999999999999998 99999754321
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...............+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus 274 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 274 -------------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111111222223457899999999999999999999999999987754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=304.84 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=202.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC----CCChHHHHHHHHHHhccCCCcceeeeEEEEc---CC
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSD---RR 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 110 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3579999999999999999999964 68899999986432 2345678899999999999999999998843 24
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||+|+.++ |.+++.... ...+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+||
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~df 153 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEehhccCC-HHHHHHhCc-----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecc
Confidence 57999999876 666664332 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCC--CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|++................++..|+|||++.+.. ++.++||||||+++|+|++|..||.....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------- 218 (305)
T 2wtk_C 154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------------- 218 (305)
T ss_dssp TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---------------
T ss_pred ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---------------
Confidence 9998765444334445567899999999987643 37799999999999999999999974321
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
......+.... ...+...+..+.+||.+||..||++|||+.+++++ .+++..
T Consensus 219 -~~~~~~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~ 270 (305)
T 2wtk_C 219 -YKLFENIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH--SWFRKK 270 (305)
T ss_dssp -HHHHHHHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS--HHHHSC
T ss_pred -HHHHHHHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC--cccccC
Confidence 01111111111 11222234568899999999999999999999987 455543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.14 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=202.4
Q ss_pred CCCcCceeeecCceEEEEEEEc-CC---cEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC--eEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~---~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~v 114 (351)
.|.+.+.||+|+||.||+|.+. ++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556789999999999999843 33 2689998864322 23466888999999999999999999997553 3699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 102 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP------QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp ECCCTTCBHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred EecccCCCHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 9999999999999542 24688999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC--CCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCC-CCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKA--GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
...... .........++..|+|||.+.+..++.++|||||||++|+|++|..| |..... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----------------~ 235 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----------------F 235 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----------------G
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----------------H
Confidence 543321 11122335577899999999999999999999999999999995555 432221 1
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
..............+...+..+.+++.+||+.||.+|||+.++++.|+++++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111111111122223345789999999999999999999999999999987544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=310.53 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=200.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc--CCc--EEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS--NGR--KVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~--~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 112 (351)
.++|++.+.||+|+||.||+|.+. +++ .+++|++.... ....+.+.+|+.+++.++||||+++++++.....+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 478999999999999999999853 333 58999886432 22346788999999999999999999999988888
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|++++.+++|.+++.... ..+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccc
Confidence 9999999999999985432 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 193 AKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 193 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~ 231 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------------S 231 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------H
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----------------H
Confidence 98754433221 1223456778999999998889999999999999999999 9999974332 1
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.....+.........+...+..+.+++.+||..||++|||+.++++.|.++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1222222222222223334557999999999999999999999999999887643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.14 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=200.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~~ 116 (351)
..++|++.+.||+|++|.||++.+ .++.+++|++... ...+.+.+|+.+++.++||||+++++++.+. ..++|++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999987 4789999998643 3457788999999999999999999987543 4579999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
++.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred cCCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 999999999985432 12378899999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .....
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------------~~~~~ 225 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVP 225 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHH
T ss_pred cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHH
Confidence 3321 23356778999999998899999999999999999998 9999964332 11111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+........+...+..+.++|.+||+.||++|||+.++++.|+++....
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 11111112223334457999999999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.36 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=203.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~ 112 (351)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+..|..++..+ +||+|+++++++.+.. .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999965 4788999998643 234556788899999988 7999999999998765 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||+|+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||+
T Consensus 98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 999999999999998543 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...
T Consensus 168 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~ 229 (353)
T 2i0e_A 168 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DEL 229 (353)
T ss_dssp CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHH
T ss_pred ccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----------------HHH
Confidence 87532221 223456789999999999999999999999999999999999999975432 112
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
...+....+ .++...+..+.+||.+||..||++||+ +.++++|
T Consensus 230 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 230 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222222211 222334457899999999999999995 5888876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.60 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=202.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC------ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-e
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 111 (351)
.++|++.+.||+|+||.||+|.+. +++.+|+|++...... ....+.+|+.+++.++||||+++++++.+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999965 6899999998643322 3567889999999999999999999998775 4
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l 187 (351)
++|++|+.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEE
Confidence 5999999999999999432 3689999999999999999999999 999999999999999887 7999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------- 223 (321)
T 2a2a_A 161 IDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 223 (321)
T ss_dssp CCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------------
T ss_pred ccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 9999997654422 22345689999999999999999999999999999999999999964331
Q ss_pred cchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+..... ..+. ..+..+.+||.+||..||++|||+.+++++
T Consensus 224 --~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 --QETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --HHHHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111112111111 1111 123468999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.83 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=192.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999954 6889999998643 2223456788999999999999999999986542
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++||||+.++ |.+.+. ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEEeCCCCC-HHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 37999999875 555552 2488999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc--
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-- 267 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-- 267 (351)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...............
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999764432 12344678999999999999999999999999999999999999997654211000000000000
Q ss_pred ----cchhHHHhhcCc---------------cccCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 ----TDREKILEIMDP---------------ALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ----~~~~~~~~~~~~---------------~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.........+.. .+..... ......+.+||.+||..||++|||+.|+++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000011100 0000000 1124578999999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.30 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=204.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+.+. +++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999965 578899999864422 234567889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++++.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCce
Confidence 9999999999988432 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .....
T Consensus 164 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~~ 225 (294)
T 2rku_A 164 KVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----------------KETYL 225 (294)
T ss_dssp ECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHH
T ss_pred ecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHH
Confidence 654322 123345688899999999988899999999999999999999999964321 11111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+..... ..+......+.+++.+||+.||++|||+.+++++ .++...
T Consensus 226 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~--~~~~~~ 272 (294)
T 2rku_A 226 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSG 272 (294)
T ss_dssp HHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTS
T ss_pred HHhhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC--hheecC
Confidence 1111111 1122233468899999999999999999999987 445543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=312.89 Aligned_cols=264 Identities=29% Similarity=0.447 Sum_probs=205.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEE--EEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~--~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v 114 (351)
++|++.+.||+|+||.||+|.+. ++..+ ++|.+... .......+.+|+++++.+ +||||+++++++.+.. .++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999954 56544 88887632 233456788999999999 8999999999988765 4599
Q ss_pred EEEccCCChhhhccccCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 115 YDYMANGGLQEHLYPANG---------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
|+|+.+++|.+++..... .......+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 999999999999864320 001234789999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 264 (351)
+|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------- 247 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------- 247 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----------
Confidence 99999998642221 11223446778999999998889999999999999999998 9999965432
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
......+........+...+..+.+||.+||..||.+|||+.+++++|.+++.....
T Consensus 248 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 248 ------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 111111111112222333445799999999999999999999999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.57 Aligned_cols=261 Identities=28% Similarity=0.405 Sum_probs=201.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC--Ce
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RK 111 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 111 (351)
...+|++.+.||+|+||.||+|.+.. ...+++|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34678899999999999999998532 23578888764322 2346688899999999999999999986443 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 103 ~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred EEEEeCCCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccc
Confidence 7999999999999999542 24688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC--ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 192 LAKIGSDKAGG--HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 192 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------------- 240 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------------- 240 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------------
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------------
Confidence 99765432211 12233456778999999999999999999999999999999 666665433210
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
........... ..+...+..+.+++.+||+.||++|||+.++++.|++++..-
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 241 ITVYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00011111111 111223346899999999999999999999999999998853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=308.54 Aligned_cols=267 Identities=25% Similarity=0.284 Sum_probs=195.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-----CCChHHHHHHHHHHhccC---CCcceeeeEEEEcC
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-----KQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 109 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999995 478999999986432 122345667877777764 99999999998764
Q ss_pred C------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 110 R------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 110 ~------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
. .+++++++. ++|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 3 358999987 59999885433 13489999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 184 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.............
T Consensus 158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997654322 234467899999999999999999999999999999999999999754321000000000
Q ss_pred cccccch-----hHH-HhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDR-----EKI-LEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~-----~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... ... ...+...... .........+.+||.+||+.||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 000 0000000000 0001123468899999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.72 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=193.3
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--------CCChHHHHHHHHHHhccCCCcceeeeEEEE
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--------KQGEDEFKMEVELLGRLRSPYLLALLGYCS 107 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 107 (351)
....++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999954 68999999986431 111234778999999999999999999998
Q ss_pred cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC---c
Q 018744 108 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---H 184 (351)
Q Consensus 108 ~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~ 184 (351)
.+..++||+|+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++ .
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCC
T ss_pred cCceEEEEEcCCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcce
Confidence 8888899999999999998843 34689999999999999999999999 999999999999996544 5
Q ss_pred EEEeecccccccCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 261 (351)
++|+|||++...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 281 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----- 352 (419)
T 3i6u_A 281 IKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----- 352 (419)
T ss_dssp EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-----
T ss_pred EEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-----
Confidence 999999999865432 22334668999999999863 5678899999999999999999999975432110
Q ss_pred cccccccchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 262 WALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+ ..... .... ..+..+.+||.+||..||++|||+.+++++
T Consensus 353 -------~~~~i---~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 353 -------LKDQI---TSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -------HHHHH---HTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHHHH---hcCCC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00001 10000 1111 123468999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.82 Aligned_cols=272 Identities=20% Similarity=0.252 Sum_probs=202.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC------CcEEEEEEccccCCCC-----------hHHHHHHHHHHhccCCCccee
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQG-----------EDEFKMEVELLGRLRSPYLLA 101 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~~vk~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~ 101 (351)
..++|++.+.||+|+||.||+|.+.. ++.||+|++....... ...+..++..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999654 4789999986432110 012233555667778999999
Q ss_pred eeEEEEcC-----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 102 LLGYCSDR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 102 ~~~~~~~~-----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
+++++... ..++||+|+ +++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99988653 246999999 999999985432 4699999999999999999999999 99999999999
Q ss_pred EEeC--CCCcEEEeecccccccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCC
Q 018744 177 ILLD--KNFHAKVSDFGLAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249 (351)
Q Consensus 177 ilv~--~~~~v~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~ 249 (351)
||++ .++.++|+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998 88999999999997654322111 1123458999999999999999999999999999999999999997
Q ss_pred CCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 250 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
............ .......+..+++..+.. ...+..+.+++..||..||++||++.+|++.|+++++....
T Consensus 263 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 263 DNLKDPKYVRDS----KIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp GGTTCHHHHHHH----HHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccccCHHHHHHH----HHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 533210000000 000011122222222210 11234689999999999999999999999999999986443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.13 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=200.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v 114 (351)
++|++.+.||+|+||.||+|++. +++.+|+|++...... ....+..|..++..+ +||||+++++++.+.. .++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999965 6889999998754322 234577899999887 8999999999998765 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|..++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 89 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccc
Confidence 9999999999988543 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh-HH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE-KI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 273 (351)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ..
T Consensus 159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~ 228 (345)
T 3a8x_A 159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLF 228 (345)
T ss_dssp CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHH
T ss_pred cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc--------ccccHHHHH
Confidence 532221 2234567899999999999999999999999999999999999999643221000 000111 11
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~------~eil~~ 317 (351)
..+..... .++...+..+.+||.+||+.||++||++ .++++|
T Consensus 229 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 229 QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11111111 2223344578999999999999999995 677766
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=312.45 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=192.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC-hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~ 117 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+.. .++||+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999965 78899999986432211 123446999999999999999999998764 4599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+. ++|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 48888875432 3689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec--------cccccc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW--------ALPRLT 268 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~~~ 268 (351)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+............ ..+...
T Consensus 152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 322 22234567899999999876 5689999999999999999999999976432100000000 000000
Q ss_pred chhHHHhhcCccccCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 269 DREKILEIMDPALEGQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..........+...... .......+.+||.+||+.||++|||+.|++++ .++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 287 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLS 287 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhh
Confidence 00000000000000000 01123468899999999999999999999997 45544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=310.25 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=196.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--------CChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999964 688999999864321 1223477899999999999999999999988
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc---EE
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AK 186 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~---v~ 186 (351)
..++|++|+.+++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++. ++
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVG-------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SEEEEEECCTTEETHHHHST-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred ceEEEEecCCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 88899999999999998843 34689999999999999999999999 9999999999999987654 99
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
|+|||++...... .......|+..|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 158 l~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------- 227 (322)
T 2ycf_A 158 ITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------- 227 (322)
T ss_dssp ECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------
T ss_pred EccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------
Confidence 9999998764332 1223356889999999874 46788999999999999999999999975432210
Q ss_pred cccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 264 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+........ .......+..+.+||.+||..||++|||+.+++++
T Consensus 228 -----~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 228 -----LKDQITSGKYNFI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -----HHHHHHHTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHhCccccC-chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000111000000 00000123468999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=306.73 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=204.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc---------
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--------- 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 108 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4577999999999999999999975 78999999986442 356779999999999999999998753
Q ss_pred --------CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC
Q 018744 109 --------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180 (351)
Q Consensus 109 --------~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~ 180 (351)
...++||+|+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 22469999999999999996432 24689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 181 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------- 224 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------- 224 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred CCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence 99999999999987654432 223456889999999999989999999999999999999999886311
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
......+....+...+ +..+.++|.+||+.||++|||+.+++++|+.+.+....
T Consensus 225 ---------~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 225 ---------SKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ---------HHHHHHHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ---------HHHHHHhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111222222222222 34588999999999999999999999999998875443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=325.55 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=204.0
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR 110 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 110 (351)
.+....++|++.+.||+|+||.||+|++. +++.||+|++... .......+..|..++..++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445689999999999999999999965 5889999998531 2233455788999999999999999999998875
Q ss_pred e-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 K-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 ~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
. ++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence 4 599999999999998843 2588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCC----CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 265 (351)
||++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.
T Consensus 212 FG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------ 278 (410)
T 3v8s_A 212 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------ 278 (410)
T ss_dssp CTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------------
T ss_pred cceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------------
Confidence 99997654322 11233567999999999998654 78999999999999999999999975432
Q ss_pred cccchhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 266 RLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
......++.......++ ...+..+.+||.+||..+|.+ ||++.+|++|
T Consensus 279 ----~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 279 ----VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11222222211111111 123456899999999999988 9999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=303.37 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=203.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. ++..+++|++... .......+.+|+++++.++||||+++++++.+... ++|+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999965 5788999998532 23345678899999999999999999999987654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 94 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999998543 3689999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ......++..|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 164 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~~~~~~ 223 (284)
T 2vgo_A 164 APSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----------------TETHRR 223 (284)
T ss_dssp CSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHH
T ss_pred Cccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----------------hHHHHH
Confidence 4332 12345688999999999998999999999999999999999999964321 111112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
+..... .++...+..+.+||.+||..||.+|||+.+++++ .+++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h--~~~~ 267 (284)
T 2vgo_A 224 IVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH--PWVK 267 (284)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC--HHHH
T ss_pred Hhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC--HHHH
Confidence 221111 1222334568999999999999999999999987 4444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.46 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=202.6
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++..+..++||+|+.+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 37999999999999643 467899999875322 3357789999999999999999999999988888999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++........
T Consensus 455 ~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 455 PLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999432 4689999999999999999999999 999999999999999999999999999986544322
Q ss_pred C-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 202 G-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 202 ~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+... ..+...+..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~ 587 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEK 587 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHT
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHc
Confidence 1 12223445678999999999999999999999999999998 9999975432 222222222
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
......+...+..+.+||..||+.||++|||+.++++.|++++..
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222333444556799999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=316.74 Aligned_cols=276 Identities=20% Similarity=0.261 Sum_probs=211.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367999999999999999999965 58999999987433 34457788899999999999999999998764 34699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe----CCCCcEEEeec
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDF 190 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----~~~~~v~l~df 190 (351)
|+|+.+++|.+++.... ....+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.++|+||
T Consensus 88 ~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp ECCCTTEEHHHHTTSGG----GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred EecCCCCCHHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 99999999999995433 122489999999999999999999999 99999999999999 77888999999
Q ss_pred ccccccCCCCCCceecccCCCccccccccccc--------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
|++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 161 GAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 9997654321 2234568999999999865 5678899999999999999999999975432211100000
Q ss_pred cc-cccc----------chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 263 AL-PRLT----------DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 263 ~~-~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.. .... ........-...............+.+++..||+.||++|||+.++++.+.+++...
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 00 0000 000000000011122344677788999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=320.41 Aligned_cols=210 Identities=27% Similarity=0.380 Sum_probs=176.1
Q ss_pred ceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-----CCccee
Q 018744 28 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----SPYLLA 101 (351)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~ 101 (351)
...+++..-....++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34444455555568999999999999999999996 46889999998632 223456677999999986 999999
Q ss_pred eeEEEEcCC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC
Q 018744 102 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180 (351)
Q Consensus 102 ~~~~~~~~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~ 180 (351)
+++++...+ .++||+++ +++|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+||+++
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD 171 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence 999887765 45999999 889999986433 23589999999999999999999999 999999999999997
Q ss_pred C-------------------------CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehH
Q 018744 181 K-------------------------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 235 (351)
Q Consensus 181 ~-------------------------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG 235 (351)
. ++.++|+|||++...... .....|++.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 789999999999764332 2345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 018744 236 VVLLELLTGRVPIDVNK 252 (351)
Q Consensus 236 ~~l~~lltg~~pf~~~~ 252 (351)
|++|+|++|..||....
T Consensus 247 ~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHCCCCCCCCc
Confidence 99999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=305.62 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=202.6
Q ss_pred HHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEE-EcC-CeEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDR-RKLLV 114 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~-~~~~v 114 (351)
...++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+..|+.+++.++|++++..+..+ ... ..+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4558899999999999999999995 5788999998754322 23577899999999988877777765 333 34599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg 191 (351)
|+++ +++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||++ +.++.++|+|||
T Consensus 84 ~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEcc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 9999 999999985332 3689999999999999999999999 99999999999999 788999999999
Q ss_pred cccccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 192 LAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 192 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----- 228 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----- 228 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-----
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh-----
Confidence 998765443211 2234568999999999999999999999999999999999999997654321111100
Q ss_pred ccchhHHHhhcC---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 267 LTDREKILEIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 267 ~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
........ ......+ +..+.+|+..||+.||++|||+.++++.|++++.....
T Consensus 229 ----~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 229 ----RISEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHHHHHHSCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ----hhhcccccchhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00000000 0001111 34699999999999999999999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.96 Aligned_cols=265 Identities=19% Similarity=0.242 Sum_probs=194.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc----CCcEEEEEEccccCCC-----------ChHHHHHHHHHHhccCCCcceeeeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQ-----------GEDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
.++|++.+.||+|+||.||+|.+. ++..+++|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 378999999999999999999964 5678999988644321 1123556888899999999999999
Q ss_pred EEEc----C-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe
Q 018744 105 YCSD----R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 105 ~~~~----~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv 179 (351)
++.. . ..++||+++ +++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 8866 3 446999999 99999999533 3789999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEeecccccccCCCCCC-----ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 180 DKNF--HAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 180 ~~~~--~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
+.++ .++|+|||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8777 9999999999765332111 11234568999999999999999999999999999999999999996422
Q ss_pred CCCCcceeecccccccchhHHHhhcCccccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 253 PSGEGVLVSWALPRLTDREKILEIMDPALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
........ ........+...+.. ......+..+.++|..||..||++|||+.++++.|+++..
T Consensus 265 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQT--------AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHH--------HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHH--------HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11000000 000000000000000 0000223469999999999999999999999999988765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=303.93 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=200.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++..... ++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999965 688999999864432 223567789999999999999999999987754 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc---EEEeeccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSDFGL 192 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~---v~l~dfg~ 192 (351)
+++.+++|.+.+... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||+
T Consensus 85 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999998888543 3689999999999999999999999 9999999999999976655 99999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------------~~~ 215 (284)
T 3kk8_A 155 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------------HRL 215 (284)
T ss_dssp CEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHH
T ss_pred eEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----------------hHH
Confidence 97654322 22345689999999999999999999999999999999999999964331 111
Q ss_pred HHhhcCcccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+...... .......+..+.+|+.+||+.||++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111111 11111234568999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.55 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=196.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+. +++.+|+|++...... ....+.+|+.+++.++||||+++++++.+... ++|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 378999999999999999999965 5899999988644322 13557789999999999999999999987654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|..++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 82 EYCDHTVLHELDRY-------QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp ECCSEEHHHHHHHT-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCchHHHHHhh-------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 99999999888743 24689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh-HH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE-KI 273 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 273 (351)
..... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+..................... ..
T Consensus 152 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 152 LTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 54322 12234568889999999876 5689999999999999999999999975432111000000000000000 00
Q ss_pred H-------hhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 L-------EIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~-------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
. ....+....... ...+..+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~ 290 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH--PYFEN 290 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS--GGGTT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC--hHHHh
Confidence 0 000000000000 1123468899999999999999999999987 44443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.13 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=194.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
++|++.+.||+|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++||||+++++++.+... ++|++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67999999999999999999964 68899999986543 3456788999999999999999999999987654 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeeccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAK 194 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg~~~ 194 (351)
+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++.
T Consensus 102 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 102 CEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred CCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999998854321 124689999999999999999999999 99999999999999 456789999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... ......++..|+|||++. ..++.++||||||+++|+|++|..||.+.... ......
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------------~~~~~~ 237 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------------EVQQKA 237 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------HHHHHH
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------------HHHhhh
Confidence 543321 234456889999999875 56889999999999999999999999754311 000000
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... ....+..+.+||.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 238 TYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111000 00123468899999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.86 Aligned_cols=275 Identities=22% Similarity=0.293 Sum_probs=210.1
Q ss_pred hcCCCcCceeeecCceEEEEEEE-----cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC---Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 111 (351)
.++|++.+.||+|+||.||+|.+ .+++.|++|++........+.+.+|+.+++.++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36699999999999999999983 36889999999765555567789999999999999999999988654 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++|++++.+++|.+++.... ..+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 79999999999999995432 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||............ .........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~ 269 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG-NDKQGQMIV 269 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC-TTCCTHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc-cccchhhhH
Confidence 9987554332111 22344667799999999888999999999999999999999998632100000000 000000000
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+.+.+........+...+..+.+||.+||+.||++|||+.++++.|+++..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122222222223334456799999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=325.23 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=205.3
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
..++....++|++.+.||+|+||.||+|++. +++.||+|++... .......+..|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455689999999999999999999965 5788999998632 22233457889999999999999999999987
Q ss_pred CCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 RRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 ~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
... ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~------~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEE
Confidence 754 5999999999999999542 24689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
+|||++....... ........||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.
T Consensus 217 ~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------- 286 (437)
T 4aw2_A 217 ADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------- 286 (437)
T ss_dssp CCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---------
T ss_pred cchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---------
Confidence 9999997644322 12233467999999999987 45789999999999999999999999975432
Q ss_pred ccccccchhHHHhhcCccccCCCC---HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 317 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~P~~--Rpt~~eil~~ 317 (351)
......++.......++ ...+..+.+||.+||..+|++ ||++.|+++|
T Consensus 287 -------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 -------VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -------HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -------hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11122222111000111 123446899999999998888 9999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.47 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=192.8
Q ss_pred CceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEccCCCh
Q 018744 46 SNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGL 123 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~~~~~L 123 (351)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.. .++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999995 468999999987654445577889999999999999999999998765 4599999999999
Q ss_pred hhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe--CCCCcEEEeecccccccCCCCC
Q 018744 124 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 124 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv--~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.++|+|||++.......
T Consensus 174 ~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 174 FDRIIDES------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp HHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 98885432 3589999999999999999999999 99999999999999 677899999999998654332
Q ss_pred CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccc
Q 018744 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (351)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------------~~~~~~i~~~~~ 305 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----------------AETLNNILACRW 305 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHTCC
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhccC
Confidence 22345689999999999988999999999999999999999999975432 111222211111
Q ss_pred c--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 282 E--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 282 ~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. .......+..+.+||.+||..||.+|||+.+++++
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00011224578999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=308.05 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=198.2
Q ss_pred hcCCCcC-ceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~-~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++. +.||+|+||.||+|.+ .+++.||+|++..........+.+|+.++.++ +||||+++++++.+.+. ++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3678885 7899999999999995 47899999999766666678889999999985 79999999999987654 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc---EEEeeccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSDFGL 192 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~---v~l~dfg~ 192 (351)
||+.+++|.+++... ..+++..++.++.||+.||+|||++ +++|+||||+||+++.++. ++|+|||+
T Consensus 91 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999543 3689999999999999999999999 9999999999999988766 99999999
Q ss_pred ccccCCCCC-----CceecccCCCccccccccccc-----CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec
Q 018744 193 AKIGSDKAG-----GHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262 (351)
Q Consensus 193 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~ 262 (351)
+........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 875432211 111223458999999999875 4678999999999999999999999986554322111100
Q ss_pred ccccccchhHHHhhcCccccCCCCHH----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 263 ALPRLTDREKILEIMDPALEGQYSMK----EVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... ........+..... ..+.. .+..+.+||.+||..||++|||+.+++++
T Consensus 241 ~~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPA-CQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHH-HHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchh-HHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 00001111111111 11211 23468999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=307.69 Aligned_cols=254 Identities=20% Similarity=0.339 Sum_probs=202.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+. +|+.+++|++..........+.+|+.+++.++||||+++++++.+... ++|++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4578999999999999999999965 689999999976544455678899999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg~~ 193 (351)
++.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||++ +.++.++|+|||++
T Consensus 87 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 87 LVSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp CCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred cCCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999988543 3689999999999999999999999 99999999999999 78899999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ......+++.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~~~~ 216 (304)
T 2jam_A 157 KMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----------------SKLF 216 (304)
T ss_dssp CCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHH
T ss_pred eecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHH
Confidence 653321 12334588999999999999999999999999999999999999964321 1111
Q ss_pred HhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+.... .........+..+.+||.+||..||++|||+.+++++ .+++.
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~ 267 (304)
T 2jam_A 217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH--PWIDG 267 (304)
T ss_dssp HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS--HHHHS
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--ccccC
Confidence 1111111 1111122334578999999999999999999999987 34443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=302.82 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=182.1
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+ .+++.+++|++... .....+.+.+|+.+++.++||||+++++++.+... ++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999996 47899999998632 23345778899999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR------VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp EECCTTEEHHHHHHTC------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 9999999999998543 24689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......... .
T Consensus 161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~ 222 (278)
T 3cok_A 161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------N 222 (278)
T ss_dssp ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------H
Confidence 6543221 123356788999999999888999999999999999999999999754432110 0
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... ...+...+..+.+||.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 223 KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000000 01112233468899999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=308.06 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-e
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 111 (351)
....++|++.+.||+|+||.||+|.+. +++.|++|++....... .+.+.+|+.+++.++||||+++++++.... .
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 344589999999999999999999965 68899999986543322 366888999999999999999999987765 4
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++++.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence 5999999999999998543 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++........ .......++..|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 180 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------------~ 241 (309)
T 2h34_A 180 IASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----------------S 241 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----------------H
T ss_pred cCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----------------H
Confidence 9876443221 122345688899999999998999999999999999999999999974321 0
Q ss_pred HHHhhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhccCC
Q 018744 272 KILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 272 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~l~~~~~~~~~ 327 (351)
.+...+.... ........+..+.++|.+||+.||++|| |+.++++.|++++.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 242 VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 1111111100 0111222334689999999999999999 999999999998876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.01 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=193.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .......+..|+.+++.++||||+++++++...+. ++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999954 6899999998642 33344567789999999999999999999987654 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|||+.+++|..++... ..+++..++.++.||+.||+|||+ . +++|+||||+|||++.++.++|+|||++
T Consensus 227 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999988443 368999999999999999999998 8 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 297 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~ 358 (446)
T 4ejn_A 297 KEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLF 358 (446)
T ss_dssp CTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHH
T ss_pred eeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------HHHH
Confidence 753222 1223456789999999999999999999999999999999999999964332 1111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
..+..... .++...+..+.+||.+||+.||++|| |+.++++|
T Consensus 359 ~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 359 ELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11111111 12223345789999999999999999 99999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.41 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=205.9
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEE-cC-CeEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DR-RKLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~-~~~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+.++. .. ..++|++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999996 5789999999864432 346888999999999988777776653 33 3469999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg~~ 193 (351)
++ +++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||++ +.++.++|+|||++
T Consensus 86 ~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 99 899999985332 3689999999999999999999999 99999999999999 48889999999999
Q ss_pred cccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 194 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 194 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
.......... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------- 228 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE------- 228 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-------
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh-------
Confidence 8755443211 1234568999999999999999999999999999999999999998644321111000
Q ss_pred chhHHHhhcC---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 269 DREKILEIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 269 ~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
........ ..+...+ +..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 229 --~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 229 --RISEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp --HHHHHHHHSCHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --hhcccccCCchHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00000000 0011122 34689999999999999999999999999999886544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=310.40 Aligned_cols=276 Identities=22% Similarity=0.250 Sum_probs=194.8
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC-----ChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
+....++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445688999999999999999999964 6899999998643221 124677899999999999999999999766
Q ss_pred -CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
..++|++|+.+ +|..++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CceEEEEEcCCC-CHHHHHHhc------CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEE
Confidence 45699999986 788877432 23578889999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.................
T Consensus 155 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 155 DFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999997654322 223445689999999998754 58899999999999999999999997543210000000000000
Q ss_pred -----cchhHHHhhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 268 -----TDREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 268 -----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.......+..........+ ...+..+.+||.+||..||++|||+.|++++ .+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~~ 298 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNR 298 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhcC
Confidence 0000000000000000001 1123579999999999999999999999998 455543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.28 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=194.3
Q ss_pred CCCcCceeeecCceEEEEEEEc--CC--cEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEc--CCeEEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS--NG--RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--RRKLLV 114 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~--~~--~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v 114 (351)
.|.+.+.||+|+||.||+|.+. ++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999853 22 357889886432 2334678899999999999999999998753 355799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 99999999999995432 3578999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCc--eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchh
Q 018744 195 IGSDKAGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 195 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------------~~~ 307 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITV 307 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------------HHH
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------------HHH
Confidence 643322111 1233456778999999999999999999999999999999 777876543210 000
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.+.... ....+...+..+.+++.+||+.||++|||+.++++.|++++..-..
T Consensus 308 ~~~~~~----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 308 YLLQGR----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp HHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHcCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 111111 1111222345689999999999999999999999999999986543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.12 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=182.6
Q ss_pred cCCCcC---ceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKS---NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~---~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~v 114 (351)
++|.+. +.||+|+||.||+|.+. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+.. .++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 445554 78999999999999965 6899999998543 3466778999999997 999999999998775 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC---cEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~---~v~l~dfg 191 (351)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++ .++|+|||
T Consensus 85 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 85 MELLNGGELFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp ECCCCSCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999999999999543 4689999999999999999999999 999999999999997665 89999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++....... .......+++.|+|||++.+..++.++|||||||++|+|++|..||......... .....
T Consensus 155 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~ 223 (325)
T 3kn6_A 155 FARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---------TSAVE 223 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------CCHHH
T ss_pred cceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------ccHHH
Confidence 997644322 2234456789999999999999999999999999999999999999764432100 00111
Q ss_pred HHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 272 KILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
....+.......... ...+..+.+||.+||..||++|||+.+++++ .+++.
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h--~w~~~ 276 (325)
T 3kn6_A 224 IMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN--EWLQD 276 (325)
T ss_dssp HHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC--GGGCT
T ss_pred HHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC--hhhcc
Confidence 122222221111110 1234578999999999999999999999987 45554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=311.55 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=204.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
.++|.+.+.||+|+||.||++.+. +++.+++|++..... ...+.+.+|+.+++.++|+||+++++++.+... ++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 478999999999999999999965 578899999864422 234567889999999999999999999987754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|+|+.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 120 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 9999999999988433 3689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..||..... .....
T Consensus 190 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~~~~~ 251 (335)
T 2owb_A 190 KVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----------------KETYL 251 (335)
T ss_dssp ECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHH
T ss_pred ecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----------------HHHHH
Confidence 654322 123345688999999999988899999999999999999999999964321 01111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+..... ..+......+.+||.+||+.||++|||+.+++++ .++..
T Consensus 252 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~--~~~~~ 297 (335)
T 2owb_A 252 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTS 297 (335)
T ss_dssp HHHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHT
T ss_pred HHhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC--ccccC
Confidence 1111111 1122233468899999999999999999999987 44444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=304.37 Aligned_cols=277 Identities=24% Similarity=0.336 Sum_probs=202.0
Q ss_pred HHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc--CCCcceeeeEEEEcC---
Q 018744 35 QLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL--RSPYLLALLGYCSDR--- 109 (351)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~--- 109 (351)
.-....++|++.+.||+|+||.||+|.+. ++.||+|++... ....+..|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34445688999999999999999999974 889999998533 234445566666655 899999999988765
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCceecCCCCCcEEeCCC
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC-----SPPVIHRDFKSSNILLDKN 182 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~di~p~Nilv~~~ 182 (351)
..++||+|+.+++|.+++.. ..+++..++.++.|++.||.|||+.. ..+++|+||||+||+++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCceEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 34699999999999999943 25889999999999999999999651 2379999999999999999
Q ss_pred CcEEEeecccccccCCCCCCce--ecccCCCcccccccccccCCCCCc------cceeehHHHHHHHHhCCCCCCCCCCC
Q 018744 183 FHAKVSDFGLAKIGSDKAGGHV--STRVLGTQGYVAPEYALTGHLTTK------SDVYSYGVVLLELLTGRVPIDVNKPS 254 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~s~~------~DiwslG~~l~~lltg~~pf~~~~~~ 254 (351)
+.++|+|||++........... .....|++.|+|||++.+..+... +|||||||++|+|++|..|+......
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 9999999999976543322111 124568999999999987766655 99999999999999995554321110
Q ss_pred CCcceeecccccccchhHHHh-hcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 255 GEGVLVSWALPRLTDREKILE-IMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..... . ............. ..........+ ...+..+.+|+.+||+.||++|||+.+++++|+++.+..
T Consensus 259 ~~p~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 259 QLPYH-D-LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCTTT-T-TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHh-h-hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 00000 0 0000011111111 11222222222 266778999999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=307.14 Aligned_cols=244 Identities=20% Similarity=0.256 Sum_probs=187.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCCh--HHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGE--DEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++........ .....|+..+..+ +|+||+++++++.+... ++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999965 789999998754322222 2333455555444 89999999999987754 5899
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++ +++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 137 e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred ecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 998 668888875432 3699999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......|++.|+|||++.+ .++.++|||||||++|+|++|..|+.... ....
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------------------~~~~ 263 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------------------GWQQ 263 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------------------HHHH
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------------------HHHH
Confidence 54322 2334568999999998876 68999999999999999999976654211 1111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.............+..+.+||.+||+.||++|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111111111223579999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=312.07 Aligned_cols=277 Identities=21% Similarity=0.283 Sum_probs=202.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 37899999999999999999996 4789999998864332 2345678899999999999999999988753
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..++||+|+.+ +|.+.+... ...+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl 165 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred CceEEEEEeccCC-CHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 24699999986 666666432 24689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCC--ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc-
Q 018744 188 SDFGLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA- 263 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~- 263 (351)
+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999865432221 22344568999999999876 46899999999999999999999999764321000000000
Q ss_pred -------cccccchhHHHhhcCccccCCCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018744 264 -------LPRLTDREKILEIMDPALEGQYSMK-------EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 329 (351)
Q Consensus 264 -------~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~~~ 329 (351)
.+.... ......+........... ....+.+||.+||..||++|||+.|++++ .++.....+.
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~~~~ 322 (351)
T 3mi9_A 246 GSITPEVWPNVDN-YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDPMPS 322 (351)
T ss_dssp CCCCTTTSTTGGG-CGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGSSSCCC
T ss_pred CCCChhhcccccc-chhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC--CCcCCCCCcc
Confidence 000000 000000000000001111 02358899999999999999999999998 6666544433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=304.63 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=195.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----CeE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 112 (351)
..|++.+.||+|+||.||+|.+. ++..+++|.+.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888999999999999999964 67889999886432 22345688899999999999999999987642 246
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeC-CCCcEEEee
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLD-KNFHAKVSD 189 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~-~~~~v~l~d 189 (351)
+|++|+.+++|.+++... ..+++..++.++.||+.||.|||+. + ++|+||+|+||+++ .++.++|+|
T Consensus 106 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 999999999999999543 3689999999999999999999999 8 99999999999997 789999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 176 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------- 235 (290)
T 1t4h_A 176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--------------- 235 (290)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------------
T ss_pred CCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---------------
Confidence 9998754332 2234568999999998764 5899999999999999999999999643221
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......................+.+||.+||..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111111111111111122468999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=312.01 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=197.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+|++++..+ +||||+++++++.+... ++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999965 6889999999654332 24588888887 79999999999988755 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC----CcEEEeecc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN----FHAKVSDFG 191 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~----~~v~l~dfg 191 (351)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||++..+ +.++|+|||
T Consensus 96 E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp CCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999999988432 4689999999999999999999999 99999999999998433 359999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++....... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 166 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------~~~~ 230 (342)
T 2qr7_A 166 FAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-------------TPEE 230 (342)
T ss_dssp TCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-------------CHHH
T ss_pred CcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-------------CHHH
Confidence 998654432 1234457899999999998888899999999999999999999999753211 0011
Q ss_pred HHHhhcCcc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 272 KILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 272 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+.... +...+....+..+.+||.+||..||++|||+.+++++-
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 111111111 11112223345789999999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=304.17 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=203.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.+.|++.+.||+|+||.||+|.+. +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.+.. .++|++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 367999999999999999999954 68899999986443 344578899999999999999999999887664 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 101 YLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp CCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceec
Confidence 9999999999832 3689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~ 234 (303)
T 3a7i_A 170 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------------KVLFLIPKN 234 (303)
T ss_dssp BTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHHHHS
T ss_pred Cccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------------HHHHHhhcC
Confidence 4322 1223456888999999999999999999999999999999999999643210 000011111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
....+.. ..+..+.+||.+||+.||++|||+.+++++..
T Consensus 235 ~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 235 NPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1112222 23346899999999999999999999998743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=312.74 Aligned_cols=242 Identities=21% Similarity=0.345 Sum_probs=197.7
Q ss_pred HhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--------CChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999995 4688999999864321 1234567799999999999999999999877
Q ss_pred Ce-EEEEEEccCC-ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 RK-LLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 ~~-~~v~~~~~~~-~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
.. ++|++++.+| +|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEE
Confidence 65 4999988776 898888432 3689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||++....... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 172 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------ 236 (335)
T 3dls_A 172 IDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------ 236 (335)
T ss_dssp CCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred eecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence 9999998654432 2234568999999999988776 78999999999999999999999642110
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...... .+...+..+.+||.+||+.||++|||+.+++++
T Consensus 237 ----------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011010 011123468999999999999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=311.24 Aligned_cols=276 Identities=20% Similarity=0.273 Sum_probs=191.1
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR 110 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 110 (351)
.......++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 334455689999999999999999999954 7889999998643322 2345678999999999999999999998775
Q ss_pred e-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe-----CCCCc
Q 018744 111 K-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-----DKNFH 184 (351)
Q Consensus 111 ~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv-----~~~~~ 184 (351)
. ++||+|+.+ +|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||++ +.++.
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCE
T ss_pred EEEEEEecCCC-CHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccce
Confidence 4 599999975 898888433 3689999999999999999999999 99999999999999 45556
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 263 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 263 (351)
++|+|||++....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...............
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 9999999997654322 122345678999999999874 5899999999999999999999999754321000000000
Q ss_pred c--ccccc---hhHHHhhcC--ccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 264 L--PRLTD---REKILEIMD--PALEGQ-----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 264 ~--~~~~~---~~~~~~~~~--~~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
. +.... ......... +..... ........+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 324 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH--PYFSH 324 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSS
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC--cccCC
Confidence 0 00000 000000000 000000 000023468899999999999999999999987 45543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=317.75 Aligned_cols=266 Identities=22% Similarity=0.322 Sum_probs=188.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC---Ce
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RK 111 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~---~~ 111 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.+. ||||+++++++... ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4589999999999999999999954 6899999998533 2223355778999999997 99999999998754 35
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
++||+|+. ++|..++.. ..++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 87 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 79999997 578888843 3688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-------------------CCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 192 LAKIGSDKA-------------------GGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 192 ~~~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997653311 0112234578999999999886 67899999999999999999999999765
Q ss_pred CCCCCcceeecccccccchhHH------------Hhhc------CccccCCC------------CHHHHHHHHHHHHhcc
Q 018744 252 KPSGEGVLVSWALPRLTDREKI------------LEIM------DPALEGQY------------SMKEVIQVAAIAAMCV 301 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~------~~~~~~~~------------~~~~~~~l~~li~~~l 301 (351)
+............ .......+ ..+. .......+ .......+.+||.+||
T Consensus 235 ~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 4211100000000 00000000 0000 00000000 0012346889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 018744 302 QPEADYRPLMADVVQS 317 (351)
Q Consensus 302 ~~~P~~Rpt~~eil~~ 317 (351)
..||++|||+.|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=312.07 Aligned_cols=246 Identities=30% Similarity=0.393 Sum_probs=196.0
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+.|++.+.||+|+||.||+|.+ .+++.||+|++....... .+.+.+|+++++.++||||+++++++.... .++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5589999999999999999995 578999999986443322 246788999999999999999999987765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+. |+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 134 e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9997 57777774322 4689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... .....|++.|+|||++. +..++.++|||||||++|+|++|..||..... ...
T Consensus 204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----------------~~~ 261 (348)
T 1u5q_A 204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSA 261 (348)
T ss_dssp SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHH
T ss_pred cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----------------HHH
Confidence 432 13356899999999985 56789999999999999999999999964331 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
+..+.............+..+.+||.+||+.||++|||+.+++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111111111111122344688999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.97 Aligned_cols=246 Identities=17% Similarity=0.202 Sum_probs=189.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHH---HHhccCCCcceeee-------EE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVE---LLGRLRSPYLLALL-------GY 105 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 105 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999995 56899999998633 2334467888994 55555799999988 66
Q ss_pred EEcC------------------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 018744 106 CSDR------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 167 (351)
Q Consensus 106 ~~~~------------------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 167 (351)
+.+. ..+++|||+ +|+|.+++............+++..++.++.||+.||+|||++ ++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 6654 256999999 6799999965432111123455688999999999999999999 99
Q ss_pred eecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccC-----------CCCCccceeehHH
Q 018744 168 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----------HLTTKSDVYSYGV 236 (351)
Q Consensus 168 ~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~s~~~DiwslG~ 236 (351)
+|+||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2344556 899999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 237 VLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 237 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
++|+|++|..||......... ..+... ...+ +..+.+||.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999754432110 011110 0122 346889999999999999999999997
Q ss_pred H
Q 018744 317 S 317 (351)
Q Consensus 317 ~ 317 (351)
+
T Consensus 360 h 360 (377)
T 3byv_A 360 T 360 (377)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.09 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=200.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcce-eeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+..|+++++.++|++.+ .+..++.... .++||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999995 4689999998764432 23477899999999875444 4444444444 458999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~dfg~~ 193 (351)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+|||| +.++.++|+|||++
T Consensus 84 ~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 99 899999985432 4699999999999999999999999 99999999999999 58899999999999
Q ss_pred cccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 194 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 194 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
.......... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~------------ 221 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------------ 221 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH------------
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH------------
Confidence 8765433221 12256789999999999999999999999999999999999999976443211
Q ss_pred chhHHHhhcCccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 269 DREKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+..+......... ....+..+.+||..||..+|++||++.+|++.|++++..
T Consensus 222 -~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 222 -KQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -HHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0111111111000000 001134689999999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.49 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=205.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 113 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+... ++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4478999999999999999999965 7899999998543 23456788999999999999999999999988754 59
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe---CCCCcEEEeec
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDF 190 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv---~~~~~v~l~df 190 (351)
|++++.+++|.+.+... ..+++..++.++.||+.||.|||++ +++|+||||+||++ +.++.++|+||
T Consensus 104 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 99999999999988533 4689999999999999999999999 99999999999999 56789999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+... .
T Consensus 174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~ 233 (484)
T 3nyv_A 174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----------------Y 233 (484)
T ss_dssp THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 9997654332 2344568999999998876 689999999999999999999999975432 1
Q ss_pred hHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 271 EKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.....+.........+ ...+..+.+||.+||..||++|||+.++++| .+++.
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h--~~~~~ 287 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH--EWIQT 287 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--HHHHH
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC--hhhcc
Confidence 1111221111111111 1234578999999999999999999999998 44443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.86 Aligned_cols=257 Identities=20% Similarity=0.341 Sum_probs=202.4
Q ss_pred HHHHHHhcCCCcC-ceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccC-CCcceeeeEEEEc
Q 018744 34 KQLHSATGGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR-SPYLLALLGYCSD 108 (351)
Q Consensus 34 ~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 108 (351)
.......++|.+. +.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++..+. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3355666889998 89999999999999965 68999999986432 233567888999999994 6999999999987
Q ss_pred CCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCc
Q 018744 109 RRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFH 184 (351)
Q Consensus 109 ~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~ 184 (351)
... ++||+|+.+++|.+++... ....+++..++.++.||+.||+|||++ +++|+||||+||+++. ++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE-----LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC-----C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred CCeEEEEEEecCCCcHHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 754 5999999999999998432 224689999999999999999999999 9999999999999987 789
Q ss_pred EEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 264 (351)
++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------- 238 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----------- 238 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------
Confidence 9999999998654322 22345689999999999999999999999999999999999999965332
Q ss_pred ccccchhHHHhhc--CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 265 PRLTDREKILEIM--DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 265 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+. ............+..+.+||.+||..||++|||+.+++++
T Consensus 239 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 239 -----QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111111 1111112222334568999999999999999999999988
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=307.64 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=200.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEc---CCeE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSD---RRKL 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 112 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|.+..... ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3478999999999999999999965 689999999864322 234568889999999999999999998743 2456
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----ceecCCCCCcEEeCCCCcEEE
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-----VIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----i~H~di~p~Nilv~~~~~v~l 187 (351)
+|++|+.+++|.+++..... ....+++..++.++.|++.||.|||+. + ++|+||+|+||+++.++.++|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEE
T ss_pred EEEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 99999999999999865431 223589999999999999999999999 8 999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------- 221 (279)
T 2w5a_A 158 GDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------- 221 (279)
T ss_dssp CCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred ecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------------
Confidence 9999987654321 112334678899999999988999999999999999999999999974321
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
......+.... ....+...+..+.++|.+||+.||++|||+.++++++.
T Consensus 222 --~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 222 --KELAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp --HHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --HHHHHHHhhcc-cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 01111111111 11222233457999999999999999999999998743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.41 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=189.6
Q ss_pred hcCCCcC-ceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhc-cCCCcceeeeEEEEc-----CCe
Q 018744 40 TGGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGR-LRSPYLLALLGYCSD-----RRK 111 (351)
Q Consensus 40 ~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~-----~~~ 111 (351)
.++|.+. +.||+|+||.||+|.+. +++.||+|++.. ...+.+|+.++.. .+||||+++++++.. ...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 68999999999999965 688999999852 2456778888744 589999999998864 235
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEe
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVS 188 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~ 188 (351)
++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++. ++.++|+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 69999999999999996432 13589999999999999999999999 9999999999999987 7899999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------- 274 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--------- 274 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---------
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---------
Confidence 999997643321 23456689999999999999999999999999999999999999976543211000
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
....+... ...+........+..+.+||.+||+.||++|||+.+++++-
T Consensus 275 ~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 275 MKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHHHHT-CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcC-cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00001000 00000011112345689999999999999999999999983
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.33 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=189.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---CChHHHHHHHHH-HhccCCCcceeeeEEEEcCCe-EE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVEL-LGRLRSPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~-~~ 113 (351)
.++|++.+.||+|+||.||+|++. +++.||+|++..... .....+..|..+ ++.++||||+++++++.+... ++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 478999999999999999999965 588999999864322 223345556665 567899999999999987754 59
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++
T Consensus 117 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccc
Confidence 99999999999998543 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ....
T Consensus 187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~ 248 (373)
T 2r5t_A 187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----------------AEMY 248 (373)
T ss_dssp GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----------------HHHH
T ss_pred cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHH
Confidence 7533221 223456789999999999999999999999999999999999999964331 1122
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 312 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 312 (351)
..++...+ .++......+.+||.+||+.||.+||++.
T Consensus 249 ~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 249 DNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 22222221 12223345689999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.59 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=198.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC------CChHHHHHHHHHHhccCCCcceeeeEEEEcCC-e
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 111 (351)
.++|++.+.||+|+||.||+|.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999965 689999998864322 13577899999999999999999999998765 4
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l 187 (351)
++|++++.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEE
Confidence 5999999999999998532 3689999999999999999999999 999999999999998877 8999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------- 216 (283)
T 3bhy_A 154 IDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------------- 216 (283)
T ss_dssp CCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------------
T ss_pred EecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------------
Confidence 9999987653322 22345688899999999988999999999999999999999999964331
Q ss_pred cchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+..... .... ..+..+.+|+.+||..||++|||+.+++++
T Consensus 217 --~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 217 --QETLTNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --HHHHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --HHHHHHhHhccc--CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 111111111110 1111 123468999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.81 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=201.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC-----------------hHHHHHHHHHHhccCCCcceee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-----------------EDEFKMEVELLGRLRSPYLLAL 102 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~ 102 (351)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... ...+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999986432111 1778899999999999999999
Q ss_pred eEEEEcCCe-EEEEEEccCCChhhhccccCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEe
Q 018744 103 LGYCSDRRK-LLVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILL 179 (351)
Q Consensus 103 ~~~~~~~~~-~~v~~~~~~~~L~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv 179 (351)
++++.+.+. ++||+|+.+++|.+++..... .......+++..++.++.|++.||.|||+ . +++|+||+|+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 999987754 599999999999998322110 01124579999999999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccC-CCCC-ccceeehHHHHHHHHhCCCCCCCCCCCCCc
Q 018744 180 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTT-KSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257 (351)
Q Consensus 180 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~-~~DiwslG~~l~~lltg~~pf~~~~~~~~~ 257 (351)
+.++.++|+|||++...... ......++..|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 99999999999999865332 33456789999999999877 6666 999999999999999999999754431
Q ss_pred ceeecccccccchhHHHhhcCccccC-----------------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEG-----------------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+....... ......+..+.+||.+||+.||.+|||+.+++++
T Consensus 259 ------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ------------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111111110000 0012234578999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.66 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=203.2
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEc
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 108 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 108 (351)
..+.....++|++.+.||+|+||.||+|+.. +++.||+|++... .......+..|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444555689999999999999999999964 7899999998632 12223457789999999999999999999987
Q ss_pred CCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 RRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 ~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
... ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEE
Confidence 754 59999999999999995432 3689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccc-------cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
+|||++....... ........||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 204 ~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 275 (412)
T 2vd5_A 204 ADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------- 275 (412)
T ss_dssp CCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred eechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-------
Confidence 9999997654322 11223457999999999987 35689999999999999999999999975432
Q ss_pred ecccccccchhHHHhhcCcc--cc-CCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 018744 261 SWALPRLTDREKILEIMDPA--LE-GQYSMKEVIQVAAIAAMCVQPEADYR---PLMADVVQS 317 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~li~~~l~~~P~~R---pt~~eil~~ 317 (351)
......++... +. .......+..+.+||.+||. +|.+| |++.++++|
T Consensus 276 ---------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 276 ---------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11112222111 00 01112234578999999999 99998 589999887
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=319.89 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=199.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.. .++||+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999965 68899999986442 223456888999999999999999999887765 459999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|+.+++|.+++... ..+++..++.++.|++.||.|||+ + +++|+||||+||+++.++.++|+|||++..
T Consensus 112 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999543 368999999999999999999998 5 899999999999999999999999999865
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee--------------
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS-------------- 261 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~-------------- 261 (351)
.... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 182 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 3221 1234568899999999999999999999999999999999999997543210000000
Q ss_pred -----------c-ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 262 -----------W-ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 262 -----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
. .............+.............+..+.+||.+||+.||++|||+.++++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0000000011111111111111111234468999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.95 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=200.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+++++.++||||+++++++.+... ++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4478999999999999999999965 7899999998532 34456788999999999999999999999988755 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC---CCCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~---~~~~v~l~dfg 191 (351)
++|+.+++|.+.+... ..+++..++.++.||+.||.|||++ +++|+||||+||+++ .++.++|+|||
T Consensus 100 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 9999999999988543 3689999999999999999999999 999999999999994 46679999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~ 229 (486)
T 3mwu_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------------YD 229 (486)
T ss_dssp CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 997654322 2344568999999999876 589999999999999999999999975432 11
Q ss_pred HHHhhcCccccCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+......... ....+..+.+||.+||..||++|||+.+++++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111111111 11234568999999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=312.97 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=194.9
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999996 4689999999854322 22356788999999999999999999987642
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++||+++ +++|.+++.. ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 37999999 7899988843 3588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc-
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL- 267 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~- 267 (351)
||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...............
T Consensus 172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865432 234568899999999887 679999999999999999999999997654211000000000000
Q ss_pred -------cch--hHHHhhcCcccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 268 -------TDR--EKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 268 -------~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
... ......+..... ..........+.+||.+||..||++|||+.++++| .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h--p~f~~ 313 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFES 313 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--hHHHh
Confidence 000 000000000000 01111224568999999999999999999999997 44443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=314.19 Aligned_cols=266 Identities=18% Similarity=0.259 Sum_probs=202.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC---------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCccee---------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN---------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA--------- 101 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------- 101 (351)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999653 788999998643 35778999999999999887
Q ss_pred ------eeEEEEc--CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC
Q 018744 102 ------LLGYCSD--RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173 (351)
Q Consensus 102 ------~~~~~~~--~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~ 173 (351)
+++++.. ...++||+|+ +++|.+++.... ...+++..++.++.||+.||.|||++ +++|+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik 186 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence 5666654 3456999999 999999996431 24699999999999999999999999 99999999
Q ss_pred CCcEEeCCCC--cEEEeecccccccCCCCCC-----ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCC
Q 018744 174 SSNILLDKNF--HAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 246 (351)
Q Consensus 174 p~Nilv~~~~--~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~ 246 (351)
|+||+++.++ .++|+|||++......... .......|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999988 8999999999765432211 11233478999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcceeecccccccchhHHHhhcCccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 247 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ-YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 247 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
||........... ................. .....+..+.+|+.+||..||++|||+.++++.|+++++..
T Consensus 267 pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTEDIM--------KQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHHHHH--------HHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHHHHH--------HHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 9975432100000 00000000011000000 00012346899999999999999999999999999999876
Q ss_pred CC
Q 018744 326 RS 327 (351)
Q Consensus 326 ~~ 327 (351)
..
T Consensus 339 ~~ 340 (352)
T 2jii_A 339 RV 340 (352)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=299.97 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=199.5
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
++|.....||+|+||.||+|.+ .++..|++|.+........+.+.+|+.+++.++||||+++++++.... .++|++++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4466667999999999999995 468899999987665666678899999999999999999999997765 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEEeecccccccC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGS 197 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l~dfg~~~~~~ 197 (351)
.+++|.+++..... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++. ++.++|+|||++....
T Consensus 102 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 102 PGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp SEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred CCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999865431 23567899999999999999999999 9999999999999987 8999999999987654
Q ss_pred CCCCCceecccCCCcccccccccccCC--CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||...... ......
T Consensus 175 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------------~~~~~~ 237 (295)
T 2clq_A 175 GIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------------QAAMFK 237 (295)
T ss_dssp C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------------HHHHHH
T ss_pred CCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------------hHHHHh
Confidence 321 1123456888999999987653 789999999999999999999999632210 000001
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..........+...+..+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--~~~~~ 284 (295)
T 2clq_A 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD--EFLKV 284 (295)
T ss_dssp HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS--GGGCC
T ss_pred hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC--hhhhh
Confidence 000011112223344578999999999999999999999987 45543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.39 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++... .......+..|+.+++.++||||+++++++.+.. .++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999965 6899999998632 2344567888999999999999999999988765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+|+|..++..... ....+++..++.++.||+.||.|||++ +++|+||||+||+++.+|.++|+|||++..
T Consensus 265 E~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp CCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999998865431 234699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 339 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~------------~~~~~~~~ 404 (543)
T 3c4z_A 339 LKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV------------ENKELKQR 404 (543)
T ss_dssp CCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC------------CHHHHHHH
T ss_pred ccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch------------hHHHHHHH
Confidence 54322 11233579999999999999999999999999999999999999997643210 00111112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
+..... .++...+..+.+||.+||+.||++||++ .++++|
T Consensus 405 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 405 VLEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred Hhhccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 221111 2233345578999999999999999965 677765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.49 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=205.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 113 (351)
..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 7899999998532 2344567888999999999999999999998765 459
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||+|+.+|+|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++
T Consensus 262 VmEy~~gg~L~~~l~~~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence 999999999999885432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 334 ~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-------------~~~~i 397 (576)
T 2acx_A 334 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-------------KREEV 397 (576)
T ss_dssp EECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-------------CHHHH
T ss_pred eecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-------------hHHHH
Confidence 8654322 2334579999999999999899999999999999999999999997644210 11111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
...+.. ....++...+..+.+||.+||..||++|| ++.++++|
T Consensus 398 ~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 398 ERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111110 11122233345789999999999999999 78999887
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=309.66 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=198.3
Q ss_pred eeeHHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEE
Q 018744 30 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCS 107 (351)
Q Consensus 30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 107 (351)
.+.+.++....++|++.+.||+|+||.||+|.+ .+++.+++|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344455666778999999999999999999996 47899999998644 33457788999999999 7999999999886
Q ss_pred c-------CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC
Q 018744 108 D-------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 180 (351)
Q Consensus 108 ~-------~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~ 180 (351)
. ...++||+|+.+++|.+++.... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT 163 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence 5 24569999999999999986432 23689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 181 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
.++.++|+|||++....... .......++..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~- 240 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM- 240 (326)
T ss_dssp TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-
T ss_pred CCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-
Confidence 99999999999987643321 1123456889999999987 557889999999999999999999999643311
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+.............+..+.+||.+||..||++|||+.+++++
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 ---------------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---------------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---------------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111111111111223468999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=316.60 Aligned_cols=286 Identities=20% Similarity=0.280 Sum_probs=204.6
Q ss_pred ccCccceEEecCCCceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHh
Q 018744 14 KGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLG 92 (351)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~ 92 (351)
..+++....+..+++......++. .++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|+.+++
T Consensus 12 ~~~~e~~~~~~~~~~~~~~~g~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~ 88 (397)
T 1wak_A 12 DDEQEDPNDYCKGGYHLVKIGDLF--NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLK 88 (397)
T ss_dssp ----------CC--CCSSCTTCEE--TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceEEehhhhc--CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHH
Confidence 445556666666666666655532 588999999999999999999954 6889999998633 223466788999999
Q ss_pred ccC--------CCcceeeeEEEE----cC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018744 93 RLR--------SPYLLALLGYCS----DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159 (351)
Q Consensus 93 ~l~--------h~~i~~~~~~~~----~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 159 (351)
.++ |+||+++++++. .. ..++||+++ +++|.+.+.... ...+++..++.++.||+.||.||
T Consensus 89 ~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~l 162 (397)
T 1wak_A 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-----YQGLPLPCVKKIIQQVLQGLDYL 162 (397)
T ss_dssp HHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 985 788999999886 22 446999999 556666664322 23689999999999999999999
Q ss_pred HcCCCCCceecCCCCCcEEeCCCC-------------------------------------------------cEEEeec
Q 018744 160 HEHCSPPVIHRDFKSSNILLDKNF-------------------------------------------------HAKVSDF 190 (351)
Q Consensus 160 H~~~~~~i~H~di~p~Nilv~~~~-------------------------------------------------~v~l~df 190 (351)
|++. +++|+||||+|||++.++ .++|+||
T Consensus 163 H~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 240 (397)
T 1wak_A 163 HTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240 (397)
T ss_dssp HHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCG
T ss_pred HHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccc
Confidence 9853 799999999999998775 7999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec------cc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW------AL 264 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~------~~ 264 (351)
|++...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.............. ..
T Consensus 241 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 241 GNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp GGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred ccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 999765432 2445689999999999999999999999999999999999999976543211100000 00
Q ss_pred ccccchh--------------------------HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 265 PRLTDRE--------------------------KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 265 ~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....... ...+.+. -....+......+.+||.+||+.||++|||+.++++|
T Consensus 316 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV--EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH--HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhcccccccccCCccccccccccCCcchhHhhh--hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000000 0000000 0113456677789999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=305.37 Aligned_cols=252 Identities=21% Similarity=0.388 Sum_probs=197.6
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~ 116 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|++..........+.+|+.+++.++||||+++++++... ..++|++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999965 5889999999876667778899999999999999999999988766 4569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 97 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999885432 3689999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
.... .......++..|+|||++. +..++.++||||||+++|+|++|..||...... .
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~ 229 (302)
T 2j7t_A 168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------R 229 (302)
T ss_dssp HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------H
T ss_pred cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----------------H
Confidence 1110 1112346788999999883 567889999999999999999999999743321 1
Q ss_pred HHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... ....+...+..+.++|.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 230 VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111110 011122234568999999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=297.88 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=193.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.++|++.+.||+|++|.||+|.+. +++.+++|++... .......+.+|+.+++.++||||+++++++.... .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 378999999999999999999965 7899999998633 2345567889999999999999999999988765 4599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++++.+++|.+++... ..+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 9999999999998543 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ....
T Consensus 160 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~ 220 (276)
T 2h6d_A 160 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----------------PTLF 220 (276)
T ss_dssp CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHH
T ss_pred ccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----------------HHHH
Confidence 644321 2234567889999999987765 6899999999999999999999964321 0111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..... ..+......+.++|.+||+.||++|||+.+++++
T Consensus 221 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 221 KKIRGGVF--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhhcCcc--cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111100 1122233468999999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=308.69 Aligned_cols=259 Identities=16% Similarity=0.162 Sum_probs=207.2
Q ss_pred HHhcCCCcCceeeecCceEEEEEE------EcCCcEEEEEEccccCCCChHHHHHHHHHHhccC---CCcceeeeEEEEc
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSD 108 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~------~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 108 (351)
...++|++.+.||+|+||.||+|. ..+++.||+|++... ....+..|..++..++ |+||+.+++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999993 446889999998643 4566777888888886 8999999998876
Q ss_pred C-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC------
Q 018744 109 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK------ 181 (351)
Q Consensus 109 ~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~------ 181 (351)
. ..++||||+.+|+|.+++..... .....+++..++.++.||+.||+|||++ +++||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHT--STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 5 55699999999999999965332 1234699999999999999999999999 9999999999999988
Q ss_pred -----CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 182 -----NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 182 -----~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
++.++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-- 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence 8999999999997654433344556677999999999999999999999999999999999999999543221
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHhhhccC
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR-PLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R-pt~~eil~~l~~~~~~~~ 326 (351)
.+. ....+.... ....+.+++..||+.+|.+| |++.++.+.|++++....
T Consensus 292 ----~~~-------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 ----ECK-------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ----EEE-------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----cee-------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 000 111111111 23457789999999999988 578889999999888643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=321.63 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=195.9
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
..++|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+... ++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999965 68899999986432 3345678899999999999999999999988754 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEeecc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFG 191 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~dfg 191 (351)
|+|+.+|+|.+.+... ..+++..++.++.||+.||.|||++ +++|+||||+||+++. ++.++|+|||
T Consensus 115 ~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 9999999999888543 3689999999999999999999999 9999999999999976 4559999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||.+... ..
T Consensus 185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~ 244 (494)
T 3lij_A 185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----------------QE 244 (494)
T ss_dssp TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 997654322 234466899999999876 4689999999999999999999999975432 11
Q ss_pred HHHhhcCccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+....... ......+..+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111111111110 0001223468899999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.97 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=163.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC------C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 110 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++|+||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999964 688999999864322 2335678899999999999999999998654 3
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||+++. ++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-------PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecCC-cCHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 579999876 589988843 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC--------------------ceecccCCCccccccccc-ccCCCCCccceeehHHHHHHHHhCCCCCC
Q 018744 191 GLAKIGSDKAGG--------------------HVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTGRVPID 249 (351)
Q Consensus 191 g~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~s~~~DiwslG~~l~~lltg~~pf~ 249 (351)
|++......... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 999875443211 123456789999999986 46679999999999999999999766664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=305.10 Aligned_cols=274 Identities=22% Similarity=0.346 Sum_probs=198.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHH--HhccCCCcceeeeEEEEc----C--C
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL--LGRLRSPYLLALLGYCSD----R--R 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~----~--~ 110 (351)
..++|++.+.||+|+||.||+|.. +++.||+|++... ....+..+.++ +..++|+||+++++.+.. . .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999987 6789999998643 23344445555 445799999999975532 1 2
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCceecCCCCCcEEeCCCCc
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------SPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~i~H~di~p~Nilv~~~~~ 184 (351)
.++||||+.+|+|.+++... ..++..++.++.||+.||.|||+.. ..+++|+||||+||+++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 36999999999999999432 3588899999999999999999762 227999999999999999999
Q ss_pred EEEeecccccccCCCCC------CceecccCCCccccccccccc-------CCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 185 AKVSDFGLAKIGSDKAG------GHVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
++|+|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999976543221 111224568999999999876 35667899999999999999997776543
Q ss_pred CCCCCccee-ecccccccchhHHHhhc-CccccCCC------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 252 KPSGEGVLV-SWALPRLTDREKILEIM-DPALEGQY------SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 252 ~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......... ................. ........ ....+..+.+||.+||+.||++|||+.++++.|++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 322111111 00011111111111111 11111111 12356679999999999999999999999999999986
Q ss_pred c
Q 018744 324 Y 324 (351)
Q Consensus 324 ~ 324 (351)
.
T Consensus 319 ~ 319 (336)
T 3g2f_A 319 I 319 (336)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=309.32 Aligned_cols=278 Identities=21% Similarity=0.253 Sum_probs=199.5
Q ss_pred eeHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC-----------hHHHHHHHHHHhccCCCcc
Q 018744 31 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-----------EDEFKMEVELLGRLRSPYL 99 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i 99 (351)
..+.++....++|++.+.||+|+||.||+|.+.+++.||+|++....... .+.+.+|+.+++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34567888899999999999999999999998789999999986432221 2678899999999999999
Q ss_pred eeeeEEEEcC------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC
Q 018744 100 LALLGYCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173 (351)
Q Consensus 100 ~~~~~~~~~~------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~ 173 (351)
+++++++... ..++||+++. ++|.+.+... ...+++..++.++.||+.||.|||++ +++|+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 161 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ------RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH 161 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence 9999988432 2369999998 5777777532 24689999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 174 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 174 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
|+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987433221 2334567889999999876 678999999999999999999999997543
Q ss_pred CCCCcceeeccccccc-------chhHHHhhcCccccCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 253 PSGEGVLVSWALPRLT-------DREKILEIMDPALEGQY-------SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
................ ................. .......+.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h- 317 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH- 317 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS-
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC-
Confidence 2100000000000000 00000111111110000 01123468899999999999999999999987
Q ss_pred HHhhh
Q 018744 319 VPLVK 323 (351)
Q Consensus 319 ~~~~~ 323 (351)
.+++
T Consensus 318 -p~f~ 321 (362)
T 3pg1_A 318 -PYFE 321 (362)
T ss_dssp -GGGT
T ss_pred -chhh
Confidence 4444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=306.17 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=200.9
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC--------hHHHHHHHHHHhcc-CCCcceeeeEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--------EDEFKMEVELLGRL-RSPYLLALLGY 105 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--------~~~~~~e~~~l~~l-~h~~i~~~~~~ 105 (351)
.....++|.+.+.||+|++|.||+|.+. +|+.||+|++....... .+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999975 78999999986443211 34577899999999 79999999999
Q ss_pred EEcCC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 106 CSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 106 ~~~~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+.... .++||+|+.+++|.+++... ..+++..++.++.||+.||.|||+. |++|+||+|+||+++.++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 88765 45999999999999998533 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCCceecccCCCccccccccccc------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 258 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 258 (351)
++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----- 310 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----- 310 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----
Confidence 9999999987654322 2344678999999999863 3578899999999999999999999964321
Q ss_pred eeecccccccchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 259 LVSWALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+..... .... ..+..+.+||.+||..||++|||+.+++++
T Consensus 311 -----------~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 -----------ILMLRMIMEGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----------HHHHHHHHHTCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----------HHHHHHHHhCCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111111 1111 123468999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=302.26 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=196.5
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
...++|++.+.||+|+||.||+|.+. +|+.|++|.+... .....+.+|+.+++.++||||+++++++.... .++|+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999965 5899999998643 34567889999999999999999999887664 46999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 104 e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 104 EYCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp ECCTTEEHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999998532 24689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 175 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~ 239 (314)
T 3com_A 175 LTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------------RAIFMIPT 239 (314)
T ss_dssp CBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHHHH
T ss_pred hhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------------HHHHHHhc
Confidence 54322 1223456888999999999888999999999999999999999999643210 00000111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... ...+...+..+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 NPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111 11112224568999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.56 Aligned_cols=258 Identities=17% Similarity=0.280 Sum_probs=196.4
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC---CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~---~~~~v~ 115 (351)
++|++.+.||+|+||.||+|.+ .+++.||+|++.. .....+.+|+.+++.++ ||||+++++++.+. ..++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999995 4789999999853 34577889999999997 99999999999863 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAK 194 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~~~ 194 (351)
+++.+++|.+++. .++...++.++.||+.||.|||++ +++|+||||+||+++.++ .++|+|||++.
T Consensus 113 e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp ECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 9999999999882 488899999999999999999999 999999999999998766 89999999997
Q ss_pred ccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc-cc-------
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA-LP------- 265 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~------- 265 (351)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||............... ..
T Consensus 180 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 180 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred EcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 654332 2334568889999999876 67899999999999999999999999532211000000000 00
Q ss_pred ----cccchhHHHhhcCc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 266 ----RLTDREKILEIMDP--------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 266 ----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.............. ..........+..+.+||.+||+.||++|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000000 00011111134578999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.00 Aligned_cols=247 Identities=19% Similarity=0.276 Sum_probs=195.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LL 113 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~ 113 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|++..... .....+.+|+..+..+ +||||+++++++.+.+. ++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3478999999999999999999965 789999999864322 2345677899999998 89999999999877654 59
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-----------
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN----------- 182 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~----------- 182 (351)
|++|+.+++|.+++..... ....+++..++.++.||+.||.|||++ +++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------
T ss_pred EEEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccc
Confidence 9999999999999965321 124689999999999999999999999 99999999999999844
Q ss_pred --------CcEEEeecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCC
Q 018744 183 --------FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253 (351)
Q Consensus 183 --------~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~ 253 (351)
..++|+|||.+...... ....++..|+|||++.+. .++.++|||||||++|+|++|..++....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~- 235 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD- 235 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-
T ss_pred cccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-
Confidence 47999999998865442 223588999999998865 56789999999999999999987764211
Q ss_pred CCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 254 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+..... ...+...+..+.+||.+||+.||++|||+.+++++
T Consensus 236 ------------------~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ------------------QWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------------------HHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------------------HHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111111111 11222234568999999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=320.53 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=198.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-------------CChHHHHHHHHHHhccCCCcceeeeE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-------------QGEDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
..++|++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4588999999999999999999965 688999999864321 33467889999999999999999999
Q ss_pred EEEcCCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 105 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 105 ~~~~~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
++.+... ++||+|+.+++|.+.+... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN 183 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC
Confidence 9988754 5999999999999988543 3689999999999999999999999 999999999999998776
Q ss_pred ---cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 184 ---HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 184 ---~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
.++|+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||.+...
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------- 252 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------- 252 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------
Confidence 69999999998654432 234456899999999886 4689999999999999999999999975432
Q ss_pred ecccccccchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+..+..... .... ..+..+.+||.+||..||.+|||+.+++++
T Consensus 253 ---------~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 ---------QDIIKKVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---------HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHHHHHHHcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111222211111 1111 123578999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=310.78 Aligned_cols=266 Identities=24% Similarity=0.403 Sum_probs=195.1
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC--hHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+. +++.|++|++....... ...+.+|+.+++.++||||+++++++.+... ++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999965 58999999885443222 3457789999999999999999999987754 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+++|..+... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 104 e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 104 EFVDHTILDDLELF-------PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp ECCSEEHHHHHHHS-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred ecCCcchHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999988887632 24689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch----
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR---- 270 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 270 (351)
..... .......++..|+|||++.+. .++.++|||||||++|+|++|..||......................
T Consensus 174 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 174 LAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 43322 223345688999999998875 78999999999999999999999997543210000000000000000
Q ss_pred ----hHHHhhcCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 ----EKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ----~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........+......+ ...+..+.+||.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000011111111 1224579999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=308.14 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=189.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 378999999999999999999954 688999999864322 22356778999999999999999999987543
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++||+|+.+ +|.+.+. ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEcCCC-CHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 4699999975 6777763 2488999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc----
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP---- 265 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~---- 265 (351)
||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.............
T Consensus 171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999764332 122345688999999999998999999999999999999999999976442100000000000
Q ss_pred ----cccc-------------hhHHHhhcCccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 266 ----RLTD-------------REKILEIMDPALEGQ---YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 266 ----~~~~-------------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... ............... ........+.+||.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000000000000000 011235679999999999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.13 Aligned_cols=266 Identities=19% Similarity=0.263 Sum_probs=193.0
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC------
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 109 (351)
....++|++.+.||+|+||.||+|.+ .+|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45568999999999999999999995 57899999988644322 23599999999999999999987432
Q ss_pred ---------------------------------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018744 110 ---------------------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156 (351)
Q Consensus 110 ---------------------------------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 156 (351)
..++||+|+.+ +|.+.+.... .....+++..++.++.||+.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI---RSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHH
Confidence 14589999984 7777665422 1234789999999999999999
Q ss_pred HHHHcCCCCCceecCCCCCcEEeC-CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeeh
Q 018744 157 EFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSY 234 (351)
Q Consensus 157 ~~LH~~~~~~i~H~di~p~Nilv~-~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~Diwsl 234 (351)
.|||+. +++|+||||+||+++ .++.++|+|||++....... ......++..|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999999 999999999999997 68899999999998653322 22345678899999998765 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc------------CccccCCCCHHHHHHHHHHHHhccC
Q 018744 235 GVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM------------DPALEGQYSMKEVIQVAAIAAMCVQ 302 (351)
Q Consensus 235 G~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~ 302 (351)
||++|+|++|..||.+............... ......+...- ........+...+..+.+||.+||.
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMG-TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999976432110000000000 00000000000 0000000111234468999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 018744 303 PEADYRPLMADVVQS 317 (351)
Q Consensus 303 ~~P~~Rpt~~eil~~ 317 (351)
.||++|||+.|+++|
T Consensus 308 ~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 308 YEPDLRINPYEAMAH 322 (383)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=313.27 Aligned_cols=283 Identities=20% Similarity=0.273 Sum_probs=204.7
Q ss_pred CceeeeHHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeE
Q 018744 27 GLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
+.......++....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++
T Consensus 13 ~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 92 (364)
T 3qyz_A 13 AGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92 (364)
T ss_dssp --CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred cceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcccee
Confidence 3334444444455679999999999999999999965 688899999864322 22356788999999999999999999
Q ss_pred EEEcC------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 105 YCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 105 ~~~~~------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
++... ..++|++++.+ +|.+++.. ..+++..++.++.||+.||.|||++ +++|+||||+||+
T Consensus 93 ~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl 160 (364)
T 3qyz_A 93 IIRAPTIEQMKDVYIVQDLMET-DLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 160 (364)
T ss_dssp EECCSSTTTCCCEEEEEECCSE-EHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred EEecCCccccceEEEEEcccCc-CHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEE
Confidence 98654 34689999874 88888843 3589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCc-eecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
++.++.++|+|||++.......... ......|++.|+|||++. +..++.++|||||||++|+|++|..||.+......
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 9999999999999998654322111 123457899999999876 45589999999999999999999999976543211
Q ss_pred cceeecccccccchhHH--------Hhh-cCccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 257 GVLVSWALPRLTDREKI--------LEI-MDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
........... ..... ... .........+ ......+.+||.+||..||++|||+.+++++ .++
T Consensus 241 ~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~~ 317 (364)
T 3qyz_A 241 LNHILGILGSP-SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYL 317 (364)
T ss_dssp HHHHHHHHCSC-CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGG
T ss_pred HHHHHHHhCCC-CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cch
Confidence 10000000000 00000 000 0000000111 1123468999999999999999999999987 455
Q ss_pred hc
Q 018744 323 KY 324 (351)
Q Consensus 323 ~~ 324 (351)
+.
T Consensus 318 ~~ 319 (364)
T 3qyz_A 318 EQ 319 (364)
T ss_dssp TT
T ss_pred hh
Confidence 44
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=302.42 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=198.4
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--CChHHHHHHHHHHhccC--CCcceeeeEEEE
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLR--SPYLLALLGYCS 107 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 107 (351)
.++.+....++|++.+.||+|+||.||++.+.+++.+|+|++..... .....+.+|+.++..++ |+||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 33444455688999999999999999999988899999999864322 23466888999999997 599999999998
Q ss_pred cCCeE-EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 108 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 108 ~~~~~-~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
....+ ++|+ +.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||++++ +.++
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence 77655 7777 7788999998543 3689999999999999999999999 9999999999999964 7999
Q ss_pred EeecccccccCCCCCCceecccCCCccccccccccc-----------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCC
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 255 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~ 255 (351)
|+|||++................+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 244 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-- 244 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--
Confidence 999999986544332223344568999999999865 4678899999999999999999999964321
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l 318 (351)
.........+.......+......+.+||.+||..||++|||+.+++++-
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 245 -------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp -------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------------HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11122233333332233333345789999999999999999999999883
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=308.32 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=199.5
Q ss_pred eHHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 32 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
...+.....++|++.+.||+|+||.||+|.+.. .+++|++.... ......+.+|+.+++.++|+||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345555667899999999999999999999754 48999886432 23335567799999999999999999999876
Q ss_pred C-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 110 R-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 110 ~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
. .+++++|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++ ++.++|+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA------KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS------CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred CceEEEeecccCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence 4 56999999999999999542 23688999999999999999999999 999999999999998 6799999
Q ss_pred ecccccccCCCCC---CceecccCCCccccccccccc---------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 189 DFGLAKIGSDKAG---GHVSTRVLGTQGYVAPEYALT---------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 189 dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 249 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-- 249 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999765432111 112233558889999999864 35788999999999999999999999743321
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
.....+.............+..+.+++.+||..||++|||+.++++.|+++.+..+.
T Consensus 250 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 250 --------------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp --------------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred --------------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111111111112233588999999999999999999999999999886544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.48 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=199.7
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC---------CChHHHHHHHHHHhccC-CCcceeeeEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---------QGEDEFKMEVELLGRLR-SPYLLALLGYC 106 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 106 (351)
...++|++.+.||+|++|.||+|.+. +++.|++|++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34589999999999999999999965 688999999864321 11245678999999995 99999999999
Q ss_pred EcCC-eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 107 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 107 ~~~~-~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
.... .++|++++.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcE
Confidence 8775 45999999999999998543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccc------cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 259 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 259 (351)
+|+|||++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 234 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ 234 (298)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred EEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------
Confidence 999999987654322 223456888999999885 45678999999999999999999999964321
Q ss_pred eecccccccchhHHHhhcCcccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 260 VSWALPRLTDREKILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+...... .......+..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 ----------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ----------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1111111111111 11112334579999999999999999999999976
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.77 Aligned_cols=194 Identities=24% Similarity=0.357 Sum_probs=150.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC------C
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------R 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 110 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+|+.++||||+++++++... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 378999999999999999999954 689999999864322 2335678899999999999999999998432 3
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||+++ +++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-------PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecc-ccchhhhccc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 46899986 5688888843 24699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-------------------------ceecccCCCccccccccc-ccCCCCCccceeehHHHHHHHHhC
Q 018744 191 GLAKIGSDKAGG-------------------------HVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTG 244 (351)
Q Consensus 191 g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~s~~~DiwslG~~l~~lltg 244 (351)
|++......... .......||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999875432211 122345679999999986 466799999999999999999993
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=313.59 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=166.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhcc------CCCcceeeeEEEEcCC-e
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL------RSPYLLALLGYCSDRR-K 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~-~ 111 (351)
..+|++.+.||+|+||.||+|.+. +++.||+|++... ......+..|+.+++.+ .|+||+.+++++.... .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 367999999999999999999854 5889999998643 22335567788888877 4679999999988665 4
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc--EEEee
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVSD 189 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~--v~l~d 189 (351)
++|++++. ++|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+|||++.++. ++|+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred EEEEeccC-CCHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 58999986 58888885432 23589999999999999999999999 9999999999999999887 99999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 246 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9998754332 234578899999999999999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.63 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=182.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999995 4689999999864322 2335677899999999999999999998643
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..+++++++ +++|.+++.. ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp CCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 346788877 6788888732 3689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc----
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL---- 264 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---- 264 (351)
||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............
T Consensus 176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998764332 234568999999999886 678999999999999999999999997654211000000000
Q ss_pred ----ccccchhHHHhhcCcccc-CCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 265 ----PRLTDREKILEIMDPALE-GQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 265 ----~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..... ......+..... ..... .....+.+||.+||..||++|||+.++++| .+++.
T Consensus 251 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h--p~~~~ 317 (367)
T 2fst_X 251 AELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ 317 (367)
T ss_dssp HHHHTTCCC-HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HHHHHHhhh-HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--hhhhh
Confidence 00000 000000000000 00111 123468899999999999999999999988 44443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=327.77 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=207.1
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR 110 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 110 (351)
.....++|++.+.||+|+||.||+|.+.. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++.++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 464 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc
Confidence 33445789999999999999999998632 45689998764322 22366888999999999999999999998888
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||+|+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+||
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 889999999999999985432 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 536 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---------------- 598 (656)
T 2j0j_A 536 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------------- 598 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------
T ss_pred CCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----------------
Confidence 99976543221 11223446678999999998899999999999999999997 9999975332
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
......+.. ......+...+..+.+||.+||..||++|||+.++++.|++++...
T Consensus 599 ~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 599 NDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111111111 1111223334457999999999999999999999999999988653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=304.06 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=195.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-----
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRRK----- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 111 (351)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999965 6899999998653222 23567789999999999999999999976532
Q ss_pred --EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 112 --LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 112 --~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
++|++++. ++|.+.+. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 79999997 57777762 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc----
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL---- 264 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---- 264 (351)
||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..............
T Consensus 188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 9998754332 234567899999999887 688999999999999999999999997543210000000000
Q ss_pred ----ccccc--hhHHHhhcCccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 265 ----PRLTD--REKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 265 ----~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..... .......+........ .......+.+||.+||+.||++|||+.+++++ .+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~ 329 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEP 329 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--ccccc
Confidence 00000 0000000000000000 01124578999999999999999999999988 45543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=308.27 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=199.1
Q ss_pred hcCCCcCceeeecCceEEEEEEE----cCCcEEEEEEccccC----CCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 110 (351)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999996 368999999986421 23345567799999999 6999999999887765
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++||+|+.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred eEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEee
Confidence 45999999999999999543 3689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 203 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---------- 271 (355)
T 1vzo_A 203 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---------- 271 (355)
T ss_dssp SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----------
T ss_pred CCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----------
Confidence 99987543221 1122335689999999999853 4788999999999999999999999754321110
Q ss_pred cchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 018744 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQSL 318 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~l 318 (351)
......+... ...++......+.+||.+||..||++|| |+.+++++.
T Consensus 272 --~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 272 --AEISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --HHHHHHHhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111111111 1122233445688999999999999999 999999884
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=303.28 Aligned_cols=279 Identities=21% Similarity=0.230 Sum_probs=191.9
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR- 110 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 110 (351)
-.......++|++.+.||+|+||.||+|.+. +++.||+|++... .........++..+..++||||+++++++....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556777899999999999999999999964 6899999988543 333455677888889999999999999885421
Q ss_pred -------eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCceecCCCCCcEEeCC
Q 018744 111 -------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--EHCSPPVIHRDFKSSNILLDK 181 (351)
Q Consensus 111 -------~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~i~H~di~p~Nilv~~ 181 (351)
.++||+|+.++ |...+.... .....+++..++.++.|++.||.||| +. +++|+||||+||+++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYY---RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE 166 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence 45899999874 444332211 12346889999999999999999999 88 9999999999999986
Q ss_pred -CCcEEEeecccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcce
Q 018744 182 -NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 259 (351)
Q Consensus 182 -~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 259 (351)
++.++|+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 8999999999998654322 22345678999999998765 489999999999999999999999976432100000
Q ss_pred eecccccccchhHHHhhcCc---------------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 260 VSWALPRLTDREKILEIMDP---------------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..... .............. .............+.+||.+||+.||.+|||+.++++| .+++.
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~ 320 (360)
T 3e3p_A 244 IVRVL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH--PYFDE 320 (360)
T ss_dssp HHHHH-CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS--GGGGG
T ss_pred HHHHc-CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC--ccccc
Confidence 00000 00000000000000 00001111235679999999999999999999999998 55554
Q ss_pred c
Q 018744 325 N 325 (351)
Q Consensus 325 ~ 325 (351)
.
T Consensus 321 ~ 321 (360)
T 3e3p_A 321 L 321 (360)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.96 Aligned_cols=271 Identities=23% Similarity=0.315 Sum_probs=197.4
Q ss_pred HhcCCCcCceeeecCceEEEEEEE--cCCcEEEEEEccccC--CCChHHHHHHHHHHhcc---CCCcceeeeEEEE----
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVL--SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRL---RSPYLLALLGYCS---- 107 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~--~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---- 107 (351)
+.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 367889999886432 22233456677777766 8999999999886
Q ss_pred -cC-CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 108 -DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 108 -~~-~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
.. ..++|++++. ++|.+++.... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence 22 3459999997 59999885432 13589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee-----
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV----- 260 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----- 260 (351)
+|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||.+..........
T Consensus 160 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 160 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp EECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999998754321 1223456888999999999889999999999999999999999999754321000000
Q ss_pred -----ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 261 -----SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 261 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.|............. .............+..+.+||.+||..||++|||+.+++++ .+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~~ 302 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQD 302 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTT
T ss_pred CCCcccCccccccchhhhcc-cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC--ccccc
Confidence 000000000000000 00000001111233468899999999999999999999986 44443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.21 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=205.3
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-E
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-L 112 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~ 112 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+..|..++..+ +||+|+.+++++.+.+. +
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999955 6889999998632 234456778899999987 79999999999987654 5
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+.+|+|..++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||+
T Consensus 419 lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecce
Confidence 999999999999999543 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+. ...
T Consensus 489 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----------------~~~ 550 (674)
T 3pfq_A 489 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DEL 550 (674)
T ss_dssp CEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHH
T ss_pred eeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----------------HHH
Confidence 97533222 223456799999999999999999999999999999999999999975432 222
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~eil~~ 317 (351)
...++...+ .++.....++.+||..||+.||++||++ .+|++|
T Consensus 551 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 551 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 333333322 2333445679999999999999999997 778776
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=299.87 Aligned_cols=270 Identities=23% Similarity=0.351 Sum_probs=184.0
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
....++|++.+.||+|+||.||+|.+ .+++.|++|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34458999999999999999999994 478899999886432 23346678899999999999999999998776 4569
Q ss_pred EEEEccCCChhhhccccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 114 VYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
|++|+.+++|.+++...... ......+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998542111 11234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---CceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 193 AKIGSDKAG---GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 193 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
+........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||............... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CCC
Confidence 876543221 111233568899999999875 56899999999999999999999999754321000000000 000
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ....... ......+..+.+||.+||+.||.+|||+.+++++
T Consensus 246 ~~--~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SL--ETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CT--TC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc--ccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0000000 0111123468899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.26 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=192.4
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-------eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-------KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------~~~ 113 (351)
.+|++.+.||+|+||.||+|++..+..+++|.+...... ..+|+++++.++||||+++++++.... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 569999999999999999999876666888887543322 235999999999999999999885332 458
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-CCCcEEEeeccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGL 192 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-~~~~v~l~dfg~ 192 (351)
||+|+.++.+....... .....+++..++.++.||+.||.|||++ +++||||||+||+++ .++.++|+|||+
T Consensus 116 v~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYA----KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEECCSEEHHHHHHHHH----HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EeeccCccHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 99999875443332111 1234689999999999999999999999 999999999999998 799999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+....... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.............. ......
T Consensus 189 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~-g~p~~~ 264 (394)
T 4e7w_A 189 AKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL-GTPSRE 264 (394)
T ss_dssp CEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCHH
T ss_pred cccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCCHH
Confidence 98653322 22345678999999998765 58999999999999999999999997644210000000000 000000
Q ss_pred HHHhh----cCcccc--------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 272 KILEI----MDPALE--------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 272 ~~~~~----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+... ....+. ..+....+..+.+||.+||..||++|||+.++++| .+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 327 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH--PFFDE 327 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS--GGGST
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC--hhhhh
Confidence 00000 000000 00111133478999999999999999999999987 44443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=305.75 Aligned_cols=277 Identities=20% Similarity=0.289 Sum_probs=184.1
Q ss_pred cCCCc-CceeeecCceEEEEEEEc---CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc--C-CeEE
Q 018744 41 GGFSK-SNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RKLL 113 (351)
Q Consensus 41 ~~y~~-~~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~~~~ 113 (351)
+.|.+ .+.||+|+||.||+|.+. +++.||+|++... .....+.+|+.+++.++||||+++++++.. . ..++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45777 457999999999999954 5788999998643 234567889999999999999999999853 3 3458
Q ss_pred EEEEccCCChhhhccccCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe----CCCCcEEE
Q 018744 114 VYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKV 187 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----~~~~~v~l 187 (351)
||+|+.+ +|.+++..... .......+++..++.++.||+.||.|||++ +++|+||||+|||+ +.++.++|
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999865 77777643221 111223589999999999999999999999 99999999999999 67889999
Q ss_pred eecccccccCCCCCC-ceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee-----
Q 018744 188 SDFGLAKIGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV----- 260 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----- 260 (351)
+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999865432211 22334678999999999887 45899999999999999999999999765432110000
Q ss_pred --------------ecc-cccccchhHHHhhcCccccCCCCHH---------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 261 --------------SWA-LPRLTDREKILEIMDPALEGQYSMK---------EVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 261 --------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
.|. .............+........... ....+.+||.+||..||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0000000000000000000000000 1236889999999999999999999999
Q ss_pred HHHHhhhcc
Q 018744 317 SLVPLVKYN 325 (351)
Q Consensus 317 ~l~~~~~~~ 325 (351)
| .++...
T Consensus 334 h--p~f~~~ 340 (405)
T 3rgf_A 334 D--PYFLED 340 (405)
T ss_dssp S--GGGTSS
T ss_pred C--hhhccC
Confidence 8 566543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.50 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=184.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+..+...++.++||||+++++++.+. ..++|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999996 47899999998643221 123344455567888999999999998876 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+ +|.+++.... .....+++..++.++.|++.||.|||++. +++|+||||+||+++.++.++|+|||++..
T Consensus 86 e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVI---DKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp ECCSE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred ehhcc-chHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99975 8877764422 12246899999999999999999999832 899999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCccccccccc----ccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYA----LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
..... ......+++.|+|||++ .+..++.++|||||||++|+|++|..||...... ..
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~ 221 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------------FQ 221 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------------HH
T ss_pred ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---------------HH
Confidence 43322 22334688999999996 4567899999999999999999999999642211 11
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..................+..+.+|+.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1222222211111122334568999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=293.67 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=199.1
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-E
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-L 112 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 112 (351)
....++|++.+.||+|++|.||+|.+. +++.|++|++... .......+.+|+++++.++||||+++++++.+... +
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999965 6889999998643 23456788899999999999999999999987654 5
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC---CcEEEee
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHAKVSD 189 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~---~~v~l~d 189 (351)
++++++.+++|.+++... ..+++..++.++.||+.||.+||+. +++|+||+|+||+++.+ +.++|+|
T Consensus 98 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred EEEEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEec
Confidence 999999999999888543 3689999999999999999999999 99999999999999654 4699999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++....... ......++..|+|||.+.+. ++.++||||||+++|+|++|..||......
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------------- 228 (287)
T 2wei_A 168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY--------------- 228 (287)
T ss_dssp TTGGGTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------
T ss_pred cCcceeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---------------
Confidence 99987654322 12233477889999988754 899999999999999999999999753311
Q ss_pred hhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.....+.........+ ...+..+.+||.+||..||++|||+.+++++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 229 -DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111111111110100 1223468999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.03 Aligned_cols=254 Identities=11% Similarity=0.051 Sum_probs=179.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC---ChHHHHHHHHHHhcc--CCCcceeee-------EEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRL--RSPYLLALL-------GYC 106 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 106 (351)
..+|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999965 7899999999764332 234566775444444 699987754 444
Q ss_pred EcC------------------CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcC
Q 018744 107 SDR------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR------LRIALEAAKGLEFLHEH 162 (351)
Q Consensus 107 ~~~------------------~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~ 162 (351)
... ..++||||+. ++|.+++.... ..+....+ +.++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 322 2479999998 89999996542 12344455 67789999999999999
Q ss_pred CCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccccc--CCCCCccceeehHHHHHH
Q 018744 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLE 240 (351)
Q Consensus 163 ~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~ 240 (351)
+++|+||||+|||++.++.+||+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+
T Consensus 214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ---CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999999986432 1224556699999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 241 LLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 241 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
|++|..||....+............ ...............+..+.+||.+||+.||++|||+.+++++
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLR---------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTT---------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHhCCCCCCCcCcccccchhhhhhh---------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999987654321111100000 0000011111111234578999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=299.73 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=195.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999964 6899999998643222 2356788999999999999999999997653
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.+++|+++. ++|.+++. ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred eEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence 379999997 57777762 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc----
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL---- 264 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---- 264 (351)
||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+..............
T Consensus 170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998754332 234567899999999876 678999999999999999999999997644210000000000
Q ss_pred ----ccccch--hHHHhhcCccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 265 ----PRLTDR--EKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 265 ----~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...... ......+...... ......+..+.+||.+||..||++|||+.+++++ .+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h--p~f~~ 311 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEP 311 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC--cchhh
Confidence 000000 0000000000000 1112334579999999999999999999999987 44443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=298.85 Aligned_cols=263 Identities=19% Similarity=0.305 Sum_probs=198.0
Q ss_pred hcCCCcCceeeecCceEEEEEEE-c-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCC------cceeeeEEEEcCC-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-S-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP------YLLALLGYCSDRR- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~- 110 (351)
.++|++.+.||+|+||.||+|.+ . +++.||+|++... ......+.+|+.+++.++|+ +++++++++....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6789999998643 22345678899999888654 4899999887665
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---------
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--------- 181 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~--------- 181 (351)
.++||+++ +++|.+++.... ...+++..++.++.||+.||+|||++ +++|+||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred EEEEEcCC-CCCHHHHHHhcC-----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 45999999 889999885432 13688999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 182 ----------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 182 ----------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
++.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999998764332 23456889999999999989999999999999999999999999754
Q ss_pred CCCCCcceeeccccccc-------------------------chhHHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCC
Q 018744 252 KPSGEGVLVSWALPRLT-------------------------DREKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEA 305 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P 305 (351)
+................ ............. ...........+.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 32110000000000000 0000000000000 011223456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 018744 306 DYRPLMADVVQS 317 (351)
Q Consensus 306 ~~Rpt~~eil~~ 317 (351)
.+|||+.|++++
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=303.76 Aligned_cols=268 Identities=20% Similarity=0.310 Sum_probs=198.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-----------CCcceeeeEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----------SPYLLALLGYCS 107 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 107 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 37899999999999999999996 46889999998632 223456778999998876 789999999886
Q ss_pred cC-----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--
Q 018744 108 DR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-- 180 (351)
Q Consensus 108 ~~-----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-- 180 (351)
.. ..+++++++ +++|.+++.... ...+++..++.++.||+.||.|||++. +++|+||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 53 345888888 889999986532 235899999999999999999999842 899999999999994
Q ss_pred ----CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC
Q 018744 181 ----KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 256 (351)
Q Consensus 181 ----~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~ 256 (351)
..+.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4458999999999765432 2345689999999999999999999999999999999999999976542211
Q ss_pred cceeec------ccccccch--------------------------hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCC
Q 018744 257 GVLVSW------ALPRLTDR--------------------------EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPE 304 (351)
Q Consensus 257 ~~~~~~------~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 304 (351)
...... ........ ......+. .....+......+.+||.+||+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccC
Confidence 000000 00000000 00000000 011345677789999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhcc
Q 018744 305 ADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 305 P~~Rpt~~eil~~l~~~~~~~ 325 (351)
|++|||+.+++++ .+++..
T Consensus 322 P~~Rpt~~ell~h--p~f~~~ 340 (373)
T 1q8y_A 322 PRKRADAGGLVNH--PWLKDT 340 (373)
T ss_dssp TTTCBCHHHHHTC--GGGTTC
T ss_pred ccccCCHHHHhhC--hhhhcc
Confidence 9999999999997 455543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=304.82 Aligned_cols=270 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC------Ce
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RK 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 111 (351)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999965 688999999864322 2235577899999999999999999987653 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecc
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 191 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg 191 (351)
+++++++. ++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 90 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 69999987 588888743 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc--------eecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee-
Q 018744 192 LAKIGSDKAGGH--------VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS- 261 (351)
Q Consensus 192 ~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~- 261 (351)
++.......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998654322111 1123467899999998764 678999999999999999999999997643210000000
Q ss_pred --------cccccccchhHHHhhcCcccc-CCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 262 --------WALPRLTDREKILEIMDPALE-GQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
....... .....+....... ... ....+..+.+||.+||..||++|||+.+++++ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIE-SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH--PYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCC-CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HhCCCchhccccccc-cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC--ccccc
Confidence 0000000 0000010000000 000 01223468899999999999999999999987 45543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.12 Aligned_cols=269 Identities=21% Similarity=0.312 Sum_probs=192.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc----------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---------- 108 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 108 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|.+...+....+.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999965 589999999876554555778899999999999999999998742
Q ss_pred -----CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-CC
Q 018744 109 -----RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KN 182 (351)
Q Consensus 109 -----~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-~~ 182 (351)
...++|++|+. ++|.+++.. ..+++..++.++.|++.||+|||++ +++|+||||+||+++ .+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 23469999997 589988832 3688999999999999999999999 999999999999996 57
Q ss_pred CcEEEeecccccccCCCCC-CceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 183 FHAKVSDFGLAKIGSDKAG-GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 183 ~~v~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
+.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||............
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999986543221 111233456888999998865 67899999999999999999999999754321000000
Q ss_pred ecccccccchhHHHhhcCc-------cc-cCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 261 SWALPRLTDREKILEIMDP-------AL-EGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~-------~~-~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
....+. .......+.... .. ....+ ...+..+.+||.+||+.||++|||+.+++++ .+++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~ 310 (320)
T 2i6l_A 238 LESIPV-VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH--PYMS 310 (320)
T ss_dssp HHHSCC-CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--HHHH
T ss_pred HHhcCC-CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC--cccc
Confidence 000000 000000000000 00 00000 1124578999999999999999999999987 4454
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.98 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=190.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------CeE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RKL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~~~ 112 (351)
.+|++.+.||+|+||.||+|.+. +++.||+|++..... ...+|+++++.++||||+++++++... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999965 689999999864322 234599999999999999999987431 134
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-CcEEEeecc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFG 191 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-~~v~l~dfg 191 (351)
+|++|+.+ ++.+.+.... .....+++..++.++.||+.||.|||++ +++||||||+|||++.+ +.+||+|||
T Consensus 130 lv~e~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eehhcccc-cHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 89999976 5555553321 1224689999999999999999999999 99999999999999854 678999999
Q ss_pred cccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 192 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.............. .....
T Consensus 203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l-g~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-GTPTR 278 (420)
T ss_dssp TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CSCCH
T ss_pred hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCCH
Confidence 998654322 22345689999999998765 78999999999999999999999997643210000000000 00000
Q ss_pred hHHHhhcC-------ccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 271 EKILEIMD-------PALEG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 271 ~~~~~~~~-------~~~~~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..... +.+.. .+....+..+.+||.+||..||++|||+.|+++|
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11111100 00000 0111223578999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.82 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=191.5
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc---------
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--------- 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 108 (351)
..++|++.+.||+|+||.||+|.+. +++.+++|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999964 7899999998543 2334678889999999999999999998754
Q ss_pred -----CCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC
Q 018744 109 -----RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 183 (351)
Q Consensus 109 -----~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~ 183 (351)
...++|++|+.+++|.+++.... ..++...++.++.|++.||+|||++ +++|+||+|+||+++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 23469999999999999996432 3578899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC------------CceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCC
Q 018744 184 HAKVSDFGLAKIGSDKAG------------GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDV 250 (351)
Q Consensus 184 ~v~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~ 250 (351)
.++|+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 999999999876543211 1122345688899999998764 68999999999999999998 4431
Q ss_pred CCCCCCcceeecccccccchhHHHhhc--CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 251 NKPSGEGVLVSWALPRLTDREKILEIM--DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ........+. ...+...+....+..+.++|.+||+.||++|||+.+++++
T Consensus 231 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 GM---------------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH---------------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ch---------------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 10 0001111111 1122233334445578999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.82 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=195.9
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC------ChHHHHHHHHHHhccC--CCcceeee
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLR--SPYLLALL 103 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~ 103 (351)
..+.....++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344455678999999999999999999995 46889999998654322 2244667999999996 59999999
Q ss_pred EEEEcCCe-EEEEEEccC-CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-
Q 018744 104 GYCSDRRK-LLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD- 180 (351)
Q Consensus 104 ~~~~~~~~-~~v~~~~~~-~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~- 180 (351)
+++..... +++++++.+ ++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL 184 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC
Confidence 99987755 489999876 8999988542 3689999999999999999999999 999999999999998
Q ss_pred CCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcce
Q 018744 181 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 259 (351)
Q Consensus 181 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~ 259 (351)
.++.++|+|||++...... ......++..|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------ 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------
Confidence 7899999999998765432 2234568899999999887665 6889999999999999999999963210
Q ss_pred eecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 260 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.... .......+ +..+.+||.+||..||++|||+.+++++
T Consensus 255 ------------~~~~--~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ------------IIRG--QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------------HHHC--CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------hhcc--cccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01111222 3468899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=299.06 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=197.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CC-cEEEEEEccccCCCChHHHHHHHHHHhccCCCc------ceeeeEEEEcCC-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NG-RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY------LLALLGYCSDRR- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~- 110 (351)
.++|++.+.||+|+||.||+|.+. ++ ..||+|++... ....+.+.+|+.+++.++|++ ++.+.+++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999964 34 68999998642 233456778999999987655 888888887654
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEe-----------
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----------- 179 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv----------- 179 (351)
.++||+++ ++++.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred EEEEEecc-CCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 45999999 566766664332 13689999999999999999999999 99999999999999
Q ss_pred --------CCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCC
Q 018744 180 --------DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 251 (351)
Q Consensus 180 --------~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~ 251 (351)
+.++.++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999764332 23456899999999999999999999999999999999999999754
Q ss_pred CCCCCcceeeccccccc-------------------------chhHHHhhcCcc-ccCCCCHHHHHHHHHHHHhccCCCC
Q 018744 252 KPSGEGVLVSWALPRLT-------------------------DREKILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEA 305 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P 305 (351)
................. ............ ............+.+||.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 32100000000000000 000000000000 0011223445689999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhc
Q 018744 306 DYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 306 ~~Rpt~~eil~~l~~~~~~ 324 (351)
++|||+.+++++ .+++.
T Consensus 323 ~~Rpt~~e~l~h--p~f~~ 339 (355)
T 2eu9_A 323 AQRITLAEALLH--PFFAG 339 (355)
T ss_dssp TTSCCHHHHTTS--GGGGG
T ss_pred hhCcCHHHHhcC--hhhcC
Confidence 999999999987 45543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=293.55 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=189.2
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC------ChHHHHHHHHHHhcc----CCCcceeeeE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRL----RSPYLLALLG 104 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~~ 104 (351)
.....++|++.+.||+|+||.||+|.+ .+++.|++|++...... ....+.+|+.++..+ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445568899999999999999999995 46889999998644321 223345688888888 8999999999
Q ss_pred EEEcC-CeEEEEEE-ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC-C
Q 018744 105 YCSDR-RKLLVYDY-MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-K 181 (351)
Q Consensus 105 ~~~~~-~~~~v~~~-~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~-~ 181 (351)
++... ..++++++ +.+++|.+++... ..+++..++.++.||+.||.|||++ +++|+||+|+||+++ .
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR 175 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC
Confidence 88765 45689998 7899999998543 3689999999999999999999999 999999999999998 8
Q ss_pred CCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 182 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 182 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
++.++|+|||++....... .....++..|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 8999999999988654322 234568889999999887665 458999999999999999999996321
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..... .. ..+......+.+||.+||+.||++|||+.+++++
T Consensus 244 -----------~~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -----------EILEA-EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----------HHHHT-CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------HHhhh-cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01110 01 1122233468999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.14 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=185.3
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~~~~ 118 (351)
+.|.+.+.||+|+||+||.+...+|+.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+... ++|+|++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667889999999998776668999999988543 245677899999876 89999999999987754 5899999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCC-------------CcE
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-------------FHA 185 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~-------------~~v 185 (351)
. |+|.+++.............++..++.++.||+.||+|||++ +++|+||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 599999865432111111123445678999999999999999 99999999999999654 489
Q ss_pred EEeecccccccCCCCCCc--eecccCCCccccccccccc-------CCCCCccceeehHHHHHHHHh-CCCCCCCCCCCC
Q 018744 186 KVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSG 255 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~ 255 (351)
+|+|||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 999999998765432211 1234568999999999875 568999999999999999999 99999643221
Q ss_pred CcceeecccccccchhHHHhhcC-ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 256 EGVLVSWALPRLTDREKILEIMD-PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.......... ...........+..+.+||.+||+.||++|||+.+++++
T Consensus 247 -------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 -------------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -------------HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0011111111 111122234566789999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=297.22 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=165.2
Q ss_pred HhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccC-CC-----cceeeeEEEEcCC-
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SP-----YLLALLGYCSDRR- 110 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~- 110 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+..|+.+++.++ |+ +++.+.+++....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999965 6888999998632 223456677888888875 44 4899999887654
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--CCCcEEEe
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVS 188 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~--~~~~v~l~ 188 (351)
.++|||++. ++|.+++.... ...+++..++.++.|++.||.|||.+ ..+++|+||||+||+++ .++.++|+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-----FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eEEEEecCC-CCHHHHHhhcC-----cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 459999996 49999885432 13589999999999999999999942 12899999999999994 57889999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCC
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 252 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~ 252 (351)
|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865432 234568899999999999999999999999999999999999998644
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.26 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=174.4
Q ss_pred hcCCCcCc-eeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEc----C-CeE
Q 018744 40 TGGFSKSN-VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----R-RKL 112 (351)
Q Consensus 40 ~~~y~~~~-~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~-~~~ 112 (351)
.++|.+.+ .||+|+||.||+|.+. +++.||+|++... ..........++.+.||||+++++++.. . ..+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 47899965 6999999999999965 6899999998532 2222333445666799999999998865 2 246
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEee
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSD 189 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~d 189 (351)
+||+|+.+++|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++. ++.++|+|
T Consensus 103 lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEECCTTEEHHHHHHTC------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 9999999999999996432 13689999999999999999999999 9999999999999976 45599999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
||++...... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------- 242 (336)
T 3fhr_A 175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-------- 242 (336)
T ss_dssp CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--------
Confidence 9998754332 2234567889999999988889999999999999999999999997544321100000
Q ss_pred hhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 270 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+ ...............+..+.+||.+||..||++|||+.+++++ .+++..
T Consensus 243 -~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~ 294 (336)
T 3fhr_A 243 -RRI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH--PWINQS 294 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS--HHHHTG
T ss_pred -Hhh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC--cccccc
Confidence 000 0000000111111234568999999999999999999999997 445543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.29 Aligned_cols=234 Identities=16% Similarity=0.134 Sum_probs=181.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 114 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+|+..+..++||||+++++++...+ .++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 378999999999999999999965 58999999997543332 266888999999999999999999987764 5699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+++|.+++.. ......+..++.|++.||.|||++ |++|+||||+||+++.++.++|++++
T Consensus 110 ~e~~~g~~L~~~l~~---------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT---------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EECCCEEEHHHHHTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEecCCCCHHHHHhc---------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---
Confidence 999999999999832 134557889999999999999999 99999999999999999999997443
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc-ccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL-PRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 273 (351)
|++ .++.++|||||||++|+|++|..||.+.............. .......
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 226 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-- 226 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH--
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh--
Confidence 333 26889999999999999999999998655432111110000 0000000
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
. .....+..+.+||.+||+.||++| |+.++++.|+++......
T Consensus 227 -~---------~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 227 -D---------IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp -H---------HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred -h---------cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 0 001123468999999999999999 999999999998875443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=289.95 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=175.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC--hHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+. +++.|++|++....... .+.+..+..+++.++||||+++++++.+... ++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 477999999999999999999965 68999999986432211 2334445567788899999999999987654 5899
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
+++ ++.+..+.... ...+++..++.++.|++.||.|||+ + +++|+||+|+||+++.++.++|+|||++.
T Consensus 104 e~~-~~~~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM------QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp CCC-SEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred ecc-CCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 998 44555444321 2468999999999999999999998 6 89999999999999999999999999986
Q ss_pred ccCCCCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
...... ......++..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------------- 235 (318)
T 2dyl_A 174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--------------- 235 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------
T ss_pred hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------
Confidence 543321 223456889999999984 456889999999999999999999999743211
Q ss_pred hhHHHhhcCccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 REKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............ ........+..+.+||.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111110 000011233468999999999999999999999885
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.37 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=173.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHH-HHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVE-LLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+..|+. +++.++||||+++++++..... ++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 388999999999999999999964 689999999864322 12233444555 7777899999999999887654 5899
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+ +|.+++..... .....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.++|+|||++..
T Consensus 101 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp CCCSE-EHHHHHHHHHH--TTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eecCC-ChHHHHHHHHh--hhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99975 77777643110 11346899999999999999999999842 799999999999999999999999999876
Q ss_pred cCCCCCCceecccCCCccccccccc----ccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYA----LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
..... ......|+..|+|||++ .+..++.++|||||||++|+|++|..||............. .
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-------- 243 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-V-------- 243 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-C--------
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-h--------
Confidence 43321 22334688899999998 45678999999999999999999999997543211000000 0
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
....+.+........+..+.+|+.+||..||++|||+.+++++
T Consensus 244 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 ---KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000001111111223468999999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.67 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=182.4
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCCe-EEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRK-LLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~v~~~~ 118 (351)
.+|.+.+.||+|+||.|+.....+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+... ++||+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 5688899999999999776556688999999985432 23356799999999 79999999999887755 5899998
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-----CCcEEEeecccc
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLA 193 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-----~~~v~l~dfg~~ 193 (351)
. ++|.+++..... ......++.++.||+.||.|||++ +++||||||+||+++. ...++|+|||++
T Consensus 101 ~-g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 101 A-ATLQEYVEQKDF------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp S-EEHHHHHHSSSC------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred C-CCHHHHHHhcCC------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 6 589998864431 233445678999999999999999 9999999999999943 335789999999
Q ss_pred cccCCCCCC-ceecccCCCcccccccccc---cCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeeccccccc
Q 018744 194 KIGSDKAGG-HVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 194 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
......... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------------- 235 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------------- 235 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------------
Confidence 865433211 2233466899999999987 4567889999999999999999 9999964321
Q ss_pred chhHHHhhcCccc-c-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPAL-E-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........... . ..........+.+||.+||+.||++|||+.++++|
T Consensus 236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 236 --RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp --HHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11111111111 0 11122345568899999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=309.05 Aligned_cols=275 Identities=22% Similarity=0.288 Sum_probs=200.1
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEc-------CC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-------RR 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 110 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... .......+.+|+++++.++||||+++++++.. ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999995 46899999998643 22234568889999999999999999998654 24
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc---EEE
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKV 187 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~---v~l 187 (351)
.++||+|+.+++|.+++..... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++. ++|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred EEEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 4699999999999999965431 23588889999999999999999999 9999999999999987665 999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCC-------ccee
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE-------GVLV 260 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~-------~~~~ 260 (351)
+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||........ ....
T Consensus 166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999998654332 22446789999999999999999999999999999999999999965311000 0000
Q ss_pred ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHHhhhcc
Q 018744 261 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD-----VVQSLVPLVKYN 325 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e-----il~~l~~~~~~~ 325 (351)
......... ....-..............+..+.+||..||..||++|||+.+ +.+.+++++...
T Consensus 243 ~~~~~~~l~-g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLT-GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCS-SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhc-cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000000 0000000000112233456678999999999999999999988 556677777654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.32 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=190.8
Q ss_pred hcCCCcCceeeecCceEEEEEEEc--CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|++.+.||+|+||.||+|.+. +++.|++|++..... .....+..|+.++..++||||+++++++....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999965 588999998864322 23356788999999999999999999987653
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||||+.+++|.+++. ..+++..++.++.||+.||.|||++ +++|+||||+||+++.+ .++|+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred eEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 379999999999988762 2689999999999999999999999 99999999999999886 9999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccch
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
|++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... ..
T Consensus 226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-- 285 (681)
T 2pzi_A 226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-- 285 (681)
T ss_dssp TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC--
T ss_pred ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc--
Confidence 999765432 4456899999999987654 889999999999999999998886422110 00
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHHhhh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQSLVPLVK 323 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-~~eil~~l~~~~~ 323 (351)
...........+.+||.+||..||++||+ +.++.+.|..++.
T Consensus 286 -----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 -----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00001122346889999999999999995 5566666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=297.30 Aligned_cols=245 Identities=16% Similarity=0.157 Sum_probs=177.3
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCC---CChHHHHHHHHHHhccCC-Ccc---------eeee---
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRS-PYL---------LALL--- 103 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i---------~~~~--- 103 (351)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++| .+. +...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999995 4689999999873322 235778899999999976 211 1111
Q ss_pred ---------EEEEcC-----CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcee
Q 018744 104 ---------GYCSDR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIH 169 (351)
Q Consensus 104 ---------~~~~~~-----~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H 169 (351)
.+.... ..++++....+++|.+++............+++..++.++.||+.||.|||++ +++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 111111 12344444557889888843211112234678889999999999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccc----------ccCCCCCccceeehHHHHH
Q 018744 170 RDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA----------LTGHLTTKSDVYSYGVVLL 239 (351)
Q Consensus 170 ~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~s~~~DiwslG~~l~ 239 (351)
|||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998753322 344566 899999998 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 018744 240 ELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316 (351)
Q Consensus 240 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~ 316 (351)
+|++|..||........ ...++... ..+ +..+.+||.+||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432110 01111111 122 246999999999999999999776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=274.71 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=178.8
Q ss_pred hcCCCcC-ceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHH-hccCCCcceeeeEEEEc----C-Ce
Q 018744 40 TGGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELL-GRLRSPYLLALLGYCSD----R-RK 111 (351)
Q Consensus 40 ~~~y~~~-~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~-~~ 111 (351)
.++|.+. +.||+|+||.||+|.+ .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. . ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3678887 7899999999999996 4689999999853 24567788888 55689999999998865 3 34
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEe
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVS 188 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~ 188 (351)
++||+|+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++. ++.++|+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 69999999999999996532 23689999999999999999999999 9999999999999987 7889999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|||++.... +..++.++|||||||++|+|++|..||...............
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~----- 213 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----- 213 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----
Confidence 999886422 244678999999999999999999999754332110000000
Q ss_pred chhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 269 DREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
.... ....+. ..+..+.+||.+||+.||++|||+.+++++ .++++..
T Consensus 214 -------~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h--p~~~~~~ 264 (299)
T 3m2w_A 214 -------IRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH--PWIMQST 264 (299)
T ss_dssp -------SCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHTGG
T ss_pred -------Hhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC--hhhcccc
Confidence 0000 001111 123468999999999999999999999997 4444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=273.45 Aligned_cols=238 Identities=16% Similarity=0.185 Sum_probs=183.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccC--------CCChHHHHHHHHHHhccC---------CCcceee
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--------KQGEDEFKMEVELLGRLR---------SPYLLAL 102 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~ 102 (351)
.++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 47799999999999999999998 78999999987542 223477888999998885 7777777
Q ss_pred eEEEE-------------------------------cCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHH
Q 018744 103 LGYCS-------------------------------DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALE 151 (351)
Q Consensus 103 ~~~~~-------------------------------~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~q 151 (351)
.+++. ....++||||+.+|++.+.+.. ..+++..++.++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHHH
Confidence 76542 4566799999999977776632 35899999999999
Q ss_pred HHHHHHHHH-cCCCCCceecCCCCCcEEeCCCC--------------------cEEEeecccccccCCCCCCceecccCC
Q 018744 152 AAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNF--------------------HAKVSDFGLAKIGSDKAGGHVSTRVLG 210 (351)
Q Consensus 152 i~~~l~~LH-~~~~~~i~H~di~p~Nilv~~~~--------------------~v~l~dfg~~~~~~~~~~~~~~~~~~~ 210 (351)
|+.||.||| ++ +++||||||+|||++.++ .+||+|||++..... ....|
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~g 239 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVF 239 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEEC
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEE
Confidence 999999999 89 999999999999998887 899999999986543 23468
Q ss_pred CcccccccccccCCCCCccceeehHHH-HHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc-----CccccCC
Q 018744 211 TQGYVAPEYALTGHLTTKSDVYSYGVV-LLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM-----DPALEGQ 284 (351)
Q Consensus 211 ~~~y~aPE~~~~~~~s~~~DiwslG~~-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 284 (351)
|+.|+|||++.+.. +.++||||||++ .+++++|..||.... | .......+. .......
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~------~~~~~~~~~~~~~~~~~~~~~ 303 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------W------LHYLTDKMLKQMTFKTKCNTP 303 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------H------HHHHHHHHHHTCCCSSCCCSH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------h------hhHHHHhhhhhhccCcccchh
Confidence 99999999998766 889999998877 667888998884210 0 000111111 1111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HH
Q 018744 285 YSMKEVIQVAAIAAMCVQPEADYRPLMADVV-QS 317 (351)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil-~~ 317 (351)
.....+..+.+||.+||+.| |+.|++ +|
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 12356678999999999976 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=242.70 Aligned_cols=183 Identities=17% Similarity=0.111 Sum_probs=124.1
Q ss_pred eecCceEEEEEE-EcCCcEEEEEEccccCC----------CChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEEEE
Q 018744 50 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGK----------QGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYD 116 (351)
Q Consensus 50 g~G~~g~v~~~~-~~~~~~~~vk~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~~ 116 (351)
..|+.|....++ .-.|+.+++|++..... ...+.+.+|+++|+++ .|+||++++++++++. .|+|||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 344444444444 33577799998854311 1235688999999999 7999999999998875 569999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|++|++|.+.+... .+++.. .|+.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 323 yv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 323 KLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp CCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred cCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999543 356654 4789999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCC
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 248 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf 248 (351)
.... ......+||+.|+|||++.+. +..++|+|++|++++.|.++..++
T Consensus 390 ~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 4322 223446799999999998754 677899999999988776654443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=211.68 Aligned_cols=185 Identities=21% Similarity=0.201 Sum_probs=137.8
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCC--------hHHHHHHHHHHhccCCCcceeeeEEE-EcCCeEE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--------EDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLL 113 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 113 (351)
+...+.||+|+||.||++.. .+..+++|......... .+.+.+|+++++.++||||+.+..++ .....++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567899999999999954 56778888764322211 23478899999999999999444333 3445689
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
||||+++++|.+++.. +..++.|++.+|.|||++ +++|+||||+||+++. .++|+|||++
T Consensus 417 VmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp EEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred EEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccC
Confidence 9999999999999932 568999999999999999 9999999999999998 9999999999
Q ss_pred cccCCCCCCc-----eecccCCCccccccccccc--CCCCCccceeehHHHHHHHHhCCCCC
Q 018744 194 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPI 248 (351)
Q Consensus 194 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~s~~~DiwslG~~l~~lltg~~pf 248 (351)
.......... ......||+.|+|||++.+ ..|+..+|+|+..+-..+.+.++-+|
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 8754421111 1124568999999999986 56788899999988888877666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=185.27 Aligned_cols=154 Identities=12% Similarity=0.067 Sum_probs=122.8
Q ss_pred HHHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC------------------ChHHHHHHHHHHhcc
Q 018744 33 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ------------------GEDEFKMEVELLGRL 94 (351)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~------------------~~~~~~~e~~~l~~l 94 (351)
...+......|.+.+.||+|+||.||+|.+.+|+.+|+|++...... ....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 33444555667777999999999999999977999999998643211 234578899999999
Q ss_pred CCCcceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCC
Q 018744 95 RSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 174 (351)
Q Consensus 95 ~h~~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p 174 (351)
+ | +++.+++..+..++||+|+++++|.+ +.. .....++.|++.||.+||++ +++|+||||
T Consensus 162 ~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp 221 (282)
T 1zar_A 162 Q--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 221 (282)
T ss_dssp T--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred c--C-CCcCeEEeccceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence 8 5 66666666677799999999999998 411 12446999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCCCceecccCCCccccccccccc
Q 018744 175 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222 (351)
Q Consensus 175 ~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (351)
+||+++ ++.++|+|||++.. +..+.|||.+..
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred HHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999999 99999999999863 234688887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-20 Score=158.25 Aligned_cols=137 Identities=17% Similarity=0.102 Sum_probs=104.6
Q ss_pred CCCcCceeeecCceEEEEEEE-cCCcE--EEEEEccccCCCC------------------------hHHHHHHHHHHhcc
Q 018744 42 GFSKSNVVGHGGFGLVYRGVL-SNGRK--VAIKLMDQAGKQG------------------------EDEFKMEVELLGRL 94 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~-~~~~~--~~vk~~~~~~~~~------------------------~~~~~~e~~~l~~l 94 (351)
-|.+.+.||+|+||.||+|.+ .+|+. +|+|++....... ...+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68888 9999875321110 12577899999999
Q ss_pred CCCcc--eeeeEEEEcCCeEEEEEEccC-C----ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCC
Q 018744 95 RSPYL--LALLGYCSDRRKLLVYDYMAN-G----GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCSPP 166 (351)
Q Consensus 95 ~h~~i--~~~~~~~~~~~~~~v~~~~~~-~----~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ 166 (351)
.|+++ +.+++ ....++||+|+.+ | +|.+.... .++..+..++.|++.+|.+|| +. +
T Consensus 128 ~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~---g 191 (258)
T 1zth_A 128 KEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQEA---E 191 (258)
T ss_dssp HHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHHTS---C
T ss_pred HhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHHHC---C
Confidence 87754 33333 2466899999942 3 45554421 123456789999999999999 88 9
Q ss_pred ceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 167 VIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 167 i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
++|+||||.|||++. .++|+|||++...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.1e-17 Score=147.47 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=100.9
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCC--------------CChHH--------HHHHHHHHhccCCCc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--------------QGEDE--------FKMEVELLGRLRSPY 98 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~~ 98 (351)
.=|++.+.||.|++|.||+|...+|+.+|+|++..... ..... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999988899999998752210 00111 224566666664443
Q ss_pred ceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 99 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 99 i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
+ ++...+.....++||+|++|++|..+.. . .....++.|++.+|.+||+. |++||||||.|||
T Consensus 175 v-~vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL 237 (397)
T 4gyi_A 175 F-PVPEPIAQSRHTIVMSLVDALPMRQVSS-----------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNIL 237 (397)
T ss_dssp C-SCCCEEEEETTEEEEECCSCEEGGGCCC-----------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred C-CCCeeeeccCceEEEEecCCccHhhhcc-----------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence 3 2222233345589999999988876541 1 12356789999999999999 9999999999999
Q ss_pred eCCCC----------cEEEeeccccccc
Q 018744 179 LDKNF----------HAKVSDFGLAKIG 196 (351)
Q Consensus 179 v~~~~----------~v~l~dfg~~~~~ 196 (351)
+++++ .+.++||+-+...
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 98776 3899999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=5e-12 Score=109.50 Aligned_cols=146 Identities=15% Similarity=0.081 Sum_probs=110.4
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~ 113 (351)
+.....+|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.+++++.... ..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445578999999999999999999854 6789999986532233445788999999884 56778888877655 4569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------ 163 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------ 163 (351)
||++++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 9999999998876411 1123467889999999999820
Q ss_pred --------------------------CCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 164 --------------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 164 --------------------------~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
...++|||++|.||+++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0258999999999999876556799998664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-10 Score=99.29 Aligned_cols=136 Identities=18% Similarity=0.101 Sum_probs=96.5
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc--ceeeeEEEEcC-CeEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGYCSDR-RKLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~-~~~~v~~~ 117 (351)
.+|.+....+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +.+++.+.... ..++||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554444466679999998767788999987543 2345677999998885434 45577777654 45799999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC---------------------------------- 163 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 163 (351)
++|.++. .. ..+ ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~----------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 97 VPGQDLL--SS----------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp CSSEETT--TS----------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred cCCcccC--cC----------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9998874 21 111 1256777888888888752
Q ss_pred ---------------------CCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 164 ---------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 164 ---------------------~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.3e-09 Score=98.81 Aligned_cols=142 Identities=13% Similarity=0.227 Sum_probs=104.2
Q ss_pred CcCceeeecCceEEEEEEEcCCcEEEEEEcc--ccC-CCChHHHHHHHHHHhccC--CCcceeeeEEEEcC----CeEEE
Q 018744 44 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAG-KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDR----RKLLV 114 (351)
Q Consensus 44 ~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~----~~~~v 114 (351)
.-.+.|+.|.++.+|++...+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. ..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346678999999999988644 678889875 221 122346778999999886 34578888887665 26799
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------- 163 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------- 163 (351)
|++++|..+.+... ..++......++.+++++|+.||+..
T Consensus 120 me~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp EECCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred EEecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 99999987754221 24677888899999999999999731
Q ss_pred ------------------------CCCceecCCCCCcEEeCCCCc--EEEeecccccc
Q 018744 164 ------------------------SPPVIHRDFKSSNILLDKNFH--AKVSDFGLAKI 195 (351)
Q Consensus 164 ------------------------~~~i~H~di~p~Nilv~~~~~--v~l~dfg~~~~ 195 (351)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=7.4e-10 Score=97.99 Aligned_cols=185 Identities=21% Similarity=0.255 Sum_probs=118.1
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCc--ceeeeEEEEcCC----eEEEEEEc
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPY--LLALLGYCSDRR----KLLVYDYM 118 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~----~~~v~~~~ 118 (351)
++.++.|....+|++. ..+++|+.... .....+..|+.+++.+. +.. +..++....... .++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999998863 45888986422 23456888999998873 332 334444433322 35899999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----------------------------------- 163 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------- 163 (351)
+|.++..... ..++......++.+++..++.||+..
T Consensus 99 ~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 99 KGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred CCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9988765331 24566777788888888888888621
Q ss_pred --------------------CCCceecCCCCCcEEeCC--CCcEEEeecccccccCCCCCCceecccCCCcccccccccc
Q 018744 164 --------------------SPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221 (351)
Q Consensus 164 --------------------~~~i~H~di~p~Nilv~~--~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (351)
...++|+|++|.||+++. +..+.|+||+.+........ .........-..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHH
Confidence 125799999999999987 55678999998765322110 00000000001222111
Q ss_pred c-----CC---------CCCccceeehHHHHHHHHhCCCCC
Q 018744 222 T-----GH---------LTTKSDVYSYGVVLLELLTGRVPI 248 (351)
Q Consensus 222 ~-----~~---------~s~~~DiwslG~~l~~lltg~~pf 248 (351)
. +. .....+.|++|.++|.+.+|..+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 012358899999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.8e-06 Score=76.18 Aligned_cols=135 Identities=22% Similarity=0.246 Sum_probs=92.0
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC---cceeeeEEEE--cCCeEEEEEEccC
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCS--DRRKLLVYDYMAN 120 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~--~~~~~~v~~~~~~ 120 (351)
.+.++.|....+|+. +..+++|+... ......+..|+.+|+.+.+. .+..++.+.. .+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 56788898531 22345688899999998642 3556666654 2346799999999
Q ss_pred CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 018744 121 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------------- 163 (351)
Q Consensus 121 ~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------- 163 (351)
.++..... ..++......++.++.+.|+.||+..
T Consensus 98 ~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 98 QILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred eECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 88866321 12344455555566666666665531
Q ss_pred --------------------CCCceecCCCCCcEEeCC---CCc-EEEeecccccc
Q 018744 164 --------------------SPPVIHRDFKSSNILLDK---NFH-AKVSDFGLAKI 195 (351)
Q Consensus 164 --------------------~~~i~H~di~p~Nilv~~---~~~-v~l~dfg~~~~ 195 (351)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124699999999999987 455 48999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.7e-06 Score=73.43 Aligned_cols=140 Identities=19% Similarity=0.106 Sum_probs=96.0
Q ss_pred hcCCCcCceeeecCce-EEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-CeEEEE
Q 018744 40 TGGFSKSNVVGHGGFG-LVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g-~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~ 115 (351)
...|+.. .+..|..+ .||+.... ++..+++|+-... ....+..|+..|+.+. +-.+.+++.++.+. ..++||
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 3445543 34455554 68988754 4667899976432 3456788999998874 33467777777655 457999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-------------------------------
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS------------------------------- 164 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~------------------------------- 164 (351)
++++|.++.+..... ......+..+++..|+.||....
T Consensus 100 e~l~G~~~~~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD 168 (272)
T ss_dssp ECCCSEEHHHHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred EeeCCccccccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence 999998877654211 12234566777788888886420
Q ss_pred ------------------------CCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 165 ------------------------PPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 165 ------------------------~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
..++|||+.+.||+++.++.+-|+||+.+.
T Consensus 169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 027999999999999987777799998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.30 E-value=4.4e-06 Score=72.92 Aligned_cols=80 Identities=16% Similarity=0.204 Sum_probs=59.3
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC---cceeeeEEEEcCCeEEEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCSDRRKLLVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~v~~~ 117 (351)
....-++.+|.|..+.||+....+|+.+++|+...........+..|+..|+.+... .+++++.+ +..+++|++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv~e~ 91 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLAMEW 91 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEEEEC
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEEEEe
Confidence 455557789999999999999889999999987655555556788899999888432 33444433 345899999
Q ss_pred ccCCCh
Q 018744 118 MANGGL 123 (351)
Q Consensus 118 ~~~~~L 123 (351)
..++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 887653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.6e-06 Score=76.82 Aligned_cols=80 Identities=9% Similarity=-0.021 Sum_probs=54.3
Q ss_pred Ccee-eecCceEEEEEEEc-------CCcEEEEEEccccC---CCChHHHHHHHHHHhccC-C--CcceeeeEEEEcC--
Q 018744 46 SNVV-GHGGFGLVYRGVLS-------NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLR-S--PYLLALLGYCSDR-- 109 (351)
Q Consensus 46 ~~~l-g~G~~g~v~~~~~~-------~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~-- 109 (351)
.+.| +.|....+|+.... ++..+++|+..... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3556 78888999988753 26679999875432 111245667888888774 2 3567777777654
Q ss_pred --CeEEEEEEccCCChhh
Q 018744 110 --RKLLVYDYMANGGLQE 125 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~ 125 (351)
..++||++++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 3579999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=2.9e-06 Score=77.69 Aligned_cols=75 Identities=17% Similarity=0.185 Sum_probs=48.9
Q ss_pred CceeeecCceEEEEEEEc-CCcEEEEEEccccCC-------CChHHHHHHHHHHhccCC--Cc-ceeeeEEEEcCCeEEE
Q 018744 46 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-------QGEDEFKMEVELLGRLRS--PY-LLALLGYCSDRRKLLV 114 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~v 114 (351)
.+.||.|..+.||++... +++.+++|....... .....+..|+++++.+.. +. +..++. +..+..++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-SDTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-EETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-EcCCccEEE
Confidence 557899999999999743 567899997643211 233556778888887732 33 344554 344566899
Q ss_pred EEEccCC
Q 018744 115 YDYMANG 121 (351)
Q Consensus 115 ~~~~~~~ 121 (351)
|+++.+.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00015 Score=64.47 Aligned_cols=29 Identities=28% Similarity=0.398 Sum_probs=26.6
Q ss_pred CceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 166 ~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
.++|||+.+.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 89999999999999888899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00016 Score=63.31 Aligned_cols=74 Identities=11% Similarity=0.103 Sum_probs=45.4
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEc-cC
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYM-AN 120 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~-~~ 120 (351)
+.-.+.|+.|....+|++ ..+++|+......... ....|+.+++.+...++ .+++.+ ..+..+++++|+ ++
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~-~r~~E~~~l~~l~~~g~~P~~~~~-~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYI-NRANEAVAAREAAKAGVSPEVLHV-DPATGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CC-CHHHHHHHHHHHHHTTSSCCEEEE-CTTTCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcccee-CHHHHHHHHHHHHHcCCCCceEEE-ECCCCEEEEeecCCC
Confidence 333778999999999998 5588898764322211 22457777777643233 344433 334467899999 66
Q ss_pred CCh
Q 018744 121 GGL 123 (351)
Q Consensus 121 ~~L 123 (351)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00035 Score=61.65 Aligned_cols=165 Identities=14% Similarity=0.149 Sum_probs=87.1
Q ss_pred CceeeeHHHHHHHhcCCCcC-----ceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc--c
Q 018744 27 GLQVFTFKQLHSATGGFSKS-----NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--L 99 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 99 (351)
++...+.+++.....+|-+. +.|+.|....+|+....++ .+++|+.... .....+..|+.++..+...+ +
T Consensus 3 v~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~v 79 (322)
T 2ppq_A 3 VYTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSC 79 (322)
T ss_dssp --CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCC
T ss_pred ccccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCC
Confidence 34556677777777778762 2355677889999886555 6889987642 12334566777776663211 2
Q ss_pred eeeeEE-------EEcCCeEEEEEEccCCChhhh--------------ccccCCC--CCCCCCCC---HHHHHH------
Q 018744 100 LALLGY-------CSDRRKLLVYDYMANGGLQEH--------------LYPANGS--NSVASKLD---WETRLR------ 147 (351)
Q Consensus 100 ~~~~~~-------~~~~~~~~v~~~~~~~~L~~~--------------~~~~~~~--~~~~~~l~---~~~~~~------ 147 (351)
..++.. ...+..++++++++|..+... ++..... ........ +...+.
T Consensus 80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence 222211 122345689999988764321 1111100 00000011 111000
Q ss_pred ------HHHHHHHHHHHHHcC----CCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 148 ------IALEAAKGLEFLHEH----CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 148 ------i~~qi~~~l~~LH~~----~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
+...+...+..+... ...+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344444421 12379999999999999887556899998664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=58.62 Aligned_cols=98 Identities=15% Similarity=0.140 Sum_probs=63.9
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+.+..++ .++++.++|.++.|.+.+|..+-... .-...=+.|..|++..+|+|.+.+- .+.
T Consensus 34 SL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~~-~s~------- 97 (229)
T 2yle_A 34 SLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAPA-ADD------- 97 (229)
T ss_dssp EHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECCC-----------
T ss_pred cHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceecccc-ccc-------
Confidence 5777775444 58999999999999999998873210 1123344578999999999887631 110
Q ss_pred CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh
Q 018744 202 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 243 (351)
Q Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt 243 (351)
.....+.|||... ...+.+.-|||||+++|.-+-
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123477888653 344677889999999999886
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0008 Score=59.15 Aligned_cols=74 Identities=14% Similarity=0.168 Sum_probs=56.1
Q ss_pred CceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC---CCcceeeeEEEEcC-CeEEEEEEccCC
Q 018744 46 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVYDYMANG 121 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-~~~~v~~~~~~~ 121 (351)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.+. ...+++++.+.... ..++||+++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45688999999999886 4678889987532 3567888999888873 35677788777654 467999999987
Q ss_pred Ch
Q 018744 122 GL 123 (351)
Q Consensus 122 ~L 123 (351)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00038 Score=62.93 Aligned_cols=143 Identities=20% Similarity=0.214 Sum_probs=82.4
Q ss_pred CceeeecCceEEEEEEEc--------CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCc-ceeeeEEEEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~--------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~v~~ 116 (351)
++.|..|....+|++... +++.+++|+.... ......+.+|+.+++.+...+ ..++++++.+ .+|++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---ccEEE
Confidence 456777888899998864 2478999987432 234556678999988874222 3555655543 38999
Q ss_pred EccCCChhhh-----------------ccccCCCCCCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 018744 117 YMANGGLQEH-----------------LYPANGSNSVASKLD--WETRLRIALEAAK-------------------GLEF 158 (351)
Q Consensus 117 ~~~~~~L~~~-----------------~~~~~~~~~~~~~l~--~~~~~~i~~qi~~-------------------~l~~ 158 (351)
|++|.+|... ++..... ...... +..+..+..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~--~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP--FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS--SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC--CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9988665421 1111100 111222 3455555544322 1222
Q ss_pred ----HHcC-CCCCceecCCCCCcEEeCCC----CcEEEeeccccc
Q 018744 159 ----LHEH-CSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAK 194 (351)
Q Consensus 159 ----LH~~-~~~~i~H~di~p~Nilv~~~----~~v~l~dfg~~~ 194 (351)
|... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 12369999999999999876 789999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00057 Score=62.87 Aligned_cols=29 Identities=17% Similarity=0.377 Sum_probs=26.4
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 166 ~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.++|||+++.||+++.++ +.++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 899999999999998876 99999988765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0005 Score=63.41 Aligned_cols=73 Identities=19% Similarity=0.209 Sum_probs=48.5
Q ss_pred CceeeecCceEEEEEEEcC--------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~ 116 (351)
.+.|+.|....+|++...+ ++.+++|+.... .....+..|+.+++.+...++ .++++.+.+ .+|++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CEEEE
Confidence 4467788889999998643 478999988432 222455678888888753333 555555432 38889
Q ss_pred EccCCCh
Q 018744 117 YMANGGL 123 (351)
Q Consensus 117 ~~~~~~L 123 (351)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9876544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0017 Score=57.59 Aligned_cols=31 Identities=35% Similarity=0.469 Sum_probs=27.0
Q ss_pred CCceecCCCCCcEEeCCC----CcEEEeecccccc
Q 018744 165 PPVIHRDFKSSNILLDKN----FHAKVSDFGLAKI 195 (351)
Q Consensus 165 ~~i~H~di~p~Nilv~~~----~~v~l~dfg~~~~ 195 (351)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 389999999999999874 6799999988765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0024 Score=56.37 Aligned_cols=165 Identities=12% Similarity=0.079 Sum_probs=90.1
Q ss_pred CceeeeHHHHHHHhcCCCcC-----ceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCC--cc
Q 018744 27 GLQVFTFKQLHSATGGFSKS-----NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YL 99 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~--~i 99 (351)
++...+.+.+....+.|-+. ..|+ |....+|++...+|+.+++|..... ......+..|..+++.+... .+
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCee
Confidence 35555666666666656442 3455 7788999887766778999998532 22455677788887776421 23
Q ss_pred eeeeEE------EEcCCeEEEEEEccCCChhh-----h---------ccccCCC--CCCCCCCCHHH-------------
Q 018744 100 LALLGY------CSDRRKLLVYDYMANGGLQE-----H---------LYPANGS--NSVASKLDWET------------- 144 (351)
Q Consensus 100 ~~~~~~------~~~~~~~~v~~~~~~~~L~~-----~---------~~~~~~~--~~~~~~l~~~~------------- 144 (351)
+.++.. ...+..++++++++|..+.. . ++..... .......+...
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 333332 11233457999998755421 0 1111100 00001122111
Q ss_pred ---------HHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 145 ---------RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 145 ---------~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
....+..++..+..+-. .....++|||+++.||+++ + .+.|+||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222222322211 0123689999999999998 4 899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0019 Score=60.01 Aligned_cols=74 Identities=11% Similarity=0.070 Sum_probs=46.8
Q ss_pred CceeeecCceEEEEEEEcC-CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEEEccCCCh
Q 018744 46 SNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMANGGL 123 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~~~~~~~L 123 (351)
.+.|+.|....+|++...+ +..+++|+.........+ ...|+.+++.+...++ .++++.+. + .+|++|++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~-G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N-GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T-EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C-eEEEEeeCCccC
Confidence 3467778889999998754 478999987543222111 2468888888864444 45666552 2 369999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0011 Score=59.77 Aligned_cols=74 Identities=11% Similarity=0.053 Sum_probs=43.1
Q ss_pred CceeeecCceEEEEEEEcC---------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCc-ceeeeEEEEcCCeEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSN---------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRRKLLVY 115 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~v~ 115 (351)
.+.|+.|....+|++...+ +..+++|+....... ......|+.+++.+...+ ..++++.. ..++|+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---NGGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---TTEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---CCcEEE
Confidence 3456778888999988643 268899987543211 112356777777774333 34555443 247899
Q ss_pred EEccCCCh
Q 018744 116 DYMANGGL 123 (351)
Q Consensus 116 ~~~~~~~L 123 (351)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.018 Score=51.06 Aligned_cols=30 Identities=17% Similarity=0.319 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 166 ~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 799999999999999888899999977653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.015 Score=53.18 Aligned_cols=74 Identities=8% Similarity=0.087 Sum_probs=47.5
Q ss_pred CceeeecCceEEEEEEEcC--------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCc-ceeeeEEEEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~v~~ 116 (351)
++.|..|....+|+....+ ++.+++|+......... ...+|+.+++.+...+ ..++++.+ ..++|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~---~~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF---PEGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE---TTEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc---CCCEEEE
Confidence 4567778889999998653 57899999754322221 2345888887774222 34445433 2478999
Q ss_pred EccCCCh
Q 018744 117 YMANGGL 123 (351)
Q Consensus 117 ~~~~~~L 123 (351)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.62 E-value=0.055 Score=49.17 Aligned_cols=30 Identities=27% Similarity=0.386 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEe------CCCCcEEEeecccccc
Q 018744 166 PVIHRDFKSSNILL------DKNFHAKVSDFGLAKI 195 (351)
Q Consensus 166 ~i~H~di~p~Nilv------~~~~~v~l~dfg~~~~ 195 (351)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.35 E-value=0.32 Score=39.65 Aligned_cols=116 Identities=13% Similarity=0.139 Sum_probs=76.2
Q ss_pred CCCcceeeeEEEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCC
Q 018744 95 RSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 174 (351)
Q Consensus 95 ~h~~i~~~~~~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p 174 (351)
.||++++. .+..+++.+. +.|-......++- .-..++....+.++.+|+....+++.+ +|--|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~-~~y~~~~~~~~f~--------~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQ-IHYDINDNHTPFD--------NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEE-EEECCCTTSEEGG--------GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred cCCcccce-EEEEcccEEE-EEEEcCcccCCHH--------HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence 57888877 4666666443 3333332222222 113678899999999999988666644 8999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCC
Q 018744 175 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249 (351)
Q Consensus 175 ~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~ 249 (351)
+|++++.++.+++.-.|+-....+.. ..+|. =.-.+=|++..+++++..|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee~----------fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEAE----------FLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSCCC--------------CCHHH----------HHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCCCCCC--------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998777643221110 01111 11245688889999988884
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.55 Score=38.45 Aligned_cols=114 Identities=11% Similarity=0.083 Sum_probs=72.4
Q ss_pred CCCcceeeeEEEEcCCeEEE-EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCceecCC
Q 018744 95 RSPYLLALLGYCSDRRKLLV-YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE-FLHEHCSPPVIHRDF 172 (351)
Q Consensus 95 ~h~~i~~~~~~~~~~~~~~v-~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~i~H~di 172 (351)
.||++ -..+..+++.+.+ +..-.++.-...+ ..++....+.++.+|+.... +++ .-+|--|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEE
Confidence 67877 3344455555533 3332232222223 26788999999999988777 555 4589999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCC
Q 018744 173 KSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 249 (351)
Q Consensus 173 ~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~ 249 (351)
.|+|++++.++.+++.-.|+-... +|..+.. ..=.-++=|++..++.++..|.
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~l-------------------pP~e~~e-----e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKESL-------------------PPDEWDD-----ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTTB-------------------SSCSCCH-----HHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCceEEEeCCCcEEEEEcCCcccC-------------------CCCCCCH-----HHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999999887764432 2221110 0011145678888888888774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 351 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-73
Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 31/293 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 100
+ +G G FG VY+G VA+K++ Q FK EV +L + R +L
Sbjct: 10 ITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 101 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+GY + + +V + L HL+ K + + IA + A+G+++LH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLH 121
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+IHRD KS+NI L ++ K+ DFGLA + S +G H ++ G+ ++APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 221 LT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
+ +SDVY++G+VL EL+TG++P + + + D K+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 330
A+ + A C++ + D RPL ++ S+ L RS PK
Sbjct: 239 PKAM------------KRLMAECLKKKRDERPLFPQILASIELLA---RSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-66
Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V+ G + KVA+K + Q G D F E L+ +L+ L+ L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+ ++ +YM NG L + L +G KL L +A + A+G+ F+ E
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
IHRD +++NIL+ K++DFGLA++ D + APE
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184
Query: 223 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 282
G T KSDV+S+G++L E++T + E + R+ + E
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE------- 237
Query: 283 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
++ + +C + + RP + L
Sbjct: 238 ---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (512), Expect = 3e-63
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 45/312 (14%)
Query: 31 FTFKQLHSATGGFSKS---------NVVGHGGFGLVYRGVL----SNGRKVAIKLMD-QA 76
FTF+ + A F+K V+G G FG V G L VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 77 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS 135
++ +F E ++G+ P ++ L G + + ++ ++M NG L L +G +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 136 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195
+ + A G+++L + +HRD + NIL++ N KVSDFGL++
Sbjct: 127 ------VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 196 GSDKAGGHVSTRVLGTQG---YVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVN 251
D T LG + + APE T+ SDV+SYG+V+ E+++ G P
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 252 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 311
+ ++ ++ M + + C Q + ++RP
Sbjct: 238 TN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 312 ADVVQSLVPLVK 323
+V +L +++
Sbjct: 281 GQIVNTLDKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-63
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 28/282 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+ +G G FGLV+ G N KVAIK + + G E++F E E++ +L P L+ L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
G C ++ + LV+++M +G L ++L G ET L + L+ +G+
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEGM---AY 116
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
VIHRD + N L+ +N KVSDFG+ + D ST + +PE
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 175
Query: 222 TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 281
++KSDV+S+GV++ E+ + N+ + E + D + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 282 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
V I C + + RP + +++ L + +
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-62
Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+ +G G FG+V G VAIK++ + G EDEF E +++ L L+ L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 103 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 161
G C+ +R + ++ +YMANG L +L + + L + + + +E+L
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAMEYLES 118
Query: 162 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 221
+HRD + N L++ KVSDFGL++ D S + PE +
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM 174
Query: 222 TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280
++KSD++++GV++ E+ + G++P + + E +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQG 217
Query: 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
L +V I C +AD RP ++ +++
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-62
Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 48 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 107
+G G FG V+RG G +VA+K+ ++ + E+ LR +L + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 108 DRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
LV DY +G L ++L + E +++AL A GL LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 163 C-----SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQGYV 215
P + HRD KS NIL+ KN ++D GLA + +GT+ Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 216 APEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNK----PSGEGVLVSWALP 265
APE ++D+Y+ G+V E+ +++ P + V ++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 266 RLTDREKILEIMDPALEGQYSMKEVIQ-VAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
+ + + + P + ++ E ++ +A I C R + ++L L +
Sbjct: 240 EM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-62
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 100
F K + +G G G+V++ +G +A KL+ K ++ E+++L SPY++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G ++ + ++M G L + L A ++ + ++++ KGL +L
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYL 120
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
E ++HRD K SNIL++ K+ DFG++ D ++ +GT+ Y++PE
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 174
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPID 249
H + +SD++S G+ L+E+ GR PI
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-61
Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 26/281 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V+ G + +VAIK + G + F E +++ +LR L+ L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
S+ +V +YM+ G L + L G + +A + A G+ ++
Sbjct: 78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMAYVERM 132
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
+HRD +++NIL+ +N KV+DFGLA++ D + APE AL
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALY 188
Query: 223 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 282
G T KSDV+S+G++L EL T ++L+ ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYR 232
Query: 283 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
+ + + C + E + RP + L
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 33/299 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNG-----RKVAIKLMDQAGKQGE-DEFKMEVELLGRLRS 96
++ V+G G FG VY+G+L VAIK + + + +F E ++G+
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 155
++ L G S + + ++ +YM NG L + L +G + + + A G
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAG 122
Query: 156 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 214
+ + +HRD + NIL++ N KVSDFGL++ + D + ++ +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274
APE T+ SDV+S+G+V+ E++T + E ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VM 223
Query: 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISS 333
+ ++ M + + C Q E RP AD+V L L++ S ++
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 4e-61
Identities = 63/291 (21%), Positives = 124/291 (42%), Gaps = 28/291 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+ + +G G +G VY GV VA+K + + + E EF E ++ ++ P L+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
LLG C+ ++ ++M G L ++L N ++ L +A + + +E+L
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLE 132
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ IHRD + N L+ +N KV+DFGL+++ + + APE
Sbjct: 133 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL 188
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280
+ KSDV+++GV+L E+ T + D ++ E+++
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKD 232
Query: 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 331
+ +V + C Q RP A++ Q+ + + + + ++
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 34/282 (12%)
Query: 46 SNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 100
+ V+G G FG VY G L + A+K +++ GE +F E ++ P +L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 101 ALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
+LLG C S+ L+V YM +G L+ + + + L+ AKG+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGM-- 143
Query: 159 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVA 216
S +HRD + N +LD+ F KV+DFGLA+ + H T ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276
E T TTKSDV+S+GV+L EL+T P + + + + RL E +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD- 261
Query: 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ + C P+A+ RP +++V +
Sbjct: 262 ---------------PLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-59
Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 33/307 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGR----KVAIKLMDQAG-KQGEDEFKMEVELLGRLRS 96
F K V+G G FG VY+G+ + G VAIK + +A + E E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
P++ LLG C L+ M G L +++ + + L ++ AKG+
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG------SQYLLNWCVQIAKGM 124
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+L + ++HRD + N+L+ H K++DFGLAK+ + + + ++A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275
E L T +SDV+SYGV + EL+T G P D +I
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISS 224
Query: 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 335
I++ I V I C +AD RP +++ + + + I
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 336 SFHASRS 342
H
Sbjct: 285 RMHLPSP 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 65/275 (23%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 50 GHGGFGLVYRGVL---SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLALLGY 105
G G FG V +GV VAIK++ Q ++ + +E E +++ +L +PY++ L+G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 106 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
C +LV + G L + L ++ + + + G+++L E
Sbjct: 78 CQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEK--- 128
Query: 166 PVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGH 224
+HRD + N+LL +AK+SDFGL+K +G+D + + + APE
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 225 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
+++SDV+SYGV + E L+ G+ P K +++ ++
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGKRM 231
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ + ++ A+ + C + + RP V Q +
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-58
Identities = 67/278 (24%), Positives = 110/278 (39%), Gaps = 34/278 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 102
+G G FG V G G KVA+K + F E ++ +LR L+ L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 103 LGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
LG + + +V +YMA G L ++L S L + L+ +L+ + +E+L
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLE 120
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ +HRD + N+L+ ++ AKVSDFGL K S + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEAL 172
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280
+TKSDV+S+G++L E+ + P + V ++ +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------PRVEKGYKMD 220
Query: 281 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
V + C +A RP + + L
Sbjct: 221 APDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-58
Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 45/297 (15%)
Query: 48 VVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRS-PYL 99
V+G G FG V +VA+K++ + E + E++++ +L S +
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 100 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS----------------VASKLDW 142
+ LLG C+ + L+++Y G L +L S + L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 143 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202
E L A + AKG+EFL +HRD + N+L+ K+ DFGLA+ +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 261
V ++APE G T KSDV+SYG++L E+ + G P
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-------------- 266
Query: 262 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
P + +++ + ++ I C ++ RP ++ L
Sbjct: 267 --YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-58
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 47 NVVGHGGFGLVYRGVL-SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLALL 103
+G G F VY+G+ +VA + + K FK E E+L L+ P ++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 104 GYCSDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 158
K +LV + M +G L+ +L + + + KGL+F
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQF 127
Query: 159 LHEHCSPPVIHRDFKSSNILL-DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
LH PP+IHRD K NI + K+ D GLA + + V+GT ++AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 182
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
E DVY++G+ +LE+ T P + + + ++ +
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------------RRVTSGV 229
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
PA + ++ EV + I C++ D R + D++
Sbjct: 230 KPASFDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-58
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 30/282 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYL 99
+ +G G +G + S+G+ + K +D + + EV LL L+ P +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 100 LALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+ DR +V +Y G L + LD E LR+ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ---YLDEEFVLRVMTQLTLAL 122
Query: 157 EFLHEH--CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
+ H V+HRD K +N+ LD + K+ DFGLA+I + + +GT Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYY 180
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274
++PE KSD++S G +L EL P A + KI
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAGKIR 227
Query: 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
E + +YS ++ I + + +RP + ++++
Sbjct: 228 EGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-58
Identities = 67/296 (22%), Positives = 106/296 (35%), Gaps = 38/296 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRL- 94
S +G G FG V VA+K++ + E + E+++L L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 95 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVAS-----------KLDW 142
++ LLG C+ ++ +Y G L L S + LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 143 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 202
E L + + AKG+ FL IHRD + NILL K+ DFGLA+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 203 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 262
V ++APE T +SDV+SYG+ L EL +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------- 248
Query: 263 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
P + K +++ ++ I C + RP +VQ +
Sbjct: 249 --PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 1e-57
Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 44/301 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLR 95
+G G FG V++ VA+K++ +A + +F+ E L+
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY-----------------PANGSNSVA 137
+P ++ LLG C+ + + L+++YMA G L E L A S+
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 138 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197
L +L IA + A G+ +L E +HRD + N L+ +N K++DFGL++
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 257
++ PE TT+SDV++YGVVL E+ + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY-------- 243
Query: 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317
+ E I + D + +++ + +C RP + +
Sbjct: 244 -------YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 318 L 318
L
Sbjct: 296 L 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 1e-57
Identities = 76/302 (25%), Positives = 113/302 (37%), Gaps = 42/302 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 98
FS +GHG FG VY + N VAIK M +GKQ + + EV L +LR P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ G LV +Y L + A +GL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHGALQGLA 129
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH H +IHRD K+ NILL + K+ DFG A I + + +GT ++AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAP 180
Query: 218 EYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274
E L G K DV+S G+ +EL + P+ + + ++ I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------FNMNAMSALYHIA 227
Query: 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSS 334
+ PAL+ + + C+Q RP +++ V R I
Sbjct: 228 QNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLLKH--RFVLRERPPTVIMDL 282
Query: 335 PS 336
Sbjct: 283 IQ 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-57
Identities = 61/281 (21%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 45 KSNVVGHGGFGLVYRGVLSN---GRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYL 99
+ +G G FG V +G + VA+K++ DE E ++ +L +PY+
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 100 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
+ ++G C +LV + G L ++L + + + + + + G+++L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYL 123
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPE 218
E +HRD + N+LL +AK+SDFGL+K + +D+ T + APE
Sbjct: 124 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 219 YALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
++KSDV+S+GV++ E + G+ P K ++ ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAML 223
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ ++ + +C + + RP A V L
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-56
Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 37/313 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNG---RKVAIKLMDQ-AGKQGEDEFKMEVELLGRL-RSP 97
+V+G G FG V + + AIK M + A K +F E+E+L +L P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKLDWETRLR 147
++ LLG C R L L +Y +G L + L +NS AS L + L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 207
A + A+G+++L IHRD + NIL+ +N+ AK++DFGL++ T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTM 185
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267
++A E TT SDV+SYGV+L E+++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YCG 229
Query: 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327
++ E + + + +V + C + + RP A ++ SL +++ ++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 328 TPKISSSPSFHAS 340
+ F +
Sbjct: 290 YVNTTLYEKFTYA 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 1e-55
Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 41/281 (14%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 98
F +G G FG VY + +A+K++ +A E + + EVE+ LR P
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+L L GY D ++ L+ +Y G + L + K D + E A L
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALS 120
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+ H VIHRD K N+LL K++DFG + A T + GT Y+ P
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 173
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
E K D++S GV+ E L G+ P + N E
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------------------ETY 213
Query: 278 DPALEGQYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQ 316
+++ + + + + ++ RP++ +V++
Sbjct: 214 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-55
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 35/290 (12%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 105
+G G FG VY+ A K++D ++ +++ +E+++L P ++ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 106 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
L ++ ++ A G + + L + + L +LH++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNYLHDN-- 129
Query: 165 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-- 222
+IHRD K+ NIL + K++DFG++ + +GT ++APE +
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCET 186
Query: 223 ---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
K+DV+S G+ L+E+ P L + KI + P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH-------------ELNPMRVLLKIAKSEPP 233
Query: 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 329
L C++ D R + ++Q P V + + P
Sbjct: 234 TLAQPSRWSS--NFKDFLKKCLEKNVDARWTTSQLLQH--PFVTVDSNKP 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-54
Identities = 65/299 (21%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L +L +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLH 133
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ VIHRD KS NILL + K++DFG + ++GT ++APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV 188
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
K D++S G++ +E++ G P ++ N ++ + P L + EK+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA---- 244
Query: 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS----TPKISSS 334
++ + C+ + + R +++Q +K + TP I+++
Sbjct: 245 ------IFRDFLN------RCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPLIAAA 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-54
Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 32/280 (11%)
Query: 47 NVVGHGGFGLVYRGVL----SNGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPYL 99
+G G FG+V RG VA+K + + + D+F EV + L L
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 100 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
+ L G +V + G L + L G T R A++ A+G+ +L
Sbjct: 74 IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQVAEGMGYL 127
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPE 218
IHRD + N+LL K+ DFGL + + + + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
T + SD + +GV L E+ T + + + + + +R E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRPEDCP 241
Query: 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+ + C + + RP + L
Sbjct: 242 QDI------------YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-54
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 29/278 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLL 100
+ +G G +G V V VA+K++D + K E+ + L ++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
G+ + L +Y + G L + + P G + R + G+ +L
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGVVYL 119
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 220 ALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
DV+S G+VL +L G +P D S + +D ++ ++
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKKTYLN 227
Query: 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
P + + ++ + R + D+ +
Sbjct: 228 PWKKIDSAPLALLH------KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-53
Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLR 95
+ S +G G FG+VY GV +VAIK +++A E EF E ++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALE 151
+++ LLG S + ++ + M G L+ +L PA +N V + +++A E
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 152 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 211
A G+ +L+ + +HRD + N ++ ++F K+ DFG+ + + + L
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 212 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271
+++PE G TT SDV+S+GVVL E+ T + + + R
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEG 251
Query: 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
+L+ D + + + MC Q RP +++ S+
Sbjct: 252 GLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 53/285 (18%), Positives = 111/285 (38%), Gaps = 31/285 (10%)
Query: 48 VVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLAL 102
+G G FG V++G+ + VAIK ++F E + + P+++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 103 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 162
+G ++ ++ + G L+ L S LD + + A + + L +L
Sbjct: 74 IGVITENPVWIIMELCTLGELRSFLQVRKYS------LDLASLILYAYQLSTALAYLESK 127
Query: 163 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 222
+HRD + N+L+ N K+ DFGL++ D + +++ ++APE
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINF 183
Query: 223 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 282
T+ SDV+ +GV + E+L V + + + +I +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------------GRIENGERLPMP 231
Query: 283 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327
+ ++ C + RP ++ L +++ ++
Sbjct: 232 PNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-51
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 98
F ++G G F V L+ R+ AIK++++ E+ E +++ RL P+
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
+ L D KL Y NG L +++ D E LE
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALE 122
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH +IHRD K NILL+++ H +++DFG AK+ S ++ + +GT YV+P
Sbjct: 123 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E SD+++ G ++ +L+ G P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-50
Identities = 61/298 (20%), Positives = 107/298 (35%), Gaps = 37/298 (12%)
Query: 47 NVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYL 99
+G G FG V + R VA+K++ + E E+++L +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 100 LALLGYC---SDRRKLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLR 147
+ L +++ ++ G L +L Y + L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 207
+ + AKG+EFL IHRD + NILL + K+ DFGLA+
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 208 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267
++APE T +SDV+S+GV+L E+ + P +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---------------PGV 240
Query: 268 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325
E+ + + ++ C E RP +++V+ L L++ N
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (425), Expect = 9e-50
Identities = 65/311 (20%), Positives = 124/311 (39%), Gaps = 35/311 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
+ +G G FG+V+R + G A K + + ++ + E++ + LR P L+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 102 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L D ++ ++Y++M+ G L E + + K+ + + + KGL +H
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMH 141
Query: 161 EHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 218
E+ +H D K NI+ ++ K+ DFGL K V+T GT + APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 195
Query: 219 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278
A + +D++S GV+ LL+G P + + L + + +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--GENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 279 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 338
K+ I+ + + + R + ++ P + + + S PS
Sbjct: 254 EDG------KDFIR------KLLLADPNTRMTIHQALEH--PWLTPGNAPGRDSQIPS-- 297
Query: 339 ASRSPAFPDKV 349
SR D +
Sbjct: 298 -SRYTKIRDSI 307
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-49
Identities = 64/292 (21%), Positives = 121/292 (41%), Gaps = 39/292 (13%)
Query: 47 NVVGHGGFGLVYRGVL--------SNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRL-RS 96
+G G FG V + KVA+K++ A ++ + E+E++ + +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 97 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRL 146
++ LLG C+ L ++ +Y + G L+E+L Y N S++ +L + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 147 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 206
A + A+G+E+L IHRD + N+L+ ++ K++DFGLA+ +T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 207 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266
++APE T +SDV+S+GV+L E+ T P
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------------- 242
Query: 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
E++ +++ ++ + C RP +V+ L
Sbjct: 243 ---VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 5e-49
Identities = 67/313 (21%), Positives = 124/313 (39%), Gaps = 42/313 (13%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG+V+R V + GR K ++ + K E+ ++ +L P L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
D+ ++ L+ ++++ G L + + + K+ + +A +GL+ +HEH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY------KMSEAEVINYMRQACEGLKHMHEH--- 146
Query: 166 PVIHRDFKSSNILLD--KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
++H D K NI+ + K K+ DFGLA + + T + APE
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDRE 203
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
+ +D+++ GV+ LL+G P L + E + P
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA--GEDDLETLQNVKRCDWEFDEDAFSSVSPEA-- 259
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ------------SLVPLVKYNRSTPKI 331
K+ I+ +Q E R + D ++ S +P +YN+ KI
Sbjct: 260 ----KDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
Query: 332 SSSPSFHASRSPA 344
+ + PA
Sbjct: 310 KEKYADWPAPQPA 322
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 2e-45
Identities = 62/284 (21%), Positives = 110/284 (38%), Gaps = 34/284 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 98
+ ++G GG V+ L R VA+K++ + F+ E + L P
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 99 LLALLGYCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 153
++A+ +V +Y+ L++ ++ + + + + +A
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADAC 121
Query: 154 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQ 212
+ L F H++ +IHRD K +NI++ KV DFG+A+ I + V+GT
Sbjct: 122 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272
Y++PE A + +SDVYS G VL E+LTG P + P V
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSA 236
Query: 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
E + L V+ + + R A ++
Sbjct: 237 RHEGLSADL------DAVVL------KALAKNPENRYQTAAEMR 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 2e-45
Identities = 56/291 (19%), Positives = 107/291 (36%), Gaps = 29/291 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 100
+ +V+G G F V + VAIK + + +G E + E+ +L +++ P ++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
AL L L+ ++ G L + + R+ + +++L
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERDASRLIFQVLDAVKYL 123
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H+ + LD++ +SDFGL+K+ G V + GT GYVAPE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEV 180
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279
+ D +S GV+ LL G P + + A + +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--DSPYWDDISD 238
Query: 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 330
+ K+ I+ ++ + + R +Q P + + + K
Sbjct: 239 SA------KDFIR------HLMEKDPEKRFTCEQALQH--PWIAGDTALDK 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 3e-44
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVE---LLGRLR 95
FS ++G GGFG VY G+ A+K +D+ KQGE E L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
P+++ + KL + D M G L HL A E
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEIIL 118
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GLE +H V++RD K +NILLD++ H ++SD GLA S K +GT GY
Sbjct: 119 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGY 171
Query: 215 VAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
+APE G + +D +S G +L +LL G P +K + + L
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-44
Identities = 52/273 (19%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG+V+R V S+ + K + G + K E+ +L R +L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 107 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
+L +++++++ + E + N+ A +L+ + + + L+FLH H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI------NTSAFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 166 PVIHRDFKSSNILLD--KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 223
+ H D + NI+ ++ K+ +FG A+ G + Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHD 178
Query: 224 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 283
++T +D++S G ++ LL+G P + + ++ + T E+ + +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFL--AETNQQIIENIMNAEYTFDEEAFKEISIEA-- 234
Query: 284 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 316
+ + + E R ++ +Q
Sbjct: 235 ----MDFVD------RLLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-43
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGR-LRSP 97
F ++G G FG V+ + AIK + + +D+ +E +L P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 98 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
+L + + L V +Y+ G L H+ + K D A E GL
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGL 116
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+FLH +++RD K NILLDK+ H K++DFG+ K G + GT Y+A
Sbjct: 117 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIA 171
Query: 217 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
PE L D +S+GV+L E+L G+ P
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 3e-43
Identities = 58/281 (20%), Positives = 102/281 (36%), Gaps = 31/281 (11%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG +Y G ++ G +VAIKL K + +E ++ ++ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 107 -SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 165
++ ++ + L++ + K +T L +A + +E++H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 166 PVIHRDFKSSNIL---LDKNFHAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAP 217
IHRD K N L K + DFGLAK D + + GT Y +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
L + + D+ S G VL+ G +P K + + EK +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEKKMSTP 236
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 318
L Y + A C D +P + + Q
Sbjct: 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-43
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 20/264 (7%)
Query: 35 QLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLG 92
Q+ ++ + +G G +G+V N +VAIK + Q E+++L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 93 RLRSPYLLALLGYC-----SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 147
R R ++ + + + + ++ L + L L +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--------TQHLSNDHICY 113
Query: 148 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVST 206
+ +GL+++H V+HRD K SN+LL+ K+ DFGLA+ D T
Sbjct: 114 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 207 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 265
+ T+ Y APE L TKS D++S G +L E+L+ R + + L
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 266 RLTDREKILEIMDPALEGQYSMKE 289
+ + I A S+
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPH 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (374), Expect = 5e-43
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 31/223 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD---------QAGKQGEDEFKMEVELLG 92
+ ++G G +V R + ++ A+K++D + ++ + EV++L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 93 RLRS-PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 150
++ P ++ L LV+D M G L ++L L + +I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMR 117
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
+ + LH+ ++HRD K NILLD + + K++DFG + G V G
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCG 171
Query: 211 TQGYVAPEYALTGHL------TTKSDVYSYGVVLLELLTGRVP 247
T Y+APE + D++S GV++ LL G P
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 1e-42
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPY 98
F +G G FG V+ NGR A+K++ + + + E +L + P+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 99 LLALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ + G D +++ + DY+ G L L + + A E LE
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALE 118
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH +I+RD K NILLDKN H K++DFG AK D + + GT Y+AP
Sbjct: 119 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAP 170
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E T D +S+G+++ E+L G P
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 1e-41
Identities = 53/289 (18%), Positives = 95/289 (32%), Gaps = 35/289 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G FG+++ G L N ++VAIK + + + + E L + + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 107 --SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 164
+LV D + G E L G K +T A + ++ +HE
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS- 121
Query: 165 PPVIHRDFKSSNILLDKNFH-----AKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGY 214
+++RD K N L+ + V DFG+ K D + GT Y
Sbjct: 122 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 215 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274
++ L + + D+ + G V + L G +P K + E+I
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------ERIG 229
Query: 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323
E + + D P + +++
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 12/208 (5%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 99
F K +G G +G+VY+ G VA+K + D + E+ LL L P +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 100 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
+ LL KL + + L++ + S + + + +GL F
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMD-----ASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H H V+HRD K N+L++ K++DFGLA+ + V+
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL 174
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+ +T D++S G + E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 9e-41
Identities = 44/287 (15%), Positives = 109/287 (37%), Gaps = 23/287 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 100
+ +G G +G+VY+ + G A+K + ++ + E+ +L L+ ++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 101 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
L +++L++ + L++ L G L+ T L+ G+ + H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCH 117
Query: 161 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 220
+ V+HRD K N+L+++ K++DFGLA+ + ++
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 221 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 280
+ +T D++S G + E++ G + + + + L + P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 281 LEGQYSMKEVIQVAAIA-----------AMCVQPEADYRPLMADVVQ 316
+ +++ E + + + ++ + + R ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 66/289 (22%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 43 FSKSNVVGHGGFGLVYRG--VLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRS-- 96
+ +G G +G V++ + + GR VA+K + + EV +L L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 97 -PYLLALLGYCSDRR-----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 150
P ++ L C+ R KL + + L +L + ET +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMF 123
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
+ +GL+FLH H V+HRD K NIL+ + K++DFGLA+I S + T V+
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVV 177
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270
T Y APE L T D++S G + E+ + + +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-------------L 224
Query: 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319
KIL+++ E + + A + QP + + ++ + L+
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-40
Identities = 63/308 (20%), Positives = 115/308 (37%), Gaps = 42/308 (13%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED------EFKMEVELLGRLR 95
+ +G G F +V + S G + A K + + + + + EV +L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 96 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
P ++ L ++ + L+ + +A G L + L L E +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILN 124
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAKIGSDKAGGHVSTRVLG 210
G+ +LH + H D K NI+L K+ DFGLA G+ + G
Sbjct: 125 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFG 178
Query: 211 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 270
T +VAPE L ++D++S GV+ LL+G P + + L + +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFE 236
Query: 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 330
++ K+ I+ + + R + D +Q P +K + T +
Sbjct: 237 DEYFSNTSALA------KDFIR------RLLVKDPKKRMTIQDSLQH--PWIK-PKDTQQ 281
Query: 331 ISSSPSFH 338
SS H
Sbjct: 282 ALSSAWSH 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-40
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 47 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLL 100
+ +G G F VY+ + + VAIK + + + E++LL L P ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 101 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
LL + + LV+D+M + L L +GLE+L
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEYL 116
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H+H ++HRD K +N+LLD+N K++DFGLAK T + T+ Y APE
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPEL 171
Query: 220 ALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
+ D+++ G +L ELL
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-40
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 22/214 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 101
++ + V+G+G FG+VY+ L +G VAIK + Q + E++++ +L ++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 102 LLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
L + + LV DY+ + + + L + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ----TLPVIYVKLYMYQLFR 133
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 213
L ++H + HRD K N+LLD + K+ DFG AK G + +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYY 188
Query: 214 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
T+ DV+S G VL ELL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 53/283 (18%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE------FKMEVELLGRLRSPY-- 98
++G GGFG VY G+ +S+ VAIK +++ E MEV LL ++ S +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 99 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
++ LL + L+ + G L E + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVR 124
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
H V+HRD K NIL+D N K+ DFG + D V T GT+ Y
Sbjct: 125 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSP 177
Query: 217 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275
PE+ +S V+S G++L +++ G +P E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--------------------------FE 211
Query: 276 IMDPALEGQYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQ 316
+ + GQ ++ + + + C+ RP ++
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-39
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 98
F ++G G FG V + GR A+K++ + +DE E +L R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 99 LLALLGYCSDRRKLLVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L AL +L ANGG L HL E E LE
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALE 119
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH V++RD K N++LDK+ H K++DFGL K G G GT Y+AP
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAP 174
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
E D + GVV+ E++ GR+P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-38
Identities = 61/299 (20%), Positives = 107/299 (35%), Gaps = 38/299 (12%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGY 105
V+G G G V + K A+K++ + + EVEL R + P+++ ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 106 CSDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 160
+ L+V + + G L + I + +++LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYLH 128
Query: 161 EHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+ HRD K N+L N K++DFG AK + + T T YVAP
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAP 182
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277
E D++S GV++ LL G P N P + R ++ +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIRMGQYE 235
Query: 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPS 336
P E +EV + ++ E R + + + P + + P+ S
Sbjct: 236 FPNPEWSEVSEEVKM---LIRNLLKTEPTQRMTITEFMNH--PWIMQSTKVPQTPLHTS 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 99
+ K +G G FG V++ G+KVA+K LM+ + E+++L L+ +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 100 LALLGYCSDRRKL---------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 150
+ L+ C + LV+D+ + K R+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQ 124
Query: 151 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS--TRV 208
GL ++H + ++HRD K++N+L+ ++ K++DFGLA+ S + T
Sbjct: 125 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 209 LGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 247
+ T Y PE L D++ G ++ E+ T
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-36
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 98
F + +G G FG V +G A+K++D+ + E +L + P+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 99 LLALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L+ L D L V +Y+A G + HL + A + E
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLTFE 155
Query: 158 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 217
+LH +I+RD K N+L+D+ + +V+DFG AK + + + GT +AP
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAP 207
Query: 218 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 253
E L+ D ++ GV++ E+ G P ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-35
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 99
+ VG G +G V V G KVAIK + + E+ LL +R +
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 100 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
+ LL + L LV +M G L KL + + +
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-------KLGEDRIQFLVYQM 130
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
KGL ++H HRD K N+ ++++ K+ DFGLA+ + G+V T+
Sbjct: 131 LKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTR 182
Query: 213 GYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 247
Y APE L T D++S G ++ E++TG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-35
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 13/209 (6%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 99
+ K +G G +G V++ VA+K + D + E+ LL L+ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 100 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 159
+ L +KL + + L+++ NG D E + KGL F
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------DPEIVKSFLFQLLKGLGFC 117
Query: 160 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 219
H V+HRD K N+L+++N K+++FGLA+ S V+
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVL 173
Query: 220 ALTGHLTTKSDVYSYGVVLLELLTGRVPI 248
+T D++S G + EL P+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 1e-33
Identities = 42/213 (19%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLL 100
+ +G G + V+ + ++N KV +K++ + + K E+++L LR P ++
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNII 93
Query: 101 ALLGYCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 157
L D R LV++++ N ++ L E K L+
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALD 143
Query: 158 FLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 216
+ H ++HRD K N+++D ++ ++ D+GLA+ G + ++ +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKG 197
Query: 217 PEYALT-GHLTTKSDVYSYGVVLLELLTGRVPI 248
PE + D++S G +L ++ + P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-33
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYL 99
+ +G G G+V R VAIK + + + E+ L+ + +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 100 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
++LL + ++ L LV + M Q D E + +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----------DHERMSYLLYQM 128
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
G++ LH +IHRD K SNI++ + K+ DFGLA+ + T + T+
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 182
Query: 213 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
Y APE L D++S G ++ E++ ++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-32
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 43 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYL 99
+ + VG G +G V G +VA+K + + + E+ LL ++ +
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 100 LALLGYCSDRRKLLVYDYM-----ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 154
+ LL + R L ++ + G ++ KL + + + +
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILR 132
Query: 155 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 214
GL+++H HRD K SN+ ++++ K+ DFGLA+ D+ G+V+TR Y
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 215 VAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 247
APE L H D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-30
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 43 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 94
F V+G G +G V+ G+ A+K++ +A + + + E ++L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 95 R-SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 152
R SP+L+ L KL L+ DY+ G L HL + E
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-------RFTEHEVQIYVGEI 138
Query: 153 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 212
LE LH+ +I+RD K NILLD N H ++DFGL+K + GT
Sbjct: 139 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTI 194
Query: 213 GYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVP 247
Y+AP+ G D +S GV++ ELLTG P
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 4e-30
Identities = 40/212 (18%), Positives = 86/212 (40%), Gaps = 15/212 (7%)
Query: 48 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 106
+G G F V+ + N VA+K++ K + + E++LL R+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 107 SDR--RKLLVYDYMANGGLQEHLYPANGSNSVASKL--------DWETRLRIALEAAKGL 156
++ + L +++ G+ + ++ + + +I+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 215
+++H C +IH D K N+L++ + +A +G+ T + T+ Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 216 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 247
+PE L +D++S ++ EL+TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 2e-18
Identities = 21/158 (13%), Positives = 41/158 (25%), Gaps = 23/158 (14%)
Query: 47 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----------KQGEDEFKMEVELLGRLRS 96
++G G V+ + +K G+ F + R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 97 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 156
L L G + Y + N L E + E + + +
Sbjct: 66 RALQKLQGLAVPKV----YAWEGNAVLMELIDAKELYRV-----RVENPDEVLDMILEEV 116
Query: 157 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194
+ ++H D N+L+ + DF +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=373.88 Aligned_cols=263 Identities=28% Similarity=0.467 Sum_probs=206.0
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEE
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYD 116 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~ 116 (351)
..++|++.+.||+|+||.||+|++. ..||+|++... +....+.+.+|+.++++++||||+++++++.+...++|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E 83 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 83 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence 3578999999999999999999864 35999998643 3334577889999999999999999999998888889999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 84 y~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred cCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999985432 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
.............||+.|+|||++.+ ..++.++|||||||++|||+||..||.+..... .....+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------------~~~~~~ 222 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------------QIIFMV 222 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------------HHHHHH
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------------HHHHHH
Confidence 54443334455678999999999864 357899999999999999999999997543210 000011
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
............+...+..+.+||.+||+.||++|||+.+|+++|+.+.++
T Consensus 223 ~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111111111122233445799999999999999999999999999988763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=373.32 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=202.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.++.. ++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999964 689999999864432 234568899999999999999999999987755 49999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 84 y~~gg~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 84 YCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp CCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999999999843 34799999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .....
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---------------~~~~~ 218 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYSD 218 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---------------HHHHH
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---------------HHHHH
Confidence 44333333455679999999999988776 678999999999999999999997544221 11111
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..............+..+.+||.+||+.||++|||+.|+++|
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111112234568899999999999999999999886
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=371.57 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=209.9
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~~ 118 (351)
++|++.+.||+|+||.||+|.+ .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+. ++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999995 4799999999976666677889999999999999999999999887654 5999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+|+|.+++.. ..+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++.....
T Consensus 100 ~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 100 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 99999988742 3589999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcC
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 278 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+.....
T Consensus 169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~~~~ 230 (293)
T d1yhwa1 169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIAT 230 (293)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHH
T ss_pred cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----------------HHHHHHHh
Confidence 22 2334567999999999999999999999999999999999999999754321 11111111
Q ss_pred -ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 279 -PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 279 -~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.......+...+..+.+||.+||+.||++|||+.|+++| .+++.
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H--p~~~~ 275 (293)
T d1yhwa1 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLKI 275 (293)
T ss_dssp HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC--GGGGG
T ss_pred CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhCC
Confidence 111112223344578999999999999999999999987 56653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=371.89 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=213.4
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 117 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~ 117 (351)
...++|++.+.||+|+||.||+|.+.+++.||||++... ....+.+.+|++++++++||||+++++++.++..++||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence 345789999999999999999999888889999999653 4556789999999999999999999999988888899999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+|+|.+++.... ..++++..++.++.||++||.|||++ +++||||||+||+|++++.+||+|||++....
T Consensus 89 ~~~g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp CTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999874432 23589999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... ........+++.|+|||++.++.++.++|||||||++|+|+||..|+..... ...+...+
T Consensus 161 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----------------~~~~~~~i 223 (272)
T d1qpca_ 161 DNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----------------NPEVIQNL 223 (272)
T ss_dssp SSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHH
T ss_pred CCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----------------HHHHHHHH
Confidence 322 1223345688899999999999999999999999999999996555432111 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
........+...+..+.+|+.+||+.||++|||+.+|++.|++++.+
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 12222233334455799999999999999999999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=364.58 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=201.2
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~~~~ 118 (351)
.++|++.+.||+|+||.||+|.+.+++.||||++.. .....+.+.+|+++++.++||||+++++++... ..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 367999999999999999999988888999999965 345567899999999999999999999999765 556999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~L~~~l~~~------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp TTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CCCcHHHHhhcc------ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence 999999988533 24688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhC-CCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......|+..|+|||++.+..++.++|||||||++|||+|+ ..||..... ..+...+
T Consensus 154 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----------------~~~~~~i 215 (263)
T d1sm2a_ 154 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDI 215 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----------------HHHHHHH
T ss_pred CCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHH
Confidence 321 122345688899999999999999999999999999999995 555543221 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
........+...+..+.+|+.+||+.||++|||+++|+++|+++..+
T Consensus 216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11122222333455789999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=363.87 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=205.3
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccc---cCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++.. ........+.+|+++++.++||||+++++++.+++. ++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999965 688999999853 234456778899999999999999999999988765 4999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 86 Ey~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred eecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999998543 4699999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......
T Consensus 156 ~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~ 215 (263)
T d2j4za1 156 APSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------------QETYKR 215 (263)
T ss_dssp CCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHH
T ss_pred cCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----------------HHHHHH
Confidence 4332 23446789999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..... ..+...+.++.+||.+||+.||++|||+.|+++|
T Consensus 216 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 216 ISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 222211 2223344578999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-53 Score=370.91 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=215.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEEE
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 115 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 115 (351)
...++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.++ ..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44578999999999999999999965 5889999998654 45677899999999999999999999999876 456999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 93 E~~~~g~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp ECCTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred ecccCcchHHHhhhcc-----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999985432 24789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||..... ...+.+
T Consensus 165 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~~~ 227 (287)
T d1opja_ 165 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYE 227 (287)
T ss_dssp CCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHHHH
T ss_pred cCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------------HHHHHH
Confidence 54322 2223345578899999999999999999999999999999997776642211 122333
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.+........+...+..+.+||.+||+.||++|||+.++++.|+.+++.+
T Consensus 228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 33333333444445567999999999999999999999999999887653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=357.12 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=211.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.++|++.+.||+|+||.||+|++++++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.++. .++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3789999999999999999999988889999999654 446678999999999999999999999998764 45999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+|+|..++.... ..+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 82 ANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp TTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999999874432 4688999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhc
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 277 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
... .......++..|+|||.+.+..++.++|||||||++|||+| |..||..... ..+...+
T Consensus 153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----------------~~~~~~i 214 (258)
T d1k2pa_ 153 DEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHI 214 (258)
T ss_dssp SSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHH
T ss_pred CCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----------------HHHHHHH
Confidence 322 22334568889999999999999999999999999999998 8999975432 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 278 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
........+...+..+.+||.+||+.||++|||+.+++++|.++
T Consensus 215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11222233334456799999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=365.02 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=193.4
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC---CeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v 114 (351)
++|++.+.||+|+||.||+|++. +|+.||+|.+..... ...+.+.+|+++++.++||||+++++++.+. ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999964 689999999865432 2235688899999999999999999988643 34699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC--SPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
|||+.+|+|.+++.... .....+++..++.++.||+.||.|||+.+ ..+++||||||+|||++.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999985432 12346999999999999999999999871 01399999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ...
T Consensus 161 a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----------------~~~ 222 (269)
T d2java1 161 ARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------KEL 222 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHH
T ss_pred eeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----------------HHH
Confidence 98754422 223446789999999999999999999999999999999999999975332 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+...... ..+...+.++.+||.+||+.||++|||+.|+++|
T Consensus 223 ~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 223 AGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122111111 2222334579999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-52 Score=365.58 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=197.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc---EEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR---KVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~---~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v 114 (351)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ....+.+.+|+++|++++||||+++++++.+. ..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888899999999999999964 232 57888875432 22345788999999999999999999999766 45699
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||||+.++.+||+|||++.
T Consensus 106 ~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999885432 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCce---ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 195 IGSDKAGGHV---STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 195 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
.......... .....+++.|+|||.+.++.++.++|||||||++|||+| |..||.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----------------- 239 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----------------- 239 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------------
Confidence 6544332221 122457889999999999999999999999999999998 8999974332
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
..+...+........+...+..+.+||.+||+.||++|||+.+|++.|++++++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 112222222222333444566799999999999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=365.45 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDYM 118 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~~ 118 (351)
+.|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+. ++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999964 688999999976666667788999999999999999999999887654 5999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.+|+|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999875432 4699999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCCceecccCCCcccccccccc-----cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
.. .......||+.|+|||++. +..|+.++|||||||++|+|++|..||....+. ..+
T Consensus 163 ~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----------------~~~ 224 (288)
T d2jfla1 163 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----------------RVL 224 (288)
T ss_dssp HH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----------------GHH
T ss_pred Cc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----------------HHH
Confidence 11 1223467899999999984 456889999999999999999999999754321 111
Q ss_pred HhhcCcc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+.... .....+...+.++.+||.+||+.||++|||+.|+++|
T Consensus 225 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 1111223344578999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=366.51 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=203.0
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+++++.++||||+++++++.+++. ++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999964 6899999998632 34456788999999999999999999999987754 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|.+++... +.+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 88 Ey~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccccee
Confidence 999999999988543 4799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------~~~~~~ 221 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------YLIFQK 221 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHH
T ss_pred cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH----------------HHHHHH
Confidence 6554433344556799999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..... .++...+.++.+||.+||+.||++|||+.|++.+
T Consensus 222 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 222 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 222211 2223344578999999999999999999997654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=361.32 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=209.3
Q ss_pred cCCCcCc-eeeecCceEEEEEEEc---CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEE
Q 018744 41 GGFSKSN-VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 115 (351)
Q Consensus 41 ~~y~~~~-~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 115 (351)
++|.+.. .||+|+||.||+|.+. ++..||||++.... ....+.+.+|++++++++||||+++++++..+..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 5677777 4999999999999753 35579999986432 23346788999999999999999999999988888999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+++|+|.+++... ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 88 E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp ECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EeCCCCcHHHHhhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999987433 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc-eecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 196 GSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 196 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
........ ......|++.|+|||++.++.++.++|||||||++|||+| |..||..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----------------~~~ 221 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEV 221 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------------HHH
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 65433221 2233567889999999999999999999999999999998 9999975432 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+........+...+.++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 222 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111111122233344556799999999999999999999999999877653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=357.55 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=202.3
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEccCC
Q 018744 47 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 121 (351)
Q Consensus 47 ~~lg~G~~g~v~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~~~ 121 (351)
+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|++++++++||||+++++++..+..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 46999999999999853 346799999864322 2246788999999999999999999999888888999999999
Q ss_pred ChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 018744 122 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 201 (351)
Q Consensus 122 ~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 201 (351)
+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||++........
T Consensus 93 ~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 93 PLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999998543 4699999999999999999999999 999999999999999999999999999987554332
Q ss_pred Cce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 202 GHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 202 ~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+... ..+...+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i~~ 225 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEK 225 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHT
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHHHc
Confidence 222 233568889999999999999999999999999999998 8999975332 122222222
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+...+..+.+||.+||+.||++|||+.+|++.|+.++.
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 22223344455679999999999999999999999999887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=369.90 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=202.9
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+... ++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999964 68999999986543 3334678899999999999999999999987754 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
|+.+|+|.+++... ..+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++..
T Consensus 85 y~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp CCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred cCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 99999999999543 368999999999999999999996 6 899999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeec-------------
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW------------- 262 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~------------- 262 (351)
.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..........
T Consensus 155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 4332 12345799999999999999999999999999999999999999976543210000000
Q ss_pred -------------ccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 263 -------------ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 263 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+........................+.++.+||.+||..||++|||+.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000001111111111000011123468899999999999999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=366.30 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=209.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC-C-----cEEEEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcC-
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 109 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~-----~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 109 (351)
..++|++.+.||+|+||.||+|.+.. + ..|++|.+... .......+.+|+.++.++ +||||+++++++.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 44789999999999999999998542 2 25888987543 334456788999999998 899999999999876
Q ss_pred CeEEEEEEccCCChhhhccccCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCC
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSN----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 173 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~ 173 (351)
..++||||+++|+|.+++....... .....+++..++.++.||+.||+|||++ +++|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 4569999999999999996543210 1124589999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCC
Q 018744 174 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNK 252 (351)
Q Consensus 174 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~ 252 (351)
|+||+++.++.+||+|||++................||+.|+|||++.++.++.++|||||||++|+|+| |..||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655544444555668999999999999999999999999999999998 899997544
Q ss_pred CCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 018744 253 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 319 (351)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~ 319 (351)
.. ..+..++........+...+..+.+||.+||+.||++|||+.||+++|.
T Consensus 272 ~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 31 2222333333333344445567999999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=358.11 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=208.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEEEEEcc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 119 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~~~~~ 119 (351)
.++|++.+.||+|+||.||+|.+.+++.||+|++... ....+.+.+|+.+++.++||||+++++++.++..++||||+.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 4789999999999999999999888888999999643 456678999999999999999999999998888889999999
Q ss_pred CCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 018744 120 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 199 (351)
Q Consensus 120 ~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 199 (351)
+|+|..++.... ...+++..++.++.||+.||+|||++ +++||||||+||||+.++.+||+|||++......
T Consensus 95 ~g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 95 KGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp TCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCchhhhhhhcc-----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999998885432 23689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhhcCc
Q 018744 200 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 279 (351)
Q Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (351)
. ........+++.|+|||++.++.++.++|||||||++|+|++|..|+..... ...+...+..
T Consensus 167 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----------------~~~~~~~i~~ 229 (285)
T d1fmka3 167 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLDQVER 229 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHHHT
T ss_pred C-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----------------HHHHHHHHHh
Confidence 2 1223345688999999999999999999999999999999997666542221 1222222222
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 280 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+...+..+.+||.+||+.||++|||+.+|++.|++++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 22233444556689999999999999999999999999998875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=363.66 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=207.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc----EEEEEEccc-cCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQ-AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~----~~~vk~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
++|++.+.||+|+||.||+|.+. +|+ +||+|.+.. .+....+.+.+|++++++++||||+++++++.++..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 46999999999999999999854 443 588888753 334456789999999999999999999999999988899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
++++.+++|.+.+.... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 89 ~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 99999999998875432 4789999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...............||+.|+|||++.++.++.++|||||||++|||+| |..||.+.... .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~~ 222 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 222 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------GH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----------------HH
Confidence 7655444434445568999999999999999999999999999999998 89998754321 11
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
...+........+...+..+.+|+.+||+.||++|||+.+++++|.++.+.
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 222222222233344556799999999999999999999999999888653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-51 Score=367.60 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=205.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+++. ++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999964 689999999976555556778899999999999999999999887754 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--CCCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~--~~~~v~l~dfg~~~~ 195 (351)
+.+|+|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+|||++..
T Consensus 105 ~~gg~L~~~l~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 105 MSGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCSCBHHHHHTCT------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999988432 24699999999999999999999999 999999999999995 467899999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...+..
T Consensus 176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~ 236 (350)
T d1koaa2 176 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DETLRN 236 (350)
T ss_dssp CCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHH
T ss_pred ccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 54432 23456789999999999999999999999999999999999999975432 111222
Q ss_pred hcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..... ........+..+.+||.+||..||++|||+.|+++|
T Consensus 237 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221111 111112234578999999999999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=356.01 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=193.3
Q ss_pred CcCceeeecCceEEEEEEEc-CCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----CeEEEE
Q 018744 44 SKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RKLLVY 115 (351)
Q Consensus 44 ~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~v~ 115 (351)
++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999965 68899999986432 22345688999999999999999999988642 246999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--ceecCCCCCcEEeC-CCCcEEEeeccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLD-KNFHAKVSDFGL 192 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--i~H~di~p~Nilv~-~~~~v~l~dfg~ 192 (351)
||+++|+|.+++... ..+++..++.++.||+.||+|||++ + ++||||||+|||++ .++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 999999999999543 3689999999999999999999998 7 99999999999996 578999999999
Q ss_pred ccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...
T Consensus 162 a~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----------------~~~ 220 (270)
T d1t4ha_ 162 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------------AAQ 220 (270)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------------HHH
T ss_pred ceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----------------HHH
Confidence 9753332 2345679999999998865 599999999999999999999999964322 111
Q ss_pred HH-hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 IL-EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+. .+.........+.....++.+||.+||+.||++|||+.|+++|
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 1111111111111223468899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=355.26 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=201.1
Q ss_pred cCCCcCceeeecCceEEEEEEEcC-C----cEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcC-CeEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSN-G----RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~-~----~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 113 (351)
+.|++.+.||+|+||.||+|.+.. + ..||||.+..... .....+.+|+.+++.++||||+++++++.+. ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 568899999999999999998543 2 3689999864322 2235688999999999999999999999766 4569
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 193 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~ 193 (351)
|++|+.++++.+.+.... ..+++..++.++.|++.||.|||++ +++||||||+||||+.++.+||+|||++
T Consensus 87 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 999999999988875432 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 194 KIGSDKAG-GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 194 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
........ ........||..|+|||++.++.++.++|||||||++|||++|..|+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----------------~~~ 221 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------NHE 221 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------HHH
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----------------HHH
Confidence 86544322 1222335678899999999999999999999999999999996666532211 122
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+...+........+...+..+.+||.+||+.||++|||+.+|++.|+++++.
T Consensus 222 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 2223333333344445566799999999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-51 Score=360.22 Aligned_cols=245 Identities=29% Similarity=0.375 Sum_probs=198.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 115 (351)
+.|++.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|+++++.++||||+++++++.+.+ .++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999954 68899999986543322 245788999999999999999999998765 45999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|..++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 95 E~~~~g~l~~~~~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp ECCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EecCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccc
Confidence 99999988766532 24799999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceecccCCCccccccccccc---CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhH
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 272 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
... .....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||..... ...
T Consensus 165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----------------~~~ 222 (309)
T d1u5ra_ 165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSA 222 (309)
T ss_dssp SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHH
T ss_pred cCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----------------HHH
Confidence 433 234579999999999864 4589999999999999999999999964332 111
Q ss_pred HHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 273 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..+.........+...+..+.+||.+||+.||++|||+.++++|
T Consensus 223 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 222221111111122234578999999999999999999999886
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-51 Score=360.55 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=189.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC-CChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
.+.|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.++.. ++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999965 689999999864332 233567789999999999999999999987755 59999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC---CCCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~---~~~~v~l~dfg~~ 193 (351)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||++. .++.+||+|||++
T Consensus 88 ~~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 88 LVSGGELFDRIVE-------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp CCCSCBHHHHHHT-------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred ccCCCcHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999943 34799999999999999999999999 999999999999994 5789999999999
Q ss_pred cccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 194 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ....
T Consensus 158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------~~~~ 218 (307)
T d1a06a_ 158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----------------AKLF 218 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHH
T ss_pred EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----------------HHHH
Confidence 7643322 23446799999999999999999999999999999999999999974332 1112
Q ss_pred HhhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 274 LEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 274 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
..+..... ........+..+.+||.+||..||++|||+.|+++|
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22222211 112223344578999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-50 Score=364.01 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=206.4
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+.+|+.+++.++||||+++++++.+++. ++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36799999999999999999996 4799999999875544445678889999999999999999999987755 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeC--CCCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~--~~~~v~l~dfg~~~~ 195 (351)
+.+|+|.+.+... ..++++..++.++.||+.||.|||++ |++||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~gg~L~~~~~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 108 LSGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp CCCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCChHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence 9999998887432 24699999999999999999999999 999999999999997 678999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~ 239 (352)
T d1koba_ 179 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LETLQN 239 (352)
T ss_dssp CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHH
T ss_pred cCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 54432 33456789999999999999999999999999999999999999975432 111122
Q ss_pred hcC--ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.. ..+........+.++.+||.+||..||++|||+.|+++|
T Consensus 240 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 211 111222223344578999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=354.85 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=205.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC------CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG------KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK- 111 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 111 (351)
.++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999996 478999999985322 2235778999999999999999999999988765
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC----cEEE
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 187 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~----~v~l 187 (351)
++||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEe
Confidence 4999999999999998543 3699999999999999999999999 999999999999998776 4999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 267 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 267 (351)
+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 159 ~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------- 221 (293)
T d1jksa_ 159 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 221 (293)
T ss_dssp CCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred cchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------------
Confidence 9999998654322 23445688999999999999999999999999999999999999975432
Q ss_pred cchhHHHhhcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 268 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+..... ..+. ..+..+.+||.+||+.||++|||+.|+++| .+++
T Consensus 222 --~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~ 275 (293)
T d1jksa_ 222 --QETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH--PWIK 275 (293)
T ss_dssp --HHHHHHHHTTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTC
T ss_pred --HHHHHHHHhcCC--CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccC
Confidence 111222222111 1111 223468899999999999999999999987 5554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=352.11 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=200.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEcC----CcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcCCeEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 114 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 114 (351)
.++|++.+.||+|+||.||+|.+.. +..+++|.+...... ....+.+|+++++.++||||+++++++.++..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 4789999999999999999998542 346888887543222 23568899999999999999999999988888899
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 86 ~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999875432 4689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 273 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 157 ~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----------------~~~ 219 (273)
T d1mp8a_ 157 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DVI 219 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHH
T ss_pred eccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----------------HHH
Confidence 654322 122334567889999999999999999999999999999998 89999754431 111
Q ss_pred HhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 274 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+.. ......+...+..+.+||.+||+.||++|||+.+|+++|+++++..
T Consensus 220 ~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 220 GRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11111 1112233344567999999999999999999999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=353.60 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=205.6
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~ 115 (351)
++|++.+.||+|+||.||+|++ .+|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+.+ +||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999996 47999999998632 344567788999999999999999999999888654 999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+|+.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++..
T Consensus 85 ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999998543 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. .....
T Consensus 155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----------------~~~~~ 216 (337)
T d1o6la_ 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFEL 216 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHH
T ss_pred cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----------------HHHHH
Confidence 43322 2334567999999999999999999999999999999999999999754421 11112
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
+....+ .++...+.++.+||.+||+.||++||+ +.++++|
T Consensus 217 i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhcCCC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 221111 222334456899999999999999995 8899886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=350.87 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc--CC--cEEEEEEccccC---CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS--NG--RKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~--~~--~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 112 (351)
.++|++.+.||+|+||.||+|.+. ++ ..||+|++.... ....+.+.+|++++++++||||+++++++.+...+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~ 86 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence 367999999999999999999843 22 368999886432 22346788999999999999999999999888888
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+|++|+++|++.+.+.... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 87 lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchh
Confidence 9999999999998875433 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCce-ecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccch
Q 018744 193 AKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 270 (351)
Q Consensus 193 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 270 (351)
+........... .....++..|+|||++.+..++.++||||||+++|||+| |..||.+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----------------~ 221 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------------S 221 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------H
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----------------H
Confidence 987655443222 233456778999999999999999999999999999998 8999974332 2
Q ss_pred hHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 018744 271 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 321 (351)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~ 321 (351)
.....+.........+...+..+.+||.+||+.||++|||+.+|++.|+++
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 223333333333333444556799999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=345.92 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=201.4
Q ss_pred hcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--CeEEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+ .|..||+|++.. ....+.+.+|++++++++||||+++++++.+. ..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 36789999999999999999998 577899999964 34457789999999999999999999988543 45799999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.+|+|.+++.... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 83 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999985432 12589999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.. .....++..|+|||++.++.++.++|||||||++|||+| |..||..... ..+...
T Consensus 155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----------------~~~~~~ 212 (262)
T d1byga_ 155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPR 212 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHH
T ss_pred CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHH
Confidence 32 233457889999999999999999999999999999998 7888864332 111222
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
+........+...+..+.+||.+||..||++|||+.+++++|+++...
T Consensus 213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 222223334444456799999999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=354.05 Aligned_cols=271 Identities=23% Similarity=0.332 Sum_probs=203.3
Q ss_pred HHHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEE
Q 018744 36 LHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCS 107 (351)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 107 (351)
+....++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+..|...+.++ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3344578999999999999999999853 246799999864322 2235567777877777 6889999999886
Q ss_pred cC--CeEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCc
Q 018744 108 DR--RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 176 (351)
Q Consensus 108 ~~--~~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~N 176 (351)
.. ..++||||+++|+|.+++...... ......+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 54 356999999999999998654321 11234589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhC-CCCCCCCCCCC
Q 018744 177 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSG 255 (351)
Q Consensus 177 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg-~~pf~~~~~~~ 255 (351)
||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++| ..||......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~- 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999999876554444444556789999999999999999999999999999999986 5677643321
Q ss_pred CcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 256 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
..+...+........+...+.++.+||.+||+.||++|||+.+++++|+++++++
T Consensus 244 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 ---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 1111111111222233334457999999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-49 Score=352.18 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+. ++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999964 6899999998632 34456788999999999999999999999988755 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
||+.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++..
T Consensus 84 E~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceE
Confidence 999999999988543 4688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......
T Consensus 154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~ 212 (316)
T d1fota_ 154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYEK 212 (316)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHH
T ss_pred eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----------------HHHHHH
Confidence 5443 2456799999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
+..... .++...+.++.+++.+||..||++|+ |++++++|
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 222211 22233445789999999999999996 89999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-50 Score=353.55 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=209.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccCCC-ChHHHHHHHHHHhccCCCcceeeeEEEEcC-
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR- 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 109 (351)
...++|++.+.||+|+||.||+|++. +++.||||++...... ....+.+|+.+++.++||||+++++++...
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34678999999999999999999853 3568999998644332 245688999999999999999999998776
Q ss_pred CeEEEEEEccCCChhhhccccCCC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCC
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGS-----------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF 172 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~-----------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di 172 (351)
..+++++++.+|+|.+++...... ......+++..++.++.|++.||+|||++ +++||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEE
Confidence 556999999999999998543210 11223589999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCC-CCCCCC
Q 018744 173 KSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR-VPIDVN 251 (351)
Q Consensus 173 ~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~-~pf~~~ 251 (351)
||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999997654443333444567888999999999999999999999999999999975 567643
Q ss_pred CCCCCcceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 018744 252 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 322 (351)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~ 322 (351)
.. ......+.+.. ....+...+.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 247 ~~----------------~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AH----------------EEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CH----------------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CH----------------HHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 32 11122222221 22333344567999999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-49 Score=344.53 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=200.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCC---hHHHHHHHHHHhccCCCcceeeeEEEEcCC-----
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSDRR----- 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 110 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ...+.+|+.+++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999996 478999999997543333 346888999999999999999999886542
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.++||||+++++|..++... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.++++||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred EEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 46999999999999988543 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc
Q 018744 191 GLAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 269 (351)
Q Consensus 191 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 269 (351)
|.+......... .......||+.|+|||++.+..++.++|||||||++|+|+||..||.+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------- 220 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------------- 220 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------------
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---------------
Confidence 998765433222 2234467899999999999999999999999999999999999999754321
Q ss_pred hhHHHhhcCc--cccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhh
Q 018744 270 REKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVK 323 (351)
Q Consensus 270 ~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-t~~eil~~l~~~~~ 323 (351)
......+.. ..........+..+.+||.+||..||++|| |++++++.|.++.+
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 221 -SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 111111111 111111122345789999999999999999 89999998887753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-49 Score=354.73 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=204.1
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccc---cCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~ 115 (351)
++|++++.||+|+||.||+|++. +|+.||+|++.. ......+.+.+|+.+|+.++||||+++++++.+... ++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999964 799999999853 233455778899999999999999999999988765 5999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
+++.+|+|..++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++..
T Consensus 121 e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 999999999998543 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......
T Consensus 191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~ 249 (350)
T d1rdqe_ 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEK 249 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHH
T ss_pred cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----------------HHHHHH
Confidence 5432 2346789999999999999999999999999999999999999975432 111222
Q ss_pred hcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 276 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
+..... ..+...+.++.+||.+||..||++|+ |+.++++|
T Consensus 250 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 222211 12223345789999999999999995 89999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=347.32 Aligned_cols=269 Identities=25% Similarity=0.378 Sum_probs=216.1
Q ss_pred HHhcCCCcCceeeecCceEEEEEEE------cCCcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEcC
Q 018744 38 SATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 109 (351)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 109 (351)
...++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.++..+ +||||+++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3457899999999999999999984 2456899999864332 2335688899999999 699999999999876
Q ss_pred C-eEEEEEEccCCChhhhccccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcE
Q 018744 110 R-KLLVYDYMANGGLQEHLYPANGS-----------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 177 (351)
Q Consensus 110 ~-~~~v~~~~~~~~L~~~~~~~~~~-----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Ni 177 (351)
+ .+++|||+.+|+|.+++...... ......+++..+..++.||+.||+|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 4 56999999999999998654321 11234689999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCC
Q 018744 178 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGE 256 (351)
Q Consensus 178 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~ 256 (351)
+++.++.++++|||.+................+++.|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--- 253 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987665554555556778999999999999999999999999999999999 5555543322
Q ss_pred cceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 257 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
...+..++........+...+..+.+||.+||+.||++|||+.+|++.|++++..+
T Consensus 254 -------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 -------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp -------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 12233333333333333444567999999999999999999999999999988753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=344.91 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=208.1
Q ss_pred HhcCCCcCceeeecCceEEEEEEEcC--------CcEEEEEEccccCC-CChHHHHHHHHHHhcc-CCCcceeeeEEEEc
Q 018744 39 ATGGFSKSNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSD 108 (351)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 108 (351)
..++|++.+.||+|+||.||+|+... +..||+|++..... .....+..|...+.++ +||||+++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34789999999999999999998432 23689999865433 2235677788888888 79999999999987
Q ss_pred CC-eEEEEEEccCCChhhhccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEE
Q 018744 109 RR-KLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 178 (351)
Q Consensus 109 ~~-~~~v~~~~~~~~L~~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nil 178 (351)
+. .++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+. +++||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 65 56999999999999999655321 12335689999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHh-CCCCCCCCCCCCCc
Q 018744 179 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 257 (351)
Q Consensus 179 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~ 257 (351)
++.++.+||+|||++................+++.|+|||.+.++.|+.++||||||+++|+|++ |..||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999999987666554444556778899999999999999999999999999999998 7888864332
Q ss_pred ceeecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 258 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
..+...+........+...+..+.+||.+||+.||++|||+.||++.|++++.
T Consensus 244 -------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222222223333445579999999999999999999999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-48 Score=339.01 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCC---------hHHHHHHHHHHhccC-CCcceeeeEEEEc
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQG---------EDEFKMEVELLGRLR-SPYLLALLGYCSD 108 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 108 (351)
.++|++.+.||+|+||+||+|++ .+|+.||+|++....... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999996 478999999986443221 135778999999997 9999999999988
Q ss_pred CCe-EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 109 RRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 109 ~~~-~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
++. ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEE
Confidence 765 5999999999999999543 4799999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCceecccCCCccccccccccc------CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceee
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 261 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~ 261 (351)
+|||++....... ......||..|+|||.+.+ ..++.++||||+||++|+|++|..||.....
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------- 220 (277)
T d1phka_ 152 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------- 220 (277)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred ccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------
Confidence 9999998754432 2345678999999999863 3468899999999999999999999975432
Q ss_pred cccccccchhHHHhhcCccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 262 WALPRLTDREKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
......+..... ........+.++.+||.+||+.||++|||+.|+++|
T Consensus 221 --------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 --------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111112221111 111222445679999999999999999999999887
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-48 Score=351.62 Aligned_cols=248 Identities=28% Similarity=0.367 Sum_probs=197.2
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHH---HHHHHhccCCCcceeeeEEEEcCC-eE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKM---EVELLGRLRSPYLLALLGYCSDRR-KL 112 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~-~~ 112 (351)
++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+ ++.+++.++||||+++++++.+.+ .+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999965 6899999998532 1222333333 467777788999999999998875 45
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||+
T Consensus 84 ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 999999999999999543 3688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ..
T Consensus 154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~ 216 (364)
T d1omwa3 154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------HE 216 (364)
T ss_dssp CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-------------HH
T ss_pred eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-------------HH
Confidence 98654422 344679999999999874 5689999999999999999999999976443210 00
Q ss_pred HHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 018744 272 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt-----~~eil~~ 317 (351)
........ ....+...+..+.+||.+||..||++||| +.++++|
T Consensus 217 ~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 217 IDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHhcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11111111 11122233456899999999999999999 6899887
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=341.60 Aligned_cols=265 Identities=22% Similarity=0.227 Sum_probs=192.6
Q ss_pred CceeeecCceEEEEEEE-cCCcEEEEEEccccCCC-----ChHHHHHHHHHHhccCCCcceeeeEEEEcCC-eEEEEEEc
Q 018744 46 SNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 118 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~~~~ 118 (351)
.+.||+|+||+||+|++ .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++ .++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 56899999999999995 46899999998643221 1346888999999999999999999998774 56999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
.++.+..+.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~~~~~~-------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 83 ETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp SEEHHHHHTT-------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred cchHHhhhhh-------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 9887776662 234688899999999999999999999 999999999999999999999999999976544
Q ss_pred CCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc-----cccchhH
Q 018744 199 KAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP-----RLTDREK 272 (351)
Q Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~ 272 (351)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... .......
T Consensus 153 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 153 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred Cc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 32 22234578999999998875 4679999999999999999999999975432100000000000 0000000
Q ss_pred HHhhcCccccCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 273 ILEIMDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 273 ~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.............+. ....++.+||.+||..||++|||+.|+++| .+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~ 285 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSN 285 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCC
Confidence 000000000000011 123468999999999999999999999987 55653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=346.43 Aligned_cols=247 Identities=20% Similarity=0.318 Sum_probs=202.3
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDY 117 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~~ 117 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+++|+.++||||+++++++.+.+. ++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999965 68899999996542 234567889999999999999999999987654 599999
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC--CCcEEEeecccccc
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 195 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~--~~~v~l~dfg~~~~ 195 (351)
+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++. .+.++|+|||++..
T Consensus 83 ~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 83 ISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999995332 3689999999999999999999999 9999999999999974 45899999999986
Q ss_pred cCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHh
Q 018744 196 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 275 (351)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (351)
.... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......
T Consensus 154 ~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----------------~~~~~~ 214 (321)
T d1tkia_ 154 LKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIEN 214 (321)
T ss_dssp CCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHH
T ss_pred cccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----------------HHHHHH
Confidence 5332 233446688999999999999999999999999999999999999975432 112222
Q ss_pred hcCccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 276 IMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 276 ~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+..... .++. ..+.++.+||.+||..||++|||+.|+++|
T Consensus 215 i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 IMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222111 1111 123468999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=343.62 Aligned_cols=263 Identities=29% Similarity=0.431 Sum_probs=205.5
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCc--EEEEEEcccc-CCCChHHHHHHHHHHhcc-CCCcceeeeEEEEcCC-eEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v 114 (351)
++|++.+.||+|+||.||+|.+. +|. .|+||.+... .....+.+.+|+++|..+ +||||+++++++.+++ .++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67999999999999999999954 454 4677776432 333456789999999998 7999999999998775 4599
Q ss_pred EEEccCCChhhhccccCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 115 YDYMANGGLQEHLYPANG---------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
|+|+++|+|.+++..... .......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 999999999999854321 012345799999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCC-CCCCCCCCCCCcceeeccc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR-VPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~ 264 (351)
||+|||++....... ......++..|+|||.+.++.++.++|||||||++|+|++|. .||...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----------- 232 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------- 232 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----------
Confidence 999999987543322 123345788999999999999999999999999999999965 56754321
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..+...+........+...+..+.+||.+||+.||++|||+.+|+++|+++++...
T Consensus 233 ------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 233 ------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 12222222222233344455689999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=346.58 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=200.7
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEcccc---CCCChHHHHHHHHHHh-ccCCCcceeeeEEEEcCCe-EEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLG-RLRSPYLLALLGYCSDRRK-LLV 114 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~-~~v 114 (351)
++|++.+.||+|+||.||+|++. +++.||+|++... .......+..|..++. .++||||+++++++.++.. ++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999964 6899999998632 2344556666777655 6899999999999988764 599
Q ss_pred EEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 115 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 115 ~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.++|+|||++.
T Consensus 82 mEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 151 (320)
T ss_dssp EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhh
Confidence 9999999999999543 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHH
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 274 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ....
T Consensus 152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~ 213 (320)
T d1xjda_ 152 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----------------ELFH 213 (320)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHH
T ss_pred hccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----------------HHHH
Confidence 644322 2334567999999999999999999999999999999999999999754421 1111
Q ss_pred hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 018744 275 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQS 317 (351)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~-eil~~ 317 (351)
.+.... ..++...+..+.+||.+||..||++|||+. ++++|
T Consensus 214 ~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 214 SIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHcCC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 121111 122223345689999999999999999995 78764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=344.80 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=196.9
Q ss_pred hcCCCcCc-eeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhcc-CCCcceeeeEEEEc-----CCe
Q 018744 40 TGGFSKSN-VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD-----RRK 111 (351)
Q Consensus 40 ~~~y~~~~-~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~ 111 (351)
.++|.+.+ .||+|+||.||+|++ .+++.||+|++.. ...+.+|++++.++ +||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36898875 599999999999996 4789999999853 34677899987654 89999999998864 234
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEe
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVS 188 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~ 188 (351)
++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+||+++. ++.+||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEECCCCCcHHHHHHhcC-----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 69999999999999996432 23699999999999999999999999 9999999999999975 5679999
Q ss_pred ecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 189 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 189 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|||++....... ......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+..........
T Consensus 157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------- 225 (335)
T d2ozaa1 157 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------- 225 (335)
T ss_dssp CCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred ccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--------
Confidence 999998654432 234567999999999999999999999999999999999999999765432111000
Q ss_pred chhHHHhhcCccccCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 269 DREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
...+.........+ ...+.++.+||.+||+.||++|||+.|+++|
T Consensus 226 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00011111111111 2334579999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=340.45 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=200.5
Q ss_pred CceeeecCceEEEEEEEcCC----cEEEEEEcccc-CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC--CeEEEEEEc
Q 018744 46 SNVVGHGGFGLVYRGVLSNG----RKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDYM 118 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~~----~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~~~~ 118 (351)
.++||+|+||+||+|.+..+ ..||||.+... +......+.+|++++++++||||+++++++.+. ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56799999999999995432 25889988632 333446789999999999999999999987643 456999999
Q ss_pred cCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccCC
Q 018744 119 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 198 (351)
Q Consensus 119 ~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 198 (351)
++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999885432 4577889999999999999999999 999999999999999999999999999987544
Q ss_pred CCCC--ceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchhHHHhh
Q 018744 199 KAGG--HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 276 (351)
Q Consensus 199 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|..||........ ....+...
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------------~~~~i~~g 250 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------------ITVYLLQG 250 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------------CHHHHHTT
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------------HHHHHHcC
Confidence 3222 122335688899999999999999999999999999999998888754322100 00111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 018744 277 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 327 (351)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~~ 327 (351)
. ....+...+..+.+||.+||+.||++|||+.||+++|+++++.-..
T Consensus 251 ~----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 251 R----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1 1112223345789999999999999999999999999999876333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=344.54 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=211.5
Q ss_pred HHHhcCCCcCceeeecCceEEEEEEEc------CCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC
Q 018744 37 HSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 109 (351)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 109 (351)
....++|++.+.||+|+||.||+|.+. .+..||||++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344578999999999999999999853 25689999986432 22234588999999999999999999998765
Q ss_pred -CeEEEEEEccCCChhhhccccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcE
Q 018744 110 -RKLLVYDYMANGGLQEHLYPANG---SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 185 (351)
Q Consensus 110 -~~~~v~~~~~~~~L~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v 185 (351)
..++||+|+.+|+|.+++..... .......+++..+..++.|++.||.|||++ +++||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 55699999999999998854321 111223578999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhC-CCCCCCCCCCCCcceeeccc
Q 018744 186 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 186 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~ 264 (351)
||+|||++................+++.|+|||.+.+..++.++|||||||++|+|+|| ..||.+...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----------- 241 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------- 241 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 99999999865554433334445688999999999999999999999999999999997 577754321
Q ss_pred ccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 265 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
......+.+.. ....+...+..+.+||.+||+.||++|||+.+|+++|++.+.
T Consensus 242 -----~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 242 -----EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----HHHHHHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12222222222 122333445679999999999999999999999999988765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=336.80 Aligned_cols=273 Identities=24% Similarity=0.316 Sum_probs=202.5
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHH--HHHHhccCCCcceeeeEEEEcCC-----eEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME--VELLGRLRSPYLLALLGYCSDRR-----KLL 113 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e--~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 113 (351)
++|.+.+.||+|+||.||+|++ +|+.||+|++... ..+.+..| +..+..++||||+++++++.+.+ .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5688899999999999999997 6789999998643 23333444 44555679999999999986542 469
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCceecCCCCCcEEeCCCCcEEEe
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-----CSPPVIHRDFKSSNILLDKNFHAKVS 188 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~i~H~di~p~Nilv~~~~~v~l~ 188 (351)
||||+.+|+|.+++.. .++++..++.++.|++.||+|||.. +.++++||||||+||||+.++.+||+
T Consensus 79 v~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999999953 2588999999999999999999963 12399999999999999999999999
Q ss_pred ecccccccCCCCCCc--eecccCCCcccccccccccCC------CCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee
Q 018744 189 DFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGH------LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 260 (351)
Q Consensus 189 dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~ 260 (351)
|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||............
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 999998764433221 233467999999999987643 567899999999999999999988654432211111
Q ss_pred ecccccccchhHHHhhcCccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 261 SWALPRLTDREKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
................+..+.... .......+.+|+.+||+.||++|||+.||++.|+++..+..
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 231 -LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp -TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 000011111112222332332222 22345679999999999999999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=339.13 Aligned_cols=270 Identities=21% Similarity=0.313 Sum_probs=197.1
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC--CCChHHHHHHHHHHhccCCCcceeeeEEEEcCCe-EEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~v~~ 116 (351)
++|++++.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|++++++++||||+++++++.+... ++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 478999999986432 2335778899999999999999999999988755 58999
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
|+.++.+ .++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.++|+|||.+...
T Consensus 82 ~~~~~~~-~~~~~~-----~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 82 FLHQDLK-KFMDAS-----ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp CCSEEHH-HHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred ecCCchh-hhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence 9876544 443222 224699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceecccCCCcccccccccccCC-CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc--cccccchhHH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA--LPRLTDREKI 273 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~ 273 (351)
.... .......|++.|+|||++.... ++.++|||||||++|+|++|..||.+.+........... .+........
T Consensus 153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 4322 2334567899999999877655 578999999999999999999999754321000000000 0000000000
Q ss_pred HhhcC--ccccC--CCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 274 LEIMD--PALEG--QYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 274 ~~~~~--~~~~~--~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
....+ ..... ... .....++.+||.+||..||++|||+.|+++| .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~ 287 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQ 287 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--Hhhc
Confidence 00000 00000 000 0122468899999999999999999999998 4454
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=333.93 Aligned_cols=240 Identities=23% Similarity=0.383 Sum_probs=192.6
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCC------ChHHHHHHHHHHhccC--CCcceeeeEEEEcCC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLR--SPYLLALLGYCSDRR 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 110 (351)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999964 7899999998643221 1233567999999986 899999999998875
Q ss_pred e-EEEEEEccC-CChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-CCcEEE
Q 018744 111 K-LLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKV 187 (351)
Q Consensus 111 ~-~~v~~~~~~-~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-~~~v~l 187 (351)
. ++||+++.+ +++.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++. ++.++|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred eEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEE
Confidence 5 599999976 5666666432 4689999999999999999999999 9999999999999984 579999
Q ss_pred eecccccccCCCCCCceecccCCCcccccccccccCCC-CCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 188 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------- 215 (273)
T d1xwsa_ 153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------- 215 (273)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------
Confidence 999999764332 2345679999999999987665 6779999999999999999999964211
Q ss_pred ccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 267 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
+.. ....+...+ +.++.+||.+||..||++|||+.|+++|
T Consensus 216 ------i~~-~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ------IIR-GQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------HHH-CCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------Hhh-cccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 011112222 3468999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-47 Score=335.45 Aligned_cols=265 Identities=18% Similarity=0.289 Sum_probs=194.7
Q ss_pred cCCCcCceeeecCceEEEEEEEcCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDY 117 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~~ 117 (351)
++|++.+.||+|+||+||+|.+.+|+.||+|++... .......+.+|+.+++.++||||+++++++.+...+ +++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999989999999998643 233357788999999999999999999999877554 77777
Q ss_pred ccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeecccccccC
Q 018744 118 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 197 (351)
Q Consensus 118 ~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~~ 197 (351)
+.++.+..+.. ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||.+....
T Consensus 82 ~~~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 82 LDQDLKKLLDV-------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp CSEEHHHHHHT-------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred ehhhhHHHHHh-------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 77665555542 235799999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc--ccccchhHHH
Q 018744 198 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL--PRLTDREKIL 274 (351)
Q Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 274 (351)
... .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.............. +.........
T Consensus 152 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 152 IPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 432 223345688899999998754 56899999999999999999999997543210000000000 0000000000
Q ss_pred hh---------cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 275 EI---------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 275 ~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.. ................+.+||.+||..||++|||+.|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000001111223468899999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=335.04 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=193.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cC-CcEEEEEEcccc--CCCChHHHHHHHHHHhcc---CCCcceeeeEEEEcC---
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SN-GRKVAIKLMDQA--GKQGEDEFKMEVELLGRL---RSPYLLALLGYCSDR--- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~-~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~--- 109 (351)
.++|++++.||+|+||.||+|++ .+ ++.||+|++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999996 34 567899998643 222334456677777665 799999999988531
Q ss_pred ---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEE
Q 018744 110 ---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 186 (351)
Q Consensus 110 ---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~ 186 (351)
..+++++++.++.+...... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cCceEEEEEEeccCCchhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence 34589999988766544422 224689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee------
Q 018744 187 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV------ 260 (351)
Q Consensus 187 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~------ 260 (351)
|+|||++..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..........
T Consensus 157 l~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 157 LADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp ECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 999999875322 22334577999999999999999999999999999999999999999765421100000
Q ss_pred ----ecccccccchhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 261 ----SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 261 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.|............. ................+.+||.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Cchhcccccccchhhhhcc-ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000000 00000001111223468899999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=325.32 Aligned_cols=273 Identities=21% Similarity=0.260 Sum_probs=197.3
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEcccc--CCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|++++.||+|+||+||+|++ .+|+.||||++... .......+.+|+++|+.++|||++++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999996 47899999998543 233446788999999999999999999987542
Q ss_pred --CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEE
Q 018744 110 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 187 (351)
Q Consensus 110 --~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l 187 (351)
..+++|+++.++.+..... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CceEEEEEeccCCCccchhhh-------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence 3468999998876665542 234688999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCCc--eecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc
Q 018744 188 SDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 264 (351)
Q Consensus 188 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 264 (351)
+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..............
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999997654332211 22335689999999998765 68999999999999999999999997543211000000000
Q ss_pred ccc-------cchhHHHhhcCccccCCCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 265 PRL-------TDREKILEIMDPALEGQYSMK-------EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 265 ~~~-------~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
... ..................... ....+.+||.+||..||++|||+.|+++| .+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H--pff~~ 310 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWS 310 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC--hhhcc
Confidence 000 000000000000001111111 12367889999999999999999999998 56653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=331.63 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=191.0
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCC------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 110 (351)
.++|++++.||+|+||+||+|.+. +|+.||+|++..... ...+.+.+|+++|+.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999964 699999999964322 22356788999999999999999999997543
Q ss_pred -eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 111 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 111 -~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
.++||+|+ +.+|..++.. ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.++++|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 47999998 5567666532 3699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccc----
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL---- 264 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---- 264 (351)
||++....... ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+............
T Consensus 165 fg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 165 FGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 99998754432 456789999999998764 56899999999999999999999997653211000000000
Q ss_pred ------ccccchhHHHhhcCcccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 265 ------PRLTDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 265 ------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
.................. ..........+.+||.+||..||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000100000 01111223467899999999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=328.56 Aligned_cols=267 Identities=19% Similarity=0.261 Sum_probs=196.2
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccC-CCChHHHHHHHHHHhccCCCcceeeeEEEEcC-----CeE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RKL 112 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 112 (351)
..+|++++.||+|+||+||+|.+ .+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999995 579999999986432 22345678899999999999999999998654 236
Q ss_pred EEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccc
Q 018744 113 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 192 (351)
Q Consensus 113 ~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~ 192 (351)
++++++.+++|.+++.. ..+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 87 ~l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 77788889999999843 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceecccCCCcccccccccc-cCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccc-
Q 018744 193 AKIGSDKAGG-HVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD- 269 (351)
Q Consensus 193 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~- 269 (351)
+......... .......|++.|+|||++. +..++.++||||+||++|+|++|..||.....................
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 9765443221 1234466899999999985 456789999999999999999999999754421000000000000000
Q ss_pred -------hhHHHhhcCccccCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 270 -------REKILEIMDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 270 -------~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
................+. ....++.+|+.+||..||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000011111 112368899999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=327.67 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=189.8
Q ss_pred CCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeEEEEcC-------CeEE
Q 018744 42 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RKLL 113 (351)
Q Consensus 42 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~~~~ 113 (351)
+|+..+.||+|+||+||+|++. +|+.||+|++...... +.+|+++|+.++|+||+++++++... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999964 6899999998654332 23599999999999999999988432 1358
Q ss_pred EEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccc
Q 018744 114 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGL 192 (351)
Q Consensus 114 v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~ 192 (351)
||||+.++.+..+.... .....+++..++.++.||+.||+|||++ |++||||||+|||++.++ .+||+|||+
T Consensus 97 v~Ey~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEECCSEEHHHHHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEeccCCccHHHHHhhh----hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 99999876433333211 1234799999999999999999999999 999999999999998765 899999999
Q ss_pred ccccCCCCCCceecccCCCccccccccccc-CCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccccccchh
Q 018744 193 AKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 271 (351)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 271 (351)
+....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.................. ....
T Consensus 170 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~-~~~~ 245 (350)
T d1q5ka_ 170 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTRE 245 (350)
T ss_dssp CEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCHH
T ss_pred hhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC-ChHH
Confidence 98654322 2344678999999998775 57899999999999999999999999754321100000000000 0000
Q ss_pred HHHhhcCc----c--------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 272 KILEIMDP----A--------LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 272 ~~~~~~~~----~--------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
........ . .........+.++.+||.+||..||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 0 0001111234468999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-44 Score=320.78 Aligned_cols=258 Identities=17% Similarity=0.276 Sum_probs=194.8
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC---CeEEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLVY 115 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~---~~~~v~ 115 (351)
++|++++.||+|+||+||+|++ .+|+.||+|++.. ...+.+.+|+.+|+.++ ||||+++++++... ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999996 4789999999853 34577889999999995 99999999998743 356999
Q ss_pred EEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCC-cEEEeeccccc
Q 018744 116 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAK 194 (351)
Q Consensus 116 ~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~-~v~l~dfg~~~ 194 (351)
+|+.+++|.... ..+++..+..++.||+.||.|||++ |++||||||+|||++.++ .++|+|||++.
T Consensus 112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 999999987765 3689999999999999999999999 999999999999998654 69999999998
Q ss_pred ccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecc-c--------
Q 018744 195 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA-L-------- 264 (351)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~-------- 264 (351)
...... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||............... .
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 654432 23456688999999998765 5799999999999999999999999654321000000000 0
Q ss_pred ---ccccchhHHHhhcCc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 018744 265 ---PRLTDREKILEIMDP--------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 317 (351)
Q Consensus 265 ---~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~ 317 (351)
............... ............++.+||.+||..||++|||++|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00001111223468899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=318.46 Aligned_cols=269 Identities=20% Similarity=0.242 Sum_probs=198.8
Q ss_pred cCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcCCeE-EEEE
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYD 116 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~v~~ 116 (351)
++|++++.||+|+||+||+|++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+...+ ++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 788999999864332 3346788999999999999999999999887665 8888
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeeccccccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 196 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~~ 196 (351)
++.++++..++.. ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.++|+|||.+...
T Consensus 82 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 82 FCDQDLKKYFDSC-------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSEEHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecccccccccccc-------ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcc
Confidence 9888887777632 34788999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceecccCCCcccccccccccCC-CCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc-eeeccccc--ccchhH
Q 018744 197 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPR--LTDREK 272 (351)
Q Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~~~--~~~~~~ 272 (351)
.... .......++..|.|||.+.+.. ++.++|||||||++|+|++|..||.......... ........ ......
T Consensus 152 ~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 4433 2223345677899999887654 6899999999999999999999974322110000 00000000 000000
Q ss_pred HHhhcC---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 018744 273 ILEIMD---------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 323 (351)
Q Consensus 273 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~ 323 (351)
.....+ ..............+.+||.+||+.||++|||++|+++| .+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H--p~f~ 287 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFS 287 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--hhhc
Confidence 000000 000001112223468899999999999999999999987 4444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-44 Score=316.92 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=195.0
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcceeeeE-EEEcCCe-EEEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRK-LLVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~v~~ 116 (351)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..... ...+..|+++++.++|++++..+. +..+... ++||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 36799999999999999999996 4688999998764332 345778999999998776655554 4455444 47888
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC---CCcEEEeecccc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLA 193 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~---~~~v~l~dfg~~ 193 (351)
++ ++++...+... ...+++..+..++.|++.||+|||++ +++||||||+||+++. +..++|+|||++
T Consensus 84 ~~-~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred Ec-CCchhhhhhhc------cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 77 45666655332 24689999999999999999999999 9999999999999853 557999999999
Q ss_pred cccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 194 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 194 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~----- 228 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----- 228 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-----
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-----
Confidence 8765433221 223457999999999999999999999999999999999999999764432111110000
Q ss_pred chhHHHhhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 018744 269 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 325 (351)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~ 325 (351)
.........+.+... .+.++.+||..||+.+|++||++.++.+.|+.++...
T Consensus 229 -~~~~~~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 229 -SEKKMSTPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -HHHHHHSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -hcccCCCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000000000011112 2346899999999999999999999999998887643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-44 Score=314.68 Aligned_cols=261 Identities=19% Similarity=0.234 Sum_probs=203.7
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCCCChHHHHHHHHHHhccCC-CcceeeeEEEEcCCeE-EEEE
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDRRKL-LVYD 116 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~-~v~~ 116 (351)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+|++.+..++| +|++.+++++...... +||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 478999999999999999999965 68899999885432 23456778999999975 8999999988777554 7777
Q ss_pred EccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCC-----CCcEEEeecc
Q 018744 117 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFG 191 (351)
Q Consensus 117 ~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~-----~~~v~l~dfg 191 (351)
++ +++|.+++.... ..++...+..++.|++.||.|||++ |++||||||+||+++. ++.++|+|||
T Consensus 82 ~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence 77 689988885433 3689999999999999999999999 9999999999999964 5789999999
Q ss_pred cccccCCCCCCc-----eecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccc
Q 018744 192 LAKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 266 (351)
Q Consensus 192 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 266 (351)
++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~------ 225 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ 225 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH------
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH------
Confidence 998765432221 123456999999999999999999999999999999999999999765432111000
Q ss_pred ccchhHHHhh----cCccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 267 LTDREKILEI----MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 267 ~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
..+... ....+...+ +.++.+++..|++.+|++||++..+.+.|+++++...
T Consensus 226 ----~~i~~~~~~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 226 ----ERIGEKKQSTPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp ----HHHHHHHHHSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHHhccCCCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 000000 000111122 3468999999999999999999999999999887654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=328.81 Aligned_cols=267 Identities=21% Similarity=0.240 Sum_probs=191.5
Q ss_pred hcCCCcCceeeecCceEEEEEEEc-CCcEEEEEEccccCC--CChHHHHHHHHHHhccCCCcceeeeEEEEcC-------
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 109 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 109 (351)
.++|++++.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999965 699999999864322 2234678899999999999999999998532
Q ss_pred CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEee
Q 018744 110 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 189 (351)
Q Consensus 110 ~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~d 189 (351)
..++||||+.++.+.... ..+++..++.++.||+.||.|||++ |++|+||||+|||++.++.++++|
T Consensus 96 ~~~iv~Ey~~~~l~~~~~----------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp EEEEEEECCSEEHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred eeEEEEeccchHHHHhhh----------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeec
Confidence 446999999776554443 3588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCccee---------
Q 018744 190 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV--------- 260 (351)
Q Consensus 190 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~--------- 260 (351)
||++...... .......+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+........
T Consensus 163 f~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 163 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 9988764432 2334566899999999999999999999999999999999999999754321100000
Q ss_pred -ecccccc-----------cchhHHHhhcCccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 018744 261 -SWALPRL-----------TDREKILEIMDPALEGQ---YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 324 (351)
Q Consensus 261 -~~~~~~~-----------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~ 324 (351)
.+..... ................. .......++.+||.+||..||++|||++|+++| .+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H--pw~~~ 316 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH--PYINV 316 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS--TTTGG
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCC
Confidence 0000000 00000011111111111 112345688999999999999999999999988 55553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=325.44 Aligned_cols=269 Identities=21% Similarity=0.300 Sum_probs=197.5
Q ss_pred hcCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCC--ChHHHHHHHHHHhccCCCcceeeeEEEEc------CC
Q 018744 40 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSD------RR 110 (351)
Q Consensus 40 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 110 (351)
.++|++.+.||+|+||+||+|++ .+|+.||+|++...... ....+.+|+.+|+.++|||++++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999996 47999999999744322 23567889999999999999999999853 23
Q ss_pred eEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 111 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 111 ~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
.+++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++ |++||||||+||+++.++.++++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 4688899999999998832 3699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccC-CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeecccc----
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP---- 265 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~---- 265 (351)
|.+..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.............
T Consensus 166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99875432 23446688899999987765 468899999999999999999999975432100000000000
Q ss_pred ---cccchhHHHhhcCcccc-CCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 018744 266 ---RLTDREKILEIMDPALE-GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 326 (351)
Q Consensus 266 ---~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~eil~~l~~~~~~~~ 326 (351)
................. .... ......+.+||.+||..||++|||+.|+++| .++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~~~ 308 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYH 308 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTC
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCCCC
Confidence 00000000000000000 0000 0123468899999999999999999999997 5665443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=320.16 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=197.9
Q ss_pred cCCCcCceeeecCceEEEEEEEc----CCcEEEEEEcccc----CCCChHHHHHHHHHHhccCC-CcceeeeEEEEcCCe
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQA----GKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDRRK 111 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~~vk~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 111 (351)
++|++.+.||+|+||.||+|+.. +|+.||+|++... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999842 4789999998632 22345667789999999976 899999999987654
Q ss_pred -EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCcEEEeec
Q 018744 112 -LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 190 (351)
Q Consensus 112 -~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~v~l~df 190 (351)
+++++|+.+|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeec
Confidence 5999999999999998543 3678899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccCCCcccccccccccC--CCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcceeeccccccc
Q 018744 191 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 268 (351)
Q Consensus 191 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 268 (351)
|++....... ........|++.|+|||.+.+. .++.++|||||||++|+|++|..||........
T Consensus 174 G~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~------------ 240 (322)
T d1vzoa_ 174 GLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS------------ 240 (322)
T ss_dssp SEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC------------
T ss_pred cchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence 9997653322 1223346689999999998754 467899999999999999999999976553211
Q ss_pred chhHHH-hhcCccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 018744 269 DREKIL-EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 317 (351)
Q Consensus 269 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----t~~eil~~ 317 (351)
...+. ..... ....+...+..+.+||.+||..||++|| |++|+++|
T Consensus 241 -~~~i~~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 241 -QAEISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -HHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -HHHHHHhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11111 11111 1122233455799999999999999999 47899876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-39 Score=291.40 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=186.5
Q ss_pred cCCCcCceeeecCceEEEEEEE-cCCcEEEEEEccccCCCChHHHHHHHHHHhccC-----------CCcceeeeEEEEc
Q 018744 41 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----------SPYLLALLGYCSD 108 (351)
Q Consensus 41 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 108 (351)
++|++++.||+|+||+||+|++ .+|+.||||++... ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999996 47899999998643 223456777888888775 5789999988754
Q ss_pred C---CeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCceecCCCCCcEEeCCCC-
Q 018744 109 R---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNF- 183 (351)
Q Consensus 109 ~---~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~di~p~Nilv~~~~- 183 (351)
. ..++++.+...+......... .....+++..++.++.||+.||.|||+ . +++||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH----TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred ccccceeeeeeeccccccccccccc----ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 3 234666665544332222111 223478899999999999999999998 6 999999999999997654
Q ss_pred -----cEEEeecccccccCCCCCCceecccCCCcccccccccccCCCCCccceeehHHHHHHHHhCCCCCCCCCCCCCcc
Q 018744 184 -----HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 258 (351)
Q Consensus 184 -----~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~ 258 (351)
.++++|||.+...... .....|++.|+|||++.+..++.++||||+||++++|++|..||..........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 3999999998754332 245668999999999999999999999999999999999999997543321110
Q ss_pred ee------ecccccccchhHH------HhhcC------c-------------cccCCCCHHHHHHHHHHHHhccCCCCCC
Q 018744 259 LV------SWALPRLTDREKI------LEIMD------P-------------ALEGQYSMKEVIQVAAIAAMCVQPEADY 307 (351)
Q Consensus 259 ~~------~~~~~~~~~~~~~------~~~~~------~-------------~~~~~~~~~~~~~l~~li~~~l~~~P~~ 307 (351)
.. ........ .... ....+ . .............+.+||.+||..||.+
T Consensus 240 ~~~~~~~~~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELP-SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp HHHHHHHHHHHHCSCC-HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred hhHHHHHHHHHhCCCC-HHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 00 00000000 0000 00000 0 0011234566778999999999999999
Q ss_pred CCCHHHHHHH
Q 018744 308 RPLMADVVQS 317 (351)
Q Consensus 308 Rpt~~eil~~ 317 (351)
|||++|+|+|
T Consensus 319 Rpta~e~L~H 328 (362)
T d1q8ya_ 319 RADAGGLVNH 328 (362)
T ss_dssp CBCHHHHHTC
T ss_pred CcCHHHHhcC
Confidence 9999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.1e-23 Score=168.63 Aligned_cols=165 Identities=11% Similarity=0.093 Sum_probs=119.1
Q ss_pred CCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCC-------------C-----hHHHHHHHHHHhccCCCcceeeeE
Q 018744 43 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-------------G-----EDEFKMEVELLGRLRSPYLLALLG 104 (351)
Q Consensus 43 y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~-------------~-----~~~~~~e~~~l~~l~h~~i~~~~~ 104 (351)
+.+.+.||+|+||.||+|.+.+|+.||+|++...... . ...+..|+..+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4567899999999999999888999999987532110 0 122345788888999999888775
Q ss_pred EEEcCCeEEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCceecCCCCCcEEeCCCCc
Q 018744 105 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 184 (351)
Q Consensus 105 ~~~~~~~~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~di~p~Nilv~~~~~ 184 (351)
+. ..+++|+++.+..+..+ +...+..++.|++++|.+||++ +++|+||||+|||++++ .
T Consensus 82 ~~---~~~lvme~~~~~~~~~l--------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 82 WE---GNAVLMELIDAKELYRV--------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp EE---TTEEEEECCCCEEGGGC--------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred ec---CCEEEEEeeccccccch--------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence 53 34799999988654432 2334567899999999999999 99999999999999865 5
Q ss_pred EEEeecccccccCCCCCCceecccCCCccccccc-----ccccCCCCCccceeehHHHH
Q 018744 185 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-----YALTGHLTTKSDVYSYGVVL 238 (351)
Q Consensus 185 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~s~~~DiwslG~~l 238 (351)
++|+|||.+.....+... .|.... .+....|+.++|+||+.--+
T Consensus 141 ~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 899999998764432210 111110 01235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=4.2e-08 Score=82.45 Aligned_cols=148 Identities=15% Similarity=0.089 Sum_probs=102.9
Q ss_pred HHHHHHhcCCCcCceeeecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC-CCcceeeeEEEEcC-Ce
Q 018744 34 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RK 111 (351)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~ 111 (351)
.++..-.+.|++++..+.++.+.||+... +++.+++|+...........+..|...+..+. +-.+.+++.+..+. ..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45667778898888766666688998764 55678888876554444555677888887764 33456777776554 45
Q ss_pred EEEEEEccCCChhhhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---------------------------
Q 018744 112 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS--------------------------- 164 (351)
Q Consensus 112 ~~v~~~~~~~~L~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--------------------------- 164 (351)
++||++++|.++....... .....++.++++.++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEEEeccccccccccccc------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 7999999998876654211 1123355666777777775420
Q ss_pred -----------------------------CCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 165 -----------------------------PPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 165 -----------------------------~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999887666799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=1.5e-05 Score=65.98 Aligned_cols=128 Identities=19% Similarity=0.107 Sum_probs=83.1
Q ss_pred eeecC-ceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCC--CcceeeeEEEEcC-CeEEEEEEccCCChh
Q 018744 49 VGHGG-FGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDR-RKLLVYDYMANGGLQ 124 (351)
Q Consensus 49 lg~G~-~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~-~~~~v~~~~~~~~L~ 124 (351)
+..|. .+.||+....++..+++|...... ...+..|+..++.+.. -.+.+++.+..+. ..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 367899988778889999765432 3345667777776642 3356677766655 456999999887654
Q ss_pred hhccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 018744 125 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----------------------------------------- 163 (351)
Q Consensus 125 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 163 (351)
... ... ...+.++...|+.||...
T Consensus 95 ~~~------------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 95 SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccc------------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 422 111 122334555555555421
Q ss_pred --------------CCCceecCCCCCcEEeCCCCcEEEeeccccc
Q 018744 164 --------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 194 (351)
Q Consensus 164 --------------~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~ 194 (351)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0137999999999999887667799998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.84 E-value=5.5e-05 Score=66.85 Aligned_cols=77 Identities=16% Similarity=0.170 Sum_probs=49.0
Q ss_pred CceeeecCceEEEEEEEc-CCcEEEEEEccc----c---CCCChHHHHHHHHHHhccC-C-C-cceeeeEEEEcCCeEEE
Q 018744 46 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ----A---GKQGEDEFKMEVELLGRLR-S-P-YLLALLGYCSDRRKLLV 114 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~-~~~~~~vk~~~~----~---~~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~v 114 (351)
.+.||.|....||++... +++.+++|.-.. . -....++...|++.|+.+. + | .+++++. +..+..+++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-~d~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-SDTEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-EETTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-EcCCCCEEE
Confidence 446899999999999854 467889885321 1 1223455667888888763 2 3 3444444 445566899
Q ss_pred EEEccCCCh
Q 018744 115 YDYMANGGL 123 (351)
Q Consensus 115 ~~~~~~~~L 123 (351)
|+++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.00078 Score=57.53 Aligned_cols=166 Identities=13% Similarity=0.071 Sum_probs=87.2
Q ss_pred CceeeeHHHHHHHhcCC--CcC-ceeeec-CceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc--e
Q 018744 27 GLQVFTFKQLHSATGGF--SKS-NVVGHG-GFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL--L 100 (351)
Q Consensus 27 ~~~~~~~~~~~~~~~~y--~~~-~~lg~G-~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~ 100 (351)
++...+.+.+..+.+.+ ... +.+.=+ .-..||++...+|+.+|+|+.... ..+...+..|...+..+...++ +
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~ 82 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVA 82 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCC
Confidence 34555566665554433 222 222222 336899999889999999997543 3456777888888877742221 1
Q ss_pred eeeE------EEEcCCeEEEEEEccCCChhhh--------------ccccCC--CCCCCCCCCH----------------
Q 018744 101 ALLG------YCSDRRKLLVYDYMANGGLQEH--------------LYPANG--SNSVASKLDW---------------- 142 (351)
Q Consensus 101 ~~~~------~~~~~~~~~v~~~~~~~~L~~~--------------~~~~~~--~~~~~~~l~~---------------- 142 (351)
..+. +...+..+.++++..|..+... ++.... .......++.
T Consensus 83 ~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~ 162 (325)
T d1zyla1 83 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 162 (325)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred CceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCc
Confidence 1111 1223344578888776443211 011000 0000111111
Q ss_pred ------HHHHHHHHHHHHHHHHHH-cCCCCCceecCCCCCcEEeCCCCcEEEeecccccc
Q 018744 143 ------ETRLRIALEAAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 195 (351)
Q Consensus 143 ------~~~~~i~~qi~~~l~~LH-~~~~~~i~H~di~p~Nilv~~~~~v~l~dfg~~~~ 195 (351)
......+.++...+..+- .....+++|+|+.+.||+++++ ..++||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 163 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 122223333333333321 1113479999999999999754 45799987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.20 E-value=0.00074 Score=59.36 Aligned_cols=73 Identities=19% Similarity=0.199 Sum_probs=49.1
Q ss_pred CceeeecCceEEEEEEEcC--------CcEEEEEEccccCCCChHHHHHHHHHHhccCCCcc-eeeeEEEEcCCeEEEEE
Q 018744 46 SNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYD 116 (351)
Q Consensus 46 ~~~lg~G~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~v~~ 116 (351)
++.|+.|-.-.+|++..++ .+.+++++... ........+|..+++.+.-.++ .++++++. ...|++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---~g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS---GGRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---TEEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---CceEEE
Confidence 4568888899999998543 35678887752 2334455678888888853333 56666654 367888
Q ss_pred EccCCCh
Q 018744 117 YMANGGL 123 (351)
Q Consensus 117 ~~~~~~L 123 (351)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 8887554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.06 E-value=0.0053 Score=51.72 Aligned_cols=62 Identities=10% Similarity=0.147 Sum_probs=39.6
Q ss_pred eeHHHHHHHhcCCCcCceee-----ecCceEEEEEEEcCCcEEEEEEccccCCCChHHHHHHHHHHhccC
Q 018744 31 FTFKQLHSATGGFSKSNVVG-----HGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR 95 (351)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~ 95 (351)
.+.+++.....+|-+.+... .|---+.|+....+| .+++|++... .....+..+.+++..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhh
Confidence 46688888899998865544 455577899887655 5999998543 22345555666666663
|